<SEC-DOCUMENT>0000055529-23-000013.txt : 20230630
<SEC-HEADER>0000055529-23-000013.hdr.sgml : 20230630
<ACCEPTANCE-DATETIME>20230630110510
ACCESSION NUMBER:		0000055529-23-000013
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		94
CONFORMED PERIOD OF REPORT:	20230430
FILED AS OF DATE:		20230630
DATE AS OF CHANGE:		20230630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KEWAUNEE SCIENTIFIC CORP /DE/
		CENTRAL INDEX KEY:			0000055529
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY APPARATUS & FURNITURE [3821]
		IRS NUMBER:				380715562
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-05286
		FILM NUMBER:		231060205

	BUSINESS ADDRESS:	
		STREET 1:		2700 W FRONT ST
		CITY:			STATESVILLE
		STATE:			NC
		ZIP:			28677
		BUSINESS PHONE:		7048737202

	MAIL ADDRESS:	
		STREET 1:		P O BOX 1842
		CITY:			STATESVILLE
		STATE:			NC
		ZIP:			28687-1842

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KEWAUNEE SCIENTIFIC EQUIPMENT CORP /DE/
		DATE OF NAME CHANGE:	19861216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KEWAUNEE MANUFACTURING CO
		DATE OF NAME CHANGE:	19680108
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>kequ-20230430.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:e58e8ac3-ecd1-406b-a8f1-c5aecee1e3ad,g:fefb243f-2e84-4dac-80b6-e3a13121b6c2,d:1de8d1053c4044f7aa1eb1bfb086781f--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:kequ="http://www.kewaunee.com/20230430" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>kequ-20230430</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-31">false</ix:nonNumeric><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:DocumentFiscalYearFocus" id="f-32">2023</ix:nonNumeric><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:DocumentFiscalPeriodFocus" id="f-33">FY</ix:nonNumeric><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityCentralIndexKey" id="f-34">0000055529</ix:nonNumeric><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-769">http://fasb.org/us-gaap/2022#PensionExpense</ix:nonNumeric><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-770">http://fasb.org/us-gaap/2022#PensionExpense</ix:nonNumeric><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" id="f-771">http://fasb.org/us-gaap/2022#PensionExpense</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="kequ-20230430.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58b08545b7074cb3a201d2e0553c4643_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ieed3ef2aaf314496a20674e2d53f2bb0_I20230626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib43bd0d59c2a4929843b0a5e1ef18ece_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18873af196c74589a636521ad47359ea_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33b2837f1a254ad8887f32c8e8b57bd2_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d828b49d10a4704808daece2df60079_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72d2e48957c54d558de63a0798e40ea8_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia08ef11dead048c8b9c14a66f2f30b19_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i915042cddaaf43d0b7ae1684758c4070_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id640e7a42f774176b13620cd072a3127_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cbc0049851e457db78badf31b1e8567_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53f6e6d09b0c4d3bb0bc3f7cca2b19b7_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c9f52a76719413ca2b86f14caf73d43_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98d4566e618a454691c20203db06f3e1_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic873590b7746431d91d9e534c1f4f8ef_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6cb154cb71b4be8aeb4451ec6960761_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47eb375d52294ca48f7e189e4064efc2_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ca2ebd535504440b59023a1e53f9d80_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39375c07149c4105a5bb96993a610b54_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id90398c44c124e6fb0320813aaf37e69_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81381b39a97b4ea58fac780296922591_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i936dc2381cd44b90a8a4da43b0dc2458_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69f3a0aef45846feb5cfcd30de4b3a46_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if150932ec89044d5a2fe26428a616330_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic49c2c59bb514ba9a98eea71a4532d83_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d7a5379c3946afbbfd4db4209a9259_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffed0786ff994d8b887d069e8f55bdc6_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d12676382c14aefb358f5cf0f5ca1e0_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeLabwayAsiaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="idb5014da29064620a8625170da6db109_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeScientificCorporationSingaporeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i035c81617bd64b739231dde89d9e390b_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeLabwayIndiaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42a4784036154c0598d9e7d078cc620b_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KoncepoScientechInternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96f00904ca244286a10a749a0fce2507_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KequipGlobalLabSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationSingaporeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief738c90b80a46dcae563091eb90527b_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a204790b1a14821b1916e1824956a58_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90242fcce5d84297ba58ac37f58d01eb_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2c67af89acc4cceb16bae291f0b924f_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e8f56e78063401992e2639148b52a7c_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1e6cacd2bfe41289beb4377632e046c_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57303180faa04cc888c13c4f5bcf55a0_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb6a852f1dc64a4c8ae4e54a59cf843c_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dd046eeca6c43a49013acada8280e5c_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadc7ed37eabf46289e1b3ede5bfd6780_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b6a962e78384b8cbbb043ce06b35ea2_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e8b0570b6534fad8da8843f53a91fcb_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83a554db45cd44afb12954d7dbcb3262_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3defb6f321ab4a0ba12e8290a4c594fa_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadd284a39a98417ea0c4e5f5d3eed853_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie12e2507d8404c55843b1ee785732570_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1252e42ba8f94788b9c2e9526358c016_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31ecee99cb564fb4853c3bcd51ee186d_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6b14126cfd04589a48a1267cb447516_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18837955ad44418ebb8430792c895f28_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86c6fb5e15db485f849df283bb68dec9_D20211222-20211222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-22</xbrli:startDate><xbrli:endDate>2021-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbabd4cac86145e9800da3c3c2fc57ed_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3433d8e1e195426ea3058452dac64693_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba363eb7d56e476996da5c8c0716bbf4_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia33e90d485ca4a4fbfa0aaa236176d1d_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i234054f8708d43f4811f8f93244fe91c_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i251e9520bea74e6991781ef0e97f7a97_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24354820914d4aee9f7707f52e56f2ff_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99d113f3a4a845649deeb8980f67ebc1_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1a86d35001449868ca80f5a24ebfdbd_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0adeca8c17f64dfeb440b21d5c2d6c40_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie91fc5afe2074e3683df40b73a01966b_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if70f929642694c0ca07d208b0d16e645_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie732b5f45f464e6ca8f0b1fb3c13d76a_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id38d9bc0dc4a4764ba3d1d2f6e881e3a_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf90038df3a74e6d8e1591581aa2c4dd_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2592da14edd14d3a9802f6465c8990d2_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="compensation_plan"><xbrli:measure>kequ:compensation_plan</xbrli:measure></xbrli:unit><xbrli:context id="i0ffefcfa990f4dd792c6f71caefc049c_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55120ad7d22e4ad3a0aff429b22a6b6b_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1396e4dd472c434789f1f0126457631e_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e80065eb8da4baab97a3125ae4f02ba_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67f1ba03114040909ce8cdfc2a78ea6d_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6751dceadb374681b0c6d52cd75ece45_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a8537ecb2f1436aaeb85e43dc13d546_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76d8faf2554a4789a61384dd2757d22e_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b8a41ff0b9c49e69f759968f6dd33fb_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic868b6191e614d7d9d37a313030673f7_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64432110caef45faafd30217f99ab7e5_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29c25bca73914a2e8b0740a217a19a70_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb71661af8d5440999566d760f9a4987_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4523e07e76d34e0986ee2172ffc114c8_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic72bb0d6c18f493c8331dbd53a1be173_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7066198457634c5c84c33711657d5762_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if62c92cef71f4d728c84fa5dbdb324b6_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0d0017306a14071a889803879b2857a_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i158c57bc39694f63be232317e782c90e_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12df3466c7ff493e867302751a24bada_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a02acdd018f43b8b0f5cc560820651a_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">kequ:FiscalYearTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb2d1acd7b3446289e9ad791d76db1de_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:ForeignSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4ff3442856846399487d370b1773546_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:ForeignSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a43198092b94ea889724f8b5846813b_I20130506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2013-05-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ffdef1e14f34eb8bad803398261c99d_I20191213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i442be4c6913b49a4b50ea772baaab2d6_I20200201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b182470888b4bfbbed867265f9c5935_I20220627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ae780b25bd64b349ff3f0cdb52c391c_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:AdvanceAmountOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e3cd898d91a4be8995d0dc84050feba_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:AdvanceAmountTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1cc410519c54218bd0491e4a36cd2ea_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:AdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8817c527703e49429894104cdd1d7ecc_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id54523868cb9492da803a3fdb87635d5_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i546d1702d5294252997efbcc4760c0d2_I20221219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77d740aedb144bb0ad536168beb98a3c_D20221219-20221219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">kequ:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-19</xbrli:startDate><xbrli:endDate>2022-12-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68739a09bcb74732ad67255efa20ec71_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc3c4ae466f84e8aa27fac57a2ef3a4a_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:InternationalSubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee2c5a57bb34a47b58f57f8e3d1c42d_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e58a0cf3d454dedbd6523de24bb050f_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18991e1526b14ffd876d57c01cbb0bde_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7d1f7a7276349cca788e17cd7c0ef20_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i040d62d3dd79442993ccc580b1141db5_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3242c4e7dfc44caa5252683fd462cbc_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07a66023f9b1454788d7c1753ac27d49_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2bdb86fad2b464f9159d4e51f919a4b_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e3b5ea3288d445dbfb4e15eb2d7eff1_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ff7bf3b6ef494bb98b7aeeb082d754_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">kequ:BankGuaranteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="renewaloption"><xbrli:measure>kequ:renewalOption</xbrli:measure></xbrli:unit><xbrli:context id="i63ec6c47db8041f29ab17eb138d30e46_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b416d20e6c41dca68290de29b3950c_D20200327-20200327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-27</xbrli:startDate><xbrli:endDate>2020-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia09ed2386bef4571af63546d7275fed5_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfFinanceIndiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76e58b3cdbee43328d425bf866be46cb_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfFinanceIndiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4fc91d4336742bca6f7d1456d6b6290_D20171222-20171222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-22</xbrli:startDate><xbrli:endDate>2017-12-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia90c11936dba4904a9531ab5d52fbbd5_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id553a2e4e4c34c41aad075cfe7d7e942_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTenAndTwoThousandEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0df14ac1694242918bf120280e13b5e4_I20170830"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id145fd41da7a42d8bf28d16bf42e6e73_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i856a73272e2d43a39d425e3dec7e46cd_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0f4be86b27e4b73ba9843141170627d_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3d01a1650ac43cca9d9a27d1d799fb8_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kequ:RestrictedStockUnitsRSUsServiceComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63348bc16c724f1f8d2b204017cbb09b_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kequ:RestrictedStockUnitsRSUsServiceComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f51b34728494fe387a9da7cbaaecf7f_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idadad6c5f93d416caf379a3ec3da9055_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if60aac1ba48e4bd790f9b0fafdf6e109_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81ebd11ae8384005a4122c79a54d0388_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7bce12c1c32423e8650a7aa2cca14a6_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ca44f1ca15a49c686f4c491a93f8591_D20150826-20150826"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-08-26</xbrli:startDate><xbrli:endDate>2015-08-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93b7e975c5f64cc6b08cfc1e4e83c167_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabe50ea0d70a4c4395aa06274568ff1c_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0587fe00cae74bec97d95dac2c6e3805_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58cc8871d7854cf58997cb98992e51f7_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i375a69d8f72741c3b852a98fd7b2e36d_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4fb45c9d24746b3a2e1197cf86d9d3a_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09cf305d1de04959b7bda23aa95706a3_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iceca130826c3475f9ab063adc1f5f5cb_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i302d0d54469e442197359aabf6bc4272_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ccfacb4e2c84a068c3ca01af64454f4_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i474fdf01402c4320988de23ca2856814_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6ebb0ed884a4d85b16577907b09659a_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i169a6334517a4b19877902820dba5e96_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">kequ:YieldCurveTechniqueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5dbb92c8fb44dc2ba4e9a4183b0e326_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">kequ:YieldCurveTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb15b53ace4d4cc89a084c541d351ce9_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">kequ:YieldCurveTechniqueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i472a2c8c23a648a2a20e3abd4d4c0d6c_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id18cf987103643748c6db3d293c21a14_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c34d5d2c07b404c96ed13f48c0378f7_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2618157cd36a473eb1be555923af9434_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i461991f9a104434190673d6c11e374a4_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7564e3aaefde4cc68eb4d66be4958117_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4021b8377b114d78bbf1ef3499af7718_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bc3127d271f40c68917d5dfd4db4ba5_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i000d0b9b003247e49169b92e76d8a09a_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03d983ee673f413c90842b0da9ff9f43_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i923a5fb9c22b4ca38cc73db048a7825c_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i312a8cb23fc94a6da460c8f4222f0639_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a4fccb41c0d41d9bad0908cc0d8c23b_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cc3a1c0b4c54acd9b37831a3bb584a3_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2aaffec262844dfacd06946a041d076_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79fc58d8bcb0411fbe11a081e6d072a8_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i896cff42816940eaaee621949ddb6194_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0eb4dc2bb954fe79a558072049a1831_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7de646a2dc541ca9f756667c74e21e8_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadfc70c5513e41bb947fe21e6b0966c1_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i897db272c7af4c3197ac2a1529dc2f8a_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic212c7fd02eb41fe97da02135a2a32b5_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84d2c48142ac411eb496c07b85230a6d_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93f86e2de3e8488eb7824809bf0d34e8_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i425180d6d80c4d73ad2fa942d6d8e85f_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaba8749a1a26404e9c8bf4ea4a8c9546_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb3130ef4af74fbabeb2632567506974_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d2b508c96c041a5999e41c866d6dac5_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c69c8ad78245338093ee6b28093169_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i789bb8f7d31e4310960e2e37137bb32a_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9efb8d4ca2d493eb707565a176dce6d_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib241eb5a32fa4fea9b004f728e78a69c_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1f810c2a94b4f1aa8f0d78dbbca6e8f_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec155c938875403a9cd89d027b15e0c1_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f78266f81774c8cb5cfab7eb95904c0_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i854a8abfd519441d95b99eb28db921d7_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b825859a1f84c25a9245c562c9110c8_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab1212417875461884b453615e64caae_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08c47e380ee54dabb1754d7ccb46e86a_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7b52ce2fc2241eb9007387adf55e35a_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43427226e74849a88e0eb5b4a25adf12_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffc659a9402841f48ab3f91f0d5a48a4_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec243beb997e4e3d9e2437b00cb92051_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe6caf6ca2e04c14b416ef5a51d235c1_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icee3a5c7b5744ec2a0b78771afc9000d_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i517e6442cdb945718bfb4a5054667765_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0449597eea9b4e8bb4321131eeadb7d3_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad9200d2ce534be78d4a456fc4ef6b6c_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d0fa294085541439c1c28e09b131ee3_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ecc70cd0abb4a2dbf24582b226b6ab8_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i912b55bb462d4adcad4393d6753058e8_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1115530ba0114611bc42e50e7b6324a4_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55beed59b26e4f22a06bf6565cb3b9a4_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f2aaa221eb94ad69d94ee9d5db0943a_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>kequ:segment</xbrli:measure></xbrli:unit><xbrli:context id="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib99cbe4793c040dd859880b6ce8c5d6c_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66409b457de24b8ea9db0e15adf2f1c1_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17f99b083fb44457829907146d217534_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba68a35a7cbd4325912b37c8a42846b6_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie729b60a90844b3893420d0d57361c11_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34c4fe4e054c42a0be6b9bb2053335ca_I20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23df5675029345c288bde9f193ac67d7_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5465457d161440f8737d4f3e58f566a_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeefffc08f9c430ebb298fa36e4c30b8_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68f7a9301a3f4938978283aee47bfa00_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93a0af5a5c704ae09f78421067a08c16_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f86e115975447b7b8aae1019a860422_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d8e2f8f245e4158ba91b25300e91af8_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07eb9ad716994fadacba37a96ffddb15_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6a0995d858b40708d0b3419cfbc2624_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e3c49b7bdf74b079553da120ca298d9_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c6621adfc5456994955d1968018f4e_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc0cd04d9ec24d0e82564984d27f29ff_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e800b6ee23a4e2894c72aa7f8abe31f_D20220501-20230430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72a92bc417734dbfa6b9630d85382b62_D20210501-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">April&#160;30</ix:nonNumeric>, 2023</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from __________ to __________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityFileNumber" id="f-6">0-5286</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityRegistrantName" id="f-7">KEWAUNEE SCIENTIFIC CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:48.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityTaxIdentificationNumber" id="f-9">38-0715562</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityAddressAddressLine1" id="f-10">2700 West Front Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityAddressCityOrTown" id="f-11">Statesville</ix:nonNumeric>, <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">North Carolina</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityAddressPostalZipCode" id="f-13">28677-2927</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant's telephone number, including area code: (<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:CityAreaCode" id="f-14">704</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:LocalPhoneNumber" id="f-15">873-7202</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:31.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name&#160;of&#160;Exchange&#160;on&#160;which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:Security12bTitle" id="f-16">Common&#160;Stock&#160;$2.50&#160;par&#160;value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:TradingSymbol" id="f-17">KEQU</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">NASDAQ Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.532%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-24">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging&#160;growth&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indicate by check mark whether the registrant has filed a report on and attestation to its management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">'</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="f-26">&#9744;</ix:nonNumeric></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167; 240.10D-1(b). </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-27">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of shares of voting stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i58b08545b7074cb3a201d2e0553c4643_I20221031" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="f-28">37,907,714</ix:nonFraction> based on the last reported sale price of the registrant's Common Stock on October&#160;31, 2022, the last business day of the registrant's most recently completed second fiscal quarter. Only shares beneficially owned by directors of the registrant (excluding shares subject to options) and each person owning more than 10% of the outstanding Common Stock of the registrant were excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes. As of June&#160;26, 2023, the registrant had outstanding <ix:nonFraction unitRef="shares" contextRef="ieed3ef2aaf314496a20674e2d53f2bb0_I20230626" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-29">2,879,785</ix:nonFraction> shares of Common Stock.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-30" escape="true">DOCUMENTS INCORPORATED BY REFERENCE: Those portions of the Company's proxy statement for use in connection with Kewaunee Scientific Corporation's annual meeting of stockholders to be held on August&#160;23, 2023, indicated in this report are incorporated by reference into Part&#160;III hereof.</ix:nonNumeric></span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Table&#160;of&#160;Contents</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Page&#160;or<br/>Reference</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_10">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_13">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_16">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_16">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_19">Item 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_19">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_19">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_22">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_22">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_22">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_25">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_25">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_25">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_28">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_28">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_28">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_31">PART II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_34">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_34">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_34">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_37">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_37">Reserved.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_37">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_43">Item 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_43">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_43">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_64">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_64">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_64">15</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_67">Item 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_67">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_67">16</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_139">Item 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_139">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_139">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_142">Item 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_142">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_142">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_145">Item&#160;9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_145">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_145">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_148">Item&#160;9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_148">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_148">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_151">PART III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_154">Item 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_154">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_154">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_157">Item 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_157">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_157">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_160">Item 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_160">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_160">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_163">Item 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_163">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_163">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_166">Item 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_166">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_166">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_169">PART IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_172">Item 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_172">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_172">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_175">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_175">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_175">45</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_178">EXHIBIT&#160;INDEX</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_178">46</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_181">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_181">49</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART I</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_13"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this document constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). All statements other than statements of historical fact included in this Annual Report, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers&#8217; required delivery schedules; risks related to fluctuations in the Company&#8217;s operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_16"> Item&#160;1A</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report, which you should review carefully. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;1. Business</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kewaunee Scientific Corporation (the "Company") was founded in 1906, incorporated in Michigan in 1941, became publicly-held in 1968, and was reincorporated in Delaware in 1970. Our principal business is the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Our products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are sold primarily through purchase orders and contracts submitted by customers through our dealers, our subsidiaries in Singapore and India, and a national distributor. Products are sold principally to pharmaceutical, biotechnology, industrial, chemical and commercial research laboratories, educational institutions, healthcare institutions, governmental entities, and manufacturing facilities. We consider the markets in which we compete to be highly competitive, with a significant amount of the business involving competitive public bidding.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the laboratory and healthcare furniture industries for customer orders to require delivery at extended future dates, as products are frequently installed in buildings yet to be constructed. Changes or delays in building construction may cause delays in delivery of the orders and our recognition of the sale. Since prices are normally quoted on a firm basis in the industry, we bear the burden of possible increases in labor and material costs between quotation of an order and delivery of the product. The impact of such possible increases is considered when determining the sales price. The primary raw materials and products manufactured by others and used by us in our products are cold-rolled carbon and stainless steel, hardwood lumber and plywood, paint, chemicals, resins, hardware, plumbing and electrical fittings. Such materials and products are purchased from multiple suppliers and are typically readily available.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our need for working capital and our credit practices are comparable to those of other companies manufacturing, selling and installing similar products in similar markets. Since our products are used in building construction projects, in many cases payments for our products are received over longer periods of time than payments for many other types of manufactured products, thus requiring increased working capital. In addition, payment terms associated with certain projects provide for a retention amount until final completion of the project, thus also increasing required working capital. On average, payments for our products are received during the quarter following shipment, with the exception of the retention amounts which are collected at the final completion of the project.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold various patents and patent rights, but do not consider that our success or growth is dependent upon our patents or patent rights. Our business is not dependent upon licenses, franchises, concessions, trademarks, royalty agreements, or labor contracts.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is not generally cyclical, although domestic sales are sometimes lower during our third quarter because of slower construction activity in certain areas of the country during the winter months. Sales for two of the Company's domestic dealers and our national stocking distributor represented, in the aggregate, approximately 35% and 38% of the Company's sales in fiscal years 2023 and 2022, respectively. Loss of all or part of our sales to a large customer would have a material effect on our financial operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our order backlog at April&#160;30, 2023 was $147.9&#160;million, as compared to $173.9&#160;million at April&#160;30, 2022. Based on scheduled shipment dates and past experience, we estimate that not less than 91% of our order backlog at April&#160;30, 2023 will be shipped during fiscal year 2024. However, it may be expected that delays in shipments will occur because of customer rescheduling or delay in completion of projects which involve the installation of our products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEGMENT INFORMATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_124">Note 11</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements included in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_67">Item&#160;8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report on Form&#160;10-K for information concerning our Domestic and International business segments.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPETITION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the industries in which we participate to be highly competitive and believe that the principal deciding factors are price, product performance, and customer service. A significant portion of our business is based upon competitive public bidding.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESEARCH AND EXPERIMENTATION EXPENDITURES</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount spent and expensed by us during the fiscal year ended April&#160;30, 2023 on research and experimentation expenditures activities related to new or redesigned products was $1,012,000. The amount spent for similar purposes in the fiscal year ended April&#160;30, 2022 was $990,000.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL COMPLIANCE</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the last two fiscal years, compliance with federal, state, or local provisions enacted or adopted regulating the discharge of materials into the environment has had no material effect on us and such regulation is not expected to have a material effect on our earnings or competitive position in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CULTURE AND WORKFORCE</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a company of passionate, talented, and motivated people. We embrace collaboration and creativity, and encourage the iteration of ideas to address complex challenges in technology and society.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2023, the Company had 603 Domestic employees and 379 International employees. Our people are critical for our continued success, so we work hard to create an environment where employees can have fulfilling careers, and be happy, healthy, and productive. We offer competitive benefits and programs to take care of the diverse needs of our employees and their families, including opportunities for career growth and development, resources to support their financial health, and access to excellent healthcare choices and resources, including access to an onsite medical clinic and separate gym facility and regular access to onsite specialists. Our competitive compensation programs help us to attract and retain top candidates, and we will continue to invest in recruiting talented people to technical and non-technical roles, and rewarding them well.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that open and honest communication among team members, managers, and leaders helps create a collaborative work environment where everyone can contribute, grow, and succeed. Team members are encouraged to come to their managers with questions, feedback, or concerns, and the Company conducts surveys that gauge employee engagement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When necessary, we contract with businesses around the world to provide specialized services where we do not have appropriate in-house expertise or resources. We also contract with temporary staffing agencies when we need to cover short-term leaves, when we have spikes in business needs, or when we need to quickly incubate special projects. We choose our partners and staffing agencies carefully and continually make improvements to promote a respectful and positive working environment for everyone - employees, vendors, and temporary staff alike.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Internet address is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">www.kewaunee.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We make available, free of charge through this website, our annual report to stockholders. Our Form&#160;10-K and 10-Q financial reports may be obtained by stockholders by writing the Secretary of the </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company, Kewaunee Scientific Corporation, P.O. Box&#160;1842, Statesville, NC 28687-1842. The public may also obtain information on our reports, proxy, and information statements at the Securities and Exchange Commission ("SEC") Internet site </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The reference to our website does not constitute incorporation by reference of any information contained at that site.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE OFFICERS OF THE REGISTRANT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in Part III, </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_154">Item&#160;10(b)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors, Executive Officers and Corporate Governance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of this Annual Report on Form 10-K.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_16"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;1A. Risk Factors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the following risks before you decide to buy shares of our common stock. If any of the following risks actually occur, our business, results of operations, or financial condition would likely suffer. In such case, the trading price of our common stock would decline, and you may lose all or part of the money you paid to buy our stock.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This and other public reports may contain forward-looking statements based on current expectations, assumptions, estimates and projections about us and our industry. These forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those forward-looking statements as a result of many factors, including those more fully described below and elsewhere in our public reports. We do not undertake to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Specific to our Company</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we lose a large customer, our sales and profits would decline.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have substantial sales to three of our domestic channel partners. The combined sales to two dealers and our national stocking distributor accounted for approximately 35% of our sales in fiscal year 2023. Loss of all or a part of our sales to a large channel partner would have a material effect on our revenues and profits until an alternative channel partner could be developed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on the talents and efforts of key management and our Associates. If we are unable to retain or motivate key personnel, hire qualified personnel, or maintain and continue to adapt our corporate culture, we may not be able to grow or operate effectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance largely depends on the talents and efforts of our Associates. Our ability to compete effectively and our future success depends on our continuing to identify, hire, develop, motivate, and retain key management and highly skilled personnel for all areas of our organization. In addition, our total compensation program may not always be successful in attracting new employees and retaining and motivating our existing employees. Restrictive immigration policy and regulatory changes may also affect our ability to hire, mobilize, or retain some of our global talent.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we believe that our corporate culture fosters innovation, creativity, and teamwork. As our organization grows and evolves, we may need to implement more complex organizational management structures or adapt our corporate culture and work environments to ever-changing circumstances, such as during times of a natural disaster or pandemic, and these changes could affect our ability to compete effectively or have an adverse effect on our corporate culture. With the constant evolution of workforce dynamics, if we do not manage these changes effectively, it could materially adversely affect our culture, reputation, and operational flexibility.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to other risks that might also cause our actual results to vary materially from our forecasts, targets, or projections, including:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failing to anticipate the need for and appropriately invest in information technology and logistical resources necessary to support our business, including managing the costs associated with such resources;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failing to generate sufficient future positive operating cash flows and, if necessary, secure and maintain adequate external financing to fund our operations and any future growth; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interruptions in service by common carriers that ship goods within our distribution channels.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business and reputation are impacted by information technology system failures and network disruptions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, and our global supply chain, are exposed to information technology system failures or network disruptions caused by natural disasters, accidents, power disruptions, telecommunications failures, acts of terrorism or war, computer viruses, physical or electronic break-ins, ransomware or other cybersecurity incidents, or other events or disruptions. System redundancy and other continuity measures may be ineffective or inadequate, and our, or our vendors', business continuity and disaster recovery planning may not be sufficient for all eventualities. Such failures or disruptions can adversely impact our business by, among other things, </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preventing access to our cloud-based systems, interfering with customer transactions or impeding the manufacturing and shipping of our products. These events could materially adversely affect our business, reputation, results of operations and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future cybersecurity incidents could expose us to liability and damage our reputation and our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect, process, store, and transmit large amounts of data, and it is critical to our business strategy that our facilities and infrastructure remain secure and are perceived by the marketplace to be secure. Our information technology systems are essential to our efforts to manufacture our products, process customer sales transactions, manage inventory levels, conduct business with our suppliers and other business partners, and record, summarize and analyze the results of our operations. These systems contain, among other things, material operational, financial and administrative information related to our business. As with most companies, there will always be some risk of physical or electronic break-ins, computer viruses, or similar disruptions.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we, like all entities, are the target of cybercriminals who attempt to compromise our systems. From time to time, we experience threats and intrusions that may require remediation to protect sensitive information, including our intellectual property and personal information, and our overall business. Any physical or electronic break-in, computer virus, cybersecurity attack or other security breach or compromise of the information handled by us or our service providers may jeopardize the security or integrity of information in our computer systems and networks or those of our customers and cause significant interruptions in our and our customers' operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any systems and processes that we have developed that are designed to protect customer, associate and vendor information, and intellectual property, and to prevent data loss and other security attacks, cannot provide absolute security. In addition, we may not successfully implement remediation plans to address all potential exposures. It is possible that we may have to expend additional financial and other resources to address these problems. Failure to prevent or mitigate data loss or other security incidents could expose us or our customers, associates and vendors to a risk of loss or misuse of such information, cause customers to lose confidence in our data protection measures, damage our reputation, adversely affect our operating results or result in litigation or potential liability for us.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we expect to continue to make investments in our information technology infrastructure. The implementation of these investments may be more costly or take longer than we anticipate, or could otherwise adversely affect our business operations, which could negatively impact our financial position, results of operations or cash flows.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Internal controls over financial reporting may not be effective at preventing or detecting material misstatements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal controls over financial reporting may not prevent or detect material misstatements in the Company's consolidated financial statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales to customers outside the United States or with international operations expose us to risks inherent in international sales.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2023, 34% of our revenues were derived from sales outside of the United States. A key element of our growth strategy is to expand our worldwide customer base and our international operations. Operating in international markets requires significant resources and management attention and subjects us to regulatory, economic and political risks that are different from those in the United States. We cannot assure you that our expansion efforts into other international markets will be successful. Our experience in the United States and other international markets in which we already have a presence may not be relevant to our ability to expand in other emerging markets. Our international expansion efforts may not be successful in creating further demand for our products outside of the United States or in effectively selling our products in the international markets we enter. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to compete effectively, our revenue and profit margins could decline.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face a variety of competition in all of the markets in which we participate. Competitive pricing, including price competition or the introduction of new products, could have material adverse effects on our revenues and profit margins.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to compete effectively depends to a significant extent on the specification or approval of our products by architects, engineers, and customers. If a significant segment of those communities were to decide that the design, materials, manufacturing, testing, or quality control of our products is inferior to that of any of our competitors, our sales and profits would be materially and adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An increase in the price of raw materials could negatively affect our sales and profits.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the laboratory and healthcare furniture industries for customers to require delivery at extended future dates, as products are frequently installed in buildings yet to be constructed. Since prices are normally quoted on a firm basis in the industry, we bear the burden of possible increases in labor and material costs between the quotation of an order and the delivery of the products. Our principal raw materials are steel, including stainless steel, wood and epoxy resin. Numerous factors beyond our control, such as general economic conditions, competition, worldwide demand, labor costs, energy costs, and import duties and other trade restrictions, influence prices for our raw materials. We have not always been able, and in the future we might not be able, to increase our product prices in amounts that correspond to increases in costs of raw materials. Where we are not able to increase our prices, increases in our raw material costs will adversely affect our profitability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Events outside our control may affect our operating results.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have little control over the timing of shipping customer orders, as customers' required delivery dates are subject to change by the customer. Construction delays and customer changes to product designs are among the factors that may delay the start of manufacturing. Weather conditions, such as unseasonably warm, cold, or wet weather, can also affect and sometimes delay projects. Political and economic events can also affect our revenues. When sales do not meet our expectations, our operating results will be reduced for the relevant quarters.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal markets are in the laboratory and healthcare building construction industry. This industry is subject to significant volatility due to various factors, none of which is within our control. Declines in construction activity or demand for our products could materially and adversely affect our business and financial condition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face numerous manufacturing and supply chain risks. In addition, our reliance upon sole or limited sources of supply for certain materials, components, and services could cause production interruptions, delays and inefficiencies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase materials, components, and equipment from third parties for use in our manufacturing operations. Our results of operations could be adversely impacted if we are unable to adjust our purchases to reflect changes in customer demand and market fluctuations. Suppliers may extend lead times, limit supplies, or increase prices. If we cannot purchase sufficient products at competitive prices and of sufficient quality on a timely enough basis to meet increasing demand, we may not be able to satisfy market demand, product shipments may be delayed, our costs may increase, or we may breach out contractual commitments and incur liabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some of our businesses purchase certain required products from sole or limited source suppliers for reasons of quality assurance, regulatory requirements, cost effectiveness, availability or uniqueness of design. If these or other suppliers encounter financial, operating, or other difficulties, or if our relationship with them changes, we might not be able to quickly establish or qualify replacement sources of supply. The supply chains for our businesses were impacted in fiscal year 2023 from factors outside our control and could also be disrupted in the future for such reasons as supplier capacity constraints, supplier bankruptcy or exiting of the business for other reasons, decreased availability of key raw materials or commodities and external events such as natural disasters, pandemics or other public health problems, war, terrorist actions, governmental actions and legislative or regulatory changes. Any of these factors could result in production interruptions, delays, extended lead times and inefficiencies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues and other operating results depend in large part on our ability to manufacture our products in sufficient quantities and in a timely manner. Any interruptions we experience in the manufacture of our products or changes to the way we manufacture products could delay our ability to recognize revenues in a particular period. In addition, we must maintain sufficient production capacity in order to meet anticipated customer demand, which carries fixed costs that we may not be able to offset because we cannot always immediately adapt our production capacity and related cost structures to changing market conditions, which would adversely affect our operating margins. If we are unable to manufacture our products consistently, in sufficient quantities, and on a timely basis, our revenues, gross margins, and our other operating results will be materially and adversely affected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruptions in the financial markets have historically created, and may continue to create, uncertainty in economic conditions that may adversely affect our customers and our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial markets in the United States, Europe and Asia have in the past been, and may in the future be, volatile. The tightening of credit in financial markets, worsening of economic conditions, a prolonged global, national or regional economic recession or other similar events could have a material adverse effect on the demand for our products and on our sales, pricing and profitability. We are unable to predict the likely occurrence or duration of these adverse economic conditions and the impact these events may have on our operations and the end users who purchase our products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future growth may depend on our ability to penetrate new international markets.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International laws and regulations, construction customs, standards, techniques and methods differ from those in the United States. Significant challenges of conducting business in foreign countries include, among other factors, geopolitical tensions, local </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acceptance of our products, political instability, currency controls, changes in import and export regulations, changes in tariff and freight rates and fluctuations in foreign exchange rates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effects of geopolitical instability, including as a result of Russia's invasion of Ukraine, may adversely affect us and heighten significant risks and uncertainties for our business, with the ultimate impact dependent on future developments, which are highly uncertain and unpredictable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ongoing geopolitical instability could negatively impact the global and U.S. economies in the future, including by causing supply chain disruptions, rising energy costs, volatility in capital markets and foreign currency exchange rates, rising interest rates, and heightened cybersecurity risks. The extent to which such geopolitical instability adversely affects our business, financial condition, and results of operations, as well as our liquidity and capital profile, is highly uncertain and unpredictable. If geopolitical instability adversely affects us, it may also have the effect of heightening other risks related to our business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the military conflict between Russia and Ukraine that began in February 2022, the United States and other North Atlantic Treaty Organization member states, as well as non-member states, announced targeted economic sanctions on Russia. The long-term impact on our business resulting from the disruption of trade in the region caused by the conflict and associated sanctions and boycotts is uncertain at this time due to the fluid nature of the ongoing military conflict and response. The potential impacts include supply chain and logistics disruptions, financial impacts including volatility in foreign exchange and interest rates, increased inflationary pressure on raw materials and energy, and other risks, including an elevated risk of cybersecurity threats and the potential for further sanctions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal and Regulatory Compliance Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in U.S. trade policy, including the imposition of tariffs and the resulting consequences, may have a material adverse impact on our business and results of operations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the extent to which the U.S. or other countries will impose quotas, duties, tariffs, taxes or other similar restrictions upon the import or export of our products or raw materials in the future, nor can we predict future trade policy or the terms of any renegotiated trade agreements and their impact on our business.&#160;Changes in U.S. trade policy could result in one or more foreign governments adopting responsive trade policies making it more difficult or costly for us to import our products or raw materials from those countries. This, together with tariffs already imposed, or that may be imposed in the future, by the U.S., could require us to increase prices to our customers which may reduce demand, or, if we are unable to increase prices, result in lowering our margin on products sold. The adoption and expansion of trade restrictions, the occurrence of a trade war, or other governmental action related to tariffs or trade agreements or policies has the potential to adversely impact demand for our products, our costs, our customers, our suppliers, and the U.S. economy, which in turn could have a material adverse effect on our business, financial condition and results of operations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expectations related to environmental, social, and governance ("ESG") considerations could expose us to potential liabilities, increased costs, and reputational harm.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws, regulations, and other measures that govern a wide range of topics, including those related to matters beyond our core products and services. For instance, new laws, regulations, policies, and international accords relating to ESG matters, including sustainability, climate change, human capital, and diversity, are being developed and formalized in Europe, the U.S., and elsewhere, which may entail specific, target-driven frameworks and/or disclosure requirements. The implementation of these may require considerable investments. Any failure, or perceived failure, by us to adhere to any public statements or initiatives, comply with federal, state or international environmental social and governance laws and regulations, or meet evolving and varied stakeholder expectations and standards could result in legal and regulatory proceedings against us and could materially adversely affect the Company's business reputation, results of operations, financial condition, and stock price.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is likely to be volatile and could drop.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our Common Stock could be subject to wide fluctuations in response to quarter-to-quarter variation in operating results, announcement of technological innovations or new products by us or our competitors, general conditions in the construction and construction materials industries, relatively low trading volume in our common stock and other events or factors. In addition, in recent years, the stock market has experienced extreme price fluctuations. This volatility has had a substantial effect on the market prices of securities issued by many companies for reasons unrelated to the operating performance of those companies. Securities market fluctuations may adversely affect the market price of our common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently, and may in the future, have assets held at financial institutions that may exceed the insurance coverage offered by the Federal Deposit Insurance Corporation ("FDIC"), the loss of which would have a severe negative effect on our operations and liquidity.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may maintain our cash assets at financial institutions in the U.S. in amounts that may be in excess of the FDIC insurance limit of $250,000. Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry of the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. In the event of a failure or liquidity issues of or at any of the financial institutions where we maintain our deposits or other assets, we may incur a loss to the extent such loss exceeds the FDIC insurance limitation, which could have a material adverse effect upon our liquidity, financial condition, and our results of operations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, if our customers or partners experience liquidity issues as a result of financial institution defaults or non-performance where they hold cash assets, their ability to pay us may become impaired and could have a material adverse effect on our results of operations, including the collection of accounts receivable and cash flows.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of investor concerns on U.S. or international financial systems could impact our ability to obtain favorable financing terms in the future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on terms favorable to us, or at all, and could have material adverse impacts on our liquidity, our business, financial condition or results of operations, and our prospects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The impact of future pandemics could adversely affect our business, results of operations, financial condition, and liquidity.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe we successfully navigated the risks associated with the recent COVID-19 pandemic and were able to successfully maintain our business operations, the extent of the impact of future COVID-19 variations or other pandemics on our business and financial results is, by nature of this type of event, highly uncertain. The sweeping nature of pandemics makes it extremely difficult to predict how and to what extent our business and operations could be affected in the long run. Our workforce, and the workforce of our vendors, service providers, and counterparties, could be affected by a pandemic, which could result in an adverse impact on our ability to conduct business. No assurance can be given that the actions we take to protect our Associates and our operations will be sufficient, nor can we predict the level of disruption that could occur to our employees' ability to provide customer support and service. New processes, procedures, and controls may be required to respond to any changes in our business environment. Further, should any key employees become ill during the course of a future health event and be unable to work, our ability to operate our internal controls may be adversely impacted.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional factors related to major public health issues that could have material and adverse effects on our ability to successfully operate include, but are not limited to, the following:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effectiveness of any governmental and non-governmental organizations in combating the spread and severity, including any legal and regulatory responses;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A general decline in business activity, especially as it relates to our customers' expansion or consolidation activities;</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The destabilization of the financial markets, which could negatively impact our customer growth and access to capital, along with our customers' ability to make payments for their purchase orders; and</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Severe disruptions to and instability in the global financial markets, and deterioration in credit and financing conditions, which could affect our access to capital necessary to fund business operations or current investment and growth strategies.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_19"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1B. Unresolved Staff Comments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_22"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;2. Properties</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease and operate three adjacent manufacturing facilities in Statesville, North Carolina. These facilities also house our corporate offices, as well as sales and marketing, administration, engineering and drafting personnel. These facilities together comprise 414,000 square feet and are located on 20 acres of land. On March 24, 2022, we entered into a Sale-Leaseback Arrangement (defined below), pursuant to which we sold, and now lease, our manufacturing and office facilities in Statesville, North Carolina. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_106">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements included in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_67">Item 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report on Form 10-K for information concerning the Sale-Leaseback Arrangement. In addition, we lease our primary distribution facility and other warehouse facilities totaling 365,000 square feet in Statesville, North Carolina. We also lease an office facility in Charlotte, North Carolina. In Bangalore, India, we lease and operate a manufacturing facility comprising </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119,000 square feet. Our international sales and administrative offices are located in Singapore, India, and Saudi Arabia. We believe our facilities are suitable for their respective uses and are adequate for our current needs.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_25"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;3. Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in disputes and litigation relating to claims arising out of our operations in the ordinary course of business. Further, we are periodically subject to government audits and inspections. We believe that any such matters presently pending will not, individually or in the aggregate, have a material adverse effect on our results of operations or financial condition.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_28"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;4. Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_31"></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART II</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the NASDAQ Global Market, under the symbol KEQU. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">June&#160;26, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, there were 111 stockholders of record. The declaration and payment of&#160;any future dividends is at the discretion of the Board of Directors and will depend upon many factors, including the Company's earnings, capital requirements, investment and growth strategies, financial conditions, the terms of the Company's indebtedness, which contains provisions that could limit the payment of dividends in certain circumstances, and other factors that the Board of Directors may deem to be relevant. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_160">Item&#160;12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in this Form&#160;10-K for a discussion of securities authorized for issuance under our equity compensation plans.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;6. Reserved</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_43"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;7. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTRODUCTION</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kewaunee Scientific Corporation is a recognized leader in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. Kewaunee Scientific Corporation's website is located at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">www.kewaunee.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The reference to our website does not constitute incorporation by reference of any information contained at that site.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are sold primarily through purchase orders and contracts submitted by customers through our dealers, our subsidiaries in Singapore and India, and a national distributor. Products are sold principally to pharmaceutical, biotechnology, industrial, chemical and commercial research laboratories, educational institutions, healthcare institutions, governmental entities, manufacturing facilities and users of networking furniture. We consider the markets in which we compete to be highly competitive, with a significant amount of the market requiring competitive public bidding.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the laboratory and healthcare furniture industries for customer orders to require delivery at extended future dates, as products are frequently to be installed in buildings yet to be constructed. Changes or delays in building construction may cause delays in delivery of the orders and our recognition of the sale. Since prices are normally quoted on a firm basis in the industry, we bear the burden of possible increases in labor and material costs between quotation of an order and delivery of the product. The impact of such possible increases is considered when determining the sales price. The principal raw materials and products manufactured by others used in our products are cold-rolled carbon and stainless steel, hardwood lumbers and plywood, paint, chemicals, resins, hardware, plumbing and electrical fittings. Such materials and products are purchased from multiple suppliers and are typically readily available.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING ESTIMATES</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we have made estimates and assumptions relating to the reporting of results of operations and financial position in the preparation of our consolidated financial statements in conformity with generally accepted accounting principles in the United States of America. Actual results could differ significantly from those estimates. We believe that the following discussion addresses our most critical accounting estimates, which are those that are most important to the portrayal of our financial condition and results of operations, and require management's most difficult, subjective and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evaluation of the allowance for doubtful accounts involves management judgments and estimates. We evaluate the collectability of our trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to us, or a project dispute makes it unlikely that the outstanding amount owed by a customer will be collected, a specific reserve for bad debts is estimated and recorded to reduce the recognized receivable to the estimated amount we believe will ultimately be collected. In addition to specific customer identification of potential bad debts, a reserve for bad debts is estimated and recorded based on our recent past loss history and an overall assessment of past due trade accounts receivable amounts outstanding.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Benefits</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor pension plans covering all employees who met eligibility requirements as of April&#160;30, 2005. These pension plans were amended as of April&#160;30, 2005, no further benefits have been, or will be, earned under the plans subsequent to the amendment date, and no additional participants have been, or will be, added to the plans. Several statistical and other factors, which attempt to anticipate future events, are used in calculating the expense and liability related to the pension plans. These factors include actuarial assumptions about the discount rate used to calculate and determine benefit obligations and the expected return on plan assets within certain guidelines. The actuarial assumptions used by us may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates, or longer or shorter life spans of participants. These differences may significantly affect the amount of pension income or expense recorded by us in future periods.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance Reserves</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's domestic operations are self-insured for employee health care costs. The Company has purchased specific stop-loss insurance policies to limit claims above a certain amount. Estimated medical costs were accrued for claims incurred but not reported using assumptions based upon historical loss experiences. The Company's exposure reflected in the self-insurance reserves varies depending upon market conditions in the insurance industry, availability of cost-effective insurance coverage, and actual claims versus estimated future claims.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in the U.S. (federal and state) and numerous foreign jurisdictions. Tax laws, regulations, administrative practices, and interpretations in various jurisdictions may be subject to significant change, with or without notice, due to economic, political, and other conditions, and significant judgment is required in evaluating and estimating our provision and accruals for these taxes. There are many transactions that occur during the ordinary course of business for which the ultimate tax determination is uncertain. In addition, our actual and forecasted earnings are subject to change due to economic, political, and other conditions.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rates could be affected by numerous factors, such as changes in our business operations, acquisitions, investments, entry into new businesses and geographies, intercompany transactions, the relative amount of our foreign earnings, including earnings being lower than anticipated in jurisdictions where we have lower statutory rates and higher than anticipated in jurisdictions where we have higher statutory rates, losses incurred in jurisdictions for which we are not able to realize related tax benefits, the applicability of special tax regimes, changes in foreign currency exchange rates, changes to our forecasts of income and loss and the mix of jurisdictions to which they relate, changes in our deferred tax assets and liabilities and their valuation, and interpretations related to tax laws and accounting rules in various jurisdictions.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales for fiscal year 2023 were $219.5 million, an increase compared to fiscal year 2022 sales of $168.9 million. Domestic Segment sales for fiscal year 2023 were $146.7 million, an increase of 15.7% compared to fiscal year 2022 sales of $126.8 million. The increase in Domestic Segment sales is primarily driven by the pricing of new orders in response to higher raw material input costs. International Segment sales for fiscal year 2023 were $72.8 million, an increase of 73.2% from fiscal year 2022 sales of $42.0 million. The increase in International Segment sales in fiscal year 2023 is due to the delivery of several large projects in India, Asia, and Africa that were awarded over the course of the past eighteen months.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our order backlog was $147.9 million at April&#160;30, 2023, as compared to $173.9 million at April&#160;30, 2022. The decrease in backlog is primarily attributable to the substantial completion of the previously announced Dangote Oil project in Nigeria during the fiscal year and a reduction in new orders within the ASEAN marketplace. The Company's backlog for the United States and Indian markets on April 30, 2023 is similar to prior fiscal year levels as order rates in these markets remain strong.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit represented 16.2% and 14.3% of sales in fiscal years 2023 and 2022, respectively. The increase in gross profit margin percentage for fiscal year 2023 is driven by the significant increase in International Segment sales, which has a higher gross profit rate than the Domestic Segment, coupled with an increase in Domestic Segment sales that had improved pricing as noted above.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses were $30.2 million and $26.8 million in fiscal years 2023 and 2022, respectively, and 13.8% and 15.9% of sales, respectively. The increase in operating expense in fiscal year 2023 as compared to fiscal year 2022 was primarily due to increases in consulting and professional fees of $552,000, corporate governance expenses of $113,000, and increases in International Segment operating expenses of $2,286,000 as a result of the significant sales growth experienced. These increases were partially offset by reductions in administrative wages, benefits, and stock-based compensation of $142,000, and marketing expense of $223,000. The increase in operating expenses for fiscal year 2023 also included a one-time charge related to the write-down of a prior year insurance claim in the amount of $260,000. The increase in international operating expenses for fiscal year 2023 is related to the continued sales growth in the International operating segment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension expense was $71,000 in fiscal year 2023, compared to pension income of $355,000 in fiscal year 2022. The increase in pension expense was primarily due to the lower expected return on plan assets driven by a decrease in plan assets in the prior fiscal year.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net was $939,000 and $400,000 in fiscal years 2023 and 2022, respectively. The increase in other income in fiscal year 2023 was primarily due to interest income earned on the cash balances held by the Company's international subsidiaries and the increased interest earned on the Note Receivable related to the Sale-Leaseback financing transaction when compared to the prior fiscal year. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_106">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on this transaction.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $1,734,000 and $632,000 in fiscal years 2023 and 2022, respectively. The increase in interest expense for fiscal year 2023 was primarily due to the Sale-Leaseback financing transaction noted above, partially offset by a decrease in interest expense related to the Company's revolving credit facility.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense was $3.1 million and $3.5 million for fiscal years 2023 and 2022, respectively, or 69.8% and 141.6% of pretax earnings (loss), respectively. The effective rate for fiscal year 2023 was unfavorably impacted by the increase in the valuation allowance attributable to changes to Internal Revenue Code Section 174 Research and Experimental Expenditures, which became effective in the current fiscal year. The primary impact of this change is the amortization of current year expenditures over a five year period, as compared to prior fiscal years where research expenditures were deductible in the year incurred. The effective rate change for fiscal year 2022 was also unfavorably impacted due to changes in the valuation allowance </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attributable to the net increase in deferred tax assets of $4,170,000 before valuation allowance as a result of the book to tax differences primarily related to the Company's execution of a Sale-Leaseback transaction for owned real property, which was treated as a taxable sale transaction for tax purposes and a financing transaction for financial statement reporting purposes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earnings attributable to the non-controlling interest related to our subsidiaries that are not 100% owned by the Company were $621,000 and $123,000 for fiscal years 2023 and 2022, respectively. The changes in the net earnings attributable to the non-controlling interest for each year were due to changes in the levels of net income of the subsidiaries.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net earnings were $738,000, or $0.25 per diluted share, as compared to net loss of $6,126,000, or $2.20 per diluted share, for fiscal years ended April 30, 2023 and April 30, 2022, respectively. The increase in net earnings was attributable to the factors discussed above.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of liquidity have historically been funds generated from operating activities, supplemented as needed by borrowings under our revolving credit facility. Additionally, certain machinery and equipment are financed by non-cancelable operating and financing leases. We believe that these sources of funds will be sufficient to support ongoing business requirements, including capital expenditures, through fiscal year 2024.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2023, we had $3,548,000 outstanding under our $15.0 million revolving credit facility. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_103">Note 4</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt and Other Credit Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements included in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_67">Item 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report for additional information concerning our credit facility. In fiscal year 2022, we executed a Sale-Leaseback financing transaction with respect to our manufacturing and corporate facilities in Statesville, North Carolina to provide additional liquidity. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_106">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information. We did not have any off balance sheet arrangements at April&#160;30, 2023 or 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the cash payment obligations for our lease and financing arrangements as of April&#160;30, 2023: </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAYMENTS DUE BY PERIOD</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">($ in thousands)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.579%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Contractual Cash Obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1 Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2-3&#160;Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4-5&#160;Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;5&#160;years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing Lease Obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale-Leaseback Financing Transaction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,917&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Contractual Cash Obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,807&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,395&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,237&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,928&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,247&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's operating activities used cash of $3,790,000 in fiscal year 2023, primarily for increases in receivables of $4,947,000 and decreases in accounts payable and accrued expenses of $5,558,000, partially offset by cash from operations, decreases in inventories of $1,907,000, and increases in deferred revenue of $568,000. Operating activities used cash of $7,885,000 in fiscal year 2022, primarily for operations, increases in inventories of $7,279,000 and receivables of $8,464,000, partially offset by increases in accounts payable and accrued expenses of $11,886,000 and a decrease in income tax receivable of $955,000.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financing activities provided cash of $14,931,000 during fiscal year 2023 as a result of the collection of $13,629,000 in final proceeds from the Sale-Leaseback transaction executed in the prior fiscal year and proceeds from the net increase in short-term borrowings of $1,998,000, partially offset by repayment of long-term debt of $121,000. The Company's financing activities provided cash of $11,031,000 during fiscal year 2022 from proceeds of $15,893,000 from the Sale-Leaseback transaction, including redemption of preferred shares from the buyer, net of debt issuance costs, partially offset by payments of $5,239,000 for short-term borrowings.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the April&#160;30, 2023 accounts receivable balances are expected to be collected during the first quarter of fiscal year 2024, with the exception of retention amounts on fixed-price contracts which are collected when the entire construction project is completed and all retention funds are paid by the owner.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, no further benefits have been, or will be, earned under our pension plans after April&#160;30, 2005, and no additional participants have been, or will be, added to the plans. In fiscal years 2023 and 2022, we made no contributions to the plans. We expect to make no contributions to the plans for fiscal year 2024. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital expenditures were $4,148,000 and $1,908,000 in fiscal years 2023 and 2022, respectively. Capital expenditures in fiscal year 2023 were funded primarily from financing activities. Fiscal year 2024 capital expenditures are anticipated to be </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approximately $4.4 million. The fiscal year 2024 expenditures are expected to be funded primarily by operating activities, supplemented as needed by borrowings under our revolving credit facility.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital was $47.9 million at April&#160;30, 2023, down from $49.3 million at April&#160;30, 2022, and the ratio of current assets to current liabilities was 2.2-to-1.0 at April&#160;30, 2023 unchanged from April 30, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No dividends were declared or paid on the Company's common stock during the last two fiscal years. The declaration and payment of&#160;any future dividends is at the discretion of the Board of Directors and will depend upon many factors, including the Company's earnings, capital requirements, investment and growth strategies, financial condition, the terms of the Company's indebtedness, which contains provisions that could limit the payment of dividends in certain circumstances, and other factors that the Board of Directors may deem to be relevant. </span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECENT ACCOUNTING STANDARDS </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_94">Note 1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our Consolidated Financial Statements in this Form 10-K for a discussion of new accounting pronouncements, which is incorporated herein by reference.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUTLOOK</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Outlook</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's ability to predict future demand for its products continues to be limited given its role as subcontractor or supplier to dealers for subcontractors. Demand for the Company's products is also dependent upon the number of laboratory and healthcare construction projects planned and/or current progress in projects already under construction.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fiscal year 2023 was a transition year for the Company as it emerged from a generally disruptive three-year period that included a global pandemic, rapid broad-based inflation, labor shortages, and supply chain disruptions. The Company believes it is well-positioned for the next fiscal year due to its strong global management team, a healthy backlog, improved manufacturing capabilities, and end-use markets that will continue to prioritize investment in projects that require the products Kewaunee designs and manufactures.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;7A. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risk in the area of interest rates. This exposure is associated with balances outstanding under our revolving credit facility and certain lease obligations for production machinery, all of which are priced on a floating rate basis. We had $3.5 million outstanding under our revolving credit facility at April&#160;30, 2023, bearing interest at floating rates. We believe that our current exposure to interest rate market risk is not material.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations could be affected by factors such as changes in foreign currency exchange rates or weak economic conditions in foreign markets. We derive net sales in U.S. dollars and other currencies including Indian rupees, Singapore dollars, and other currencies. For&#160;fiscal year 2023,&#160;27%&#160;of net sales were derived in currencies other than U.S. dollars. We incur expenses in currencies other than U.S. dollars relating to specific contracts with customers and for our operations outside the U.S.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the long term, net sales to international markets may increase as a percentage of total net sales and, consequently, a greater portion of our business could be denominated in foreign currencies. As a result, operating results may become more subject to fluctuations based upon changes in the exchange rates of certain currencies in relation to the U.S. dollar. To the extent we engage in international sales denominated in U.S. dollars, an increase in the value of the U.S. dollar relative to foreign currencies could make our products less competitive in international markets. This effect is also impacted by costs of raw materials from international sources and costs of our sales, service, and manufacturing locations outside the U.S.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have foreign currency cash accounts to operate our global business. These accounts are impacted by changes in foreign currency rates. Cash balances at&#160;April 30, 2023 of $9.4 million&#160;were held by our foreign subsidiaries and denominated in currencies other than U.S. dollars.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:10pt;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_67"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;8. Financial Statements and Supplementary Data</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.009%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_70">Report of Independent Registered Public Accounting Firm (</a><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:AuditorName" id="f-35">FORVIS, LLP</ix:nonNumeric><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_70">, </a><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:AuditorLocation" id="f-36">Charlotte, NC</ix:nonNumeric><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_70">, PCAOB Firm No. </a><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="dei:AuditorFirmId" id="f-37">686</ix:nonNumeric><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_70">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_70">17</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_76">Consolidated Statements of Operations&#8212;Years ended April 30, 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_76">3</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_76"> and 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_76">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_76">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_79">Consolidated Statements of Comprehensive Income&#8212;Years ended April&#160;30, 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_79">3</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_79"> and 202</a>2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_79">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_82">Consolidated Statements of Stockholders' Equity&#8212;Years ended April&#160;30, 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_82">3</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_82"> and 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_82">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_82">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_85">Consolidated Balance Sheets&#8212;April&#160;30, 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_85">3</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_85"> and 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_85">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_85">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_88">Consolidated Statements of Cash Flows&#8212;Years ended April&#160;30, 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_88">3</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_88"> and 202</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_88">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_88">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_91">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_91">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_136">Consent of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_136">41</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_70"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of Kewaunee Scientific Corporation</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Kewaunee Scientific Corporation and subsidiaries (the "Company") as of April 30, 2023 and 2022, the related consolidated statements of operations, comprehensive income, stockholders' equity and cash flows for each of the years in the two-year period ended April 30, 2023, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of April 30, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the two-year period ended April 30, 2023, in conformity with principles generally accepted in the United States of America.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.</span></div><div style="margin-bottom:4pt;margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ FORVIS, LLP </span></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2020.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Charlotte, NC</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30, 2023</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_76"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.270%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended April 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kewaunee&#160;Scientific&#160;Corporation</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">$ and shares in thousands, except per share amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-38">219,494</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-39">168,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-40">183,906</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-41">144,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-42">35,588</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-43">24,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-44">30,224</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-45">26,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating earnings (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-46">5,364</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-47">2,608</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension (expense) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:PensionExpense" scale="3" id="f-48">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:PensionExpense" scale="3" id="f-49">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="f-50">939</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="f-51">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-52">1,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="f-53">632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (Loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-54">4,498</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-55">2,485</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-56">3,139</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-57">3,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-58">1,359</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-59">6,003</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net earnings attributable to the non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-60">621</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-61">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-62">738</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-63">6,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-64">0.26</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-65">2.20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-66">0.25</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-67">2.20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-68">2,824</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-69">2,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-70">2,902</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-71">2,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended April 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kewaunee&#160;Scientific&#160;Corporation</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-72">1,359</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-73">6,003</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-74">290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="f-75">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-76">590</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="3" id="f-77">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-78">1,659</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-79">6,168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less comprehensive income attributable to the non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="f-80">621</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="f-81">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-82">1,038</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-83">6,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_82"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:34.697%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.610%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kewaunee Scientific Corporation</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">$ in thousands, except shares and per share amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>Equity</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib43bd0d59c2a4929843b0a5e1ef18ece_I20210430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-84">6,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18873af196c74589a636521ad47359ea_I20210430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-85">3,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33b2837f1a254ad8887f32c8e8b57bd2_I20210430" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-86">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d828b49d10a4704808daece2df60079_I20210430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-87">34,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72d2e48957c54d558de63a0798e40ea8_I20210430" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-88">3,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-89">41,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i915042cddaaf43d0b7ae1684758c4070_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-90">6,126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-91">6,126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id640e7a42f774176b13620cd072a3127_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-92">165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-93">165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cbc0049851e457db78badf31b1e8567_D20210501-20220430" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-94">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f6e6d09b0c4d3bb0bc3f7cca2b19b7_D20210501-20220430" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-95">676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-96">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9f52a76719413ca2b86f14caf73d43_I20220430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-97">6,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98d4566e618a454691c20203db06f3e1_I20220430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-98">4,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic873590b7746431d91d9e534c1f4f8ef_I20220430" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-99">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cb154cb71b4be8aeb4451ec6960761_I20220430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-100">28,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47eb375d52294ca48f7e189e4064efc2_I20220430" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-101">3,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-102">35,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39375c07149c4105a5bb96993a610b54_D20220501-20230430" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-103">738</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-104">738</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id90398c44c124e6fb0320813aaf37e69_D20220501-20230430" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-105">300</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-106">300</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81381b39a97b4ea58fac780296922591_D20220501-20230430" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-107">101</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i936dc2381cd44b90a8a4da43b0dc2458_D20220501-20230430" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-108">576</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-109">677</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69f3a0aef45846feb5cfcd30de4b3a46_I20230430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-110">7,084</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if150932ec89044d5a2fe26428a616330_I20230430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-111">5,059</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic49c2c59bb514ba9a98eea71a4532d83_I20230430" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-112">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d7a5379c3946afbbfd4db4209a9259_I20230430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-113">28,761</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffed0786ff994d8b887d069e8f55bdc6_I20230430" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-114">3,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-115">37,409</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:72.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">April 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kewaunee&#160;Scientific&#160;Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">$ and shares in thousands, except per share amounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-116">8,078</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-117">4,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-118">5,737</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-119">2,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables, less allowance: $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-120">476</ix:nonFraction> (2023); $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-121">357</ix:nonFraction> (2022)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-122">46,081</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-123">41,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-124">21,889</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-125">23,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:fixed-zero" scale="3" id="f-126">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-127">13,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-128">6,135</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-129">6,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Current Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-130">87,920</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-131">91,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-132">16,402</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-133">15,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-134">9,170</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-135">7,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-136">5,406</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-137">4,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-138">118,898</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-139">118,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-140">3,587</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-141">1,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of financing liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityCurrent" scale="3" id="f-142">642</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:FinancingLiabilityCurrent" scale="3" id="f-143">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of financing lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-144">85</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-145">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-146">1,967</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-147">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-148">23,599</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-149">27,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee compensation and amounts withheld</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-150">4,304</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-151">4,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-152">4,097</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-153">3,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-154">1,772</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-155">3,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-156">40,053</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-157">42,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term portion of financing liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-158">28,132</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:FinancingLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-159">28,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term portion of financing lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-160">148</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-161">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term portion of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-162">7,136</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-163">6,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued pension and deferred compensation costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:AccruedEmployeeBenefitPlanCosts" format="ixt:num-dot-decimal" scale="3" id="f-164">3,546</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:AccruedEmployeeBenefitPlanCosts" format="ixt:num-dot-decimal" scale="3" id="f-165">4,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="f-166">943</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="f-167">428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-168">455</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-169">531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-170">80,413</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-171">82,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commitments and Contingencies (</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_118">Note 9</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-172"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-173"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-174"><ix:nonFraction unitRef="usdPerShare" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-175">2.50</ix:nonFraction></ix:nonFraction> par value, Authorized&#8212;<ix:nonFraction unitRef="shares" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-176"><ix:nonFraction unitRef="shares" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-177">5,000</ix:nonFraction></ix:nonFraction> shares;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issued&#8212; <ix:nonFraction unitRef="shares" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-178">2,833</ix:nonFraction> shares (2023); <ix:nonFraction unitRef="shares" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-179">2,793</ix:nonFraction> shares (2022)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding&#8212; <ix:nonFraction unitRef="shares" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-180">2,830</ix:nonFraction> shares (2023); <ix:nonFraction unitRef="shares" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-181">2,790</ix:nonFraction> shares (2022)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-182">7,084</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-183">6,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-184">5,059</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-185">4,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-186">28,761</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-187">28,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-188">3,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-189">3,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock in treasury, at cost: <ix:nonFraction unitRef="shares" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:TreasuryStockCommonShares" scale="3" id="f-190"><ix:nonFraction unitRef="shares" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:TreasuryStockCommonShares" scale="3" id="f-191">3</ix:nonFraction></ix:nonFraction> shares</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="f-192">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="f-193">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Kewaunee Scientific Corporation Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-194">37,409</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-195">35,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-196">1,076</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:MinorityInterest" scale="3" id="f-197">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-198">38,485</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-199">36,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-200">118,898</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-201">118,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_88"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.739%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended April 30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Kewaunee&#160;Scientific&#160;Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-202">1,359</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-203">6,003</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings (loss) to net cash used by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-204">2,867</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-205">2,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt provision</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-206">120</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-207">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="f-208">886</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="f-209">729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for deferred income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" scale="3" id="f-210">516</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" scale="3" id="f-211">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-212">4,947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-213">8,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-214">1,907</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-215">7,279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" format="ixt:fixed-zero" scale="3" id="f-216">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="f-217">955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-218">5,558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-219">11,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="f-220">568</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="f-221">406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="f-222">1,508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" format="ixt:num-dot-decimal" scale="3" id="f-223">3,096</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-224">3,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-225">7,885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-226">4,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-227">1,908</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-228">4,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-229">1,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-230">60,599</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-231">59,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on short-term borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-232">58,601</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-233">64,598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale-leaseback transaction</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:ProceedsFromFinancingLiability" format="ixt:num-dot-decimal" scale="3" id="f-234">13,629</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:ProceedsFromFinancingLiability" format="ixt:num-dot-decimal" scale="3" id="f-235">15,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on financing liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:PaymentsOnFinancingLiability" scale="3" id="f-236">575</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:PaymentsOnFinancingLiability" format="ixt:fixed-zero" scale="3" id="f-237">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="f-238">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="f-239">377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="f-240">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="f-241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-242">14,931</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-243">11,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-244">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-245">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase in Cash, Cash Equivalents and Restricted Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-246">6,921</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-247">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, Cash Equivalents and Restricted Cash at Beginning of Year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-248">6,894</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-249">5,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, Cash Equivalents and Restricted Cash at End of Year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-250">13,815</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-251">6,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Disclosure of Cash Flow Information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-252">1,862</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="f-253">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-254">3,158</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-255">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets obtained under new finance or operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-256">3,902</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability" scale="3" id="f-257">366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying Notes are an integral part of these Consolidated Financial Statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_91"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_94"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-258" continuedAt="iceb779c948f04b25b634fb8c6a19f6be" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="iceb779c948f04b25b634fb8c6a19f6be" continuedAt="ifb0189ccb68b42cd9715ac796dd4ee4b"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kewaunee Scientific Corporation and subsidiaries (collectively the "Company") design, manufacture, and install laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's sales are made through purchase orders and contracts submitted by customers through its dealers, its subsidiaries in Singapore and India, and a national stocking distributor. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_127">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details on the closure status of the Company's China operations. The majority of the Company's products are sold to customers located in North America, primarily within the United States. The Company's laboratory products are used in chemistry, physics, biology and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government and health care markets. Technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ConsolidationPolicyTextBlock" id="f-259" continuedAt="i0605ede26bbc479f90104856202390c3" escape="true">Principles of Consolidation</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0605ede26bbc479f90104856202390c3"> The Company's consolidated financial statements include the accounts of Kewaunee Scientific Corporation and its international subsidiaries. A brief description of each subsidiary, along with the amount of the Company's controlling financial interests, as of April&#160;30, 2023 is as follows: (1) Kewaunee Labway Asia Pte. Ltd., a commercial sales organization for the Company's products in Singapore, is <ix:nonFraction unitRef="number" contextRef="i4d12676382c14aefb358f5cf0f5ca1e0_I20230430" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-260">100</ix:nonFraction>% owned by the Company; (2) Kewaunee Scientific Corporation Singapore Pte. Ltd., a holding company in Singapore, is <ix:nonFraction unitRef="number" contextRef="idb5014da29064620a8625170da6db109_I20230430" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-261">100</ix:nonFraction>% owned by the Company; (3) Kewaunee Labway India Pvt. Ltd., a design, installation, manufacturing, assembly and commercial sales operation for the Company's products in Bangalore, India, is <ix:nonFraction unitRef="number" contextRef="i035c81617bd64b739231dde89d9e390b_I20230430" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-262">95</ix:nonFraction>% owned by the Company; (4) Koncepo Scientech International Pvt. Ltd., a laboratory design and strategic advisory and construction management services firm, located in Bangalore, India, is <ix:nonFraction unitRef="number" contextRef="i42a4784036154c0598d9e7d078cc620b_I20230430" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-263">80</ix:nonFraction>% owned by the Company; (5) Kequip Global Lab Solutions Pvt. Ltd. is <ix:nonFraction unitRef="number" contextRef="i96f00904ca244286a10a749a0fce2507_I20230430" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="f-264">70</ix:nonFraction>% owned by Kewaunee Scientific Corporation Singapore Pte. Ltd. All intercompany balances, transactions, and profits have been eliminated.</ix:continuation> Included in the consolidated financial statements are net assets of $<ix:nonFraction unitRef="usd" contextRef="ief738c90b80a46dcae563091eb90527b_I20230430" decimals="-3" name="us-gaap:AssetsNet" format="ixt:num-dot-decimal" scale="0" id="f-265">16,786,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i7a204790b1a14821b1916e1824956a58_I20220430" decimals="-3" name="us-gaap:AssetsNet" format="ixt:num-dot-decimal" scale="0" id="f-266">13,127,000</ix:nonFraction> at April&#160;30, 2023 and 2022, respectively, of the Company's subsidiaries. Net sales by the Company's subsidiaries in the amounts of $<ix:nonFraction unitRef="usd" contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-267">72,778,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-268">42,024,000</ix:nonFraction> were included in the consolidated statements of operations for fiscal years 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-269" continuedAt="i787c14371d154343b938ae10ac1c6381" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the years ended April&#160;30, 2023 and 2022, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits.</span></ix:nonNumeric></div><div style="margin-bottom:7pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i787c14371d154343b938ae10ac1c6381">The Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows.</ix:continuation> <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" id="f-270" continuedAt="ib8a1e9d7ab7f459e838f48a1202a91b8" escape="true">The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows at April 30 is as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="ib8a1e9d7ab7f459e838f48a1202a91b8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"><tr><td style="width:1.0%"></td><td style="width:59.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-271">8,078</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-272">4,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-273">5,737</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-274">2,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-275">13,815</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-276">6,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-277" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="f-278" continuedAt="i0d28e9a824044e7cb5d20cda66a2648a" escape="true">Accounts Receivable and Allowance for Doubtful Accounts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0d28e9a824044e7cb5d20cda66a2648a"> Receivables are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to the Company, or a project dispute makes it unlikely that all of the receivable owed by a customer will be collected, a specific reserve for bad debts is estimated and recorded to reduce the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, a reserve for bad debts is estimated and recorded based on past loss history and an overall assessment of past due trade accounts receivable amounts outstanding. Accounts are written off when it is clearly established that the receivable&#160;is a bad debt. Recoveries of receivables previously written off are recorded when received.</ix:continuation> </span></div><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" id="f-279" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the allowance for doubtful accounts for each of the years ended April&#160;30 was:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.008%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-280">357</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-281">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-282">120</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-283">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts written off (net)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="f-284">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="f-285">371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-286">476</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="f-287">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="ifb0189ccb68b42cd9715ac796dd4ee4b" continuedAt="if9984da73660438c8a67cb7c27a4e1a8"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" id="f-288" continuedAt="ib79975a48c114f639da6756bff838fae" escape="true">Unbilled Receivables</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib79975a48c114f639da6756bff838fae"> Accounts receivable include unbilled receivables that represent amounts earned which have not yet been billed in accordance with contractually stated billing terms, excluding retention, which is included in other assets.</ix:continuation> The amount of unbilled receivables, net of unbilled retention, at April&#160;30, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="0" id="f-289">13,459,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="0" id="f-290">9,287,000</ix:nonFraction>, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:InventoryPolicyTextBlock" id="f-291" continuedAt="ia6c87c3622564af3b3f54990f1b59d28" escape="true">Inventories</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia6c87c3622564af3b3f54990f1b59d28"> The Company's inventories are valued at the lower of cost or net realizable value under the first-in, first-out ("FIFO") method.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-292" continuedAt="i10ae1f4221ea4769b29b43fe3183550b" escape="true">Property, Plant and Equipment</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i10ae1f4221ea4769b29b43fe3183550b"> Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is determined for financial reporting purposes principally on the straight-line method over the estimated useful lives of the individual assets or, for leaseholds, over the terms of the related leases, if shorter.</ix:continuation> <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-293" continuedAt="i555ffd1ea3f14f75a503a2c0e0fc6cea" escape="true">Property, plant and equipment consisted of the following at April&#160;30:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i555ffd1ea3f14f75a503a2c0e0fc6cea"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90242fcce5d84297ba58ac37f58d01eb_I20230430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-294">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2c67af89acc4cceb16bae291f0b924f_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-295">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8f56e78063401992e2639148b52a7c_I20230430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-296">17,147</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e6cacd2bfe41289beb4377632e046c_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-297">17,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i57303180faa04cc888c13c4f5bcf55a0_D20210501-20220430" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-298"><ix:nonNumeric contextRef="ieb6a852f1dc64a4c8ae4e54a59cf843c_D20220501-20230430" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-299">10</ix:nonNumeric></ix:nonNumeric>-<ix:nonNumeric contextRef="i8dd046eeca6c43a49013acada8280e5c_D20210501-20220430" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-300"><ix:nonNumeric contextRef="iadc7ed37eabf46289e1b3ede5bfd6780_D20220501-20230430" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-301">40</ix:nonNumeric></ix:nonNumeric>&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b6a962e78384b8cbbb043ce06b35ea2_I20230430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-302">44,180</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e8b0570b6534fad8da8843f53a91fcb_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-303">43,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i83a554db45cd44afb12954d7dbcb3262_D20220501-20230430" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-304"><ix:nonNumeric contextRef="i3defb6f321ab4a0ba12e8290a4c594fa_D20210501-20220430" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-305">5</ix:nonNumeric></ix:nonNumeric>-<ix:nonNumeric contextRef="iadd284a39a98417ea0c4e5f5d3eed853_D20210501-20220430" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-306"><ix:nonNumeric contextRef="ie12e2507d8404c55843b1ee785732570_D20220501-20230430" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-307">10</ix:nonNumeric></ix:nonNumeric>&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-308">61,368</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-309">60,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-310">44,966</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-311">45,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-312">16,402</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-313">15,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:PropertyPlantAndEquipmentImpairment" id="f-314" escape="true">The Company reviews the carrying value of property, plant and equipment for impairment annually or whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value.</ix:nonNumeric> There were <ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="f-315"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="f-316">no</ix:nonFraction></ix:nonFraction> impairments in fiscal years 2023 or 2022.</span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:OtherAssetsPolicyTextBlock" id="f-317" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other assets at April&#160;30, 2023 and 2022 included $<ix:nonFraction unitRef="usd" contextRef="i1252e42ba8f94788b9c2e9526358c016_I20230430" decimals="-3" name="kequ:UnbilledRetainageCurrent" format="ixt:num-dot-decimal" scale="0" id="f-318">1,191,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i31ecee99cb564fb4853c3bcd51ee186d_I20220430" decimals="-3" name="kequ:UnbilledRetainageCurrent" format="ixt:num-dot-decimal" scale="0" id="f-319">1,293,000</ix:nonFraction>, respectively, of unbilled retainage, $<ix:nonFraction unitRef="usd" contextRef="ic6b14126cfd04589a48a1267cb447516_I20230430" decimals="-3" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="0" id="f-320">2,352,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i18837955ad44418ebb8430792c895f28_I20220430" decimals="-3" name="us-gaap:AssetsHeldInTrust" format="ixt:num-dot-decimal" scale="0" id="f-321">2,480,000</ix:nonFraction>, respectively, of assets held in a trust account for non-qualified benefit plan, and $<ix:nonFraction unitRef="usd" contextRef="ic6b14126cfd04589a48a1267cb447516_I20230430" decimals="-3" name="us-gaap:CashSurrenderValueOfLifeInsurance" format="ixt:num-dot-decimal" scale="0" id="f-322">111,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i18837955ad44418ebb8430792c895f28_I20220430" decimals="-3" name="us-gaap:CashSurrenderValueOfLifeInsurance" format="ixt:num-dot-decimal" scale="0" id="f-323">110,000</ix:nonFraction>, respectively, of cash surrender values of life insurance policies. Life insurance policies are recorded at the amount that could be realized under the insurance contract as of the date of the Company's consolidated balance sheets with the change in cash surrender or contract value being recorded as income or expense during each period.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:UseOfEstimates" id="f-324" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for uncollectible accounts receivable, self-insurance reserves, income taxes, and pension liabilities.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Interest Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December 22, 2021, the Company entered into an Agreement for Purchase and Sale of Real Property with CAI Investments Sub-Series 100 LLC (the "Buyer"), for the Company&#8217;s headquarters and manufacturing facilities (the "Property") located in Statesville, North Carolina (the "Sale Agreement") in exchange for $<ix:nonFraction unitRef="usd" contextRef="i86c6fb5e15db485f849df283bb68dec9_D20211222-20211222" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-325">30,275,000</ix:nonFraction> in sales proceeds, $<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationReceived1" format="ixt:num-dot-decimal" scale="0" id="f-326">14,864,000</ix:nonFraction> of which was payable in redeemable preferred shares in CAI Investments Medical Products I Parent, LLC ("Parent"), an affiliate of Buyer. At April 30, 2022, the carrying value of the redeemable preferred shares was $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-5" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-327">13.5</ix:nonFraction>&#160;million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sale Agreement was finalized on March 24, 2022 and coincided with a <ix:nonNumeric contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" name="kequ:FinancingLiabilityTermOfContract" format="ixt-sec:durwordsen" id="f-328">20-year</ix:nonNumeric> lease, effective on such date between the Company and CAI Investments Medical Products I Master Lessee LLC ("Lessor"), an affiliate of Buyer, for the Property (the "Lease Agreement"). At the same time, the Buyer and its affiliates formed a new, debt-financed affiliate CAI Investments Medical Products I, DST ("Trust") and contributed the Property to the Trust. According to the terms of the lease, the Trust leased the Property to its affiliated Lessor, which in turn sub-leased the Property to the Company (together with the Sale Agreement, the "Sale-Leaseback Arrangement"). For additional information on the accounting for the Sale-Leaseback Arrangement, refer to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_106">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="f-329" continuedAt="i953f37f6e64c4e39a7680d54154bf33e" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company concluded as of April 30, 2022 that Parent and its direct affiliates, including the Trust, are designed primarily to acquire and manage the Property and constitute a variable interest entity because the Trust lacks sufficient equity on its own to finance its operations. The Company evaluated its lease arrangement and redeemable preferred shares in Parent as variable interests. Based on its evaluation, the Company concluded it should not consolidate Parent or its affiliates under the variable interest model or the voting interest model of ASC 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the redeemable preferred shares as a Note Receivable, classified as held to maturity at amortized cost, on its Consolidated Balance Sheet, rather than as an investment in preferred equity, due to the mandatory redemption feature of the preferred shares.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="if9984da73660438c8a67cb7c27a4e1a8" continuedAt="ie35113cc4e5e4843bb55b953df51c864"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i953f37f6e64c4e39a7680d54154bf33e">As of June 22, 2022, the Company had fully redeemed all shares and converted the Note Receivable to cash. The Company's maximum exposure to the Buyer and its affiliates as of April 30, 2023 was limited to the Company&#8217;s lease payments and right to use the Property.</ix:continuation> </span></div><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-330" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A financial instrument is defined as cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company's financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, a note receivable and corresponding sale-leaseback financing liability, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Expanded disclosures about instruments measured at fair value require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows:</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#160;&#160;&#160;&#160;Quoted prices in active markets for identical assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#160;&#160;&#160;&#160;Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="f-331" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring and nonrecurring basis as of April&#160;30, 2023 and 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:50.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbabd4cac86145e9800da3c3c2fc57ed_I20230430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-332">1,105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433d8e1e195426ea3058452dac64693_I20230430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-333">1,105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba363eb7d56e476996da5c8c0716bbf4_I20230430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-334">1,358</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia33e90d485ca4a4fbfa0aaa236176d1d_I20230430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-335">1,358</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" id="f-336">Total</ix:nonNumeric></span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234054f8708d43f4811f8f93244fe91c_I20230430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-337">1,105</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i251e9520bea74e6991781ef0e97f7a97_I20230430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-338">1,358</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-339">2,463</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24354820914d4aee9f7707f52e56f2ff_I20230430" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-340">2,910</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99d113f3a4a845649deeb8980f67ebc1_I20230430" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-341">2,910</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" id="f-342">Total</ix:nonNumeric></span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i251e9520bea74e6991781ef0e97f7a97_I20230430" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-343">2,910</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-344">2,910</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:50.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1a86d35001449868ca80f5a24ebfdbd_I20220430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-345">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0adeca8c17f64dfeb440b21d5c2d6c40_I20220430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-346">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91fc5afe2074e3683df40b73a01966b_I20220430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-347">1,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70f929642694c0ca07d208b0d16e645_I20220430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-348">1,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie732b5f45f464e6ca8f0b1fb3c13d76a_I20220430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-349">1,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38d9bc0dc4a4764ba3d1d2f6e881e3a_I20220430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-350">1,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-351">2,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf90038df3a74e6d8e1591581aa2c4dd_I20220430" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-352">3,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2592da14edd14d3a9802f6465c8990d2_I20220430" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-353">3,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38d9bc0dc4a4764ba3d1d2f6e881e3a_I20220430" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-354">3,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-355">3,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">The Company maintains <ix:nonFraction unitRef="compensation_plan" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="INF" name="kequ:NumberOfNonqualifiedCompensationPlans" format="ixt-sec:numwordsen" scale="0" id="f-356"><ix:nonFraction unitRef="compensation_plan" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="INF" name="kequ:NumberOfNonqualifiedCompensationPlans" format="ixt-sec:numwordsen" scale="0" id="f-357">two</ix:nonFraction></ix:nonFraction> non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">Plan liabilities are equal to the individual participants' account balances and other earned retirement benefits.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-358" continuedAt="i22cf636360334e86b2a3126c9295e25b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company recognizes revenue when control of a good or service promised in a contract (i.e., </span></ix:nonNumeric></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="ie35113cc4e5e4843bb55b953df51c864" continuedAt="i6024d27515b54b2fbbb4e2695dd25bdf"><ix:continuation id="i22cf636360334e86b2a3126c9295e25b"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. Sales taxes that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Certain customers' cash discounts and volume rebates are offered as sales incentives. The discounts and volume rebates are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and contractual obligations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of customer deposits and advance billings of the Company's products where sales have not yet been recognized. Accounts receivable includes retainage in the amounts of $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:ConstructionContractorReceivableRetainage" format="ixt:num-dot-decimal" scale="0" id="f-359">235,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:ConstructionContractorReceivableRetainage" format="ixt:num-dot-decimal" scale="0" id="f-360">523,000</ix:nonFraction> at April&#160;30, 2023 and 2022, respectively. Shipping and handling costs are included in cost of product sales. Because of the nature and quality of the Company's products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company's consolidated financial position and results of operations and are expensed as incurred.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ConcentrationRiskCreditRisk" id="f-361" continuedAt="i4baf2566644744d9b15ddbc76cb3c4d9" escape="true">Credit Concentration </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4baf2566644744d9b15ddbc76cb3c4d9">The Company performs credit evaluations of its customers.</ix:continuation> Revenues from three of the Company's domestic dealers represented in the aggregate approximately <ix:nonFraction unitRef="number" contextRef="i0ffefcfa990f4dd792c6f71caefc049c_D20220501-20230430" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-362">36</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i55120ad7d22e4ad3a0aff429b22a6b6b_D20210501-20220430" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-363">38</ix:nonFraction>% of the Company's sales in fiscal years 2023 and 2022, respectively. Accounts receivable for two domestic customers represented approximately <ix:nonFraction unitRef="number" contextRef="i1396e4dd472c434789f1f0126457631e_D20220501-20230430" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-364">23</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i8e80065eb8da4baab97a3125ae4f02ba_D20210501-20220430" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-365">21</ix:nonFraction>% of the Company's total accounts receivable as of April&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:SelfInsuranceReservePolicyTextBlock" id="f-366" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains a self-insured health-care program. The Company accrues estimated losses for claims incurred but not reported using assumptions based on historical loss experience. The Company has also purchased specific stop-loss insurance to limit claims above a certain amount. The Company adjusts insurance reserves, as needed, in the event that future loss experience differs from historical loss patterns.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-367" continuedAt="i4fed7e71fc9a4c439fbe9f76c992b6b4" escape="true">Income Taxes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4fed7e71fc9a4c439fbe9f76c992b6b4"> In accordance with ASC 740, "Income Taxes" ("ASC 740"), the Company uses the liability method in measuring the provision for income taxes and recognizing deferred income tax assets and liabilities on the consolidated balance sheets. ASC&#160;740 clarifies the financial statement recognition threshold and measurement attribute of a tax position taken or expected to be taken in a tax return. Under ASC 740, the Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC&#160;740 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The Company did not have any significant uncertain tax positions at April&#160;30, 2023 or 2022.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-368" continuedAt="i25132bbfde354a60829d774e81c05b48" escape="true">Research and Experimentation Expenditures</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i25132bbfde354a60829d774e81c05b48"> Research and experimentation expenditures are charged to cost of products sold in the periods incurred.</ix:continuation> Expenditures for research and experimentation expenditures were $<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="0" id="f-369">1,012,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="0" id="f-370">990,000</ix:nonFraction> for the fiscal years ended April&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="f-371" continuedAt="i0b36cfbc2f854be3b49989ded5076ee7" escape="true">Advertising Costs</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0b36cfbc2f854be3b49989ded5076ee7"> Advertising costs are expensed as incurred, and include trade shows, training materials, sales, samples, and other related expenses and are included in operating expenses.</ix:continuation> Advertising costs for the years ended April&#160;30, 2023 and 2022 were $<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="0" id="f-372">226,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="0" id="f-373">175,000</ix:nonFraction>, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-374" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements of subsidiaries located in India and China are measured using the local currency as the functional currency. Effective May 1, 2022, Kewaunee Scientific Corporation Singapore Pte. Ltd. transitioned to using the U.S. dollar as its functional currency. The financial position and operating results of Kewaunee Labway Asia Pte. Ltd. are also measured using the U.S. dollar as its functional currency. Assets and liabilities of the Company's foreign subsidiaries using local currencies are translated into United&#160;States dollars at fiscal year-end exchange rates. Sales, expenses, and cash flows are translated at weighted average exchange rates for each period. Net translation gains or losses are included in other comprehensive income, a separate component of stockholders' equity. Gains and losses from foreign currency transactions of these subsidiaries are included in operating expenses.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-375" continuedAt="iaf0a09b390734ddc82d3f003091753f5" escape="true">Earnings Per Share</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaf0a09b390734ddc82d3f003091753f5"> Basic earnings per share is based on the weighted average number of common shares outstanding during the year. Diluted earnings per share reflects the assumed exercise of outstanding stock options and the conversion of restricted stock units ("RSUs") under the Company's various stock compensation plans, except when RSUs and stock options have an antidilutive effect.</ix:continuation> There were <ix:nonFraction unitRef="shares" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-376">33,900</ix:nonFraction> antidilutive RSUs and stock options outstanding at April&#160;30, 2023. There were <ix:nonFraction unitRef="shares" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-377">44,750</ix:nonFraction> antidilutive RSUs and stock options outstanding at April&#160;30, 2022. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="i6024d27515b54b2fbbb4e2695dd25bdf"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-378" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic to diluted weighted average common shares outstanding:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:65.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-379">2,824</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-380">2,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="f-381">78</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="f-382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-383">2,902</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-384">2,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-385" continuedAt="ic10cdb2eb8a140d09731d411ff3d244a" escape="true">Accounting for Stock Options and Other Equity Awards</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic10cdb2eb8a140d09731d411ff3d244a"> Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, "Compensation&#8212;Stock Compensation." Forfeitures are accounted for in the period in which the awards are forfeited.</ix:continuation> The Company granted <ix:nonFraction unitRef="shares" contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-386">87,969</ix:nonFraction> RSUs under the 2017 Omnibus Incentive Plan in fiscal year 2023 and <ix:nonFraction unitRef="shares" contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-387">67,750</ix:nonFraction> RSUs in fiscal year 2022. There were <ix:nonFraction unitRef="shares" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-388"><ix:nonFraction unitRef="shares" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-389">no</ix:nonFraction></ix:nonFraction> stock options granted during fiscal years 2023 and 2022. (See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_112">Note&#160;7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options and Share-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-390" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments," which replaces the current incurred loss method used for determining credit losses on financial assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December&#160;15, 2022. The Company will adopt this standard in fiscal year 2024. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued&#160;ASU No. 2019-12,&#160;"Income Taxes ("Topic 740"): Simplifying the Accounting for Income Taxes." This update simplifies the accounting for income taxes through certain targeted improvements to various subtopics within Topic 740. The amendments in this update are effective for fiscal years and interim periods beginning after December 15, 2020. The Company adopted this standard effective May 1, 2021. The adoption of this standard did not have a significant impact on the Company's consolidated financial position or results of operations.</span></div></ix:nonNumeric></ix:continuation><div id="i1de8d1053c4044f7aa1eb1bfb086781f_97"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 - <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-391" continuedAt="i7ae6de1c29f7447fb237a9ec1965c5fd" escape="true">Revenue Recognition</ix:nonNumeric></span></div><ix:continuation id="i7ae6de1c29f7447fb237a9ec1965c5fd" continuedAt="ic4aac79f8cc94b54b074f79d6171a323"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a distinct good or service or bundle of goods and services that is distinct or a series of distinct goods or services that are substantially the same and have the same pattern of transfer. The Company identifies performance obligations at the inception of a contract and allocates the transaction price to individual performance obligations to reasonably reflect the Company's performance in transferring control of the promised goods or services to the customer. The Company has elected to treat shipping and handling as a fulfillment activity instead of a separate performance obligation.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="ic4aac79f8cc94b54b074f79d6171a323" continuedAt="icc7b40ecc5ad4dbbbd99bd4a1c50ac2b"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary performance obligations identified by the Company:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laboratory Furniture</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company principally generates revenue from the manufacture of custom laboratory, healthcare, and technical furniture and infrastructure products (herein referred to as "laboratory furniture"). The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. Customers can benefit from each piece of laboratory furniture on its own or with resources readily available in the market place such as separately purchased installation services. Each piece of laboratory furniture does not significantly modify or customize other laboratory furniture, and the pieces of laboratory furniture are not highly interdependent or interrelated with each other. The Company can, and frequently does, break portions of contracts into separate "runs" to meet manufacturing and construction schedules. As such, each piece of laboratory furniture is considered a separate and distinct performance obligation. The majority of the Company's products are customized to meet the specific architectural design and performance requirements of laboratory planners and end users. The finished laboratory furniture has no alternative use to the Company and the Company has an enforceable right to payment for performance completed to date. As such, revenue from the sales of customized laboratory furniture is recognized over time once the customization process has begun, using the units-of-production output method to measure progress towards completion. There is not a material amount of work-in-process for which the customization process has begun at the end of a reporting period. The Company believes this output method most reasonably reflects the Company's performance because it directly measures the value of the goods transferred to the customer. For standardized products sold by the Company, revenue is recognized when control transfers, which is typically freight on board ("FOB") shipping point.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All orders contain a standard warranty that warrants that the product is free from defects in workmanship and materials under normal use and conditions for a limited period of time. Due to the nature and quality of the Company's products, any warranty issues have historically been determined in a relatively short period after the sale, have been infrequent in nature, and have been immaterial to the Company's financial position and results of operations. The Company's standard warranties are not considered a separate and distinct performance obligation as the Company does not provide a service to customers beyond assurance that the covered product is free of initial defects. Costs of providing these short term assurance warranties are immaterial and, accordingly, are expensed as incurred. Extended separately priced warranties are available which can last up to ten years. Extended warranties are considered separate performance obligations as they are individually priced options providing assurances that the products are free of defects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Installation Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sometimes performs installation services for customers. The scope of installation services primarily relates to setting up and ensuring the proper functioning of the laboratory furniture. In certain markets, the Company may provide a broader range of installation services involving the design and installation of the laboratory's mechanical services. Installation services can be, and often are, performed by third parties and thus may be distinct from the Company's products. Installation services create or enhance assets that the customer controls as the installation services are provided. As such, revenue from installation services is recognized over time, as the installation services are performed using the cost input method, as there is a direct relationship between the Company's inputs and the transfer of control by means of the performance of installation services to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Custodial Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the laboratory and healthcare furniture industries for customers to request delivery at specific future dates, as products are often to be installed in buildings yet to be constructed. Frequently, customers will request the manufacture of these products prior to the customer's ability or readiness to receive the product due to various reasons such as changes to or delays in the construction of the building. As such, from time to time Kewaunee's customers require us to provide custodial services for their laboratory furniture. Custodial services are frequently provided by third parties and do not significantly alter the other goods or services covered by the contract and as such are considered a separate and distinct performance obligation. Custodial services are simultaneously received and consumed by the customer and as such revenue from custodial services is recognized over time using a straight-line time-based measure of progress towards completion, because the Company's services are provided evenly throughout the performance period.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="icc7b40ecc5ad4dbbbd99bd4a1c50ac2b" continuedAt="ic1d99e720c6941268b57c3cb497286d5"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment Terms and Transaction Prices</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with customers are generally fixed-price and do not contain variable consideration or a general right of return or refund. The Company's contracts with customers contain terms typical for Kewaunee's industry, including withholding a portion of the transaction price until after the goods or services have been transferred to the customer (i.e. "retainage"). The Company does not recognize this as a significant financing component because the primary purpose of retainage is to provide the customer with assurance that the Company will perform its obligations under the contract, rather than to provide financing to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allocation of Transaction Price</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with customers&#160;may cover multiple goods and services, such as differing types of laboratory furniture and installation services. For these arrangements, each good or service is evaluated to determine whether it represents a distinct performance obligation. The total transaction price is then allocated to the distinct performance obligations based on their relative standalone selling price at the inception of the arrangement. If available, the Company utilizes observable prices for goods or services sold separately to similar customers in similar circumstances to determine its relative standalone selling price. Otherwise, list prices are used if they are determined to be representative of standalone selling prices. If neither of these methods are available at contract inception, such as when the Company does not sell the product or service separately, judgment may be required and the Company determines the standalone selling price using one, or a combination of, the adjusted market assessment or expected cost-plus margin approaches.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients Used</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected the following practical expedients:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The portfolio approach was applied in evaluating the accounting for the cost of obtaining a contract.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payment terms with the Company's customers which are one year or less are not considered a significant financing component.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company excludes from revenues taxes it collects from customers that are assessed by a government authority. This is primarily relevant to domestic sales but also includes taxes on some international sales which are also excluded from the transaction price.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company's incremental cost to obtain a contract is limited to sales commissions. The Company applies the practical expedient to expense commissions as incurred for contracts having a duration of one year or less. Sales commissions related to contracts with a duration of greater than one year are immaterial to the Company's consolidated financial position and results of operations and are also expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-392" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of net sales transferred to customers at a point in time and over time for the twelve months ended April 30 is as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"></td><td style="width:52.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.080%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67f1ba03114040909ce8cdfc2a78ea6d_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-393">141,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6751dceadb374681b0c6d52cd75ece45_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-394">72,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a8537ecb2f1436aaeb85e43dc13d546_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-395">214,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76d8faf2554a4789a61384dd2757d22e_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-396">4,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8a41ff0b9c49e69f759968f6dd33fb_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-397">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic868b6191e614d7d9d37a313030673f7_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-398">4,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64432110caef45faafd30217f99ab7e5_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-399">146,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29c25bca73914a2e8b0740a217a19a70_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-400">72,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-401">219,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"></td><td style="width:52.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb71661af8d5440999566d760f9a4987_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-402">119,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4523e07e76d34e0986ee2172ffc114c8_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-403">42,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic72bb0d6c18f493c8331dbd53a1be173_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-404">162,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7066198457634c5c84c33711657d5762_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-405">6,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62c92cef71f4d728c84fa5dbdb324b6_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0d0017306a14071a889803879b2857a_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-407">6,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i158c57bc39694f63be232317e782c90e_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-408">126,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12df3466c7ff493e867302751a24bada_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-409">42,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-410">168,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:13pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing balances of contract assets included $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="0" id="f-411">13,459,000</ix:nonFraction> in accounts receivable and $<ix:nonFraction unitRef="usd" contextRef="i1252e42ba8f94788b9c2e9526358c016_I20230430" decimals="-3" name="kequ:UnbilledRetainageCurrent" format="ixt:num-dot-decimal" scale="0" id="f-412">1,191,000</ix:nonFraction> in other current assets at April&#160;30, 2023. The opening balance of contract assets arising from contracts with customers included $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="0" id="f-413">9,287,000</ix:nonFraction> in accounts receivable and $<ix:nonFraction unitRef="usd" contextRef="i31ecee99cb564fb4853c3bcd51ee186d_I20220430" decimals="-3" name="kequ:UnbilledRetainageCurrent" format="ixt:num-dot-decimal" scale="0" id="f-414">1,293,000</ix:nonFraction> in other assets at April&#160;30, 2022. The closing and opening balances of contract liabilities included in deferred revenue arising from contracts with customers were $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="0" id="f-415">4,097,000</ix:nonFraction> at April&#160;30, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="0" id="f-416">3,529,000</ix:nonFraction> at April&#160;30, 2022. The timing of revenue recognition, billings and cash collections results in accounts receivable, unbilled receivables, and deferred </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="ic1d99e720c6941268b57c3cb497286d5"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue which is disclosed on the consolidated balance sheets and in the notes to the consolidated financial statements. In general, the Company receives payments from customers based on a billing schedule established in its contracts. Unbilled receivables represent amounts earned which have not yet been billed in accordance with contractually stated billing terms. Accounts receivable are recorded when the right to consideration becomes unconditional and the Company has a right to invoice the customer. Deferred revenue relates to payments received in advance of performance under the contract. Deferred revenue is recognized as revenue as the Company performs under the contract.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended April&#160;30, 2023, changes in contract assets and liabilities were not materially impacted by any other factors. Approximately <ix:nonFraction unitRef="number" contextRef="i6a02acdd018f43b8b0f5cc560820651a_D20220501-20230430" decimals="INF" name="kequ:ContractWithCustomerLiabilityRevenueRecognizedPercentage" scale="-2" id="f-417">100</ix:nonFraction>% of the contract liability balance at April&#160;30, 2023 is expected to be recognized as revenue during fiscal year 2024.</span></div></ix:continuation><div id="i1de8d1053c4044f7aa1eb1bfb086781f_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:InventoryDisclosureTextBlock" id="f-418" continuedAt="iae3f186e93354518814db5cfb4941145" escape="true">Inventories</ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="iae3f186e93354518814db5cfb4941145" continuedAt="i52c8757e380f4fb1945cb942c72185c5"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-419" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following at April&#160;30:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.557%"><tr><td style="width:1.0%"></td><td style="width:75.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-420">3,412</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-421">4,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-422">2,380</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-423">2,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials and components</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-424">16,097</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="f-425">16,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-426">21,889</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-427">23,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i52c8757e380f4fb1945cb942c72185c5">At April&#160;30, 2023 and 2022, the Company's international subsidiaries' inventories were $<ix:nonFraction unitRef="usd" contextRef="ieb2d1acd7b3446289e9ad791d76db1de_I20230430" decimals="-3" name="us-gaap:FIFOInventoryAmount" format="ixt:num-dot-decimal" scale="0" id="f-428">2,740,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia4ff3442856846399487d370b1773546_I20220430" decimals="-3" name="us-gaap:FIFOInventoryAmount" format="ixt:num-dot-decimal" scale="0" id="f-429">2,811,000</ix:nonFraction>, respectively, measured using the lower of cost or net realizable value under the FIFO method and are included in the above tables.</ix:continuation> </span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:DebtDisclosureTextBlock" id="f-430" continuedAt="i28879a4dc3ba4a448b7a163bb59425bf" escape="true">Long-term Debt and Other Credit Arrangements </ix:nonNumeric></span></div><ix:continuation id="i28879a4dc3ba4a448b7a163bb59425bf" continuedAt="ic33e667d568e4808b134e235dc6c9dec"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;6, 2013, the Company entered into a credit and security agreement (the "Loan Agreement") consisting of a $<ix:nonFraction unitRef="usd" contextRef="i6a43198092b94ea889724f8b5846813b_I20130506" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-431">20</ix:nonFraction> million revolving credit facility ("Line of Credit") with Wells Fargo, National Bank, which originally matured in May 2018 and was extended numerous times until it was terminated in June 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, the Company entered into a Security Agreement  with Wells Fargo, National Bank, pursuant to which the Company granted a security interest in substantially all of its assets to secure its obligations under the Loan Agreement. On December&#160;13, 2019, the Company entered into an amendment to the Loan Agreement and the Line of Credit to effect a change to an asset based lending arrangement based on eligible accounts receivable and inventory, with the available amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="i6ffdef1e14f34eb8bad803398261c99d_I20191213" decimals="-6" name="kequ:DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity" scale="6" id="f-432">20</ix:nonFraction> million through January&#160;31, 2020, and with such maximum amount reduced to $<ix:nonFraction unitRef="usd" contextRef="i442be4c6913b49a4b50ea772baaab2d6_I20200201" decimals="-6" name="kequ:DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity" scale="6" id="f-433">15</ix:nonFraction> million thereafter. This amendment replaced the prior financial covenants with new financial covenants, including minimum monthly liquidity and EBITDA requirements. Additionally, a requirement for the repatriation of foreign cash and restrictions on the payment of dividends were added. The Security Agreement was amended several times during fiscal years 2022 and 2023 as the Company was finalizing the Sale-Leaseback financing transaction discussed in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_106">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These amendments were primarily driven by requirements and timing of the Company's new credit arrangement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2022, the Company terminated the Credit Agreement with Wells Fargo, National Bank. At the time of termination, there were <ix:nonFraction unitRef="usd" contextRef="i1b182470888b4bfbbed867265f9c5935_I20220627" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="0" id="f-434">no</ix:nonFraction> borrowings under the Credit Agreement, and the Company did not incur any material termination penalties as a result of the termination. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2022, there were advances of $<ix:nonFraction unitRef="usd" contextRef="i9ae780b25bd64b349ff3f0cdb52c391c_I20220430" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-435">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7e3cd898d91a4be8995d0dc84050feba_I20220430" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="0" id="f-436">716,000</ix:nonFraction> in letters of credit outstanding, leaving $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-437">2.4</ix:nonFraction> million available under the Line of Credit. The borrowing rate under the Line of Credit at that date was <ix:nonFraction unitRef="number" contextRef="ie1cc410519c54218bd0491e4a36cd2ea_I20220430" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="f-438">4.75</ix:nonFraction>%. Monthly interest payments under the Line of Credit were payable at the greater of the Daily One Month LIBOR interest rate, or <ix:nonFraction unitRef="number" contextRef="i8817c527703e49429894104cdd1d7ecc_D20210501-20220430" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-439">0.75</ix:nonFraction>%, plus <ix:nonFraction unitRef="number" contextRef="id54523868cb9492da803a3fdb87635d5_D20210501-20220430" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-440">4.0</ix:nonFraction>%. At April&#160;30, 2022, the Company was in compliance with all the financial covenants under its revolving credit facility.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2022, the Company entered into a Credit and Security Agreement (the "Credit Agreement") with Mid Cap Funding IV Trust, as agent (the "Agent"), and the lenders from time to time party thereto (collectively, the "Lenders"). The Credit Agreement provides for a secured revolving line of credit initially up to $<ix:nonFraction unitRef="usd" contextRef="i546d1702d5294252997efbcc4760c0d2_I20221219" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-441">15.0</ix:nonFraction>&#160;million (the "Revolving Credit Facility"). Availability under the Revolving Credit Facility is subject to a borrowing base calculated in accordance with the terms of the Credit Agreement and on the basis of eligible accounts and inventory and certain other reserves and adjustments. Pursuant to the Credit Agreement, the Company granted to the Agent, for itself and the Lenders, a first priority security interest in all existing and future acquired assets owned by the Company. Subject to the terms of the Credit Agreement, from time to time the Company may request that the initial revolving loan amount available under the Revolving Credit Facility be increased with additional tranches in minimum amounts of $<ix:nonFraction unitRef="usd" contextRef="i546d1702d5294252997efbcc4760c0d2_I20221219" decimals="-6" name="kequ:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="0" id="f-442">1,000,000</ix:nonFraction>, up to a maximum borrowing availability of $<ix:nonFraction unitRef="usd" contextRef="i546d1702d5294252997efbcc4760c0d2_I20221219" decimals="-5" name="kequ:LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" format="ixt:num-dot-decimal" scale="6" id="f-443">30.0</ix:nonFraction>&#160;million. The Agent and Lenders must consent to any such increase in their sole discretion. The Revolving Credit Facility matures on December 19, 2025.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="ic33e667d568e4808b134e235dc6c9dec"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to Term SOFR (Secured Overnight Financing Rate) plus <ix:nonFraction unitRef="number" contextRef="i77d740aedb144bb0ad536168beb98a3c_D20221219-20221219" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-444">4.10</ix:nonFraction>%. The Company is required to make monthly interest payments on the Revolving Credit Facility, with the entire principal payment due at maturity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="i68739a09bcb74732ad67255efa20ec71_I20230430" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="0" id="f-445">3,548,000</ix:nonFraction> outstanding under the Revolving Credit Facility, with remaining borrowing capacity under the Revolving Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="i68739a09bcb74732ad67255efa20ec71_I20230430" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="0" id="f-446">10,286,000</ix:nonFraction>. The borrowing rate under the Revolving Credit Facility was <ix:nonFraction unitRef="number" contextRef="i68739a09bcb74732ad67255efa20ec71_I20230430" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="f-447">9.02</ix:nonFraction>% as of April&#160;30, 2023. At April&#160;30, 2023, the Company was in compliance with all financial covenants under its revolving credit facility. In addition, the Company's International subsidiaries have a balance outstanding of $<ix:nonFraction unitRef="usd" contextRef="ibc3c4ae466f84e8aa27fac57a2ef3a4a_I20230430" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="0" id="f-448">39,000</ix:nonFraction> in short-term borrowings related to overdraft protection and short-term loan arrangements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2023, there were foreign bank guarantees outstanding to customers in the amounts of $<ix:nonFraction unitRef="usd" contextRef="i5ee2c5a57bb34a47b58f57f8e3d1c42d_I20230430" decimals="-5" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-449">5.2</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i3e58a0cf3d454dedbd6523de24bb050f_I20230430" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-450">142,000</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i18991e1526b14ffd876d57c01cbb0bde_I20230430" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-451">3,000</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="if7d1f7a7276349cca788e17cd7c0ef20_I20230430" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-452">233,000</ix:nonFraction> with expiration dates in fiscal years 2024, 2025, 2026, and 2027, respectively, collateralized by certain assets of the Company's subsidiaries in India. At April 30, 2022, there were bank guarantees issued by foreign banks outstanding to customers in the amounts of $<ix:nonFraction unitRef="usd" contextRef="i040d62d3dd79442993ccc580b1141db5_I20220430" decimals="-5" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-453">8.2</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="id3242c4e7dfc44caa5252683fd462cbc_I20220430" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-454">111,000</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i07a66023f9b1454788d7c1753ac27d49_I20220430" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-455">9,000</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ia2bdb86fad2b464f9159d4e51f919a4b_I20220430" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-456">3,000</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i2e3b5ea3288d445dbfb4e15eb2d7eff1_I20220430" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-457">249,000</ix:nonFraction> with expiration dates in fiscal years 2023, 2024, 2025, 2026, and 2027, respectively, collateralized by a $<ix:nonFraction unitRef="usd" contextRef="i68ff7bf3b6ef494bb98b7aeeb082d754_I20220430" decimals="-5" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" scale="6" id="f-458">6.0</ix:nonFraction> million corporate guarantee and certain assets of the Company's subsidiaries in India.</span></div></ix:continuation><div id="i1de8d1053c4044f7aa1eb1bfb086781f_106"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:SaleLeasebackTransactionDisclosureTextBlock" id="f-459" continuedAt="i548a1cc8c5454a5ca56ad5f5be098a2f" escape="true">Sale-Leaseback Financing Transaction</ix:nonNumeric></span></div><ix:continuation id="i548a1cc8c5454a5ca56ad5f5be098a2f" continuedAt="i6c25d6acb6ac4eeb9f85e3ae11349f36"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2021, the Company entered into the Sale Agreement with the Buyer for the Company&#8217;s headquarters and manufacturing facilities located at 2700 West Front Street in Statesville, North Carolina.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and the Buyer entering into the Lease Agreement. The Sale-Leaseback Arrangement is repayable over a <ix:nonNumeric contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" name="kequ:FinancingLiabilityTermOfContract" format="ixt-sec:durwordsen" id="f-460">20-year</ix:nonNumeric> term, with <ix:nonFraction unitRef="renewaloption" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="0" name="kequ:FinancingLiabilityNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="f-461">four</ix:nonFraction> renewal options of <ix:nonNumeric contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" name="kequ:FinancingLiabilityRenewalTerm" format="ixt-sec:durwordsen" id="f-462">five years</ix:nonNumeric> each. Under the terms of the Lease Agreement, the Company&#8217;s initial basic rent is approximately $<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:FinancingLiabilityBasicMonthlyPayment" format="ixt:num-dot-decimal" scale="0" id="f-463">158,000</ix:nonFraction> per month, with annual increases of approximately <ix:nonFraction unitRef="number" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="kequ:FinancingLiabilityAnnualIncreasePercent" scale="-2" id="f-464">2</ix:nonFraction>% each year of the initial term.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Sale-Leaseback Arrangement as a financing transaction with the Buyer in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as the Lease Agreement was determined to be a finance lease. The Company concluded the Lease Agreement met the qualifications to be classified as a finance lease due to the significance of the present value of the lease payments, using a discount rate of <ix:nonFraction unitRef="number" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="INF" name="us-gaap:LesseeFinanceLeaseDiscountRate" scale="-2" id="f-465">4.75</ix:nonFraction>% to reflect the Company&#8217;s incremental borrowing rate, compared to the fair value of the leased property as of the lease commencement date. In measuring the lease payments for the present value analysis, the Company elected the practical expedient to combine the lease component (the leased facilities) with the non-lease component (property management provided by the Buyer/Lessor) into a single lease component. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presence of a finance lease indicates that control of the Property has not transferred to the Buyer/Lessor and, as such, the transaction was deemed a failed sale-leaseback and accounted for as a financing arrangement. As a result of this determination, the Company is viewed as having received the sales proceeds from the Buyer/Lessor in the form of a hypothetical loan collateralized by its leased facilities. The hypothetical loan is payable as principal and interest in the form of &#8220;lease payments&#8221; to the Buyer/Lessor. As such, the Company will not derecognize the Property from its books for accounting purposes until the lease ends. <ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" format="ixt:fixed-zero" scale="0" id="f-466">No</ix:nonFraction> gain or loss was recognized related to the Sale-Leaseback Arrangement under U.S. GAAP.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 30, 2023, the carrying value of the financing liability was $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiability" format="ixt:num-dot-decimal" scale="0" id="f-467">28,774,000</ix:nonFraction>, net of $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="0" id="f-468">708,000</ix:nonFraction> in debt issuance costs, of which $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-469">642,000</ix:nonFraction> was classified as current on the Consolidated Balance Sheet with $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-470">28,132,000</ix:nonFraction> classified as long-term. As of April&#160;30, 2022, the carrying value of the financing liability was $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:FinancingLiability" format="ixt:num-dot-decimal" scale="0" id="f-471">29,350,000</ix:nonFraction>, net of $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="0" id="f-472">768,000</ix:nonFraction> in debt issuance costs, of which $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:FinancingLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-473">575,000</ix:nonFraction> was classified as current on the Consolidated Balance Sheet with $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:FinancingLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-474">28,775,000</ix:nonFraction> classified as long-term. The monthly lease payments are split between a reduction of principal and interest expense using the effective interest rate method. Interest expense associated with the financing arrangement was $<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:InterestExpenseFinancingLiability" format="ixt:num-dot-decimal" scale="0" id="f-475">1,316,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:InterestExpenseFinancingLiability" format="ixt:num-dot-decimal" scale="0" id="f-476">147,000</ix:nonFraction> for the years ended April 30, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will depreciate the building down to zero over the <ix:nonNumeric contextRef="i63ec6c47db8041f29ab17eb138d30e46_D20220501-20230430" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-477">20-year</ix:nonNumeric> assumed economic life of the Property so that at the end of the lease term, the remaining carrying amount of the financing liability will equal the carrying amount of the land of $<ix:nonFraction unitRef="usd" contextRef="i90242fcce5d84297ba58ac37f58d01eb_I20230430" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-478">41,000</ix:nonFraction>.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" id="f-479" continuedAt="ibc4bd74f1b1d478dbe1db37065ed03cd" escape="true">Remaining future cash payments related to the financing liability for the fiscal years ending April 30 are as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="text-align:center"><ix:continuation id="i6c25d6acb6ac4eeb9f85e3ae11349f36"><ix:continuation id="ibc4bd74f1b1d478dbe1db37065ed03cd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.293%"><tr><td style="width:1.0%"></td><td style="width:67.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityToBePaidYearOne" format="ixt:num-dot-decimal" scale="3" id="f-480">1,931</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityToBePaidYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-481">1,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityToBePaidYearThree" format="ixt:num-dot-decimal" scale="3" id="f-482">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityToBePaidYearFour" format="ixt:num-dot-decimal" scale="3" id="f-483">2,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityToBePaidYearFive" format="ixt:num-dot-decimal" scale="3" id="f-484">2,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityToBePaidAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-485">33,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Liability Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityToBePaid" format="ixt:num-dot-decimal" scale="3" id="f-486">43,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-487">15,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:FinancingLiability" format="ixt:num-dot-decimal" scale="3" id="f-488">28,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_109"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-489" continuedAt="if4962a2484854b04bbd4754e32d0f219" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="if4962a2484854b04bbd4754e32d0f219" continuedAt="id9eba7eb61934f0fab71bdb61577a214"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") was signed into law, which contains several income tax provisions, as well as other measures, aimed at assisting businesses impacted by the economic effects of the COVID-19 pandemic. The CARES Act includes a broad range of tax reform provisions affecting businesses, including permissible net operating losses ("NOLs") carrybacks up to <ix:nonNumeric contextRef="ia4b416d20e6c41dca68290de29b3950c_D20200327-20200327" name="kequ:CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod" format="ixt-sec:durwordsen" id="f-490">five years</ix:nonNumeric>, changes in business deductions limitations, and deferral of Social Security withholdings. The Company applied the NOL carryback provision of the CARES Act with respect to its estimated NOL for fiscal year 2021 to years that had higher enacted tax rates. The Company also applied the deferral of Social Security withholdings in accordance with the CARES Act; 50% of these deferred withholdings were due and paid by December 31, 2021, with the remainder due and paid by December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 1, 2019, the Company elected to revoke the indefinite reinvestment of foreign unremitted earnings position set forth by ASC 740-30-25-17 for multiple foreign subsidiaries. As a result of this election, the Company recorded a tax withholding expense imposed by the India Income Tax Department of $<ix:nonFraction unitRef="usd" contextRef="ia09ed2386bef4571af63546d7275fed5_D20220501-20230430" decimals="-3" name="kequ:TaxWithholdingExpense" format="ixt:num-dot-decimal" scale="0" id="f-491">406,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i76e58b3cdbee43328d425bf866be46cb_D20210501-20220430" decimals="-3" name="kequ:TaxWithholdingExpense" format="ixt:num-dot-decimal" scale="0" id="f-492">240,000</ix:nonFraction> for the years ended April 30, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the Tax Cuts and Job Act amended Internal Revenue Code Section 174, effective for tax years beginning after December 31, 2021. This amendment to Section 174, effective during fiscal year 2023 for the Company, eliminated the current year deductibility of research and experimentation expenditures and required the Company to deduct these expenditures over <ix:nonNumeric contextRef="ic4fc91d4336742bca6f7d1456d6b6290_D20171222-20171222" name="kequ:Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility" format="ixt-sec:durwordsen" id="f-493">five years</ix:nonNumeric>. The impact of this tax regulation required the Company to record a new deferred tax asset of $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:DeferredTaxAssetsSection174REAddback" format="ixt:num-dot-decimal" scale="0" id="f-494">1,558,000</ix:nonFraction> as of April 30, 2023. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's accounting policy with respect to the Global Intangible Low-Taxed Income ("GILTI") tax rules is that GILTI will be treated as a periodic charge in the year in which it arises.</span></div><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-495" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:64.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="f-496">691</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-497">1,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-498">197</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="f-499">490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-500">1,736</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:CurrentForeignTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-501">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-502">2,624</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-503">3,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-504">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-505">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-506">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-507">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="f-508">515</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" id="f-509">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-510">515</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-511">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-512">3,139</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-513">3,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="id9eba7eb61934f0fab71bdb61577a214" continuedAt="icb5a660a3e354caeaecfd523be24832c"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-514" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reasons for the differences between the above net income tax expense and the amounts computed by applying the statutory federal income tax rate to earnings before income taxes are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"><tr><td style="width:1.0%"></td><td style="width:66.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="f-515">945</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="f-516">432</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal income tax benefit </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="f-517">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="f-518">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits (state, net of federal benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCredits" scale="3" id="f-519">433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCredits" scale="3" id="f-520">457</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of differing US and foreign tax rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-521">260</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-522">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" format="ixt:fixed-zero" scale="3" id="f-523">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" scale="3" id="f-524">286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" scale="3" id="f-525">413</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" format="ixt:fixed-zero" scale="3" id="f-526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign subsidiary income to parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="3" id="f-527">99</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="3" id="f-528">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-529">1,667</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-530">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="f-531">307</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="f-532">456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-533">3,139</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-534">3,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-535" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items comprising deferred tax assets and liabilities as of April&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee benefit expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" scale="3" id="f-536">153</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" scale="3" id="f-537">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="f-538">114</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="f-539">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" format="ixt:num-dot-decimal" scale="3" id="f-540">1,156</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" format="ixt:num-dot-decimal" scale="3" id="f-541">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits (state, net of federal benefits)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="f-542">170</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="f-543">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" scale="3" id="f-544">638</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" scale="3" id="f-545">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;E Addback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:DeferredTaxAssetsSection174REAddback" format="ixt:num-dot-decimal" scale="3" id="f-546">1,558</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:DeferredTaxAssetsSection174REAddback" format="ixt:fixed-zero" scale="3" id="f-547">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial loss, defined benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" format="ixt:num-dot-decimal" scale="3" id="f-548">1,064</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" format="ixt:num-dot-decimal" scale="3" id="f-549">1,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves and capitalized costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="f-550">201</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="f-551">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="f-552">249</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="f-553">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:DeferredTaxAssetsProceedsOnSaleLeaseback" format="ixt:num-dot-decimal" scale="3" id="f-554">6,963</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:DeferredTaxAssetsProceedsOnSaleLeaseback" format="ixt:num-dot-decimal" scale="3" id="f-555">7,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:DeferredTaxAssetLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-556">1,558</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:DeferredTaxAssetLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-557">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-558">254</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-559">449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-560">14,078</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-561">11,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-562">1,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-563">1,758</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of Sale Leaseback property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:DeferredTaxLiabilitiesSaleLeasebackProperty" format="ixt:num-dot-decimal" scale="3" id="f-564">1,106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:DeferredTaxLiabilitiesSaleLeasebackProperty" format="ixt:num-dot-decimal" scale="3" id="f-565">1,122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid pension</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:DeferredTaxLiabilitiesPrepaidPensionCost" scale="3" id="f-566">919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:DeferredTaxLiabilitiesPrepaidPensionCost" scale="3" id="f-567">949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APB 23 Assertion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="kequ:DeferredTaxLiabilitiesAPB23Assertion" format="ixt:num-dot-decimal" scale="3" id="f-568">1,318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="kequ:DeferredTaxLiabilitiesAPB23Assertion" scale="3" id="f-569">976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-570">1,526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:fixed-zero" scale="3" id="f-571">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt Issuance Cost on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" scale="3" id="f-572">167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" scale="3" id="f-573">184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-574">6,453</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-575">4,989</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-576">8,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-577">6,901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="f-578">943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="f-579">428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities) classified in the balance sheet:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b14126cfd04589a48a1267cb447516_I20230430" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="f-580">943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18837955ad44418ebb8430792c895f28_I20220430" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="f-581">428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="f-582">943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="f-583">428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to evaluate the realization of the deferred tax asset and any requirement for a valuation allowance in accordance with ASC 740-10-30-2(b). This guidance provides that the future realization of the tax benefit of an existing deductible temporary difference or carryforward ultimately depends on sufficient taxable income of the appropriate character within the carryback or carryforward period available under the tax law. The Company evaluates all available evidence, both </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="icb5a660a3e354caeaecfd523be24832c"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">positive and negative, to determine the amount of any required valuation allowance. The valuation allowance totaled $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="f-584">8,568,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="0" id="f-585">6,901,000</ix:nonFraction> at April&#160;30, 2023 and 2022, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2023, the Company had foreign tax credit carryforwards in the amount of $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign" format="ixt:num-dot-decimal" scale="0" id="f-586">638,000</ix:nonFraction>, which are subject to a full valuation allowance, and which will begin to expire in 2028.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal, state and local tax returns with statutes of limitation generally ranging from <ix:nonNumeric contextRef="ia90c11936dba4904a9531ab5d52fbbd5_D20220501-20230430" name="kequ:FederalStateAndLocalTaxReturnsPeriod" format="ixt-sec:duryear" id="f-587">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430" name="kequ:FederalStateAndLocalTaxReturnsPeriod" format="ixt-sec:duryear" id="f-588">4</ix:nonNumeric> years. The Company is generally no longer subject to federal tax examinations for years prior to fiscal year 2019 or state and local tax examinations for years prior to fiscal year 2018. Tax returns filed by the Company's significant foreign subsidiaries are generally subject to statutes of limitations of <ix:nonNumeric contextRef="ia90c11936dba4904a9531ab5d52fbbd5_D20220501-20230430" name="kequ:ForeignSubsidiariesTaxReturnsPeriod" format="ixt-sec:duryear" id="f-589">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430" name="kequ:ForeignSubsidiariesTaxReturnsPeriod" format="ixt-sec:duryear" id="f-590">7</ix:nonNumeric> years and are generally no longer subject to examination for years prior to fiscal year 2017. The Company has no unrecognized tax benefits.</span></div></ix:continuation><div id="i1de8d1053c4044f7aa1eb1bfb086781f_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="f-591" continuedAt="iae05dca21fe14d45ab2b76f24793f0e0" escape="true">Stock Options and Share-Based Compensation </ix:nonNumeric></span></div><ix:continuation id="iae05dca21fe14d45ab2b76f24793f0e0" continuedAt="ibacaf17991304713b6ceed44cf89e4d9"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's stockholders approved the 2017 Omnibus Incentive Plan ("2017 Plan") on August&#160;30, 2017, which enables the Company to grant a broad range of equity, equity-related, and non-equity types of awards, with potential recipients including directors, consultants and employees. This plan replaced the 2010 Stock Option Plan for Directors and the 2008 Key Employee Stock Option Plan. <ix:nonFraction unitRef="shares" contextRef="id553a2e4e4c34c41aad075cfe7d7e942_I20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="0" id="f-592">No</ix:nonFraction> new awards will be granted under the prior plans and all outstanding options granted under the prior plans will remain subject to the prior plans. At the date of approval of the 2017 Plan there were <ix:nonFraction unitRef="shares" contextRef="i0df14ac1694242918bf120280e13b5e4_I20170830" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-593">280,100</ix:nonFraction> shares available for issuance under the prior plans. These shares and any shares subject to outstanding awards that subsequently cease to be subject to such awards are available under the 2017 Plan. The 2017 Plan did not increase the total number of shares available for issuance under the Company's equity compensation plans. At April&#160;30, 2023 there were <ix:nonFraction unitRef="shares" contextRef="id145fd41da7a42d8bf28d16bf42e6e73_I20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-594">149,007</ix:nonFraction> shares available for future issuance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2017 Plan, the Company recorded stock-based compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i856a73272e2d43a39d425e3dec7e46cd_D20220501-20230430" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-595">845,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie0f4be86b27e4b73ba9843141170627d_D20210501-20220430" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-596">701,000</ix:nonFraction> and deferred income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i856a73272e2d43a39d425e3dec7e46cd_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-597">199,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie0f4be86b27e4b73ba9843141170627d_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-598">165,000</ix:nonFraction> in fiscal years 2023 and 2022, respectively. The RSUs include grants with both a service and performance component vesting over a <ix:nonNumeric contextRef="i856a73272e2d43a39d425e3dec7e46cd_D20220501-20230430" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="f-599">3</ix:nonNumeric> year period and grants with only service components vesting over <ix:nonNumeric contextRef="ie3d01a1650ac43cca9d9a27d1d799fb8_D20220501-20230430" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="f-600">2</ix:nonNumeric> and <ix:nonNumeric contextRef="i63348bc16c724f1f8d2b204017cbb09b_D20220501-20230430" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="f-601">3</ix:nonNumeric> year periods. The recognized expense is based upon the vesting period for service criteria and estimated attainment of the performance criteria at the end of the performance period based on the ratio of cumulative days incurred to total days over the performance period. The remaining estimated compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i7f51b34728494fe387a9da7cbaaecf7f_I20230430" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="0" id="f-602">812,000</ix:nonFraction> will be recorded over the remaining vesting periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RSU granted to employees was estimated on the date of grant based on the weighted average price of the Company's stock reduced by the present value of the expected dividend stream during the vesting period using the risk-free interest rate. The Company issued new shares of common stock to satisfy RSUs that vested during fiscal year 2023. <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-603" continuedAt="i9200f42ef0dd4ab0a694507272636d1b" escape="true">The following table summarizes the RSU activity and weighted averages.</ix:nonNumeric></span></div><div style="text-align:justify"><ix:continuation id="i9200f42ef0dd4ab0a694507272636d1b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.839%"><tr><td style="width:1.0%"></td><td style="width:48.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idadad6c5f93d416caf379a3ec3da9055_I20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-604">144,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idadad6c5f93d416caf379a3ec3da9055_I20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-605">12.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if60aac1ba48e4bd790f9b0fafdf6e109_I20210430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-606">125,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if60aac1ba48e4bd790f9b0fafdf6e109_I20210430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-607">12.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-608">87,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-609">13.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-610">67,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-611">13.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-612">50,315</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-613">13.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-614">31,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-615">12.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-616">22,841</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-617">15.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-618">16,197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-619">21.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i81ebd11ae8384005a4122c79a54d0388_I20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-620">159,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i81ebd11ae8384005a4122c79a54d0388_I20230430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-621">11.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idadad6c5f93d416caf379a3ec3da9055_I20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-622">144,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idadad6c5f93d416caf379a3ec3da9055_I20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-623">12.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stockholders approved the 2008 Key Employee Stock Option Plan ("2008 Plan") in fiscal year 2009 which allowed the Company to grant options on an aggregate of <ix:nonFraction unitRef="shares" contextRef="ib7bce12c1c32423e8650a7aa2cca14a6_I20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-624">300,000</ix:nonFraction> shares of the Company's common stock. On August&#160;26, 2015, the stockholders approved an amendment to this plan to increase the number of shares available under the 2008 Plan by <ix:nonFraction unitRef="shares" contextRef="i4ca44f1ca15a49c686f4c491a93f8591_D20150826-20150826" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-625">300,000</ix:nonFraction> shares. Under the plan, options were granted at not less than the fair market value at the date of grant and options are exercisable in such installments, for such terms (up to <ix:nonNumeric contextRef="i93b7e975c5f64cc6b08cfc1e4e83c167_D20220501-20230430" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="f-626">10</ix:nonNumeric> years), and at such times, as the Board of Directors determined at the time of the grant. At April&#160;30, 2023, there were <ix:nonFraction unitRef="shares" contextRef="iabe50ea0d70a4c4395aa06274568ff1c_D20220501-20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-627">no</ix:nonFraction> shares available for future grants under the 2008 Plan. Under the 2008 Plan, the Company recorded <ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:ShareBasedCompensationDeferredTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-628"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:fixed-zero" scale="0" id="f-629"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:ShareBasedCompensationDeferredTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-630"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:fixed-zero" scale="0" id="f-631">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> compensation expense or deferred income tax benefit in fiscal year 2023 or 2022. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to determine the fair value of stock options on the date of grant, the Company applied the Black-Scholes option pricing model. Inherent in the model are assumptions related to expected stock-price volatility, option life, risk-free interest rate, and dividend yield. The stock options outstanding have the "plain-vanilla" characteristics as defined in SEC Staff Accounting Bulletin No.&#160;107 (SAB 107). The Company utilized the Safe Harbor option "Simplified Method" to determine the expected term of these options in accordance with the guidance of SAB&#160;107 for options outstanding. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="ibacaf17991304713b6ceed44cf89e4d9"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued new shares of common stock to satisfy options exercised during fiscal years 2023 and 2022. <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-632" continuedAt="ie06a4f9134c048b6907e5e9af20b639d" escape="true">Stock option activity and weighted average exercise price are summarized as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ie06a4f9134c048b6907e5e9af20b639d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:40.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-633">47,400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-634">19.34</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-635">84,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-636">18.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-637">7,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-638">20.08</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-639">35,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-640">17.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-641">5,650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-642">14.54</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-643">1,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-644">8.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-645">33,900</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-646">19.97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-647">47,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-648">19.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-649">33,900</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-650">19.97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-651">47,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-652">19.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="f-653" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of options outstanding, exercisable, and their weighted average exercise prices were within the following ranges at April&#160;30, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.717%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-654">15.85</ix:nonFraction>-$<ix:nonFraction unitRef="usdPerShare" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-655">23.62</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-656">33,900</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-657">19.97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining contractual life</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-658">2.5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-659">1,400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="0" id="f-660">33,900</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="2" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" id="f-661">19.97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-662">1,400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_115"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="f-663" continuedAt="i56239fa92cd94b5081790e71ccb51429" escape="true">Accumulated Other Comprehensive Income (Loss)</ix:nonNumeric></span></div><ix:continuation id="i56239fa92cd94b5081790e71ccb51429"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's other comprehensive income (loss) consists of unrealized gains and losses on the translation of the assets, liabilities, and equity of its foreign subsidiaries, and additional minimum pension liability adjustments, net of income taxes. <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="f-664" continuedAt="ie82ded9dccca43e19be3b44393e010e1" escape="true">The before tax income (loss), related income tax effect, and accumulated balances are as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ie82ded9dccca43e19be3b44393e010e1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum<br/>Pension<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0587fe00cae74bec97d95dac2c6e3805_I20210430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-665">2,357</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58cc8871d7854cf58997cb98992e51f7_I20210430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-666">1,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-667">3,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i375a69d8f72741c3b852a98fd7b2e36d_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-668">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-669">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4fb45c9d24746b3a2e1197cf86d9d3a_D20210501-20220430" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="f-670">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="f-671">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09cf305d1de04959b7bda23aa95706a3_I20220430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-672">2,543</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iceca130826c3475f9ab063adc1f5f5cb_I20220430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-673">1,199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-674">3,742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i302d0d54469e442197359aabf6bc4272_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-675">290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="3" id="f-676">290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ccfacb4e2c84a068c3ca01af64454f4_D20220501-20230430" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="f-677">590</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="3" id="f-678">590</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i474fdf01402c4320988de23ca2856814_I20230430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-679">2,833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6ebb0ed884a4d85b16577907b09659a_I20230430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-680">609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-681">3,442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_118"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-682" continuedAt="i5ed344b57576499ab0fabf5949ba3847" escape="true">Leases, Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i5ed344b57576499ab0fabf5949ba3847" continuedAt="icea0307b89b641669bc91792e4120356"><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes lease assets and lease liabilities with respect to the rights and obligations created by leased assets previously classified as operating leases. The Company elected to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Record the impact of adoption using a modified retrospective method with any cumulative effect as an adjustment to retained earnings (accumulated deficit) as opposed to restating comparative periods to reflect the effects of applying the new standard.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elect the package of three transition practical expedients which alleviate the requirements to reassess embedded leases, lease classification and initial direct costs for leases that commenced prior to the adoption date.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="icea0307b89b641669bc91792e4120356"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elected to use the short-term lease recognition exemption for all asset classes. This means, for those leases that qualify, the Company will not recognize right-of-use ("ROU") assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets.</span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating type leases for real estate and equipment in both the U.S. and internationally and financing leases for equipment in the United States. ROU assets totaled $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-683">9,170,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="0" id="f-684">7,573,000</ix:nonFraction> at April&#160;30, 2023 and 2022, respectively. Operating cash paid to settle lease liabilities was $<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-1" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="0" id="f-685">2,278,640</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="0" id="f-686">2,019,000</ix:nonFraction> for the fiscal year ended April 30, 2023 and 2022, respectively. The Company's leases have remaining lease terms of up to <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:LesseeRemainingLeaseTerm" format="ixt-sec:duryear" id="f-687">8</ix:nonNumeric> years. In addition, some of the leases may include options to extend the leases for up to <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:LesseeOptiontoExtendTerm" format="ixt-sec:duryear" id="f-688">5</ix:nonNumeric> years or options to terminate the leases within <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:LesseeOptiontoTerminateTerm" format="ixt-sec:duryear" id="f-689">1</ix:nonNumeric> year. Operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="f-690">3,344,000</ix:nonFraction> for the twelve months ended April 30, 2023, inclusive of period cost for short-term leases, not included in lease liabilities, of $<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:OperatingLeaseShortTermExpense" format="ixt:num-dot-decimal" scale="0" id="f-691">1,065,000</ix:nonFraction>. Operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="0" id="f-692">3,067,000</ix:nonFraction> for the fiscal year ended April 30, 2022, inclusive of period cost for short-term leases, not included in lease liabilities, of $<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:OperatingLeaseShortTermExpense" format="ixt:num-dot-decimal" scale="0" id="f-693">1,048,000</ix:nonFraction>.</span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2023, the weighted average remaining lease term for the capitalized operating leases was <ix:nonNumeric contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-694">5.1</ix:nonNumeric> years and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-695">5.0</ix:nonFraction>%. At April&#160;30, 2022, the weighted average remaining lease term for the capitalized operating leases was <ix:nonNumeric contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-696">5.8</ix:nonNumeric> years and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-697">4.1</ix:nonFraction>%. For the financing leases, the weighted average remaining lease term was <ix:nonNumeric contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-698">3.1</ix:nonNumeric> years and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-699">6.8</ix:nonFraction>% at April&#160;30, 2023 as compared to <ix:nonNumeric contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-700">3.8</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-701">6.6</ix:nonFraction>% at April&#160;30, 2022. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-702" continuedAt="id9586e5c9d70495c903d567658dff7e2" escape="true"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-703" continuedAt="i1ba12e4d82294ef496aa01106d1fd19c" escape="true">Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="id9586e5c9d70495c903d567658dff7e2"><ix:continuation id="i1ba12e4d82294ef496aa01106d1fd19c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"><tr><td style="width:1.0%"></td><td style="width:60.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.221%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.198%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-704">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="f-705">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-706">2,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="f-707">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-708">1,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="f-709">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-710">1,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:fixed-zero" scale="3" id="f-711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-712">1,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" format="ixt:fixed-zero" scale="3" id="f-713">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-714">1,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="3" id="f-715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Lease Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-716">10,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="f-717">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-718">1,533</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-719">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-720">9,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="f-721">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain claims and legal proceedings in the normal course of business which management believes will not have a material adverse effect on the Company's consolidated financial condition or results of operations.</span></div></ix:continuation><div id="i1de8d1053c4044f7aa1eb1bfb086781f_121"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-722" continuedAt="i3081f3f3978e4b8c8a273529f0035dd2" escape="true">Retirement Benefits</ix:nonNumeric></span></div><ix:continuation id="i3081f3f3978e4b8c8a273529f0035dd2" continuedAt="i8f0d9ecf027745adb1e077f9f3970d61"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has non-contributory defined benefit pension plans covering some of its domestic employees. These plans were amended as of April&#160;30, 2005, no further benefits have been, or will be, earned under the plans subsequent to the amendment date, and no additional participants will be added to the plans. The defined benefit plan for salaried employees provides pension benefits that are based on each employee's years of service and average annual compensation during the last ten consecutive calendar years of employment as of April&#160;30, 2005. The benefit plan for hourly employees provides benefits at stated amounts based on years of service as of April&#160;30, 2005. The Company uses an April&#160;30 measurement date for its defined benefit plans. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="i8f0d9ecf027745adb1e077f9f3970d61" continuedAt="ib5753d2a55444c9e98e6619f4a6855fc"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" id="f-723" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in projected benefit obligations and the change in fair value of plan assets for the non-contributory defined benefit pension plans for each of the years ended April&#160;30 are summarized as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation, April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-724">18,368</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-725">20,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-726">20,022</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-727">22,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-728">845</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-729">710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-730">1,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-731">2,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="f-732">1,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="f-733">1,412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-734">18,368</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="3" id="f-735">20,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-736">18,867</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-737">21,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="3" id="f-738">251</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-739">1,180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="3" id="f-740">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="3" id="f-741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="f-742">1,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" format="ixt:num-dot-decimal" scale="3" id="f-743">1,412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-744">17,732</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-745">18,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status&#8212;under</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="3" id="f-746">636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="3" id="f-747">1,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in the Consolidated Balance Sheets consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="3" id="f-748">636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-749">1,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actual loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-750">4,526</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-751">5,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" format="ixt:num-dot-decimal" scale="3" id="f-752">1,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" format="ixt:num-dot-decimal" scale="3" id="f-753">1,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax actuarial loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-754">3,462</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-755">3,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Benefit Obligations at April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-756">5.10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="f-757">4.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pri-2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pri-2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projection scale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MP-2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP-2020</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended April 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-758">5.10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="f-759">4.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-760">7.75</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="f-761">7.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="f-762" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net periodic pension (income) expense for each of the fiscal years ended April&#160;30 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-763">845</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="f-764">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-765">1,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-766">1,604</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="3" id="f-767">628</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="3" id="f-768">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-769"><span style="-sec-ix-hidden:f-770"><span style="-sec-ix-hidden:f-771">Net periodic pension expense (income)</span></span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="f-772">71</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="f-773">355</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated net actuarial loss for the defined benefit pension plans that will be amortized from accumulated other comprehensive income into net periodic benefit cost during fiscal year 2024 is $<ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedAmortizationNextFiscalYear" format="ixt:num-dot-decimal" scale="0" id="f-774">580,000</ix:nonFraction>.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's funding policy is to contribute to the plans when pension laws and economics either require or encourage funding. The Company expects to make <ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="INF" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:fixed-zero" scale="0" id="f-775">no</ix:nonFraction> contributions during fiscal year 2024. There were <ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="INF" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="0" id="f-776"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="0" id="f-777">no</ix:nonFraction></ix:nonFraction> contributions made to the plans in fiscal year 2023 or 2022.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="ib5753d2a55444c9e98e6619f4a6855fc" continuedAt="i995a6a520f6e43b5bb5d61aca674d4f4"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="f-778" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following benefit payments are expected to be paid from the benefit plans in the fiscal years ending April&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-779">1,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-780">1,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" format="ixt:num-dot-decimal" scale="3" id="f-781">1,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" format="ixt:num-dot-decimal" scale="3" id="f-782">1,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" format="ixt:num-dot-decimal" scale="3" id="f-783">1,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029- 2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="3" id="f-784">7,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected long-term portfolio return is established via a building block approach with proper consideration of diversification and rebalancing. Historical markets are studied and long-term historical relationships between equities and fixed-income securities are preserved consistent with the widely accepted capital market principle that assets with higher volatility generate a greater return over the long term. Current market factors such as inflation and interest rates are evaluated before long-term capital market assumptions are determined. Peer data and historical returns are also reviewed to check for reasonableness and appropriateness.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a Yield Curve methodology to determine its GAAP discount rate. Under this approach, future benefit payment cash flows are projected from the pension plan on a projected benefit obligation basis. The payment stream is discounted to a present value using an interest rate applicable to the timing of each respective cash flow. The graph of these time-dependent interest rates is known as a yield curve. The interest rates comprising the Yield Curve are determined through a statistical analysis performed by the IRS and issued each month in the form of a pension discount curve. For this purpose, the universe of possible bonds consists of a set of bonds which are designated as corporate, have high quality ratings (AAA or AA) from nationally recognized statistical rating organizations, and have at least $<ix:nonFraction unitRef="usd" contextRef="i169a6334517a4b19877902820dba5e96_I20230430" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-785">250</ix:nonFraction> million in par amount outstanding on at least one day during the reporting period. A <ix:nonFraction unitRef="number" contextRef="ib5dbb92c8fb44dc2ba4e9a4183b0e326_D20210501-20220430" decimals="2" name="kequ:DefinedBenefitPlanPercentageChangesInDiscountRate" scale="-2" id="f-786"><ix:nonFraction unitRef="number" contextRef="ibb15b53ace4d4cc89a084c541d351ce9_D20220501-20230430" decimals="2" name="kequ:DefinedBenefitPlanPercentageChangesInDiscountRate" scale="-2" id="f-787">1</ix:nonFraction></ix:nonFraction>% increase/decrease in the discount rate for fiscal years 2023 and 2022 would increase/decrease pension expense by approximately $<ix:nonFraction unitRef="usd" contextRef="ibb15b53ace4d4cc89a084c541d351ce9_D20220501-20230430" decimals="-3" name="us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations" format="ixt:num-dot-decimal" scale="0" id="f-788">231,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib5dbb92c8fb44dc2ba4e9a4183b0e326_D20210501-20220430" decimals="-3" name="us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations" format="ixt:num-dot-decimal" scale="0" id="f-789">271,000</ix:nonFraction>, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a total return investment approach, whereby a mix of equities and fixed-income investments are used to attempt to maximize the long-term return on plan assets for a prudent level of risk. Risk tolerance is established through careful consideration of plan liabilities, plan funded status, and corporate financial condition. The investment portfolio contains a diversified blend of equity and fixed-income investments. Furthermore, equity investments are diversified across U.S. and non-U.S. stocks, as well as growth, value, and small and large capitalizations. The target allocations based on the Company's investment policy were <ix:nonFraction unitRef="number" contextRef="i472a2c8c23a648a2a20e3abd4d4c0d6c_I20220430" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-790"><ix:nonFraction unitRef="number" contextRef="id18cf987103643748c6db3d293c21a14_I20230430" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-791">75</ix:nonFraction></ix:nonFraction>% in equity securities and <ix:nonFraction unitRef="number" contextRef="i8c34d5d2c07b404c96ed13f48c0378f7_I20230430" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-792"><ix:nonFraction unitRef="number" contextRef="i2618157cd36a473eb1be555923af9434_I20220430" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="f-793">25</ix:nonFraction></ix:nonFraction>% in fixed-income securities at April&#160;30, 2023 and April&#160;30, 2022. A <ix:nonFraction unitRef="number" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="2" name="kequ:DefinedBenefitPlanPercentageChangesInDiscountRate" scale="-2" id="f-794"><ix:nonFraction unitRef="number" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="2" name="kequ:DefinedBenefitPlanPercentageChangesInDiscountRate" scale="-2" id="f-795">1</ix:nonFraction></ix:nonFraction>% increase/decrease in the expected return on assets for fiscal years 2023 and 2022 would increase/decrease pension expense by approximately $<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations" format="ixt:num-dot-decimal" scale="0" id="f-796">181,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations" format="ixt:num-dot-decimal" scale="0" id="f-797">207,000</ix:nonFraction>, respectively.</span></div><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" id="f-798" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan assets by asset categories as of April&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:49.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i461991f9a104434190673d6c11e374a4_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-799">12,724</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i461991f9a104434190673d6c11e374a4_I20230430" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-800">72</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7564e3aaefde4cc68eb4d66be4958117_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-801">13,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7564e3aaefde4cc68eb4d66be4958117_I20220430" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-802">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021b8377b114d78bbf1ef3499af7718_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-803">4,845</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4021b8377b114d78bbf1ef3499af7718_I20230430" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-804">27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bc3127d271f40c68917d5dfd4db4ba5_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-805">4,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3bc3127d271f40c68917d5dfd4db4ba5_I20220430" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-806">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i000d0b9b003247e49169b92e76d8a09a_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-807">163</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i000d0b9b003247e49169b92e76d8a09a_I20230430" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-808">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03d983ee673f413c90842b0da9ff9f43_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-809">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03d983ee673f413c90842b0da9ff9f43_I20220430" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-810">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-811">17,732</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-812">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-813">18,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="f-814">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="i995a6a520f6e43b5bb5d61aca674d4f4"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" id="f-815" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the assets in the Company's defined benefit pension plans at April&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i923a5fb9c22b4ca38cc73db048a7825c_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-816">7,326</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i312a8cb23fc94a6da460c8f4222f0639_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-817">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4fccb41c0d41d9bad0908cc0d8c23b_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-818">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small/Mid Cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cc3a1c0b4c54acd9b37831a3bb584a3_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-819">2,326</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2aaffec262844dfacd06946a041d076_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-820">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc58d8bcb0411fbe11a081e6d072a8_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-821">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i896cff42816940eaaee621949ddb6194_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-822">1,743</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0eb4dc2bb954fe79a558072049a1831_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-823">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7de646a2dc541ca9f756667c74e21e8_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-824">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadfc70c5513e41bb947fe21e6b0966c1_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-825">702</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897db272c7af4c3197ac2a1529dc2f8a_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-826">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic212c7fd02eb41fe97da02135a2a32b5_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-827">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84d2c48142ac411eb496c07b85230a6d_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-828">4,845</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f86e2de3e8488eb7824809bf0d34e8_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-829">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425180d6d80c4d73ad2fa942d6d8e85f_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-830">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquid Alternatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba8749a1a26404e9c8bf4ea4a8c9546_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-831">627</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3130ef4af74fbabeb2632567506974_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-832">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d2b508c96c041a5999e41c866d6dac5_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-833">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c69c8ad78245338093ee6b28093169_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-834">163</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i789bb8f7d31e4310960e2e37137bb32a_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-835">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9efb8d4ca2d493eb707565a176dce6d_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-836">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234054f8708d43f4811f8f93244fe91c_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-837">17,732</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i251e9520bea74e6991781ef0e97f7a97_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-838">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib241eb5a32fa4fea9b004f728e78a69c_I20230430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-839">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1f810c2a94b4f1aa8f0d78dbbca6e8f_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-840">7,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec155c938875403a9cd89d027b15e0c1_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-841">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f78266f81774c8cb5cfab7eb95904c0_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small/Mid Cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854a8abfd519441d95b99eb28db921d7_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-843">2,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b825859a1f84c25a9245c562c9110c8_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-844">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1212417875461884b453615e64caae_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-845">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08c47e380ee54dabb1754d7ccb46e86a_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-846">2,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b52ce2fc2241eb9007387adf55e35a_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43427226e74849a88e0eb5b4a25adf12_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-848">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc659a9402841f48ab3f91f0d5a48a4_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-849">794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec243beb997e4e3d9e2437b00cb92051_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-850">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6caf6ca2e04c14b416ef5a51d235c1_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icee3a5c7b5744ec2a0b78771afc9000d_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-852">4,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i517e6442cdb945718bfb4a5054667765_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-853">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0449597eea9b4e8bb4321131eeadb7d3_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-854">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquid Alternatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad9200d2ce534be78d4a456fc4ef6b6c_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-855">897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d0fa294085541439c1c28e09b131ee3_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-856">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecc70cd0abb4a2dbf24582b226b6ab8_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i912b55bb462d4adcad4393d6753058e8_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="3" id="f-858">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1115530ba0114611bc42e50e7b6324a4_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55beed59b26e4f22a06bf6565cb3b9a4_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-860">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie732b5f45f464e6ca8f0b1fb3c13d76a_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-861">18,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38d9bc0dc4a4764ba3d1d2f6e881e3a_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f2aaa221eb94ad69d94ee9d5db0943a_I20220430" decimals="-3" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="3" id="f-863">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1 retirement plan assets include United States currency held by a designated trustee and equity funds of common and preferred securities issued by domestic and foreign corporations. These equity funds are traded actively on exchanges and price quotes for these shares are readily available.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Contribution Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a defined contribution plan covering substantially all domestic salaried and hourly employees. The plan provides benefits to all employees who have attained age <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" format="ixt-sec:duryear" id="f-864">21</ix:nonNumeric>, completed <ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="kequ:DefinedContributionPlanEligibilityMinimumServicePeriod" format="ixt-sec:durwordsen" id="f-865">three months</ix:nonNumeric> of service, and who elect to participate. The plan provides that the Company make matching contributions equal to <ix:nonFraction unitRef="number" contextRef="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430" decimals="INF" name="kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" scale="-2" id="f-866">100</ix:nonFraction>% of the employee's qualifying contribution up to <ix:nonFraction unitRef="number" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="f-867">3</ix:nonFraction>% of the employee's compensation, and make matching contributions equal to <ix:nonFraction unitRef="number" contextRef="ia90c11936dba4904a9531ab5d52fbbd5_D20220501-20230430" decimals="INF" name="kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" scale="-2" id="f-868">50</ix:nonFraction>% of the employee's contributions between <ix:nonFraction unitRef="number" contextRef="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-869">3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ia90c11936dba4904a9531ab5d52fbbd5_D20220501-20230430" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-870">5</ix:nonFraction>% of the employee's compensation, resulting in a maximum employer contribution equal to <ix:nonFraction unitRef="number" contextRef="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-871">4</ix:nonFraction>% of the employee's compensation. The Company's matching contributions were $<ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:DefinedContributionPlanEmployerMatchingContributionsAmount" format="ixt:num-dot-decimal" scale="0" id="f-872">932,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:DefinedContributionPlanEmployerMatchingContributionsAmount" format="ixt:num-dot-decimal" scale="0" id="f-873">967,000</ix:nonFraction> for years ending April&#160;30, 2023 and 2022. Additionally, the plan provides that the Company may elect to make a non-matching contribution for participants employed by the Company on December&#160;31 of each year. The Company did not elect to make a non-matching contribution in fiscal years 2023 and 2022.</span></div></ix:continuation><div id="i1de8d1053c4044f7aa1eb1bfb086781f_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-874" continuedAt="i10034037cd3b4fa794cf573c63ecaf5c" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="i10034037cd3b4fa794cf573c63ecaf5c" continuedAt="i4969691a7f6545838d55a4af743a06c5"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are classified into <ix:nonFraction unitRef="segment" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-875">two</ix:nonFraction> business segments: Domestic and International. The Domestic business segment principally designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. The International business segment, which consists of the foreign subsidiaries identified in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_94">Note&#160;1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, provides the Company's products and services, including facility design, detailed engineering, construction, and project management from the planning stage through testing and commissioning of laboratories.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intersegment transactions are recorded at normal profit margins. All intercompany balances and transactions have been eliminated. Certain corporate expenses shown below are net of expenses that have been allocated to the business segments.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><ix:continuation id="i4969691a7f6545838d55a4af743a06c5"><ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-876" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows revenues, earnings, and other financial information by business segment and unallocated corporate expenses for each of the years ended April&#160;30: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:49.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-877">146,716</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-878">72,778</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-879">219,494</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib99cbe4793c040dd859880b6ce8c5d6c_D20220501-20230430" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:num-dot-decimal" scale="3" id="f-880">1,604</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66409b457de24b8ea9db0e15adf2f1c1_D20220501-20230430" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:num-dot-decimal" scale="3" id="f-881">9,822</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17f99b083fb44457829907146d217534_D20220501-20230430" decimals="-3" sign="-" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:num-dot-decimal" scale="3" id="f-882">11,426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:fixed-zero" scale="3" id="f-883">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-884">2,394</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-885">282</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f99b083fb44457829907146d217534_D20220501-20230430" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-886">191</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-887">2,867</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-888">3,408</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-889">7,382</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba68a35a7cbd4325912b37c8a42846b6_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-890">6,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-891">4,498</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-892">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-893">2,250</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba68a35a7cbd4325912b37c8a42846b6_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-894">889</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-895">3,139</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-896">621</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-897">621</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-898">3,408</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-899">4,511</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba68a35a7cbd4325912b37c8a42846b6_D20220501-20230430" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-900">7,181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-901">738</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie729b60a90844b3893420d0d57361c11_I20230430" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-902">80,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c4fe4e054c42a0be6b9bb2053335ca_I20230430" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-903">38,898</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-904">118,898</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-905">2,856</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-906">1,292</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-907">4,148</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23df5675029345c288bde9f193ac67d7_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-908">2,559</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5465457d161440f8737d4f3e58f566a_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-909">72,778</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeefffc08f9c430ebb298fa36e4c30b8_D20220501-20230430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-910">75,337</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-911">126,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-912">42,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-913">168,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68f7a9301a3f4938978283aee47bfa00_D20210501-20220430" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" scale="3" id="f-914">882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a0af5a5c704ae09f78421067a08c16_D20210501-20220430" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:num-dot-decimal" scale="3" id="f-915">3,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f86e115975447b7b8aae1019a860422_D20210501-20220430" decimals="-3" sign="-" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:num-dot-decimal" scale="3" id="f-916">4,401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="kequ:RevenuesIncludingIntersegmentMarkup" format="ixt:fixed-zero" scale="3" id="f-917">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-918">2,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-919">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f86e115975447b7b8aae1019a860422_D20210501-20220430" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-920">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="f-921">2,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-922">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-923">3,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d8e2f8f245e4158ba91b25300e91af8_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-924">5,891</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-925">2,485</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-926">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-927">1,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d8e2f8f245e4158ba91b25300e91af8_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-928">2,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-929">3,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-930">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-931">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="f-932">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-933">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d8e2f8f245e4158ba91b25300e91af8_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-934">8,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-935">6,126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07eb9ad716994fadacba37a96ffddb15_I20220430" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-936">91,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6a0995d858b40708d0b3419cfbc2624_I20220430" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-937">27,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-938">118,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-939">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="f-940">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-941">1,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e3c49b7bdf74b079553da120ca298d9_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-942">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c6621adfc5456994955d1968018f4e_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-943">42,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0cd04d9ec24d0e82564984d27f29ff_D20210501-20220430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-944">43,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_127"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12&#8212;<ix:nonNumeric contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="f-945" continuedAt="ib35fb08b7969410cba6dac5898cf26e4" escape="true">Restructuring Costs</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib35fb08b7969410cba6dac5898cf26e4">In December 2019, the Company initiated a restructuring, which included the closure of the Company's subsidiary in China, a commercial sales organization for the Company's products in China, that was completed in March 2023. The Company incurred operating expenses of $<ix:nonFraction unitRef="usd" contextRef="i7e800b6ee23a4e2894c72aa7f8abe31f_D20220501-20230430" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="0" id="f-946">32,000</ix:nonFraction> in its international operations related to the closure of the China subsidiary in fiscal year 2023, offset by the recovery of bad debt collections of $<ix:nonFraction unitRef="usd" contextRef="i7e800b6ee23a4e2894c72aa7f8abe31f_D20220501-20230430" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" format="ixt:num-dot-decimal" scale="0" id="f-947">51,000</ix:nonFraction> that were originally written off when the Company initiated the restructuring. The Company incurred operating expenses of $<ix:nonFraction unitRef="usd" contextRef="i72a92bc417734dbfa6b9630d85382b62_D20210501-20220430" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="0" id="f-948">28,000</ix:nonFraction> related to the closure in the prior year period. The Company reflected all the expenses as operating expenses in the Consolidated Statement of Operations.</ix:continuation></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_136"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We consent to the incorporation by reference in the Registration Statements on Forms S&#8209;8 (Nos. 333&#8209;160276, 333&#8209;176447, 333&#8209;213413 and 333&#8209;220389) of Kewaunee Scientific Corporation of our report dated June 30, 2023, with respect to the consolidated financial statements of Kewaunee Scientific Corporation, included in this Annual Report on Form 10&#8209;K for the year ended April 30, 2023.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">/s/ FORVIS, LLP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Charlotte, North Carolina</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June 30, 2023</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_139"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_142"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;9A. Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are intended to ensure that the information required to be disclosed in our filings under the Securities Exchange Act of 1934 (the "Exchange Act") is properly and timely recorded, processed, summarized, and reported. Our management, including the Chief Executive Officer and Chief Financial Officer, have conducted an evaluation of the effectiveness of disclosure controls and procedures as of April&#160;30, 2023 pursuant to Exchange Act Rule&#160;13a-14. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures are effective. In designing disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving desired control objectives, and that management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management's Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States. Management conducted an evaluation of the effectiveness of internal control over financial reporting based on the framework in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#8212;Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded the Company maintained effective internal control over financial reporting as of April&#160;30, 2023.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by our registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit us to provide only management's report in this Annual Report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in our internal controls over financial reporting that occurred during our fourth fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_145"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;9B. Other Information</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_148"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_151"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART III</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_154"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-top:10pt;padding-left:49.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">The information appearing in the sections entitled "Election of Directors" and "Meetings and Committees of the Board" included in our Proxy Statement for use in connection with our annual meeting of stockholders to be held on August&#160;23, 2023 (the "Proxy Statement") is incorporated herein by reference. The Proxy Statement will be filed with the SEC within 120 days of our most recently completed fiscal year.</span></div><div style="margin-top:10pt;padding-left:49.5pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">The names and ages of our executive officers as of June&#160;30, 2023 and their business experience during the past five years are set forth below: </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Executive Officers</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:23.792%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.374%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.096%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas D. Hull III</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald T. Gardner III</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Finance, Chief Financial Officer, Treasurer and Secretary</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ryan S. Noble</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Sales and Marketing&#8212;Americas</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elizabeth D. Phillips</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Human Resources</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mandar Ranade</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President of Information Technology and Engineering</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Douglas J. Batdorff</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President of Manufacturing Operations</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boopathy Sathyamurthy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Kewaunee Scientific Corporation Singapore Pte. Ltd., Managing Director, International Operations</span></td></tr></table></div><div style="margin-top:13pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thomas D. Hull III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in November 2015 as Vice President, Finance, Chief Financial Officer, Treasurer and Secretary. Mr. Hull was elected President and Chief Executive Officer and appointed as a member of the Board of Directors in March 2019. Mr. Hull earned a Bachelor of Science degree in Accounting from LaRoche College and an MBA from the University of Pittsburgh, Joseph M. Katz School of Business. He is a certified public accountant (inactive status) and a member of the American Institute of Certified Public Accountants and the Pennsylvania Institute of Certified Public Accountants. Prior to joining the Company, Mr. Hull held several management positions with Ernst &amp; Young, LLP in Pittsburgh, Pennsylvania from 1998 through 2011. From 2011 until joining the Company in 2015, he served as the Vice President of Finance, Accounting, and Information Technology with ATI Specialty Materials in Charlotte, North Carolina.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Donald T. Gardner III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in April 2019 as Vice President of Finance and Chief Financial Officer and was also elected by the Board of Directors to the positions of Secretary and Treasurer. Mr. Gardner has a Bachelor of Science degree in Accounting from the Indiana University of Pennsylvania and a Master of Business Administration from the University of Pittsburgh, Joseph M. Katz School of Business. Prior to joining the Company, from 2017 to 2019, he served as Vice President, Financial Planning &amp; Analysis of Victra, a privately held retailer of wireless products and services. During 2017, he served as the Chief Financial Officer of Component Sourcing International, a privately held provider of global sourcing supply chain solutions. From February 2016 to June 2017, Mr. Gardner served in various leadership roles for Dollar Express Stores, LLC, most recently as Vice President and Treasurer. Dollar Express was an operator of discount retail stores that was sold to a strategic buyer in 2017. Mr. Gardner was a key member of the leadership team that completed the transaction and full wind down of the Company. From 2012 to February 2016, he worked at ATI Specialty Materials, a manufacturer of technically advanced specialty materials and complex components, serving in various financial leadership roles.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ryan S. Noble</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in July 2018 as Vice President of Sales and Marketing - Americas. He has a Bachelor of Science degree in Human Ecology from the University of Tennessee. Prior to joining the Company, he was Director of Sales at Dodge Data &amp; Analytics, a provider of analytics and software-based solutions for the construction industry, from March 2018 to July 2018. From 2014 to 2018, he was a Regional Sales Director at Wausau Window and Wall Systems, a manufacturer of metal and glass solutions for commercial buildings. From 2008 to 2014, he held several sales management positions at AGC Glass Company, a glass and high performance coatings manufacturer for architectural, residential, interior, and industrial applications.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Elizabeth D. Phillips</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in August 2006 as Human Resources and Training Manager. She was promoted to Director of Human Resources in June 2007 and was elected Vice President of Human Resources in June 2009. Ms. Phillips has a Bachelor of Science degree in Psychology from Western Carolina University. Prior to joining the Company, she held Human Resources leadership positions at Thomasville Furniture and Hickory Chair and immediately prior to joining Kewaunee was Director of Human Resources for Vanguard Furniture Co., Inc., a manufacturer of household furniture, from April 2004 until August 2006.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mandar Ranade</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in December 2019 as Vice President of Information Technology. In February 2020, Mr. Ranade's responsibilities were expanded to include Engineering and Standards oversight and he now holds the position of Vice President of Information Technology and Engineering. He has a Master of Business Administration, Finance, from the University of Leeds, Leeds, United Kingdom, and a Bachelor of Engineering, Polymers, from University of Pune, Pune, India. He also has certifications as a Project Management Professional, Certified Scrum Master, ITIL (Foundation) Certification and a Master of Oracle Applications. Prior to joining the Company, Mr. Ranade most recently held the position of Division IT Leader for EnPro Industries-Fairbanks Morse, Wisconsin from 2018 to November 2019. From 2015 to 2018, he held several Director positions, the most recent being Director of Technical Services, with Aurora Health Care, ACL Laboratories, Milwaukee, Wisconsin. Prior to these positions he was Senior Manager of IT with IMS Health, Milwaukee, Wisconsin, from 2010 to 2015, and ThermoFisher Scientific in Two Rivers, Wisconsin, from 2005 to 2010. From 1995 to 2005, he held various IT positions with GE Healthcare, Milwaukee, Wisconsin and Mumbai, India, idm Limited, in Doncaster, UK, and GREAVES Limited, Mumbai, India</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Douglas J. Batdorff</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in June 2020 as Vice President of Manufacturing Operations. He has significant experience in directing and guiding manufacturing operations, focusing on improvement of business performance, maximizing growth and profitability. Mr. Batdorff has a Bachelor of Science Degree in Mechanical Engineering from Michigan State University and a Masters in Manufacturing Operations from Kettering University. Prior to joining the Company, Mr. Batdorff was the Chief Operations Officer for Legacy Cabinets, Inc. in Eastaboga, Alabama from 2018 to 2019. From 2005 to 2018 he held various management positions with Steelcase, the most recent as Director of Manufacturing - US Operations from 2014 to 2018. He was with General Motors, Lansing, Michigan from 1998 to 2004 in many management roles, the most recent being Manufacturing Coordinator - General Assembly - Final Process.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bhoopathy Sathyamurthy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> joined the Company in 2000 as General Manager of India Operations and Kewaunee Labway India Pvt. Ltd. He was subsequently promoted to Managing Director of Kewaunee Labway India Pvt. Ltd. He has served as Managing Director of International Operations, which includes responsibilities for all sales and operations in Asia, as well as sales efforts in the Middle East, since September 2013. Mr. Sathyamurthy was elected Vice President of Kewaunee Scientific Corporation Singapore Pte. Ltd., the holding company for Kewaunee's subsidiaries in India, Singapore, and China, in September 2014. He holds a Bachelor Degree in Mechanical Engineering from University of Madras and a Masters of Business Administration from University of Madras.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Ethics</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of our code of ethics that applies to our Chief Executive Officer and Chief Financial Officer, entitled "Ethics Obligations for Chief Executive Officer and Employees with Financial Reporting Responsibilities," is available free of charge through our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">www.kewaunee.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The reference to our website does not constitute incorporation by reference of any information contained at that site.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the section entitled "Election of Directors &#8211; Meetings and Committees of the Board" in our Proxy Statement is incorporated herein by reference.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Delinquent Section 16(a) Reports</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the section entitled "Delinquent Section 16(a) Reports" in our Proxy Statement, if applicable, is incorporated herein by reference.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_157"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;11. Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the sections entitled "Compensation Discussion and Analysis," "Compensation Tables," "Agreements with Certain Executives," and "Election of Directors &#8211; Compensation Committee Interlocks and Insider Participation" in the Proxy Statement is incorporated herein by reference.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_160"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the sections entitled "Security Ownership of Directors and Executive Officers" and "Security Ownership of Certain Beneficial Owners" in the Proxy Statement is incorporated herein by reference.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information as of April&#160;30, 2023 with respect to compensation plans under which our equity securities are authorized for issuance:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.419%"><tr><td style="width:1.0%"></td><td style="width:49.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.352%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.082%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plan Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>securities&#160;to&#160;be<br/>issued upon<br/>exercise&#160;of<br/>outstanding<br/>options,&#160;warrants<br/>and rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-average<br/>exercise&#160;price&#160;of<br/>outstanding&#160;options,<br/>warrants and&#160;rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;securities<br/>remaining&#160;available&#160;for<br/>future issuance under<br/>equity&#160;compensation<br/>plans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Compensation Plans approved by Security Holders:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2008 Key Employee Stock Option Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Omnibus Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Compensation Plans not approved by Security Holders:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total Equity Compensation Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,540&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,007&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_112"> Note 7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options and Share-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Company's consolidated financial statements included in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_67">Item 8</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_163"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the sections entitled "Election of Directors" and "Agreements with Certain Executives" in the Proxy Statement is incorporated herein by reference.</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_166"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;14. Principal Accountant Fees and Services</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information appearing in the section entitled "Ratification of Appointment of Independent Registered Public Accounting Firm&#8212;Audit Fees and Non-Audit Fees" in the Proxy Statement is incorporated herein by reference.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_169"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART IV</span></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_172"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;15. Exhibits and Financial Statement Schedules</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed or incorporated by reference as part of this Annual Report:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.516%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Financial Statements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_70">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_70">17</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_76">Consolidated Statements of Operations&#8212;Years ended April&#160;30, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_76">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_76"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_76">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_76">18</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_79">Consolidated Statements of Comprehensive Income&#8212;Years ended April&#160;30, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_79">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_79"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_79">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_79">19</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_82">Consolidated Statements of Stockholders' Equity&#8212;Years ended April&#160;30, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_82">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_82"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_82">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_82">20</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_85">Consolidated Balance Sheets&#8212;April&#160;30, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_85">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_85"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_85">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_85">21</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_88">Consolidated Statements of Cash Flows&#8212;Years ended April&#160;30, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_88">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_88"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_88">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_88">22</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_91">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_91">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_136">Consent of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_136">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Financial Statement Schedules</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial statement schedules have been omitted because the information required has been separately disclosed in the consolidated financial statements or related notes.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibits</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits required by Item&#160;601 of Regulation&#160;S-K are listed in the Exhibit Index, which is attached hereto at pages&#160;47 through 49 and which is incorporated herein by reference.</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_175"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;16. Form 10-K Summary</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_178"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KEWAUNEE SCIENTIFIC CORPORATION</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit Index</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:2.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.406%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Articles of incorporation and bylaws</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312518222169/d614312dex31.htm">Conformed copy of Restated Certificate of Incorporation (reflecting all amendments to date)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000119312520120021/d923297d8k.htm">By-Laws (as amended as of April 21, 2020)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of Registrant's Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552919000040/exhibit41.htm">Description of Capital Stock</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Material Contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312512501038/d448348dex101.htm">Re-Established Retirement Plan for Salaried Employees of Kewaunee Scientific Corporation (as amended and restated effective as of May&#160;1, 2012)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1A*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312514328719/d784897dex107.htm">First Amendment to the Re-Established Retirement Plan for Salaried Employees of Kewaunee Scientific Corporation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1B*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312516653120/d187472dex101b.htm">Second Amendment to the Re-Established Retirement Plan for Salaried Employees of Kewaunee Scientific Corporation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1C*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312517080185/d354815dex101c.htm">Third Amendment to the Re-Established Retirement Plan for Salaried Employees of Kewaunee Scientific Corporation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1D*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312518222169/d614312dex101d.htm">Fourth Amendment to the Re-Established Retirement Plan for Salaried Employees of Kewaunee Scientific Corporation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312512501038/d448348dex102.htm">Re-Established Retirement Plan for Hourly Employees of Kewaunee Scientific Corporation (as amended and restated effective as of May&#160;1, 2012)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2A*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312514328719/d784897dex108.htm">First Amendment to the Re-Established Retirement Plan for Hourly Employees of Kewaunee Scientific Corporation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2B*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312516653120/d187472dex102b.htm">Second Amendment to the Re-Established Retirement Plan for Hourly Employees of Kewaunee Scientific Corporation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2C*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312517080185/d354815dex102c.htm">Third Amendment to the Re-Established Retirement Plan for Hourly Employees of Kewaunee Scientific Corporation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2D*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312518222169/d614312dex102d.htm">Fourth Amendment to the Re-Established Retirement Plan for Hourly Employees of Kewaunee Scientific Corporation</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312505242780/dex1030.htm">Kewaunee Scientific Corporation Executive Severance Pay Policy</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312515403383/d83123dex101.htm">401(k) Incentive Savings Plan for Salaried and Hourly Employees of Kewaunee Scientific Corporation (as amended and restated effective June&#160;29, 2015)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34A*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552920000006/first401kadmendment.htm">First Amendment to the 401(k) Incentive Savings Plan for Salaried and Hourly Employees of Kewaunee Scientific Corporation (as amended and restated effective January 1, 2020)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34B*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1034b.htm">Second Amendment to the 401(k) Incentive Savings Plan for Salaried and Hourly Employees of Kewaunee Scientific Corporation effective May 15, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312515260753/d14316ddef14a.htm">Amended and Restated 2008 Key Employee Stock Option Plan effective August&#160;26, 2015</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.61</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000005552923000006/iibcreditagreement.htm">Credit and Security Agreement, dated as of December 19, 2022, by and among Kewaunee Scientific Corporation, Mid Cap Funding IV Trust, as agent, and the lenders from time to time party thereto</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000005552922000007/psa-kewauneefullyexecute.htm">Agreement for Purchase and Sale of Real Property dated as of December 22, 2021 between CAI Investments Sub Series 100, LLC and Kewaunee Scientific Corporation </a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000005552922000007/psa-kewauneex1stamendmen.htm">First Amendment to the Agreement for Purchase and Sale of Real Property dated as of January 21, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000005552922000007/psa-kewauneex2ndamendmen.htm">Second Amendment to the Agreement for Purchase and Sale of Real Property dated as of January 24, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62C</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000005552922000007/psa-kewauneex3rdamendmen.htm">Third Amendment to the Agreement for Purchase and Sale of Real Property dated as of January 26, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62D</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000055529/000119312522089748/d340464dex105.htm">Fourth Amendment to the Agreement for Purchase and Sale of Real Property dated as of March 23, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.68*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312515256731/d949549dex1068a.htm">401Plus Executive Deferred Compensation Plan (as amended and restated January&#160;1, 2009)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.68A*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312515256731/d949549dex1068a.htm">Amendment No. One to the Kewaunee Scientific Corporation 401Plus Executive Deferred Compensation Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.68B*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312518077010/d544804dex1068b.htm">Amendment No. Two to the Kewaunee Scientific Corporation 401Plus Executive Deferred Compensation Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:2.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.406%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reference</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.69*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312515256731/d949549dex1069.htm">Pension Equalization Plan (as amended and restated January&#160;1, 2009)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.69A*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312515256731/d949549dex1069a.htm">Amendment No. One to the Kewaunee Scientific Corporation Pension Equalization Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.72*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312517232927/d405586ddef14a.htm">Kewaunee Scientific Corporation 2017 Omnibus Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.73*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312519128960/d645439dex101.htm">Offer Letter to Donald T. Gardner III dated April 2, 2019.   </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">       </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.74*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312519178888/d765375dex101.htm">Change of Control Employment Agreement dated as of June 18, 2019 between Kewaunee Scientific Corporation and Thomas D. Hull III.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.75*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312519178888/d765375dex102.htm">Change of Control Employment Agreement dated as of June 18, 2019 between Kewaunee Scientific Corporation and Donald T. Gardner III.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.77*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000055529/000119312519178888/d765375dex105.htm">Change of Control Employment Agreement dated as of June 18, 2019 between Kewaunee Scientific Corporation and Elizabeth D. Phillips.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.78*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000119312519178888/d765375dex106.htm">Change of Control Employment Agreement dated as of June 18, 2019 between Kewaunee Scientific Corporation and Ryan S. Noble</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.79*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552919000040/empagree.htm">Employment agreement dated October 1, 2017 between Kewaunee Labway India Pvt. Ltd and Bhoopathy Sathyamurthy.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.80*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/55529/000005552919000050/offerlettermandarranade1.htm">Employment Agreement dated as of October 28, 2019 between Kewaunee Scientific Corporation and Mandar Ranade</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.81*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000055529/000005552920000006/changeofcontroldocforman.htm">Change of Control Employment Agreement dated as of December 2, 2019 between Kewaunee Scientific Corporation and Mandar Ranade</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.82*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000005552920000010/dougbatdorffofferletter.htm">Offer Letter dated as of May 7, 2020 between Kewaunee Scientific Corporation and Douglas J. Batdorff</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.83*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/55529/000005552920000010/changeofcontrolbatdorff.htm">Change of Control Employment Agreement dated as of June 1, 2020 between Kewaunee Scientific Corporation and Douglas J. Batdorff</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211.htm">Subsidiaries of the Company</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231.htm">Consent dated Ju</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231.htm">ne 30</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231.htm"> of FORVIS, LLP, Independent Registered Public Accounting Firm (incorporated by reference to page&#160;42 of this Report on Form 10-K)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311.htm">Certification of Principal Executive Officer of the Company pursuant to Exchange Act Rule 13a-14(a) or Rule 15d-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312.htm">Certification of Principal Financial Officer of the Company pursuant to Exchange Act Rule 13a-14(a) or Rule 15d-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321.htm">Certification of Principal Executive Officer pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322.htm">Certification of Principal Financial Officer pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;The referenced exhibit is a management contract or compensatory plan or arrangement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(All other exhibits are either inapplicable or not required.)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Footnotes</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed with this Form 10-K with the Securities and Exchange Commission.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended October&#160;31, 2005, and incorporated herein by reference.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended October&#160;31, 2012, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No.&#160;0-5286) filed on September&#160;2, 2014, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Annual Report to the Securities and Exchange Commission on Form 10-K (Commission File No.&#160;0-5286) for the fiscal year ended April&#160;30, 2015, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as Appendix A to the Kewaunee Scientific Corporation Proxy Statement for its Annual Meeting of Stockholders on August&#160;26, 2015 (Commission File No.&#160;0-5286) filed on July&#160;23, 2015, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended October&#160;31, 2015, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Annual Report to the Securities and Exchange Commission on Form 10-K (Commission File No.&#160;0-5286) for the fiscal year ended April&#160;30, 2016, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended January&#160;31, 2017, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)&#160;&#160;&#160;&#160;Filed as Appendix A to the Kewaunee Scientific Corporation Proxy Statement for its Annual Meeting of Stockholders on August&#160;30, 2017 (Commission File No.&#160;0-5286) filed on July&#160;21, 2017, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission  on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended January&#160;31, 2018, and incorporated herein by reference.</span></div><div style="margin-bottom:0.3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Annual Report to the Securities and Exchange Commission on Form 10-K (Commission File No.&#160;0-5286) for the fiscal year ended April&#160;30, 2018, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No.&#160;0-5286) filed on April 30, 2019, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No.&#160;0-5286) filed on June 21, 2019, and incorporated herein by reference.</span></div><div style="margin-bottom:0.3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Annual Report to the Securities and Exchange Commission on Form 10-K (Commission File No.&#160;0-5286) for the fiscal year ended April&#160;30, 2019, and incorporated herein by reference.</span></div><div style="margin-bottom:0.3pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission  on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended October 31, 2019, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission  on Form 10-Q (Commission File No.&#160;0-5286) for the quarterly period ended January&#160;31, 2020, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No.&#160;0-5286) filed on April 27, 2020, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)       Filed as an exhibit to the Kewaunee Scientific Corporation Annual Report to the Securities and Exchange Commission on Form 10-K (Commission File No.&#160;0-5286) for the fiscal year ended April&#160;30, 2020, and incorporated herein by reference.</span></div><div style="margin-bottom:0.3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Quarterly Report to the Securities and Exchange Commission &#160;&#160;&#160;&#160;on Form 10-Q (Commission File 0-5286) for the quarterly period ended January 31, 2022, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No. 0-5286) filed on March 30, 2022, and incorporated herein by reference.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22)&#160;&#160;&#160;&#160;Filed as an exhibit to the Kewaunee Scientific Corporation Current Report on Form 8-K (Commission File No. 0-5286) filed on December 19, 2022, and incorporated herein by reference.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i1de8d1053c4044f7aa1eb1bfb086781f_181"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i1de8d1053c4044f7aa1eb1bfb086781f_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KEWAUNEE SCIENTIFIC CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas D. Hull III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas D. Hull III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: June&#160;30, 2023 </span></div><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities indicated on June&#160;30, 2023.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.999%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Executive Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas D. Hull III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas D. Hull III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Financial and Accounting Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald T. Gardner III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald T. Gardner III</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Finance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasurer and Secretary</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A majority of the Board of Directors:</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Keith M. Gehl</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;John D. Russell</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Keith M. Gehl</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John&#160;D.&#160;Russell</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Margaret B. Pyle</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Donald F. Shaw</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Margaret B. Pyle</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Donald F. Shaw</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas D. Hull, III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas D. Hull, III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David S. Rhind</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David&#160;S.&#160;Rhind</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.34B
<SEQUENCE>2
<FILENAME>exhibit1034b.htm
<DESCRIPTION>EX-10.34B
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit1034b</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- exhibit1034b001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1034b001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Pre-Approved Defined Contribution Plan &#8211; 06/30/2020 PS Plan 42325-1680602680AA &#61651; 2020 FMR LLC All rights reserved. 1 1.07       DEFERRAL CONTRIBUTIONS (a) &#61694; Deferral Contributions - Participants may elect to have a portion of their Compensation  contributed to the Plan on a before-tax basis pursuant to Code Section 401(k). (1) Regular Contributions - The Employer shall make a Deferral Contribution in accordance with  Section 5.03 of the Basic Plan Document on behalf of each Participant who has an executed salary  reduction agreement in effect with the Employer for the payroll period in question. Such Deferral  Contribution shall not exceed the deferral limit below. (A) The deferral limit is 60% (must be a whole number multiple of one percent) of  Compensation. (i) &#61608; The following lower deferral limit applies to Highly Compensated  Employees: _________% Note:  If Catch-Up Contributions are selected below, a Participant eligible to make Catch-Up  Contributions shall (subject to the statutory limits in Treasury Regulation Section 1.414(v)- 1(b)(1)(i)) in any event be permitted to contribute in excess of the specified deferral limit up to  100% of the Participant's &quot;effectively available Compensation&quot; (as defined in Section 5.03), unless  elected otherwise in Option 1.07(a)(2). (B) &#61608; Instead of specifying a percentage of Compensation, a Participant's salary  reduction agreement may specify a dollar amount to be contributed each payroll  period, provided such dollar amount does not exceed the maximum percentage  of Compensation specified in Subsection 5.03(a) or in Subsection 1.07(a)(1)(A),  as applicable, and is not less than the minimum percentage of Compensation  specified in Subsection 1.07(a)(1)(E), if applicable. (C) A Participant may change, on a prospective basis, his salary reduction agreement (check  one): (i) &#61608; as of the beginning of each payroll period. (ii) &#61608; as of the first day of each month. (iii) &#61694; as of each Entry Date.  (Do not select if immediate entry is elected with  respect to Deferral Contributions in Subsection 1.04(e).) (iv) &#61608; as of the first day of each calendar quarter. (v) &#61608; as of the first day of each Plan Year. (vi) &#61608; other.  (Specify, but must be at least once per Plan Year) ____________________________________________ Note: Notwithstanding the Employer's election hereunder, if Option 1.11(a)(3), 401(k)  Safe Harbor Matching Employer Contributions, or Option 1.12(a)(3), 401(k) Safe Harbor  Formula, with respect to Nonelective Employer Contributions is checked, the Plan  provides that an Active Participant may change his salary reduction agreement for the  Plan Year within a reasonable period (not fewer than 30 days) of receiving the notice  described in Section 6.09 of the Basic Plan Document. (D) A Participant may revoke, on a prospective basis, a salary reduction agreement at any  time upon proper notice to the Administrator, but in such case a new salary reduction  DocuSign Envelope ID: F94E01AB-0933-4190-A536-6068006A1294 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1034b002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1034b002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Pre-Approved Defined Contribution Plan &#8211; 06/30/2020 PS Plan 42325-1680602680AA &#61651; 2020 FMR LLC All rights reserved. 2 agreement may not become effective until the time selected in 1.07(a)(1)(C), unless one  of the below options is selected. (Check one if applicable): (i) &#61608; the beginning of the next payroll period. (ii) &#61608; the first day of the next month. (iii) &#61694; the next Entry Date.  (Do not select if immediate entry is elected with  respect to Deferral Contributions in Subsection 1.04(e).) (iv) &#61608; as of the first day of each calendar quarter. (v) &#61608; as of the first day of each Plan Year. (vi) &#61608; other.  (Specify, but must be at least once per Plan Year) _____________________________________________ (E) &#61608; The minimum Deferral Contribution is _________% of Compensation. Note: The ability to make Deferral Contributions is a benefit, right or feature subject to  discrimination testing under Code Section 401(a)(4). If a minimum percentage is  specified above, it should be reviewed to be sure that under the facts and circumstances  of the Plan, Deferral Contributions are effectively available to Employees who are not  Highly Compensated Employees. (2) &#61694; Catch-Up Contributions - The following deferral limit applies to Participants eligible to  make Catch-Up Contributions: 100% (cannot be less than 75% and must be a whole  number multiple of one percent) of Compensation. The following Participants who have  attained or are expected to attain age 50 before the close of the taxable year will be  permitted to make Catch-Up Contributions to the Plan, as described in Subsection  5.03(a): (A) &#61694; All such Participants. (B) &#61608; All such Participants except those covered by a collective-bargaining agreement  under which retirement benefits were a subject of good faith bargaining unless  the bargaining agreement specifically provides for Catch-Up Contributions to be  made on behalf of such Participants. Note: The Employer must not select Option 1.07(a)(2) above unless all applicable plans (as  defined in Code Section 414(v)(6)(A), other than any plan that is qualified under Puerto Rican law  or that covers only employees who are covered by a collective bargaining agreement under which  retirement benefits were a subject of good faith bargaining) maintained by the Employer and by  any other employer that is  treated as a single employer with the Employer under Code Section  414(b), (c), (m), or (o) also permit Catch-Up Contributions in the same dollar amount.  (3) &#61694; Roth 401(k) Contributions. Participants shall be permitted to irrevocably designate  pursuant to Subsection 5.03(b) that a portion or all of the Deferral Contributions made  under this Subsection 1.07(a) are Roth 401(k) Contributions that are includable in the  Participant's gross income at the time deferred. (4) &#61608; Automatic Enrollment Contributions.  Unless they affirmatively elect otherwise, certain  Eligible Employees will have their Compensation reduced in accordance with the  provisions of Subsection 5.03(c) (an &quot;Automatic Enrollment Contribution&quot;), the  Administrator&#8217;s separate procedures described therein, and the following, if applicable: DocuSign Envelope ID: F94E01AB-0933-4190-A536-6068006A1294 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1034b003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1034b003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Pre-Approved Defined Contribution Plan &#8211; 06/30/2020 PS Plan 42325-1680602680AA &#61651; 2020 FMR LLC All rights reserved. 3 (A) &#61608; A qualified automatic contribution arrangement described in Code Section  401(k)(13) (&#8220;QACA&#8221;) has been adopted. (Select Option 1.11(a)(3) or  1.12(a)(3).) See Automatic Enrollment Addendum. (B) &#61608; An eligible automatic enrollment arrangement described in Code Section 414(w)  (&#8220;EACA&#8221;) has been adopted.  See Automatic Enrollment Addendum. 1.09       ROLLOVER CONTRIBUTIONS (a) &#61694; Rollover Contributions - Except as may be indicated below, Eligible Employees who have  satisfied the age and Eligibility Service requirements specified in Subsections 1.04(a) and (b) may  roll over any eligible rollover distribution as described in Section 5.06 of the Basic Plan  Document. (1) &#61694; Expanded Rollover Eligibility &#8211; The following Employees and/or Participants are also  eligible to make Rollover Contributions to the Plan:  (A) &#61694; Eligible Employees who have not yet satisfied the age and Eligibility Service  requirements specified in Subsections 1.04(a) and (b). (B) &#61608; Inactive Participants who have not terminated employment. (C) &#61608; All Inactive Participants. (2) &#61608; The Plan will not accept rollovers of after-tax employee contributions. (3) &#61608; The Plan will not accept rollovers of designated Roth contributions. (Must be selected if  Roth 401(k) Contributions are not elected in Subsection 1.07(a)(3).) (b) &#61608; In-Plan Roth Rollover Contributions (Choose only if Roth 401(k) Contributions are selected in  Option 1.07(a)(3) above) &#8211; Unless Option 1.09(b)(1) is selected below and in accordance with  Section 5.06 of the Basic Plan Document, any Participant, spousal alternate payee or spousal  Beneficiary may elect to have otherwise distributable portions of his Account, which are not part  of an outstanding loan balance pursuant to Article 9 of the Basic Plan Document and are not  &#8220;designated Roth contributions&#8221; under the Plan, be considered &#8220;designated Roth contributions&#8221; for  purposes of the Plan. (1) &#61608; Only a Participant who is still employed by the Employer (or a spousal alternate payee or  spousal Beneficiary of such a Participant) may elect to make such an in-plan Roth  Rollover. (c) &#61608; In-Plan Roth Conversions.  In accordance with Section 5.06 and as may be limited in (2) below,  any Participant who is still employed by the Employer may elect to have any part of the below- listed portions of his Account, which is fully vested, not part of an outstanding loan balance  pursuant to Article 9 of the Basic Plan Document, not currently distributable and not &#8220;designated  Roth contributions&#8221; under the Plan, be considered &#8220;designated Roth contributions&#8221; for purposes of  the Plan. (1) The following sub-accounts are available to be converted: _________. (2) &#61608; A Participant may not make an In-Plan Roth Conversion more frequently than:  ________. DocuSign Envelope ID: F94E01AB-0933-4190-A536-6068006A1294 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1034b004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1034b004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Pre-Approved Defined Contribution Plan &#8211; 06/30/2020 PS Plan 42325-1680602680AA &#61651; 2020 FMR LLC All rights reserved. 4 AMENDMENT EXECUTION PAGE Plan Name: 401(k) Incentive Savings Plan for Salaried and Hourly Employees of Kewaunee Scientific Corporation (the  &quot;Plan&quot;) Employer: Kewaunee Scientific Corp. [Note: These execution pages are to be completed in the event the Employer modifies any prior election(s) or makes a new  election(s) in this Adoption Agreement.  Attach the amended page(s) of the Adoption Agreement to these execution pages.] The following section(s) of the Plan are hereby amended effective as of the date(s) set forth below:  Section Amended Effective Date 1.07 05/15/2023 1.09 05/15/2023 IN WITNESS WHEREOF, the Employer has caused this Amendment to be executed on the date given below. Employer: Kewaunee Scientific Corp. Employer: Kewaunee Scientific Corp. By: By: Title: Title: Date: Date: Note: Only one authorized signature is required to execute this Adoption Agreement unless the Employer's corporate policy  mandates two authorized signatures. Note: This page may be duplicated, if needed, to allow separate execution when the Employer indicated in Section 1.02(a) is  changing.               DocuSign Envelope ID: F94E01AB-0933-4190-A536-6068006A1294 4/10/2023 | 1:21:00 PM EDT Vice President, Human Resources </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>exhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit211</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- exhibit211001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit211001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">`          Exhibit 21.1           Name of Subsidiary  Jurisdiction of Organization  Percentage Ownership   Kewaunee Labway Asia Pte. Ltd.  Singapore  100%   Kewaunee Labway India Pvt. Ltd.  India  95%   Kewaunee Scientific Corporation Singapore Pte. Ltd.  Singapore  100%   Koncepo Scientech International Pvt. Ltd. India 80%  Kequip Global Lab Solutions Pvt. Ltd. India 70%      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit231</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- exhibit231001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit231001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      Consent of Independent Registered Public Accounting Firm  We consent to the incorporation by reference in the Registration Statements on Forms  S-8 (Nos.  333-160276, 333-176447, 333-213413 and 333-220389) of Kewaunee Scientific Corporation of our report  dated June 30, 2023, with respect to the consolidated financial statements of Kewaunee Scientific  Corporation, included in this Annual Report on Form 10-K for the year ended April 30, 2023.   /s/ FORVIS, LLP  Charlotte, North Carolina  June 30, 2023  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit311</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:829;"><!-- exhibit311001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit311001.jpg" title="slide1" width="829" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Exhibit 31.1   CERTIFICATION    I, Thomas D. Hull III, certify that:    1. I have reviewed this report on Form 10-K of Kewaunee Scientific Corporation;   2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a  material fact necessary to make the statements made, in light of the circumstances under which such statements were made,  not misleading with respect to the period covered by this report;   3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly  present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the  periods presented in this report;    4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as  defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:      a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed  under our supervision, to ensure that material information relating to the registrant, including its consolidated  subsidiaries, is made known to us by others within those entities, particularly during the period in which this  report is being prepared;   b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be  designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting  and the preparation of financial statements for external purposes in accordance with generally accepted  accounting principles;    c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our  conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered  by this report based on such evaluation; and   d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred  during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual  report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control  over financial reporting; and   5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons  performing the equivalent functions):   a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial  reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize  and report financial information; and   b) Any fraud, whether or not material, that involves management or other employees who have a significant  role in the registrant&#8217;s internal control over financial reporting.   /s/ Thomas D. Hull III  Thomas D. Hull III President and Chief Executive Officer   Date: June 30, 2023   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit312</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:829;"><!-- exhibit312001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit312001.jpg" title="slide1" width="829" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Exhibit 31.2   CERTIFICATION    I, Donald T. Gardner III, certify that:   1. I have reviewed this report on Form 10-K of Kewaunee Scientific Corporation;   2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a  material fact necessary to make the statements made, in light of the circumstances under which such statements were made,  not misleading with respect to the period covered by this report;   3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly  present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the  periods presented in this report;    4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as  defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:      a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed  under our supervision, to ensure that material information relating to the registrant, including its consolidated  subsidiaries, is made known to us by others within those entities, particularly during the period in which this  report is being prepared;   b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be  designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting  and the preparation of financial statements for external purposes in accordance with generally accepted  accounting principles;    c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our  conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered  by this report based on such evaluation; and   d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred  during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual  report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control  over financial reporting; and   5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons  performing the equivalent functions):   a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial  reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize  and report financial information; and   b) Any fraud, whether or not material, that involves management or other employees who have a significant  role in the registrant&#8217;s internal control over financial reporting.   /s/ Donald T. Gardner III  Donald T. Gardner III Vice President, Finance and Chief Financial Officer   Date: June 30, 2023  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit321</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:829;"><!-- exhibit321001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit321001.jpg" title="slide1" width="829" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Exhibit 32.1   CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED  PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   In connection with the accompanying Annual Report of Kewaunee Scientific Corporation (the &#8220;Company&#8221;) on Form 10-K for  the fiscal year ended April 30, 2023, as filed with the Securities and Exchange Commission on the date hereof, I, Thomas D.  Hull III, President and Chief Executive Officer of the Company, hereby certify pursuant to 18   U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:    (1) such Form 10-K of the Company for the period ended April 30, 2023, fully complies with the requirements of section  13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and   (2) the information contained in such Form 10-K of the Company for the period ended April 30, 2023, fairly presents, in all  material respects, the financial condition and results of operations of the Company.      Date: June 30, 2023  /s/ Thomas D. Hull III  Thomas D. Hull III President and Chief Executive Officer   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit322</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:829;"><!-- exhibit322001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit322001.jpg" title="slide1" width="829" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   Exhibit 32.2   CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED  PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   In connection with the accompanying Annual Report of Kewaunee Scientific Corporation (the &#8220;Company&#8221;) on Form 10-K for  the fiscal year ended April 30, 2023, as filed with the Securities and Exchange Commission on the date hereof, I, Donald T.  Gardner III, Vice President, Finance and Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C.  Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:   (1) such Form 10-K of the Company for the period ended April 30, 2023, fully complies with the requirements of section  13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and   (2) the information contained in such Form 10-K of the Company for the period ended April 30, 2023, fairly presents, in all  material respects, the financial condition and results of operations of the Company.      Date: June 30, 2023   /s/ Donald T. Gardner III  Donald T. Gardner III Vice President, Finance and Chief  Financial Officer   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>kequ-20230430.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:e58e8ac3-ecd1-406b-a8f1-c5aecee1e3ad,g:fefb243f-2e84-4dac-80b6-e3a13121b6c2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:kequ="http://www.kewaunee.com/20230430" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.kewaunee.com/20230430">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kequ-20230430_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kequ-20230430_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kequ-20230430_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kequ-20230430_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.kewaunee.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.kewaunee.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofOperations">
        <link:definition>0000003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000004 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementofStockholdersEquity" roleURI="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity">
        <link:definition>0000005 - Statement - Consolidated Statement of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.kewaunee.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000006 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000007 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.kewaunee.com/role/RevenueRecognition">
        <link:definition>0000010 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.kewaunee.com/role/Inventories">
        <link:definition>0000011 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermDebtandOtherCreditArrangements" roleURI="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements">
        <link:definition>0000012 - Disclosure - Long-term Debt and Other Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleLeasebackFinancingTransaction" roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction">
        <link:definition>0000013 - Disclosure - Sale-Leaseback Financing Transaction</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.kewaunee.com/role/IncomeTaxes">
        <link:definition>0000014 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensation" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation">
        <link:definition>0000015 - Disclosure - Stock Options and Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>0000016 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingencies" roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingencies">
        <link:definition>0000017 - Disclosure - Leases, Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefits" roleURI="http://www.kewaunee.com/role/RetirementBenefits">
        <link:definition>0000018 - Disclosure - Retirement Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.kewaunee.com/role/SegmentInformation">
        <link:definition>0000019 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCosts" roleURI="http://www.kewaunee.com/role/RestructuringCosts">
        <link:definition>0000020 - Disclosure - Restructuring Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000021 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000022 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.kewaunee.com/role/RevenueRecognitionTables">
        <link:definition>0000023 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.kewaunee.com/role/InventoriesTables">
        <link:definition>0000024 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleLeasebackFinancingTransactionTables" roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables">
        <link:definition>0000025 - Disclosure - Sale-Leaseback Financing Transaction (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.kewaunee.com/role/IncomeTaxesTables">
        <link:definition>0000026 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensationTables" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables">
        <link:definition>0000027 - Disclosure - Stock Options and Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>0000028 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesTables" roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables">
        <link:definition>0000029 - Disclosure - Leases, Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsTables" roleURI="http://www.kewaunee.com/role/RetirementBenefitsTables">
        <link:definition>0000030 - Disclosure - Retirement Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.kewaunee.com/role/SegmentInformationTables">
        <link:definition>0000031 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>0000032 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails">
        <link:definition>0000033 - Disclosure - Summary of Significant Accounting Policies - Cash Equivalents Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail">
        <link:definition>0000034 - Disclosure - Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail">
        <link:definition>0000035 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail">
        <link:definition>0000036 - Disclosure - Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail" roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail">
        <link:definition>0000037 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail" roleURI="http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail">
        <link:definition>0000038 - Disclosure - Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail">
        <link:definition>0000039 - Disclosure - Revenue Recognition - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesSummaryofInventoriesDetail" roleURI="http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail">
        <link:definition>0000040 - Disclosure - Inventories - Summary of Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail">
        <link:definition>0000041 - Disclosure - Inventories - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail">
        <link:definition>0000042 - Disclosure - Long-term Debt and Other Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleLeasebackFinancingTransactionNarrativeDetails" roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails">
        <link:definition>0000043 - Disclosure - Sale-Leaseback Financing Transaction - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails" roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails">
        <link:definition>0000044 - Disclosure - Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1" roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1">
        <link:definition>0000044 - Disclosure - Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail">
        <link:definition>0000045 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxExpenseDetail" roleURI="http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail">
        <link:definition>0000046 - Disclosure - Income Taxes - Income Tax Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeTaxReconciliationDetail" roleURI="http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail">
        <link:definition>0000047 - Disclosure - Income Taxes - Schedule of Income Tax Reconciliation (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail">
        <link:definition>0000048 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1" roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1">
        <link:definition>0000048 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensationAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail">
        <link:definition>0000049 - Disclosure - Stock Options and Share-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails">
        <link:definition>0000050 - Disclosure - Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail">
        <link:definition>0000051 - Disclosure - Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail" roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail">
        <link:definition>0000052 - Disclosure - Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail" roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail">
        <link:definition>0000053 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail">
        <link:definition>0000054 - Disclosure - Leases, Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails" roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails">
        <link:definition>0000055 - Disclosure - Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1" roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1">
        <link:definition>0000055 - Disclosure - Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail">
        <link:definition>0000056 - Disclosure - Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail">
        <link:definition>0000057 - Disclosure - Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail">
        <link:definition>0000058 - Disclosure - Retirement Benefits - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail">
        <link:definition>0000059 - Disclosure - Retirement Benefits - Summary of Expected Benefit Payments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail">
        <link:definition>0000060 - Disclosure - Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail" roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail">
        <link:definition>0000061 - Disclosure - Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAdditionalInformationDetail" roleURI="http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail">
        <link:definition>0000062 - Disclosure - Segment Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetail" roleURI="http://www.kewaunee.com/role/SegmentInformationDetail">
        <link:definition>0000063 - Disclosure - Segment Information - (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsAdditionalInformationDetails" roleURI="http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails">
        <link:definition>0000064 - Disclosure - Restructuring Costs - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility" abstract="false" name="Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_DeferredTaxAssetLeaseLiability" abstract="false" name="DeferredTaxAssetLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_KewauneeLabwayAsiaMember" abstract="true" name="KewauneeLabwayAsiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_InternationalOperationsMember" abstract="true" name="InternationalOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_DefinedBenefitPlanLiquidAlternativesMember" abstract="true" name="DefinedBenefitPlanLiquidAlternativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidAfterYearFive" abstract="false" name="FinancingLiabilityToBePaidAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_AdvancesMember" abstract="true" name="AdvancesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_RevenueRecognitionTable" abstract="true" name="RevenueRecognitionTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="kequ_KequipGlobalLabSolutionsMember" abstract="true" name="KequipGlobalLabSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidYearFour" abstract="false" name="FinancingLiabilityToBePaidYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_FinancingLiabilityBasicMonthlyPayment" abstract="false" name="FinancingLiabilityBasicMonthlyPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_FederalStateAndLocalTaxReturnsPeriod" abstract="false" name="FederalStateAndLocalTaxReturnsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidYearThree" abstract="false" name="FinancingLiabilityToBePaidYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="kequ_BankGuaranteesMember" abstract="true" name="BankGuaranteesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" abstract="false" name="DeferredTaxAssetsProceedsOnSaleLeaseback" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_KewauneeScientificCorporationSingaporeMember" abstract="true" name="KewauneeScientificCorporationSingaporeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" abstract="true" name="TwoThousandSeventeenOmnibusIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_RevenuesIncludingIntersegmentMarkup" abstract="false" name="RevenuesIncludingIntersegmentMarkup" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_TradingSecuritiesMember" abstract="true" name="TradingSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" abstract="false" name="ContractWithCustomerLiabilityRevenueRecognizedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="kequ_KewauneeLabwayIndiaMember" abstract="true" name="KewauneeLabwayIndiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" abstract="false" name="DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod" abstract="false" name="CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_LesseeRemainingLeaseTerm" abstract="false" name="LesseeRemainingLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="kequ_DeferredTaxLiabilitiesPrepaidPensionCost" abstract="false" name="DeferredTaxLiabilitiesPrepaidPensionCost" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_SignificantAccountingPoliciesLineItems" abstract="true" name="SignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" abstract="false" name="ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="kequ_FinancingLiabilityNoncurrent" abstract="false" name="FinancingLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_PaymentsOnFinancingLiability" abstract="false" name="PaymentsOnFinancingLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_RestrictedStockUnitsRSUsServiceComponentMember" abstract="true" name="RestrictedStockUnitsRSUsServiceComponentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_ProceedsFromFinancingLiability" abstract="false" name="ProceedsFromFinancingLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_KewauneeScientificCorporationMember" abstract="true" name="KewauneeScientificCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_FinancingLiabilityAnnualIncreasePercent" abstract="false" name="FinancingLiabilityAnnualIncreasePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="kequ_AdvanceAmountOneMember" abstract="true" name="AdvanceAmountOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_TaxWithholdingExpense" abstract="false" name="TaxWithholdingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_TwoThousandAndEightPlanMember" abstract="true" name="TwoThousandAndEightPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_NonQualifiedCompensationPlanMember" abstract="true" name="NonQualifiedCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability" abstract="false" name="RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" abstract="false" name="ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="kequ_UnbilledRetainageCurrent" abstract="false" name="UnbilledRetainageCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" abstract="false" name="ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="kequ_KoncepoScientechInternationalMember" abstract="true" name="KoncepoScientechInternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" abstract="false" name="DeferredTaxLiabilitiesSaleLeasebackProperty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_LesseeOptiontoTerminateTerm" abstract="false" name="LesseeOptiontoTerminateTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_FinancingLiabilityLineItems" abstract="true" name="FinancingLiabilityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" abstract="false" name="DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_AdvanceAmountTwoMember" abstract="true" name="AdvanceAmountTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_FiscalYearTwoThousandTwentyFourMember" abstract="true" name="FiscalYearTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" abstract="false" name="ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="kequ_AccruedEmployeeBenefitPlanCosts" abstract="false" name="AccruedEmployeeBenefitPlanCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity" abstract="false" name="DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaid" abstract="false" name="FinancingLiabilityToBePaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" abstract="false" name="LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_ForeignSubsidiariesTaxReturnsPeriod" abstract="false" name="ForeignSubsidiariesTaxReturnsPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_LesseeOptiontoExtendTerm" abstract="false" name="LesseeOptiontoExtendTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidYearOne" abstract="false" name="FinancingLiabilityToBePaidYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_FinancingLiabilityNumberOfRenewalOptions" abstract="false" name="FinancingLiabilityNumberOfRenewalOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="kequ_OperatingLeaseShortTermExpense" abstract="false" name="OperatingLeaseShortTermExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" abstract="false" name="DefinedContributionPlanEligibilityMinimumServicePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_DefinedBenefitPlanPercentageChangesInDiscountRate" abstract="false" name="DefinedBenefitPlanPercentageChangesInDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="kequ_OtherAssetsPolicyTextBlock" abstract="false" name="OtherAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="kequ_FinancingLiabilityTable" abstract="true" name="FinancingLiabilityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="kequ_FinancingLiabilityTermOfContract" abstract="false" name="FinancingLiabilityTermOfContract" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_InternationalSubsidiariesMember" abstract="true" name="InternationalSubsidiariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_DeferredTaxAssetsSection174REAddback" abstract="false" name="DeferredTaxAssetsSection174REAddback" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_NumberOfNonqualifiedCompensationPlans" abstract="false" name="NumberOfNonqualifiedCompensationPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="kequ_FinancingLiabilityUndiscountedExcessAmount" abstract="false" name="FinancingLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DeferredTaxLiabilitiesAPB23Assertion" abstract="false" name="DeferredTaxLiabilitiesAPB23Assertion" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_YieldCurveTechniqueMember" abstract="true" name="YieldCurveTechniqueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" abstract="false" name="DefinedContributionPlanEmployerMatchingContributionsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_ShareBasedCompensationDeferredTaxExpenseBenefit" abstract="false" name="ShareBasedCompensationDeferredTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_RevenueRecognitionLineItems" abstract="true" name="RevenueRecognitionLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_DomesticOperationsMember" abstract="true" name="DomesticOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" abstract="false" name="DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="kequ_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_TwoThousandTenAndTwoThousandEightPlanMember" abstract="true" name="TwoThousandTenAndTwoThousandEightPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_FinancingLiabilityAbstract" abstract="true" name="FinancingLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_FinancingLiabilityRenewalTerm" abstract="false" name="FinancingLiabilityRenewalTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_TermLoanBMember" abstract="true" name="TermLoanBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" abstract="false" name="ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidYearTwo" abstract="false" name="FinancingLiabilityToBePaidYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" abstract="false" name="DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="kequ_DefinedBenefitPlanEmergingMarketsMember" abstract="true" name="DefinedBenefitPlanEmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_ForeignSubsidiariesMember" abstract="true" name="ForeignSubsidiariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_CreditAgreementMidCapFundingIVTrustMember" abstract="true" name="CreditAgreementMidCapFundingIVTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_FinancingLiabilityCurrent" abstract="false" name="FinancingLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_InterestExpenseFinancingLiability" abstract="false" name="InterestExpenseFinancingLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" abstract="false" name="DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" abstract="true" name="DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="kequ_FinancingLiabilityToBePaidYearFive" abstract="false" name="FinancingLiabilityToBePaidYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="kequ_FinancingLiability" abstract="false" name="FinancingLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>kequ-20230430_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:e58e8ac3-ecd1-406b-a8f1-c5aecee1e3ad,g:fefb243f-2e84-4dac-80b6-e3a13121b6c2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8c30dd5f-c390-48cf-80ac-694a9b3b0391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8bb42851-61f2-4c4e-b049-6293015c2ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_8c30dd5f-c390-48cf-80ac-694a9b3b0391" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8bb42851-61f2-4c4e-b049-6293015c2ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c444bd4e-a5e5-47a8-9a4d-571d3e12de49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_8c30dd5f-c390-48cf-80ac-694a9b3b0391" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c444bd4e-a5e5-47a8-9a4d-571d3e12de49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7163ae6e-6f72-46e0-a8b7-372700c36377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7ae32165-ade1-4096-a6de-759f83d64eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7163ae6e-6f72-46e0-a8b7-372700c36377" xlink:to="loc_us-gaap_ProfitLoss_7ae32165-ade1-4096-a6de-759f83d64eba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cada3fae-9271-4600-89f3-6043bdc79b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7163ae6e-6f72-46e0-a8b7-372700c36377" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cada3fae-9271-4600-89f3-6043bdc79b5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3d06f169-7887-4659-9b80-7d1b9bffbc30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d016aa7-238a-4f86-88ec-7afb8decbb94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_3d06f169-7887-4659-9b80-7d1b9bffbc30" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6d016aa7-238a-4f86-88ec-7afb8decbb94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_58cc457f-362e-431d-959d-cc3f8400dc35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_3d06f169-7887-4659-9b80-7d1b9bffbc30" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_58cc457f-362e-431d-959d-cc3f8400dc35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3fd152f1-f00e-46bd-b906-d741992b3efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f06c428e-59dd-46f5-9c71-b6325cff87ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3fd152f1-f00e-46bd-b906-d741992b3efb" xlink:to="loc_us-gaap_GrossProfit_f06c428e-59dd-46f5-9c71-b6325cff87ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_924332c9-28ff-4e54-b888-f3b6f6c2390b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3fd152f1-f00e-46bd-b906-d741992b3efb" xlink:to="loc_us-gaap_OperatingExpenses_924332c9-28ff-4e54-b888-f3b6f6c2390b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00dad8a2-dd8f-4072-9309-861388f4df7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c27fe925-6705-415a-b78c-e0d3485f4a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00dad8a2-dd8f-4072-9309-861388f4df7f" xlink:to="loc_us-gaap_OperatingIncomeLoss_c27fe925-6705-415a-b78c-e0d3485f4a5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_d07ad950-9060-4f1e-9e8e-90b210bbf4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00dad8a2-dd8f-4072-9309-861388f4df7f" xlink:to="loc_us-gaap_OtherIncome_d07ad950-9060-4f1e-9e8e-90b210bbf4d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2f6498ec-73e2-4ae7-94f5-689a188debef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00dad8a2-dd8f-4072-9309-861388f4df7f" xlink:to="loc_us-gaap_InterestExpense_2f6498ec-73e2-4ae7-94f5-689a188debef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense_d33b1cff-e7e0-4b8f-bd6e-028b960bae8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_00dad8a2-dd8f-4072-9309-861388f4df7f" xlink:to="loc_us-gaap_PensionExpense_d33b1cff-e7e0-4b8f-bd6e-028b960bae8b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cbb1733a-ef3d-4add-bce2-515968a3a097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7b1d8ed1-fa6e-4c75-9b0c-ee8577d52040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cbb1733a-ef3d-4add-bce2-515968a3a097" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_7b1d8ed1-fa6e-4c75-9b0c-ee8577d52040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_21cd6323-da29-488a-b04c-d2394dc9b605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cbb1733a-ef3d-4add-bce2-515968a3a097" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_21cd6323-da29-488a-b04c-d2394dc9b605" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b61b3e79-94a5-47b8-bd51-6d86d5ac6e95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cac816ae-ee63-4eb9-ad19-5c91055fe4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b61b3e79-94a5-47b8-bd51-6d86d5ac6e95" xlink:to="loc_us-gaap_ProfitLoss_cac816ae-ee63-4eb9-ad19-5c91055fe4e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_51754cd1-1dd7-4c42-9c3a-9431feedcbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b61b3e79-94a5-47b8-bd51-6d86d5ac6e95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_51754cd1-1dd7-4c42-9c3a-9431feedcbb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_b1565345-80a7-41ed-ba62-ab8ee8360014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b61b3e79-94a5-47b8-bd51-6d86d5ac6e95" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_b1565345-80a7-41ed-ba62-ab8ee8360014" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7abae4e3-abbb-4c96-9349-877d96473952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1ccd8655-bdb4-4e96-93d4-a915a0bba848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7abae4e3-abbb-4c96-9349-877d96473952" xlink:to="loc_us-gaap_CommonStockValue_1ccd8655-bdb4-4e96-93d4-a915a0bba848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7de6c66a-8379-4687-a39e-4b6ac5d89758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7abae4e3-abbb-4c96-9349-877d96473952" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7de6c66a-8379-4687-a39e-4b6ac5d89758" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e57d7636-765e-43cb-852a-4a933e7f6e61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7abae4e3-abbb-4c96-9349-877d96473952" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e57d7636-765e-43cb-852a-4a933e7f6e61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_26f40792-5ade-4678-9162-0df46db28dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7abae4e3-abbb-4c96-9349-877d96473952" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_26f40792-5ade-4678-9162-0df46db28dda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_1c4468ab-3d04-4fd4-add1-bd3ed124fd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7abae4e3-abbb-4c96-9349-877d96473952" xlink:to="loc_us-gaap_TreasuryStockValue_1c4468ab-3d04-4fd4-add1-bd3ed124fd4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8ea9f3b6-86c9-4a34-9583-285ce36758bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a5c76532-ab34-4903-99c9-f1023fd1f216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8ea9f3b6-86c9-4a34-9583-285ce36758bf" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a5c76532-ab34-4903-99c9-f1023fd1f216" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c5e029da-cbc9-4c2b-b228-cd0baaeffa5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8ea9f3b6-86c9-4a34-9583-285ce36758bf" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c5e029da-cbc9-4c2b-b228-cd0baaeffa5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_5a9d9687-0f16-4e66-a7ff-3298b4fd4a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8ea9f3b6-86c9-4a34-9583-285ce36758bf" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_5a9d9687-0f16-4e66-a7ff-3298b4fd4a2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f4a68461-dfce-442d-9400-b7d56f7bc586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8ea9f3b6-86c9-4a34-9583-285ce36758bf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f4a68461-dfce-442d-9400-b7d56f7bc586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_87a3320b-3db9-4d84-bbb8-8e24f803a5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8ea9f3b6-86c9-4a34-9583-285ce36758bf" xlink:to="loc_us-gaap_InventoryNet_87a3320b-3db9-4d84-bbb8-8e24f803a5bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_35ca53a5-6f02-45af-bac5-e02e9f240664" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8ea9f3b6-86c9-4a34-9583-285ce36758bf" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_35ca53a5-6f02-45af-bac5-e02e9f240664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4b95698b-10bf-4889-ac17-2898383e24b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e405b215-fe0a-4917-8b07-ecf6de9af342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4b95698b-10bf-4889-ac17-2898383e24b6" xlink:to="loc_us-gaap_StockholdersEquity_e405b215-fe0a-4917-8b07-ecf6de9af342" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_710fe3bb-4095-47a2-abc0-f6f82f549310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4b95698b-10bf-4889-ac17-2898383e24b6" xlink:to="loc_us-gaap_MinorityInterest_710fe3bb-4095-47a2-abc0-f6f82f549310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9d9a3ceb-b6ec-40f6-bbae-6cabbf9c9e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_89c2e608-95d6-4a2d-bb64-90ed7848bd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9d9a3ceb-b6ec-40f6-bbae-6cabbf9c9e77" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_89c2e608-95d6-4a2d-bb64-90ed7848bd0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ca16d0ba-a1a4-4256-bc74-1201ce7d582f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9d9a3ceb-b6ec-40f6-bbae-6cabbf9c9e77" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ca16d0ba-a1a4-4256-bc74-1201ce7d582f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d95bc9aa-8226-40c8-9c9d-5254c83ff610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9d9a3ceb-b6ec-40f6-bbae-6cabbf9c9e77" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d95bc9aa-8226-40c8-9c9d-5254c83ff610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AccruedEmployeeBenefitPlanCosts_28b7cc2f-c8fe-4bfb-a7ad-2d72c7f703e8" xlink:href="kequ-20230430.xsd#kequ_AccruedEmployeeBenefitPlanCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9d9a3ceb-b6ec-40f6-bbae-6cabbf9c9e77" xlink:to="loc_kequ_AccruedEmployeeBenefitPlanCosts_28b7cc2f-c8fe-4bfb-a7ad-2d72c7f703e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNoncurrent_8233a98e-764b-4543-84c9-46be76587055" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9d9a3ceb-b6ec-40f6-bbae-6cabbf9c9e77" xlink:to="loc_kequ_FinancingLiabilityNoncurrent_8233a98e-764b-4543-84c9-46be76587055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_9d5cf7dc-dc6f-47fc-80a7-e1ea03b6bd75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9d9a3ceb-b6ec-40f6-bbae-6cabbf9c9e77" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_9d5cf7dc-dc6f-47fc-80a7-e1ea03b6bd75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bd6930d9-4e24-419d-b391-f25a0eb0dfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9d9a3ceb-b6ec-40f6-bbae-6cabbf9c9e77" xlink:to="loc_us-gaap_LiabilitiesCurrent_bd6930d9-4e24-419d-b391-f25a0eb0dfaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_84b297b4-d7f7-413e-adc7-7d6203025ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_03404b7c-fb5a-41d0-9c1a-dc22a6c0d672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_84b297b4-d7f7-413e-adc7-7d6203025ea1" xlink:to="loc_us-gaap_AssetsCurrent_03404b7c-fb5a-41d0-9c1a-dc22a6c0d672" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_eb26ba15-101d-4893-a03d-da3cc1ed55dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_84b297b4-d7f7-413e-adc7-7d6203025ea1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_eb26ba15-101d-4893-a03d-da3cc1ed55dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a7051548-928f-4bda-9393-9e3cae2bc29d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_84b297b4-d7f7-413e-adc7-7d6203025ea1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a7051548-928f-4bda-9393-9e3cae2bc29d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b76e9e4a-f227-4db0-bda0-1026466e2777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_84b297b4-d7f7-413e-adc7-7d6203025ea1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b76e9e4a-f227-4db0-bda0-1026466e2777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_70d5f4b9-4b2f-4986-81b2-60fd3e0b823e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_2c3cdd4f-88ed-462c-bda8-2c27de014ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_70d5f4b9-4b2f-4986-81b2-60fd3e0b823e" xlink:to="loc_us-gaap_ShortTermBorrowings_2c3cdd4f-88ed-462c-bda8-2c27de014ace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_fc924fbb-b205-448e-bba4-0f4dbd78661a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_70d5f4b9-4b2f-4986-81b2-60fd3e0b823e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_fc924fbb-b205-448e-bba4-0f4dbd78661a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5f7ffcf6-8bec-4f02-806a-0d7fc427f275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_70d5f4b9-4b2f-4986-81b2-60fd3e0b823e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5f7ffcf6-8bec-4f02-806a-0d7fc427f275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_12a4ea01-e699-41e8-98d7-de624adb7b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_70d5f4b9-4b2f-4986-81b2-60fd3e0b823e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_12a4ea01-e699-41e8-98d7-de624adb7b24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bf8f960a-981d-419a-9300-93314d1f7be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_70d5f4b9-4b2f-4986-81b2-60fd3e0b823e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bf8f960a-981d-419a-9300-93314d1f7be2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bf71972b-bce9-49d7-a308-140365473c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_70d5f4b9-4b2f-4986-81b2-60fd3e0b823e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bf71972b-bce9-49d7-a308-140365473c19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityCurrent_0dbd1193-6674-45e8-9d01-5dcc8f09dfef" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_70d5f4b9-4b2f-4986-81b2-60fd3e0b823e" xlink:to="loc_kequ_FinancingLiabilityCurrent_0dbd1193-6674-45e8-9d01-5dcc8f09dfef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_cfc7ba55-6f31-49ef-9f85-c468641cef49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_70d5f4b9-4b2f-4986-81b2-60fd3e0b823e" xlink:to="loc_us-gaap_AccountsPayableCurrent_cfc7ba55-6f31-49ef-9f85-c468641cef49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_79bbd480-ad49-4d83-b349-2c0a6009df5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_52d8613f-b85c-4be0-827d-7111d37a4c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_79bbd480-ad49-4d83-b349-2c0a6009df5f" xlink:to="loc_us-gaap_Liabilities_52d8613f-b85c-4be0-827d-7111d37a4c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3dcb61a5-9933-4d68-82ba-b281a30577fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_79bbd480-ad49-4d83-b349-2c0a6009df5f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3dcb61a5-9933-4d68-82ba-b281a30577fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e3f4a9aa-646f-48b1-b694-201cb3af4318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_79bbd480-ad49-4d83-b349-2c0a6009df5f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e3f4a9aa-646f-48b1-b694-201cb3af4318" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4b8f78a0-3cf1-41c3-94c6-90cbfcc48f83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_014b57b5-7132-411b-86c1-924344aa0406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4b8f78a0-3cf1-41c3-94c6-90cbfcc48f83" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_014b57b5-7132-411b-86c1-924344aa0406" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ProceedsFromFinancingLiability_452a8347-af88-433e-87f4-2478e1648f0c" xlink:href="kequ-20230430.xsd#kequ_ProceedsFromFinancingLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4b8f78a0-3cf1-41c3-94c6-90cbfcc48f83" xlink:to="loc_kequ_ProceedsFromFinancingLiability_452a8347-af88-433e-87f4-2478e1648f0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a940935e-c516-4df4-b17c-04c5aed8ac71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4b8f78a0-3cf1-41c3-94c6-90cbfcc48f83" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a940935e-c516-4df4-b17c-04c5aed8ac71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_PaymentsOnFinancingLiability_5a168448-4090-4d48-ab61-c1514d751aad" xlink:href="kequ-20230430.xsd#kequ_PaymentsOnFinancingLiability"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4b8f78a0-3cf1-41c3-94c6-90cbfcc48f83" xlink:to="loc_kequ_PaymentsOnFinancingLiability_5a168448-4090-4d48-ab61-c1514d751aad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_6ec5158a-e772-4b9e-8ab4-e75e344ab897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4b8f78a0-3cf1-41c3-94c6-90cbfcc48f83" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_6ec5158a-e772-4b9e-8ab4-e75e344ab897" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_18d6f39e-1e54-4824-ae3d-25f0bc785af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4b8f78a0-3cf1-41c3-94c6-90cbfcc48f83" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_18d6f39e-1e54-4824-ae3d-25f0bc785af4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b1b007cd-742e-4389-8cfb-97dada8c24fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_us-gaap_ProfitLoss_b1b007cd-742e-4389-8cfb-97dada8c24fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_56792f92-d15f-4b57-a161-2ccc14807d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_us-gaap_Depreciation_56792f92-d15f-4b57-a161-2ccc14807d1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_b0c53865-8e68-42f4-8bbc-20dc194ed1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_b0c53865-8e68-42f4-8bbc-20dc194ed1ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_07ffa0f0-a282-4237-b125-f3fe54d02a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_us-gaap_ShareBasedCompensation_07ffa0f0-a282-4237-b125-f3fe54d02a30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_314aa138-036b-47b5-88da-9ea2bf71d39b" xlink:href="kequ-20230430.xsd#kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_314aa138-036b-47b5-88da-9ea2bf71d39b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bc825523-2bcc-4c04-ae4c-8a66c5636283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_bc825523-2bcc-4c04-ae4c-8a66c5636283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c1344473-7daa-42f3-bd8a-bfa6d76f44ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c1344473-7daa-42f3-bd8a-bfa6d76f44ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_44b9c501-395c-4617-850d-37daec5ff0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_44b9c501-395c-4617-850d-37daec5ff0e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a522597f-9a10-4356-b792-47b67abff60f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a522597f-9a10-4356-b792-47b67abff60f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_74fdc466-8f05-481d-9733-e147261f9ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_74fdc466-8f05-481d-9733-e147261f9ee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ff22e1fc-7a9e-4da4-aaed-1d6c85e9103e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d9ef494-1ffe-487e-aca3-28b5e2f50fd1" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ff22e1fc-7a9e-4da4-aaed-1d6c85e9103e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e1b329f-61fe-4012-ab79-40bdd61485ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_f1a22368-3de4-4d09-8d0c-9c03b01453d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e1b329f-61fe-4012-ab79-40bdd61485ae" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_f1a22368-3de4-4d09-8d0c-9c03b01453d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_263b5df9-2cbb-4e8a-8910-3dab1cbc8d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f39ef2c8-9bfa-4066-808b-66e22ddae1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_263b5df9-2cbb-4e8a-8910-3dab1cbc8d7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f39ef2c8-9bfa-4066-808b-66e22ddae1bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bfec18bb-5cd4-46f2-b29f-711b4b820b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_263b5df9-2cbb-4e8a-8910-3dab1cbc8d7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bfec18bb-5cd4-46f2-b29f-711b4b820b92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_82970b5f-60ac-4cbb-a843-a268b596c366" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_263b5df9-2cbb-4e8a-8910-3dab1cbc8d7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_82970b5f-60ac-4cbb-a843-a268b596c366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e06ba01a-0aa8-4816-a690-4fb026c69384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_263b5df9-2cbb-4e8a-8910-3dab1cbc8d7c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e06ba01a-0aa8-4816-a690-4fb026c69384" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c7691b4-a58f-46e2-9bd8-8a639743b12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5c29b554-c941-4302-8295-58f5fe56a391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c7691b4-a58f-46e2-9bd8-8a639743b12b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5c29b554-c941-4302-8295-58f5fe56a391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_20201eb7-2c7b-4bca-a81a-1cd586817c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0c7691b4-a58f-46e2-9bd8-8a639743b12b" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_20201eb7-2c7b-4bca-a81a-1cd586817c6f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c2e8fb27-cb42-4f15-a7ef-ad6404e20681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_02ade297-903a-4324-a162-7a9cfe4c3855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_c2e8fb27-cb42-4f15-a7ef-ad6404e20681" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_02ade297-903a-4324-a162-7a9cfe4c3855" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_aa3bcd73-e9e4-4e88-a767-bf2825b01e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_c2e8fb27-cb42-4f15-a7ef-ad6404e20681" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_aa3bcd73-e9e4-4e88-a767-bf2825b01e69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c4090c03-74d0-45e8-989b-c6edfa9cf88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_12e12652-4592-47c4-961d-7b8488ba1a28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c4090c03-74d0-45e8-989b-c6edfa9cf88b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_12e12652-4592-47c4-961d-7b8488ba1a28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c8714862-7368-4601-bb95-bafc11ae68ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c4090c03-74d0-45e8-989b-c6edfa9cf88b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c8714862-7368-4601-bb95-bafc11ae68ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#InventoriesSummaryofInventoriesDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ee25389d-6332-498a-baff-8ed88cb5b360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4cec4f4d-360d-4771-96cc-5696bbb5c092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_ee25389d-6332-498a-baff-8ed88cb5b360" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4cec4f4d-360d-4771-96cc-5696bbb5c092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9d8b756b-204a-4cba-b397-047101873940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_ee25389d-6332-498a-baff-8ed88cb5b360" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9d8b756b-204a-4cba-b397-047101873940" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_436f55c4-39e4-41e3-9d3a-1f0e6967a325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_ee25389d-6332-498a-baff-8ed88cb5b360" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_436f55c4-39e4-41e3-9d3a-1f0e6967a325" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaid_e1751abd-e7c7-48f9-b5ee-6ead5503c7c9" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearTwo_7539492d-0865-43ff-b2fe-11e7060b1a3f" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_e1751abd-e7c7-48f9-b5ee-6ead5503c7c9" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearTwo_7539492d-0865-43ff-b2fe-11e7060b1a3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearOne_8e8ae09f-e5a3-412c-90b1-0f3e9c07cb5c" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearOne"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_e1751abd-e7c7-48f9-b5ee-6ead5503c7c9" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearOne_8e8ae09f-e5a3-412c-90b1-0f3e9c07cb5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidAfterYearFive_2ae5ae9e-18de-42d4-b40f-b19598c4def9" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_e1751abd-e7c7-48f9-b5ee-6ead5503c7c9" xlink:to="loc_kequ_FinancingLiabilityToBePaidAfterYearFive_2ae5ae9e-18de-42d4-b40f-b19598c4def9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFive_58280ac2-8b95-410f-bffa-db21ecef45ce" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_e1751abd-e7c7-48f9-b5ee-6ead5503c7c9" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearFive_58280ac2-8b95-410f-bffa-db21ecef45ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFour_a220f6e8-86d8-4c83-91ca-a8da0d666acd" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_e1751abd-e7c7-48f9-b5ee-6ead5503c7c9" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearFour_a220f6e8-86d8-4c83-91ca-a8da0d666acd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearThree_25951ca0-9064-4996-b81c-4b127e288108" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_e1751abd-e7c7-48f9-b5ee-6ead5503c7c9" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearThree_25951ca0-9064-4996-b81c-4b127e288108" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1" xlink:type="simple" xlink:href="kequ-20230430.xsd#SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaid_fc843617-4bd9-499c-a5b6-ec8e21137660" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiability_9f92458c-50c5-41d6-a9b0-bdabc5b74acf" xlink:href="kequ-20230430.xsd#kequ_FinancingLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_fc843617-4bd9-499c-a5b6-ec8e21137660" xlink:to="loc_kequ_FinancingLiability_9f92458c-50c5-41d6-a9b0-bdabc5b74acf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityUndiscountedExcessAmount_80a2059b-54da-4de9-ab21-dce216b610ea" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_kequ_FinancingLiabilityToBePaid_fc843617-4bd9-499c-a5b6-ec8e21137660" xlink:to="loc_kequ_FinancingLiabilityUndiscountedExcessAmount_80a2059b-54da-4de9-ab21-dce216b610ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesIncomeTaxExpenseDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5a8d9442-b484-4e91-ac29-cc2bdae32666" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4281a0ee-7319-45ab-b502-c13728b4dc51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5a8d9442-b484-4e91-ac29-cc2bdae32666" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4281a0ee-7319-45ab-b502-c13728b4dc51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8d927fba-95aa-492d-9dde-559f16d797d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5a8d9442-b484-4e91-ac29-cc2bdae32666" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8d927fba-95aa-492d-9dde-559f16d797d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_8ee53f4c-dea5-4d2a-b60a-d485cdf85fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_5a8d9442-b484-4e91-ac29-cc2bdae32666" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_8ee53f4c-dea5-4d2a-b60a-d485cdf85fee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_91680363-6ae1-4659-83b4-50b43d13b69a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_89efb0bf-1c00-4952-ac33-3a89b3f3334e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91680363-6ae1-4659-83b4-50b43d13b69a" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_89efb0bf-1c00-4952-ac33-3a89b3f3334e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_081e74ba-8a76-4b8a-bb15-e824a3a56aee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_91680363-6ae1-4659-83b4-50b43d13b69a" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_081e74ba-8a76-4b8a-bb15-e824a3a56aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c1770ec6-290f-485f-89c8-30e6e8880b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e189aff7-7721-451c-a232-af469868dd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c1770ec6-290f-485f-89c8-30e6e8880b49" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e189aff7-7721-451c-a232-af469868dd7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c7e22089-cc28-49e8-af7d-8c3ffe0eaf4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c1770ec6-290f-485f-89c8-30e6e8880b49" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c7e22089-cc28-49e8-af7d-8c3ffe0eaf4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_8007c5d9-be30-469b-9522-2fbb0abc9389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c1770ec6-290f-485f-89c8-30e6e8880b49" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_8007c5d9-be30-469b-9522-2fbb0abc9389" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesScheduleofIncomeTaxReconciliationDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e216030a-4123-483d-828a-5d9548f76705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_485c80ca-2530-4ae6-a183-0df913c2bebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e216030a-4123-483d-828a-5d9548f76705" xlink:to="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_485c80ca-2530-4ae6-a183-0df913c2bebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_05677cd8-6a91-4f7a-a56d-711f442f319a" xlink:href="kequ-20230430.xsd#kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e216030a-4123-483d-828a-5d9548f76705" xlink:to="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_05677cd8-6a91-4f7a-a56d-711f442f319a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_83f6fd7c-5e71-4b97-946a-3213510ac946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e216030a-4123-483d-828a-5d9548f76705" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_83f6fd7c-5e71-4b97-946a-3213510ac946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6ce3882f-edb5-40ef-93f4-2726f1b5a8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e216030a-4123-483d-828a-5d9548f76705" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6ce3882f-edb5-40ef-93f4-2726f1b5a8d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_9ce1c883-dbfe-4010-b084-8e451d433265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e216030a-4123-483d-828a-5d9548f76705" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_9ce1c883-dbfe-4010-b084-8e451d433265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_9e2e00cc-f86b-4698-8edd-876608cfb1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e216030a-4123-483d-828a-5d9548f76705" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_9e2e00cc-f86b-4698-8edd-876608cfb1ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_958edb47-288a-42d5-8a98-a3d90ebd43e6" xlink:href="kequ-20230430.xsd#kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e216030a-4123-483d-828a-5d9548f76705" xlink:to="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_958edb47-288a-42d5-8a98-a3d90ebd43e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_25f270a6-ec47-4854-aeb5-7b689dde31ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e216030a-4123-483d-828a-5d9548f76705" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_25f270a6-ec47-4854-aeb5-7b689dde31ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a2538944-1839-4dab-8c75-aefd03e12c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_e216030a-4123-483d-828a-5d9548f76705" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a2538944-1839-4dab-8c75-aefd03e12c4d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_98c02c7c-d4d1-4914-a758-0758e14c8bee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_63b610a9-f803-47d2-9c73-a380203e548f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_98c02c7c-d4d1-4914-a758-0758e14c8bee" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_63b610a9-f803-47d2-9c73-a380203e548f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1fb62ad5-5ce4-4592-ae1d-b022b327d28e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_98c02c7c-d4d1-4914-a758-0758e14c8bee" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_1fb62ad5-5ce4-4592-ae1d-b022b327d28e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_70a97956-251a-4d44-8bda-f61670307da1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_98c02c7c-d4d1-4914-a758-0758e14c8bee" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_70a97956-251a-4d44-8bda-f61670307da1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_5ef8c295-f578-41c9-9756-1e41c3783400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_5ef8c295-f578-41c9-9756-1e41c3783400" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_a43682bb-c00a-4916-a0ed-5d5e3de9a4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_a43682bb-c00a-4916-a0ed-5d5e3de9a4e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_6cd617e8-482d-4871-82d4-341d0c0c9343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_6cd617e8-482d-4871-82d4-341d0c0c9343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_adfaa42c-987a-47de-abd3-519e18b280c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_adfaa42c-987a-47de-abd3-519e18b280c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ac23a2b6-b84d-467a-bdc2-0dcaff75d4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_ac23a2b6-b84d-467a-bdc2-0dcaff75d4a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a1d32066-f0d2-487d-9017-93a221ed98f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a1d32066-f0d2-487d-9017-93a221ed98f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback_05d5dc84-a5c2-411b-9767-26e44ff582f4" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_kequ_DeferredTaxAssetsSection174REAddback_05d5dc84-a5c2-411b-9767-26e44ff582f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_13eca240-994f-4a01-a4cf-31ca2d87d154" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetsProceedsOnSaleLeaseback"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_13eca240-994f-4a01-a4cf-31ca2d87d154" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetLeaseLiability_1b22117a-97d3-4343-877f-f3c6ad3d7149" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetLeaseLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_kequ_DeferredTaxAssetLeaseLiability_1b22117a-97d3-4343-877f-f3c6ad3d7149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_8294f5a0-c20c-4fce-a0e0-61ad7d70f417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_8294f5a0-c20c-4fce-a0e0-61ad7d70f417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_a663ff6f-46f7-485a-be01-72730f202594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_a663ff6f-46f7-485a-be01-72730f202594" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_27085f6a-4abc-437e-ac99-2273d2b64d58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ac46c299-80aa-4138-853d-1239571ede7a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_27085f6a-4abc-437e-ac99-2273d2b64d58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_572d87e1-b002-4a28-a967-10fdd3fcc446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_d8022237-4d73-49d4-aa52-7e6f88ccdef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_572d87e1-b002-4a28-a967-10fdd3fcc446" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_d8022237-4d73-49d4-aa52-7e6f88ccdef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_82af981d-230c-4dae-829c-039aca76d494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_572d87e1-b002-4a28-a967-10fdd3fcc446" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_82af981d-230c-4dae-829c-039aca76d494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_dd24ef8c-1c26-4d65-9ebf-272b372d1925" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesPrepaidPensionCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_572d87e1-b002-4a28-a967-10fdd3fcc446" xlink:to="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_dd24ef8c-1c26-4d65-9ebf-272b372d1925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_00931957-bdea-4402-b4df-8cb36bc5527a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_572d87e1-b002-4a28-a967-10fdd3fcc446" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_00931957-bdea-4402-b4df-8cb36bc5527a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_d698ef71-5ce6-48aa-bab5-2d144afcdcd9" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesAPB23Assertion"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_572d87e1-b002-4a28-a967-10fdd3fcc446" xlink:to="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_d698ef71-5ce6-48aa-bab5-2d144afcdcd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_0bd40759-166e-4b69-9d93-401bfe5b3e14" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesSaleLeasebackProperty"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_572d87e1-b002-4a28-a967-10fdd3fcc446" xlink:to="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_0bd40759-166e-4b69-9d93-401bfe5b3e14" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_6df04fc6-d6da-47cd-9da4-671c7c1e2813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_93f38997-2f70-4bfd-b9cc-c039ebe39f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_6df04fc6-d6da-47cd-9da4-671c7c1e2813" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_93f38997-2f70-4bfd-b9cc-c039ebe39f3a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f5b9c138-9952-482d-9329-5eed7fbf9b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_56a8e6c4-e9df-4855-bc60-fda987217367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f5b9c138-9952-482d-9329-5eed7fbf9b5a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_56a8e6c4-e9df-4855-bc60-fda987217367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d12b4172-fd75-4c49-8da5-e3e784f3a5ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f5b9c138-9952-482d-9329-5eed7fbf9b5a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d12b4172-fd75-4c49-8da5-e3e784f3a5ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_66da5b3b-544d-422f-a765-2c86dbe95845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f5b9c138-9952-482d-9329-5eed7fbf9b5a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_66da5b3b-544d-422f-a765-2c86dbe95845" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5d2b6b79-d85a-494f-ae6b-209c672ef488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f5b9c138-9952-482d-9329-5eed7fbf9b5a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5d2b6b79-d85a-494f-ae6b-209c672ef488" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_44bbc225-4dc3-4282-bc1f-be71cb9ac7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f5b9c138-9952-482d-9329-5eed7fbf9b5a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_44bbc225-4dc3-4282-bc1f-be71cb9ac7f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5fc9d727-a3f0-44e2-b2a6-2d739f841b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f5b9c138-9952-482d-9329-5eed7fbf9b5a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_5fc9d727-a3f0-44e2-b2a6-2d739f841b65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fb350729-71b3-4f0a-a897-b04bdda39bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f1ba7506-a740-4592-b1b5-bb0251b807b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fb350729-71b3-4f0a-a897-b04bdda39bf0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f1ba7506-a740-4592-b1b5-bb0251b807b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f0fcab51-ced8-4d65-89e6-e49a51d9816e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fb350729-71b3-4f0a-a897-b04bdda39bf0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f0fcab51-ced8-4d65-89e6-e49a51d9816e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8ffb86fd-0ba0-4f98-bd4b-0475cf719e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fb350729-71b3-4f0a-a897-b04bdda39bf0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8ffb86fd-0ba0-4f98-bd4b-0475cf719e31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fc5c4eda-ab31-46df-ba64-7aab38648f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fb350729-71b3-4f0a-a897-b04bdda39bf0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_fc5c4eda-ab31-46df-ba64-7aab38648f91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4d200b0b-01a6-4a48-bd90-7e45a741ad30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fb350729-71b3-4f0a-a897-b04bdda39bf0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4d200b0b-01a6-4a48-bd90-7e45a741ad30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c7262518-fa74-4ae1-8272-7ee9e0e7b32f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fb350729-71b3-4f0a-a897-b04bdda39bf0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c7262518-fa74-4ae1-8272-7ee9e0e7b32f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1" xlink:type="simple" xlink:href="kequ-20230430.xsd#LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a7f78fc2-d548-42ff-8e81-2dae75acf684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_03201311-8cf0-4f62-b8f0-fafd73a43476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a7f78fc2-d548-42ff-8e81-2dae75acf684" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_03201311-8cf0-4f62-b8f0-fafd73a43476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b94333df-b37b-45ea-a0cd-c3e5eddc943f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a7f78fc2-d548-42ff-8e81-2dae75acf684" xlink:to="loc_us-gaap_FinanceLeaseLiability_b94333df-b37b-45ea-a0cd-c3e5eddc943f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a1288a0f-d264-47fb-8bb1-bd4dda77ae0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_168c0ca7-246b-4391-8420-eea29076a5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a1288a0f-d264-47fb-8bb1-bd4dda77ae0b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_168c0ca7-246b-4391-8420-eea29076a5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_562ce054-52ef-4859-a078-5df068b7990d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a1288a0f-d264-47fb-8bb1-bd4dda77ae0b" xlink:to="loc_us-gaap_OperatingLeaseLiability_562ce054-52ef-4859-a078-5df068b7990d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_d0c49448-ec4d-4194-9e51-081f7bd3cfb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_6c288a32-2f93-423f-a69d-585eead38738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_d0c49448-ec4d-4194-9e51-081f7bd3cfb4" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_6c288a32-2f93-423f-a69d-585eead38738" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_68d59ee1-4df8-4136-acff-ffc665f8b6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_d0c49448-ec4d-4194-9e51-081f7bd3cfb4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_68d59ee1-4df8-4136-acff-ffc665f8b6a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_1507390d-9829-4d99-bcb8-0df2055c5648" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e2104f4a-8ac4-485a-a496-7a377006effb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_1507390d-9829-4d99-bcb8-0df2055c5648" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_e2104f4a-8ac4-485a-a496-7a377006effb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7c11e55c-311d-4d5d-84eb-75f741e61bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_1507390d-9829-4d99-bcb8-0df2055c5648" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7c11e55c-311d-4d5d-84eb-75f741e61bef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"/>
  <link:calculationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_da366f5d-9020-49e6-b3e4-641a06c4b1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_89cbd41e-a0ae-494b-8313-ed80b9514a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_da366f5d-9020-49e6-b3e4-641a06c4b1fe" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_89cbd41e-a0ae-494b-8313-ed80b9514a3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_dc8ea0e5-bf21-41fd-9232-1f4cd5b35a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_da366f5d-9020-49e6-b3e4-641a06c4b1fe" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_dc8ea0e5-bf21-41fd-9232-1f4cd5b35a25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_145c9ebb-c941-47b0-8f78-69f922edf63d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_da366f5d-9020-49e6-b3e4-641a06c4b1fe" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_145c9ebb-c941-47b0-8f78-69f922edf63d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>kequ-20230430_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:e58e8ac3-ecd1-406b-a8f1-c5aecee1e3ad,g:fefb243f-2e84-4dac-80b6-e3a13121b6c2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedStatementofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="extended" id="ia52c6fca4a4e4639a2da666cda197811_ConsolidatedStatementofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5395fee2-4e8f-4776-9f4f-e134ceec595a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5395fee2-4e8f-4776-9f4f-e134ceec595a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0a3fff1f-ccb1-4da5-b4b6-2852e2a5c3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:to="loc_us-gaap_StockholdersEquity_0a3fff1f-ccb1-4da5-b4b6-2852e2a5c3cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ff402fa9-2f30-4a11-8f4a-11231737ca3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:to="loc_us-gaap_NetIncomeLoss_ff402fa9-2f30-4a11-8f4a-11231737ca3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d961946-d2b3-4cc4-94a7-428bac5096d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d961946-d2b3-4cc4-94a7-428bac5096d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_06a48777-f2ae-4dec-81d8-9dd0892d14bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_06a48777-f2ae-4dec-81d8-9dd0892d14bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_596ee686-a8d7-4c4d-9b59-998bbb917602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bd725a10-0bd5-4767-93eb-dc9cd0a81182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5395fee2-4e8f-4776-9f4f-e134ceec595a" xlink:to="loc_us-gaap_StatementTable_bd725a10-0bd5-4767-93eb-dc9cd0a81182" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_25c3ff1f-0768-4e03-9fa8-40eafedf658c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bd725a10-0bd5-4767-93eb-dc9cd0a81182" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_25c3ff1f-0768-4e03-9fa8-40eafedf658c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_25c3ff1f-0768-4e03-9fa8-40eafedf658c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25c3ff1f-0768-4e03-9fa8-40eafedf658c" xlink:to="loc_us-gaap_EquityComponentDomain_25c3ff1f-0768-4e03-9fa8-40eafedf658c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25c3ff1f-0768-4e03-9fa8-40eafedf658c" xlink:to="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3e4c2015-3304-447a-b93e-dfa66d4b05dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:to="loc_us-gaap_CommonStockMember_3e4c2015-3304-447a-b93e-dfa66d4b05dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d41638fc-7794-4d91-bc8a-f288d086a669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d41638fc-7794-4d91-bc8a-f288d086a669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_1913b75f-c8cc-4286-9d02-d4af068d067b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:to="loc_us-gaap_TreasuryStockCommonMember_1913b75f-c8cc-4286-9d02-d4af068d067b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b5416cea-94b7-4ae0-b8e3-64e43f4ff59c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:to="loc_us-gaap_RetainedEarningsMember_b5416cea-94b7-4ae0-b8e3-64e43f4ff59c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4097f0c5-9143-4fbd-8ed9-c775a3ba21b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4097f0c5-9143-4fbd-8ed9-c775a3ba21b1" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended" id="i4a4c61a0f7a047198e40c322ad920bd7_SummaryofSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:href="kequ-20230430.xsd#kequ_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_c02960aa-7cc6-4256-a5d9-8423ec8f7baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_c02960aa-7cc6-4256-a5d9-8423ec8f7baf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_e69fd7d4-da03-4d5f-b2ab-e570f87e03f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_AssetsNet_e69fd7d4-da03-4d5f-b2ab-e570f87e03f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7f08ca74-3b1a-456e-8b23-c30a9ed95edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7f08ca74-3b1a-456e-8b23-c30a9ed95edf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_e5876e39-b0f9-45fa-8531-1962dcbe3d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_e5876e39-b0f9-45fa-8531-1962dcbe3d2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_8d96d46e-11f5-4a79-827d-102f2b07839b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_AssetImpairmentCharges_8d96d46e-11f5-4a79-827d-102f2b07839b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_UnbilledRetainageCurrent_f140bf35-7838-4d25-a2e8-562b647a8a7d" xlink:href="kequ-20230430.xsd#kequ_UnbilledRetainageCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_kequ_UnbilledRetainageCurrent_f140bf35-7838-4d25-a2e8-562b647a8a7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust_3b87be8c-1c26-411d-9439-e600718f9b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_AssetsHeldInTrust_3b87be8c-1c26-411d-9439-e600718f9b49" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_f4ffbd7f-7aff-4bab-a7ab-2de7551e952c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_f4ffbd7f-7aff-4bab-a7ab-2de7551e952c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_47d1b70e-7557-470b-901f-f9789dce688a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_47d1b70e-7557-470b-901f-f9789dce688a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1_7cc62b57-5233-4c40-b361-b3724529a878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1_7cc62b57-5233-4c40-b361-b3724529a878" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_ab8facf1-fc26-4d8f-92e5-cf196d9032f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_ab8facf1-fc26-4d8f-92e5-cf196d9032f6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTermOfContract_dff61c9a-a182-43ff-a1d1-b4c3bfc2ce07" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_kequ_FinancingLiabilityTermOfContract_dff61c9a-a182-43ff-a1d1-b4c3bfc2ce07" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionContractorReceivableRetainage_1d498fde-e039-4d81-8d20-ce75af2e3cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionContractorReceivableRetainage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ConstructionContractorReceivableRetainage_1d498fde-e039-4d81-8d20-ce75af2e3cf8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_5711dd9c-ad61-40d6-bd43-da6773ba57ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_5711dd9c-ad61-40d6-bd43-da6773ba57ff" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0726c03b-bc2a-44f8-a5c5-d9b9ced8fd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0726c03b-bc2a-44f8-a5c5-d9b9ced8fd95" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_ebebfa8e-ad2d-42c6-a98e-a4f19bb1b3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_AdvertisingExpense_ebebfa8e-ad2d-42c6-a98e-a4f19bb1b3fc" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_177204ff-c987-47f5-9e2c-e7b7ec42d5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_177204ff-c987-47f5-9e2c-e7b7ec42d5f5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_645dbd5c-bbba-45c0-8e4c-cfa19eb115ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_645dbd5c-bbba-45c0-8e4c-cfa19eb115ac" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_df90d1f4-1ef4-42ef-920d-520fc246456a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_df90d1f4-1ef4-42ef-920d-520fc246456a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:href="kequ-20230430.xsd#kequ_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_c52ac7a1-f897-436a-8c23-6dd1a95072f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_srt_OwnershipAxis_c52ac7a1-f897-436a-8c23-6dd1a95072f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_c52ac7a1-f897-436a-8c23-6dd1a95072f4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_c52ac7a1-f897-436a-8c23-6dd1a95072f4" xlink:to="loc_srt_OwnershipDomain_c52ac7a1-f897-436a-8c23-6dd1a95072f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_39f72438-51a1-45f8-a294-62247b33fc69" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_c52ac7a1-f897-436a-8c23-6dd1a95072f4" xlink:to="loc_srt_OwnershipDomain_39f72438-51a1-45f8-a294-62247b33fc69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationMember_1450bc81-9126-42dd-903b-80e133438969" xlink:href="kequ-20230430.xsd#kequ_KewauneeScientificCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_39f72438-51a1-45f8-a294-62247b33fc69" xlink:to="loc_kequ_KewauneeScientificCorporationMember_1450bc81-9126-42dd-903b-80e133438969" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationSingaporeMember_4d4d5ccb-0864-45b8-842d-2d3b82bad61c" xlink:href="kequ-20230430.xsd#kequ_KewauneeScientificCorporationSingaporeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_39f72438-51a1-45f8-a294-62247b33fc69" xlink:to="loc_kequ_KewauneeScientificCorporationSingaporeMember_4d4d5ccb-0864-45b8-842d-2d3b82bad61c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_60e46748-90af-478d-9037-29d322dbc415" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_dei_LegalEntityAxis_60e46748-90af-478d-9037-29d322dbc415" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_60e46748-90af-478d-9037-29d322dbc415_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_60e46748-90af-478d-9037-29d322dbc415" xlink:to="loc_dei_EntityDomain_60e46748-90af-478d-9037-29d322dbc415_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_60e46748-90af-478d-9037-29d322dbc415" xlink:to="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayAsiaMember_8d83d440-686f-403a-8da4-91b159c977df" xlink:href="kequ-20230430.xsd#kequ_KewauneeLabwayAsiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:to="loc_kequ_KewauneeLabwayAsiaMember_8d83d440-686f-403a-8da4-91b159c977df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationSingaporeMember_c679abb8-5766-4ea0-bed2-9b6f8ae6a433" xlink:href="kequ-20230430.xsd#kequ_KewauneeScientificCorporationSingaporeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:to="loc_kequ_KewauneeScientificCorporationSingaporeMember_c679abb8-5766-4ea0-bed2-9b6f8ae6a433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayIndiaMember_90cdf724-2af6-4a99-ae4a-72f61cc8e2d4" xlink:href="kequ-20230430.xsd#kequ_KewauneeLabwayIndiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:to="loc_kequ_KewauneeLabwayIndiaMember_90cdf724-2af6-4a99-ae4a-72f61cc8e2d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KoncepoScientechInternationalMember_f8efdfde-873b-43b3-ad89-63ce0d30d57d" xlink:href="kequ-20230430.xsd#kequ_KoncepoScientechInternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:to="loc_kequ_KoncepoScientechInternationalMember_f8efdfde-873b-43b3-ad89-63ce0d30d57d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KequipGlobalLabSolutionsMember_4f98812e-95c4-4e9e-a3ac-962fbeee7fd6" xlink:href="kequ-20230430.xsd#kequ_KequipGlobalLabSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:to="loc_kequ_KequipGlobalLabSolutionsMember_4f98812e-95c4-4e9e-a3ac-962fbeee7fd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9df12bc1-2549-44a5-8134-430f735e2ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9df12bc1-2549-44a5-8134-430f735e2ff7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9df12bc1-2549-44a5-8134-430f735e2ff7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9df12bc1-2549-44a5-8134-430f735e2ff7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9df12bc1-2549-44a5-8134-430f735e2ff7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c22282b9-11a1-4ecc-ae1b-5e4a8f1f8734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9df12bc1-2549-44a5-8134-430f735e2ff7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c22282b9-11a1-4ecc-ae1b-5e4a8f1f8734" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c91e7dd2-5cad-4df7-867d-6ff5e5bb0245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c22282b9-11a1-4ecc-ae1b-5e4a8f1f8734" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c91e7dd2-5cad-4df7-867d-6ff5e5bb0245" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_91b07c2b-c2c6-40b5-8b5a-d5f1552e3ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c22282b9-11a1-4ecc-ae1b-5e4a8f1f8734" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_91b07c2b-c2c6-40b5-8b5a-d5f1552e3ca5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7333d779-a964-45f7-aec0-9e44a2791bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7333d779-a964-45f7-aec0-9e44a2791bdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7333d779-a964-45f7-aec0-9e44a2791bdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7333d779-a964-45f7-aec0-9e44a2791bdf" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7333d779-a964-45f7-aec0-9e44a2791bdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9171ab15-6650-4066-a043-5caffa7b8fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7333d779-a964-45f7-aec0-9e44a2791bdf" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9171ab15-6650-4066-a043-5caffa7b8fcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_dd71163c-0aa1-4928-b06d-2f900d9aa411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9171ab15-6650-4066-a043-5caffa7b8fcf" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_dd71163c-0aa1-4928-b06d-2f900d9aa411" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c951028e-78d1-4ae5-bdb6-c2c08076b4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_AwardTypeAxis_c951028e-78d1-4ae5-bdb6-c2c08076b4a6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c951028e-78d1-4ae5-bdb6-c2c08076b4a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c951028e-78d1-4ae5-bdb6-c2c08076b4a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c951028e-78d1-4ae5-bdb6-c2c08076b4a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee0211de-9e08-4707-827d-a1a52707a52c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c951028e-78d1-4ae5-bdb6-c2c08076b4a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee0211de-9e08-4707-827d-a1a52707a52c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e2569eb2-0fc4-466b-a9f9-3b80f903d9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee0211de-9e08-4707-827d-a1a52707a52c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e2569eb2-0fc4-466b-a9f9-3b80f903d9f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e67f2638-47d0-4300-8581-b1a90dda1f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e67f2638-47d0-4300-8581-b1a90dda1f38" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e67f2638-47d0-4300-8581-b1a90dda1f38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e67f2638-47d0-4300-8581-b1a90dda1f38" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e67f2638-47d0-4300-8581-b1a90dda1f38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4ba9df85-3d97-43f4-b140-c1bd02e1c4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e67f2638-47d0-4300-8581-b1a90dda1f38" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4ba9df85-3d97-43f4-b140-c1bd02e1c4de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueSegmentMember_33a129cd-a863-4943-9c8e-079938128a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4ba9df85-3d97-43f4-b140-c1bd02e1c4de" xlink:to="loc_us-gaap_SalesRevenueSegmentMember_33a129cd-a863-4943-9c8e-079938128a19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_967ad088-0c27-4bae-af2e-57fc7c29c108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4ba9df85-3d97-43f4-b140-c1bd02e1c4de" xlink:to="loc_us-gaap_AccountsReceivableMember_967ad088-0c27-4bae-af2e-57fc7c29c108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_f778d300-09fa-4028-8645-fa86a4aae075" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_srt_ConsolidatedEntitiesAxis_f778d300-09fa-4028-8645-fa86a4aae075" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f778d300-09fa-4028-8645-fa86a4aae075_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f778d300-09fa-4028-8645-fa86a4aae075" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f778d300-09fa-4028-8645-fa86a4aae075_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_0b3578c7-81c4-45f6-a63d-3607980deaeb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f778d300-09fa-4028-8645-fa86a4aae075" xlink:to="loc_srt_ConsolidatedEntitiesDomain_0b3578c7-81c4-45f6-a63d-3607980deaeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_560f96e9-6dec-4e5d-b1d9-411bbf2d50f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_0b3578c7-81c4-45f6-a63d-3607980deaeb" xlink:to="loc_srt_SubsidiariesMember_560f96e9-6dec-4e5d-b1d9-411bbf2d50f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_0c1eb7af-4ad4-4ac9-b3e9-32ce17cb99e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_GeographicDistributionAxis_0c1eb7af-4ad4-4ac9-b3e9-32ce17cb99e6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_0c1eb7af-4ad4-4ac9-b3e9-32ce17cb99e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_0c1eb7af-4ad4-4ac9-b3e9-32ce17cb99e6" xlink:to="loc_us-gaap_GeographicDistributionDomain_0c1eb7af-4ad4-4ac9-b3e9-32ce17cb99e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_c3182961-4291-4324-90a7-4ec8b27dba31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_0c1eb7af-4ad4-4ac9-b3e9-32ce17cb99e6" xlink:to="loc_us-gaap_GeographicDistributionDomain_c3182961-4291-4324-90a7-4ec8b27dba31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_22c9311c-1551-4b04-8971-59f43a0574e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_c3182961-4291-4324-90a7-4ec8b27dba31" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_22c9311c-1551-4b04-8971-59f43a0574e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3a954e3b-eb48-4684-8521-fb898abdbfaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_srt_ConsolidationItemsAxis_3a954e3b-eb48-4684-8521-fb898abdbfaf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3a954e3b-eb48-4684-8521-fb898abdbfaf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_3a954e3b-eb48-4684-8521-fb898abdbfaf" xlink:to="loc_srt_ConsolidationItemsDomain_3a954e3b-eb48-4684-8521-fb898abdbfaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_edcc5cbf-50f1-41f1-b589-990f84b50705" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_3a954e3b-eb48-4684-8521-fb898abdbfaf" xlink:to="loc_srt_ConsolidationItemsDomain_edcc5cbf-50f1-41f1-b589-990f84b50705" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b7d1ad6b-d16a-4d8d-a0cf-7392216114a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_edcc5cbf-50f1-41f1-b589-990f84b50705" xlink:to="loc_us-gaap_OperatingSegmentsMember_b7d1ad6b-d16a-4d8d-a0cf-7392216114a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6dfd3360-51e9-4384-b3a2-ac7e20c65f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6dfd3360-51e9-4384-b3a2-ac7e20c65f63" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6dfd3360-51e9-4384-b3a2-ac7e20c65f63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6dfd3360-51e9-4384-b3a2-ac7e20c65f63" xlink:to="loc_us-gaap_SegmentDomain_6dfd3360-51e9-4384-b3a2-ac7e20c65f63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_901c6035-85ac-4d47-8c50-d3fec590244e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6dfd3360-51e9-4384-b3a2-ac7e20c65f63" xlink:to="loc_us-gaap_SegmentDomain_901c6035-85ac-4d47-8c50-d3fec590244e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalOperationsMember_8471e3ba-5710-406b-8b3e-125c1d59fd6e" xlink:href="kequ-20230430.xsd#kequ_InternationalOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_901c6035-85ac-4d47-8c50-d3fec590244e" xlink:to="loc_kequ_InternationalOperationsMember_8471e3ba-5710-406b-8b3e-125c1d59fd6e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="extended" id="i7f45b061002a4ec084d91967eef5504e_SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_32f0a0b3-24b5-4bcb-9cea-44ae3fe20a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_32f0a0b3-24b5-4bcb-9cea-44ae3fe20a72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_153e05b6-a41c-41cb-87cd-9647178aef45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_153e05b6-a41c-41cb-87cd-9647178aef45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8933e7a8-813c-49a7-a971-b781233198ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8933e7a8-813c-49a7-a971-b781233198ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d8f23a3e-e5ae-4836-bcdd-65e343e669c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d8f23a3e-e5ae-4836-bcdd-65e343e669c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_836965fd-a111-4ce5-9c07-1b51855eeb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_836965fd-a111-4ce5-9c07-1b51855eeb1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d844543b-eb3b-4f07-8a1a-609077c963ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_836965fd-a111-4ce5-9c07-1b51855eeb1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d844543b-eb3b-4f07-8a1a-609077c963ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d844543b-eb3b-4f07-8a1a-609077c963ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d844543b-eb3b-4f07-8a1a-609077c963ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d844543b-eb3b-4f07-8a1a-609077c963ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef43a03c-b228-4f52-8995-31d5e9979386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d844543b-eb3b-4f07-8a1a-609077c963ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef43a03c-b228-4f52-8995-31d5e9979386" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_6102a0b2-5abe-421e-8900-b03a66218f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef43a03c-b228-4f52-8995-31d5e9979386" xlink:to="loc_us-gaap_LandMember_6102a0b2-5abe-421e-8900-b03a66218f82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_6132db05-425e-4cf2-8994-8307381cb8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef43a03c-b228-4f52-8995-31d5e9979386" xlink:to="loc_us-gaap_BuildingImprovementsMember_6132db05-425e-4cf2-8994-8307381cb8dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_81023f38-c167-4805-b05f-ebbfd0547017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef43a03c-b228-4f52-8995-31d5e9979386" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_81023f38-c167-4805-b05f-ebbfd0547017" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fc49c3a3-2240-49ad-8801-42b2643aee75" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_836965fd-a111-4ce5-9c07-1b51855eeb1b" xlink:to="loc_srt_RangeAxis_fc49c3a3-2240-49ad-8801-42b2643aee75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fc49c3a3-2240-49ad-8801-42b2643aee75_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fc49c3a3-2240-49ad-8801-42b2643aee75" xlink:to="loc_srt_RangeMember_fc49c3a3-2240-49ad-8801-42b2643aee75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_39cfda1e-c4c6-4ee5-8165-81938cda5e02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fc49c3a3-2240-49ad-8801-42b2643aee75" xlink:to="loc_srt_RangeMember_39cfda1e-c4c6-4ee5-8165-81938cda5e02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_49f72111-4848-44a8-bea5-4d1016265022" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_39cfda1e-c4c6-4ee5-8165-81938cda5e02" xlink:to="loc_srt_MinimumMember_49f72111-4848-44a8-bea5-4d1016265022" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ff7827ef-a64d-4265-809e-ffd259907bb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_39cfda1e-c4c6-4ee5-8165-81938cda5e02" xlink:to="loc_srt_MaximumMember_ff7827ef-a64d-4265-809e-ffd259907bb7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail" xlink:type="extended" id="i732edea894fa4df4a9325a3f341f3b6d_SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_03e006c6-6a48-4492-8468-c9bad16a7e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_us-gaap_DerivativeAssets_03e006c6-6a48-4492-8468-c9bad16a7e9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_62e5c633-ad2d-4f62-a61c-12f11d76b608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_us-gaap_DerivativeLiabilities_62e5c633-ad2d-4f62-a61c-12f11d76b608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_0136eb86-cd0b-4979-972f-e8d3ef30f033" xlink:href="kequ-20230430.xsd#kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_0136eb86-cd0b-4979-972f-e8d3ef30f033" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NumberOfNonqualifiedCompensationPlans_94c796a2-4458-46d9-9fcc-e73dfced53a9" xlink:href="kequ-20230430.xsd#kequ_NumberOfNonqualifiedCompensationPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_kequ_NumberOfNonqualifiedCompensationPlans_94c796a2-4458-46d9-9fcc-e73dfced53a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_8fa046e0-e401-4ea4-82ee-c4d4802d1999" xlink:href="kequ-20230430.xsd#kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_8fa046e0-e401-4ea4-82ee-c4d4802d1999" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2a9fadfb-82c8-4925-b49e-b1b65245e37b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2a9fadfb-82c8-4925-b49e-b1b65245e37b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2a9fadfb-82c8-4925-b49e-b1b65245e37b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2a9fadfb-82c8-4925-b49e-b1b65245e37b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2a9fadfb-82c8-4925-b49e-b1b65245e37b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3cdf4bee-44d5-4d3a-95ca-34d10b80d47d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2a9fadfb-82c8-4925-b49e-b1b65245e37b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3cdf4bee-44d5-4d3a-95ca-34d10b80d47d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e97b9079-3b2c-4748-a0c4-8d0401658ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3cdf4bee-44d5-4d3a-95ca-34d10b80d47d" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e97b9079-3b2c-4748-a0c4-8d0401658ab6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2619b460-4814-4998-8b82-bd7abea49313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3cdf4bee-44d5-4d3a-95ca-34d10b80d47d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2619b460-4814-4998-8b82-bd7abea49313" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_68cbc1b7-5598-470f-ab1e-5b3890bd0a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_68cbc1b7-5598-470f-ab1e-5b3890bd0a65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_68cbc1b7-5598-470f-ab1e-5b3890bd0a65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_68cbc1b7-5598-470f-ab1e-5b3890bd0a65" xlink:to="loc_us-gaap_EquityComponentDomain_68cbc1b7-5598-470f-ab1e-5b3890bd0a65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_76369315-b8b7-46a1-a531-d03803c6dff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_68cbc1b7-5598-470f-ab1e-5b3890bd0a65" xlink:to="loc_us-gaap_EquityComponentDomain_76369315-b8b7-46a1-a531-d03803c6dff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NonQualifiedCompensationPlanMember_9972ee69-fa7c-46d2-93b3-fb866f91faef" xlink:href="kequ-20230430.xsd#kequ_NonQualifiedCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_76369315-b8b7-46a1-a531-d03803c6dff0" xlink:to="loc_kequ_NonQualifiedCompensationPlanMember_9972ee69-fa7c-46d2-93b3-fb866f91faef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_fefd7051-8d6f-4605-ac9e-8379787109eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_fefd7051-8d6f-4605-ac9e-8379787109eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fefd7051-8d6f-4605-ac9e-8379787109eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_fefd7051-8d6f-4605-ac9e-8379787109eb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fefd7051-8d6f-4605-ac9e-8379787109eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_620635aa-cddc-4121-86af-ca8273286f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_fefd7051-8d6f-4605-ac9e-8379787109eb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_620635aa-cddc-4121-86af-ca8273286f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TradingSecuritiesMember_84c436ff-280b-4794-aba4-86d67f1ad2e4" xlink:href="kequ-20230430.xsd#kequ_TradingSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_620635aa-cddc-4121-86af-ca8273286f14" xlink:to="loc_kequ_TradingSecuritiesMember_84c436ff-280b-4794-aba4-86d67f1ad2e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueMember_1e6fc665-8cd1-4091-8a02-3159ee50505f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_620635aa-cddc-4121-86af-ca8273286f14" xlink:to="loc_us-gaap_CashSurrenderValueMember_1e6fc665-8cd1-4091-8a02-3159ee50505f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail" xlink:type="extended" id="i6250299268994a4d8dc086a2a5ff6642_RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3156d994-b602-46f1-85a2-ca09f961c06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e70eb0d-13ab-4216-91c3-06ca52e2771d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3156d994-b602-46f1-85a2-ca09f961c06e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e70eb0d-13ab-4216-91c3-06ca52e2771d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0522844a-ce8c-4fd3-8451-149e132b7942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3156d994-b602-46f1-85a2-ca09f961c06e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0522844a-ce8c-4fd3-8451-149e132b7942" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_7380e30d-2cba-47a4-9cb7-4e2ede0aa16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0522844a-ce8c-4fd3-8451-149e132b7942" xlink:to="loc_us-gaap_GeographicDistributionAxis_7380e30d-2cba-47a4-9cb7-4e2ede0aa16c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_7380e30d-2cba-47a4-9cb7-4e2ede0aa16c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_7380e30d-2cba-47a4-9cb7-4e2ede0aa16c" xlink:to="loc_us-gaap_GeographicDistributionDomain_7380e30d-2cba-47a4-9cb7-4e2ede0aa16c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_b441c878-160b-40fb-b472-b2a828726ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_7380e30d-2cba-47a4-9cb7-4e2ede0aa16c" xlink:to="loc_us-gaap_GeographicDistributionDomain_b441c878-160b-40fb-b472-b2a828726ebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_93a79da1-9492-435f-985b-b773b0a9ab65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_b441c878-160b-40fb-b472-b2a828726ebf" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_93a79da1-9492-435f-985b-b773b0a9ab65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_d52fb2ab-9c65-4e88-ae44-d58e11fd80c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_b441c878-160b-40fb-b472-b2a828726ebf" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_d52fb2ab-9c65-4e88-ae44-d58e11fd80c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a515c97-ffd9-4fe2-8f9a-0659d98ac114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0522844a-ce8c-4fd3-8451-149e132b7942" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a515c97-ffd9-4fe2-8f9a-0659d98ac114" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_9a515c97-ffd9-4fe2-8f9a-0659d98ac114_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a515c97-ffd9-4fe2-8f9a-0659d98ac114" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_9a515c97-ffd9-4fe2-8f9a-0659d98ac114_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d6a2f9ad-c0aa-42e9-a5dc-a7b9e4761bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a515c97-ffd9-4fe2-8f9a-0659d98ac114" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d6a2f9ad-c0aa-42e9-a5dc-a7b9e4761bf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_e60c6c54-31f0-4e33-b931-6cbfcb2203d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d6a2f9ad-c0aa-42e9-a5dc-a7b9e4761bf6" xlink:to="loc_us-gaap_TransferredOverTimeMember_e60c6c54-31f0-4e33-b931-6cbfcb2203d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_2c0f8013-af03-419a-8b29-c377a58b272d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d6a2f9ad-c0aa-42e9-a5dc-a7b9e4761bf6" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_2c0f8013-af03-419a-8b29-c377a58b272d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RevenueRecognitionAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail" xlink:type="extended" id="ice572c7539de4d2fb0ecb888f357f1fc_RevenueRecognitionAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:href="kequ-20230430.xsd#kequ_RevenueRecognitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_25b13b20-4d1b-48a4-8d50-57037d6c4990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_25b13b20-4d1b-48a4-8d50-57037d6c4990" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_UnbilledRetainageCurrent_9251cc19-8fb9-4bf6-acf5-0e85d87013b1" xlink:href="kequ-20230430.xsd#kequ_UnbilledRetainageCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:to="loc_kequ_UnbilledRetainageCurrent_9251cc19-8fb9-4bf6-acf5-0e85d87013b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_5566a6aa-140e-4801-bd9a-5bf540a8cb28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_5566a6aa-140e-4801-bd9a-5bf540a8cb28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_ee82033e-2010-4028-b926-e94105d543d7" xlink:href="kequ-20230430.xsd#kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:to="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_ee82033e-2010-4028-b926-e94105d543d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionTable_a5c19dbd-07eb-4b3a-b9e8-a89610a144a8" xlink:href="kequ-20230430.xsd#kequ_RevenueRecognitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:to="loc_kequ_RevenueRecognitionTable_a5c19dbd-07eb-4b3a-b9e8-a89610a144a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_9f71ec53-24cf-4fdd-8969-11b4c70ff8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_RevenueRecognitionTable_a5c19dbd-07eb-4b3a-b9e8-a89610a144a8" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_9f71ec53-24cf-4fdd-8969-11b4c70ff8ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_9f71ec53-24cf-4fdd-8969-11b4c70ff8ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_9f71ec53-24cf-4fdd-8969-11b4c70ff8ea" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_9f71ec53-24cf-4fdd-8969-11b4c70ff8ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_3c90f0fa-6a15-4b59-ad4d-32226191f98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_9f71ec53-24cf-4fdd-8969-11b4c70ff8ea" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_3c90f0fa-6a15-4b59-ad4d-32226191f98a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FiscalYearTwoThousandTwentyFourMember_9de74e7d-885b-42aa-b485-d48a8f1677b2" xlink:href="kequ-20230430.xsd#kequ_FiscalYearTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain_3c90f0fa-6a15-4b59-ad4d-32226191f98a" xlink:to="loc_kequ_FiscalYearTwoThousandTwentyFourMember_9de74e7d-885b-42aa-b485-d48a8f1677b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bdd5a243-4cdc-49f2-8de9-a5b332784e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_RevenueRecognitionTable_a5c19dbd-07eb-4b3a-b9e8-a89610a144a8" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bdd5a243-4cdc-49f2-8de9-a5b332784e9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bdd5a243-4cdc-49f2-8de9-a5b332784e9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bdd5a243-4cdc-49f2-8de9-a5b332784e9a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bdd5a243-4cdc-49f2-8de9-a5b332784e9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_19b85fe2-742e-4680-afe6-2c2f92e6f78b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bdd5a243-4cdc-49f2-8de9-a5b332784e9a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_19b85fe2-742e-4680-afe6-2c2f92e6f78b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_28f5a94b-6d0e-4819-906d-eb3e9238fa27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_19b85fe2-742e-4680-afe6-2c2f92e6f78b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_28f5a94b-6d0e-4819-906d-eb3e9238fa27" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#InventoriesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail" xlink:type="extended" id="i089549f21fdb4fc7824744bf5325e09a_InventoriesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_37ccf809-6fc5-4beb-aedf-0cf8ad4b489a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FIFOInventoryAmount_50ff387b-badd-4e05-bc26-95db6b59b108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FIFOInventoryAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_37ccf809-6fc5-4beb-aedf-0cf8ad4b489a" xlink:to="loc_us-gaap_FIFOInventoryAmount_50ff387b-badd-4e05-bc26-95db6b59b108" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_273dfbc4-fd0a-422a-a967-2c22cfd9e429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_37ccf809-6fc5-4beb-aedf-0cf8ad4b489a" xlink:to="loc_us-gaap_InventoryCurrentTable_273dfbc4-fd0a-422a-a967-2c22cfd9e429" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_fb2d6b34-5ffc-4f7b-a5d0-288992b2f9a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_273dfbc4-fd0a-422a-a967-2c22cfd9e429" xlink:to="loc_srt_ConsolidatedEntitiesAxis_fb2d6b34-5ffc-4f7b-a5d0-288992b2f9a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_fb2d6b34-5ffc-4f7b-a5d0-288992b2f9a1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_fb2d6b34-5ffc-4f7b-a5d0-288992b2f9a1" xlink:to="loc_srt_ConsolidatedEntitiesDomain_fb2d6b34-5ffc-4f7b-a5d0-288992b2f9a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1cadb178-5b2d-42bd-808a-bd5d79477347" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_fb2d6b34-5ffc-4f7b-a5d0-288992b2f9a1" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1cadb178-5b2d-42bd-808a-bd5d79477347" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesMember_5cf6e3fe-c281-4904-890c-75fd5424f618" xlink:href="kequ-20230430.xsd#kequ_ForeignSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1cadb178-5b2d-42bd-808a-bd5d79477347" xlink:to="loc_kequ_ForeignSubsidiariesMember_5cf6e3fe-c281-4904-890c-75fd5424f618" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail" xlink:type="extended" id="ie24c77977146438d8a1ce34b06cfdede_LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6e94a9eb-d40d-4480-81e7-5ff87357a214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6e94a9eb-d40d-4480-81e7-5ff87357a214" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity_6acd47a5-66c3-49db-8c53-6419cfab0c77" xlink:href="kequ-20230430.xsd#kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity_6acd47a5-66c3-49db-8c53-6419cfab0c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3cc89677-ebbe-4da1-a8ef-ebd37967e9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_LongTermDebt_3cc89677-ebbe-4da1-a8ef-ebd37967e9fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_914629ab-247e-48a7-ab49-918162af6b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_LineOfCredit_914629ab-247e-48a7-ab49-918162af6b95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_f83a70b1-a24e-47d2-9f19-774884705b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_f83a70b1-a24e-47d2-9f19-774884705b31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_4e838e85-48a9-4469-913e-b40db7029496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_4e838e85-48a9-4469-913e-b40db7029496" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_27136b17-60a6-4495-9ad4-56e17882565b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_27136b17-60a6-4495-9ad4-56e17882565b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_d2e4df16-4f57-4df7-b98d-8667fa42e7bb" xlink:href="kequ-20230430.xsd#kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_d2e4df16-4f57-4df7-b98d-8667fa42e7bb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_3385d654-e01a-4d68-9b8e-e9c6d1414a90" xlink:href="kequ-20230430.xsd#kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_3385d654-e01a-4d68-9b8e-e9c6d1414a90" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f038c180-e1b9-44dd-ab8f-4311e631093d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_ShortTermBorrowings_f038c180-e1b9-44dd-ab8f-4311e631093d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_ae2916dd-db7d-428a-89ce-7ba8beee2d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_ae2916dd-db7d-428a-89ce-7ba8beee2d4e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f6b0456a-b2fb-4d72-b47b-1e4d0a961c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_CreditFacilityAxis_f6b0456a-b2fb-4d72-b47b-1e4d0a961c83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f6b0456a-b2fb-4d72-b47b-1e4d0a961c83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f6b0456a-b2fb-4d72-b47b-1e4d0a961c83" xlink:to="loc_us-gaap_CreditFacilityDomain_f6b0456a-b2fb-4d72-b47b-1e4d0a961c83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f6b0456a-b2fb-4d72-b47b-1e4d0a961c83" xlink:to="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AdvanceAmountOneMember_eef76d22-ab71-476e-bf86-aa2f1476b89e" xlink:href="kequ-20230430.xsd#kequ_AdvanceAmountOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_kequ_AdvanceAmountOneMember_eef76d22-ab71-476e-bf86-aa2f1476b89e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AdvanceAmountTwoMember_aebf0295-062d-433b-9137-44ffd04fea59" xlink:href="kequ-20230430.xsd#kequ_AdvanceAmountTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_kequ_AdvanceAmountTwoMember_aebf0295-062d-433b-9137-44ffd04fea59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AdvancesMember_66d14419-e664-446b-90be-8d8895098778" xlink:href="kequ-20230430.xsd#kequ_AdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_kequ_AdvancesMember_66d14419-e664-446b-90be-8d8895098778" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ea76d4f8-42d8-462a-bbf0-5fb628cca098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_us-gaap_LineOfCreditMember_ea76d4f8-42d8-462a-bbf0-5fb628cca098" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TermLoanBMember_9fa4cca9-88b2-4d93-b0e3-d01bcfe2ea59" xlink:href="kequ-20230430.xsd#kequ_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_kequ_TermLoanBMember_9fa4cca9-88b2-4d93-b0e3-d01bcfe2ea59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_140079b5-0532-46cc-bbe5-6a36791b66c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_140079b5-0532-46cc-bbe5-6a36791b66c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_cf9a6c42-c807-4e78-8ae6-9f2b8437eaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_cf9a6c42-c807-4e78-8ae6-9f2b8437eaa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_cf9a6c42-c807-4e78-8ae6-9f2b8437eaa4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_cf9a6c42-c807-4e78-8ae6-9f2b8437eaa4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_cf9a6c42-c807-4e78-8ae6-9f2b8437eaa4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_cf9a6c42-c807-4e78-8ae6-9f2b8437eaa4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_feb8754f-b2ea-458d-974b-1adaec7ded98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_feb8754f-b2ea-458d-974b-1adaec7ded98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_25c639e6-17bd-4b9e-81d4-a48229514d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_25c639e6-17bd-4b9e-81d4-a48229514d50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_7774ffbe-0686-408b-be8a-a70fd63f0443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_7774ffbe-0686-408b-be8a-a70fd63f0443" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_3508a651-7d2a-4cfb-9692-f5ec54ff0e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_3508a651-7d2a-4cfb-9692-f5ec54ff0e2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_2c58e1c7-fe55-4b1e-9940-cd9f98062cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_2c58e1c7-fe55-4b1e-9940-cd9f98062cca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_4f066875-1485-47b8-9034-0799c65ff49f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_4f066875-1485-47b8-9034-0799c65ff49f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_4f066875-1485-47b8-9034-0799c65ff49f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_4f066875-1485-47b8-9034-0799c65ff49f" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_4f066875-1485-47b8-9034-0799c65ff49f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_6ebe630b-6c74-4a0a-9ba3-b3296aa5dc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_4f066875-1485-47b8-9034-0799c65ff49f" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_6ebe630b-6c74-4a0a-9ba3-b3296aa5dc9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_BankGuaranteesMember_a843fe64-2889-47eb-b76b-06a2d0874f61" xlink:href="kequ-20230430.xsd#kequ_BankGuaranteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_6ebe630b-6c74-4a0a-9ba3-b3296aa5dc9f" xlink:to="loc_kequ_BankGuaranteesMember_a843fe64-2889-47eb-b76b-06a2d0874f61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_eb511cc5-7441-4e5d-a46e-937d79dfbbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_VariableRateAxis_eb511cc5-7441-4e5d-a46e-937d79dfbbb0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_eb511cc5-7441-4e5d-a46e-937d79dfbbb0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_eb511cc5-7441-4e5d-a46e-937d79dfbbb0" xlink:to="loc_us-gaap_VariableRateDomain_eb511cc5-7441-4e5d-a46e-937d79dfbbb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b9bcd0bd-36e6-4197-878b-0c2e0d4e6a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_eb511cc5-7441-4e5d-a46e-937d79dfbbb0" xlink:to="loc_us-gaap_VariableRateDomain_b9bcd0bd-36e6-4197-878b-0c2e0d4e6a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_0544e551-24ec-4946-98be-85a849ccf514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b9bcd0bd-36e6-4197-878b-0c2e0d4e6a1e" xlink:to="loc_us-gaap_BaseRateMember_0544e551-24ec-4946-98be-85a849ccf514" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9b6cd5a7-d3bd-42e8-94dc-acfef4fdaaeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b9bcd0bd-36e6-4197-878b-0c2e0d4e6a1e" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9b6cd5a7-d3bd-42e8-94dc-acfef4fdaaeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SecuredOvernightFinancingRateSOFRMember_4feab70f-4250-487d-a9b3-3bd8d2a95154" xlink:href="kequ-20230430.xsd#kequ_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b9bcd0bd-36e6-4197-878b-0c2e0d4e6a1e" xlink:to="loc_kequ_SecuredOvernightFinancingRateSOFRMember_4feab70f-4250-487d-a9b3-3bd8d2a95154" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5f0d489f-76d3-4b02-aa63-8b2fccaf4f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_DebtInstrumentAxis_5f0d489f-76d3-4b02-aa63-8b2fccaf4f90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5f0d489f-76d3-4b02-aa63-8b2fccaf4f90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5f0d489f-76d3-4b02-aa63-8b2fccaf4f90" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5f0d489f-76d3-4b02-aa63-8b2fccaf4f90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_09f70ef4-3103-4fe1-af28-ff5bbcdc6f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5f0d489f-76d3-4b02-aa63-8b2fccaf4f90" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_09f70ef4-3103-4fe1-af28-ff5bbcdc6f3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_CreditAgreementMidCapFundingIVTrustMember_8e494ef5-4141-492b-8818-7b209281c255" xlink:href="kequ-20230430.xsd#kequ_CreditAgreementMidCapFundingIVTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_09f70ef4-3103-4fe1-af28-ff5bbcdc6f3a" xlink:to="loc_kequ_CreditAgreementMidCapFundingIVTrustMember_8e494ef5-4141-492b-8818-7b209281c255" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_05443a3a-d585-454a-b2eb-f5c1b50d82f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_05443a3a-d585-454a-b2eb-f5c1b50d82f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_05443a3a-d585-454a-b2eb-f5c1b50d82f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_05443a3a-d585-454a-b2eb-f5c1b50d82f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_05443a3a-d585-454a-b2eb-f5c1b50d82f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_222efd5c-270b-4eb7-9b49-a7420e680f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_05443a3a-d585-454a-b2eb-f5c1b50d82f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_222efd5c-270b-4eb7-9b49-a7420e680f02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_b3d13b87-b366-4b98-8c66-1d6d3e33c88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_222efd5c-270b-4eb7-9b49-a7420e680f02" xlink:to="loc_us-gaap_LineOfCreditMember_b3d13b87-b366-4b98-8c66-1d6d3e33c88b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_acd439c1-2179-4fb3-ba60-3ddead7b1556" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_srt_ConsolidatedEntitiesAxis_acd439c1-2179-4fb3-ba60-3ddead7b1556" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_acd439c1-2179-4fb3-ba60-3ddead7b1556_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_acd439c1-2179-4fb3-ba60-3ddead7b1556" xlink:to="loc_srt_ConsolidatedEntitiesDomain_acd439c1-2179-4fb3-ba60-3ddead7b1556_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_32ee6a05-072c-4406-b5a1-89d6c823385c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_acd439c1-2179-4fb3-ba60-3ddead7b1556" xlink:to="loc_srt_ConsolidatedEntitiesDomain_32ee6a05-072c-4406-b5a1-89d6c823385c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalSubsidiariesMember_749767ba-84b0-4933-a88e-7b67d26afdb5" xlink:href="kequ-20230430.xsd#kequ_InternationalSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_32ee6a05-072c-4406-b5a1-89d6c823385c" xlink:to="loc_kequ_InternationalSubsidiariesMember_749767ba-84b0-4933-a88e-7b67d26afdb5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#SaleLeasebackFinancingTransactionNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails" xlink:type="extended" id="i3a76468cd5a84bbcbc96a9098a296675_SaleLeasebackFinancingTransactionNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityLineItems_45fc27af-678f-4a1c-894d-2a9c30328bc2" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_039c3922-aacb-4b68-b000-78acf72efc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_FinancingLiabilityLineItems_45fc27af-678f-4a1c-894d-2a9c30328bc2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_039c3922-aacb-4b68-b000-78acf72efc0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_01cb72c8-6df0-492e-b696-ac01fc605ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_FinancingLiabilityLineItems_45fc27af-678f-4a1c-894d-2a9c30328bc2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_01cb72c8-6df0-492e-b696-ac01fc605ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTable_c42c5922-6444-4d99-97a3-76faf36cdcbb" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_kequ_FinancingLiabilityLineItems_45fc27af-678f-4a1c-894d-2a9c30328bc2" xlink:to="loc_kequ_FinancingLiabilityTable_c42c5922-6444-4d99-97a3-76faf36cdcbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cf2cc23d-7658-4698-a93b-8a6b3867e34a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_FinancingLiabilityTable_c42c5922-6444-4d99-97a3-76faf36cdcbb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cf2cc23d-7658-4698-a93b-8a6b3867e34a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cf2cc23d-7658-4698-a93b-8a6b3867e34a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cf2cc23d-7658-4698-a93b-8a6b3867e34a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_cf2cc23d-7658-4698-a93b-8a6b3867e34a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bd98ec9-6b10-4a9c-8682-fda19825f552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cf2cc23d-7658-4698-a93b-8a6b3867e34a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bd98ec9-6b10-4a9c-8682-fda19825f552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_62c9734d-65cf-415c-9cde-93be3887a583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bd98ec9-6b10-4a9c-8682-fda19825f552" xlink:to="loc_us-gaap_BuildingMember_62c9734d-65cf-415c-9cde-93be3887a583" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_45c8e847-7c2d-4054-8cb2-1378bc00fe24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bd98ec9-6b10-4a9c-8682-fda19825f552" xlink:to="loc_us-gaap_LandMember_45c8e847-7c2d-4054-8cb2-1378bc00fe24" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended" id="i525af74fb255490e87ea223690ab9342_IncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:href="kequ-20230430.xsd#kequ_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod_22cee69a-7961-4836-b9d9-fbde6a01a786" xlink:href="kequ-20230430.xsd#kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod_22cee69a-7961-4836-b9d9-fbde6a01a786" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TaxWithholdingExpense_f794ab53-1f15-4a06-ab0e-2a292843c647" xlink:href="kequ-20230430.xsd#kequ_TaxWithholdingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_TaxWithholdingExpense_f794ab53-1f15-4a06-ab0e-2a292843c647" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility_e9fdea8f-cff3-4006-875a-60a544caa771" xlink:href="kequ-20230430.xsd#kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility_e9fdea8f-cff3-4006-875a-60a544caa771" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback_1a59c2fa-ea84-43e8-a761-e58249a5dada" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_DeferredTaxAssetsSection174REAddback_1a59c2fa-ea84-43e8-a761-e58249a5dada" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_546f3ccf-2d05-43f0-90b6-f41dd79f9cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_546f3ccf-2d05-43f0-90b6-f41dd79f9cf6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_20ed276b-5d3f-40ef-b1ed-db28c8c9aa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_20ed276b-5d3f-40ef-b1ed-db28c8c9aa2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FederalStateAndLocalTaxReturnsPeriod_b72e6343-5c00-4d74-850b-198722bbbba9" xlink:href="kequ-20230430.xsd#kequ_FederalStateAndLocalTaxReturnsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_FederalStateAndLocalTaxReturnsPeriod_b72e6343-5c00-4d74-850b-198722bbbba9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod_08ce9214-a137-41c3-adb9-78e2ecd8e391" xlink:href="kequ-20230430.xsd#kequ_ForeignSubsidiariesTaxReturnsPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod_08ce9214-a137-41c3-adb9-78e2ecd8e391" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesTable_b4bcc9ca-3a39-4c4e-82a0-23a4f7d33a80" xlink:href="kequ-20230430.xsd#kequ_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_IncomeTaxesTable_b4bcc9ca-3a39-4c4e-82a0-23a4f7d33a80" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_90d80b42-6683-4c95-b209-f20a19967ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_IncomeTaxesTable_b4bcc9ca-3a39-4c4e-82a0-23a4f7d33a80" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_90d80b42-6683-4c95-b209-f20a19967ab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_90d80b42-6683-4c95-b209-f20a19967ab7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_90d80b42-6683-4c95-b209-f20a19967ab7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_90d80b42-6683-4c95-b209-f20a19967ab7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_b6232ba9-ce55-411a-af72-2ab13c2794cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_90d80b42-6683-4c95-b209-f20a19967ab7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_b6232ba9-ce55-411a-af72-2ab13c2794cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinistryOfFinanceIndiaMember_9a6eae3b-210e-4104-92eb-13230a8c94c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinistryOfFinanceIndiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_b6232ba9-ce55-411a-af72-2ab13c2794cd" xlink:to="loc_us-gaap_MinistryOfFinanceIndiaMember_9a6eae3b-210e-4104-92eb-13230a8c94c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f277643d-7892-4477-8207-9b763ded34e6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_IncomeTaxesTable_b4bcc9ca-3a39-4c4e-82a0-23a4f7d33a80" xlink:to="loc_srt_RangeAxis_f277643d-7892-4477-8207-9b763ded34e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f277643d-7892-4477-8207-9b763ded34e6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f277643d-7892-4477-8207-9b763ded34e6" xlink:to="loc_srt_RangeMember_f277643d-7892-4477-8207-9b763ded34e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_699f566c-0f1e-4ab4-b951-f9196c93afcb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f277643d-7892-4477-8207-9b763ded34e6" xlink:to="loc_srt_RangeMember_699f566c-0f1e-4ab4-b951-f9196c93afcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ebdf9c03-3d7e-4924-96ad-57dd0a18d401" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_699f566c-0f1e-4ab4-b951-f9196c93afcb" xlink:to="loc_srt_MinimumMember_ebdf9c03-3d7e-4924-96ad-57dd0a18d401" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1ad4b1de-dc81-4434-b671-79cca74538b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_699f566c-0f1e-4ab4-b951-f9196c93afcb" xlink:to="loc_srt_MaximumMember_1ad4b1de-dc81-4434-b671-79cca74538b3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended" id="ie3566645bdf74ee2bc4a9ab9840600e9_IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:href="kequ-20230430.xsd#kequ_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_1f73d792-69ad-4bb1-8bdd-e7a5e626715e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_1f73d792-69ad-4bb1-8bdd-e7a5e626715e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_57013a5a-717c-4778-b600-df05ab69277e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_57013a5a-717c-4778-b600-df05ab69277e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_8ca6e992-4879-4069-9bd3-e22ac1f79f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_8ca6e992-4879-4069-9bd3-e22ac1f79f17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_6311336a-409d-4d7c-adb2-bb7ebe2484c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_6311336a-409d-4d7c-adb2-bb7ebe2484c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_5c5183e1-8fbc-4722-8c34-60740ed09826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_5c5183e1-8fbc-4722-8c34-60740ed09826" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback_ea655033-b4e9-4ef9-84d4-76abed4d7ac6" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_kequ_DeferredTaxAssetsSection174REAddback_ea655033-b4e9-4ef9-84d4-76abed4d7ac6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_8b3199f7-aa4e-48df-a5a6-e15a41f4295c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_8b3199f7-aa4e-48df-a5a6-e15a41f4295c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_0694bb84-14b3-4a2f-bdaa-c50a4c1da4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_0694bb84-14b3-4a2f-bdaa-c50a4c1da4af" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_75c4d6e6-4a11-4f03-8512-b969a9eb58a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_75c4d6e6-4a11-4f03-8512-b969a9eb58a8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_9aa0b646-ab73-4ed0-b4f5-7b12141f25c9" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetsProceedsOnSaleLeaseback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_9aa0b646-ab73-4ed0-b4f5-7b12141f25c9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetLeaseLiability_2d55bf88-52a0-4e41-b4fe-5b999c478c1e" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_kequ_DeferredTaxAssetLeaseLiability_2d55bf88-52a0-4e41-b4fe-5b999c478c1e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_b976992d-1796-4af7-b17b-b90d9af5c772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_b976992d-1796-4af7-b17b-b90d9af5c772" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f9f63028-c2d7-42c2-a31d-bfbfd76f5fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_f9f63028-c2d7-42c2-a31d-bfbfd76f5fb0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b15134ad-8f5b-4ba8-bb34-ae376285fde9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b15134ad-8f5b-4ba8-bb34-ae376285fde9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_83fa57ed-e595-46cf-b69a-9315a67144e2" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesSaleLeasebackProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_83fa57ed-e595-46cf-b69a-9315a67144e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_fc4a28b1-ac8c-4fe3-be4c-d07dff4b5586" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesPrepaidPensionCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_fc4a28b1-ac8c-4fe3-be4c-d07dff4b5586" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_00612007-74a3-48eb-a4a4-fb5fac3af2a6" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesAPB23Assertion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_00612007-74a3-48eb-a4a4-fb5fac3af2a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_9c6ed00c-b042-42eb-bc5f-b92ea7a1091c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_9c6ed00c-b042-42eb-bc5f-b92ea7a1091c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_560a180e-2fcc-4a51-af65-4ff22d7dc961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_560a180e-2fcc-4a51-af65-4ff22d7dc961" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c531f92b-9ad7-4cbd-a4aa-4e2d41cd4d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_c531f92b-9ad7-4cbd-a4aa-4e2d41cd4d9d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5d1daae9-32a9-41f2-995c-6175c1d7a7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5d1daae9-32a9-41f2-995c-6175c1d7a7a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_35ea5be6-5c17-4876-819e-7512f5fdc53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_us-gaap_DeferredTaxLiabilities_35ea5be6-5c17-4876-819e-7512f5fdc53d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_7266a082-43fb-45bc-8d9d-58d40c0a9001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_7266a082-43fb-45bc-8d9d-58d40c0a9001" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_86cbd53e-dafd-4c03-8228-21461616f4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_7266a082-43fb-45bc-8d9d-58d40c0a9001" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_86cbd53e-dafd-4c03-8228-21461616f4f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_a4c02c5e-5fd4-471e-bfa0-688e717c6b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesTable_5b72e6ce-9eda-4e5c-8e64-09bb6db70377" xlink:href="kequ-20230430.xsd#kequ_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_kequ_IncomeTaxesTable_5b72e6ce-9eda-4e5c-8e64-09bb6db70377" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_adee756e-c2c1-461a-971e-1c89daa87a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_kequ_IncomeTaxesTable_5b72e6ce-9eda-4e5c-8e64-09bb6db70377" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_adee756e-c2c1-461a-971e-1c89daa87a9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_adee756e-c2c1-461a-971e-1c89daa87a9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_adee756e-c2c1-461a-971e-1c89daa87a9a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_adee756e-c2c1-461a-971e-1c89daa87a9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7f63d917-0330-4c27-b995-ed00cdd487fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_adee756e-c2c1-461a-971e-1c89daa87a9a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7f63d917-0330-4c27-b995-ed00cdd487fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_8955e811-09b8-4602-b81b-2003159f400a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f63d917-0330-4c27-b995-ed00cdd487fc" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_8955e811-09b8-4602-b81b-2003159f400a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#StockOptionsandShareBasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail" xlink:type="extended" id="i6455767760b849f39c7e6cfd45314fc9_StockOptionsandShareBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8a5b924-73b1-4d6c-ba17-0dc8c2c30a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8a5b924-73b1-4d6c-ba17-0dc8c2c30a32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_18ec692e-0c49-45ee-89f8-6bd07d1033a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_18ec692e-0c49-45ee-89f8-6bd07d1033a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9ab84232-897b-4a2c-a8b4-c91be4552f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9ab84232-897b-4a2c-a8b4-c91be4552f05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_caddfee5-cba6-4ece-bfaf-1e99288ca860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_caddfee5-cba6-4ece-bfaf-1e99288ca860" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_69910a5c-c8fb-42c8-9f0f-feb91d414aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_69910a5c-c8fb-42c8-9f0f-feb91d414aa3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ca26caab-d707-4dd0-959f-5a9f64cb2c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ca26caab-d707-4dd0-959f-5a9f64cb2c2b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_ca764426-7f93-4913-8d25-ed2457d1c8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_ca764426-7f93-4913-8d25-ed2457d1c8fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7ed488c0-912e-46ab-a21d-135d1f7544e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7ed488c0-912e-46ab-a21d-135d1f7544e5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_181fe810-ba3f-40ef-976e-e348837a5589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_181fe810-ba3f-40ef-976e-e348837a5589" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_aaba17e3-df0f-41a9-b993-c2cbcf935183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_aaba17e3-df0f-41a9-b993-c2cbcf935183" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit_e34a00c9-a130-4de2-b27a-d1d32aad9588" xlink:href="kequ-20230430.xsd#kequ_ShareBasedCompensationDeferredTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit_e34a00c9-a130-4de2-b27a-d1d32aad9588" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3fd40fe6-e1df-42b7-954e-fd3094fd4466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:to="loc_us-gaap_PlanNameAxis_3fd40fe6-e1df-42b7-954e-fd3094fd4466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3fd40fe6-e1df-42b7-954e-fd3094fd4466_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3fd40fe6-e1df-42b7-954e-fd3094fd4466" xlink:to="loc_us-gaap_PlanNameDomain_3fd40fe6-e1df-42b7-954e-fd3094fd4466_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e50e26dd-9889-448b-b9a2-9603e61ec3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3fd40fe6-e1df-42b7-954e-fd3094fd4466" xlink:to="loc_us-gaap_PlanNameDomain_e50e26dd-9889-448b-b9a2-9603e61ec3c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandTenAndTwoThousandEightPlanMember_38e9bbc2-29a9-4e74-b130-92e5b91e9adc" xlink:href="kequ-20230430.xsd#kequ_TwoThousandTenAndTwoThousandEightPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e50e26dd-9889-448b-b9a2-9603e61ec3c1" xlink:to="loc_kequ_TwoThousandTenAndTwoThousandEightPlanMember_38e9bbc2-29a9-4e74-b130-92e5b91e9adc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_705b87bd-ab23-4852-bc0d-53a874b3f3f0" xlink:href="kequ-20230430.xsd#kequ_TwoThousandSeventeenOmnibusIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e50e26dd-9889-448b-b9a2-9603e61ec3c1" xlink:to="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_705b87bd-ab23-4852-bc0d-53a874b3f3f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandAndEightPlanMember_461c5e89-0bd7-442c-845a-57286806ddab" xlink:href="kequ-20230430.xsd#kequ_TwoThousandAndEightPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e50e26dd-9889-448b-b9a2-9603e61ec3c1" xlink:to="loc_kequ_TwoThousandAndEightPlanMember_461c5e89-0bd7-442c-845a-57286806ddab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b151742b-cbc8-42ad-b1d0-2b80c5c8c1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:to="loc_us-gaap_AwardTypeAxis_b151742b-cbc8-42ad-b1d0-2b80c5c8c1d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b151742b-cbc8-42ad-b1d0-2b80c5c8c1d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b151742b-cbc8-42ad-b1d0-2b80c5c8c1d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b151742b-cbc8-42ad-b1d0-2b80c5c8c1d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_849cf841-4cad-4673-b3d9-cc1fc98233c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b151742b-cbc8-42ad-b1d0-2b80c5c8c1d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_849cf841-4cad-4673-b3d9-cc1fc98233c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2374d8ce-2f25-4065-a28a-f8f4cd8b7e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_849cf841-4cad-4673-b3d9-cc1fc98233c4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2374d8ce-2f25-4065-a28a-f8f4cd8b7e27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember_65cb4a97-1718-443f-8de1-47476ded7461" xlink:href="kequ-20230430.xsd#kequ_RestrictedStockUnitsRSUsServiceComponentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2374d8ce-2f25-4065-a28a-f8f4cd8b7e27" xlink:to="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember_65cb4a97-1718-443f-8de1-47476ded7461" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8c91aedc-a701-46e6-9730-745c0416b176" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:to="loc_srt_RangeAxis_8c91aedc-a701-46e6-9730-745c0416b176" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8c91aedc-a701-46e6-9730-745c0416b176_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8c91aedc-a701-46e6-9730-745c0416b176" xlink:to="loc_srt_RangeMember_8c91aedc-a701-46e6-9730-745c0416b176_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4beadd05-c509-4bd4-9ad5-807e72f87133" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8c91aedc-a701-46e6-9730-745c0416b176" xlink:to="loc_srt_RangeMember_4beadd05-c509-4bd4-9ad5-807e72f87133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_27895534-d736-4653-b7e1-10e96f7b4e36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4beadd05-c509-4bd4-9ad5-807e72f87133" xlink:to="loc_srt_MinimumMember_27895534-d736-4653-b7e1-10e96f7b4e36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e26de11b-560b-455d-a0fb-c6f62daf575e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4beadd05-c509-4bd4-9ad5-807e72f87133" xlink:to="loc_srt_MaximumMember_e26de11b-560b-455d-a0fb-c6f62daf575e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails" xlink:type="extended" id="id1fa2deef32a478e8a576bc907bfb61d_StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2c8934e-d781-426a-a156-4a04fc3f24ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2c8934e-d781-426a-a156-4a04fc3f24ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c0b9e29a-7eac-4928-be6c-b50e03472a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c0b9e29a-7eac-4928-be6c-b50e03472a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_980a0e61-f6df-4798-8a84-a391172e8487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_980a0e61-f6df-4798-8a84-a391172e8487" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7b952337-5b75-4f24-97d2-4856ac6fbebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7b952337-5b75-4f24-97d2-4856ac6fbebb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_28283d8f-544e-4bab-9dde-c9f5a568b82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_28283d8f-544e-4bab-9dde-c9f5a568b82f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f5d2f95b-220a-43ca-a468-722e84785ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2c8934e-d781-426a-a156-4a04fc3f24ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c1305a15-35cd-4c37-bc1d-3d52c68d4f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c1305a15-35cd-4c37-bc1d-3d52c68d4f1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a2ed605e-a983-4025-8145-ee5c1aa0b9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a2ed605e-a983-4025-8145-ee5c1aa0b9c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bdf78098-6faf-408f-89f6-631fa2df915a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bdf78098-6faf-408f-89f6-631fa2df915a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2b5fb0d0-b644-439c-89f4-a5f909aa4e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2b5fb0d0-b644-439c-89f4-a5f909aa4e87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c6095ea1-7021-4ded-83ea-6924d68ac9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf359770-0939-400a-8bb9-9a29b8aacae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2c8934e-d781-426a-a156-4a04fc3f24ba" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf359770-0939-400a-8bb9-9a29b8aacae4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_98b3b5ee-4c92-430a-9555-c404b7a63097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf359770-0939-400a-8bb9-9a29b8aacae4" xlink:to="loc_us-gaap_AwardTypeAxis_98b3b5ee-4c92-430a-9555-c404b7a63097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98b3b5ee-4c92-430a-9555-c404b7a63097_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_98b3b5ee-4c92-430a-9555-c404b7a63097" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98b3b5ee-4c92-430a-9555-c404b7a63097_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d21c2bc3-9355-4651-ba45-130d957b3a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_98b3b5ee-4c92-430a-9555-c404b7a63097" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d21c2bc3-9355-4651-ba45-130d957b3a9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4914998d-91f9-4fd1-86ae-acc6e9977216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d21c2bc3-9355-4651-ba45-130d957b3a9e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4914998d-91f9-4fd1-86ae-acc6e9977216" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail" xlink:type="extended" id="i7ebe0e534bd743aba68d50a79f9cba19_AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_614b5ce9-46a0-49b5-92af-cb3322c2ba27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_614b5ce9-46a0-49b5-92af-cb3322c2ba27" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_95075450-e421-4294-bbd4-c858b36183a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_95075450-e421-4294-bbd4-c858b36183a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d3013260-96a6-40b8-bc5c-f9f644ae4b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d3013260-96a6-40b8-bc5c-f9f644ae4b64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_952ff762-7288-4bc3-841a-75a244395617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_952ff762-7288-4bc3-841a-75a244395617" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cc6f5520-c976-426d-933d-cec241502cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_867b9c8b-64b2-4f98-963d-96d4cdf19df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_614b5ce9-46a0-49b5-92af-cb3322c2ba27" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_867b9c8b-64b2-4f98-963d-96d4cdf19df4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8ddf4d7b-6419-4869-a6c3-92461ea37d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_867b9c8b-64b2-4f98-963d-96d4cdf19df4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8ddf4d7b-6419-4869-a6c3-92461ea37d39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8ddf4d7b-6419-4869-a6c3-92461ea37d39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8ddf4d7b-6419-4869-a6c3-92461ea37d39" xlink:to="loc_us-gaap_EquityComponentDomain_8ddf4d7b-6419-4869-a6c3-92461ea37d39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_48d71c6b-a200-4c68-b894-c5bd0f066ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8ddf4d7b-6419-4869-a6c3-92461ea37d39" xlink:to="loc_us-gaap_EquityComponentDomain_48d71c6b-a200-4c68-b894-c5bd0f066ed8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_51a0ae28-1d9a-4608-affd-9f837ea351b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_48d71c6b-a200-4c68-b894-c5bd0f066ed8" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_51a0ae28-1d9a-4608-affd-9f837ea351b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dd96aeb4-ba5f-47c8-8530-007c1f84d638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_48d71c6b-a200-4c68-b894-c5bd0f066ed8" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dd96aeb4-ba5f-47c8-8530-007c1f84d638" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail" xlink:type="extended" id="idb1ec18630684b30b6b90c129ec9fbdc_RetirementBenefitsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_5cfffda4-6326-4d8c-97ac-5386d0543e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_5cfffda4-6326-4d8c-97ac-5386d0543e08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_96d45b30-d136-4ec3-afd1-b6ca75c06a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_96d45b30-d136-4ec3-afd1-b6ca75c06a99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_9f6df692-34d1-4d5a-bb9f-5806b3819316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_9f6df692-34d1-4d5a-bb9f-5806b3819316" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_3b5acf3d-6c3d-4cc4-8fb7-2c7ef411b84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_3b5acf3d-6c3d-4cc4-8fb7-2c7ef411b84a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate_ee53ed13-5267-45d3-9a21-53cc081c8eac" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanPercentageChangesInDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate_ee53ed13-5267-45d3-9a21-53cc081c8eac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_7da4aadf-a45c-4c06-b4ef-ce0ef8f1b7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_7da4aadf-a45c-4c06-b4ef-ce0ef8f1b7cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_954fd409-58d5-4c39-b9a3-6c9794f8a9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_954fd409-58d5-4c39-b9a3-6c9794f8a9a9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_2b1cd2ec-fbd9-4b62-b3ae-8bc954598034" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_2b1cd2ec-fbd9-4b62-b3ae-8bc954598034" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_cf78b8a7-1ff1-4e51-9264-21327b24e2e1" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanEligibilityMinimumServicePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_cf78b8a7-1ff1-4e51-9264-21327b24e2e1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_81695c9b-56d1-408d-8521-08dd77be32ef" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_81695c9b-56d1-408d-8521-08dd77be32ef" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_e89741a3-cd3b-4b5b-874f-696fbb4b4a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_e89741a3-cd3b-4b5b-874f-696fbb4b4a23" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_c37e1408-a5ac-43a6-ae0d-066402b93ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_c37e1408-a5ac-43a6-ae0d-066402b93ebc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_55755421-5bd0-4e30-8454-166a63aa11f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_55755421-5bd0-4e30-8454-166a63aa11f7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_8594c846-1800-427d-91f6-a0f1090e8c79" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanEmployerMatchingContributionsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_8594c846-1800-427d-91f6-a0f1090e8c79" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_00b244b8-3357-499d-a70d-378a236ba9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:to="loc_us-gaap_ValuationTechniqueAxis_00b244b8-3357-499d-a70d-378a236ba9bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_00b244b8-3357-499d-a70d-378a236ba9bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_00b244b8-3357-499d-a70d-378a236ba9bb" xlink:to="loc_us-gaap_ValuationTechniqueDomain_00b244b8-3357-499d-a70d-378a236ba9bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_9602573b-baf2-4fec-b5a2-0f7c3dc0937e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_00b244b8-3357-499d-a70d-378a236ba9bb" xlink:to="loc_us-gaap_ValuationTechniqueDomain_9602573b-baf2-4fec-b5a2-0f7c3dc0937e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_YieldCurveTechniqueMember_6067b24e-9f90-43ff-96f2-2b1e4953a7e8" xlink:href="kequ-20230430.xsd#kequ_YieldCurveTechniqueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_9602573b-baf2-4fec-b5a2-0f7c3dc0937e" xlink:to="loc_kequ_YieldCurveTechniqueMember_6067b24e-9f90-43ff-96f2-2b1e4953a7e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_63d9cf7c-94a8-4fb3-85d5-252ea364060a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_63d9cf7c-94a8-4fb3-85d5-252ea364060a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_63d9cf7c-94a8-4fb3-85d5-252ea364060a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_63d9cf7c-94a8-4fb3-85d5-252ea364060a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_63d9cf7c-94a8-4fb3-85d5-252ea364060a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_109a3963-18ac-4b5f-a987-cf4eb5bb8223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_63d9cf7c-94a8-4fb3-85d5-252ea364060a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_109a3963-18ac-4b5f-a987-cf4eb5bb8223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_0de123d1-5e80-4133-a279-eafbfeb9cf27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_109a3963-18ac-4b5f-a987-cf4eb5bb8223" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_0de123d1-5e80-4133-a279-eafbfeb9cf27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_556b78d4-d649-45da-9ddb-f6d96c66d76a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_109a3963-18ac-4b5f-a987-cf4eb5bb8223" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_556b78d4-d649-45da-9ddb-f6d96c66d76a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2dcf92a2-f35b-4752-9453-fa07125653fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:to="loc_srt_RangeAxis_2dcf92a2-f35b-4752-9453-fa07125653fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2dcf92a2-f35b-4752-9453-fa07125653fb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2dcf92a2-f35b-4752-9453-fa07125653fb" xlink:to="loc_srt_RangeMember_2dcf92a2-f35b-4752-9453-fa07125653fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_638af877-541a-4050-810f-d7805f07339a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2dcf92a2-f35b-4752-9453-fa07125653fb" xlink:to="loc_srt_RangeMember_638af877-541a-4050-810f-d7805f07339a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_12181755-6250-438e-ad33-f9b4bac29903" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_638af877-541a-4050-810f-d7805f07339a" xlink:to="loc_srt_MaximumMember_12181755-6250-438e-ad33-f9b4bac29903" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9e51fc2a-f82b-4831-8512-762719c6a6dd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_638af877-541a-4050-810f-d7805f07339a" xlink:to="loc_srt_MinimumMember_9e51fc2a-f82b-4831-8512-762719c6a6dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_3e378db9-dd23-461e-9180-7ab7bb1b4b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_3e378db9-dd23-461e-9180-7ab7bb1b4b40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3e378db9-dd23-461e-9180-7ab7bb1b4b40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3e378db9-dd23-461e-9180-7ab7bb1b4b40" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3e378db9-dd23-461e-9180-7ab7bb1b4b40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9ec404b0-c86d-4317-9557-f241c07482a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3e378db9-dd23-461e-9180-7ab7bb1b4b40" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9ec404b0-c86d-4317-9557-f241c07482a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e59d4f29-a02a-4ec9-ab16-696a2f12bcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9ec404b0-c86d-4317-9557-f241c07482a2" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e59d4f29-a02a-4ec9-ab16-696a2f12bcaa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail" xlink:type="extended" id="i3af4ca1dd59649f1af31594426f464b2_RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9f6880ef-56cc-44ab-901c-07b5acccd282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bff25733-e2b9-4cd2-b07c-dcba6ff48a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9f6880ef-56cc-44ab-901c-07b5acccd282" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bff25733-e2b9-4cd2-b07c-dcba6ff48a39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_12ba333b-5642-441a-a58d-4d9aaecec4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9f6880ef-56cc-44ab-901c-07b5acccd282" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_12ba333b-5642-441a-a58d-4d9aaecec4ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_72d98a1f-04ad-4cb5-9a45-57450df86030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9f6880ef-56cc-44ab-901c-07b5acccd282" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_72d98a1f-04ad-4cb5-9a45-57450df86030" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c18dc98c-a785-42eb-a51d-b4ec78cc0553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_72d98a1f-04ad-4cb5-9a45-57450df86030" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c18dc98c-a785-42eb-a51d-b4ec78cc0553" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_c18dc98c-a785-42eb-a51d-b4ec78cc0553_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c18dc98c-a785-42eb-a51d-b4ec78cc0553" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_c18dc98c-a785-42eb-a51d-b4ec78cc0553_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_4897fb7e-ca73-4515-848c-9b9106da7ece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c18dc98c-a785-42eb-a51d-b4ec78cc0553" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_4897fb7e-ca73-4515-848c-9b9106da7ece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_64f05182-7e30-47cd-8f50-8f3cebffe07e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_4897fb7e-ca73-4515-848c-9b9106da7ece" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_64f05182-7e30-47cd-8f50-8f3cebffe07e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_c28fab2a-2cc7-428d-b0c6-096eebfc3a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_4897fb7e-ca73-4515-848c-9b9106da7ece" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_c28fab2a-2cc7-428d-b0c6-096eebfc3a9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_668fb910-40bb-40ff-a71e-a4aa4a4473ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_4897fb7e-ca73-4515-848c-9b9106da7ece" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_668fb910-40bb-40ff-a71e-a4aa4a4473ce" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail" xlink:type="extended" id="i165ab698432f4ef1899b9b9b2e5d1414_RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_03c5c174-c985-4513-9948-3323b2455d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_69b8c256-4cd4-4af0-9375-62426334e22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_03c5c174-c985-4513-9948-3323b2455d0e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_69b8c256-4cd4-4af0-9375-62426334e22c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4752fdd-1a19-4c22-9a28-fd4e1dc404c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_03c5c174-c985-4513-9948-3323b2455d0e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4752fdd-1a19-4c22-9a28-fd4e1dc404c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d915d71-d231-4fd9-a087-20460c4ee352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4752fdd-1a19-4c22-9a28-fd4e1dc404c8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d915d71-d231-4fd9-a087-20460c4ee352" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3d915d71-d231-4fd9-a087-20460c4ee352_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d915d71-d231-4fd9-a087-20460c4ee352" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3d915d71-d231-4fd9-a087-20460c4ee352_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b082ca70-c466-4b3b-a607-a46828d28211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d915d71-d231-4fd9-a087-20460c4ee352" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b082ca70-c466-4b3b-a607-a46828d28211" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_84d5abf4-93fb-490a-8e12-50177bf85290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b082ca70-c466-4b3b-a607-a46828d28211" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_84d5abf4-93fb-490a-8e12-50177bf85290" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b4cbe864-71d8-4dab-89d4-846c45db6afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b082ca70-c466-4b3b-a607-a46828d28211" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b4cbe864-71d8-4dab-89d4-846c45db6afe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4388668c-18fb-49d0-9ede-276d940f0884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b082ca70-c466-4b3b-a607-a46828d28211" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4388668c-18fb-49d0-9ede-276d940f0884" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fa8132c9-d83b-4c0f-9354-c3986af95556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4752fdd-1a19-4c22-9a28-fd4e1dc404c8" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fa8132c9-d83b-4c0f-9354-c3986af95556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_fa8132c9-d83b-4c0f-9354-c3986af95556_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fa8132c9-d83b-4c0f-9354-c3986af95556" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_fa8132c9-d83b-4c0f-9354-c3986af95556_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_5d4fddf2-cd86-4f6f-8575-09e06e3676bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fa8132c9-d83b-4c0f-9354-c3986af95556" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_5d4fddf2-cd86-4f6f-8575-09e06e3676bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5d4fddf2-cd86-4f6f-8575-09e06e3676bd" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_d1d8604e-d3f7-4a7c-b866-a5409f544e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_d1d8604e-d3f7-4a7c-b866-a5409f544e14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_535fdf59-9a18-4a8b-a9c4-af75c11ff27b" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:to="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_535fdf59-9a18-4a8b-a9c4-af75c11ff27b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_adaa618a-adca-4dbd-b01c-ffe28f85543a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_adaa618a-adca-4dbd-b01c-ffe28f85543a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEmergingMarketsMember_905560a7-5deb-4a9c-8135-9a85fca610d1" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanEmergingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:to="loc_kequ_DefinedBenefitPlanEmergingMarketsMember_905560a7-5deb-4a9c-8135-9a85fca610d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember_7f407dcb-4fa1-456c-b0ad-b45f31ead911" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanLiquidAlternativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:to="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember_7f407dcb-4fa1-456c-b0ad-b45f31ead911" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_5a5a9963-f178-4607-903b-565ba8bdb89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5d4fddf2-cd86-4f6f-8575-09e06e3676bd" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_5a5a9963-f178-4607-903b-565ba8bdb89b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_3609920e-69d7-4cd0-abf2-e3a59d33cbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5d4fddf2-cd86-4f6f-8575-09e06e3676bd" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_3609920e-69d7-4cd0-abf2-e3a59d33cbd7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SegmentInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SegmentInformationDetail"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/SegmentInformationDetail" xlink:type="extended" id="if7893e201abb4856af7c456164016437_SegmentInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_22b04014-be73-4fa5-a6cb-61195771e29d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_22b04014-be73-4fa5-a6cb-61195771e29d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenuesIncludingIntersegmentMarkup_f3cf79a8-fa6e-455e-ab60-7496764218b2" xlink:href="kequ-20230430.xsd#kequ_RevenuesIncludingIntersegmentMarkup"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_kequ_RevenuesIncludingIntersegmentMarkup_f3cf79a8-fa6e-455e-ab60-7496764218b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f4633bb8-8fd0-45bb-b6a7-53d9d6738aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_Depreciation_f4633bb8-8fd0-45bb-b6a7-53d9d6738aa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2f7e6d4-fc46-45be-a9dd-e2ef764f8123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2f7e6d4-fc46-45be-a9dd-e2ef764f8123" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3e9b49e7-9414-4878-b494-2950a213f308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3e9b49e7-9414-4878-b494-2950a213f308" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0bfd5750-3f80-47a4-bb71-4cead5088edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0bfd5750-3f80-47a4-bb71-4cead5088edc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_055c5f45-df47-4fa0-a513-eef6789e3730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_NetIncomeLoss_055c5f45-df47-4fa0-a513-eef6789e3730" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cac90fbe-73ac-47d2-a3e2-962ce1482406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_Assets_cac90fbe-73ac-47d2-a3e2-962ce1482406" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_05c83310-e3a1-4e28-9e06-9421441cdf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_05c83310-e3a1-4e28-9e06-9421441cdf2f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d88b7656-f5e7-4a6c-a461-654cf790b65f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d88b7656-f5e7-4a6c-a461-654cf790b65f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d88b7656-f5e7-4a6c-a461-654cf790b65f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d88b7656-f5e7-4a6c-a461-654cf790b65f" xlink:to="loc_us-gaap_SegmentDomain_d88b7656-f5e7-4a6c-a461-654cf790b65f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_29bfd0ea-9bfa-4fee-a262-0cf89b5e8c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d88b7656-f5e7-4a6c-a461-654cf790b65f" xlink:to="loc_us-gaap_SegmentDomain_29bfd0ea-9bfa-4fee-a262-0cf89b5e8c87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DomesticOperationsMember_3f9cff34-b6fc-4d00-aba2-9a6f10aefef4" xlink:href="kequ-20230430.xsd#kequ_DomesticOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_29bfd0ea-9bfa-4fee-a262-0cf89b5e8c87" xlink:to="loc_kequ_DomesticOperationsMember_3f9cff34-b6fc-4d00-aba2-9a6f10aefef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalOperationsMember_72117532-59de-40b8-ae44-8db1193a54f6" xlink:href="kequ-20230430.xsd#kequ_InternationalOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_29bfd0ea-9bfa-4fee-a262-0cf89b5e8c87" xlink:to="loc_kequ_InternationalOperationsMember_72117532-59de-40b8-ae44-8db1193a54f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_dff54992-9b60-4890-a8a3-2cd3e8f88002" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:to="loc_srt_ConsolidationItemsAxis_dff54992-9b60-4890-a8a3-2cd3e8f88002" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_dff54992-9b60-4890-a8a3-2cd3e8f88002_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_dff54992-9b60-4890-a8a3-2cd3e8f88002" xlink:to="loc_srt_ConsolidationItemsDomain_dff54992-9b60-4890-a8a3-2cd3e8f88002_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ae2cd7ad-d6af-43fd-af0f-464c5c2221d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_dff54992-9b60-4890-a8a3-2cd3e8f88002" xlink:to="loc_srt_ConsolidationItemsDomain_ae2cd7ad-d6af-43fd-af0f-464c5c2221d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_78c2517a-81aa-4cb9-9132-1bafa052e55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ae2cd7ad-d6af-43fd-af0f-464c5c2221d8" xlink:to="loc_us-gaap_OperatingSegmentsMember_78c2517a-81aa-4cb9-9132-1bafa052e55b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_6df56f60-dd86-4b3a-ae2c-c191bb028032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ae2cd7ad-d6af-43fd-af0f-464c5c2221d8" xlink:to="loc_us-gaap_CorporateNonSegmentMember_6df56f60-dd86-4b3a-ae2c-c191bb028032" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_67eff680-15ab-4b3d-8682-0daeb3685be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ae2cd7ad-d6af-43fd-af0f-464c5c2221d8" xlink:to="loc_us-gaap_IntersegmentEliminationMember_67eff680-15ab-4b3d-8682-0daeb3685be0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_43fd9383-0ecc-4177-aa01-6ac18ce5d515" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:to="loc_srt_StatementGeographicalAxis_43fd9383-0ecc-4177-aa01-6ac18ce5d515" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_43fd9383-0ecc-4177-aa01-6ac18ce5d515_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_43fd9383-0ecc-4177-aa01-6ac18ce5d515" xlink:to="loc_srt_SegmentGeographicalDomain_43fd9383-0ecc-4177-aa01-6ac18ce5d515_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_817b556c-587b-40d4-8585-1260aadcaa84" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_43fd9383-0ecc-4177-aa01-6ac18ce5d515" xlink:to="loc_srt_SegmentGeographicalDomain_817b556c-587b-40d4-8585-1260aadcaa84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_e38db88d-e409-4374-b895-8b10c377fc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_817b556c-587b-40d4-8585-1260aadcaa84" xlink:to="loc_us-gaap_NonUsMember_e38db88d-e409-4374-b895-8b10c377fc5a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#RestructuringCostsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails" xlink:type="extended" id="ie17ebd0069a8430a960227b14af822ca_RestructuringCostsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4a0c1e4d-9115-45a0-acff-eb1da8574589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_755d8203-7b80-4a4e-b753-b5deea0a3632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4a0c1e4d-9115-45a0-acff-eb1da8574589" xlink:to="loc_us-gaap_RestructuringCosts_755d8203-7b80-4a4e-b753-b5deea0a3632" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_3750fe1f-28e7-4130-831c-ab51998f22da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4a0c1e4d-9115-45a0-acff-eb1da8574589" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_3750fe1f-28e7-4130-831c-ab51998f22da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60390cee-5688-408c-a3e5-8555c90f827a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4a0c1e4d-9115-45a0-acff-eb1da8574589" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60390cee-5688-408c-a3e5-8555c90f827a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_a1d312be-0664-4d50-8807-815ccbad8fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60390cee-5688-408c-a3e5-8555c90f827a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_a1d312be-0664-4d50-8807-815ccbad8fe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_a1d312be-0664-4d50-8807-815ccbad8fe2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_a1d312be-0664-4d50-8807-815ccbad8fe2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_a1d312be-0664-4d50-8807-815ccbad8fe2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c2568785-b6ed-4a97-bc31-5e8e61082d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_a1d312be-0664-4d50-8807-815ccbad8fe2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c2568785-b6ed-4a97-bc31-5e8e61082d49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_a412a23c-7cf8-426f-b93d-8e49fd929fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c2568785-b6ed-4a97-bc31-5e8e61082d49" xlink:to="loc_us-gaap_FacilityClosingMember_a412a23c-7cf8-426f-b93d-8e49fd929fb3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_PensionExpense" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>kequ-20230430_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:e58e8ac3-ecd1-406b-a8f1-c5aecee1e3ad,g:fefb243f-2e84-4dac-80b6-e3a13121b6c2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc8a0d59-69fe-495c-a7ab-d12b82949cee_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a0e634de-5758-4c5f-98c9-e4f15e1b62d7_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_a7fec967-929e-4f0d-b3f9-ad54a0a55f1d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_46ab2919-2967-41a6-a87b-be5aa2aa1682_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_8cb15ed9-e922-4e04-a540-1ee56b6ec806_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_726124b3-8d2d-4b16-8d7c-8d4114a28f25_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_3fac5dcc-fe00-4e7d-b20a-8af2900bb497_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt provision</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FederalStateAndLocalTaxReturnsPeriod_699019a3-7b79-4cfa-afe3-ba6356f69ab3_terseLabel_en-US" xlink:label="lab_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal, state and local tax returns period (in years)</link:label>
    <link:label id="lab_kequ_FederalStateAndLocalTaxReturnsPeriod_label_en-US" xlink:label="lab_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal, state and local tax returns period</link:label>
    <link:label id="lab_kequ_FederalStateAndLocalTaxReturnsPeriod_documentation_en-US" xlink:label="lab_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal, state and local tax returns period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:href="kequ-20230430.xsd#kequ_FederalStateAndLocalTaxReturnsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:to="lab_kequ_FederalStateAndLocalTaxReturnsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1d6db88c-a16e-46d6-a008-b771135711bc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_InterestExpenseFinancingLiability_8748ef2e-00c1-4ce0-bc85-0b6173cc5d3c_terseLabel_en-US" xlink:label="lab_kequ_InterestExpenseFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on financing liability</link:label>
    <link:label id="lab_kequ_InterestExpenseFinancingLiability_label_en-US" xlink:label="lab_kequ_InterestExpenseFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Financing Liability</link:label>
    <link:label id="lab_kequ_InterestExpenseFinancingLiability_documentation_en-US" xlink:label="lab_kequ_InterestExpenseFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InterestExpenseFinancingLiability" xlink:href="kequ-20230430.xsd#kequ_InterestExpenseFinancingLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_InterestExpenseFinancingLiability" xlink:to="lab_kequ_InterestExpenseFinancingLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_57af1b4e-7e9a-4fc2-8be5-8ed9f4c94eae_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bc2f4e14-4e1a-4e27-b8ec-257a5f573fa8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax expense:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_RevenueRecognitionTable_bcf624bf-5a78-4f67-a48b-901f4fc79df8_terseLabel_en-US" xlink:label="lab_kequ_RevenueRecognitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Table]</link:label>
    <link:label id="lab_kequ_RevenueRecognitionTable_label_en-US" xlink:label="lab_kequ_RevenueRecognitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Table]</link:label>
    <link:label id="lab_kequ_RevenueRecognitionTable_documentation_en-US" xlink:label="lab_kequ_RevenueRecognitionTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionTable" xlink:href="kequ-20230430.xsd#kequ_RevenueRecognitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_RevenueRecognitionTable" xlink:to="lab_kequ_RevenueRecognitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_aa7d8c82-a6b2-4c5b-8f94-0921cc2ef223_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LesseeOptiontoTerminateTerm_d07508a8-8810-429d-ac17-d2a5bf283265_terseLabel_en-US" xlink:label="lab_kequ_LesseeOptiontoTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to terminate, term (in years)</link:label>
    <link:label id="lab_kequ_LesseeOptiontoTerminateTerm_label_en-US" xlink:label="lab_kequ_LesseeOptiontoTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Option to Terminate, Term</link:label>
    <link:label id="lab_kequ_LesseeOptiontoTerminateTerm_documentation_en-US" xlink:label="lab_kequ_LesseeOptiontoTerminateTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Option to Terminate, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeOptiontoTerminateTerm" xlink:href="kequ-20230430.xsd#kequ_LesseeOptiontoTerminateTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LesseeOptiontoTerminateTerm" xlink:to="lab_kequ_LesseeOptiontoTerminateTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_5d9c942a-ef4f-4798-b1ed-61209d9db6d7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_718a7655-deef-42be-a3fa-a3b7c4c3c74f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_a6e92d50-1dde-42f0-8d87-1fc5356598e7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property plant and equipment gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d6833787-0bf0-49af-9060-6ac7f8092d09_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_c0a719a6-bcda-4a71-855c-331f624aca06_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_af80c300-4e12-4a8b-b721-c3451f5e26a6_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book basis in excess of tax basis of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidAfterYearFive_30958210-c9b0-464e-af79-a11260bbcfba_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidAfterYearFive_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, After Year Five</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidAfterYearFive_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:to="lab_kequ_FinancingLiabilityToBePaidAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFour_aff34428-0b2e-4835-a1d8-8d320df4975b_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFour_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, Year Four</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFour_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFour" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidYearFour" xlink:to="lab_kequ_FinancingLiabilityToBePaidYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_UnbilledRetainageCurrent_a6f464c4-1958-44a9-960a-d9e5743aab23_terseLabel_en-US" xlink:label="lab_kequ_UnbilledRetainageCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled retainage included in other assets</link:label>
    <link:label id="lab_kequ_UnbilledRetainageCurrent_35633d82-9382-4d1c-90b3-77766540ac08_verboseLabel_en-US" xlink:label="lab_kequ_UnbilledRetainageCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets in other assets</link:label>
    <link:label id="lab_kequ_UnbilledRetainageCurrent_label_en-US" xlink:label="lab_kequ_UnbilledRetainageCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Retainage, Current</link:label>
    <link:label id="lab_kequ_UnbilledRetainageCurrent_documentation_en-US" xlink:label="lab_kequ_UnbilledRetainageCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Retainage, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_UnbilledRetainageCurrent" xlink:href="kequ-20230430.xsd#kequ_UnbilledRetainageCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_UnbilledRetainageCurrent" xlink:to="lab_kequ_UnbilledRetainageCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_32a6d03b-16df-4c9c-b775-3e2daea0fb64_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxAssetsSection174REAddback_418ea84e-fd76-47e1-bb69-ace98e614232_verboseLabel_en-US" xlink:label="lab_kequ_DeferredTaxAssetsSection174REAddback" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset, Section 174 addback</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetsSection174REAddback_25f2ce34-0129-488e-9811-0a72e6379fc1_terseLabel_en-US" xlink:label="lab_kequ_DeferredTaxAssetsSection174REAddback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 174 R&amp;E Addback</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetsSection174REAddback_label_en-US" xlink:label="lab_kequ_DeferredTaxAssetsSection174REAddback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Section 174 R&amp;E Addback</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetsSection174REAddback_documentation_en-US" xlink:label="lab_kequ_DeferredTaxAssetsSection174REAddback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Section 174 R&amp;E Addback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxAssetsSection174REAddback" xlink:to="lab_kequ_DeferredTaxAssetsSection174REAddback" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DomesticOperationsMember_0feca35b-ee8e-41c3-923a-241f61e1df7c_terseLabel_en-US" xlink:label="lab_kequ_DomesticOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_kequ_DomesticOperationsMember_label_en-US" xlink:label="lab_kequ_DomesticOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Operations [Member]</link:label>
    <link:label id="lab_kequ_DomesticOperationsMember_documentation_en-US" xlink:label="lab_kequ_DomesticOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DomesticOperationsMember" xlink:href="kequ-20230430.xsd#kequ_DomesticOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DomesticOperationsMember" xlink:to="lab_kequ_DomesticOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_84d9009c-45cb-4e06-a223-af1ba59d68ba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, variable interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_7f7b3f05-6e74-431f-955f-6ecc6d2102e2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_17b8bd99-72e0-422a-968a-3e20ab492b50_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_0e8d2a86-929a-4d64-8e6b-e93251d3274b_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2f350cda-65e7-4a33-ad83-23d8f91eb09b_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8f7e4851-0c39-4417-bb69-87a525b32133_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted average discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_1f82b624-e7e9-40d4-af8a-534c20dce74a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_70a67575-c6b4-4fb1-934f-b0485f3aaba8_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_e9cd223a-d7ce-4f55-8ea6-e35471f3db5f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_9c941349-04b9-4a04-9215-38bdca2e2a3a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Date, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_d471788f-56b8-4e69-bb8e-36d2090bc094_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_19070dbf-bcec-4954-9ebb-e9a288a8186c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_da9e15cb-b381-4596-9ef4-1deed038b116_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_262d7873-a1eb-4983-9aee-22624a3565d1_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss) attributable to Kewaunee Scientific Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_9fb88b78-bce8-4c84-a925-b9bf95c93bbf_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss) attributable to Kewaunee Scientific Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ac4c91ca-767a-4ead-bdc3-99743c5b5221_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss) attributable to Kewaunee Scientific Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_ac2e3a32-cda6-4f00-b9ab-b52bcc046f5c_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note receivable</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_ec36db77-db96-4eba-8ddc-673a2d044835_verboseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of redeemable preferred shares</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_29d2ad14-89ad-4e2d-bfae-afd9909d1048_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive options exclude from computation of earning per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_e8d07007-db95-46f1-bb92-9ea4ab6ff3cc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_38e78321-9173-4ae0-a95d-a3b52863f249_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_474e1635-7934-4129-9478-98f70c06f442_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_e47c113e-b5d2-458b-967a-0ac01ddb2d95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_160b9903-c788-4ff2-a0ab-4ddf0a449835_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a9057ce2-c0ba-45f7-8fca-ea85d267754c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_8a5a3607-2f5e-460d-9b73-836276620b67_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_24f718da-1142-4f58-a275-03ded843e19e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityLineItems_635d5a57-8d35-48f1-804b-8a8c25349642_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability [Line Items]</link:label>
    <link:label id="lab_kequ_FinancingLiabilityLineItems_label_en-US" xlink:label="lab_kequ_FinancingLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability [Line Items]</link:label>
    <link:label id="lab_kequ_FinancingLiabilityLineItems_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityLineItems" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityLineItems" xlink:to="lab_kequ_FinancingLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_559064bf-f14d-44c8-8678-0ae2851a8fb6_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_7a488a09-ab1f-4e00-8d33-e8f686428443_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_c67cdf6a-7db0-4469-b1ea-7edc34841a60_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_00a36c4e-b874-4870-b9d8-17339170bbc7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets in accounts receivable</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_a8e27677-36d6-4b46-ac22-2c9699319dd1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax actuarial loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_f701c4d1-9def-4aae-861b-af24447b2484_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_08de219f-a4c8-42ed-8c75-2cd761089ff2_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_d149e5c9-a7bf-4fcb-976e-4f6ae8ef0ba3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, Plan asset</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_03268cc7-be0a-4dc8-bf39-d39e3949568f_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityAnnualIncreasePercent_ad821d88-9f1a-4024-9bc1-fbe4209e5709_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual rental increase, as a percent</link:label>
    <link:label id="lab_kequ_FinancingLiabilityAnnualIncreasePercent_label_en-US" xlink:label="lab_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Annual Increase, Percent</link:label>
    <link:label id="lab_kequ_FinancingLiabilityAnnualIncreasePercent_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Annual Increase, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityAnnualIncreasePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:to="lab_kequ_FinancingLiabilityAnnualIncreasePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_69a0a335-7049-48b7-9a68-e46a6d2a382f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8d9feaee-bbe2-48aa-ab34-1a3a01c6346f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_ebfc967e-3ad5-406f-97d9-ae41e9fcdc4b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business segment</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_0131297d-a927-4432-a981-7fd9b3b76393_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining estimated compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d46abe46-84a7-4e08-ace2-48ca0e43cdcd_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_7c35bb74-3671-4dca-87c4-df8020d4026f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_19d14bf0-40dd-4b9d-b177-6ff083988ea9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6350df0f-3d81-48d9-971c-3c2fcef765f6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_68e43a17-e630-48a1-8944-0812d9a50e94_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d28f16cd-80c0-46e6-ab55-5063fb822517_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_f6bf45bc-0bf8-411b-a40d-d417fba94dd1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_1111f825-a58b-4b52-b504-0097513588eb_terseLabel_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing availability</link:label>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_label_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option</link:label>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_documentation_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:href="kequ-20230430.xsd#kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:to="lab_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_cb245ebf-a72a-4ef5-8035-a6cb24a7449d_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_0c7c6a71-561e-4c6f-9465-1941a0d8c200_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_7a3da7ea-fa3f-49b7-911e-ae37b111caac_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3359b5f-2019-415e-a5c3-e7aa8c1eb341_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_538b9574-d799-40e1-b148-03975169ceba_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_24b90376-7669-4775-930f-373c860e86ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_a197fe53-62e7-4c23-b7b7-7de17dbf7028_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_a457670e-e8c2-4b4a-b012-2e8802787043_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other items, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_b3604e10-b780-4def-ac03-64dcb7c4616c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee's compensation (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cf24f2db-346b-4099-baf1-ffdd7afac59d_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_4b46cb0f-c6ee-4976-868e-b135a8cc2640_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_ab88298f-b2a3-4419-adeb-170cfe43ce9b_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of bad debt collections</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_11aa640b-a37e-46ec-992e-bf6eac5eca4a_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_9dc648aa-389b-4452-b1cf-e9cb1ae88590_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b5270342-4da5-4093-aa22-caf1404367ba_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_39149c88-bb48-4ee6-8f81-4139f164711b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) increase pension expense</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:to="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1d55b34b-06f3-4858-b9f3-4d30220ce7ed_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_d387dcf8-de9a-4ef0-9b71-64ebeac59424_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5be2490c-3229-46a2-9164-27fd1df13ebd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1f3787f5-026c-432a-94e2-441c0de34056_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_78757263-19f9-4257-ba12-8d670d03eb6b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8276eb86-4ee3-44e4-904e-4a30f0368b86_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityTable_efce4ed5-d10e-489e-bdda-2c6465bfe339_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability [Table]</link:label>
    <link:label id="lab_kequ_FinancingLiabilityTable_label_en-US" xlink:label="lab_kequ_FinancingLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability [Table]</link:label>
    <link:label id="lab_kequ_FinancingLiabilityTable_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTable" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityTable" xlink:to="lab_kequ_FinancingLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8f645d01-7d8d-468c-b9a5-1d279fea9ebd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_ab8f6da6-35a9-4fd5-b4f3-b5ae017ad0c6_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KequipGlobalLabSolutionsMember_948d538c-7742-4905-9d17-4e49811fd419_terseLabel_en-US" xlink:label="lab_kequ_KequipGlobalLabSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kequip Global Lab Solutions Pvt. Ltd.</link:label>
    <link:label id="lab_kequ_KequipGlobalLabSolutionsMember_label_en-US" xlink:label="lab_kequ_KequipGlobalLabSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kequip Global Lab Solutions [Member]</link:label>
    <link:label id="lab_kequ_KequipGlobalLabSolutionsMember_documentation_en-US" xlink:label="lab_kequ_KequipGlobalLabSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kequip Global Lab Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KequipGlobalLabSolutionsMember" xlink:href="kequ-20230430.xsd#kequ_KequipGlobalLabSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KequipGlobalLabSolutionsMember" xlink:to="lab_kequ_KequipGlobalLabSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityUndiscountedExcessAmount_2259286c-aa70-4dbf-9380-8fd9226ab221_negatedTerseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imputed Interest</link:label>
    <link:label id="lab_kequ_FinancingLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_kequ_FinancingLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:to="lab_kequ_FinancingLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_c3d4d0e4-d778-4fc2-a409-32a7ae9a951b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_cb784df2-184d-4327-8190-16fb68db574d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0e07dc86-f833-4aa4-8fbb-3868f8691e25_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_9e256356-a1c7-4ebd-9c21-e343c3a63399_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax expense:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_5dc167dd-3682-4494-aad3-6a543b94fa15_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_128360f3-2a97-4c23-a629-2545fea809fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_bbccecbc-794a-40ff-9eb9-cef16e859edb_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Point in Time</link:label>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred at Point in Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredAtPointInTimeMember" xlink:to="lab_us-gaap_TransferredAtPointInTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDiscountRate_320dd0d1-6979-4cc6-84e8-f573a4d06526_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDiscountRate_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:to="lab_us-gaap_LesseeFinanceLeaseDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_3b1530d2-4f8f-42f8-8635-c964746ff7e1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4967eda8-796e-40ce-ab33-18bd4ba4af2f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of RSUs</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_038dc45e-508d-4960-9164-88c9ae04e503_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_15de9e31-a174-4d05-8f2a-8018edcf6c52_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_55bdb1cb-3d23-432c-89f5-782b086e2147_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_IncomeTaxesLineItems_731ddf90-8205-4614-8de6-502bce0d7337_terseLabel_en-US" xlink:label="lab_kequ_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_kequ_IncomeTaxesLineItems_label_en-US" xlink:label="lab_kequ_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_kequ_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_kequ_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesLineItems" xlink:href="kequ-20230430.xsd#kequ_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_IncomeTaxesLineItems" xlink:to="lab_kequ_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_60cdb512-fa10-41eb-bb45-ce52696ae06d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_73abb251-fe6b-4f8a-b740-f362de37fe4a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of year (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_f9317cda-3b97-491c-a4df-46ce98e8f8c7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_b6fead20-f638-4571-ac13-5f331670a8b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Other Credit Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_c685941c-0ff1-4b05-8c73-a154bc6047f0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_eaa8f9fe-7ba8-4443-ab86-7aecfa308da7_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_a26041e4-9c0a-48ba-a6aa-05457141ac83_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_5911e6b4-0262-4ccd-927e-936832c37b9e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_24990a9b-d4f2-43f6-b76e-87444b690657_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_fa8c2d8b-5fda-4faa-b9b1-afbf1f8fa50b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_e3016b8d-40dc-4a43-a76e-be7d6d2c383b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined pension benefit plan, net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Amortization, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_3316abda-facc-4984-be29-623f4b597b87_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_bbb6e572-c68d-4ea5-b55d-4a119f95c917_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f4e9ac28-a894-4e4f-a23c-ecef3a15bd1b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_35f41386-ae32-4d11-aa96-68984685eb69_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_30cacd5b-ed93-4b03-9b53-91761c89a4fe_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Doubtful accounts written off (net)</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_381f8633-3058-4572-b319-2fd382db50f4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_RevenuesIncludingIntersegmentMarkup_bf85ae67-5bbe-40f9-a869-761d94a8efed_terseLabel_en-US" xlink:label="lab_kequ_RevenuesIncludingIntersegmentMarkup" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment revenues</link:label>
    <link:label id="lab_kequ_RevenuesIncludingIntersegmentMarkup_label_en-US" xlink:label="lab_kequ_RevenuesIncludingIntersegmentMarkup" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues Including Intersegment Markup</link:label>
    <link:label id="lab_kequ_RevenuesIncludingIntersegmentMarkup_documentation_en-US" xlink:label="lab_kequ_RevenuesIncludingIntersegmentMarkup" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues including intersegment markup.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenuesIncludingIntersegmentMarkup" xlink:href="kequ-20230430.xsd#kequ_RevenuesIncludingIntersegmentMarkup"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_RevenuesIncludingIntersegmentMarkup" xlink:to="lab_kequ_RevenuesIncludingIntersegmentMarkup" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_21e9a894-672e-4822-ac3d-218e69a9deac_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_9a470377-02fa-4ffb-9630-4d7ed1b22708_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d2d80dbe-1277-4ced-af1c-c98527e4606e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionDisclosureTextBlock_57374593-7133-4097-a5b0-ef9ed4fca6b2_terseLabel_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale-Leaseback Financing Transaction</link:label>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Leaseback Transactions [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleLeasebackTransactionDisclosureTextBlock" xlink:to="lab_us-gaap_SaleLeasebackTransactionDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d33f8a57-42a0-4a7e-8343-47276fb9da9f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_53cda6cb-ceb4-42a4-8677-759fa000fd6a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_68935367-d5a2-4943-83ca-62b0c1ed58c7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_4aff269e-a2a3-4fb5-89cd-5295114872cd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_180148ec-deee-45d7-8955-0e31a6ebd17c_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomesticMember" xlink:to="lab_us-gaap_GeographicDistributionDomesticMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_ae2bc9a2-1660-4dc7-b303-2ec0aa586890_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and amounts withheld</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LesseeRemainingLeaseTerm_73b3d75b-31be-404f-bfcc-3c426a747a85_terseLabel_en-US" xlink:label="lab_kequ_LesseeRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term (in years)</link:label>
    <link:label id="lab_kequ_LesseeRemainingLeaseTerm_label_en-US" xlink:label="lab_kequ_LesseeRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Remaining Lease Term</link:label>
    <link:label id="lab_kequ_LesseeRemainingLeaseTerm_documentation_en-US" xlink:label="lab_kequ_LesseeRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeRemainingLeaseTerm" xlink:href="kequ-20230430.xsd#kequ_LesseeRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LesseeRemainingLeaseTerm" xlink:to="lab_kequ_LesseeRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_5628da47-c6a5-4656-8164-9aa5346fcfce_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_84644fa8-ec8e-4334-a4a6-878bae23da07_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_94812f51-eb4a-464c-a32e-7e737ab4b347_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_26972ead-91f0-40ee-a721-ac262c990a2d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_f174a2a6-cfea-4cb0-88df-d39629dca77a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_568f6ece-8f1b-4960-8c1a-bd50692a2fe7_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Receivables</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade and Other Accounts Receivable, Unbilled Receivables, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_4fe6c9e2-e425-44ad-87aa-d17ac3468e41_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_a795273c-c4cd-442a-a829-6f6a420d65d5_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of RSU Activity and Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_7a1fb0cf-a04f-4fcd-904a-928bb0709cc9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d209a516-b680-4b33-b131-f9cf3dc76609_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0f6f65eb-6360-476e-8edd-7da04050f4e3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_83ee1658-309c-4618-8862-c2aa619d8148_negatedTerseLabel_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss adjustment</link:label>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_label_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Net Operating Loss Carryback, Amount</link:label>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_documentation_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Net Operating Loss Carryback, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:href="kequ-20230430.xsd#kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:to="lab_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e46eebb8-9313-4c32-834d-38c0388ee488_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_722145a4-771b-4fd4-a655-12f46030d313_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueMember_dfdfe144-f8a6-4e62-92aa-09aa3a28d769_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value of Life Insurance Policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueMember_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueMember" xlink:to="lab_us-gaap_CashSurrenderValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_373ffa95-b86b-43ee-af35-f7fdb332d44a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Recognized in the Consolidated Balance Sheets consist of:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_d93301d1-831b-41bb-a114-ecc2870c9dfc_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_a12dcb68-f675-4552-9110-93b6eddf8085_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_74fbcf23-df7d-4904-a37d-d6ed9b4f5247_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_241a37f3-5259-469e-af2b-77bed3c4cc03_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_4be9e612-231b-4d48-bccc-47857f23c066_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_d509b629-61db-4ec1-addc-d21124abd7da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price range upper limit (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_df16475f-d26a-4dbc-b069-fb7fa932ab57_negatedTerseLabel_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book basis in excess of tax basis of Sale Leaseback property</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_label_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Sale Leaseback Property</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_documentation_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Sale Leaseback Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesSaleLeasebackProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:to="lab_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_1e760043-a34b-4659-967e-f8b2a06b4df2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_8e0c378c-d39f-4175-a58c-3544c89f7841_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_232804ba-bdda-44e8-9c1b-6e75e068b0a3_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_fc183cbf-677a-4f46-8857-294581ebc8d5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_0b1dd629-b3b0-4daf-8694-9f7c7d3a5e3b_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_1007636d-8206-42fe-8e6e-1452c107f766_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f3e57081-20c7-4ed5-a96f-12da0f98221f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_b758013a-3650-4791-ab62-c72dc91e2b46_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomain" xlink:to="lab_us-gaap_GeographicDistributionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_8b471ea4-d596-405a-80e2-5a7b3b1ecbba_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment revenues</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a3fa62cb-cdbb-4893-8590-85467a8f39ce_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_44f20b96-e262-436b-bacb-add1ebba7d6c_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_26ed16c5-a8c9-46b9-b247-dc28d02ef21f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_09d15fc5-3b04-4a1e-b1ff-3bbb9c0fc81b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029- 2033</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_cf7de640-6691-4dcc-814b-5ac9637dcfb6_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_cdde7423-b7a4-4800-a1c1-eaaf1f1e31c6_terseLabel_en-US" xlink:label="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Age limit of employees to be eligible for contribution (in years)</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_label_en-US" xlink:label="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Age Limit Of Employees To Be Eligible For Catch Up Contributions</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_documentation_en-US" xlink:label="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan age limit of employees to be eligible for catch up contributions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:to="lab_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_PaymentsOnFinancingLiability_92ab1bae-2d66-46f3-b6ff-d66bde736883_negatedTerseLabel_en-US" xlink:label="lab_kequ_PaymentsOnFinancingLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments on financing liability</link:label>
    <link:label id="lab_kequ_PaymentsOnFinancingLiability_label_en-US" xlink:label="lab_kequ_PaymentsOnFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments On Financing Liability</link:label>
    <link:label id="lab_kequ_PaymentsOnFinancingLiability_documentation_en-US" xlink:label="lab_kequ_PaymentsOnFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments On Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_PaymentsOnFinancingLiability" xlink:href="kequ-20230430.xsd#kequ_PaymentsOnFinancingLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_PaymentsOnFinancingLiability" xlink:to="lab_kequ_PaymentsOnFinancingLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_48436163-8d6f-4cf5-aafe-57a6241d044c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_269b3cc3-9bec-48d6-ab73-30ce8fbe6a54_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_2149e453-3de2-4a7e-99c7-92955ac6a720_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_80a15c6a-90a5-4378-82a3-59f7771f4e23_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_75deb140-3677-46e0-8644-59bb9e8ca1d0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_50c44674-418b-41f4-aaaa-d7ccb14f315f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materials and components</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1_6b4ca885-26df-4a48-aaa4-d337b58a849a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of sale agreement payable in redeemable preferred stock</link:label>
    <link:label id="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1_label_en-US" xlink:label="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Significant Noncash Transaction, Value of Consideration Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1" xlink:to="lab_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_add5ab90-b1a5-4f8b-bb6f-24fd182b8c75_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs on financing liability</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_ebeddb08-12d2-4116-bea1-e81cbc7f390e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Date, Period Five</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_eb58ab03-256d-4d0c-959e-5d34f2fe9d55_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2f739f84-a098-442e-a95c-4a62808f0c68_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_292d4f3d-c8a5-4b2a-9148-78ab898c9e54_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_695e11bf-80c1-4d86-964f-5af558cb61c1_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_ca82c241-e234-4afa-aef2-ddcb37be6c7b_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_a10f463f-9f30-4f93-8d70-4cb13b5bff32_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionForeignMember" xlink:to="lab_us-gaap_GeographicDistributionForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a575f878-ce75-4ea4-ae23-39e76bcd1018_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_cfb59b97-f4b0-46b8-9a53-655ba68f68c9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_ffd608da-5b6b-4016-8f07-9cc7383bba29_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b800e7e3-c918-4dba-9d62-833d90e6f091_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_8e19abb1-b446-4f1a-b96a-d00e3cbb47bc_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3f3c2c36-69f1-46f4-b0e3-fa16c166fb63_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less comprehensive income attributable to the non-controlling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_c4f75d4b-8605-47ca-a0d8-8d625df34f9c_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_fe1f65c3-25f7-47a8-8343-18bc80c76f38_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion_cc2b762f-e683-4695-a777-8e40d1bacbcd_negatedTerseLabel_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APB 23 Assertion</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion_label_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, APB 23 Assertion</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion_documentation_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, APB 23 Assertion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesAPB23Assertion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:to="lab_kequ_DeferredTaxLiabilitiesAPB23Assertion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ad3e0fbc-a5c0-4151-a41f-6366b219b19b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_875320b3-b28a-4685-acb3-6d808afbb1dd_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_17cb9b64-6183-4071-a84e-dd95e047e753_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_574c1efd-9eb2-417f-ab14-d1b6db68a2d0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anticipated contribution in the next fiscal year related to pension plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_be80a10c-c448-4a97-8db2-f36cef61d9e8_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_486d4108-6d7b-4e10-af95-c2f4bc9d1191_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Components of Net Periodic Pension Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_361f8d8f-cf01-4dc5-93aa-c7d1d81cb792_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_811ed371-649a-4402-a8b2-8da4cf11a148_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_6f3708e6-f363-46aa-bf7f-8e0cfe6f9956_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in number of shares available under stock option plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6ca247cf-7d57-427f-8458-b1f2d92b0d51_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_497d6c1e-bc9f-4240-b040-d18e0ead561d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity_9c30522e-adc1-4e1a-ad05-df94b37df973_terseLabel_en-US" xlink:label="lab_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateralized debt instrument, borrowing capacity</link:label>
    <link:label id="lab_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity_label_en-US" xlink:label="lab_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Asset Based Lending, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Asset Based Lending, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity" xlink:href="kequ-20230430.xsd#kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity" xlink:to="lab_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_733b0883-aa08-4406-b998-d6aaf433f1eb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_991cd043-a3b5-48ee-ab15-8a136eb2dd48_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_10269192-de0b-4dfb-bc48-59ad32b8571e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_7f21e51f-0ea8-4963-9ffe-7fc491caa74d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_df765d5c-be17-4cdb-be79-84a9d72a2220_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_8ffef0a9-bd41-48c1-a5b6-c8b8b65892d7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_afbea831-516a-4996-8c29-1461d2078dd5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_9b0f455b-ed1a-4dff-a26f-0ae42eaa88ba_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_d759f390-79b9-4305-9d72-5a9896f4d42d_terseLabel_en-US" xlink:label="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allowance For Doubtful Accounts</link:label>
    <link:label id="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_label_en-US" xlink:label="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allowance For Doubtful Accounts [Table Text Block]</link:label>
    <link:label id="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_documentation_en-US" xlink:label="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the amount of bad debt provision charged against earnings and the amounts of accounts receivable written off.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:href="kequ-20230430.xsd#kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:to="lab_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9c26e525-2bbf-43b5-aea9-643e0e151e09_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_2c72072a-6de8-4da3-bea8-ccb6bc3b5b5f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_a81493f2-b2c2-48dd-8374-3e8ddd9eed2f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3a4639d9-d244-404a-9ecc-bc81b97e1e23_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Pension Liability Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_69d57ebd-f28e-4299-a1e6-d38aca79eab2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_38458196-bce6-46d0-ac07-d80050a3d321_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LesseeOptiontoExtendTerm_52ed7129-1d68-4809-970e-0d533d6d7db0_terseLabel_en-US" xlink:label="lab_kequ_LesseeOptiontoExtendTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend, term (in years)</link:label>
    <link:label id="lab_kequ_LesseeOptiontoExtendTerm_label_en-US" xlink:label="lab_kequ_LesseeOptiontoExtendTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Option to Extend, Term</link:label>
    <link:label id="lab_kequ_LesseeOptiontoExtendTerm_documentation_en-US" xlink:label="lab_kequ_LesseeOptiontoExtendTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Option to Extend, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeOptiontoExtendTerm" xlink:href="kequ-20230430.xsd#kequ_LesseeOptiontoExtendTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LesseeOptiontoExtendTerm" xlink:to="lab_kequ_LesseeOptiontoExtendTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_31b48a80-81e2-4a1e-bd01-9f6daf891144_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_29c9f9e5-24c2-4cca-b50a-8f5f790d8daf_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a952e89a-7ba4-4f67-82c8-aee35c1ec12d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Kewaunee Scientific Corporation Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0e0f5a8c-1100-404c-9479-57c6ea7bdf17_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_fc1991f5-c810-4a7d-830b-c8e11ce27b79_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized actuarial loss on pension obligations</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_0be53e17-f0be-41ee-b5a2-d239aaf40c9b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits (state, net of federal benefits)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_0b2c8ab6-6712-4360-98d0-57df243540d6_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_e53842a0-1aa4-4e62-a601-a5d4614615b5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_77ae2aef-faf5-4a7d-9459-956c6ba50285_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_6c049666-68f7-4688-a593-6ad879aab5d3_terseLabel_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contributions</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_label_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contributions, Amount</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_documentation_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contributions, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanEmployerMatchingContributionsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:to="lab_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TermLoanBMember_bd2b7ba6-c7a7-4bf3-9762-3a0af4d4f50e_verboseLabel_en-US" xlink:label="lab_kequ_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B</link:label>
    <link:label id="lab_kequ_TermLoanBMember_label_en-US" xlink:label="lab_kequ_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B [Member]</link:label>
    <link:label id="lab_kequ_TermLoanBMember_documentation_en-US" xlink:label="lab_kequ_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TermLoanBMember" xlink:href="kequ-20230430.xsd#kequ_TermLoanBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TermLoanBMember" xlink:to="lab_kequ_TermLoanBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_b5dc4210-655f-438f-9eb6-2cc4ce84e6a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_17ffafac-488e-4f41-af24-87052cd85ae0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_ad93793f-a654-43d4-ac35-dfabed900b7a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_2d4e8922-949c-4375-9235-5b70e691614c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_074c7316-fc63-4e46-afc1-e2ab8991de92_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_23a83b6a-9609-4e9b-87cd-9f40ff76a50e_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_716087c4-db3d-4acc-b192-8897b0ab8c09_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_af8a8b3a-8c42-4ea2-96c7-556647aec9aa_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_3b500fa8-88b0-4504-b968-03108d9926af_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_da7c587c-c8d9-48f5-92bd-664483d3cc6c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_9a130a50-a4d0-450d-8f4e-2917da6e669a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_fe4e6ae2-5a65-4e41-b741-b608cf711e87_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b5b79718-2839-48fa-b9d5-c4456dedd7c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_AccruedEmployeeBenefitPlanCosts_916e9c8c-385a-4275-a22a-be6c17a7bbee_terseLabel_en-US" xlink:label="lab_kequ_AccruedEmployeeBenefitPlanCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pension and deferred compensation costs</link:label>
    <link:label id="lab_kequ_AccruedEmployeeBenefitPlanCosts_label_en-US" xlink:label="lab_kequ_AccruedEmployeeBenefitPlanCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefit Plan Costs</link:label>
    <link:label id="lab_kequ_AccruedEmployeeBenefitPlanCosts_documentation_en-US" xlink:label="lab_kequ_AccruedEmployeeBenefitPlanCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total of the aggregate carrying amounts of the noncurrent liabilities for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans and deferred compensation arrangements representing currently earned compensation under cash arrangements (such as a rabbi trust) that is not actually paid until a later date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AccruedEmployeeBenefitPlanCosts" xlink:href="kequ-20230430.xsd#kequ_AccruedEmployeeBenefitPlanCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_AccruedEmployeeBenefitPlanCosts" xlink:to="lab_kequ_AccruedEmployeeBenefitPlanCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_68dc0c39-248d-4c8d-980e-e27bc1093d14_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Cost on Sale Leaseback</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_c4470448-3af1-47eb-9271-7e2053752265_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f12f5b8f-f883-454f-a5c9-b86fb6ef02f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_616d409e-9150-41b3-aba1-806df25c3dd7_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiability_94bd2fd4-bc72-4b15-9849-87a47b3c2c08_verboseLabel_en-US" xlink:label="lab_kequ_FinancingLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing liability</link:label>
    <link:label id="lab_kequ_FinancingLiability_a47c378e-dbaa-4a17-90a4-246d5134e356_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_kequ_FinancingLiability_label_en-US" xlink:label="lab_kequ_FinancingLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability</link:label>
    <link:label id="lab_kequ_FinancingLiability_documentation_en-US" xlink:label="lab_kequ_FinancingLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiability" xlink:href="kequ-20230430.xsd#kequ_FinancingLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiability" xlink:to="lab_kequ_FinancingLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_609240dc-ed44-4633-b037-55074c1f172b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_d6658820-cbf8-45b9-b8a4-8814ff2380a4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaid_8250a3a3-bce8-4355-93ef-609860e0261c_totalLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Minimum Liability Payments</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaid_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaid_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaid" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaid" xlink:to="lab_kequ_FinancingLiabilityToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_e1d5e0e6-9dcd-4bed-af08-58339846483b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_7bada83e-c27d-4c3d-bb6b-478012613d82_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, less allowance: $476 (2023); $357 (2022)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5d63e59b-bd73-476c-b357-b800ff3fed63_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_fadeace1-db33-48da-b742-0fa0e7490c3e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40e60d51-e27d-4b1e-bee1-a05fddf7dc78_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of year (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FiscalYearTwoThousandTwentyFourMember_f696ef21-4056-4a1a-ab5a-2132170a7ea9_terseLabel_en-US" xlink:label="lab_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year 2024</link:label>
    <link:label id="lab_kequ_FiscalYearTwoThousandTwentyFourMember_label_en-US" xlink:label="lab_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year Two Thousand Twenty Four [Member]</link:label>
    <link:label id="lab_kequ_FiscalYearTwoThousandTwentyFourMember_documentation_en-US" xlink:label="lab_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year Two Thousand Twenty Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:href="kequ-20230430.xsd#kequ_FiscalYearTwoThousandTwentyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:to="lab_kequ_FiscalYearTwoThousandTwentyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_2dabbb07-9f4a-433d-b6f0-131633f34cfc_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ForeignSubsidiariesMember_1cdfdd86-3388-4dfb-8c5f-57081e91f0a5_terseLabel_en-US" xlink:label="lab_kequ_ForeignSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Subsidiaries</link:label>
    <link:label id="lab_kequ_ForeignSubsidiariesMember_label_en-US" xlink:label="lab_kequ_ForeignSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Subsidiaries [Member]</link:label>
    <link:label id="lab_kequ_ForeignSubsidiariesMember_documentation_en-US" xlink:label="lab_kequ_ForeignSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesMember" xlink:href="kequ-20230430.xsd#kequ_ForeignSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ForeignSubsidiariesMember" xlink:to="lab_kequ_ForeignSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_5d7f14b4-acf8-43f0-809a-00d37b1363a1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_InternationalSubsidiariesMember_145afa09-e2c5-4893-a221-afd713078f25_terseLabel_en-US" xlink:label="lab_kequ_InternationalSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Subsidiaries</link:label>
    <link:label id="lab_kequ_InternationalSubsidiariesMember_label_en-US" xlink:label="lab_kequ_InternationalSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Subsidiaries [Member]</link:label>
    <link:label id="lab_kequ_InternationalSubsidiariesMember_documentation_en-US" xlink:label="lab_kequ_InternationalSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalSubsidiariesMember" xlink:href="kequ-20230430.xsd#kequ_InternationalSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_InternationalSubsidiariesMember" xlink:to="lab_kequ_InternationalSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_de572a29-18a0-43f4-af18-55ac7fe211e7_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0f701562-1fa2-4117-a052-239bfebac2d2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_NonQualifiedCompensationPlanMember_2e8e0024-13c8-491c-827d-30a90eadbeed_terseLabel_en-US" xlink:label="lab_kequ_NonQualifiedCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Qualified Compensation Plans</link:label>
    <link:label id="lab_kequ_NonQualifiedCompensationPlanMember_label_en-US" xlink:label="lab_kequ_NonQualifiedCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Qualified Compensation Plan [Member]</link:label>
    <link:label id="lab_kequ_NonQualifiedCompensationPlanMember_documentation_en-US" xlink:label="lab_kequ_NonQualifiedCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Qualified Compensation Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NonQualifiedCompensationPlanMember" xlink:href="kequ-20230430.xsd#kequ_NonQualifiedCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_NonQualifiedCompensationPlanMember" xlink:to="lab_kequ_NonQualifiedCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d2c44b34-dbc3-4c6d-97a3-d9004ffbace7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember_f2a9d104-cfe6-48dd-ac25-5cd9b624e5e5_terseLabel_en-US" xlink:label="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquid Alternatives</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember_label_en-US" xlink:label="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Liquid Alternatives [Member]</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember_documentation_en-US" xlink:label="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Liquid Alternatives [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanLiquidAlternativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:to="lab_kequ_DefinedBenefitPlanLiquidAlternativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_21a38622-b757-443c-857f-36e4a9ae8ca7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_270d59d1-7aa5-41d3-a425-8182a72c7ba6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit_5eb76cf5-b821-4135-86e7-3f96f12eb355_terseLabel_en-US" xlink:label="lab_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax benefit</link:label>
    <link:label id="lab_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit_label_en-US" xlink:label="lab_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Deferred Tax Expense Benefit</link:label>
    <link:label id="lab_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit_documentation_en-US" xlink:label="lab_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred tax expense benefit related to deductible temporary differences from share-based compensation expense stock options at exercise.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit" xlink:href="kequ-20230430.xsd#kequ_ShareBasedCompensationDeferredTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit" xlink:to="lab_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_b3de2e77-cf84-4fed-a1b3-5e0d63eb13db_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_570dff17-abf3-40b1-bbb8-280c0ff17388_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_aaa96115-b6e2-4a3d-8968-93e180a8a736_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_110948aa-0b0d-45ec-98fb-91452ffca331_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_67f69610-eb07-44d7-a087-37ca658bf866_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cc8c00a3-902d-4af8-95af-60fc9704d8f8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_cbd7e9f3-4553-4ee8-a289-a620ed2dade7_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate_fba1c82a-8d2e-4843-94d4-9ab9583599f4_terseLabel_en-US" xlink:label="lab_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease in the discount rate</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate_label_en-US" xlink:label="lab_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Percentage Changes In Discount Rate</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate_documentation_en-US" xlink:label="lab_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan percentage changes in discount rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanPercentageChangesInDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate" xlink:to="lab_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_0c72bbaf-6fe9-44c0-8039-4353da51c61f_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_dca65a05-003f-4eac-ab7d-240ab2c71be4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_26afad2f-c6fe-47d2-bc08-7cb7d1554b77_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueSegmentMember_5851710d-3284-4412-9cb0-7dab9866d325_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Segment</link:label>
    <link:label id="lab_us-gaap_SalesRevenueSegmentMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Segment Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueSegmentMember" xlink:to="lab_us-gaap_SalesRevenueSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_aff03d9d-722b-40b7-9640-79a5a4c4034b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_5fce352b-fe66-479b-96e6-437f71be3e85_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenditures for segment assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_828bcf42-53a9-4d8d-8018-8ad6ad1b09ac_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_33fac7cc-f47f-407a-9f01-1c40dbf766e6_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_76dc60c5-6f7a-4468-976a-7031d459bcb0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_346099aa-bd29-4670-9c98-5421c4f9950e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5e8f0c7d-8414-4e0c-b22e-ce7a78b74879_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Option Activity and Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3b305630-55e2-49ed-92ab-f964ef68b6ee_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating earnings (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_79e1c101-1be0-4c51-86d9-45656461500e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory reserves and capitalized costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_OtherAssetsPolicyTextBlock_62e85d3b-c9f1-4d50-99a1-d4f78d46dba2_terseLabel_en-US" xlink:label="lab_kequ_OtherAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_kequ_OtherAssetsPolicyTextBlock_label_en-US" xlink:label="lab_kequ_OtherAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Policy Text Block]</link:label>
    <link:label id="lab_kequ_OtherAssetsPolicyTextBlock_documentation_en-US" xlink:label="lab_kequ_OtherAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for other noncurrent assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_OtherAssetsPolicyTextBlock" xlink:href="kequ-20230430.xsd#kequ_OtherAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_OtherAssetsPolicyTextBlock" xlink:to="lab_kequ_OtherAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_d3488e9c-bd96-45a9-9b0a-d22147415f7b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_66ff1399-2013-4f49-859b-5d873c80f1c1_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cde22199-aa1f-4197-9b5e-625f9c252613_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_18280d3a-a36e-4ce8-9643-d6b6520e239e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_cbddbc2d-6f10-4af9-a375-9bdae663af2d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_1b4411a2-138f-4964-964f-f6fe17cc2547_terseLabel_en-US" xlink:label="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_label_en-US" xlink:label="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_documentation_en-US" xlink:label="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:href="kequ-20230430.xsd#kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:to="lab_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_9baf9b23-3e88-430d-97c4-19065c1726f6_negatedLabel_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid pension</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_label_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Prepaid Pension Cost</link:label>
    <link:label id="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_documentation_en-US" xlink:label="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Prepaid Pension Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesPrepaidPensionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:to="lab_kequ_DeferredTaxLiabilitiesPrepaidPensionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_e8f21c3c-7b5d-4ec9-9e74-6b744e9b8340_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of differing US and foreign tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5cf4e82e-fd88-4b28-9b7d-4f882b3e1726_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings (loss) to net cash used by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_222286b3-91f3-4f0a-8e11-19bfbb657c55_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9fd8cbb8-6ef3-4a27-a7b4-13a6af5193e5_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_17a8782c-9b05-4a7e-97ec-ef097283962b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_10f15ced-7e75-41ee-be69-2e24c064cdec_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_a34f4962-7b07-4767-86fa-1379ff383f4f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_33c1de58-79c2-418f-a898-61610b8d2536_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityBasicMonthlyPayment_9d8fa8be-ee7e-4ae3-88fc-8a60fc82d121_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial basic monthly rent</link:label>
    <link:label id="lab_kequ_FinancingLiabilityBasicMonthlyPayment_label_en-US" xlink:label="lab_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Basic Monthly Payment</link:label>
    <link:label id="lab_kequ_FinancingLiabilityBasicMonthlyPayment_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Basic Monthly Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityBasicMonthlyPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:to="lab_kequ_FinancingLiabilityBasicMonthlyPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ca3fbf5c-0d7f-4ee1-8f9d-e1f0c1331f81_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_808d3e15-290f-48d1-9b9c-3f5028062f99_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_ddfdbb13-958b-4919-8831-8ead17471cba_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax labilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_af7938b3-20c5-4b17-a4a3-0ed8240dd8aa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_733d94d9-2ba2-4829-b8c3-45161db33d4e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_5984b311-4e08-4f6c-804b-863646feccea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1cd3abd7-1f1c-403e-baa7-7abb67e3cc20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_7a55c72b-9877-4dd2-9da3-e7b4da148513_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_9e5cbcf0-920e-4f6e-b394-ae096dffcdfc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5ba671cf-a9eb-4115-b643-4d044e6a6790_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_f8ce7af1-c935-460f-b10e-48fc70602688_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_de1fedd6-b117-4203-b426-0d29e47bcd8c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KewauneeScientificCorporationMember_5893c371-09d4-4325-9e12-a667d90fc609_terseLabel_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Scientific Corporation</link:label>
    <link:label id="lab_kequ_KewauneeScientificCorporationMember_label_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Scientific Corporation [Member]</link:label>
    <link:label id="lab_kequ_KewauneeScientificCorporationMember_documentation_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Scientific Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationMember" xlink:href="kequ-20230430.xsd#kequ_KewauneeScientificCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KewauneeScientificCorporationMember" xlink:to="lab_kequ_KewauneeScientificCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_b16d8826-1bfc-42fa-8eca-d2729f570c95_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FIFOInventoryAmount_d582ef34-d5ca-4b15-88c2-f80aa74344c2_terseLabel_en-US" xlink:label="lab_us-gaap_FIFOInventoryAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories measured using FIFO method</link:label>
    <link:label id="lab_us-gaap_FIFOInventoryAmount_label_en-US" xlink:label="lab_us-gaap_FIFOInventoryAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FIFO Inventory Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FIFOInventoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FIFOInventoryAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FIFOInventoryAmount" xlink:to="lab_us-gaap_FIFOInventoryAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_380ebfb2-6ddd-4fc9-a11b-e9272efb3ed0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7b49182c-d0fa-40a3-bcb8-94fd650edd96_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding-diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_7ea60dbc-d8b6-4fc8-8978-da99c60c46af_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_629f5416-a1ed-45a5-b740-9d3fe6612219_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_f62d11a6-8f85-40bc-8f34-c3961f37cbfd_terseLabel_en-US" xlink:label="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds on Sale Leaseback</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_label_en-US" xlink:label="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Proceeds on Sale Leaseback</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_documentation_en-US" xlink:label="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Proceeds on Sale Leaseback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetsProceedsOnSaleLeaseback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:to="lab_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f22ae53d-46a4-4772-bfb7-4d14f9e30073_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_NumberOfNonqualifiedCompensationPlans_8264b589-c471-43ee-b6ab-a77f7c68e0b9_terseLabel_en-US" xlink:label="lab_kequ_NumberOfNonqualifiedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of non-qualified compensation plans maintained</link:label>
    <link:label id="lab_kequ_NumberOfNonqualifiedCompensationPlans_label_en-US" xlink:label="lab_kequ_NumberOfNonqualifiedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Nonqualified Compensation Plans</link:label>
    <link:label id="lab_kequ_NumberOfNonqualifiedCompensationPlans_documentation_en-US" xlink:label="lab_kequ_NumberOfNonqualifiedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of nonqualified compensation plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NumberOfNonqualifiedCompensationPlans" xlink:href="kequ-20230430.xsd#kequ_NumberOfNonqualifiedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_NumberOfNonqualifiedCompensationPlans" xlink:to="lab_kequ_NumberOfNonqualifiedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityRenewalTerm_1bad8770-26ed-47dc-8f5a-62406884e9f1_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_kequ_FinancingLiabilityRenewalTerm_label_en-US" xlink:label="lab_kequ_FinancingLiabilityRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Renewal Term</link:label>
    <link:label id="lab_kequ_FinancingLiabilityRenewalTerm_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityRenewalTerm" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityRenewalTerm" xlink:to="lab_kequ_FinancingLiabilityRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_4227ba77-c1cb-4582-a2ab-c3737edf2ed7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_253d1ff4-3c6f-4c0b-b4f3-f3aeccd759ac_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_7b51a1e1-c365-43e0-8d91-5a6121639bf7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_fe36dcb1-a6f1-41b6-8bd1-bff1906ace36_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_e371ba85-b726-47c5-abf6-6e91dbc7268b_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_OperatingLeaseShortTermExpense_76b642f2-6dac-4aea-9235-64dedffd84fd_terseLabel_en-US" xlink:label="lab_kequ_OperatingLeaseShortTermExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, short term, expense</link:label>
    <link:label id="lab_kequ_OperatingLeaseShortTermExpense_label_en-US" xlink:label="lab_kequ_OperatingLeaseShortTermExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Short Term, Expense</link:label>
    <link:label id="lab_kequ_OperatingLeaseShortTermExpense_documentation_en-US" xlink:label="lab_kequ_OperatingLeaseShortTermExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Short Term, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_OperatingLeaseShortTermExpense" xlink:href="kequ-20230430.xsd#kequ_OperatingLeaseShortTermExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_OperatingLeaseShortTermExpense" xlink:to="lab_kequ_OperatingLeaseShortTermExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_2e2d838a-f02f-4e73-b0d6-a50b306df572_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_076d9ccb-7aac-49c6-b23a-d3b3f5cdbc5f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_3ca9af81-b4df-4441-8acc-8a3c475160d7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_443e16ba-3750-4527-8299-f12216319367_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability_85f83ae5-ea23-407f-bd6b-27e32e7f6047_terseLabel_en-US" xlink:label="lab_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets obtained under new finance or operating leases</link:label>
    <link:label id="lab_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability_label_en-US" xlink:label="lab_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Finance Or Operating Lease Liability</link:label>
    <link:label id="lab_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability_documentation_en-US" xlink:label="lab_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Finance Or Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability" xlink:href="kequ-20230430.xsd#kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability" xlink:to="lab_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinistryOfFinanceIndiaMember_c7b6680f-d5c8-464b-a95f-bb947408b7d2_terseLabel_en-US" xlink:label="lab_us-gaap_MinistryOfFinanceIndiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">India Income Tax Department</link:label>
    <link:label id="lab_us-gaap_MinistryOfFinanceIndiaMember_label_en-US" xlink:label="lab_us-gaap_MinistryOfFinanceIndiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ministry of Finance, India [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinistryOfFinanceIndiaMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinistryOfFinanceIndiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinistryOfFinanceIndiaMember" xlink:to="lab_us-gaap_MinistryOfFinanceIndiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_56b9ea5c-b565-4c9b-a7d9-211a7d1a5c03_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2d5a3d36-272e-4274-8acd-ac4f1aeb8a5a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_8d3bb30d-a018-410b-b0a1-0492d51b100f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_657d4a7c-44f7-4f4a-9a3a-aef3b1ab5119_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f6cd39c-0315-4d9c-8cdd-920e4bcdafc0_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash at End of Year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0550ac49-5a8d-47d3-8585-cf07429dc8f1_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1c09c917-24f3-4ce4-9e61-8190bccdecbc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_fa72b5ba-43c9-43b6-8681-fccd6c8ca7f2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized actuarial loss, defined benefit plans</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_b318dda3-836c-47a2-827b-f8eb69380ad0_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_BankGuaranteesMember_3fe05feb-882b-450a-98e5-932aaee31d48_terseLabel_en-US" xlink:label="lab_kequ_BankGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees</link:label>
    <link:label id="lab_kequ_BankGuaranteesMember_label_en-US" xlink:label="lab_kequ_BankGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees [Member]</link:label>
    <link:label id="lab_kequ_BankGuaranteesMember_documentation_en-US" xlink:label="lab_kequ_BankGuaranteesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_BankGuaranteesMember" xlink:href="kequ-20230430.xsd#kequ_BankGuaranteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_BankGuaranteesMember" xlink:to="lab_kequ_BankGuaranteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9cdb5fa2-adaa-4bcc-8466-653f25d17575_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: net earnings attributable to the non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_060b827a-545e-4db5-aed8-1fa4b517857f_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_43cb3cc0-8f61-4b52-8a0e-4fcb02313363_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_2023bbdd-e849-4d9b-b5cf-840ffd7a4d9f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2d2f5507-6965-4dac-b3d0-f1a3f0d1b0ff_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_3852fa43-90ce-467c-96bf-f922bccc0e0e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_YieldCurveTechniqueMember_ed8de8f7-ad3b-4e4e-9293-6ad5841a1a80_terseLabel_en-US" xlink:label="lab_kequ_YieldCurveTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield Curve Technique</link:label>
    <link:label id="lab_kequ_YieldCurveTechniqueMember_label_en-US" xlink:label="lab_kequ_YieldCurveTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield Curve Technique [Member]</link:label>
    <link:label id="lab_kequ_YieldCurveTechniqueMember_documentation_en-US" xlink:label="lab_kequ_YieldCurveTechniqueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield Curve Technique [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_YieldCurveTechniqueMember" xlink:href="kequ-20230430.xsd#kequ_YieldCurveTechniqueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_YieldCurveTechniqueMember" xlink:to="lab_kequ_YieldCurveTechniqueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KewauneeLabwayAsiaMember_4d86d4e4-651b-45e0-92ec-ac90c3ba5921_terseLabel_en-US" xlink:label="lab_kequ_KewauneeLabwayAsiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Labway Asia Pte. Ltd.</link:label>
    <link:label id="lab_kequ_KewauneeLabwayAsiaMember_label_en-US" xlink:label="lab_kequ_KewauneeLabwayAsiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Labway Asia [Member]</link:label>
    <link:label id="lab_kequ_KewauneeLabwayAsiaMember_documentation_en-US" xlink:label="lab_kequ_KewauneeLabwayAsiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Labway Asia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayAsiaMember" xlink:href="kequ-20230430.xsd#kequ_KewauneeLabwayAsiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KewauneeLabwayAsiaMember" xlink:to="lab_kequ_KewauneeLabwayAsiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_9477f864-cc1b-4628-a4e7-6796de6d839f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_1e6853f0-11ab-424f-a43f-dd2273062d5d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions by employer per employee's compensation (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_5b3b5b90-3668-459f-a7c6-899e71448075_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_00b531f8-0096-444b-b3fb-a0fda47fc517_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_68381bd2-31a4-4f75-8ed2-6f143afe0519_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_baaa0451-28c3-43b8-a022-a6774e0f9a29_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_InternationalOperationsMember_82e72dd5-6864-4370-a62e-2606370836c4_terseLabel_en-US" xlink:label="lab_kequ_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_kequ_InternationalOperationsMember_label_en-US" xlink:label="lab_kequ_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Operations [Member]</link:label>
    <link:label id="lab_kequ_InternationalOperationsMember_documentation_en-US" xlink:label="lab_kequ_InternationalOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalOperationsMember" xlink:href="kequ-20230430.xsd#kequ_InternationalOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_InternationalOperationsMember" xlink:to="lab_kequ_InternationalOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_29d08b2f-510e-4bca-888d-51c32bd0499e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_371647f8-2c56-4dd5-8232-2132447fbe4d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_111a16ab-445e-4584-a730-c8b1e2d5624c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued employee benefit expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionContractorReceivableRetainage_384992f6-1f31-4c28-836e-c48d4b913a1b_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionContractorReceivableRetainage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retainage included in accounts receivable</link:label>
    <link:label id="lab_us-gaap_ConstructionContractorReceivableRetainage_label_en-US" xlink:label="lab_us-gaap_ConstructionContractorReceivableRetainage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Contractor, Receivable, Retainage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionContractorReceivableRetainage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionContractorReceivableRetainage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionContractorReceivableRetainage" xlink:to="lab_us-gaap_ConstructionContractorReceivableRetainage" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityNoncurrent_32411ef9-56fc-4255-b08b-ca4cda9e76ec_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of financing liability</link:label>
    <link:label id="lab_kequ_FinancingLiabilityNoncurrent_label_en-US" xlink:label="lab_kequ_FinancingLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Noncurrent</link:label>
    <link:label id="lab_kequ_FinancingLiabilityNoncurrent_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNoncurrent" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityNoncurrent" xlink:to="lab_kequ_FinancingLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d22ea901-ac20-4628-bcac-384ad43d3e9d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_5950f505-fd5f-47f6-9efd-14a51a78907e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income (loss) attributable to Kewaunee Scientific Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_cfe1c906-ed54-4435-9806-75c0416a0902_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Guarantees outstanding to customers</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock_9ef22baf-3d96-4c63-9c36-e8e480b9463d_terseLabel_en-US" xlink:label="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Fair Value Assets in Defined Benefit Pension Plans</link:label>
    <link:label id="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock_label_en-US" xlink:label="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Allocation Of Plan Assets Fair Value Hierarchy Table [Text Block]</link:label>
    <link:label id="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock_documentation_en-US" xlink:label="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:href="kequ-20230430.xsd#kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:to="lab_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_5fa0334a-b345-4342-b8b8-2b2dcc3d96f1_terseLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale leaseback agreement</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_label_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:to="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_fe111087-4706-41e7-9655-bdf01160cc1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6899ddb4-8a0d-47fd-a4b7-1375f3b59617_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_735937c1-6237-4c1c-8866-b381af6f68a6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b7a14582-9d75-41e4-a69b-527fc02cca34_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_8939430d-d526-4ce5-8624-4dcd6cf26979_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_1ea87d1a-5783-46f9-bde8-ccaa2e775cf1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of foreign subsidiary income to parent</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:to="lab_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_AdvanceAmountOneMember_3a036aff-0f11-4b3b-9598-e5d8e53b6e88_terseLabel_en-US" xlink:label="lab_kequ_AdvanceAmountOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Amount One</link:label>
    <link:label id="lab_kequ_AdvanceAmountOneMember_label_en-US" xlink:label="lab_kequ_AdvanceAmountOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Amount One [Member]</link:label>
    <link:label id="lab_kequ_AdvanceAmountOneMember_documentation_en-US" xlink:label="lab_kequ_AdvanceAmountOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Amount One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AdvanceAmountOneMember" xlink:href="kequ-20230430.xsd#kequ_AdvanceAmountOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_AdvanceAmountOneMember" xlink:to="lab_kequ_AdvanceAmountOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_1d4b0163-869d-4d86-853f-e4c6f8a1728f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_96d2e554-cf95-4bce-871c-452d049d33a2_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:to="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredTaxAssetLeaseLiability_e952ff6d-4df7-4c3c-84bc-89a407aec410_terseLabel_en-US" xlink:label="lab_kequ_DeferredTaxAssetLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetLeaseLiability_label_en-US" xlink:label="lab_kequ_DeferredTaxAssetLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Lease Liability</link:label>
    <link:label id="lab_kequ_DeferredTaxAssetLeaseLiability_documentation_en-US" xlink:label="lab_kequ_DeferredTaxAssetLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetLeaseLiability" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredTaxAssetLeaseLiability" xlink:to="lab_kequ_DeferredTaxAssetLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_2af424b3-74ce-4279-a2b1-d7fa48af4c22_terseLabel_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Small/Mid Cap</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_label_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US, Small Cap And Mid Cap [Member]</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_documentation_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US, Small Cap And Mid Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:to="lab_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1c9d8e64-4d8d-46ec-9663-8a5e11841514_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59cd9cf2-aee9-4097-8615-2e88ff7f5c82_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b4e01925-aa19-4cfd-ae07-0959a21ed774_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_efc6249d-fb80-42e5-b159-c073abe108dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_3cf5a834-3d35-41df-8b6d-a0595f75a7dd_terseLabel_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional tranche available, minimum amount</link:label>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="kequ-20230430.xsd#kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_6f45e9db-907c-41bf-a3aa-2fa8fb718674_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrecognized actuarial loss on pension obligations</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2eec2a20-d188-44d1-a9f0-296d3dac7cbb_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ProceedsFromFinancingLiability_e0510636-5f3f-4d10-b8b4-a8cd310637ac_terseLabel_en-US" xlink:label="lab_kequ_ProceedsFromFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale-leaseback transaction</link:label>
    <link:label id="lab_kequ_ProceedsFromFinancingLiability_label_en-US" xlink:label="lab_kequ_ProceedsFromFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Financing Liability</link:label>
    <link:label id="lab_kequ_ProceedsFromFinancingLiability_documentation_en-US" xlink:label="lab_kequ_ProceedsFromFinancingLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ProceedsFromFinancingLiability" xlink:href="kequ-20230430.xsd#kequ_ProceedsFromFinancingLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ProceedsFromFinancingLiability" xlink:to="lab_kequ_ProceedsFromFinancingLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_bad2d90b-7511-4e2e-8225-5b2ebe0a5bee_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_ae67e42c-5635-4cf2-ab86-30a8c6ae3d91_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_e6b76ccc-6e42-4f38-a728-5abb905e7be6_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets (liabilities) classified in the balance sheet:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_98e044a1-e151-4b45-9b25-42c67bc11ed0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, net</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_5af45b5a-7418-465c-89af-d306ecd4a46c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7889af8d-70b1-458d-9ca5-35f54f49ef00_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TwoThousandAndEightPlanMember_73ac5b6b-b4c2-4ce9-9f43-cf41e6fdaa20_terseLabel_en-US" xlink:label="lab_kequ_TwoThousandAndEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2008 Plan</link:label>
    <link:label id="lab_kequ_TwoThousandAndEightPlanMember_label_en-US" xlink:label="lab_kequ_TwoThousandAndEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Eight Plan [Member]</link:label>
    <link:label id="lab_kequ_TwoThousandAndEightPlanMember_documentation_en-US" xlink:label="lab_kequ_TwoThousandAndEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Eight Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandAndEightPlanMember" xlink:href="kequ-20230430.xsd#kequ_TwoThousandAndEightPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TwoThousandAndEightPlanMember" xlink:to="lab_kequ_TwoThousandAndEightPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_6ea1cf59-c529-4a4a-bc8a-deb9f0aa77c0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_1348e1ec-1d3d-4d7a-977d-a3a5468334dd_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_92a38c35-4a04-4753-b7f5-e57de1e037f8_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_30f54665-2ba5-4b7e-b3fe-6d548d5237ac_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average Assumptions Used to Determine Benefit Obligations at April 30</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_78867a8f-0bc7-4b36-ae19-b7df367f4f17_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock in treasury, at cost: 3 shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_7c100e84-f005-4f61-9245-70e801d89fd9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_82b617b2-187a-4dce-9db5-bd2df62613f3_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for receivables</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7343c529-0f9c-4fdd-8c73-ddb6f92bbee9_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d67de428-b185-4537-98a6-0b1c8ca75eec_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_16ec9a0b-0d2f-4e0b-8f09-3ce9695742f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_46a99bfa-40aa-4573-88d2-98d7ddfd00d0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_afff1035-c0c6-4aa4-b39f-cdea8cac4c9c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearTwo_57fb8160-694d-4586-bb4e-fa1e385889a3_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearTwo_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearTwo_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearTwo" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidYearTwo" xlink:to="lab_kequ_FinancingLiabilityToBePaidYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_3b8e050b-b798-498f-9c09-5a2733caaa04_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c38dd407-a09c-4bdb-a2b8-2f2c7433022d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_239fae3f-a021-4287-8495-978ed2a75eec_terseLabel_en-US" xlink:label="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum service period of employees to be eligible for contribution (in months)</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_label_en-US" xlink:label="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Eligibility Minimum Service Period</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_documentation_en-US" xlink:label="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan eligibility minimum service period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanEligibilityMinimumServicePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:to="lab_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_099f1bb4-30d5-4d4c-98b9-909a92ec343b_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsNatureDomain_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain" xlink:to="lab_us-gaap_GuaranteeObligationsNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_82e2c487-615e-474e-b303-8513e05dc739_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_6404549c-fa06-4660-8410-6c4fb8d942d2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_4a00b7dc-0e9f-4aa3-8ec2-399c2215bbac_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFive_c10295ec-68d7-433c-ab64-da21ddb0cea1_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFive_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, Year Five</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearFive_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFive" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidYearFive" xlink:to="lab_kequ_FinancingLiabilityToBePaidYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_02cd020b-0afd-419f-97c3-e3b38668cead_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_03fb815a-7b73-487c-b83d-36204e6d7ceb_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3c60cb86-7bb0-499a-8649-b6af1ecf121b_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_1bb71555-c429-4811-9308-78b2cc681965_terseLabel_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Matching contributions by company (as a percent)</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_label_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Employer Matching Percent Of Employee Contribution</link:label>
    <link:label id="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_documentation_en-US" xlink:label="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan employer matching percent of employee contribution.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:to="lab_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_d2301eaa-e641-4acd-8b83-6d8aa9beac25_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term return on plan assets (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_cd3437be-36a9-4c20-980f-6eaa1f617bc8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_afd21e6a-15f7-44f3-847d-0acf82d90026_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_f34ff600-a91f-436c-80fd-5059e9f6a3f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy for Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_6f8b8573-9ba6-478b-90e7-514ac71b0a1e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_7d3fd7e3-3b0c-4fb4-9386-a19492f5ca97_terseLabel_en-US" xlink:label="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for deferred income taxes</link:label>
    <link:label id="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_label_en-US" xlink:label="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense Benefit Net Of Rate Adjustment</link:label>
    <link:label id="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_documentation_en-US" xlink:label="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense benefit net of rate adjustment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:href="kequ-20230430.xsd#kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:to="lab_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_46299380-bc28-404b-a21d-c6f9e9945909_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_8aa2e813-0fe9-49e6-a919-7174b986c6ac_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_333a6698-549e-4d96-b5fb-72da37910a4f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:to="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_148d5c5c-3a6e-43e8-baaa-58f5a0507910_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0291306d-032f-424a-8782-8ba280c77c25_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldInTrust_13c765d6-7bfe-416e-bd8b-386e051ae241_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held in trust account for non-qualified benefit plans included in other assets</link:label>
    <link:label id="lab_us-gaap_AssetsHeldInTrust_label_en-US" xlink:label="lab_us-gaap_AssetsHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-in-trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldInTrust" xlink:to="lab_us-gaap_AssetsHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_20381ba2-1b45-4b64-ab15-ed69ffcb1c0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of&#160;Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_0fec9429-bf1f-477a-94fb-a8f37687a8a6_terseLabel_en-US" xlink:label="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability recognized as revenue percentage</link:label>
    <link:label id="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_label_en-US" xlink:label="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized Percentage</link:label>
    <link:label id="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_documentation_en-US" xlink:label="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability, revenue recognized percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:href="kequ-20230430.xsd#kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:to="lab_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_cccefd8a-48b1-4beb-880b-a2ec5d4a29c2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Large Cap</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US, Large Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_85647031-6043-4d1d-b2f6-2ce11668df9d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, Plan asset percentage</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityAbstract_label_en-US" xlink:label="lab_kequ_FinancingLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability [Abstract]</link:label>
    <link:label id="lab_kequ_FinancingLiabilityAbstract_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAbstract" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityAbstract" xlink:to="lab_kequ_FinancingLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_8cb473f8-16e4-4414-9ab9-79705e8ed4eb_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_02a1125a-eefb-4186-b6f6-799d934b6c40_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_075566d3-8e27-460c-848e-b9bbb5464047_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_48072a80-3639-45e0-a61b-9da713328c13_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_c000954c-3ef4-4094-8d1e-cb04bc3b4b31_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d66d09c3-85c3-49d0-adce-e2c29512eb9c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b7248aa6-4d93-4da7-a6b3-7151061d1216_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_fa77f03a-ecbb-4b00-a291-8c97c157b0a2_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_4972904c-9961-4927-bfbc-c3528c734bf0_verboseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:to="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearOne_f693ffda-1a26-48b4-8fd7-9e4e0890655f_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearOne_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, Year One</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearOne_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearOne" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidYearOne" xlink:to="lab_kequ_FinancingLiabilityToBePaidYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_38e55c06-1581-4898-a806-d2c5dca9609a_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_AuditInformationAbstract_label_en-US" xlink:label="lab_kequ_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_kequ_AuditInformationAbstract_documentation_en-US" xlink:label="lab_kequ_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AuditInformationAbstract" xlink:href="kequ-20230430.xsd#kequ_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_AuditInformationAbstract" xlink:to="lab_kequ_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_SignificantAccountingPoliciesTable_effca2fa-0c37-4f91-bdd2-e6cc7ee255e6_terseLabel_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_kequ_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_kequ_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesTable" xlink:href="kequ-20230430.xsd#kequ_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_SignificantAccountingPoliciesTable" xlink:to="lab_kequ_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_2b2c66d2-ab81-4a2e-a389-d5304a5a0e91_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_2a89ca87-da65-4ad1-b9e0-364e9222b5f8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_00687de5-1368-41d2-a627-35402d98a262_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember_68c825ee-be4a-44e2-b93c-9ded170f7b2e_terseLabel_en-US" xlink:label="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Components</link:label>
    <link:label id="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember_label_en-US" xlink:label="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs), Service Component [Member]</link:label>
    <link:label id="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember_documentation_en-US" xlink:label="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs), Service Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:href="kequ-20230430.xsd#kequ_RestrictedStockUnitsRSUsServiceComponentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:to="lab_kequ_RestrictedStockUnitsRSUsServiceComponentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c3bf775c-3514-4177-b1e4-47e470c64a17_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting for Stock Options and Other Equity Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_e3f30279-e92f-4085-8db5-23f2e239837f_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_d1ff3814-5849-49f2-bbe7-5a84f9247aa0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finance Lease Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_023d72f7-60b1-456d-8501-d946fb6c7707_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8bed945e-b2c9-45cc-b33d-13a52a056fc5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityCurrent_3d2b7242-e2eb-43bd-a5f0-69f39bb36d7e_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of financing liability</link:label>
    <link:label id="lab_kequ_FinancingLiabilityCurrent_label_en-US" xlink:label="lab_kequ_FinancingLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Current</link:label>
    <link:label id="lab_kequ_FinancingLiabilityCurrent_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityCurrent" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityCurrent" xlink:to="lab_kequ_FinancingLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_c6fc61c2-4bdb-4db3-9307-6283390d0ff7_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b8489d06-26a3-4412-a7c1-61ece12b853d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_548f51dd-b928-452e-b992-19d9a493777f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TwoThousandTenAndTwoThousandEightPlanMember_eda71600-0cd7-4d91-a7d9-1cd3a7cc75de_terseLabel_en-US" xlink:label="lab_kequ_TwoThousandTenAndTwoThousandEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 and 2008 Plan</link:label>
    <link:label id="lab_kequ_TwoThousandTenAndTwoThousandEightPlanMember_label_en-US" xlink:label="lab_kequ_TwoThousandTenAndTwoThousandEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Ten And Two Thousand Eight Plan [Member]</link:label>
    <link:label id="lab_kequ_TwoThousandTenAndTwoThousandEightPlanMember_documentation_en-US" xlink:label="lab_kequ_TwoThousandTenAndTwoThousandEightPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand ten and two thousand eight plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandTenAndTwoThousandEightPlanMember" xlink:href="kequ-20230430.xsd#kequ_TwoThousandTenAndTwoThousandEightPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TwoThousandTenAndTwoThousandEightPlanMember" xlink:to="lab_kequ_TwoThousandTenAndTwoThousandEightPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_c79fdb14-2f63-4808-b6f3-0d0c4273feee_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_3e9f30e5-219d-4fc3-a9de-315b65dadead_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_24ef5ea3-6674-4a60-ba4a-d7f0965bb045_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_CreditAgreementMidCapFundingIVTrustMember_5d62582c-446d-445c-9061-11d39f5db3b2_terseLabel_en-US" xlink:label="lab_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement, Mid Cap Funding IV Trust</link:label>
    <link:label id="lab_kequ_CreditAgreementMidCapFundingIVTrustMember_label_en-US" xlink:label="lab_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement, Mid Cap Funding IV Trust [Member]</link:label>
    <link:label id="lab_kequ_CreditAgreementMidCapFundingIVTrustMember_documentation_en-US" xlink:label="lab_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement, Mid Cap Funding IV Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:href="kequ-20230430.xsd#kequ_CreditAgreementMidCapFundingIVTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:to="lab_kequ_CreditAgreementMidCapFundingIVTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KoncepoScientechInternationalMember_9a25486c-de8e-46b9-bb92-5dd11e316a34_terseLabel_en-US" xlink:label="lab_kequ_KoncepoScientechInternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Koncepo Scientech International</link:label>
    <link:label id="lab_kequ_KoncepoScientechInternationalMember_label_en-US" xlink:label="lab_kequ_KoncepoScientechInternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Koncepo Scientech International [Member]</link:label>
    <link:label id="lab_kequ_KoncepoScientechInternationalMember_documentation_en-US" xlink:label="lab_kequ_KoncepoScientechInternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Koncepo Scientech International.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KoncepoScientechInternationalMember" xlink:href="kequ-20230430.xsd#kequ_KoncepoScientechInternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KoncepoScientechInternationalMember" xlink:to="lab_kequ_KoncepoScientechInternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_45151f0b-fd70-4b5e-a13e-62bc371d3d9c_terseLabel_en-US" xlink:label="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_label_en-US" xlink:label="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:label id="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_documentation_en-US" xlink:label="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:href="kequ-20230430.xsd#kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:to="lab_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_4180d948-8e9c-4520-9341-290470912755_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_b0a4c545-3288-4fe2-8a18-486a57339172_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_ae1a7640-4bab-4655-a239-042006aa6cfe_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_7aad61f1-936a-43c1-b150-087ecfd67e68_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_efad3ca9-8800-4199-a307-5ecf5178c202_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6602c033-9b2d-4406-9d61-464d259c7283_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_3db39ddf-302f-4941-89ff-46830f5e989b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_RevenueRecognitionLineItems_e93f5f3b-606d-4b5a-897e-d144ce6ad940_terseLabel_en-US" xlink:label="lab_kequ_RevenueRecognitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Line Items]</link:label>
    <link:label id="lab_kequ_RevenueRecognitionLineItems_label_en-US" xlink:label="lab_kequ_RevenueRecognitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Line Items]</link:label>
    <link:label id="lab_kequ_RevenueRecognitionLineItems_documentation_en-US" xlink:label="lab_kequ_RevenueRecognitionLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionLineItems" xlink:href="kequ-20230430.xsd#kequ_RevenueRecognitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_RevenueRecognitionLineItems" xlink:to="lab_kequ_RevenueRecognitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_515acfbd-6268-440c-a925-e88785878077_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_1fdf2e4c-6c63-46a9-ab3a-68ad10873d8f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (Note 9)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9bf73570-bba2-46ea-9989-bf0e9ab67b1e_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_af9b08e2-96d8-45e6-bdef-c7ada21da332_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_833f3d60-6468-4b64-a606-8985ec177dc5_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of year (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0b435a9a-3dab-4224-84c7-22e0ca6cb4d0_netLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of year (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1088813d-6ed8-44ec-b19d-3af743c55c44_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_ad7be4a1-8e42-4d9e-88a2-1f2cd3f0510a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, Plan asset percentage</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock_5b3d7cab-3273-4e0e-ac68-132971e1a795_terseLabel_en-US" xlink:label="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Plan Assets by Asset Categories</link:label>
    <link:label id="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock_label_en-US" xlink:label="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Plan Assets By Asset Category Table [Text Block]</link:label>
    <link:label id="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock_documentation_en-US" xlink:label="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of additional asset categories and amounts within a category that is useful in understanding the risks associated with each asset category.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:href="kequ-20230430.xsd#kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:to="lab_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TradingSecuritiesMember_fca4076f-8976-46ff-ba48-5f51f56f8e48_terseLabel_en-US" xlink:label="lab_kequ_TradingSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities Held in Non-Qualified Compensation Plans</link:label>
    <link:label id="lab_kequ_TradingSecuritiesMember_label_en-US" xlink:label="lab_kequ_TradingSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities [Member]</link:label>
    <link:label id="lab_kequ_TradingSecuritiesMember_documentation_en-US" xlink:label="lab_kequ_TradingSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TradingSecuritiesMember" xlink:href="kequ-20230430.xsd#kequ_TradingSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TradingSecuritiesMember" xlink:to="lab_kequ_TradingSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_fad50acb-412d-4a46-b198-1640e0a4ebca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNet_831bd780-ed36-40c9-89cd-8822e7bfe46d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets</link:label>
    <link:label id="lab_us-gaap_AssetsNet_label_en-US" xlink:label="lab_us-gaap_AssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNet" xlink:to="lab_us-gaap_AssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e3270db0-e079-41c3-97d6-3728d8aad996_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2abb7b6b-9eba-4309-953c-de41aef3e842_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ced1d526-3f52-46be-8ffa-68c65adce303_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales transferred to customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_7632ba48-79da-4413-b768-03dc9ce28d31_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_41542eae-b77f-40fe-b409-d26525ea23c0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_ba510efd-0d29-48df-a8ad-d939e726b6d3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee's compensation (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityNumberOfRenewalOptions_f1ed0e7b-37b2-4cb7-b7e6-c47715699840_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of renewal options</link:label>
    <link:label id="lab_kequ_FinancingLiabilityNumberOfRenewalOptions_label_en-US" xlink:label="lab_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Number of Renewal Options</link:label>
    <link:label id="lab_kequ_FinancingLiabilityNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Number of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:to="lab_kequ_FinancingLiabilityNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TaxWithholdingExpense_b0d7ff41-a072-46c9-bef5-31c8d641d2f8_terseLabel_en-US" xlink:label="lab_kequ_TaxWithholdingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax withholding expense</link:label>
    <link:label id="lab_kequ_TaxWithholdingExpense_label_en-US" xlink:label="lab_kequ_TaxWithholdingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Withholding Expense</link:label>
    <link:label id="lab_kequ_TaxWithholdingExpense_documentation_en-US" xlink:label="lab_kequ_TaxWithholdingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Withholding Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TaxWithholdingExpense" xlink:href="kequ-20230430.xsd#kequ_TaxWithholdingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TaxWithholdingExpense" xlink:to="lab_kequ_TaxWithholdingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_74fe8e22-dc61-4074-8b14-8f5d5d978bc2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_1ac8b161-255f-452b-b8b6-439a9f17fef7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_93196d8d-b569-42ac-9f62-90cce4e030f0_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_58bc4eef-97df-4dd4-bb9e-92e5012ce6cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod_1434b977-df43-42fd-a318-ab0fae12a2c8_terseLabel_en-US" xlink:label="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign subsidiaries tax returns period (in years)</link:label>
    <link:label id="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod_label_en-US" xlink:label="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign subsidiaries tax returns period</link:label>
    <link:label id="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod_documentation_en-US" xlink:label="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign subsidiaries tax returns period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:href="kequ-20230430.xsd#kequ_ForeignSubsidiariesTaxReturnsPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:to="lab_kequ_ForeignSubsidiariesTaxReturnsPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_d029b6e5-af41-4f99-9de7-88fd7ed247cf_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionAxis" xlink:to="lab_us-gaap_GeographicDistributionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_5e904188-7a1d-4f45-87db-2cec691acabc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_416b147d-7634-4add-b840-94bb0734bb88_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_a75992a0-19cc-47a3-8389-2890d3eb9cf6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a4ad5961-059d-45af-a791-1440bb99c6e2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, weighted average discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_14da55a1-1cdc-4fd1-ad05-dc4ecc833268_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_196dc4e2-0b80-413c-a41c-157eab0b3ca2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8e768b65-07b0-439d-94d8-ac3c8f5ed16c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Projected Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_88130e6d-8f7f-483d-9dfb-689c2879027b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Date, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_5e4eaed9-c508-45c1-9d9a-9f5e8c7eb9eb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_8f16357c-a878-47f0-bcf9-1d368cce077a_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_8282b09f-35b3-4df4-a6f5-e70c1a754a39_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_3cdb83ed-b595-4f11-86a8-145e5f915eee_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0f026797-f400-42aa-89ac-26bdb28d5d70_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_64e53699-b1aa-4821-a223-25618932d6d8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits (state, net of federal benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionExpense_94b66b2f-28a5-4a37-8a79-0625e3c4ce2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension (expense) income</link:label>
    <link:label id="lab_us-gaap_PensionExpense_label_en-US" xlink:label="lab_us-gaap_PensionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Cost (Reversal of Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionExpense" xlink:to="lab_us-gaap_PensionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_438cf6d9-0747-4f52-a653-b541f3e45989_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_472833b9-edf9-455f-b2bf-ed85f86734c2_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsByNatureAxis_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis" xlink:to="lab_us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_e7a1e549-f6c3-4fab-9066-0120275fe3e3_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_039c4fb7-c63e-47df-88ae-03e73459876e_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_82ed07ab-fd8e-4692-902f-3fd0b6a3ee3f_terseLabel_en-US" xlink:label="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_label_en-US" xlink:label="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]</link:label>
    <link:label id="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_documentation_en-US" xlink:label="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:href="kequ-20230430.xsd#kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:to="lab_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_0efd5d2f-7e91-457a-ae2b-2ed94e791efc_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_142a6634-9187-4386-8b57-4a1f1db14e39_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1653c4f9-5e3a-4500-9feb-c9ebcd82d631_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_SecuredOvernightFinancingRateSOFRMember_842ab163-9c07-49b5-b64b-9eef82946a13_terseLabel_en-US" xlink:label="lab_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_kequ_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_kequ_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:href="kequ-20230430.xsd#kequ_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_kequ_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_5f39cd9e-077e-4db5-ab0d-71298af48e35_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_756358dd-1ac1-4b85-a421-24aa6935f315_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Date, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_666fe8b8-d4d4-41f9-96c0-07135015998a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_7f9ce414-21b2-458c-b0c2-e833df2635f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration Date, Period Four</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_659e5ff6-89c0-43fe-8a26-d0466c44e33f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imputed Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a56cec06-94bb-4d30-b6a5-b6348503b823_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_49d3b23e-b118-453e-9112-0f0191eaf096_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_aa778648-633a-4d66-b7d6-c997c9b927bf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale agreement for property</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_33bdf971-2d8f-40e8-aa43-6804443c0910_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Benefit Obligation, April 30</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_0171a494-45a0-44c1-823b-cc80e9b99c48_terseLabel_en-US" xlink:label="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Plan</link:label>
    <link:label id="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_label_en-US" xlink:label="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Omnibus Incentive Plan [Member]</link:label>
    <link:label id="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_documentation_en-US" xlink:label="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand seventeen omnibus incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:href="kequ-20230430.xsd#kequ_TwoThousandSeventeenOmnibusIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:to="lab_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KewauneeLabwayIndiaMember_7b16a72b-c4c4-4d2f-9891-4d815251d28f_terseLabel_en-US" xlink:label="lab_kequ_KewauneeLabwayIndiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Labway India Pvt. Ltd.</link:label>
    <link:label id="lab_kequ_KewauneeLabwayIndiaMember_label_en-US" xlink:label="lab_kequ_KewauneeLabwayIndiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Labway India [Member]</link:label>
    <link:label id="lab_kequ_KewauneeLabwayIndiaMember_documentation_en-US" xlink:label="lab_kequ_KewauneeLabwayIndiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Labway India [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayIndiaMember" xlink:href="kequ-20230430.xsd#kequ_KewauneeLabwayIndiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KewauneeLabwayIndiaMember" xlink:to="lab_kequ_KewauneeLabwayIndiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_32b87cb9-938f-46bc-a893-fb8844c00f04_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_06a8a5c4-1cd5-4209-8b44-53637ff7d3a9_terseLabel_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to provision adjustment</link:label>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_label_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return To Provision Adjustment, Amount</link:label>
    <link:label id="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_documentation_en-US" xlink:label="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Return To Provision Adjustment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:href="kequ-20230430.xsd#kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:to="lab_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_846a7bc4-174e-40e5-bb08-fed9e3a047c7_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of controlling interest in subsidiaries</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6fe28cc4-a579-4f2c-8b3d-b8f34d7039fb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_65060ba3-0227-4ec9-9a97-cd8d6e1886fb_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_4eeb3d4f-64a6-4680-b40d-82ca2bff83af_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_bb7b339b-c785-4ce2-98e7-e2a1ef6501c0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6d5ea8c5-76ac-4018-90f3-80c8174ca86f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_deb1fbe1-7310-4732-9bbd-d56e84a36283_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_1d9b3abe-2527-4ca6-8fae-fc108efd1c46_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:to="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_98fcda28-9aa4-4bfe-bc44-6d5d3c84f6f4_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_ab12e87d-2df0-46dd-ae02-41d46806805b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e0cb484d-967c-4b49-b207-d152e6ff8085_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terms of award (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_0d9fd918-10b0-4433-babf-4712d250bbe8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_112a8970-9ac7-4be1-8d42-f27d7db562bf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_1c3481b2-628f-453d-a72d-8dfbd398e665_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price range lower limit (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1de19230-6ff0-4f1d-8554-b4b2292dbade_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_5644473a-78d6-41d6-a3f4-39a6d548962e_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_DefinedBenefitPlanEmergingMarketsMember_bf62d61f-1f29-4613-aada-77ee509d8b0e_terseLabel_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanEmergingMarketsMember_label_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Emerging Markets [Member]</link:label>
    <link:label id="lab_kequ_DefinedBenefitPlanEmergingMarketsMember_documentation_en-US" xlink:label="lab_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Emerging Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanEmergingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:to="lab_kequ_DefinedBenefitPlanEmergingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_319ef564-e7e2-4e42-a6ae-636df12a9f88_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_eeb7fe88-6ac0-49f6-bd72-b11c813488c4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_2e364cec-0f22-4d8f-a50c-22d8f2850b23_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_06221603-1f5c-4f05-a4c1-a81c13e51fca_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused and available credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_57a3b8a9-bcd6-493c-a19f-d46a59657813_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock_ce751792-903b-4b8d-b86a-f21a991e651f_terseLabel_en-US" xlink:label="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Remaining Future Cash Payments for Financing Liability</link:label>
    <link:label id="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock_label_en-US" xlink:label="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Remaining Future Cash Payments for Financing Liability [Table Text Block]</link:label>
    <link:label id="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock_documentation_en-US" xlink:label="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Remaining Future Cash Payments for Financing Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:href="kequ-20230430.xsd#kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:to="lab_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_f71c1eb7-f7d8-4f94-b35d-06493749fa83_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_7ea38732-cfd3-4270-ba17-086c7a5106ad_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_SignificantAccountingPoliciesLineItems_8ff7bb7f-c607-4388-af45-42983d70bdf6_terseLabel_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_kequ_SignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_kequ_SignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_kequ_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesLineItems" xlink:href="kequ-20230430.xsd#kequ_SignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems" xlink:to="lab_kequ_SignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_e32c09f6-bd41-4c9a-b62a-2a5d0ef9d929_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_e788b8d1-7459-41cf-9a2d-45b3cc066de5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_c6df1de8-9fcd-44e3-9359-de6ebec4f7f5_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f137241b-45fe-4f2d-a957-1c7696073482_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_90897f07-722f-4490-a8b5-f772c33536f0_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c7eb17c7-adcc-463f-a490-ecdf24775e28_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_d8ed93f1-edd0-4304-813c-6e185bb23f1e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9593fc0e-6f89-4ca9-80bc-22ec03c99fe2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_6871f909-7a82-4159-8afc-19bc265c2d2a_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status&#8212;under</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6bf703f0-3ad5-48f7-b1a1-247566749595_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized under stock option plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_85ca6947-9091-406d-8dc3-f812a522f5d2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_c0674e43-d720-4300-b062-0cb67831e524_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_bf9792e6-4d36-4c52-bafe-09eaa3de2583_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_f5204968-5465-4721-910a-ea236151722b_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_AdvancesMember_32dc12fc-5e10-4fc1-8f52-336fafca5481_terseLabel_en-US" xlink:label="lab_kequ_AdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances</link:label>
    <link:label id="lab_kequ_AdvancesMember_label_en-US" xlink:label="lab_kequ_AdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances [Member]</link:label>
    <link:label id="lab_kequ_AdvancesMember_documentation_en-US" xlink:label="lab_kequ_AdvancesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AdvancesMember" xlink:href="kequ-20230430.xsd#kequ_AdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_AdvancesMember" xlink:to="lab_kequ_AdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_287c6e3f-9be5-42a3-894c-5264123da3f2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_6a631f6d-6915-43ee-a7b9-566f4e1eabe0_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_IncomeTaxesTable_8b63ff8a-e272-4fbd-b496-d42db699111f_terseLabel_en-US" xlink:label="lab_kequ_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_kequ_IncomeTaxesTable_label_en-US" xlink:label="lab_kequ_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_kequ_IncomeTaxesTable_documentation_en-US" xlink:label="lab_kequ_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesTable" xlink:href="kequ-20230430.xsd#kequ_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_IncomeTaxesTable" xlink:to="lab_kequ_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_052987a4-0fd6-4fb9-9e48-3a7cec4e039d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_7db4bd9a-1c5c-40ef-a08c-bffe0ce14257_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_11be5e3e-2e7a-4cc1-b37f-aad94126b879_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_6f6e6dcf-498f-4d5a-8fd0-35c751c1b980_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income Tax Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e7ef7cea-6a09-4ed4-801f-8b52a0881287_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_2976d682-0e95-481f-83ec-78d2a0dfccd2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local taxes, net of federal income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d4462b60-4bbc-4079-b4b8-2db8fb32c972_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of stock options and RSUs (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_d41db629-7aa2-46bd-976f-a51693068388_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost for Years Ended April 30</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b53625a7-f9c1-437e-9e3b-6ae4cd3b0555_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_126184b7-1dd6-415a-9a21-daca55230ad9_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Experimentation Expenditures</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentImpairment_a6023eaf-3dd2-4700-864e-4ebdbd70c949_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Impairment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentImpairment_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Impairment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentImpairment" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b6f921ec-8e7c-47e1-bd31-0b36f6d022ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aaf7dba4-792a-48d1-b566-b943939056cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_d2dc487c-3e8e-4a68-b9ba-f57760aa83b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Before Tax Income (Loss) Related Income Tax Effect and Accumulated Balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_2f774251-e8f2-42fd-8b3d-6e27d46f9895_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_e4826f96-a40e-4c13-9958-5c9786ae297e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_076da4f0-062c-49f9-8e5a-1bdebd3132b8_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7ef7cebf-f043-489a-81d0-1ff1812b87cf_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_72156621-22df-4978-b462-259df4dc1a91_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (in dollar per shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_43bb4405-8917-43da-b8d9-215dd6d81f8e_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_1cc46a03-b4c0-41ab-9017-5741e48958ca_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actual loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_cb7bfdbd-132e-4cd3-bb4d-f0281623cfaa_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_c3b466cf-782d-4523-a700-fddac77b9986_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_c0ae0237-9193-4a5c-a15a-b7bd469fdafc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_AdvanceAmountTwoMember_ea93c154-0557-4b98-b48a-6c0952a76c49_terseLabel_en-US" xlink:label="lab_kequ_AdvanceAmountTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Amount Two</link:label>
    <link:label id="lab_kequ_AdvanceAmountTwoMember_label_en-US" xlink:label="lab_kequ_AdvanceAmountTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Amount Two [Member]</link:label>
    <link:label id="lab_kequ_AdvanceAmountTwoMember_documentation_en-US" xlink:label="lab_kequ_AdvanceAmountTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Amount Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AdvanceAmountTwoMember" xlink:href="kequ-20230430.xsd#kequ_AdvanceAmountTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_AdvanceAmountTwoMember" xlink:to="lab_kequ_AdvanceAmountTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3727ee77-7888-46c8-a555-d793677b917e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) at statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_97fc61a5-20b2-40b0-bcf6-5f273a34aa57_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_e8ed3668-5a21-4456-8056-23f534923523_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_605204d0-7fca-4bbb-a95d-c38f3b3cdc8f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_0c868fef-5427-4b0b-9ca4-fea4ab89db50_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_b0f72b90-7843-49af-922b-242a1fe1b74c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_ea1e7167-a903-43d9-9339-a9c89e6d93c1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_3d1776d5-6a10-4535-8291-3f27285f54ac_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments on short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_891ddfcc-35a5-41fb-8012-88959c1be7cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_06c7905a-428c-4d17-a25b-07bcd2226807_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_1cb68a32-b197-40f4-81ca-b7b86a7cdf1a_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of life insurance policies included in other assets</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueOfLifeInsurance_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value of Life Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:to="lab_us-gaap_CashSurrenderValueOfLifeInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_96b6161c-ac1e-4cf5-ab28-6195e99b8115_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imputed Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_0a9b62a2-cfdd-4f0a-b699-90bc44567759_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility_af71d518-07e0-4e64-9e10-43f56aaf5f1e_terseLabel_en-US" xlink:label="lab_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 174 expenditure deduction period</link:label>
    <link:label id="lab_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility_label_en-US" xlink:label="lab_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 174 Research And Experimentation Expenditures, Period Of Deductibility</link:label>
    <link:label id="lab_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility_documentation_en-US" xlink:label="lab_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 174 Research And Experimentation Expenditures, Period Of Deductibility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility" xlink:href="kequ-20230430.xsd#kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility" xlink:to="lab_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod_05f18eea-7caa-4a08-ad60-769704964bc0_terseLabel_en-US" xlink:label="lab_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act, NOL carryback period (in years)</link:label>
    <link:label id="lab_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod_label_en-US" xlink:label="lab_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief And Economic Security Act, Net Operating Loss Carryback, Period</link:label>
    <link:label id="lab_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod_documentation_en-US" xlink:label="lab_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coronavirus Aid, Relief And Economic Security Act, Net Operating Loss Carryback, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod" xlink:href="kequ-20230430.xsd#kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod" xlink:to="lab_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_8c1add2d-0de2-4c4b-b639-148ac0173980_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property plant and equipment impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_85ccc34b-9640-4220-9354-2d1a67650036_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityTermOfContract_d7113d6b-5cf7-4d43-9ded-f99eb5560a74_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of agreement</link:label>
    <link:label id="lab_kequ_FinancingLiabilityTermOfContract_label_en-US" xlink:label="lab_kequ_FinancingLiabilityTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Term of Contract</link:label>
    <link:label id="lab_kequ_FinancingLiabilityTermOfContract_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityTermOfContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTermOfContract" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityTermOfContract" xlink:to="lab_kequ_FinancingLiabilityTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_a0840c5a-be3b-4dff-ae69-82ac45a196f6_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligations, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_6d3624ab-d8c3-4c47-85b9-066e0f57f022_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligations, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_96db9775-26a3-4487-98d7-8b4dcebe5421_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_58d71371-0e22-426f-b424-983c32fa3b0f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic to Diluted Weighted Average Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_69b3ecca-adf0-4d4e-971d-bb45d2b3c56d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at period end</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_KewauneeScientificCorporationSingaporeMember_01448bbb-89ce-4c90-ba55-8085f405b9a3_terseLabel_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationSingaporeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Scientific Corporation Singapore Pte. Ltd.</link:label>
    <link:label id="lab_kequ_KewauneeScientificCorporationSingaporeMember_label_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationSingaporeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Scientific Corporation Singapore [Member]</link:label>
    <link:label id="lab_kequ_KewauneeScientificCorporationSingaporeMember_documentation_en-US" xlink:label="lab_kequ_KewauneeScientificCorporationSingaporeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kewaunee Scientific Corporation Singapore [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationSingaporeMember" xlink:href="kequ-20230430.xsd#kequ_KewauneeScientificCorporationSingaporeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_KewauneeScientificCorporationSingaporeMember" xlink:to="lab_kequ_KewauneeScientificCorporationSingaporeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearThree_6c96bc27-3175-431c-ab0d-1dc96c672e6f_terseLabel_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearThree_label_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, Year Three</link:label>
    <link:label id="lab_kequ_FinancingLiabilityToBePaidYearThree_documentation_en-US" xlink:label="lab_kequ_FinancingLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearThree" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_kequ_FinancingLiabilityToBePaidYearThree" xlink:to="lab_kequ_FinancingLiabilityToBePaidYearThree" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>kequ-20230430_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:e58e8ac3-ecd1-406b-a8f1-c5aecee1e3ad,g:fefb243f-2e84-4dac-80b6-e3a13121b6c2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.kewaunee.com/role/CoverPage" xlink:type="simple" xlink:href="kequ-20230430.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a484e923-5d40-4ad2-a111-25b0d0f9120b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_DocumentType_a484e923-5d40-4ad2-a111-25b0d0f9120b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_12fb9273-6a9f-44f3-939f-e00657c111f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_DocumentAnnualReport_12fb9273-6a9f-44f3-939f-e00657c111f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7670202c-9170-4f3b-a703-5be1e6ea7cd0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_DocumentPeriodEndDate_7670202c-9170-4f3b-a703-5be1e6ea7cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f5bff3f5-672c-479b-a241-928525a4d731" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_CurrentFiscalYearEndDate_f5bff3f5-672c-479b-a241-928525a4d731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_882b0628-c544-4432-a03f-1fec9cd8609b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_DocumentTransitionReport_882b0628-c544-4432-a03f-1fec9cd8609b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3079db8b-70f1-4e60-bc57-b5daa8b089ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityFileNumber_3079db8b-70f1-4e60-bc57-b5daa8b089ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_88ab1ba5-3293-4730-9c80-72156ba55aca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityRegistrantName_88ab1ba5-3293-4730-9c80-72156ba55aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2185a60f-7f07-45f6-95ac-f4f28a475117" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2185a60f-7f07-45f6-95ac-f4f28a475117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_48d24b84-7b9e-42ac-a21b-84a1979a5ac1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityTaxIdentificationNumber_48d24b84-7b9e-42ac-a21b-84a1979a5ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9df61d1f-a904-4626-875a-c7c0e53fabaa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityAddressAddressLine1_9df61d1f-a904-4626-875a-c7c0e53fabaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_844c4b0a-af02-4173-bf71-364b5405d323" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityAddressCityOrTown_844c4b0a-af02-4173-bf71-364b5405d323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8fce9af6-2ab5-468a-ac58-22595d41fb1f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityAddressStateOrProvince_8fce9af6-2ab5-468a-ac58-22595d41fb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d090e2a8-e22b-4bf0-b9f0-9b104fde8549" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityAddressPostalZipCode_d090e2a8-e22b-4bf0-b9f0-9b104fde8549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b8e8da4a-9052-4bf1-a15f-5d84cc0bb144" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_CityAreaCode_b8e8da4a-9052-4bf1-a15f-5d84cc0bb144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_efa8b068-2a22-4d97-a10e-ce40840f25ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_LocalPhoneNumber_efa8b068-2a22-4d97-a10e-ce40840f25ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_eae7502b-b07f-4586-b754-0de5c8add226" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_Security12bTitle_eae7502b-b07f-4586-b754-0de5c8add226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b612be71-61a9-444a-9a7d-d3f33058dadb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_TradingSymbol_b612be71-61a9-444a-9a7d-d3f33058dadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9cc44df0-51f6-47e6-9215-0b2faf0624e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_SecurityExchangeName_9cc44df0-51f6-47e6-9215-0b2faf0624e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_e026b7bc-8a4d-48eb-a63c-a0110f396d2e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_e026b7bc-8a4d-48eb-a63c-a0110f396d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_a257060a-834c-42f0-8e2b-c21eafe2e540" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityVoluntaryFilers_a257060a-834c-42f0-8e2b-c21eafe2e540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_423ebdbe-6578-4890-8b2a-9afb8f5756e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityCurrentReportingStatus_423ebdbe-6578-4890-8b2a-9afb8f5756e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_0f461fe9-15d0-4e5d-8f9c-a3bc5e943d57" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityInteractiveDataCurrent_0f461fe9-15d0-4e5d-8f9c-a3bc5e943d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_04b2151c-55be-4614-92df-ac8e4dbeb03d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityFilerCategory_04b2151c-55be-4614-92df-ac8e4dbeb03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_7de8a50a-50fe-46c3-85f0-56d4aaa15c28" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntitySmallBusiness_7de8a50a-50fe-46c3-85f0-56d4aaa15c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_2daa55b1-aeb4-4d5b-b4d4-6f7a64b28ea5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityEmergingGrowthCompany_2daa55b1-aeb4-4d5b-b4d4-6f7a64b28ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_78fc2779-50c8-484e-b975-d03f64ea3159" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_IcfrAuditorAttestationFlag_78fc2779-50c8-484e-b975-d03f64ea3159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ec25a05b-f799-4ad1-a948-1775eb82e268" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityShellCompany_ec25a05b-f799-4ad1-a948-1775eb82e268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_b52b2b8d-293c-415d-bc89-3190f665253d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityPublicFloat_b52b2b8d-293c-415d-bc89-3190f665253d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b8d52409-7698-4db0-9352-ec681b79e5c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b8d52409-7698-4db0-9352-ec681b79e5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d4020c2a-6305-4620-9350-7e993cf6ee43" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d4020c2a-6305-4620-9350-7e993cf6ee43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a5e60a43-84f0-4844-be9a-edb07d29f708" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_AmendmentFlag_a5e60a43-84f0-4844-be9a-edb07d29f708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_21042547-7474-4e0a-a653-75960e7dc96d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_DocumentFiscalYearFocus_21042547-7474-4e0a-a653-75960e7dc96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_fedfe8bd-764e-4593-9cf3-eb090d6d633c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_DocumentFiscalPeriodFocus_fedfe8bd-764e-4593-9cf3-eb090d6d633c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_bb3eb388-67a2-4a71-9816-5cc43e72b566" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ec712e6b-98e6-4239-a75c-e221646838be" xlink:to="loc_dei_EntityCentralIndexKey_bb3eb388-67a2-4a71-9816-5cc43e72b566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/AuditInformation" xlink:type="simple" xlink:href="kequ-20230430.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AuditInformationAbstract_06585d6f-df54-4887-ac5c-c20984f7629f" xlink:href="kequ-20230430.xsd#kequ_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_cfdc0822-2b1d-4a50-8089-caf7f7f4bf04" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_AuditInformationAbstract_06585d6f-df54-4887-ac5c-c20984f7629f" xlink:to="loc_dei_AuditorName_cfdc0822-2b1d-4a50-8089-caf7f7f4bf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_0365d19b-6d7b-4a2b-b788-ad7f23ba5ae3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_AuditInformationAbstract_06585d6f-df54-4887-ac5c-c20984f7629f" xlink:to="loc_dei_AuditorLocation_0365d19b-6d7b-4a2b-b788-ad7f23ba5ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_63721652-2962-46d9-ada2-d0792bec0471" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_AuditInformationAbstract_06585d6f-df54-4887-ac5c-c20984f7629f" xlink:to="loc_dei_AuditorFirmId_63721652-2962-46d9-ada2-d0792bec0471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_742b9df2-ef73-40c7-900c-20acc7f88a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_742b9df2-ef73-40c7-900c-20acc7f88a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_36717c8e-c342-4246-8017-540db8412d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_36717c8e-c342-4246-8017-540db8412d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_40eacc5c-1587-4a21-bff8-4427648d4a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_GrossProfit_40eacc5c-1587-4a21-bff8-4427648d4a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b1b15ca0-cebe-496f-9e46-38ecca71c6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_OperatingExpenses_b1b15ca0-cebe-496f-9e46-38ecca71c6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_123d3655-ce38-4ab2-bf4d-5d1e3e146c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_OperatingIncomeLoss_123d3655-ce38-4ab2-bf4d-5d1e3e146c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionExpense_5dbdcafe-abda-4b77-a36e-35a64d086eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_PensionExpense_5dbdcafe-abda-4b77-a36e-35a64d086eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_e2771a7c-cadb-43b2-ad8d-6f723527ed97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_OtherIncome_e2771a7c-cadb-43b2-ad8d-6f723527ed97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e55462d2-0d15-4d49-8c84-091e60c44c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_InterestExpense_e55462d2-0d15-4d49-8c84-091e60c44c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_40d8ec7b-539e-406b-89e8-4aff9112da7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_40d8ec7b-539e-406b-89e8-4aff9112da7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6c5e890e-ca12-4c0e-97ec-1f1f1b32930c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6c5e890e-ca12-4c0e-97ec-1f1f1b32930c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_334eb22f-1edf-42f3-9add-a5d914c7710f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_ProfitLoss_334eb22f-1edf-42f3-9add-a5d914c7710f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1d0d7543-2b99-4689-8e1e-76fd8192879d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1d0d7543-2b99-4689-8e1e-76fd8192879d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d5b36fe6-6696-43e5-8d62-68119d27e2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_NetIncomeLoss_d5b36fe6-6696-43e5-8d62-68119d27e2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_493568c3-108b-40f1-ad8f-92414c51a75b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_EarningsPerShareAbstract_493568c3-108b-40f1-ad8f-92414c51a75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_efeafaf6-2a7a-4803-9515-ed728fd93789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_493568c3-108b-40f1-ad8f-92414c51a75b" xlink:to="loc_us-gaap_EarningsPerShareBasic_efeafaf6-2a7a-4803-9515-ed728fd93789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0bb8d994-2fb2-4a15-8e5f-e3b5ac92095f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_493568c3-108b-40f1-ad8f-92414c51a75b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0bb8d994-2fb2-4a15-8e5f-e3b5ac92095f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1a585ca6-73e7-4383-b29c-7537d3038439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226cf933-d320-437d-ab2a-40f79949f9d8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1a585ca6-73e7-4383-b29c-7537d3038439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e661da3d-7863-4f20-803f-5f94417eecd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1a585ca6-73e7-4383-b29c-7537d3038439" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e661da3d-7863-4f20-803f-5f94417eecd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_22dfe830-6adc-475b-8fd0-4951f6b2b2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1a585ca6-73e7-4383-b29c-7537d3038439" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_22dfe830-6adc-475b-8fd0-4951f6b2b2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_638b8a67-b2a4-4fa8-8c37-9c0b29fc129f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e7e6cb29-094b-4949-8c35-2ac158a0af27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_638b8a67-b2a4-4fa8-8c37-9c0b29fc129f" xlink:to="loc_us-gaap_ProfitLoss_e7e6cb29-094b-4949-8c35-2ac158a0af27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0d109148-7eb1-40d4-a0d5-6ab46221687e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_638b8a67-b2a4-4fa8-8c37-9c0b29fc129f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0d109148-7eb1-40d4-a0d5-6ab46221687e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6118db13-06f3-41ee-bca5-e2a36a8ac7af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0d109148-7eb1-40d4-a0d5-6ab46221687e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_6118db13-06f3-41ee-bca5-e2a36a8ac7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_e7110a91-4659-40d5-927f-62e1daae1ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0d109148-7eb1-40d4-a0d5-6ab46221687e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_e7110a91-4659-40d5-927f-62e1daae1ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_01e5fbf1-85e7-40b5-8a6a-e865a348ff08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_638b8a67-b2a4-4fa8-8c37-9c0b29fc129f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_01e5fbf1-85e7-40b5-8a6a-e865a348ff08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6d48cdbf-728d-4ead-9a66-fa595baf1662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_638b8a67-b2a4-4fa8-8c37-9c0b29fc129f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6d48cdbf-728d-4ead-9a66-fa595baf1662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_998c80a3-b213-40cd-bb59-3532ccc99c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_638b8a67-b2a4-4fa8-8c37-9c0b29fc129f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_998c80a3-b213-40cd-bb59-3532ccc99c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedStatementofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6d1ad97e-b026-4129-bf11-507199f82a17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bd725a10-0bd5-4767-93eb-dc9cd0a81182" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6d1ad97e-b026-4129-bf11-507199f82a17" xlink:to="loc_us-gaap_StatementTable_bd725a10-0bd5-4767-93eb-dc9cd0a81182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_25c3ff1f-0768-4e03-9fa8-40eafedf658c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bd725a10-0bd5-4767-93eb-dc9cd0a81182" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_25c3ff1f-0768-4e03-9fa8-40eafedf658c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25c3ff1f-0768-4e03-9fa8-40eafedf658c" xlink:to="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3e4c2015-3304-447a-b93e-dfa66d4b05dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:to="loc_us-gaap_CommonStockMember_3e4c2015-3304-447a-b93e-dfa66d4b05dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d41638fc-7794-4d91-bc8a-f288d086a669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d41638fc-7794-4d91-bc8a-f288d086a669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_1913b75f-c8cc-4286-9d02-d4af068d067b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:to="loc_us-gaap_TreasuryStockCommonMember_1913b75f-c8cc-4286-9d02-d4af068d067b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b5416cea-94b7-4ae0-b8e3-64e43f4ff59c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:to="loc_us-gaap_RetainedEarningsMember_b5416cea-94b7-4ae0-b8e3-64e43f4ff59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4097f0c5-9143-4fbd-8ed9-c775a3ba21b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_feb744f7-617e-4f49-84e3-c326245eb007" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4097f0c5-9143-4fbd-8ed9-c775a3ba21b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5395fee2-4e8f-4776-9f4f-e134ceec595a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bd725a10-0bd5-4767-93eb-dc9cd0a81182" xlink:to="loc_us-gaap_StatementLineItems_5395fee2-4e8f-4776-9f4f-e134ceec595a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5395fee2-4e8f-4776-9f4f-e134ceec595a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0a3fff1f-ccb1-4da5-b4b6-2852e2a5c3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:to="loc_us-gaap_StockholdersEquity_0a3fff1f-ccb1-4da5-b4b6-2852e2a5c3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ff402fa9-2f30-4a11-8f4a-11231737ca3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:to="loc_us-gaap_NetIncomeLoss_ff402fa9-2f30-4a11-8f4a-11231737ca3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d961946-d2b3-4cc4-94a7-428bac5096d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d961946-d2b3-4cc4-94a7-428bac5096d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_06a48777-f2ae-4dec-81d8-9dd0892d14bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_06a48777-f2ae-4dec-81d8-9dd0892d14bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_596ee686-a8d7-4c4d-9b59-998bbb917602" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f5ec9832-1024-40f5-9212-0264a8e3a846" xlink:to="loc_us-gaap_StockholdersEquity_596ee686-a8d7-4c4d-9b59-998bbb917602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f36773b3-67f5-4119-8b45-07b6bbc536e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_da1ec285-36cf-4f7c-8ddf-8162208f9c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f36773b3-67f5-4119-8b45-07b6bbc536e0" xlink:to="loc_us-gaap_AssetsAbstract_da1ec285-36cf-4f7c-8ddf-8162208f9c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f984bfcf-a8bf-4c38-b632-f2a932d7a717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_da1ec285-36cf-4f7c-8ddf-8162208f9c54" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f984bfcf-a8bf-4c38-b632-f2a932d7a717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_19d40c39-487d-44ea-a117-c2ed1d641544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f984bfcf-a8bf-4c38-b632-f2a932d7a717" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_19d40c39-487d-44ea-a117-c2ed1d641544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_894e011a-a12b-4032-95e4-d31c0e4b1c94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f984bfcf-a8bf-4c38-b632-f2a932d7a717" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_894e011a-a12b-4032-95e4-d31c0e4b1c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b65ac0bd-9fe5-4eab-8e46-0196e06e2967" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f984bfcf-a8bf-4c38-b632-f2a932d7a717" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b65ac0bd-9fe5-4eab-8e46-0196e06e2967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cd469290-7130-4335-925b-18620092bc28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f984bfcf-a8bf-4c38-b632-f2a932d7a717" xlink:to="loc_us-gaap_InventoryNet_cd469290-7130-4335-925b-18620092bc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_859fb99b-945a-41a1-b7d9-406c5854c01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f984bfcf-a8bf-4c38-b632-f2a932d7a717" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_859fb99b-945a-41a1-b7d9-406c5854c01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7aaf195d-e1c8-4293-9564-fa5fd9aca071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f984bfcf-a8bf-4c38-b632-f2a932d7a717" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7aaf195d-e1c8-4293-9564-fa5fd9aca071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_dac68434-cc13-49fa-841d-0949e42e20f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f984bfcf-a8bf-4c38-b632-f2a932d7a717" xlink:to="loc_us-gaap_AssetsCurrent_dac68434-cc13-49fa-841d-0949e42e20f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_58e75e2e-4a85-4e5c-85b9-42b4f5e7511b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_da1ec285-36cf-4f7c-8ddf-8162208f9c54" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_58e75e2e-4a85-4e5c-85b9-42b4f5e7511b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_89919b69-69c4-4309-93de-64bf96090a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_da1ec285-36cf-4f7c-8ddf-8162208f9c54" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_89919b69-69c4-4309-93de-64bf96090a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5c7a1dc0-771c-40d7-9f8b-546f3ea3ab12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_da1ec285-36cf-4f7c-8ddf-8162208f9c54" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5c7a1dc0-771c-40d7-9f8b-546f3ea3ab12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8266b0a4-3223-4fb0-a5a4-392d21040e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_da1ec285-36cf-4f7c-8ddf-8162208f9c54" xlink:to="loc_us-gaap_Assets_8266b0a4-3223-4fb0-a5a4-392d21040e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f36773b3-67f5-4119-8b45-07b6bbc536e0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_0861b582-8b19-446f-b7b6-9286e5b7190c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:to="loc_us-gaap_ShortTermBorrowings_0861b582-8b19-446f-b7b6-9286e5b7190c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityCurrent_0ec097dd-6de9-46e7-9969-77423b337505" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:to="loc_kequ_FinancingLiabilityCurrent_0ec097dd-6de9-46e7-9969-77423b337505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c1755b0f-bcb1-4a8f-be9e-b0f2f21dae90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c1755b0f-bcb1-4a8f-be9e-b0f2f21dae90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b22eb19a-c643-499a-bd73-5f69f1289e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b22eb19a-c643-499a-bd73-5f69f1289e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_db894fc1-c697-4b87-96f0-105540029b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:to="loc_us-gaap_AccountsPayableCurrent_db894fc1-c697-4b87-96f0-105540029b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ec0e431e-aac6-4075-a545-74f4e078d616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ec0e431e-aac6-4075-a545-74f4e078d616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_dce207f7-f1d7-4fc8-a2f8-fe04c831de1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_dce207f7-f1d7-4fc8-a2f8-fe04c831de1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7fbf0671-67ff-454d-b56b-e6e8dcb11f07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7fbf0671-67ff-454d-b56b-e6e8dcb11f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e3e3fcf2-9834-4ad8-941a-94ce9bff3a30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fcf82534-af78-472b-a6fe-128543ef6f1c" xlink:to="loc_us-gaap_LiabilitiesCurrent_e3e3fcf2-9834-4ad8-941a-94ce9bff3a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNoncurrent_5396a383-295a-4052-97da-359d181ab569" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_kequ_FinancingLiabilityNoncurrent_5396a383-295a-4052-97da-359d181ab569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_e2589fff-872d-4d7a-b8af-db4cdba39c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_e2589fff-872d-4d7a-b8af-db4cdba39c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e5c8f47b-4563-427b-8b54-9b9da9841aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e5c8f47b-4563-427b-8b54-9b9da9841aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AccruedEmployeeBenefitPlanCosts_47ad69ac-3633-4e28-a955-27929780f3cb" xlink:href="kequ-20230430.xsd#kequ_AccruedEmployeeBenefitPlanCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_kequ_AccruedEmployeeBenefitPlanCosts_47ad69ac-3633-4e28-a955-27929780f3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_286c8d19-b9c7-44df-87b8-3a040f613e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_286c8d19-b9c7-44df-87b8-3a040f613e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2e6154fa-ae83-47fc-88f3-247eec6b6d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2e6154fa-ae83-47fc-88f3-247eec6b6d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_409a58f2-18ac-44f9-9e13-69ce6f5cda35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_us-gaap_Liabilities_409a58f2-18ac-44f9-9e13-69ce6f5cda35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_bb5b949f-37d2-485f-885c-49bac4b0d422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_us-gaap_CommitmentsAndContingencies_bb5b949f-37d2-485f-885c-49bac4b0d422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_175dc551-64d6-4c95-8b48-2532f1553e75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_175dc551-64d6-4c95-8b48-2532f1553e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0a015df8-67e3-4824-a097-6c9dba6d21b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_175dc551-64d6-4c95-8b48-2532f1553e75" xlink:to="loc_us-gaap_CommonStockValue_0a015df8-67e3-4824-a097-6c9dba6d21b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_40f0ab80-f612-40be-bf03-d698ce473554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_175dc551-64d6-4c95-8b48-2532f1553e75" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_40f0ab80-f612-40be-bf03-d698ce473554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d59a577d-11a3-446f-a32e-ca61e9bd6ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_175dc551-64d6-4c95-8b48-2532f1553e75" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d59a577d-11a3-446f-a32e-ca61e9bd6ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9288c510-4502-468b-906c-d4cf05f0aab0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_175dc551-64d6-4c95-8b48-2532f1553e75" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9288c510-4502-468b-906c-d4cf05f0aab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_2d0cad79-7f7a-431e-8242-2970cbca6b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_175dc551-64d6-4c95-8b48-2532f1553e75" xlink:to="loc_us-gaap_TreasuryStockValue_2d0cad79-7f7a-431e-8242-2970cbca6b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_78969a33-c180-48e7-bd7f-356ec2cc9bca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_175dc551-64d6-4c95-8b48-2532f1553e75" xlink:to="loc_us-gaap_StockholdersEquity_78969a33-c180-48e7-bd7f-356ec2cc9bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_efc04d46-4d94-4680-a744-9e582c28d219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_175dc551-64d6-4c95-8b48-2532f1553e75" xlink:to="loc_us-gaap_MinorityInterest_efc04d46-4d94-4680-a744-9e582c28d219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8d4f0f47-ae65-46f9-a8b0-6dde13208fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_175dc551-64d6-4c95-8b48-2532f1553e75" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8d4f0f47-ae65-46f9-a8b0-6dde13208fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f51b4a51-64f7-4a3c-bc7f-ba3836e3f751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c58d7004-9f5b-4410-bead-009e69f16853" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_f51b4a51-64f7-4a3c-bc7f-ba3836e3f751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6b37bcca-d911-4c86-97fe-8fbf3fa587a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3f553676-ba17-45e8-9e4b-dfffa9f72dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6b37bcca-d911-4c86-97fe-8fbf3fa587a9" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3f553676-ba17-45e8-9e4b-dfffa9f72dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9beb3c7b-3baa-4b33-91b2-beec380477a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6b37bcca-d911-4c86-97fe-8fbf3fa587a9" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9beb3c7b-3baa-4b33-91b2-beec380477a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2e6d78c5-9398-4809-bd39-721b17e8a64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6b37bcca-d911-4c86-97fe-8fbf3fa587a9" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2e6d78c5-9398-4809-bd39-721b17e8a64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_325422b3-010c-4ac7-9a21-b13f44f64f78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6b37bcca-d911-4c86-97fe-8fbf3fa587a9" xlink:to="loc_us-gaap_CommonStockSharesIssued_325422b3-010c-4ac7-9a21-b13f44f64f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_875c9f5d-32f4-47c7-b97d-6d1a0333c641" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6b37bcca-d911-4c86-97fe-8fbf3fa587a9" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_875c9f5d-32f4-47c7-b97d-6d1a0333c641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_1094caf3-4212-4fec-90f9-29a861703430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6b37bcca-d911-4c86-97fe-8fbf3fa587a9" xlink:to="loc_us-gaap_TreasuryStockCommonShares_1094caf3-4212-4fec-90f9-29a861703430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="kequ-20230430.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_183db70d-1dce-4b1a-bf8e-e347929e707b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40c17d79-d0a9-4f38-ab19-d432e3e288ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_183db70d-1dce-4b1a-bf8e-e347929e707b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40c17d79-d0a9-4f38-ab19-d432e3e288ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0111feae-12ea-400f-b2a3-38c74afc3cba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40c17d79-d0a9-4f38-ab19-d432e3e288ff" xlink:to="loc_us-gaap_ProfitLoss_0111feae-12ea-400f-b2a3-38c74afc3cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ec8a03ef-5d6d-4756-adf5-06ff2c9d16be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40c17d79-d0a9-4f38-ab19-d432e3e288ff" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ec8a03ef-5d6d-4756-adf5-06ff2c9d16be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_71368e0f-3fbe-45e6-9fc1-a7655c198599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ec8a03ef-5d6d-4756-adf5-06ff2c9d16be" xlink:to="loc_us-gaap_Depreciation_71368e0f-3fbe-45e6-9fc1-a7655c198599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_ea93c851-b006-4be0-a28e-2d726eda7104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ec8a03ef-5d6d-4756-adf5-06ff2c9d16be" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_ea93c851-b006-4be0-a28e-2d726eda7104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_268fbcf3-c698-4599-9395-7c74da2420c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ec8a03ef-5d6d-4756-adf5-06ff2c9d16be" xlink:to="loc_us-gaap_ShareBasedCompensation_268fbcf3-c698-4599-9395-7c74da2420c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_9966a557-09b6-4ffb-8577-c3fa6ec57d99" xlink:href="kequ-20230430.xsd#kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ec8a03ef-5d6d-4756-adf5-06ff2c9d16be" xlink:to="loc_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment_9966a557-09b6-4ffb-8577-c3fa6ec57d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4002bb3f-c378-47ff-ae16-b77eb0e77a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40c17d79-d0a9-4f38-ab19-d432e3e288ff" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4002bb3f-c378-47ff-ae16-b77eb0e77a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_927b9475-5924-42f7-bd08-d7b5aeec7939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4002bb3f-c378-47ff-ae16-b77eb0e77a35" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_927b9475-5924-42f7-bd08-d7b5aeec7939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_28ba6f98-6d60-43f6-86dd-081176451a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4002bb3f-c378-47ff-ae16-b77eb0e77a35" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_28ba6f98-6d60-43f6-86dd-081176451a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_8f88e784-944a-4a01-b865-9e77c55fb5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4002bb3f-c378-47ff-ae16-b77eb0e77a35" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_8f88e784-944a-4a01-b865-9e77c55fb5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d72493cb-41ea-4960-8606-cbaddc81fd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4002bb3f-c378-47ff-ae16-b77eb0e77a35" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d72493cb-41ea-4960-8606-cbaddc81fd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_ff58dd51-99ee-4826-9efc-56e66cc2c3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4002bb3f-c378-47ff-ae16-b77eb0e77a35" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_ff58dd51-99ee-4826-9efc-56e66cc2c3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_7c2957eb-62cb-4e00-94c1-89eea5aa56ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4002bb3f-c378-47ff-ae16-b77eb0e77a35" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_7c2957eb-62cb-4e00-94c1-89eea5aa56ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_080d5a26-7755-443d-97d3-86af2161d758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_40c17d79-d0a9-4f38-ab19-d432e3e288ff" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_080d5a26-7755-443d-97d3-86af2161d758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_32726264-86e9-4cba-8829-3e9b5d63ec55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_183db70d-1dce-4b1a-bf8e-e347929e707b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_32726264-86e9-4cba-8829-3e9b5d63ec55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_d5fa2678-5270-4de8-8788-654a8fa0570e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_32726264-86e9-4cba-8829-3e9b5d63ec55" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_d5fa2678-5270-4de8-8788-654a8fa0570e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6facca48-1a7d-4cf0-b7c5-1e750833c9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_32726264-86e9-4cba-8829-3e9b5d63ec55" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6facca48-1a7d-4cf0-b7c5-1e750833c9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a4964c6-024f-4566-ba99-0cbd91fe60d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_183db70d-1dce-4b1a-bf8e-e347929e707b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a4964c6-024f-4566-ba99-0cbd91fe60d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_ce3a91f6-66f0-4667-aa30-45b391e470dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a4964c6-024f-4566-ba99-0cbd91fe60d5" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_ce3a91f6-66f0-4667-aa30-45b391e470dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_ee5c60d3-e74b-42a4-802e-ef0b18064d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a4964c6-024f-4566-ba99-0cbd91fe60d5" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_ee5c60d3-e74b-42a4-802e-ef0b18064d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ProceedsFromFinancingLiability_1f6bd1ac-138b-4e98-b745-c9fdb4427fe2" xlink:href="kequ-20230430.xsd#kequ_ProceedsFromFinancingLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a4964c6-024f-4566-ba99-0cbd91fe60d5" xlink:to="loc_kequ_ProceedsFromFinancingLiability_1f6bd1ac-138b-4e98-b745-c9fdb4427fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_PaymentsOnFinancingLiability_b675fa6a-d782-4e9e-9f3f-30edd365a9c0" xlink:href="kequ-20230430.xsd#kequ_PaymentsOnFinancingLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a4964c6-024f-4566-ba99-0cbd91fe60d5" xlink:to="loc_kequ_PaymentsOnFinancingLiability_b675fa6a-d782-4e9e-9f3f-30edd365a9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_34d84142-769b-4aec-8ffb-186c2b069159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a4964c6-024f-4566-ba99-0cbd91fe60d5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_34d84142-769b-4aec-8ffb-186c2b069159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_35fc8239-f311-40d8-8f31-989e86b0379e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a4964c6-024f-4566-ba99-0cbd91fe60d5" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_35fc8239-f311-40d8-8f31-989e86b0379e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5c1a7c9-9d2f-4711-8a8e-f85981b9d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a4964c6-024f-4566-ba99-0cbd91fe60d5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e5c1a7c9-9d2f-4711-8a8e-f85981b9d7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3f5f8a84-131a-4cb8-8c89-d252275822b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_183db70d-1dce-4b1a-bf8e-e347929e707b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3f5f8a84-131a-4cb8-8c89-d252275822b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c5dedcd4-c434-42be-8501-caf2c2037334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_183db70d-1dce-4b1a-bf8e-e347929e707b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c5dedcd4-c434-42be-8501-caf2c2037334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6100113c-ccc5-49e9-bff8-ad1093353c16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_183db70d-1dce-4b1a-bf8e-e347929e707b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6100113c-ccc5-49e9-bff8-ad1093353c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a74bcea-1f84-459a-afe4-a597007d9dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_183db70d-1dce-4b1a-bf8e-e347929e707b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a74bcea-1f84-459a-afe4-a597007d9dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_747a4869-01d1-4e98-a925-349e475bc8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_183db70d-1dce-4b1a-bf8e-e347929e707b" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_747a4869-01d1-4e98-a925-349e475bc8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_593533ed-8a58-4fb0-b66a-3855df59fa38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_747a4869-01d1-4e98-a925-349e475bc8c0" xlink:to="loc_us-gaap_InterestPaidNet_593533ed-8a58-4fb0-b66a-3855df59fa38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_9b214d6d-7b01-430b-b6bb-292eafdfdfe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_747a4869-01d1-4e98-a925-349e475bc8c0" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_9b214d6d-7b01-430b-b6bb-292eafdfdfe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability_fce5ddd8-dab8-4278-b38f-f40af65f3164" xlink:href="kequ-20230430.xsd#kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_747a4869-01d1-4e98-a925-349e475bc8c0" xlink:to="loc_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability_fce5ddd8-dab8-4278-b38f-f40af65f3164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_48e68b54-4f44-4467-b245-f189848a1322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_b71dc127-2ffe-4ec1-9cab-3477cb949dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_48e68b54-4f44-4467-b245-f189848a1322" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_b71dc127-2ffe-4ec1-9cab-3477cb949dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognition" xlink:type="simple" xlink:href="kequ-20230430.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a7277227-a10e-4131-9331-2941afb8050d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_e64c5808-4e3f-4b84-8930-941e968cf7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a7277227-a10e-4131-9331-2941afb8050d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_e64c5808-4e3f-4b84-8930-941e968cf7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/Inventories" xlink:type="simple" xlink:href="kequ-20230430.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_cc268c37-c433-4b05-bf2e-14b9fe24d14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_8299651f-e301-460e-a467-d1cde2928eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_cc268c37-c433-4b05-bf2e-14b9fe24d14f" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_8299651f-e301-460e-a467-d1cde2928eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements" xlink:type="simple" xlink:href="kequ-20230430.xsd#LongtermDebtandOtherCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a7c1df1e-4212-4c45-8101-ff3df5c3b883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_fc529d49-66dd-4cce-865b-55b4ec7220f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a7c1df1e-4212-4c45-8101-ff3df5c3b883" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_fc529d49-66dd-4cce-865b-55b4ec7220f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction" xlink:type="simple" xlink:href="kequ-20230430.xsd#SaleLeasebackFinancingTransaction"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAbstract_76a153f3-1ec1-4650-be7c-d9e00ac299d4" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionDisclosureTextBlock_a68f67af-cfd6-4145-a3ca-bb42b053362f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleLeasebackTransactionDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_76a153f3-1ec1-4650-be7c-d9e00ac299d4" xlink:to="loc_us-gaap_SaleLeasebackTransactionDisclosureTextBlock_a68f67af-cfd6-4145-a3ca-bb42b053362f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxes" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a94d76ff-f8de-49a7-82e6-99fe844f62ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_053d4dc6-2d6e-4880-b387-14029c301bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a94d76ff-f8de-49a7-82e6-99fe844f62ef" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_053d4dc6-2d6e-4880-b387-14029c301bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation" xlink:type="simple" xlink:href="kequ-20230430.xsd#StockOptionsandShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a702f0d9-11d3-4a8a-9d85-cddcb4ce0058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_e6feae3a-abc5-43d2-8baf-cdbb341b3ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a702f0d9-11d3-4a8a-9d85-cddcb4ce0058" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_e6feae3a-abc5-43d2-8baf-cdbb341b3ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="kequ-20230430.xsd#AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9732e2eb-480f-458f-aea1-15f585819ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a7bc0c99-9d50-4c83-ad6a-fca52e722794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9732e2eb-480f-458f-aea1-15f585819ef4" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a7bc0c99-9d50-4c83-ad6a-fca52e722794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingencies" xlink:type="simple" xlink:href="kequ-20230430.xsd#LeasesCommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0ff793df-ea7b-46e3-862b-8e9d256d840f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_39a7aad6-b59a-48d2-b8cd-5735c8a948d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0ff793df-ea7b-46e3-862b-8e9d256d840f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_39a7aad6-b59a-48d2-b8cd-5735c8a948d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefits" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefits"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce3bfad1-42e2-4cf9-9875-69f8b4df6db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5df3692e-7541-4120-96c0-3e82c25366b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ce3bfad1-42e2-4cf9-9875-69f8b4df6db1" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_5df3692e-7541-4120-96c0-3e82c25366b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SegmentInformation" xlink:type="simple" xlink:href="kequ-20230430.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6cca0666-f672-4f25-b9cb-707ef73b32aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_250ba55f-2287-4ff7-ad0d-8f01b425cdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6cca0666-f672-4f25-b9cb-707ef73b32aa" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_250ba55f-2287-4ff7-ad0d-8f01b425cdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RestructuringCosts" xlink:type="simple" xlink:href="kequ-20230430.xsd#RestructuringCosts"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RestructuringCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5d20fa9b-5f0a-4ec7-9c43-a97135dd7bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_686d63b4-a53b-4da8-80f2-ed3b19408136" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5d20fa9b-5f0a-4ec7-9c43-a97135dd7bbb" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_686d63b4-a53b-4da8-80f2-ed3b19408136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_b3fffd16-93d0-441b-80e4-fc73393dd740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_b3fffd16-93d0-441b-80e4-fc73393dd740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f39e794c-e855-42a3-8553-aa67ff70c9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f39e794c-e855-42a3-8553-aa67ff70c9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_abacdfad-440d-4dfa-96fd-435d19da25f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_abacdfad-440d-4dfa-96fd-435d19da25f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_4570c2f6-5ea8-4ea3-b4ce-599507bb712a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_4570c2f6-5ea8-4ea3-b4ce-599507bb712a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_bc200373-f09e-4d60-8229-0d3ad6f2dcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy_bc200373-f09e-4d60-8229-0d3ad6f2dcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_b799e8d4-1e89-4b46-9b77-d79927a1c903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_b799e8d4-1e89-4b46-9b77-d79927a1c903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_cc9496f7-0dfb-4544-8307-175f724355b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_cc9496f7-0dfb-4544-8307-175f724355b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentImpairment_4690b856-531c-4aaa-9782-aaf3ef387a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentImpairment_4690b856-531c-4aaa-9782-aaf3ef387a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_OtherAssetsPolicyTextBlock_826e2ce6-f49e-4446-99db-7a944af16ba4" xlink:href="kequ-20230430.xsd#kequ_OtherAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_kequ_OtherAssetsPolicyTextBlock_826e2ce6-f49e-4446-99db-7a944af16ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_3980a654-0d25-40f3-91bd-b2daf7fd1806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_UseOfEstimates_3980a654-0d25-40f3-91bd-b2daf7fd1806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_d3945269-44e7-483d-9c46-c4462b4e5c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_d3945269-44e7-483d-9c46-c4462b4e5c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_3b170bcb-e9ff-4a3e-b17d-1ade34febe78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_3b170bcb-e9ff-4a3e-b17d-1ade34febe78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_acf7e790-822c-481a-8680-4e6f44f2df03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_acf7e790-822c-481a-8680-4e6f44f2df03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_3535a9cb-f7c6-4de2-ac41-98e67598b67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_3535a9cb-f7c6-4de2-ac41-98e67598b67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_51eb2114-5791-4c1c-8cc5-37a5058e2fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_51eb2114-5791-4c1c-8cc5-37a5058e2fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_b530c817-49a6-4568-a621-54cfb5180301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_b530c817-49a6-4568-a621-54cfb5180301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_4fd93d0e-20a5-4b03-b81e-962f7822d7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_4fd93d0e-20a5-4b03-b81e-962f7822d7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_94862dda-d03b-4daa-a8ab-574bc3c9b17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_94862dda-d03b-4daa-a8ab-574bc3c9b17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7241b5f6-1563-42e4-9d57-8e598ff662b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7241b5f6-1563-42e4-9d57-8e598ff662b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_86ad4613-9f05-4a3a-b907-d7d35efaa129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_86ad4613-9f05-4a3a-b907-d7d35efaa129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_e6fbed30-cd84-4fff-be48-54305d99d0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_e6fbed30-cd84-4fff-be48-54305d99d0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1555894e-9cd1-45bd-81da-fb60b9ef4be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eafa5d24-4399-4f35-b3b3-d4c4e3c6eb0b" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1555894e-9cd1-45bd-81da-fb60b9ef4be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_59a37f24-487d-48b7-bab1-499b52f8194f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_303ec35b-c18a-430e-a21b-c51b07d82e9c" xlink:href="kequ-20230430.xsd#kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59a37f24-487d-48b7-bab1-499b52f8194f" xlink:to="loc_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock_303ec35b-c18a-430e-a21b-c51b07d82e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_00213a59-8317-455a-8a79-59a232edef61" xlink:href="kequ-20230430.xsd#kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59a37f24-487d-48b7-bab1-499b52f8194f" xlink:to="loc_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock_00213a59-8317-455a-8a79-59a232edef61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0948fab9-c3d5-4963-b10b-02bd096d81ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59a37f24-487d-48b7-bab1-499b52f8194f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0948fab9-c3d5-4963-b10b-02bd096d81ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7114ea8e-f883-4c6e-af44-6ba18fb0359b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59a37f24-487d-48b7-bab1-499b52f8194f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_7114ea8e-f883-4c6e-af44-6ba18fb0359b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a7f36f48-e952-4f13-8715-87768df63f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59a37f24-487d-48b7-bab1-499b52f8194f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a7f36f48-e952-4f13-8715-87768df63f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="kequ-20230430.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eeee0c88-cbdf-4a2e-a8db-5c489c6e7085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8b4d0e28-8287-4eb6-8060-e0fd7cd98bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eeee0c88-cbdf-4a2e-a8db-5c489c6e7085" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8b4d0e28-8287-4eb6-8060-e0fd7cd98bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/InventoriesTables" xlink:type="simple" xlink:href="kequ-20230430.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_727c4f45-87ba-4a62-a3b3-6b56a94d01b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6d2b9ca2-6c80-464d-aa91-2945edfa03f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_727c4f45-87ba-4a62-a3b3-6b56a94d01b2" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6d2b9ca2-6c80-464d-aa91-2945edfa03f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables" xlink:type="simple" xlink:href="kequ-20230430.xsd#SaleLeasebackFinancingTransactionTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAbstract_e42ee73f-5ae2-4dd1-8a48-4d1ffcd8b71e" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock_5eb5d0ed-0861-4aa3-bbb8-f24245d663ee" xlink:href="kequ-20230430.xsd#kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_e42ee73f-5ae2-4dd1-8a48-4d1ffcd8b71e" xlink:to="loc_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock_5eb5d0ed-0861-4aa3-bbb8-f24245d663ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f48ad280-3cca-4490-95c0-0d98e3dfe1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_b2c9cee2-2fef-466c-86cf-cbf046fcd02c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f48ad280-3cca-4490-95c0-0d98e3dfe1e9" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_b2c9cee2-2fef-466c-86cf-cbf046fcd02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_145c5b4c-f979-437c-ab11-d93601599141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f48ad280-3cca-4490-95c0-0d98e3dfe1e9" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_145c5b4c-f979-437c-ab11-d93601599141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0c899890-25a2-4262-ad82-16e54619a4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f48ad280-3cca-4490-95c0-0d98e3dfe1e9" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0c899890-25a2-4262-ad82-16e54619a4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables" xlink:type="simple" xlink:href="kequ-20230430.xsd#StockOptionsandShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5b5d6275-80ab-4c3c-bde6-2e230476b677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_1e91c64d-a757-42af-b761-00c67aef14ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b5d6275-80ab-4c3c-bde6-2e230476b677" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_1e91c64d-a757-42af-b761-00c67aef14ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_54a41d81-539b-4f43-9545-c0a0ac61aa20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b5d6275-80ab-4c3c-bde6-2e230476b677" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_54a41d81-539b-4f43-9545-c0a0ac61aa20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_b1c5b32e-1d8d-40ad-9511-96dbc1cd90fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5b5d6275-80ab-4c3c-bde6-2e230476b677" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_b1c5b32e-1d8d-40ad-9511-96dbc1cd90fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="kequ-20230430.xsd#AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_06705664-dc7b-49e9-b8b0-0e854ee2beae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_d00526f2-1b43-4d65-bd7e-f43bdfe59616" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_06705664-dc7b-49e9-b8b0-0e854ee2beae" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_d00526f2-1b43-4d65-bd7e-f43bdfe59616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables" xlink:type="simple" xlink:href="kequ-20230430.xsd#LeasesCommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2d6fada3-381b-4822-a559-e75f1b7c1292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_cfb807e4-90a9-46b0-8ac0-57a3e88124cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2d6fada3-381b-4822-a559-e75f1b7c1292" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_cfb807e4-90a9-46b0-8ac0-57a3e88124cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_b1344830-85c2-4d25-8c29-35fcb4d24f65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2d6fada3-381b-4822-a559-e75f1b7c1292" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_b1344830-85c2-4d25-8c29-35fcb4d24f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsTables" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_05447ef1-a12b-4b24-90a2-dfb2a20aedac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_f8be1399-473d-4b58-866a-1f885b55127c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_05447ef1-a12b-4b24-90a2-dfb2a20aedac" xlink:to="loc_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock_f8be1399-473d-4b58-866a-1f885b55127c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_56bf6a98-033e-41f2-8595-69569c9014ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_05447ef1-a12b-4b24-90a2-dfb2a20aedac" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_56bf6a98-033e-41f2-8595-69569c9014ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_dacbe1fa-0887-40f3-8365-a9130d6d6ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_05447ef1-a12b-4b24-90a2-dfb2a20aedac" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_dacbe1fa-0887-40f3-8365-a9130d6d6ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock_262e723d-e581-447e-b8b4-bc64c00177e3" xlink:href="kequ-20230430.xsd#kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_05447ef1-a12b-4b24-90a2-dfb2a20aedac" xlink:to="loc_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock_262e723d-e581-447e-b8b4-bc64c00177e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock_c70a7bd9-ffbc-4b74-81e6-e2d8e2268540" xlink:href="kequ-20230430.xsd#kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_05447ef1-a12b-4b24-90a2-dfb2a20aedac" xlink:to="loc_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock_c70a7bd9-ffbc-4b74-81e6-e2d8e2268540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="kequ-20230430.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_639bdfaa-3d65-44c2-a246-db8c53747fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5c51f982-50a5-4c70-a23d-782d081cc12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_639bdfaa-3d65-44c2-a246-db8c53747fb4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_5c51f982-50a5-4c70-a23d-782d081cc12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7cc2098f-e8ad-4892-8244-3f8ec417d49a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:href="kequ-20230430.xsd#kequ_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7cc2098f-e8ad-4892-8244-3f8ec417d49a" xlink:to="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_c52ac7a1-f897-436a-8c23-6dd1a95072f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_srt_OwnershipAxis_c52ac7a1-f897-436a-8c23-6dd1a95072f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_39f72438-51a1-45f8-a294-62247b33fc69" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_c52ac7a1-f897-436a-8c23-6dd1a95072f4" xlink:to="loc_srt_OwnershipDomain_39f72438-51a1-45f8-a294-62247b33fc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationMember_1450bc81-9126-42dd-903b-80e133438969" xlink:href="kequ-20230430.xsd#kequ_KewauneeScientificCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_39f72438-51a1-45f8-a294-62247b33fc69" xlink:to="loc_kequ_KewauneeScientificCorporationMember_1450bc81-9126-42dd-903b-80e133438969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationSingaporeMember_4d4d5ccb-0864-45b8-842d-2d3b82bad61c" xlink:href="kequ-20230430.xsd#kequ_KewauneeScientificCorporationSingaporeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_39f72438-51a1-45f8-a294-62247b33fc69" xlink:to="loc_kequ_KewauneeScientificCorporationSingaporeMember_4d4d5ccb-0864-45b8-842d-2d3b82bad61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_60e46748-90af-478d-9037-29d322dbc415" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_dei_LegalEntityAxis_60e46748-90af-478d-9037-29d322dbc415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_60e46748-90af-478d-9037-29d322dbc415" xlink:to="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayAsiaMember_8d83d440-686f-403a-8da4-91b159c977df" xlink:href="kequ-20230430.xsd#kequ_KewauneeLabwayAsiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:to="loc_kequ_KewauneeLabwayAsiaMember_8d83d440-686f-403a-8da4-91b159c977df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeScientificCorporationSingaporeMember_c679abb8-5766-4ea0-bed2-9b6f8ae6a433" xlink:href="kequ-20230430.xsd#kequ_KewauneeScientificCorporationSingaporeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:to="loc_kequ_KewauneeScientificCorporationSingaporeMember_c679abb8-5766-4ea0-bed2-9b6f8ae6a433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KewauneeLabwayIndiaMember_90cdf724-2af6-4a99-ae4a-72f61cc8e2d4" xlink:href="kequ-20230430.xsd#kequ_KewauneeLabwayIndiaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:to="loc_kequ_KewauneeLabwayIndiaMember_90cdf724-2af6-4a99-ae4a-72f61cc8e2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KoncepoScientechInternationalMember_f8efdfde-873b-43b3-ad89-63ce0d30d57d" xlink:href="kequ-20230430.xsd#kequ_KoncepoScientechInternationalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:to="loc_kequ_KoncepoScientechInternationalMember_f8efdfde-873b-43b3-ad89-63ce0d30d57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_KequipGlobalLabSolutionsMember_4f98812e-95c4-4e9e-a3ac-962fbeee7fd6" xlink:href="kequ-20230430.xsd#kequ_KequipGlobalLabSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a2a81850-8541-4c6d-b4e2-7435f849e46c" xlink:to="loc_kequ_KequipGlobalLabSolutionsMember_4f98812e-95c4-4e9e-a3ac-962fbeee7fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9df12bc1-2549-44a5-8134-430f735e2ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9df12bc1-2549-44a5-8134-430f735e2ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c22282b9-11a1-4ecc-ae1b-5e4a8f1f8734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9df12bc1-2549-44a5-8134-430f735e2ff7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c22282b9-11a1-4ecc-ae1b-5e4a8f1f8734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c91e7dd2-5cad-4df7-867d-6ff5e5bb0245" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c22282b9-11a1-4ecc-ae1b-5e4a8f1f8734" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_c91e7dd2-5cad-4df7-867d-6ff5e5bb0245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_91b07c2b-c2c6-40b5-8b5a-d5f1552e3ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c22282b9-11a1-4ecc-ae1b-5e4a8f1f8734" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_91b07c2b-c2c6-40b5-8b5a-d5f1552e3ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7333d779-a964-45f7-aec0-9e44a2791bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7333d779-a964-45f7-aec0-9e44a2791bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9171ab15-6650-4066-a043-5caffa7b8fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7333d779-a964-45f7-aec0-9e44a2791bdf" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9171ab15-6650-4066-a043-5caffa7b8fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_dd71163c-0aa1-4928-b06d-2f900d9aa411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9171ab15-6650-4066-a043-5caffa7b8fcf" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_dd71163c-0aa1-4928-b06d-2f900d9aa411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c951028e-78d1-4ae5-bdb6-c2c08076b4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_AwardTypeAxis_c951028e-78d1-4ae5-bdb6-c2c08076b4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee0211de-9e08-4707-827d-a1a52707a52c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c951028e-78d1-4ae5-bdb6-c2c08076b4a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee0211de-9e08-4707-827d-a1a52707a52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e2569eb2-0fc4-466b-a9f9-3b80f903d9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ee0211de-9e08-4707-827d-a1a52707a52c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e2569eb2-0fc4-466b-a9f9-3b80f903d9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e67f2638-47d0-4300-8581-b1a90dda1f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e67f2638-47d0-4300-8581-b1a90dda1f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4ba9df85-3d97-43f4-b140-c1bd02e1c4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e67f2638-47d0-4300-8581-b1a90dda1f38" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4ba9df85-3d97-43f4-b140-c1bd02e1c4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueSegmentMember_33a129cd-a863-4943-9c8e-079938128a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4ba9df85-3d97-43f4-b140-c1bd02e1c4de" xlink:to="loc_us-gaap_SalesRevenueSegmentMember_33a129cd-a863-4943-9c8e-079938128a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_967ad088-0c27-4bae-af2e-57fc7c29c108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4ba9df85-3d97-43f4-b140-c1bd02e1c4de" xlink:to="loc_us-gaap_AccountsReceivableMember_967ad088-0c27-4bae-af2e-57fc7c29c108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_f778d300-09fa-4028-8645-fa86a4aae075" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_srt_ConsolidatedEntitiesAxis_f778d300-09fa-4028-8645-fa86a4aae075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_0b3578c7-81c4-45f6-a63d-3607980deaeb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f778d300-09fa-4028-8645-fa86a4aae075" xlink:to="loc_srt_ConsolidatedEntitiesDomain_0b3578c7-81c4-45f6-a63d-3607980deaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_560f96e9-6dec-4e5d-b1d9-411bbf2d50f5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_0b3578c7-81c4-45f6-a63d-3607980deaeb" xlink:to="loc_srt_SubsidiariesMember_560f96e9-6dec-4e5d-b1d9-411bbf2d50f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_0c1eb7af-4ad4-4ac9-b3e9-32ce17cb99e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_GeographicDistributionAxis_0c1eb7af-4ad4-4ac9-b3e9-32ce17cb99e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_c3182961-4291-4324-90a7-4ec8b27dba31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_0c1eb7af-4ad4-4ac9-b3e9-32ce17cb99e6" xlink:to="loc_us-gaap_GeographicDistributionDomain_c3182961-4291-4324-90a7-4ec8b27dba31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_22c9311c-1551-4b04-8971-59f43a0574e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_c3182961-4291-4324-90a7-4ec8b27dba31" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_22c9311c-1551-4b04-8971-59f43a0574e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3a954e3b-eb48-4684-8521-fb898abdbfaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_srt_ConsolidationItemsAxis_3a954e3b-eb48-4684-8521-fb898abdbfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_edcc5cbf-50f1-41f1-b589-990f84b50705" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_3a954e3b-eb48-4684-8521-fb898abdbfaf" xlink:to="loc_srt_ConsolidationItemsDomain_edcc5cbf-50f1-41f1-b589-990f84b50705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b7d1ad6b-d16a-4d8d-a0cf-7392216114a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_edcc5cbf-50f1-41f1-b589-990f84b50705" xlink:to="loc_us-gaap_OperatingSegmentsMember_b7d1ad6b-d16a-4d8d-a0cf-7392216114a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6dfd3360-51e9-4384-b3a2-ac7e20c65f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6dfd3360-51e9-4384-b3a2-ac7e20c65f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_901c6035-85ac-4d47-8c50-d3fec590244e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6dfd3360-51e9-4384-b3a2-ac7e20c65f63" xlink:to="loc_us-gaap_SegmentDomain_901c6035-85ac-4d47-8c50-d3fec590244e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalOperationsMember_8471e3ba-5710-406b-8b3e-125c1d59fd6e" xlink:href="kequ-20230430.xsd#kequ_InternationalOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_901c6035-85ac-4d47-8c50-d3fec590244e" xlink:to="loc_kequ_InternationalOperationsMember_8471e3ba-5710-406b-8b3e-125c1d59fd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:href="kequ-20230430.xsd#kequ_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesTable_7c3836c4-3396-418e-b853-b27019d36232" xlink:to="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_c02960aa-7cc6-4256-a5d9-8423ec8f7baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_c02960aa-7cc6-4256-a5d9-8423ec8f7baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNet_e69fd7d4-da03-4d5f-b2ab-e570f87e03f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_AssetsNet_e69fd7d4-da03-4d5f-b2ab-e570f87e03f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7f08ca74-3b1a-456e-8b23-c30a9ed95edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7f08ca74-3b1a-456e-8b23-c30a9ed95edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_e5876e39-b0f9-45fa-8531-1962dcbe3d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_e5876e39-b0f9-45fa-8531-1962dcbe3d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_8d96d46e-11f5-4a79-827d-102f2b07839b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_AssetImpairmentCharges_8d96d46e-11f5-4a79-827d-102f2b07839b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_UnbilledRetainageCurrent_f140bf35-7838-4d25-a2e8-562b647a8a7d" xlink:href="kequ-20230430.xsd#kequ_UnbilledRetainageCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_kequ_UnbilledRetainageCurrent_f140bf35-7838-4d25-a2e8-562b647a8a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldInTrust_3b87be8c-1c26-411d-9439-e600718f9b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldInTrust"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_AssetsHeldInTrust_3b87be8c-1c26-411d-9439-e600718f9b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueOfLifeInsurance_f4ffbd7f-7aff-4bab-a7ab-2de7551e952c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueOfLifeInsurance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_CashSurrenderValueOfLifeInsurance_f4ffbd7f-7aff-4bab-a7ab-2de7551e952c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_47d1b70e-7557-470b-901f-f9789dce688a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_47d1b70e-7557-470b-901f-f9789dce688a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1_7cc62b57-5233-4c40-b361-b3724529a878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1_7cc62b57-5233-4c40-b361-b3724529a878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_ab8facf1-fc26-4d8f-92e5-cf196d9032f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_ab8facf1-fc26-4d8f-92e5-cf196d9032f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTermOfContract_dff61c9a-a182-43ff-a1d1-b4c3bfc2ce07" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityTermOfContract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_kequ_FinancingLiabilityTermOfContract_dff61c9a-a182-43ff-a1d1-b4c3bfc2ce07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionContractorReceivableRetainage_1d498fde-e039-4d81-8d20-ce75af2e3cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionContractorReceivableRetainage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ConstructionContractorReceivableRetainage_1d498fde-e039-4d81-8d20-ce75af2e3cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_5711dd9c-ad61-40d6-bd43-da6773ba57ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_5711dd9c-ad61-40d6-bd43-da6773ba57ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0726c03b-bc2a-44f8-a5c5-d9b9ced8fd95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0726c03b-bc2a-44f8-a5c5-d9b9ced8fd95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_ebebfa8e-ad2d-42c6-a98e-a4f19bb1b3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_AdvertisingExpense_ebebfa8e-ad2d-42c6-a98e-a4f19bb1b3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_177204ff-c987-47f5-9e2c-e7b7ec42d5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_177204ff-c987-47f5-9e2c-e7b7ec42d5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_645dbd5c-bbba-45c0-8e4c-cfa19eb115ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_645dbd5c-bbba-45c0-8e4c-cfa19eb115ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_df90d1f4-1ef4-42ef-920d-520fc246456a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_SignificantAccountingPoliciesLineItems_1f5d0c35-25aa-476b-b6da-9ac432281311" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_df90d1f4-1ef4-42ef-920d-520fc246456a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_448b76ce-7926-47a6-8270-49dd2f98d81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1bdc5acf-424e-4bc7-a427-015348925957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_448b76ce-7926-47a6-8270-49dd2f98d81f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1bdc5acf-424e-4bc7-a427-015348925957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c78ef59b-bd9d-4020-b00f-cb3ac0decb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_448b76ce-7926-47a6-8270-49dd2f98d81f" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_c78ef59b-bd9d-4020-b00f-cb3ac0decb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_29d52ce4-dc64-499c-8b8e-e044665928f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_448b76ce-7926-47a6-8270-49dd2f98d81f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_29d52ce4-dc64-499c-8b8e-e044665928f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_da436a06-6c58-47fa-a541-f98919b8b541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_2b1be4a1-eecd-4634-9b65-7187669af62e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_da436a06-6c58-47fa-a541-f98919b8b541" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_2b1be4a1-eecd-4634-9b65-7187669af62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a3fe3a0a-cd9e-44de-9353-23f7eceb82d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_2b1be4a1-eecd-4634-9b65-7187669af62e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a3fe3a0a-cd9e-44de-9353-23f7eceb82d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_2ebe3636-0556-41f9-8b19-b1a23b6c95ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_2b1be4a1-eecd-4634-9b65-7187669af62e" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_2ebe3636-0556-41f9-8b19-b1a23b6c95ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_19e21be3-5185-4dc5-abff-8b6d20b00d63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_2b1be4a1-eecd-4634-9b65-7187669af62e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_19e21be3-5185-4dc5-abff-8b6d20b00d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3383c4ba-8a78-400e-93ae-0de3a454ceb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_2b1be4a1-eecd-4634-9b65-7187669af62e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3383c4ba-8a78-400e-93ae-0de3a454ceb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_730b042a-e600-44c7-ab00-f589b3c36cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_836965fd-a111-4ce5-9c07-1b51855eeb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_730b042a-e600-44c7-ab00-f589b3c36cd1" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_836965fd-a111-4ce5-9c07-1b51855eeb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d844543b-eb3b-4f07-8a1a-609077c963ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_836965fd-a111-4ce5-9c07-1b51855eeb1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d844543b-eb3b-4f07-8a1a-609077c963ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef43a03c-b228-4f52-8995-31d5e9979386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d844543b-eb3b-4f07-8a1a-609077c963ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef43a03c-b228-4f52-8995-31d5e9979386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_6102a0b2-5abe-421e-8900-b03a66218f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef43a03c-b228-4f52-8995-31d5e9979386" xlink:to="loc_us-gaap_LandMember_6102a0b2-5abe-421e-8900-b03a66218f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_6132db05-425e-4cf2-8994-8307381cb8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef43a03c-b228-4f52-8995-31d5e9979386" xlink:to="loc_us-gaap_BuildingImprovementsMember_6132db05-425e-4cf2-8994-8307381cb8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_81023f38-c167-4805-b05f-ebbfd0547017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef43a03c-b228-4f52-8995-31d5e9979386" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_81023f38-c167-4805-b05f-ebbfd0547017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fc49c3a3-2240-49ad-8801-42b2643aee75" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_836965fd-a111-4ce5-9c07-1b51855eeb1b" xlink:to="loc_srt_RangeAxis_fc49c3a3-2240-49ad-8801-42b2643aee75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_39cfda1e-c4c6-4ee5-8165-81938cda5e02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fc49c3a3-2240-49ad-8801-42b2643aee75" xlink:to="loc_srt_RangeMember_39cfda1e-c4c6-4ee5-8165-81938cda5e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_49f72111-4848-44a8-bea5-4d1016265022" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39cfda1e-c4c6-4ee5-8165-81938cda5e02" xlink:to="loc_srt_MinimumMember_49f72111-4848-44a8-bea5-4d1016265022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ff7827ef-a64d-4265-809e-ffd259907bb7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39cfda1e-c4c6-4ee5-8165-81938cda5e02" xlink:to="loc_srt_MaximumMember_ff7827ef-a64d-4265-809e-ffd259907bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_836965fd-a111-4ce5-9c07-1b51855eeb1b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_32f0a0b3-24b5-4bcb-9cea-44ae3fe20a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_32f0a0b3-24b5-4bcb-9cea-44ae3fe20a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_153e05b6-a41c-41cb-87cd-9647178aef45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_153e05b6-a41c-41cb-87cd-9647178aef45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8933e7a8-813c-49a7-a971-b781233198ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8933e7a8-813c-49a7-a971-b781233198ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d8f23a3e-e5ae-4836-bcdd-65e343e669c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9ff54d4c-6442-4571-9e70-e6ca3ddff41e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d8f23a3e-e5ae-4836-bcdd-65e343e669c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_711007d3-2d96-4cc0-aa72-2daec6375d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_711007d3-2d96-4cc0-aa72-2daec6375d83" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2a9fadfb-82c8-4925-b49e-b1b65245e37b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2a9fadfb-82c8-4925-b49e-b1b65245e37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3cdf4bee-44d5-4d3a-95ca-34d10b80d47d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_2a9fadfb-82c8-4925-b49e-b1b65245e37b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3cdf4bee-44d5-4d3a-95ca-34d10b80d47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e97b9079-3b2c-4748-a0c4-8d0401658ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3cdf4bee-44d5-4d3a-95ca-34d10b80d47d" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e97b9079-3b2c-4748-a0c4-8d0401658ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2619b460-4814-4998-8b82-bd7abea49313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3cdf4bee-44d5-4d3a-95ca-34d10b80d47d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2619b460-4814-4998-8b82-bd7abea49313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_68cbc1b7-5598-470f-ab1e-5b3890bd0a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_68cbc1b7-5598-470f-ab1e-5b3890bd0a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_76369315-b8b7-46a1-a531-d03803c6dff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_68cbc1b7-5598-470f-ab1e-5b3890bd0a65" xlink:to="loc_us-gaap_EquityComponentDomain_76369315-b8b7-46a1-a531-d03803c6dff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NonQualifiedCompensationPlanMember_9972ee69-fa7c-46d2-93b3-fb866f91faef" xlink:href="kequ-20230430.xsd#kequ_NonQualifiedCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_76369315-b8b7-46a1-a531-d03803c6dff0" xlink:to="loc_kequ_NonQualifiedCompensationPlanMember_9972ee69-fa7c-46d2-93b3-fb866f91faef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_fefd7051-8d6f-4605-ac9e-8379787109eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_fefd7051-8d6f-4605-ac9e-8379787109eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_620635aa-cddc-4121-86af-ca8273286f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_fefd7051-8d6f-4605-ac9e-8379787109eb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_620635aa-cddc-4121-86af-ca8273286f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TradingSecuritiesMember_84c436ff-280b-4794-aba4-86d67f1ad2e4" xlink:href="kequ-20230430.xsd#kequ_TradingSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_620635aa-cddc-4121-86af-ca8273286f14" xlink:to="loc_kequ_TradingSecuritiesMember_84c436ff-280b-4794-aba4-86d67f1ad2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueMember_1e6fc665-8cd1-4091-8a02-3159ee50505f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_620635aa-cddc-4121-86af-ca8273286f14" xlink:to="loc_us-gaap_CashSurrenderValueMember_1e6fc665-8cd1-4091-8a02-3159ee50505f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_7cc5b9a8-0cf0-48cd-946c-157f957e2048" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_03e006c6-6a48-4492-8468-c9bad16a7e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_us-gaap_DerivativeAssets_03e006c6-6a48-4492-8468-c9bad16a7e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_62e5c633-ad2d-4f62-a61c-12f11d76b608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_us-gaap_DerivativeLiabilities_62e5c633-ad2d-4f62-a61c-12f11d76b608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_0136eb86-cd0b-4979-972f-e8d3ef30f033" xlink:href="kequ-20230430.xsd#kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_0136eb86-cd0b-4979-972f-e8d3ef30f033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_NumberOfNonqualifiedCompensationPlans_94c796a2-4458-46d9-9fcc-e73dfced53a9" xlink:href="kequ-20230430.xsd#kequ_NumberOfNonqualifiedCompensationPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_kequ_NumberOfNonqualifiedCompensationPlans_94c796a2-4458-46d9-9fcc-e73dfced53a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_8fa046e0-e401-4ea4-82ee-c4d4802d1999" xlink:href="kequ-20230430.xsd#kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_30393854-ac31-40ec-9900-09b2e1438b8b" xlink:to="loc_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag_8fa046e0-e401-4ea4-82ee-c4d4802d1999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7c6dafe5-6a74-44e0-ad61-3b94e6250c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d95835d8-89b1-4fa4-9060-4b303795dff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7c6dafe5-6a74-44e0-ad61-3b94e6250c41" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d95835d8-89b1-4fa4-9060-4b303795dff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32b3b014-4c1b-4c00-97e6-97869763d5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d95835d8-89b1-4fa4-9060-4b303795dff2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_32b3b014-4c1b-4c00-97e6-97869763d5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_dee5b755-0d07-4d87-9602-08c0438d26c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d95835d8-89b1-4fa4-9060-4b303795dff2" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_dee5b755-0d07-4d87-9602-08c0438d26c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e58f8d31-872f-4c72-b9d5-a0577ba24d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d95835d8-89b1-4fa4-9060-4b303795dff2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e58f8d31-872f-4c72-b9d5-a0577ba24d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2dde463b-4db6-469d-a4e1-691c5cd63d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0522844a-ce8c-4fd3-8451-149e132b7942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2dde463b-4db6-469d-a4e1-691c5cd63d39" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0522844a-ce8c-4fd3-8451-149e132b7942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_7380e30d-2cba-47a4-9cb7-4e2ede0aa16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0522844a-ce8c-4fd3-8451-149e132b7942" xlink:to="loc_us-gaap_GeographicDistributionAxis_7380e30d-2cba-47a4-9cb7-4e2ede0aa16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_b441c878-160b-40fb-b472-b2a828726ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_7380e30d-2cba-47a4-9cb7-4e2ede0aa16c" xlink:to="loc_us-gaap_GeographicDistributionDomain_b441c878-160b-40fb-b472-b2a828726ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_93a79da1-9492-435f-985b-b773b0a9ab65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_b441c878-160b-40fb-b472-b2a828726ebf" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_93a79da1-9492-435f-985b-b773b0a9ab65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_d52fb2ab-9c65-4e88-ae44-d58e11fd80c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_b441c878-160b-40fb-b472-b2a828726ebf" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_d52fb2ab-9c65-4e88-ae44-d58e11fd80c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a515c97-ffd9-4fe2-8f9a-0659d98ac114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0522844a-ce8c-4fd3-8451-149e132b7942" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a515c97-ffd9-4fe2-8f9a-0659d98ac114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d6a2f9ad-c0aa-42e9-a5dc-a7b9e4761bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_9a515c97-ffd9-4fe2-8f9a-0659d98ac114" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d6a2f9ad-c0aa-42e9-a5dc-a7b9e4761bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_e60c6c54-31f0-4e33-b931-6cbfcb2203d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d6a2f9ad-c0aa-42e9-a5dc-a7b9e4761bf6" xlink:to="loc_us-gaap_TransferredOverTimeMember_e60c6c54-31f0-4e33-b931-6cbfcb2203d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_2c0f8013-af03-419a-8b29-c377a58b272d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d6a2f9ad-c0aa-42e9-a5dc-a7b9e4761bf6" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_2c0f8013-af03-419a-8b29-c377a58b272d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_3156d994-b602-46f1-85a2-ca09f961c06e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0522844a-ce8c-4fd3-8451-149e132b7942" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_3156d994-b602-46f1-85a2-ca09f961c06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e70eb0d-13ab-4216-91c3-06ca52e2771d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_3156d994-b602-46f1-85a2-ca09f961c06e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8e70eb0d-13ab-4216-91c3-06ca52e2771d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RevenueRecognitionAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6c1db9c9-a92d-48a8-bff9-6d1178486ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionTable_a5c19dbd-07eb-4b3a-b9e8-a89610a144a8" xlink:href="kequ-20230430.xsd#kequ_RevenueRecognitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6c1db9c9-a92d-48a8-bff9-6d1178486ac2" xlink:to="loc_kequ_RevenueRecognitionTable_a5c19dbd-07eb-4b3a-b9e8-a89610a144a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_9f71ec53-24cf-4fdd-8969-11b4c70ff8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionTable_a5c19dbd-07eb-4b3a-b9e8-a89610a144a8" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_9f71ec53-24cf-4fdd-8969-11b4c70ff8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_3c90f0fa-6a15-4b59-ad4d-32226191f98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_9f71ec53-24cf-4fdd-8969-11b4c70ff8ea" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_3c90f0fa-6a15-4b59-ad4d-32226191f98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FiscalYearTwoThousandTwentyFourMember_9de74e7d-885b-42aa-b485-d48a8f1677b2" xlink:href="kequ-20230430.xsd#kequ_FiscalYearTwoThousandTwentyFourMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain_3c90f0fa-6a15-4b59-ad4d-32226191f98a" xlink:to="loc_kequ_FiscalYearTwoThousandTwentyFourMember_9de74e7d-885b-42aa-b485-d48a8f1677b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bdd5a243-4cdc-49f2-8de9-a5b332784e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionTable_a5c19dbd-07eb-4b3a-b9e8-a89610a144a8" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bdd5a243-4cdc-49f2-8de9-a5b332784e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_19b85fe2-742e-4680-afe6-2c2f92e6f78b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bdd5a243-4cdc-49f2-8de9-a5b332784e9a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_19b85fe2-742e-4680-afe6-2c2f92e6f78b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_28f5a94b-6d0e-4819-906d-eb3e9238fa27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_19b85fe2-742e-4680-afe6-2c2f92e6f78b" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_28f5a94b-6d0e-4819-906d-eb3e9238fa27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:href="kequ-20230430.xsd#kequ_RevenueRecognitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionTable_a5c19dbd-07eb-4b3a-b9e8-a89610a144a8" xlink:to="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_25b13b20-4d1b-48a4-8d50-57037d6c4990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_25b13b20-4d1b-48a4-8d50-57037d6c4990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_UnbilledRetainageCurrent_9251cc19-8fb9-4bf6-acf5-0e85d87013b1" xlink:href="kequ-20230430.xsd#kequ_UnbilledRetainageCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:to="loc_kequ_UnbilledRetainageCurrent_9251cc19-8fb9-4bf6-acf5-0e85d87013b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_5566a6aa-140e-4801-bd9a-5bf540a8cb28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:to="loc_us-gaap_ContractWithCustomerLiability_5566a6aa-140e-4801-bd9a-5bf540a8cb28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_ee82033e-2010-4028-b926-e94105d543d7" xlink:href="kequ-20230430.xsd#kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_RevenueRecognitionLineItems_83ef9639-3da5-4fe8-ae8b-5ca7866f993f" xlink:to="loc_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage_ee82033e-2010-4028-b926-e94105d543d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#InventoriesSummaryofInventoriesDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_2754bdb2-6ed2-475c-8325-45e0cc198923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_279989c8-1881-480b-935c-c9de73cd23d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2754bdb2-6ed2-475c-8325-45e0cc198923" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_279989c8-1881-480b-935c-c9de73cd23d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a2e0bdfe-0a94-4b6c-a12e-dbd69c949e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2754bdb2-6ed2-475c-8325-45e0cc198923" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a2e0bdfe-0a94-4b6c-a12e-dbd69c949e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_f30099e4-011a-4ddd-8e41-1ca52f8f0a42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2754bdb2-6ed2-475c-8325-45e0cc198923" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_f30099e4-011a-4ddd-8e41-1ca52f8f0a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b9e6408a-0f4b-4d36-a827-7e8f6ec06f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2754bdb2-6ed2-475c-8325-45e0cc198923" xlink:to="loc_us-gaap_InventoryNet_b9e6408a-0f4b-4d36-a827-7e8f6ec06f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#InventoriesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c4ee81d2-ba08-44ca-a691-06f109ae640e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_273dfbc4-fd0a-422a-a967-2c22cfd9e429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c4ee81d2-ba08-44ca-a691-06f109ae640e" xlink:to="loc_us-gaap_InventoryCurrentTable_273dfbc4-fd0a-422a-a967-2c22cfd9e429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_fb2d6b34-5ffc-4f7b-a5d0-288992b2f9a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_273dfbc4-fd0a-422a-a967-2c22cfd9e429" xlink:to="loc_srt_ConsolidatedEntitiesAxis_fb2d6b34-5ffc-4f7b-a5d0-288992b2f9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1cadb178-5b2d-42bd-808a-bd5d79477347" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_fb2d6b34-5ffc-4f7b-a5d0-288992b2f9a1" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1cadb178-5b2d-42bd-808a-bd5d79477347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesMember_5cf6e3fe-c281-4904-890c-75fd5424f618" xlink:href="kequ-20230430.xsd#kequ_ForeignSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1cadb178-5b2d-42bd-808a-bd5d79477347" xlink:to="loc_kequ_ForeignSubsidiariesMember_5cf6e3fe-c281-4904-890c-75fd5424f618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_37ccf809-6fc5-4beb-aedf-0cf8ad4b489a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_273dfbc4-fd0a-422a-a967-2c22cfd9e429" xlink:to="loc_us-gaap_InventoryLineItems_37ccf809-6fc5-4beb-aedf-0cf8ad4b489a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FIFOInventoryAmount_50ff387b-badd-4e05-bc26-95db6b59b108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FIFOInventoryAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_37ccf809-6fc5-4beb-aedf-0cf8ad4b489a" xlink:to="loc_us-gaap_FIFOInventoryAmount_50ff387b-badd-4e05-bc26-95db6b59b108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b4f5378a-6637-42b9-9e89-846c3f184325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b4f5378a-6637-42b9-9e89-846c3f184325" xlink:to="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f6b0456a-b2fb-4d72-b47b-1e4d0a961c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_CreditFacilityAxis_f6b0456a-b2fb-4d72-b47b-1e4d0a961c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f6b0456a-b2fb-4d72-b47b-1e4d0a961c83" xlink:to="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AdvanceAmountOneMember_eef76d22-ab71-476e-bf86-aa2f1476b89e" xlink:href="kequ-20230430.xsd#kequ_AdvanceAmountOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_kequ_AdvanceAmountOneMember_eef76d22-ab71-476e-bf86-aa2f1476b89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AdvanceAmountTwoMember_aebf0295-062d-433b-9137-44ffd04fea59" xlink:href="kequ-20230430.xsd#kequ_AdvanceAmountTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_kequ_AdvanceAmountTwoMember_aebf0295-062d-433b-9137-44ffd04fea59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_AdvancesMember_66d14419-e664-446b-90be-8d8895098778" xlink:href="kequ-20230430.xsd#kequ_AdvancesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_kequ_AdvancesMember_66d14419-e664-446b-90be-8d8895098778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ea76d4f8-42d8-462a-bbf0-5fb628cca098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_us-gaap_LineOfCreditMember_ea76d4f8-42d8-462a-bbf0-5fb628cca098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TermLoanBMember_9fa4cca9-88b2-4d93-b0e3-d01bcfe2ea59" xlink:href="kequ-20230430.xsd#kequ_TermLoanBMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_kequ_TermLoanBMember_9fa4cca9-88b2-4d93-b0e3-d01bcfe2ea59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_140079b5-0532-46cc-bbe5-6a36791b66c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b5399401-8147-405e-86c3-72ae415f5172" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_140079b5-0532-46cc-bbe5-6a36791b66c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_cf9a6c42-c807-4e78-8ae6-9f2b8437eaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_cf9a6c42-c807-4e78-8ae6-9f2b8437eaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_cf9a6c42-c807-4e78-8ae6-9f2b8437eaa4" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_feb8754f-b2ea-458d-974b-1adaec7ded98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_feb8754f-b2ea-458d-974b-1adaec7ded98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_25c639e6-17bd-4b9e-81d4-a48229514d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_25c639e6-17bd-4b9e-81d4-a48229514d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_7774ffbe-0686-408b-be8a-a70fd63f0443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_7774ffbe-0686-408b-be8a-a70fd63f0443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_3508a651-7d2a-4cfb-9692-f5ec54ff0e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_3508a651-7d2a-4cfb-9692-f5ec54ff0e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_2c58e1c7-fe55-4b1e-9940-cd9f98062cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_a1a0f634-0ea2-42cf-af18-e37a1f27005d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_2c58e1c7-fe55-4b1e-9940-cd9f98062cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsByNatureAxis_4f066875-1485-47b8-9034-0799c65ff49f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsByNatureAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_GuaranteeObligationsByNatureAxis_4f066875-1485-47b8-9034-0799c65ff49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsNatureDomain_6ebe630b-6c74-4a0a-9ba3-b3296aa5dc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsByNatureAxis_4f066875-1485-47b8-9034-0799c65ff49f" xlink:to="loc_us-gaap_GuaranteeObligationsNatureDomain_6ebe630b-6c74-4a0a-9ba3-b3296aa5dc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_BankGuaranteesMember_a843fe64-2889-47eb-b76b-06a2d0874f61" xlink:href="kequ-20230430.xsd#kequ_BankGuaranteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteeObligationsNatureDomain_6ebe630b-6c74-4a0a-9ba3-b3296aa5dc9f" xlink:to="loc_kequ_BankGuaranteesMember_a843fe64-2889-47eb-b76b-06a2d0874f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_eb511cc5-7441-4e5d-a46e-937d79dfbbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_VariableRateAxis_eb511cc5-7441-4e5d-a46e-937d79dfbbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b9bcd0bd-36e6-4197-878b-0c2e0d4e6a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_eb511cc5-7441-4e5d-a46e-937d79dfbbb0" xlink:to="loc_us-gaap_VariableRateDomain_b9bcd0bd-36e6-4197-878b-0c2e0d4e6a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_0544e551-24ec-4946-98be-85a849ccf514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b9bcd0bd-36e6-4197-878b-0c2e0d4e6a1e" xlink:to="loc_us-gaap_BaseRateMember_0544e551-24ec-4946-98be-85a849ccf514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9b6cd5a7-d3bd-42e8-94dc-acfef4fdaaeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b9bcd0bd-36e6-4197-878b-0c2e0d4e6a1e" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_9b6cd5a7-d3bd-42e8-94dc-acfef4fdaaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_SecuredOvernightFinancingRateSOFRMember_4feab70f-4250-487d-a9b3-3bd8d2a95154" xlink:href="kequ-20230430.xsd#kequ_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b9bcd0bd-36e6-4197-878b-0c2e0d4e6a1e" xlink:to="loc_kequ_SecuredOvernightFinancingRateSOFRMember_4feab70f-4250-487d-a9b3-3bd8d2a95154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5f0d489f-76d3-4b02-aa63-8b2fccaf4f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_DebtInstrumentAxis_5f0d489f-76d3-4b02-aa63-8b2fccaf4f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_09f70ef4-3103-4fe1-af28-ff5bbcdc6f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5f0d489f-76d3-4b02-aa63-8b2fccaf4f90" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_09f70ef4-3103-4fe1-af28-ff5bbcdc6f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_CreditAgreementMidCapFundingIVTrustMember_8e494ef5-4141-492b-8818-7b209281c255" xlink:href="kequ-20230430.xsd#kequ_CreditAgreementMidCapFundingIVTrustMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_09f70ef4-3103-4fe1-af28-ff5bbcdc6f3a" xlink:to="loc_kequ_CreditAgreementMidCapFundingIVTrustMember_8e494ef5-4141-492b-8818-7b209281c255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_05443a3a-d585-454a-b2eb-f5c1b50d82f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_05443a3a-d585-454a-b2eb-f5c1b50d82f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_222efd5c-270b-4eb7-9b49-a7420e680f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_05443a3a-d585-454a-b2eb-f5c1b50d82f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_222efd5c-270b-4eb7-9b49-a7420e680f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_b3d13b87-b366-4b98-8c66-1d6d3e33c88b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_222efd5c-270b-4eb7-9b49-a7420e680f02" xlink:to="loc_us-gaap_LineOfCreditMember_b3d13b87-b366-4b98-8c66-1d6d3e33c88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_acd439c1-2179-4fb3-ba60-3ddead7b1556" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_srt_ConsolidatedEntitiesAxis_acd439c1-2179-4fb3-ba60-3ddead7b1556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_32ee6a05-072c-4406-b5a1-89d6c823385c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_acd439c1-2179-4fb3-ba60-3ddead7b1556" xlink:to="loc_srt_ConsolidatedEntitiesDomain_32ee6a05-072c-4406-b5a1-89d6c823385c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalSubsidiariesMember_749767ba-84b0-4933-a88e-7b67d26afdb5" xlink:href="kequ-20230430.xsd#kequ_InternationalSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_32ee6a05-072c-4406-b5a1-89d6c823385c" xlink:to="loc_kequ_InternationalSubsidiariesMember_749767ba-84b0-4933-a88e-7b67d26afdb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f77cec2-fefe-4838-8701-e5132b44b4f5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6e94a9eb-d40d-4480-81e7-5ff87357a214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6e94a9eb-d40d-4480-81e7-5ff87357a214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity_6acd47a5-66c3-49db-8c53-6419cfab0c77" xlink:href="kequ-20230430.xsd#kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity_6acd47a5-66c3-49db-8c53-6419cfab0c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3cc89677-ebbe-4da1-a8ef-ebd37967e9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_LongTermDebt_3cc89677-ebbe-4da1-a8ef-ebd37967e9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_914629ab-247e-48a7-ab49-918162af6b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_LineOfCredit_914629ab-247e-48a7-ab49-918162af6b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_f83a70b1-a24e-47d2-9f19-774884705b31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_f83a70b1-a24e-47d2-9f19-774884705b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_4e838e85-48a9-4469-913e-b40db7029496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_4e838e85-48a9-4469-913e-b40db7029496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_27136b17-60a6-4495-9ad4-56e17882565b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_27136b17-60a6-4495-9ad4-56e17882565b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_d2e4df16-4f57-4df7-b98d-8667fa42e7bb" xlink:href="kequ-20230430.xsd#kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit_d2e4df16-4f57-4df7-b98d-8667fa42e7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_3385d654-e01a-4d68-9b8e-e9c6d1414a90" xlink:href="kequ-20230430.xsd#kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption_3385d654-e01a-4d68-9b8e-e9c6d1414a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f038c180-e1b9-44dd-ab8f-4311e631093d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_ShortTermBorrowings_f038c180-e1b9-44dd-ab8f-4311e631093d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_ae2916dd-db7d-428a-89ce-7ba8beee2d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_8a43f694-db80-4b94-823a-be75e62b3559" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_ae2916dd-db7d-428a-89ce-7ba8beee2d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#SaleLeasebackFinancingTransactionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTermOfContract_9054564c-70e7-4c7a-81ca-6957fdf7d6a3" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_kequ_FinancingLiabilityTermOfContract_9054564c-70e7-4c7a-81ca-6957fdf7d6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNumberOfRenewalOptions_89c3fae5-3cf2-4b30-89d8-79cda831ec56" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityNumberOfRenewalOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_kequ_FinancingLiabilityNumberOfRenewalOptions_89c3fae5-3cf2-4b30-89d8-79cda831ec56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityRenewalTerm_589291b3-a410-4172-805b-6842288545e1" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_kequ_FinancingLiabilityRenewalTerm_589291b3-a410-4172-805b-6842288545e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityBasicMonthlyPayment_e98f38bf-fb29-42a9-b9dc-7892b250e54e" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityBasicMonthlyPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_kequ_FinancingLiabilityBasicMonthlyPayment_e98f38bf-fb29-42a9-b9dc-7892b250e54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAnnualIncreasePercent_66b86a34-507e-411e-91ab-62c101990151" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityAnnualIncreasePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_kequ_FinancingLiabilityAnnualIncreasePercent_66b86a34-507e-411e-91ab-62c101990151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDiscountRate_f241d804-a8d0-4e53-8efe-08ad007d4b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseDiscountRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_us-gaap_LesseeFinanceLeaseDiscountRate_f241d804-a8d0-4e53-8efe-08ad007d4b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_d270c012-90e3-44f8-99a8-b531937880a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_d270c012-90e3-44f8-99a8-b531937880a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiability_be96ab5a-3248-49c4-baa4-65167e02d195" xlink:href="kequ-20230430.xsd#kequ_FinancingLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_kequ_FinancingLiability_be96ab5a-3248-49c4-baa4-65167e02d195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_d8e003e4-f998-4b12-ab23-5a6506d8d08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_d8e003e4-f998-4b12-ab23-5a6506d8d08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityCurrent_99e75f85-7f3a-4122-a379-8ee88d55fb4c" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_kequ_FinancingLiabilityCurrent_99e75f85-7f3a-4122-a379-8ee88d55fb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityNoncurrent_a1ce61ef-3619-4676-a83f-1b13897be7e9" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_kequ_FinancingLiabilityNoncurrent_a1ce61ef-3619-4676-a83f-1b13897be7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InterestExpenseFinancingLiability_55adb273-1ff5-4ec0-ab4f-3cbeb0922d26" xlink:href="kequ-20230430.xsd#kequ_InterestExpenseFinancingLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_kequ_InterestExpenseFinancingLiability_55adb273-1ff5-4ec0-ab4f-3cbeb0922d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityTable_c42c5922-6444-4d99-97a3-76faf36cdcbb" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityTable"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7bd8cbd2-87e1-4c02-93c1-d468019155ff" xlink:to="loc_kequ_FinancingLiabilityTable_c42c5922-6444-4d99-97a3-76faf36cdcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cf2cc23d-7658-4698-a93b-8a6b3867e34a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityTable_c42c5922-6444-4d99-97a3-76faf36cdcbb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cf2cc23d-7658-4698-a93b-8a6b3867e34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bd98ec9-6b10-4a9c-8682-fda19825f552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_cf2cc23d-7658-4698-a93b-8a6b3867e34a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bd98ec9-6b10-4a9c-8682-fda19825f552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_62c9734d-65cf-415c-9cde-93be3887a583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bd98ec9-6b10-4a9c-8682-fda19825f552" xlink:to="loc_us-gaap_BuildingMember_62c9734d-65cf-415c-9cde-93be3887a583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_45c8e847-7c2d-4054-8cb2-1378bc00fe24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3bd98ec9-6b10-4a9c-8682-fda19825f552" xlink:to="loc_us-gaap_LandMember_45c8e847-7c2d-4054-8cb2-1378bc00fe24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityLineItems_45fc27af-678f-4a1c-894d-2a9c30328bc2" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityTable_c42c5922-6444-4d99-97a3-76faf36cdcbb" xlink:to="loc_kequ_FinancingLiabilityLineItems_45fc27af-678f-4a1c-894d-2a9c30328bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_039c3922-aacb-4b68-b000-78acf72efc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityLineItems_45fc27af-678f-4a1c-894d-2a9c30328bc2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_039c3922-aacb-4b68-b000-78acf72efc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_01cb72c8-6df0-492e-b696-ac01fc605ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityLineItems_45fc27af-678f-4a1c-894d-2a9c30328bc2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_01cb72c8-6df0-492e-b696-ac01fc605ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityAbstract_7b98b805-bfc2-45c6-b839-e6a6d381d329" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearOne_481ae106-efaa-4817-9501-7d9859426199" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7b98b805-bfc2-45c6-b839-e6a6d381d329" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearOne_481ae106-efaa-4817-9501-7d9859426199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearTwo_1fe51d74-804e-4864-8392-4764eca940c0" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7b98b805-bfc2-45c6-b839-e6a6d381d329" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearTwo_1fe51d74-804e-4864-8392-4764eca940c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearThree_fa9a6ba4-c252-461f-8627-7a0477d969cd" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7b98b805-bfc2-45c6-b839-e6a6d381d329" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearThree_fa9a6ba4-c252-461f-8627-7a0477d969cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFour_fd5444e7-7e0e-47aa-97f8-6fe6ab6d024c" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7b98b805-bfc2-45c6-b839-e6a6d381d329" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearFour_fd5444e7-7e0e-47aa-97f8-6fe6ab6d024c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidYearFive_f04fec77-558a-4a5f-880e-41fdc54e6514" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7b98b805-bfc2-45c6-b839-e6a6d381d329" xlink:to="loc_kequ_FinancingLiabilityToBePaidYearFive_f04fec77-558a-4a5f-880e-41fdc54e6514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaidAfterYearFive_5e53db36-7dc7-48ae-841b-9e72782abe0c" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaidAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7b98b805-bfc2-45c6-b839-e6a6d381d329" xlink:to="loc_kequ_FinancingLiabilityToBePaidAfterYearFive_5e53db36-7dc7-48ae-841b-9e72782abe0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityToBePaid_d6e70a8e-d019-4429-bedd-4afb03755083" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityToBePaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7b98b805-bfc2-45c6-b839-e6a6d381d329" xlink:to="loc_kequ_FinancingLiabilityToBePaid_d6e70a8e-d019-4429-bedd-4afb03755083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiabilityUndiscountedExcessAmount_34579e17-6107-4421-85e3-2bbea04bd11e" xlink:href="kequ-20230430.xsd#kequ_FinancingLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7b98b805-bfc2-45c6-b839-e6a6d381d329" xlink:to="loc_kequ_FinancingLiabilityUndiscountedExcessAmount_34579e17-6107-4421-85e3-2bbea04bd11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FinancingLiability_663cc672-5392-44cf-8a7f-ec50b636cb8c" xlink:href="kequ-20230430.xsd#kequ_FinancingLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_FinancingLiabilityAbstract_7b98b805-bfc2-45c6-b839-e6a6d381d329" xlink:to="loc_kequ_FinancingLiability_663cc672-5392-44cf-8a7f-ec50b636cb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1" xlink:type="simple" xlink:href="kequ-20230430.xsd#SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_39957259-8d02-44f5-b863-41ef8de63cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesTable_b4bcc9ca-3a39-4c4e-82a0-23a4f7d33a80" xlink:href="kequ-20230430.xsd#kequ_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39957259-8d02-44f5-b863-41ef8de63cc1" xlink:to="loc_kequ_IncomeTaxesTable_b4bcc9ca-3a39-4c4e-82a0-23a4f7d33a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_90d80b42-6683-4c95-b209-f20a19967ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesTable_b4bcc9ca-3a39-4c4e-82a0-23a4f7d33a80" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_90d80b42-6683-4c95-b209-f20a19967ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_b6232ba9-ce55-411a-af72-2ab13c2794cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_90d80b42-6683-4c95-b209-f20a19967ab7" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_b6232ba9-ce55-411a-af72-2ab13c2794cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinistryOfFinanceIndiaMember_9a6eae3b-210e-4104-92eb-13230a8c94c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinistryOfFinanceIndiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_b6232ba9-ce55-411a-af72-2ab13c2794cd" xlink:to="loc_us-gaap_MinistryOfFinanceIndiaMember_9a6eae3b-210e-4104-92eb-13230a8c94c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f277643d-7892-4477-8207-9b763ded34e6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesTable_b4bcc9ca-3a39-4c4e-82a0-23a4f7d33a80" xlink:to="loc_srt_RangeAxis_f277643d-7892-4477-8207-9b763ded34e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_699f566c-0f1e-4ab4-b951-f9196c93afcb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f277643d-7892-4477-8207-9b763ded34e6" xlink:to="loc_srt_RangeMember_699f566c-0f1e-4ab4-b951-f9196c93afcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ebdf9c03-3d7e-4924-96ad-57dd0a18d401" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_699f566c-0f1e-4ab4-b951-f9196c93afcb" xlink:to="loc_srt_MinimumMember_ebdf9c03-3d7e-4924-96ad-57dd0a18d401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1ad4b1de-dc81-4434-b671-79cca74538b3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_699f566c-0f1e-4ab4-b951-f9196c93afcb" xlink:to="loc_srt_MaximumMember_1ad4b1de-dc81-4434-b671-79cca74538b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:href="kequ-20230430.xsd#kequ_IncomeTaxesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesTable_b4bcc9ca-3a39-4c4e-82a0-23a4f7d33a80" xlink:to="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod_22cee69a-7961-4836-b9d9-fbde6a01a786" xlink:href="kequ-20230430.xsd#kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod_22cee69a-7961-4836-b9d9-fbde6a01a786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TaxWithholdingExpense_f794ab53-1f15-4a06-ab0e-2a292843c647" xlink:href="kequ-20230430.xsd#kequ_TaxWithholdingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_TaxWithholdingExpense_f794ab53-1f15-4a06-ab0e-2a292843c647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility_e9fdea8f-cff3-4006-875a-60a544caa771" xlink:href="kequ-20230430.xsd#kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility_e9fdea8f-cff3-4006-875a-60a544caa771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback_1a59c2fa-ea84-43e8-a761-e58249a5dada" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_DeferredTaxAssetsSection174REAddback_1a59c2fa-ea84-43e8-a761-e58249a5dada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_546f3ccf-2d05-43f0-90b6-f41dd79f9cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_546f3ccf-2d05-43f0-90b6-f41dd79f9cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_20ed276b-5d3f-40ef-b1ed-db28c8c9aa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_20ed276b-5d3f-40ef-b1ed-db28c8c9aa2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_FederalStateAndLocalTaxReturnsPeriod_b72e6343-5c00-4d74-850b-198722bbbba9" xlink:href="kequ-20230430.xsd#kequ_FederalStateAndLocalTaxReturnsPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_FederalStateAndLocalTaxReturnsPeriod_b72e6343-5c00-4d74-850b-198722bbbba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod_08ce9214-a137-41c3-adb9-78e2ecd8e391" xlink:href="kequ-20230430.xsd#kequ_ForeignSubsidiariesTaxReturnsPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_c455288b-fa77-499d-8c34-e23a2518e114" xlink:to="loc_kequ_ForeignSubsidiariesTaxReturnsPeriod_08ce9214-a137-41c3-adb9-78e2ecd8e391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesIncomeTaxExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f043dad4-27fc-41b4-a915-29acfec8bcbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c6cb1f2b-2e7a-44d8-aed4-425962da5373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f043dad4-27fc-41b4-a915-29acfec8bcbb" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c6cb1f2b-2e7a-44d8-aed4-425962da5373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_dbec02f0-2d84-4e21-a7fa-a2a715694d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c6cb1f2b-2e7a-44d8-aed4-425962da5373" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_dbec02f0-2d84-4e21-a7fa-a2a715694d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a445d912-2957-4b0b-9bb3-75dc5470e9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c6cb1f2b-2e7a-44d8-aed4-425962da5373" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a445d912-2957-4b0b-9bb3-75dc5470e9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d5a0412e-b022-48c2-8db5-90f4cd773aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c6cb1f2b-2e7a-44d8-aed4-425962da5373" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_d5a0412e-b022-48c2-8db5-90f4cd773aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_88f3633f-1ed1-41d2-ab09-e815682836d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c6cb1f2b-2e7a-44d8-aed4-425962da5373" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_88f3633f-1ed1-41d2-ab09-e815682836d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ecea3d13-571e-4182-8372-d1f3d49f0962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f043dad4-27fc-41b4-a915-29acfec8bcbb" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ecea3d13-571e-4182-8372-d1f3d49f0962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_00457a2c-ea4c-4dcd-8300-f2a576a055d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ecea3d13-571e-4182-8372-d1f3d49f0962" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_00457a2c-ea4c-4dcd-8300-f2a576a055d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_31ff1c8c-b82f-47ab-8e23-0dd6bb612a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ecea3d13-571e-4182-8372-d1f3d49f0962" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_31ff1c8c-b82f-47ab-8e23-0dd6bb612a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_b56f99e6-5b11-4b58-97da-1b8b240e3588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ecea3d13-571e-4182-8372-d1f3d49f0962" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_b56f99e6-5b11-4b58-97da-1b8b240e3588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_29c76ca8-3d99-49f3-bd04-c98da29dace0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ecea3d13-571e-4182-8372-d1f3d49f0962" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_29c76ca8-3d99-49f3-bd04-c98da29dace0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_96e70fd1-b651-4365-8a3d-07784f627ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f043dad4-27fc-41b4-a915-29acfec8bcbb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_96e70fd1-b651-4365-8a3d-07784f627ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesScheduleofIncomeTaxReconciliationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9f9fb663-02c3-482b-b16c-33d6047a40b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9f9fb663-02c3-482b-b16c-33d6047a40b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_af39560b-2fde-440f-8350-ff744bcdbd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_af39560b-2fde-440f-8350-ff744bcdbd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCredits_6a6a8145-fbbf-40f1-b7e5-eec9f034ec77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCredits_6a6a8145-fbbf-40f1-b7e5-eec9f034ec77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c4d1ea1f-f564-44b1-933b-ff9b8ee1cfec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_c4d1ea1f-f564-44b1-933b-ff9b8ee1cfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_75424b01-79eb-401f-a098-0c9c3073a757" xlink:href="kequ-20230430.xsd#kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:to="loc_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount_75424b01-79eb-401f-a098-0c9c3073a757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_c091588f-6c37-47fb-a768-1fb3684c43b5" xlink:href="kequ-20230430.xsd#kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:to="loc_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount_c091588f-6c37-47fb-a768-1fb3684c43b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_31118171-f02e-45df-b753-9cba9387a317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:to="loc_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_31118171-f02e-45df-b753-9cba9387a317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_fe3eebd0-4857-4872-8979-289d0d68b4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_fe3eebd0-4857-4872-8979-289d0d68b4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_bbbe350b-c593-49e8-a464-449804ce0421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_bbbe350b-c593-49e8-a464-449804ce0421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_01927cb4-1a1f-435f-b23d-47d47fb8e448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_69c8ab27-5146-4950-a82c-e2b2a38b37e9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_01927cb4-1a1f-435f-b23d-47d47fb8e448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_687ba7b3-71eb-4826-9b9a-2d4d5bf83dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesTable_5b72e6ce-9eda-4e5c-8e64-09bb6db70377" xlink:href="kequ-20230430.xsd#kequ_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_687ba7b3-71eb-4826-9b9a-2d4d5bf83dd6" xlink:to="loc_kequ_IncomeTaxesTable_5b72e6ce-9eda-4e5c-8e64-09bb6db70377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_adee756e-c2c1-461a-971e-1c89daa87a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesTable_5b72e6ce-9eda-4e5c-8e64-09bb6db70377" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_adee756e-c2c1-461a-971e-1c89daa87a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7f63d917-0330-4c27-b995-ed00cdd487fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_adee756e-c2c1-461a-971e-1c89daa87a9a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7f63d917-0330-4c27-b995-ed00cdd487fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_8955e811-09b8-4602-b81b-2003159f400a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7f63d917-0330-4c27-b995-ed00cdd487fc" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_8955e811-09b8-4602-b81b-2003159f400a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:href="kequ-20230430.xsd#kequ_IncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesTable_5b72e6ce-9eda-4e5c-8e64-09bb6db70377" xlink:to="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_1f73d792-69ad-4bb1-8bdd-e7a5e626715e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_1f73d792-69ad-4bb1-8bdd-e7a5e626715e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_57013a5a-717c-4778-b600-df05ab69277e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_57013a5a-717c-4778-b600-df05ab69277e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_8ca6e992-4879-4069-9bd3-e22ac1f79f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_8ca6e992-4879-4069-9bd3-e22ac1f79f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_6311336a-409d-4d7c-adb2-bb7ebe2484c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_6311336a-409d-4d7c-adb2-bb7ebe2484c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_5c5183e1-8fbc-4722-8c34-60740ed09826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign_5c5183e1-8fbc-4722-8c34-60740ed09826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsSection174REAddback_ea655033-b4e9-4ef9-84d4-76abed4d7ac6" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetsSection174REAddback"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_kequ_DeferredTaxAssetsSection174REAddback_ea655033-b4e9-4ef9-84d4-76abed4d7ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_8b3199f7-aa4e-48df-a5a6-e15a41f4295c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_8b3199f7-aa4e-48df-a5a6-e15a41f4295c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_0694bb84-14b3-4a2f-bdaa-c50a4c1da4af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_0694bb84-14b3-4a2f-bdaa-c50a4c1da4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_75c4d6e6-4a11-4f03-8512-b969a9eb58a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_75c4d6e6-4a11-4f03-8512-b969a9eb58a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_9aa0b646-ab73-4ed0-b4f5-7b12141f25c9" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetsProceedsOnSaleLeaseback"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback_9aa0b646-ab73-4ed0-b4f5-7b12141f25c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxAssetLeaseLiability_2d55bf88-52a0-4e41-b4fe-5b999c478c1e" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxAssetLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_kequ_DeferredTaxAssetLeaseLiability_2d55bf88-52a0-4e41-b4fe-5b999c478c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_b976992d-1796-4af7-b17b-b90d9af5c772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_b976992d-1796-4af7-b17b-b90d9af5c772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f9f63028-c2d7-42c2-a31d-bfbfd76f5fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_455bbff3-090a-4e72-b4ed-7c8fb4b0d53c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_f9f63028-c2d7-42c2-a31d-bfbfd76f5fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b15134ad-8f5b-4ba8-bb34-ae376285fde9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b15134ad-8f5b-4ba8-bb34-ae376285fde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_83fa57ed-e595-46cf-b69a-9315a67144e2" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesSaleLeasebackProperty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty_83fa57ed-e595-46cf-b69a-9315a67144e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_fc4a28b1-ac8c-4fe3-be4c-d07dff4b5586" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesPrepaidPensionCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_kequ_DeferredTaxLiabilitiesPrepaidPensionCost_fc4a28b1-ac8c-4fe3-be4c-d07dff4b5586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_00612007-74a3-48eb-a4a4-fb5fac3af2a6" xlink:href="kequ-20230430.xsd#kequ_DeferredTaxLiabilitiesAPB23Assertion"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_kequ_DeferredTaxLiabilitiesAPB23Assertion_00612007-74a3-48eb-a4a4-fb5fac3af2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_9c6ed00c-b042-42eb-bc5f-b92ea7a1091c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_9c6ed00c-b042-42eb-bc5f-b92ea7a1091c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_560a180e-2fcc-4a51-af65-4ff22d7dc961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_560a180e-2fcc-4a51-af65-4ff22d7dc961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c531f92b-9ad7-4cbd-a4aa-4e2d41cd4d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6a85cee4-294a-4cdd-81ed-601a135d7b21" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_c531f92b-9ad7-4cbd-a4aa-4e2d41cd4d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5d1daae9-32a9-41f2-995c-6175c1d7a7a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5d1daae9-32a9-41f2-995c-6175c1d7a7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_35ea5be6-5c17-4876-819e-7512f5fdc53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_us-gaap_DeferredTaxLiabilities_35ea5be6-5c17-4876-819e-7512f5fdc53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_7266a082-43fb-45bc-8d9d-58d40c0a9001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_kequ_IncomeTaxesLineItems_5b30e84c-dd6f-4fe8-ab23-132207e3fa06" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_7266a082-43fb-45bc-8d9d-58d40c0a9001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_86cbd53e-dafd-4c03-8228-21461616f4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_7266a082-43fb-45bc-8d9d-58d40c0a9001" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_86cbd53e-dafd-4c03-8228-21461616f4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_a4c02c5e-5fd4-471e-bfa0-688e717c6b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_7266a082-43fb-45bc-8d9d-58d40c0a9001" xlink:to="loc_us-gaap_DeferredTaxLiabilities_a4c02c5e-5fd4-471e-bfa0-688e717c6b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1" xlink:type="simple" xlink:href="kequ-20230430.xsd#IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#StockOptionsandShareBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e4670472-3843-4d3a-906c-0c29b7e2d3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e4670472-3843-4d3a-906c-0c29b7e2d3ef" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3fd40fe6-e1df-42b7-954e-fd3094fd4466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:to="loc_us-gaap_PlanNameAxis_3fd40fe6-e1df-42b7-954e-fd3094fd4466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e50e26dd-9889-448b-b9a2-9603e61ec3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3fd40fe6-e1df-42b7-954e-fd3094fd4466" xlink:to="loc_us-gaap_PlanNameDomain_e50e26dd-9889-448b-b9a2-9603e61ec3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandTenAndTwoThousandEightPlanMember_38e9bbc2-29a9-4e74-b130-92e5b91e9adc" xlink:href="kequ-20230430.xsd#kequ_TwoThousandTenAndTwoThousandEightPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e50e26dd-9889-448b-b9a2-9603e61ec3c1" xlink:to="loc_kequ_TwoThousandTenAndTwoThousandEightPlanMember_38e9bbc2-29a9-4e74-b130-92e5b91e9adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_705b87bd-ab23-4852-bc0d-53a874b3f3f0" xlink:href="kequ-20230430.xsd#kequ_TwoThousandSeventeenOmnibusIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e50e26dd-9889-448b-b9a2-9603e61ec3c1" xlink:to="loc_kequ_TwoThousandSeventeenOmnibusIncentivePlanMember_705b87bd-ab23-4852-bc0d-53a874b3f3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_TwoThousandAndEightPlanMember_461c5e89-0bd7-442c-845a-57286806ddab" xlink:href="kequ-20230430.xsd#kequ_TwoThousandAndEightPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e50e26dd-9889-448b-b9a2-9603e61ec3c1" xlink:to="loc_kequ_TwoThousandAndEightPlanMember_461c5e89-0bd7-442c-845a-57286806ddab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b151742b-cbc8-42ad-b1d0-2b80c5c8c1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:to="loc_us-gaap_AwardTypeAxis_b151742b-cbc8-42ad-b1d0-2b80c5c8c1d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_849cf841-4cad-4673-b3d9-cc1fc98233c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b151742b-cbc8-42ad-b1d0-2b80c5c8c1d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_849cf841-4cad-4673-b3d9-cc1fc98233c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2374d8ce-2f25-4065-a28a-f8f4cd8b7e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_849cf841-4cad-4673-b3d9-cc1fc98233c4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2374d8ce-2f25-4065-a28a-f8f4cd8b7e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember_65cb4a97-1718-443f-8de1-47476ded7461" xlink:href="kequ-20230430.xsd#kequ_RestrictedStockUnitsRSUsServiceComponentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_2374d8ce-2f25-4065-a28a-f8f4cd8b7e27" xlink:to="loc_kequ_RestrictedStockUnitsRSUsServiceComponentMember_65cb4a97-1718-443f-8de1-47476ded7461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8c91aedc-a701-46e6-9730-745c0416b176" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:to="loc_srt_RangeAxis_8c91aedc-a701-46e6-9730-745c0416b176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4beadd05-c509-4bd4-9ad5-807e72f87133" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8c91aedc-a701-46e6-9730-745c0416b176" xlink:to="loc_srt_RangeMember_4beadd05-c509-4bd4-9ad5-807e72f87133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_27895534-d736-4653-b7e1-10e96f7b4e36" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4beadd05-c509-4bd4-9ad5-807e72f87133" xlink:to="loc_srt_MinimumMember_27895534-d736-4653-b7e1-10e96f7b4e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e26de11b-560b-455d-a0fb-c6f62daf575e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4beadd05-c509-4bd4-9ad5-807e72f87133" xlink:to="loc_srt_MaximumMember_e26de11b-560b-455d-a0fb-c6f62daf575e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d8371697-09eb-4ed1-898b-92644c11ff59" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8a5b924-73b1-4d6c-ba17-0dc8c2c30a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b8a5b924-73b1-4d6c-ba17-0dc8c2c30a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_18ec692e-0c49-45ee-89f8-6bd07d1033a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_18ec692e-0c49-45ee-89f8-6bd07d1033a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9ab84232-897b-4a2c-a8b4-c91be4552f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9ab84232-897b-4a2c-a8b4-c91be4552f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_caddfee5-cba6-4ece-bfaf-1e99288ca860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_caddfee5-cba6-4ece-bfaf-1e99288ca860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_69910a5c-c8fb-42c8-9f0f-feb91d414aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_69910a5c-c8fb-42c8-9f0f-feb91d414aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ca26caab-d707-4dd0-959f-5a9f64cb2c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ca26caab-d707-4dd0-959f-5a9f64cb2c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_ca764426-7f93-4913-8d25-ed2457d1c8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_ca764426-7f93-4913-8d25-ed2457d1c8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7ed488c0-912e-46ab-a21d-135d1f7544e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7ed488c0-912e-46ab-a21d-135d1f7544e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_181fe810-ba3f-40ef-976e-e348837a5589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_181fe810-ba3f-40ef-976e-e348837a5589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_aaba17e3-df0f-41a9-b993-c2cbcf935183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_aaba17e3-df0f-41a9-b993-c2cbcf935183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit_e34a00c9-a130-4de2-b27a-d1d32aad9588" xlink:href="kequ-20230430.xsd#kequ_ShareBasedCompensationDeferredTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_29e0628f-c624-4dd9-b8aa-69256315b879" xlink:to="loc_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit_e34a00c9-a130-4de2-b27a-d1d32aad9588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd60a867-a161-40cb-a12c-6f83fe0f82d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf359770-0939-400a-8bb9-9a29b8aacae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd60a867-a161-40cb-a12c-6f83fe0f82d2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf359770-0939-400a-8bb9-9a29b8aacae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_98b3b5ee-4c92-430a-9555-c404b7a63097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf359770-0939-400a-8bb9-9a29b8aacae4" xlink:to="loc_us-gaap_AwardTypeAxis_98b3b5ee-4c92-430a-9555-c404b7a63097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d21c2bc3-9355-4651-ba45-130d957b3a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_98b3b5ee-4c92-430a-9555-c404b7a63097" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d21c2bc3-9355-4651-ba45-130d957b3a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4914998d-91f9-4fd1-86ae-acc6e9977216" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d21c2bc3-9355-4651-ba45-130d957b3a9e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4914998d-91f9-4fd1-86ae-acc6e9977216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2c8934e-d781-426a-a156-4a04fc3f24ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf359770-0939-400a-8bb9-9a29b8aacae4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2c8934e-d781-426a-a156-4a04fc3f24ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2c8934e-d781-426a-a156-4a04fc3f24ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c0b9e29a-7eac-4928-be6c-b50e03472a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c0b9e29a-7eac-4928-be6c-b50e03472a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_980a0e61-f6df-4798-8a84-a391172e8487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_980a0e61-f6df-4798-8a84-a391172e8487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7b952337-5b75-4f24-97d2-4856ac6fbebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7b952337-5b75-4f24-97d2-4856ac6fbebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_28283d8f-544e-4bab-9dde-c9f5a568b82f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_28283d8f-544e-4bab-9dde-c9f5a568b82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f5d2f95b-220a-43ca-a468-722e84785ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d23db72a-7315-4eb8-ae1c-17f5ee1669ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f5d2f95b-220a-43ca-a468-722e84785ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f2c8934e-d781-426a-a156-4a04fc3f24ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c1305a15-35cd-4c37-bc1d-3d52c68d4f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c1305a15-35cd-4c37-bc1d-3d52c68d4f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a2ed605e-a983-4025-8145-ee5c1aa0b9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a2ed605e-a983-4025-8145-ee5c1aa0b9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bdf78098-6faf-408f-89f6-631fa2df915a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bdf78098-6faf-408f-89f6-631fa2df915a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2b5fb0d0-b644-439c-89f4-a5f909aa4e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2b5fb0d0-b644-439c-89f4-a5f909aa4e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c6095ea1-7021-4ded-83ea-6924d68ac9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_49675f11-be83-48e9-b791-ca336b69405f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c6095ea1-7021-4ded-83ea-6924d68ac9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c459efd-27d0-4434-8343-78d1565adc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cb7884f6-42d3-4e09-8991-a3ff42525360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c459efd-27d0-4434-8343-78d1565adc0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cb7884f6-42d3-4e09-8991-a3ff42525360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_17db6b07-b57a-45f6-937c-ff8df95ed2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cb7884f6-42d3-4e09-8991-a3ff42525360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_17db6b07-b57a-45f6-937c-ff8df95ed2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_425692a4-81f4-4278-aab7-9fa7d71540f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cb7884f6-42d3-4e09-8991-a3ff42525360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_425692a4-81f4-4278-aab7-9fa7d71540f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5825e183-fdd0-4cfa-9f11-8982162c34fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cb7884f6-42d3-4e09-8991-a3ff42525360" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5825e183-fdd0-4cfa-9f11-8982162c34fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_da9027a7-9a21-418c-b129-bd45dadc1ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cb7884f6-42d3-4e09-8991-a3ff42525360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_da9027a7-9a21-418c-b129-bd45dadc1ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c21fe734-ef87-4b92-843b-02ed1f3dc0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_cb7884f6-42d3-4e09-8991-a3ff42525360" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c21fe734-ef87-4b92-843b-02ed1f3dc0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7579d620-007b-4510-82ec-ea8f6b56e19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c459efd-27d0-4434-8343-78d1565adc0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7579d620-007b-4510-82ec-ea8f6b56e19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5a089486-e4e9-4b84-9ef2-a2cd4fddb12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7579d620-007b-4510-82ec-ea8f6b56e19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5a089486-e4e9-4b84-9ef2-a2cd4fddb12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c1edce89-9226-4a0b-b6e2-3489632297b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7579d620-007b-4510-82ec-ea8f6b56e19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c1edce89-9226-4a0b-b6e2-3489632297b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c955c2a5-4413-417a-905b-3f606b70357c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7579d620-007b-4510-82ec-ea8f6b56e19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c955c2a5-4413-417a-905b-3f606b70357c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9e3becdf-5d79-4fb5-b0a4-f244e173a9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7579d620-007b-4510-82ec-ea8f6b56e19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9e3becdf-5d79-4fb5-b0a4-f244e173a9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_fafb4382-2b33-4e6d-a181-a1efc9ff20b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7579d620-007b-4510-82ec-ea8f6b56e19c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_fafb4382-2b33-4e6d-a181-a1efc9ff20b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad34454f-bddc-43de-b49e-aca201e49628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_d0f240c1-4f1f-453d-b571-1287f211345a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad34454f-bddc-43de-b49e-aca201e49628" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_d0f240c1-4f1f-453d-b571-1287f211345a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_5810bc44-6a16-4c09-b6a5-9d91872b0976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad34454f-bddc-43de-b49e-aca201e49628" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_5810bc44-6a16-4c09-b6a5-9d91872b0976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_61f3b2b9-36dd-4399-8348-04ff8a9cc37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad34454f-bddc-43de-b49e-aca201e49628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_61f3b2b9-36dd-4399-8348-04ff8a9cc37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d2c673a3-26ee-44a0-a3d0-3dc3230a1422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad34454f-bddc-43de-b49e-aca201e49628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d2c673a3-26ee-44a0-a3d0-3dc3230a1422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_141f135d-d4ef-44e5-94a6-5d0d4a4cb87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad34454f-bddc-43de-b49e-aca201e49628" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_141f135d-d4ef-44e5-94a6-5d0d4a4cb87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_74e8efc5-6d99-48e5-8040-8527227112f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad34454f-bddc-43de-b49e-aca201e49628" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_74e8efc5-6d99-48e5-8040-8527227112f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_5c74aa11-f33a-453f-9037-0d72a7758bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad34454f-bddc-43de-b49e-aca201e49628" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_5c74aa11-f33a-453f-9037-0d72a7758bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_0db0b343-f2d7-4d75-82fc-62823baaa468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad34454f-bddc-43de-b49e-aca201e49628" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_0db0b343-f2d7-4d75-82fc-62823baaa468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_599358be-18b6-49c5-8d81-6adb5600db87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ad34454f-bddc-43de-b49e-aca201e49628" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_599358be-18b6-49c5-8d81-6adb5600db87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6abdc46b-0a7e-4395-99d8-efeac1b3feb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_867b9c8b-64b2-4f98-963d-96d4cdf19df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6abdc46b-0a7e-4395-99d8-efeac1b3feb2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_867b9c8b-64b2-4f98-963d-96d4cdf19df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8ddf4d7b-6419-4869-a6c3-92461ea37d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_867b9c8b-64b2-4f98-963d-96d4cdf19df4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8ddf4d7b-6419-4869-a6c3-92461ea37d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_48d71c6b-a200-4c68-b894-c5bd0f066ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8ddf4d7b-6419-4869-a6c3-92461ea37d39" xlink:to="loc_us-gaap_EquityComponentDomain_48d71c6b-a200-4c68-b894-c5bd0f066ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_51a0ae28-1d9a-4608-affd-9f837ea351b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_48d71c6b-a200-4c68-b894-c5bd0f066ed8" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_51a0ae28-1d9a-4608-affd-9f837ea351b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dd96aeb4-ba5f-47c8-8530-007c1f84d638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_48d71c6b-a200-4c68-b894-c5bd0f066ed8" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_dd96aeb4-ba5f-47c8-8530-007c1f84d638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_614b5ce9-46a0-49b5-92af-cb3322c2ba27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_867b9c8b-64b2-4f98-963d-96d4cdf19df4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_614b5ce9-46a0-49b5-92af-cb3322c2ba27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_614b5ce9-46a0-49b5-92af-cb3322c2ba27" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_95075450-e421-4294-bbd4-c858b36183a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_95075450-e421-4294-bbd4-c858b36183a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d3013260-96a6-40b8-bc5c-f9f644ae4b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d3013260-96a6-40b8-bc5c-f9f644ae4b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_952ff762-7288-4bc3-841a-75a244395617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_952ff762-7288-4bc3-841a-75a244395617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cc6f5520-c976-426d-933d-cec241502cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_024d6067-2b65-48c4-9dd7-266e6ee1bd1e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cc6f5520-c976-426d-933d-cec241502cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#LeasesCommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d3136a5c-cf4e-4ff3-8f5e-217300fb4b56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d3136a5c-cf4e-4ff3-8f5e-217300fb4b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ad87600c-c7a3-43c8-9436-83e8bc0a2e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_us-gaap_OperatingLeasePayments_ad87600c-c7a3-43c8-9436-83e8bc0a2e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeRemainingLeaseTerm_6b13ba75-7d50-4626-8382-94a3e654d865" xlink:href="kequ-20230430.xsd#kequ_LesseeRemainingLeaseTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_kequ_LesseeRemainingLeaseTerm_6b13ba75-7d50-4626-8382-94a3e654d865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeOptiontoExtendTerm_84ac563e-e1d1-49d0-8784-d3a5310817ff" xlink:href="kequ-20230430.xsd#kequ_LesseeOptiontoExtendTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_kequ_LesseeOptiontoExtendTerm_84ac563e-e1d1-49d0-8784-d3a5310817ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_LesseeOptiontoTerminateTerm_41d0ba0f-4972-4a17-a437-ce3a424a6aaf" xlink:href="kequ-20230430.xsd#kequ_LesseeOptiontoTerminateTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_kequ_LesseeOptiontoTerminateTerm_41d0ba0f-4972-4a17-a437-ce3a424a6aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_664da944-aae3-4ea8-a6eb-199738374222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_us-gaap_OperatingLeaseExpense_664da944-aae3-4ea8-a6eb-199738374222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_OperatingLeaseShortTermExpense_d2c2d28e-4252-4992-9fdd-75a60ebc79a3" xlink:href="kequ-20230430.xsd#kequ_OperatingLeaseShortTermExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_kequ_OperatingLeaseShortTermExpense_d2c2d28e-4252-4992-9fdd-75a60ebc79a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f21db405-0e78-4f30-ae05-c3f1c6a61189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f21db405-0e78-4f30-ae05-c3f1c6a61189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9451a652-97e6-493f-9bd1-ad1488170642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9451a652-97e6-493f-9bd1-ad1488170642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_11e8d551-b82a-48e1-b816-fe42d1f1510f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_11e8d551-b82a-48e1-b816-fe42d1f1510f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_5864acf2-22a2-4bdc-9dc9-47eae91ec6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_82086989-45e7-4065-a93f-69788c487ec4" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_5864acf2-22a2-4bdc-9dc9-47eae91ec6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7dc9c380-3c35-41e7-9d6d-2293a3ee3e58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7dc9c380-3c35-41e7-9d6d-2293a3ee3e58" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_121e30d3-9fc1-4769-8e90-b899be108271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_121e30d3-9fc1-4769-8e90-b899be108271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_24fda69e-9da8-4724-b741-13f3394c5f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_24fda69e-9da8-4724-b741-13f3394c5f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9ae93806-e203-441e-bfa4-7b436bf3a138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9ae93806-e203-441e-bfa4-7b436bf3a138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ba9c4aa9-cc11-4e22-a37f-931b5bec9394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ba9c4aa9-cc11-4e22-a37f-931b5bec9394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f46551af-d716-48c4-a226-6a13120f1def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f46551af-d716-48c4-a226-6a13120f1def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_de662923-9af3-476b-ad19-400e37630627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_de662923-9af3-476b-ad19-400e37630627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2b08e718-0eb5-4266-a961-ff39f1e20442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2b08e718-0eb5-4266-a961-ff39f1e20442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_58e5b0c2-1e29-4e3a-980c-eebdc9e2fb36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_58e5b0c2-1e29-4e3a-980c-eebdc9e2fb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c388ab55-a107-4757-aadb-2bfd28755353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_41827659-548a-4938-ba35-74f153ad148d" xlink:to="loc_us-gaap_OperatingLeaseLiability_c388ab55-a107-4757-aadb-2bfd28755353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7dc9c380-3c35-41e7-9d6d-2293a3ee3e58" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7ff3afa2-23f5-43b7-8d34-f64e1b1a3dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7ff3afa2-23f5-43b7-8d34-f64e1b1a3dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d959a9b8-c3e1-433a-8295-57d311bd84d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_d959a9b8-c3e1-433a-8295-57d311bd84d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2e60436b-eacd-42d4-864e-b18f68f30b76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2e60436b-eacd-42d4-864e-b18f68f30b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_7162f0b1-4252-4763-b524-a5f2248d6e40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_7162f0b1-4252-4763-b524-a5f2248d6e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5840edaf-8743-4b0b-b8c8-85e04c5abbae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5840edaf-8743-4b0b-b8c8-85e04c5abbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_e74626bc-ba9e-4b9c-ac5e-a4e93f504bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_e74626bc-ba9e-4b9c-ac5e-a4e93f504bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_934609c1-ac43-467d-b18f-1fd13ade1ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_934609c1-ac43-467d-b18f-1fd13ade1ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_29c7b92b-e696-4899-bfd3-47950f3d3bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_29c7b92b-e696-4899-bfd3-47950f3d3bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b34dc372-b57a-4445-acd6-26c68605ce9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35f9abab-a4ce-4725-ba7a-298f9f674198" xlink:to="loc_us-gaap_FinanceLeaseLiability_b34dc372-b57a-4445-acd6-26c68605ce9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1" xlink:type="simple" xlink:href="kequ-20230430.xsd#LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da95bae3-d335-4528-a0b9-ce4447ecb276" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_78e5c54c-6da5-45f8-901e-4e0756e2d5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da95bae3-d335-4528-a0b9-ce4447ecb276" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_78e5c54c-6da5-45f8-901e-4e0756e2d5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_bec1d1bc-fb82-4751-ae08-cadd17d083d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da95bae3-d335-4528-a0b9-ce4447ecb276" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_bec1d1bc-fb82-4751-ae08-cadd17d083d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_b13fa481-c59a-4616-a5e7-8b6dade71be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_bec1d1bc-fb82-4751-ae08-cadd17d083d0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_b13fa481-c59a-4616-a5e7-8b6dade71be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_3aae52f5-9693-45bc-a23c-dfd2f0de4244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_bec1d1bc-fb82-4751-ae08-cadd17d083d0" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_3aae52f5-9693-45bc-a23c-dfd2f0de4244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7ef7cd2c-cda6-47a4-911d-3fb48cfebe6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_bec1d1bc-fb82-4751-ae08-cadd17d083d0" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_7ef7cd2c-cda6-47a4-911d-3fb48cfebe6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_63c76b3b-c35e-4440-9745-e77ad7f9e275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_bec1d1bc-fb82-4751-ae08-cadd17d083d0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_63c76b3b-c35e-4440-9745-e77ad7f9e275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8f491b4e-aedc-4657-afe8-a29b4af76cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_bec1d1bc-fb82-4751-ae08-cadd17d083d0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_8f491b4e-aedc-4657-afe8-a29b4af76cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ac730d83-0bb2-4f0d-961f-afd944e221ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da95bae3-d335-4528-a0b9-ce4447ecb276" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ac730d83-0bb2-4f0d-961f-afd944e221ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a811e064-4447-4498-9e28-69e1042a8be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ac730d83-0bb2-4f0d-961f-afd944e221ab" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a811e064-4447-4498-9e28-69e1042a8be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_45d0d2f4-b5ca-4efd-913d-2c81dba47431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ac730d83-0bb2-4f0d-961f-afd944e221ab" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_45d0d2f4-b5ca-4efd-913d-2c81dba47431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_b0801b75-fd0f-4eb5-a488-ada10852709f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ac730d83-0bb2-4f0d-961f-afd944e221ab" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_b0801b75-fd0f-4eb5-a488-ada10852709f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_71672a7a-260b-4ef4-aae1-b3ded55c84e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ac730d83-0bb2-4f0d-961f-afd944e221ab" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_71672a7a-260b-4ef4-aae1-b3ded55c84e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_59acd6ca-3a73-4ac5-8b85-ab1da0631556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_ac730d83-0bb2-4f0d-961f-afd944e221ab" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_59acd6ca-3a73-4ac5-8b85-ab1da0631556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_fb692fda-d2bd-4f44-b26f-e1fbfefc6f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da95bae3-d335-4528-a0b9-ce4447ecb276" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_fb692fda-d2bd-4f44-b26f-e1fbfefc6f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_07ffafbc-574e-4677-bde9-854b4ed4ff31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da95bae3-d335-4528-a0b9-ce4447ecb276" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_07ffafbc-574e-4677-bde9-854b4ed4ff31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_e0893c0e-00db-408e-a5b0-33d33f0e7d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_07ffafbc-574e-4677-bde9-854b4ed4ff31" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_e0893c0e-00db-408e-a5b0-33d33f0e7d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_618c7b6c-1b96-44a4-b995-8851bf7bde73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da95bae3-d335-4528-a0b9-ce4447ecb276" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_618c7b6c-1b96-44a4-b995-8851bf7bde73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_e4ba37a5-6937-4dae-974f-f1f3dde5eaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_618c7b6c-1b96-44a4-b995-8851bf7bde73" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_e4ba37a5-6937-4dae-974f-f1f3dde5eaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_971d5aee-912c-4a3a-a2a8-6d5072272dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_618c7b6c-1b96-44a4-b995-8851bf7bde73" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_971d5aee-912c-4a3a-a2a8-6d5072272dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_dbc98d4e-f86f-4006-9623-7a45963f4ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract_618c7b6c-1b96-44a4-b995-8851bf7bde73" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_dbc98d4e-f86f-4006-9623-7a45963f4ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_44364a83-18cd-4419-bb46-0c2b1fa9f653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da95bae3-d335-4528-a0b9-ce4447ecb276" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_44364a83-18cd-4419-bb46-0c2b1fa9f653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_c311da06-4dff-4f6c-b369-bfd4cf1073c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_44364a83-18cd-4419-bb46-0c2b1fa9f653" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_c311da06-4dff-4f6c-b369-bfd4cf1073c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_01689f1a-0340-4e6d-a9d0-6e1905c29bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_da95bae3-d335-4528-a0b9-ce4447ecb276" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_01689f1a-0340-4e6d-a9d0-6e1905c29bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_d7518acb-2581-4ea9-bd98-cd1ce8ce9ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_01689f1a-0340-4e6d-a9d0-6e1905c29bc5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_d7518acb-2581-4ea9-bd98-cd1ce8ce9ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_debea900-5d3b-4dd2-93af-818acd3b4973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_01689f1a-0340-4e6d-a9d0-6e1905c29bc5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_debea900-5d3b-4dd2-93af-818acd3b4973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b07bd08-f9ca-4aba-83f9-93127403dc46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_aa4ec561-085e-4dd6-93f2-5e8bea886c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b07bd08-f9ca-4aba-83f9-93127403dc46" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_aa4ec561-085e-4dd6-93f2-5e8bea886c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7dc51d88-c603-4867-857d-49c257ddd645" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b07bd08-f9ca-4aba-83f9-93127403dc46" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7dc51d88-c603-4867-857d-49c257ddd645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_0f29258e-64ca-451d-a656-8f962df71660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b07bd08-f9ca-4aba-83f9-93127403dc46" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_0f29258e-64ca-451d-a656-8f962df71660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_161f9d7e-0100-4bd6-b509-893e1e166b25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b07bd08-f9ca-4aba-83f9-93127403dc46" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_161f9d7e-0100-4bd6-b509-893e1e166b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_4f346991-7af0-4611-8f97-7cd936489cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b07bd08-f9ca-4aba-83f9-93127403dc46" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList_4f346991-7af0-4611-8f97-7cd936489cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_22f19103-a435-433e-a014-64bc0b46700c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b07bd08-f9ca-4aba-83f9-93127403dc46" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_22f19103-a435-433e-a014-64bc0b46700c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_87c2846f-7089-45c0-a460-1dac2cbe4117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4b07bd08-f9ca-4aba-83f9-93127403dc46" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList_87c2846f-7089-45c0-a460-1dac2cbe4117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d16192c4-9c03-41fb-a804-dac18efdd7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d16192c4-9c03-41fb-a804-dac18efdd7f8" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_00b244b8-3357-499d-a70d-378a236ba9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:to="loc_us-gaap_ValuationTechniqueAxis_00b244b8-3357-499d-a70d-378a236ba9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_9602573b-baf2-4fec-b5a2-0f7c3dc0937e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_00b244b8-3357-499d-a70d-378a236ba9bb" xlink:to="loc_us-gaap_ValuationTechniqueDomain_9602573b-baf2-4fec-b5a2-0f7c3dc0937e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_YieldCurveTechniqueMember_6067b24e-9f90-43ff-96f2-2b1e4953a7e8" xlink:href="kequ-20230430.xsd#kequ_YieldCurveTechniqueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_9602573b-baf2-4fec-b5a2-0f7c3dc0937e" xlink:to="loc_kequ_YieldCurveTechniqueMember_6067b24e-9f90-43ff-96f2-2b1e4953a7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_63d9cf7c-94a8-4fb3-85d5-252ea364060a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_63d9cf7c-94a8-4fb3-85d5-252ea364060a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_109a3963-18ac-4b5f-a987-cf4eb5bb8223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_63d9cf7c-94a8-4fb3-85d5-252ea364060a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_109a3963-18ac-4b5f-a987-cf4eb5bb8223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_0de123d1-5e80-4133-a279-eafbfeb9cf27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_109a3963-18ac-4b5f-a987-cf4eb5bb8223" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_0de123d1-5e80-4133-a279-eafbfeb9cf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_556b78d4-d649-45da-9ddb-f6d96c66d76a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_109a3963-18ac-4b5f-a987-cf4eb5bb8223" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_556b78d4-d649-45da-9ddb-f6d96c66d76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2dcf92a2-f35b-4752-9453-fa07125653fb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:to="loc_srt_RangeAxis_2dcf92a2-f35b-4752-9453-fa07125653fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_638af877-541a-4050-810f-d7805f07339a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2dcf92a2-f35b-4752-9453-fa07125653fb" xlink:to="loc_srt_RangeMember_638af877-541a-4050-810f-d7805f07339a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_12181755-6250-438e-ad33-f9b4bac29903" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_638af877-541a-4050-810f-d7805f07339a" xlink:to="loc_srt_MaximumMember_12181755-6250-438e-ad33-f9b4bac29903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9e51fc2a-f82b-4831-8512-762719c6a6dd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_638af877-541a-4050-810f-d7805f07339a" xlink:to="loc_srt_MinimumMember_9e51fc2a-f82b-4831-8512-762719c6a6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_3e378db9-dd23-461e-9180-7ab7bb1b4b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_3e378db9-dd23-461e-9180-7ab7bb1b4b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9ec404b0-c86d-4317-9557-f241c07482a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_3e378db9-dd23-461e-9180-7ab7bb1b4b40" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9ec404b0-c86d-4317-9557-f241c07482a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e59d4f29-a02a-4ec9-ab16-696a2f12bcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9ec404b0-c86d-4317-9557-f241c07482a2" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e59d4f29-a02a-4ec9-ab16-696a2f12bcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_229f1371-3af0-4fa3-bfd1-40bcf818fb52" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_5cfffda4-6326-4d8c-97ac-5386d0543e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear_5cfffda4-6326-4d8c-97ac-5386d0543e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_96d45b30-d136-4ec3-afd1-b6ca75c06a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_96d45b30-d136-4ec3-afd1-b6ca75c06a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_9f6df692-34d1-4d5a-bb9f-5806b3819316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_9f6df692-34d1-4d5a-bb9f-5806b3819316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_3b5acf3d-6c3d-4cc4-8fb7-2c7ef411b84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_3b5acf3d-6c3d-4cc4-8fb7-2c7ef411b84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate_ee53ed13-5267-45d3-9a21-53cc081c8eac" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanPercentageChangesInDiscountRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate_ee53ed13-5267-45d3-9a21-53cc081c8eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_7da4aadf-a45c-4c06-b4ef-ce0ef8f1b7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_7da4aadf-a45c-4c06-b4ef-ce0ef8f1b7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_954fd409-58d5-4c39-b9a3-6c9794f8a9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_954fd409-58d5-4c39-b9a3-6c9794f8a9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_2b1cd2ec-fbd9-4b62-b3ae-8bc954598034" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions_2b1cd2ec-fbd9-4b62-b3ae-8bc954598034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_cf78b8a7-1ff1-4e51-9264-21327b24e2e1" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanEligibilityMinimumServicePeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod_cf78b8a7-1ff1-4e51-9264-21327b24e2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_81695c9b-56d1-408d-8521-08dd77be32ef" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution_81695c9b-56d1-408d-8521-08dd77be32ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_e89741a3-cd3b-4b5b-874f-696fbb4b4a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_e89741a3-cd3b-4b5b-874f-696fbb4b4a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_c37e1408-a5ac-43a6-ae0d-066402b93ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_c37e1408-a5ac-43a6-ae0d-066402b93ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_55755421-5bd0-4e30-8454-166a63aa11f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_55755421-5bd0-4e30-8454-166a63aa11f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_8594c846-1800-427d-91f6-a0f1090e8c79" xlink:href="kequ-20230430.xsd#kequ_DefinedContributionPlanEmployerMatchingContributionsAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_fbc233e6-f4fd-442c-952d-6558384c3374" xlink:to="loc_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount_8594c846-1800-427d-91f6-a0f1090e8c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6cf1ed31-1d64-4ad2-9ed0-ac2ac2af862c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_e317ae99-888d-4f42-9a0e-9db2d6dffb18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6cf1ed31-1d64-4ad2-9ed0-ac2ac2af862c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_e317ae99-888d-4f42-9a0e-9db2d6dffb18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_aa67a965-8846-4b6a-b58b-5fc65e5a6f4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6cf1ed31-1d64-4ad2-9ed0-ac2ac2af862c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_aa67a965-8846-4b6a-b58b-5fc65e5a6f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_018d66b6-b391-4721-b10b-1802e46459c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6cf1ed31-1d64-4ad2-9ed0-ac2ac2af862c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_018d66b6-b391-4721-b10b-1802e46459c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_3823c047-ba5a-4e11-9a16-0acfd528bda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6cf1ed31-1d64-4ad2-9ed0-ac2ac2af862c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_3823c047-ba5a-4e11-9a16-0acfd528bda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_262a9327-9aae-4c81-8936-407d3bf2c9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6cf1ed31-1d64-4ad2-9ed0-ac2ac2af862c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_262a9327-9aae-4c81-8936-407d3bf2c9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_5095245b-f334-4d6e-b515-feb44ecc7a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6cf1ed31-1d64-4ad2-9ed0-ac2ac2af862c" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_5095245b-f334-4d6e-b515-feb44ecc7a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_d5cdab10-afd7-4bcd-8026-a421bd06ec10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_72d98a1f-04ad-4cb5-9a45-57450df86030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_d5cdab10-afd7-4bcd-8026-a421bd06ec10" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_72d98a1f-04ad-4cb5-9a45-57450df86030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c18dc98c-a785-42eb-a51d-b4ec78cc0553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_72d98a1f-04ad-4cb5-9a45-57450df86030" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c18dc98c-a785-42eb-a51d-b4ec78cc0553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_4897fb7e-ca73-4515-848c-9b9106da7ece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c18dc98c-a785-42eb-a51d-b4ec78cc0553" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_4897fb7e-ca73-4515-848c-9b9106da7ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_64f05182-7e30-47cd-8f50-8f3cebffe07e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_4897fb7e-ca73-4515-848c-9b9106da7ece" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_64f05182-7e30-47cd-8f50-8f3cebffe07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_c28fab2a-2cc7-428d-b0c6-096eebfc3a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_4897fb7e-ca73-4515-848c-9b9106da7ece" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_c28fab2a-2cc7-428d-b0c6-096eebfc3a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_668fb910-40bb-40ff-a71e-a4aa4a4473ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_4897fb7e-ca73-4515-848c-9b9106da7ece" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_668fb910-40bb-40ff-a71e-a4aa4a4473ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9f6880ef-56cc-44ab-901c-07b5acccd282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_72d98a1f-04ad-4cb5-9a45-57450df86030" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9f6880ef-56cc-44ab-901c-07b5acccd282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bff25733-e2b9-4cd2-b07c-dcba6ff48a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9f6880ef-56cc-44ab-901c-07b5acccd282" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_bff25733-e2b9-4cd2-b07c-dcba6ff48a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_12ba333b-5642-441a-a58d-4d9aaecec4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9f6880ef-56cc-44ab-901c-07b5acccd282" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_12ba333b-5642-441a-a58d-4d9aaecec4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e5860004-4338-413f-8ada-f354dff65d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4752fdd-1a19-4c22-9a28-fd4e1dc404c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e5860004-4338-413f-8ada-f354dff65d5e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4752fdd-1a19-4c22-9a28-fd4e1dc404c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d915d71-d231-4fd9-a087-20460c4ee352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4752fdd-1a19-4c22-9a28-fd4e1dc404c8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d915d71-d231-4fd9-a087-20460c4ee352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b082ca70-c466-4b3b-a607-a46828d28211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d915d71-d231-4fd9-a087-20460c4ee352" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b082ca70-c466-4b3b-a607-a46828d28211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_84d5abf4-93fb-490a-8e12-50177bf85290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b082ca70-c466-4b3b-a607-a46828d28211" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_84d5abf4-93fb-490a-8e12-50177bf85290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b4cbe864-71d8-4dab-89d4-846c45db6afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b082ca70-c466-4b3b-a607-a46828d28211" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b4cbe864-71d8-4dab-89d4-846c45db6afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4388668c-18fb-49d0-9ede-276d940f0884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b082ca70-c466-4b3b-a607-a46828d28211" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4388668c-18fb-49d0-9ede-276d940f0884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fa8132c9-d83b-4c0f-9354-c3986af95556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4752fdd-1a19-4c22-9a28-fd4e1dc404c8" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fa8132c9-d83b-4c0f-9354-c3986af95556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_5d4fddf2-cd86-4f6f-8575-09e06e3676bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_fa8132c9-d83b-4c0f-9354-c3986af95556" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_5d4fddf2-cd86-4f6f-8575-09e06e3676bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5d4fddf2-cd86-4f6f-8575-09e06e3676bd" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_d1d8604e-d3f7-4a7c-b866-a5409f544e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember_d1d8604e-d3f7-4a7c-b866-a5409f544e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_535fdf59-9a18-4a8b-a9c4-af75c11ff27b" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:to="loc_kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember_535fdf59-9a18-4a8b-a9c4-af75c11ff27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_adaa618a-adca-4dbd-b01c-ffe28f85543a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_adaa618a-adca-4dbd-b01c-ffe28f85543a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanEmergingMarketsMember_905560a7-5deb-4a9c-8135-9a85fca610d1" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanEmergingMarketsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:to="loc_kequ_DefinedBenefitPlanEmergingMarketsMember_905560a7-5deb-4a9c-8135-9a85fca610d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember_7f407dcb-4fa1-456c-b0ad-b45f31ead911" xlink:href="kequ-20230430.xsd#kequ_DefinedBenefitPlanLiquidAlternativesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_a1bb2bfc-736d-4e62-9754-b992fa5bbac6" xlink:to="loc_kequ_DefinedBenefitPlanLiquidAlternativesMember_7f407dcb-4fa1-456c-b0ad-b45f31ead911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_5a5a9963-f178-4607-903b-565ba8bdb89b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5d4fddf2-cd86-4f6f-8575-09e06e3676bd" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_5a5a9963-f178-4607-903b-565ba8bdb89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_3609920e-69d7-4cd0-abf2-e3a59d33cbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_5d4fddf2-cd86-4f6f-8575-09e06e3676bd" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_3609920e-69d7-4cd0-abf2-e3a59d33cbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_03c5c174-c985-4513-9948-3323b2455d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_c4752fdd-1a19-4c22-9a28-fd4e1dc404c8" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_03c5c174-c985-4513-9948-3323b2455d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_69b8c256-4cd4-4af0-9375-62426334e22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_03c5c174-c985-4513-9948-3323b2455d0e" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_69b8c256-4cd4-4af0-9375-62426334e22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SegmentInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1a9895cc-30ea-4794-8011-125d16a69f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_80aa40e7-b1b1-420c-a230-fd0985bce9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1a9895cc-30ea-4794-8011-125d16a69f8f" xlink:to="loc_us-gaap_NumberOfOperatingSegments_80aa40e7-b1b1-420c-a230-fd0985bce9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/SegmentInformationDetail" xlink:type="simple" xlink:href="kequ-20230430.xsd#SegmentInformationDetail"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/SegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b24f5610-2fec-437a-9dfb-22cdb518b893" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b24f5610-2fec-437a-9dfb-22cdb518b893" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d88b7656-f5e7-4a6c-a461-654cf790b65f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d88b7656-f5e7-4a6c-a461-654cf790b65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_29bfd0ea-9bfa-4fee-a262-0cf89b5e8c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d88b7656-f5e7-4a6c-a461-654cf790b65f" xlink:to="loc_us-gaap_SegmentDomain_29bfd0ea-9bfa-4fee-a262-0cf89b5e8c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_DomesticOperationsMember_3f9cff34-b6fc-4d00-aba2-9a6f10aefef4" xlink:href="kequ-20230430.xsd#kequ_DomesticOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_29bfd0ea-9bfa-4fee-a262-0cf89b5e8c87" xlink:to="loc_kequ_DomesticOperationsMember_3f9cff34-b6fc-4d00-aba2-9a6f10aefef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_InternationalOperationsMember_72117532-59de-40b8-ae44-8db1193a54f6" xlink:href="kequ-20230430.xsd#kequ_InternationalOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_29bfd0ea-9bfa-4fee-a262-0cf89b5e8c87" xlink:to="loc_kequ_InternationalOperationsMember_72117532-59de-40b8-ae44-8db1193a54f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_dff54992-9b60-4890-a8a3-2cd3e8f88002" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:to="loc_srt_ConsolidationItemsAxis_dff54992-9b60-4890-a8a3-2cd3e8f88002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ae2cd7ad-d6af-43fd-af0f-464c5c2221d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_dff54992-9b60-4890-a8a3-2cd3e8f88002" xlink:to="loc_srt_ConsolidationItemsDomain_ae2cd7ad-d6af-43fd-af0f-464c5c2221d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_78c2517a-81aa-4cb9-9132-1bafa052e55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ae2cd7ad-d6af-43fd-af0f-464c5c2221d8" xlink:to="loc_us-gaap_OperatingSegmentsMember_78c2517a-81aa-4cb9-9132-1bafa052e55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_6df56f60-dd86-4b3a-ae2c-c191bb028032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ae2cd7ad-d6af-43fd-af0f-464c5c2221d8" xlink:to="loc_us-gaap_CorporateNonSegmentMember_6df56f60-dd86-4b3a-ae2c-c191bb028032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_67eff680-15ab-4b3d-8682-0daeb3685be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ae2cd7ad-d6af-43fd-af0f-464c5c2221d8" xlink:to="loc_us-gaap_IntersegmentEliminationMember_67eff680-15ab-4b3d-8682-0daeb3685be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_43fd9383-0ecc-4177-aa01-6ac18ce5d515" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:to="loc_srt_StatementGeographicalAxis_43fd9383-0ecc-4177-aa01-6ac18ce5d515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_817b556c-587b-40d4-8585-1260aadcaa84" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_43fd9383-0ecc-4177-aa01-6ac18ce5d515" xlink:to="loc_srt_SegmentGeographicalDomain_817b556c-587b-40d4-8585-1260aadcaa84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_e38db88d-e409-4374-b895-8b10c377fc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_817b556c-587b-40d4-8585-1260aadcaa84" xlink:to="loc_us-gaap_NonUsMember_e38db88d-e409-4374-b895-8b10c377fc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_24f4555b-1b3a-4ddf-9f4b-ed3b9c4a009a" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_22b04014-be73-4fa5-a6cb-61195771e29d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_22b04014-be73-4fa5-a6cb-61195771e29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_kequ_RevenuesIncludingIntersegmentMarkup_f3cf79a8-fa6e-455e-ab60-7496764218b2" xlink:href="kequ-20230430.xsd#kequ_RevenuesIncludingIntersegmentMarkup"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_kequ_RevenuesIncludingIntersegmentMarkup_f3cf79a8-fa6e-455e-ab60-7496764218b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f4633bb8-8fd0-45bb-b6a7-53d9d6738aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_Depreciation_f4633bb8-8fd0-45bb-b6a7-53d9d6738aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2f7e6d4-fc46-45be-a9dd-e2ef764f8123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c2f7e6d4-fc46-45be-a9dd-e2ef764f8123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3e9b49e7-9414-4878-b494-2950a213f308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3e9b49e7-9414-4878-b494-2950a213f308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0bfd5750-3f80-47a4-bb71-4cead5088edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0bfd5750-3f80-47a4-bb71-4cead5088edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_055c5f45-df47-4fa0-a513-eef6789e3730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_NetIncomeLoss_055c5f45-df47-4fa0-a513-eef6789e3730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cac90fbe-73ac-47d2-a3e2-962ce1482406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_Assets_cac90fbe-73ac-47d2-a3e2-962ce1482406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_05c83310-e3a1-4e28-9e06-9421441cdf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8e535093-7eca-4ec6-a121-a0ec0dcb784c" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_05c83310-e3a1-4e28-9e06-9421441cdf2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails" xlink:type="simple" xlink:href="kequ-20230430.xsd#RestructuringCostsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6ec8f8a8-c6e4-42e6-b784-195b78bf63cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60390cee-5688-408c-a3e5-8555c90f827a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6ec8f8a8-c6e4-42e6-b784-195b78bf63cb" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60390cee-5688-408c-a3e5-8555c90f827a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_a1d312be-0664-4d50-8807-815ccbad8fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60390cee-5688-408c-a3e5-8555c90f827a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_a1d312be-0664-4d50-8807-815ccbad8fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c2568785-b6ed-4a97-bc31-5e8e61082d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_a1d312be-0664-4d50-8807-815ccbad8fe2" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c2568785-b6ed-4a97-bc31-5e8e61082d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_a412a23c-7cf8-426f-b93d-8e49fd929fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c2568785-b6ed-4a97-bc31-5e8e61082d49" xlink:to="loc_us-gaap_FacilityClosingMember_a412a23c-7cf8-426f-b93d-8e49fd929fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4a0c1e4d-9115-45a0-acff-eb1da8574589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_60390cee-5688-408c-a3e5-8555c90f827a" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_4a0c1e4d-9115-45a0-acff-eb1da8574589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_755d8203-7b80-4a4e-b753-b5deea0a3632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4a0c1e4d-9115-45a0-acff-eb1da8574589" xlink:to="loc_us-gaap_RestructuringCosts_755d8203-7b80-4a4e-b753-b5deea0a3632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_3750fe1f-28e7-4130-831c-ab51998f22da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4a0c1e4d-9115-45a0-acff-eb1da8574589" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_3750fe1f-28e7-4130-831c-ab51998f22da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>exhibit1034b001.jpg
<TEXT>
begin 644 exhibit1034b001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
MSC.!VSQGUK/USQ4NBWE[;FS,WV72)M4W"3;N$9QLZ<9]?TKG/"GA_5+?5-%:
M^LM4B&EVKQ%[FZMS"I*A=L2QC<RG&?FVXP.IK0\5Z#J6I:GJLUI;>9'/X<NK
M&,[U&Z9V!5>3W]>GO0!8A\6ZE;OI\FLZ$EG97\D<,=S!>"<(\GW XV*0"2!D
M9Y(KI[>[MKL2FVGCF$4C12;&!V.O53Z$>E<5+;Z]XAL=)T>XT"?3+2WGMIKJ
MXN;B%MPA97"HL;L22RJ,G&!FNRLY)9!/YMFUMMF95#,I\Q1T?Y2< ^AY]: .
M<TKQ-KVLAKBS\/6OV$74MOYLFI;7Q'*T;-L\KU4G&?QH@\:/--%<MI931I[X
MV$-Z9P7:3>8PQCQPA<;0=V>0< 57\)>";.PM_MFHZ:J:H+^YG$GFDG#3NR'@
MX^Z5_K63/X3O;S6([5--OK.VCU<7[2?;5:S"K+YF^./=NWN0 5*[068CL2 =
M6_BJW_X3.#PW% \LK022RS@_)$RA2$]VPX)'8%?6L_2/$_B'6[2*^M/#EI]C
MDD=%>34R&PKE"=OE?[)XS6;8>#-=TKQ1HDZZN+NTMQ=/<S-;(KEI"A.[YLL7
M(/('&WZ5E^'O#CZ3;P+>^ +ZXOXKB20W<=W;[6)E9E8 S ]".W:@#JKCQF\-
MW<2KIA?1[6]6PGO?/ 992RJ2(\<H&8*3N!Z\$"KA\50'QA!X>BM;AW>*5WN6
M0K&K)M.Q21\YPXSC@<=ZYV[T/6&MM3\.QZ;(]M?ZM]L&H"6/RDA:597!!;?O
M!#* %(.0<]<=)J.GW4_C+0]0CBW6MK;W:3/N VL_E;1C.3G:W3TH AN?%T%M
MXS@\/FV<I(JJ]WO^2.9U=DB(QU*QL<Y_N^M5;SQ7JR:MK-KI^@PW=OI)032O
M?B)FW1+)\JE". V.6'2L&7P/KNH:%J.HR:G>6NM75TVI1V(\AHDG0CR%+["W
M"I&IP^.O8U6O/#<U_KVMWVK> [C4O[1$#Q,EY HCQ BLA)E!&&!&0#TR,T >
MC6.JVU]H=MJZ%H[6>V6Z!D&"J,N[D>N#7.VWCO;#!=ZII;V-A=V<M[:3><)&
M>-$WD.N!L8I\P +=#R"*73_"NKR>'[&VU3Q%?>>MB+>Y@C\MH9&*E222F\GG
MKN&<9K.L]'UG4ET*SU'1A!'HUE+%,T\J-%=2&'R0$VDML(+$E@".!C.: -:T
M\776^)=2T26U>ZLY+RSCAF$[S*@!9"H Q)AEPHR#SSQ3K?Q9>+/=VFH:'+#>
MPV/VZ.VM9A<-*F2-G1</D8QR/0G!KG='\.:PFIVFH0:?>VLVF6$T5O'JM\)T
M,SA0L:;&)$0VG+'#'*^G%RTL-:_M^]US2] &DSO8.MQ!=S(5O;HLK(?W;-PH
M#C><$[^F!0!T.CZ]=7NK76E:CIRV5]!!'<;8K@3(8W+ ?-M7# H<C'T)IOB[
MQ5;>$](^V2P/<S,=L5O&<,^.6.>R@<D_0=2*P]-T&_N]?U*^M;2^\,6UW;*L
M^R2%I9KGS-QD"@R(,+E2QY.[IP#57Q3X&UR\T[4);+79KZYELUM4CNK>(NRA
MMQ <;57)Y) &=J^@H Z;7_%4&A7NGV9M;BYGO+F&']VA"1+)($WN^,#D\#J?
MIDBKJGB^:QO-56VTEKJST=%?4)_/",F4\PB-,'>0A#')7K@9-3^(=+U"]TG2
MH$(NKB#4+.::0 1[ECE5G?!/' )P/PKGO%_AV^U*_P!6ALM+O<ZG;+#]HM[Y
M8[>0[2N;A"P;Y>/N@[A@'TH UK_QO]FDO[BVTXW.DZ:8Q?7@G"E-RJY*)CYP
MJ.K'D=>,FNL+ *6)  &237G-]X<U>TTSQ#X;LM.DN+76BHAOA)&$@5H8X9/,
M!8-D!"PV@YR!Q6SX@T#67TW4(M.U;4+EM0 M1!*85CM(W8!Y%(4,2J;L98GZ
MT 6?"_C"W\2P7TOV9[06S!T$C9\VW8;HYAQP& /';!JOH'B^^UK3VU%M%6.T
M^R_:5$%XL\YRNY4,04$,1VSUXK./A#5-&UFSNM.O)]5@ELGTVYBO?)1(H@I:
M(XC1,J&&T]3ASBHM/T74AJ=C?:7X8M]!GL-/FA=7:,1W,K!=D8\IB6C#+NW-
M@],#)- &NOC1[(WJ:YI;6$EM8?V@$BG$Y:/.W:>%P^<#'(.>"<&M'1-9U#4+
MJ:WO])%F40.LD5R)TZX*,0!M<<9'(YX)KB]3\*ZGXDDU:2UT>30C>Z:\5TLT
MR$7=UO5HS^[9N%VN-YP</TXK1TKPY<SZQ<7-EIEQX3MFL%MG%N8/,DE$@8,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !5*ZTC3+ZZANKO3K2XN(?]5+- KNG?Y21D?A5VB@ HHHH **** "
MBBB@ ID,,5M D$$2111J%2-%"JH'0 #H*?10 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% &/XIUR3PWX;OM7CLFO/LD32M$) G &3R?Z T[PQJ[Z_X7TO5Y(EB>\MDG
M:-3D*6&< UG_ !#22;X?Z[;P033SSV<D444,32,[%2  %!-8^@ZS<^&?AAX;
M+:'JEY<+';V<MK#;L)8CMP696 ( QU]Q]: (=:^)PTR?Q!/#:)+IV@7%M;WA
M)/F2-*VUBG8;,C@YSSTZT[Q3XR\6Z1+?W>D^%[>\T2SA$K7T]XL6\; [%5/)
M SCCJ17&>)/".KK%X_T6WLIYI]>U"TN+%UC8HZF7<^6 PNSG.<=O45Z1XDT^
M6;3-"\-1)))!<7,,=U(%.T00CS&W'MN**GONH Z+2I[FZTFSN+V!8+J6%'EA
M4Y$;$ E<^QXJW110 4444 >?V7C77=2\:^(/#=GI^GO+I$:R*\DKH)]P! Z'
M;UZ\U$/BC'??#C4O%.G602ZTU_+NK"Y;E'! *[A_O9!Q[8';(\/O<:3\8?&>
MKW.F:K]BN88Q;R1V$S"8J%!"X7GD?2L:#P;K6D_"+Q=)>V$_]JZ[/Y\=A AE
M=!O! (4'GEB?08H ]'T3Q%K>K6>BWPM+!K>^AAGN(XW?S+>.525;D889&.WK
M6=:>-]5O/'6O^&U@T^%-(A69KJ5GPZE5;D#I@-ZGI5'P/Y'AS1]*\G3M7;4[
M^UL;2YAEM+C;"R9#NS.-J* YX! ^7CK6);>%VU[XN>,OM]GJ4%A?6T:VUUY<
MT4;NJQ]Q@, 1T/!Q0!TOB'QSKOAV3PW;W6F67VK5[YK)U\Q]L1$FQ7!QEE((
M;&!71V^I:TTM^)H;%H(H2T%S"7*M(K,KHP/0@KV)_2N*^+UC=:AKG@S[/87U
MS#:ZD)KIK6WD?RH]R9)*#(X!Z<\5T6DW5KIEE-H6G6>IO9P6]Q.;B:TF4 O(
M66-2ZY=OG;ID_+[T <W:_%?5'^'(\;2Z19M9)<>3-;).RR*N\)N4D$$Y(XP/
MK6YXG\=W6CZCX4AL+6">#Q#,L2--N5H=VS#$#K]_IQTKR;2_!OB"/X9:9?1:
M=J$UUI5^TUWH-Y%+Y=U&6X(B88) ST'0GN.>T\?^?XEU?X?7MII.KK;Q7HFN
MU6TF1[5"T>=Q494C!Y'ID4 =AHOC2>[\>:GX0U&RCBO;.W6Y2XMY"T<L9V]0
M0"I&\<<]_P ;&N>-K#0O%^A>'[@?O=5+C?GB/C"9_P!YOE%<=X+L]1\%>/-;
MT_5K&^U"WO\ %S:Z]]G>:1DQQ%*X!.0!P#W'N*@\=>'-3\5>"+O6K?>E^ER+
M^TM_L$JW2%?E6/.[(.T9QMQN_.@#K?B3XSN_ N@VVJ6UI!=B6Z6V,4C%<;@Q
MW9'^[TQWKL(Q((U$K*TF/F*C S[#)KQGXEW&K>+OA1H;QZ+J?]J->0R7-HME
M+OC94<.<;?NY/!]Q7IO_  D:SZMI]C9V5](+AF,TTEE+''"@1CDLR@9+!0![
MF@"IXS\90>$;6R1;9KS4M1G%M8V:MM,LA('+=E&1D\]14YN_$MF+-KJST^Z6
M:>..?[*SJ;=6(!8!L^8!Z_+ZXZUROQ3\.:I>:KX8\3:5:R7KZ'>"6>TB&9)(
MRR,2@[D;.G7GVKL[/Q#:ZB\*65O>R&3[Q>UDB$0[EBX&#VQR?;&2 #$T;QC<
M^+-9U>VT&*W2QTN3R'O+G<WGS<Y5%4C"C'WB>XP*JV/Q!N-6\/Z_)9Z?%'KN
MA2/%=6$LA*LRDCY7&.&VG!([<^M9'P[TV?X>WOB+1]5M[D6LUV;NRO(X'D29
M",8RH.'&!\IYYXS5/PUH&H6$'C;Q1J%E=P-KD[&TLQ SS"/<Q4LB@D$[AQVQ
MSUH W_#GQ';Q-X5U"[@M8K36]-8K>:?<$_(02.O!P<>G!!'O4OC7QAKO@_0]
M2UA]/LIK2TEBBB!=U>?<$RWHH#,1CG[M8OCWP/=OK=MXP\+[XKN0K#J=NBD?
M:8&(#-M_O =1[ ]1SI?&JTN]1^&]W8V%G<W=U--%LBMX6D8X<$\*#CB@#0U#
MQ-KVF>&=0UJ>QL6A@T];V$HSX<X):-O0@8P><YZ5C2?$Z^T[P_X:U[4=,MFT
M_6I4A86\K>9;LP)!P1AQP>XK6\3)-<_!Z\MX;:YDN)M*\E(%@<R%RF-NS&0<
M^U>:VWA[6M$TWP3XE32]2U6VL$6&^T:>*21[9_\ GK%&W0CCH.H'8G !Z5JW
MC*_T_P")VD>$H[6V>+48&G%RQ;=&%#DC;W^YUR.OM5"7Q[K1\6>)]#M['3V.
MAVHNO-ED=!,I16QWVG#=>>E9NMQW-Y\=O"FKP6%^^G0V,B2W'V.4)&S++@,2
MO!^8=>F>:Q[K1H+[XH>-[G6=&U>;2[RRCCMW@LY_WKK&@(4JO)R#UXXH WM4
M^+4T'PNL?&MEI2$3S^1):3N1M.6!*N!R,KZ<Y[8KN;R^U"W?2(T^RLUY/Y,Q
M96 7]V[Y7G_8Q@^N?:O(-3\,>--6_9_33]2LY)=4MKI9H;4*/-^SKP 0.K#)
M..N,=Z]0MM3C\07&B/96]V%MY3<3F>VDA$8\F1-IW@9;<XX&> 30!A>(/'/B
M#P]>>';:ZTRP#ZW>_947S'S "R@%N.3A@2!^=/\ &GC?7?!?A>?5KO3;*62*
M^6V5$D8++&RA@X/4'.01CMUK.^*MI>7GBGP-):6-Y<QV>J+/<O!;/(L2;X^6
M*@XZ'\JD^.5E>:M\/X[/3K&[O+E[N-Q%;P/(VT!LD@ XZCK0!O:WXTDTS6]%
M\-VMO%=Z[J@WA2Q2*&, EI&ZDC"M@#KM/(I9O&,NC^-+#PUK44(.I1EK&]@R
M$=QUC9"25/3!R<Y'2N<\0Z+>VOQ/\,^.;:UN+G3H[8VEXD<+&6$%7 ?9C<1\
M_.!D;?>G>(=)N?&OQ/\ #-Y9P3II6A;KF>\DB9%>0LI6--P!8_(,D<#)YSQ0
M!<TWXE2IX]E\+Z]81V/G.Z:=>JQ,=R5<J1ST)((QGJ,=QF]K7C>7P]HT-WJ(
MM$:ZU4Z;%(2RQ1 .R^9(?3"$X'L,]ZIZSX1LO'WA*\L)4FM;Z"]N9;.YE@>-
MHG,K,K#< 2I&,X_F!5+3;2ZE^'>E:1XTT:XU%KJ\N(=1"PM(T9#RE9ODYQD+
M\P_O9% '<Z7>ZC/>SPW<5M):B&.6WO;9CLGW%LC:<[<87^)L[LY[5K5YE\.?
M#-UX8\4ZO::7>7L_A0P(\"W:D;)RW*ID#("]2!CD#D@UZ;0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MLD4BR(W1D.0?QI]<)I>H26'QCUC0$)^QWFG1ZFJ=HY0_EN1Z;N"?<9[FN[H
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M"JH]23P*I>(=730/#U_JKQ^8+6%I F<;B.@SVR<<US>I7?B*33M>MM3T^/\
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M)2Q<K$@4%B<L<#N22?QKF?$5WJ<?C7PM:6EY'#;7#7+2QM$6WE(B1DAAQ@G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!S-SH$MKX\@\3V2>9Y]H;&]B! .W<&209ZD'((]#QR,'*M?A/H%I+9R
M0W6J V=\U] #=9".W4 8Q@X'O[UW=% ',Z1X?E'C'5/%%ZGEW%S"EG;0Y!,<
M"<DL1QEFYQV '?-=-110 4444 %%%% '"CX76,4UP]IXB\36:7$[SM#:ZB8X
MP[L6;"A>.33_ /A6L?\ T-_C#_P;M_A7;T4 9/AOP]9^%M$BTFQDGD@C9W#W
M#[W)9BQ).!GDFM:BB@ HHHH *HZOIB:QI-SITEQ/!%<QM%(\! ?:1@@$@XR#
MUZU>HH Y"S^'&BVVDV.D3RWE]I=BV^"SN9%\H-DG+!%7?R2<-D5-JWA"T?Q
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M .'O/#D5KX<A\#VFG:A>:?<1[3>S2(4ME#@\G(.Y1RN%Z@9[FNUBBC@A2&)
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MUE:KH-OJU]IU[)/<07%A(SQ/ X7(9=K*<@\$>F#Z$5J*RN@=&#*PR"#D$4M
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M?<TM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;RI?WP.>U=OWS2*JH,*H4=< 8H X?5DTVV^+FD7-]';(9=*G2*651EI5EB(
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M[Y$@7EOXCQUK)T;^R[71/"&I0S0K>GQ%/;F?SLOY+27 *9)^Z05..G(/>O:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>S6 I(N\?>C(;MZ$'J*]"U'Q1HVDW36U]?)%*BJ\GRLPB5FVJSD A 3P"V*
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MF5FA^1@LP7[WEL1A\?[)-);^(])NM+&I071DM&F$ D6)^9-VS;C&<[OE^O%
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M#'*N7W\9^4+DG@$\>AH \A/@'Q);>"=$M/[/>>[_ .$D&K3P)(G^CP\_*26
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MU.*)X)!%-YH9!$YZ*Q( 4G(QGUJ^FKV+ZR^D+/F^2 7#1;&_U9. V<8Z\=:
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M+N7:@&XG;DXQG /I0!P&@:3XBT'Q#<:NNF7,]O>ZE=)/:.T9:*&25I$GC.[
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MZC\F2-[N5CY?]Q26RJ^P(%6;CPCHEW*TES:/,SV9L&\RXD8& ]4(+8_'K[T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY@ >-P&1@C!'![&N&\3^&=5UN'Q)J%MI\D=QJ&FPV%O:/+&&8J[.7<ABH^\
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M.8XG?&U7<#:I.Y>I_B&>HKA(=-N_$.A^-= ALV*WNMS1_:F9/+C!\O+$9W9
M&0 #DXYZXT5\/ZE::YJMG-X:L-6T_4+K[3!?W#1D0;@N5D1OF;:5R-N<\=.H
M .A_X3+19+Z>PCN+DW,,CPRA+.5O+=4WD$[,#Y>1GKCC-+I>O6"Z#I4IU*?4
M6NX-\$H@/FW( R7V*HP.1G@ 9'J*J:#8:C8W_BJ:XL)%2]O?M%M^\C)D7R8T
MQPW!RAZXX(K"\/>'=<T)?"E\]B\SV&EOIE[:++'O3)1A(A+;3R@!Y!P1Z8H
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MXP\9. Z%@ ZYXRN17*>(_#VJ:\VNZG#ITL$]SH+Z7;VLDD>]W=F8LQ#%0HR
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M3W/M5VBB@ HHHH **** "BBB@ JG9:59:=/=3VL'ER74GF3MN)\Q\8W')ZX
M&?0"KE% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWA2*")0B1H,*JCH *Q;;P3X<LYX)8-+C1K>8SP+O8I"YSDHI.%SD\  5OT4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %-DD2&)Y975(T4LS,<!0.I)IU<Q\
M18KF;X<^(8[,,9C8RX"]2,?,!^&: -;1-737=-348(F2TG^:W9S\TL?9\=@>
MH[X()QTJEX7\6:;XMMKV?37W+:7<EJ_/4J>&'LPP16';:G#%\.O#6G6MQ#'<
MZG8V]O;[Y-@"^4"YR.F%! ./O%1WKDM+:3P!\:I[::.WM]*\10AVCMW+1V\X
MSC.0,9.>V/WGM0!ZGI>MPZE>7]B5\F_L)%2X@)S@,,HP/=6'0^Q!P16I7GM@
MLS?'S5I(<_9DT.%)\=/,,F4S[[0U>A4 %%%% !6+KFL7^E1W4]OIB7%M:VK7
M,LLEQY73<2JC:V3A<]NHK:K&\72)%X-UII'50;&902<9)0@#ZT 8=UXUU2V\
M)/XB.@Q&U.F_VA'B])R,*0C?N^&PV>,CY3S7912"5 P(S@$@'ID5YUJ4L;_L
M]D*ZDG04BP#SO\H#;]<\8JAJT0L]>UF/PRJ)=77A@R!;4@--,'.&R/O2;2<$
MY/- 'JRNK9VL#@X.#T-+7">##X<U#6FU?0;R\ED:R$%Q#Y*111X8%1(JHO[P
M9('4XSVQ7;7!E%K*;< S;#Y8;INQQG\: ,G6]>?2=1T>U6WCF74+P6CMYNUH
MB4=P=N#G[A'45M;UW[-PW8SMSSBO&]/OM+N+'P))(%&NV^JJFI!T_P!(24Q2
M^9YG&1E\'GKQCI5_PW_9FI:E8PZE=ZA%XKT^_D>>V2%5=B68$L^S+0E"#][&
M, <@"@#MH-?O+_4YXM-T^.XL[2^-E=2M/L="$5F=5(PR@L!C()YQ[[PD1DWJ
MZE?4'BO(8Q;6OA[Q9<:9;(?*U_-P+*)3*;,/"9 HP<K@-Q@@@&DUV#PW/X2U
MC4='OI[J"[O+!V<JL<*R+,H8Q!47#[,[B.V,]Z /7_,0#.]<<\Y]*-Z[]FX;
ML9VYYQ7F]_X:\,'XAZ1IHTZQ%C<:9=L]NJ@)(S21,N0.#GYB/ID=*RI;^Q_X
M2#3+FV3[-+#XGECN(S&SW"@I*N7?LC87:F,8Q@G' !Z-X?UR36I-726U6W;3
M]0>SPLF\.%1&W9P,9W]/:M.[FDM[.::*-9)(T+*C-M#$#.,X./RKEO TL;W_
M (M".K$ZY(V >WE1#/TR"/P-=-J+I%IMT\C!46)B68X X- &7HNMWFMZ-H.J
M0V,20:C"LUP&GY@#1[@%&WY^<#MQS6WO7<%W#)Z#->4:&UJ+7X5.[1"6.W>-
MR2,K_HK+M/I\V!CUK.%GI"^'H[I8[=;B/Q<5CF4@/' ;LY"L.50QDGCC!S0!
M[!?3W$>GW$MA%%<7*(3'')+L5F'8M@X_*D74;9M1&G&5/M@A\]HE.2J9QD_4
MYQZX->4:_;Z;:Z7\3-.LXK:*V%M!)!;Q*%02F+!*J.-VX+G'>NFMET]?BQ%<
M/%"6N=#A-O*(P?,<2ON*MCJ%*Y/ICM0!WE5;::Z:6[%U!##%')B%UEW%TV@[
MF&!M.21CGI5JO*U2U=?%UM%J,&G%O$$4D,K1AX0XBB(\Q<C*%U8'W^E 'J88
M,,@@CU%07U];:983WU[,L-M ADED<\*HY)K!\#7$MQH4WG6%M:2QW<J/]C8F
M"9LY,D6?X6)/XYJO\2;&;4/!TD4<<DL*75O-=119W/ DJM(!CG[H)X]* -%_
M$@M/#USKVI6CV5A#"9U$C9F*]LIC"D\8&2>0#@\53O/&::0EX-9LC:SP:<VH
MI''+YGF1KPR@X&'!*@CI\PY/../\3Z-=:K%XEM_#DLEWI4VF03F))C*C723;
M]L9)/S-&G('JN>M;]Q;6GBWQW8W$02[TF#2+B*Y;JC&<H!$??:K$CJ.,]10!
MO6'B2.<:JE]"+2;2V47 5S(N&C5U*G )X;&,9R._%:UI++/:12SP&"1UW-$6
MW%/8GU]??UZUR-S9K:VNL7NDVK7"V*27 5V:1KV\CCP@))R538J@?WAV*\V_
M"&LWFJ7&H0SW(O+>!+9XKH*HW-)$&=/E '!P?7YQ0!U-9.F:_;ZQ>WD5@IEM
M;1S#+=YPAE'5$_O8[GH#P,G.(/&MY=:?X'UV\LBPN8;&9XV7JI"'D?3K^%>:
MZ[H/_%$^ /!%G& ]]-'-<2;-P5$3S)F/U+?CTH ]FR/44N:^;)=.GU/3Y+@_
M;?L_B3Q,J1 ;V86T1.9&[ECV_'VQN>+]<FM/&'CO6K:VE-QINF0Z;;,(V 4R
MXW2DXQD$@#N>.P) ![N2!U-59]2L[:]M+*:X1;F[+""+.6?:I8G'H .O3IZB
MO'-=M'TG0/"[:5(E[>Z#;Q"YTFY3(OEN,*Q56Y+YSVR WX'8\-Z5IMY\9M8E
M^QHJ:%86UC:*\>3G:"7SZ@84'N.E 'JM<YIGBDZEXTUGP^ED FEQQ-)="7(9
MY!N5-N.#C)//:NB9@B%CT R<"OGS3=*D\3)87MM"_P#PD.J^(FU*649WZ?:1
ML5^;^YT  /+?A0!]"$@=317BVD*?'^N:E'KE\8;B#6<+8JC&:*"$@HBCI&I/
M+2?Q8 XXKVF@ S17@OCWQ!<7>I>-$N(IFGLQ;Z;ID11MD E(\R?.,!CP >N/
M;->UZ'90Z;H&GV-ON\FWMHXDW*5) 4#)!Y!^M %^C(K@?B1IU_?:CX0;2H/,
MO8M9CD))(58E5F?<1_#\H_\ UFN>\.6M](NKZCKJW4BZ!K]]?+>/E3<*D90*
M@'4=?8;0HZG !WOA_P 4G7M<U[3ULA%#I-PMM]H$NX3/@E@!@8V\9Y/)KHL@
M=37SWHNC7;S^ H[];C[7JNIS:[<E%;"8PR@@=V^7)/0 =!G-_5/[7\5V7B.
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MCJ<@'JE)D#O2D@#)Z5\X3:7=^)1]HC62*3Q3XC)@4*P$=I 3EV QDC/'X^O
M!]'YHSGI7@,EW):>!OB5K:Q73S:C?BRA$RL3L!\M7R?XOF8\="!TXK2T6\_L
M[QC<N8)Q8^$?#@6WB,; RN8]YD(QP6 (P>>1T.0 #T#2O'5K?-XBFO(H[+3]
M%NC:O=M-N65U^]@;1C'RC'))./KL#4[T^)1IPTF7[ ;3S_[0,@V^9NQY>WKG
M'.:\/L]+MKW0OAUHM]#YS:GJ$VK7TKQ$^80-Y3ISNW*IQ_=INHWL'_"/>/=0
MAA2&XU?5HM&LT9-B1HA"@^@) 9O8J">U 'T(6 4D$<#/)XK \%^*#XP\/C6!
M9&T@>:2.$&7?YBJ=N_.!C)#<>U>4:I9CPR/%6O:%'(FE6>AQ:-!*A)%S<,RJ
M9%/\6P$#/3(P.AJY)+)IFK^&_![745CI5KHHFC>YC8QW5T3MR4'^LQRX3(R>
M?2@#VP'(R.E%9'A;1+;P[X8T_2;1YG@MH@%:?ASGDDCMR3QVZ5S'Q"O;EM>\
M+:,\S6NCWUS))J-QNVJR1)O$3-V#\@COC'K0!V]Y>VUA8SWMU,L5M!&TDLC'
MA5 R36/X=\0WGB".&\&CR6VF7-O]HMKF292S MA0R=5)7#=2,$<YXKR'7+&^
MD^'^JQ3VAMSXI\1(FE6<L>#!&S##[#]TE5.?KGO7N6F:;::/IL&GV,"06T"[
M8XT& !_^OF@"W29!&<\>M<!X]OIV\5^%]'N)C:Z'</-<W\I.%E$2[EB)]">J
M]Q7!WVE:O>^$X-'FMI+:3Q5XD>Y@MI$(^QVF=Q)7^$\ D<<-[F@#WS(/>C(S
MC/->$#4;_0K'XE^)-)BNC=)<QV%N71FV",A&EYX/WBV!P,= *[GP'H6GC49/
M$%OJ(OI&L8[-9(0QC*@[F9I#S+(S<EN,9QB@#OJ3(SC(S6;XBU6+0_#>I:I,
M%,=K;22E6Z-A3@?B<#\:\6\*^'G \%7.EPM<7MA!/JNJ7,3$\R+E(,CC<W3;
MV )QS0![YD9QGK1D9QFO%/!SQ>([*S\5:WJ/VB_T][G4+FWB1C(K@,%1R?\
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MB?RPV[G&TQ]?]G/->NJ%50% "@8 '0"@!:*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "@@$$$9![444 4=*TJWT:T^QV>Y;56
M+10DY6($YVKWVYS@'.,X'& +U%% %'3M)MM-DNIHMSW-W)YMQ/)@O(V,#..P
M   '  ^M7J** "BBB@ HHKC/'U_<+<^'-%AED@AU?45@N9(V*L8E4LR CD;L
M 9';- '9!E.<$''!YI:QI/#&D+):36UG!9R6DJRQO;QB/@9!4XQD$$\'O@]J
MQE\<.=+TS739QG1=0NEMT<2'S8U=RD<C#&""<9'4;AUZ4 =E17!W'CK5;>QU
M#4#HUL;73M6&GSA;LEV!=$#)\@!.9 <$CT]ZDU+QOJ6CVWB7[7I5JUUH]M%=
MJD5TQ26.3< -Q3(8%#VP>.E '<45Q5UXXNM$U2[MM?TN.WA%A)?VLEM.93(L
M9 :-@5&'^9>F1SUI;[QAJ^G6^K32Z&9(K/3GODF_>Q1,4^]$2\8.['((&#[4
M =I17'Q>,-0COYK>\TE"3I#ZI;);3&1Y A ,9!488EEQC(YI]EXNFU#1+C4]
M/2PU"%!%LDM[G:JEFP_F;N4\L88YY([#I0!UM-WIYGE[EWXSMSSCUQ7GVJ^-
M=2E\.ZK+8);)<V&JV]B\P9BDJ2-%\Z<9&1*!WZ9!/%:5[XBM]'\3:G+J6FVT
M;V6B+>2WL+;Y'C#MF,94<!E8CGG(Z4 =C17+CQ-?6^JZ397UA AU>%VM6CF)
M"2JF_P MSM[KG##T/'2L_0_'&H:F?#<]SI5O;V>N>8D92Y+R1R*C/R-H&TA"
M.N>G3I0!W%%%% !1110 4444 %5-0L3?Q+&+RZM=K9W6SA2?8Y!XJW10!B?\
M(X__ $'=8_[_ *__ !-36FB-:723G5M3G"Y_=S3*4;C'(VBM6B@!  !@  >U
M"JJC"@ =>!2T4 -EC2:)XI45XW4JRL,@@]0:CL[6.QLH+2(L8X(UC3<<G"C
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M0Y*1@Y"+_=7/.!U/)S5^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R?$/A^U
M\1Z?';7$DL,L$R7%M<0D"2"5?NNN<C/7@\$$UK44 9=I8ZF#&-2U..Y6,Y @
MMO)WG_;^9L_0;1_*L>R\$16=A;:2;TRZ+:78N[>U:+YT(?>J%\\HK<@8SP 2
M1UZRB@#D)_!#SZ1JNGG4P%U'45U!W%ORC!T?:/FZ9C7]?PR_'OA^>/0?%>J)
M.UQ<:CIJ6BVT4!))0L5VX)))+MV]/2O0Z* .8G\*6VOI)/K%R+P36#V,?EQ^
M4$CDP7;J?G.U>>,;1@#FH5\'ZE-X>OM)U+Q+<WRW%H]G'));HICC88)(7[[X
M_B/Y<G/6T4 <P_A2X;4(;U-5,4T6E2:8C1P8*ABI\P?-]X%%([=:J7O@%+Z2
M]NS?K;ZA=/;.TUM;!(V:!RZL\98[R2<')Z =,<]E10!QL_@-KFUUJ*769V?4
M[F"\+^2G[J6+RR" .HS$O'IZGFKEUX0CU'5;N[U"[-S#>:9_9L\)B"[DRS%L
M@\'+'MZ?6NFHH YRR\+S02:9)>:C]LDTJ)X[)V@VD%EV;Y,-\[;>.-HY/'(Q
M4T_P0VGVGARV74MZZ'*\D1,',NY&3#?-QP[=.^*ZZB@"IIUM=6MLT=Y?->R&
M5W$C1JF%+$JN%X^48&>^*MT44 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1169KVN6WA_3#>7(9RTB0PPI
M]Z:5SM1%]R3^')[4 :=%<Y_;FK'Q/_9":=9,BV'GM,+Y<K-G_5;,;\8(._'?
MIVK0T'7+7Q#I:WUJ&3#M%+$_WX95.UT;W!']>] &G1110 4444 %<SKWC_P[
MX:U1=-U.ZG2[:$3B.*UEE^0D@'**1U4UTU</!_R7"]_[%Z+_ -'O0 O_  MK
MPA_S]7W_ (+;C_XBM;P[XVT+Q3=7-MI-S+)-;(KRI+;21%0V0#\ZC/0UT-<1
MI7_)9?$7_8+M/_0I* .WHHHH **** "BN0U+Q1KFFZAI5K)HUE_Q,[M[:'=?
M."H"LP9AY7&57H,XS4K>)=2M/$&E:;J=C:6D=VET\DJW)<*(MI!!*KP0P.3T
MY'O0!U5%0/>VD=H+M[J%;8@-YS2 )@]#NZ5+'(DL:R1NKHPRK*<@CU!H =15
M74;^WTO3KB^NG"001M(Y)QP!G ]ZQM%U^YO;1-3OFTV'2I[:.:.9)\-$[#)B
M?/!(!'S9&?04 ='16%X@UZ;2?[&>UBAGAO[^*T=RY^57S\RX'/3U_.ETC7)]
M0U[7]/N((HDTR:*-'1R=ZO&),G(&/O=* -RBJJ:E8RV[7$=[;/ IVM(LJE0?
M0G.,TY;ZT>01K=0&0KN"B09QC.<>F.: +%%4#>2RZC:+;2V4EE+'(7;S?WA8
M$;=@'!'WL\\<5/'?6<LRPQW<#RNI9460$D X) ],\4 6**@^V6OVDVWVF'SP
M,F+>-P'TZ]Q4] !16'?ZW<6?B[1]'%O$UO?Q7#M*7.Y3&%.,8Q@[ASFM5;VU
M>Z>U6YA:X09:(2 NH]2.HH GHJK_ &G8; _VZVVL=H;S5P3Z=>O(J1KNV43%
MKB(>2,RY<?NQ_M>GXT 34576^M'MX[A+J!H9#A)!("K'T!Z&I89HKB%9H9$D
MB<95T8$,/4$4 /HIDLT4$32S2)'&HRSNP  ]R:P?#WB0ZQ)KAG%M%!IUZ;=)
M8I=R.GE(^\L<#^/Z<4 =#16)KOB>PT;PY+K FAN(AA8MDHVR,6"@!O3)YZX&
M:?8ZG/$)/[7N--C1Y=MG/#-@7"D#^%CPV<C )S0!L45!)>6L,HBEN84D)4!&
M< DM]T8]\''KBFC4+([L7EN=BEVQ*O"@D$GGH"",^HH LT5SWB;Q(=(\*W&M
M::+:]$3(/];\A!<*2"N<D9Z<?6NAH **P_$6MW&C2Z.(;>*5+[4(K.1G<@H'
MSR !ST]1^-78KR5+K4#>2V26L++Y3)+\RJ5!/F9X4YSCVQ0!?HJJ^I6$:3,]
M[;*L#!9B95 C/HW/!^M,N+F=-0LEC>T%K(LAF,DA$AP 5V#H1USGH* +M%9^
MD:UI^NVC76FW,=Q")'CW(P/*L5)X[$J<'N.:T* "BJ\-_9W*2/!=P2I%_K&2
M0,$^N#Q2Q7MK/(\<-S#(\8!=4D!*@\@D#IF@">BJ\=]:SRF*"Z@EFV"0(L@)
MVGH<#L?6L#1_$.HZOHGVP0V%O.FIR6<B2S,$V).8SM.,ER!P,#)(H Z>BH)+
MRUBN8[:2YA2XD&4B:0!F^@ZF@7MJ;HVHN8?M(ZP^8-_3/3KTH GHHK/AUS3K
MC6KG2(KJ-KVV1'EB##*[]V!]<*21V!'K0!H45!!>6MT\B6]S#,T1VR"-PQ0^
MAQTJ>@ HKG[/Q!=7/C74= :SA2*SMHKC[0)B6<2%@!MV\8VGO5;3/$NHZK_P
MDD26=E;S:3.]M$\MPQCD<('#-\HVK\PSU[T =3159KV"WMX9+RYMX3(!R9 %
M+8_A)ZUDZAXA>P\5Z;IDB6ZV5W:W$[7+28*&+9D8Z ?/USVH WZ*P=:U^73K
MS0$MHX)[;5+T6S2^8?E!C=PRX&#]SU[UK+?V3PO*MW 8D.'<2#"_4YXH L44
M@(8 @@@\@BL;6_$ TR_T_2[: 76IZ@S""$OL4*@R[NV#A0,=B22 !0!M45DQ
M7FK1:I;VEW90-;S(Y-U!(<(PP0I4CC(S@Y/3M5^&\M;B66*"YAEDB.)$20,4
M/N!TH GHJLNH63R+&EY;M(REU42 DJ#@D#/0$4Z.]M)H$GBNH7A=MJR+("K'
M., ]"<\4 3T5##>6MS"TT%S#+$I(9T<,H(ZY(]*9%J%E-;?:(KNWD@W;?-60
M%<YQC.<9S0!9HJ!+VTDBEE2ZA:.(E9'60$(1U!/;%-_M&Q^RFZ^VV_V<'!E\
MU=@/USB@"S169?>(-*T\V(N;Z!?MTGEV_P"\&)#@L2#GH .OT]:N->VJW:VC
M7,(N7&Y83(-[#U"]: )Z*YWQ5XF&@6L+0?99KE[JWA:"2;:X2258]P4<G&[V
MKHJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *\]^*$4OVSP9=\_9+?Q!;&?T7)PK'VSQ^->A5
M7O["UU.QFLKV%9K>9=KHW0C^A[Y[4 >?/#+_ ,-#1W0AE^S_ -A>09O+.SS/
M,+;=V,9QSBK'PNBF^T>,KKD6EQXANF@]&P<,P]LC'X5W7V8_8OLWVB;[FSS=
MPW_7..OO26-C:Z98PV5E"L-O"NU(UZ ?U/OWH L4444 %%%% !7FNLZU'X:^
M+L^HWECJ,MK-HD4"R6EF\PWB9S@[1QQ7I5% '$?\+3T7_H&Z_P#^"F;_  JC
MX0U)==^)>OZM;V=]!:2:?;1(UW:O"696?( 8<]17HM% !1110 4444 <5XU;
M'BCP:=KE8=1>24JI(C0PNH9B.@R0,FG>)8+>Y^(/A87,"RP1PWADWQ[D4D1[
M=W89*G&>XKLZ* /'M,N)M'TKP_<SQ7T6D6M[J44YMK8NUL7F)@<H58[-FX @
M<!QZUZ+X2LK*PT!(M-CNH[)I'EB%R"K89BQ.T@%0220N!P>@K<HH Q_%84^$
M=85EW;K.557;N)8H0 !W.<8KC]/D:POO!E[<Q,-(326MW;RSMMKHK'AI!CY2
M55UR>A)'&:](HH \I%C<6&E::K12I9MXN^TV<7EG]S:[FYQCY4SN89P &%.U
MR*_FN?')L;>:;-]82O$B'-Q B1"94_O<*RD#KR.]>J44 <(VE6OB3QA?SVZ[
M]%O=$-I>LJE4ED+_ "=1RZIO]QD"L&SA\3V[Z-K(LW^WVZMX>G&P9D7)5;D_
M[ D5#]-Q[UZS10!PM[I]EI_Q \-116ZBV@TJ[MY',>0%_=;%=L8Y"OU]ZYGP
M]8V]GH_@*:*R\B[CU287#B K(D92<?/QD+S&.>.5KV"B@#QZ.71[BZATG5KM
M$BLO$,][YMW:2[Y?WD@V,2GEX);&[>1M X!X'L-<Y8>$8["(6BZQJDVFC(%C
M-)&T8!.=I;9YA7V+'/0Y%='0!Q_B'S#\0?#!B!!2WO07VDJC,L83<>@R0<9Z
MXKFM-MKJ\\->$[!89H?$>FZG&UYN0AX\,WGNS=U==W.<-N'4UZK10!Y9K/A[
M55N=<TG2[7;%!<IX@T^;8"HFY/DCT)D0G_=8CO5[6I+V/0M)\0O:7B1SZDE]
MJ,-O$'FCA,3)'E,'/E_NB1@\J2.E>BT4 >4ZEIVBS6^D75E;7<]K=>(H[J22
MZMV7>"A$CA"H*QD[020 3[<GU"TM+:PM8[6TMXK>WC&$BB0*JCV X%344 <A
MXUGFL]4\-7TT,LNCV]ZS7PCC+["8V$3LHR=JN<Y['![5Q\DDUO\ VW?65E?_
M -GQ^)H[VX$%HVY[<VZ R*K+A\28<@ GY<^]>OT4 >6:Y;:9)X#UJ[TJ*_G3
M4+ZWGW3P,IFD$L>]DCV@@;5Y.T9P3[U9UZ2T7Q1JEEK::A_8^JV,4-F]G:F:
M.0#<'B^5&*MEMPQCKUX%>E44 >=:3HFEOX_U%;W38Y(X]*L=ANXA)^\C,A8E
MB,,ZC9D]:R-*LM.T[X:V]V="22Z743'*_P!G</#']L+J[A<.R* C[1P0!VKU
MRB@#QZ^\T^%_'< BO9'GU2">+?:.AE#+ 257:/[K' YP,GUKV!65T5U(*L,@
MCN*6B@#DO'1.[PWA6;9K=O(VU2=J -ECCH!D9/3FN.\2V<4FG_$B&.S+>=<6
MSP(D)/F.(HPQ0 <D,&R1WS7KU% 'G=QIND-\0-0;[!;&R?04Y\@>6T@DD]L%
MMC#WP:S_  ]%^_\ AJ\T#^?#I<T%PSQ'=&?*10KDCCD$ 'OFO5** .0^'"_9
M_#,EE);RP7-O>W0E62%DZW$C+@D8;Y2#QG@BMSQ&_E^&=5?[')>XM)?]%B8J
M\WR'Y 1R">F1SZ5IT4 >-7ACN(]?D,,TEK/X0*H38O'"K1^:0HW#^$$8+$G/
M?L-&WT;3KR\\/WND6<2I'H\ZZHZ1;0ZM$NU)>.7W_-@\\$UZ/J^FQZSH]YID
MLLL45W"\,CQ8W!6!!QD$=#Z4D6FB'1$TQ;F;8D @$QV[\ 8STQG'M0!YAX6T
MRQN],^'=YH]O''J-K$CW\\<>UA!]G(<2'ON;9M!Z]1P,TOE*WA*U+V[F6+Q?
M]H7,1W+']M+EQQD+LYSTQ7IFAZ3%H.B6>E032RP6D2PQM-C=M48&< #H/2M"
M@#R^9+>ZUK6=$UZ+5C=3:DMW8BW@)2=!M,3+*$.PKMP<L, >A-7;'[7:>,H4
MM)%U#3YM3N6DMKB$K<:?(1)NE5_XHF.0,C^-0">E>AT4 %>::]::@=>\;V^F
MP3)J%_I$'V&5(F =E68/A\8#<@<D<D5Z710!P5FL6J>*/"FH:- ]O%:V4T=^
MGE&/RXRBA(7! PP?!"GIM8UWM%% ' 6]G!??%K7&F:[2,Z?;1QR0S2PJ[JTA
M9=R$!B,CC)Q6$MK%_P (I\3;00S2^=-</:K,'D:;-NJHRELE_G& 1GFO7**
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#SBWO(4\>>+[?4+G6Y;6U%J\$
M5M+=NL>Z(L^!$3C)YP?PK>7Q NDMHNDPV6H7TNH6\DUN[RJQPH#;6=VSD!EY
M/7U)XIMEHFLZ=XJU[6(?L$B:H8-L3R.IC\I"O)"G.<Y[8]Z<=!U:77="U2XG
MM';3TN1*J;E!\W  08X"A0.>OM0!!:>/HKF'3KA](O8;>ZO3I\DKM'^YN-[)
MM(#9(W+C<..1[XBNOB-#9PWMW+H>I"PT^]-G>W7[O$!!4;\!LLOS#.,X'/M4
M2>#=431;6R\ZS+PZX=5+;FP5\\R[/N]?FQGVSCM6;I&FS^);'QEHZRVHL+K6
MYDGE#DR*F(]P"XP20, Y&,]#B@#4AU>'1?%_C*]O;F<V5M:V4NPNSA2PEX12
M>"3@8&,FM>3Q0T&HR:;<:7<)J!M&N[:!75OM"*0&56SC>,C(/'(P2*R]5\$3
M:S<^)5GN8X;;5[:VBA:/)>!X2Q5B",'YB#C/;WXNO926^H6_B;Q)<6<']E64
ML8:%F*?/M,DA) (X0 +SC)Y- %BQ\66M_IVD7T,+>3J,+3\NO[B-5RS/]"0I
MQT) ]ZIP?$#2Y+N".53%;7-K)=17 D5P$1=S"0*24.WD ]<'N,56\*Z#8SIK
MEW;SO-I.I2R+9+T5(7&93'_LM(7/T"D<8IVE^&->&A2>'M;U2TN-*6U>SCDM
MX66>:,H4'F$DJ"%/8<D YZY )/\ A8.G123"X@E2-+"2_1XG27,:#+*VT_*^
M.<'@^O%::Z]<R:;<W<&E2W1CC22%;69'6Y#9^X^0.,<YQ^/&<_2])\6V^D26
M-_JNFS-!;M#:RQV[ RMC"M,"2/JJ]?6H]*\+7V@IK,^B+I]A+>B-H;(%Y+6*
M1<[WP-I&X$#"@#Y1UH ["BHI[B&UA,MS-'#&."\C!1^9JI_;ND?]!6Q_\"$_
MQH T**S_ .W=(_Z"MC_X$)_C1_;ND?\ 05L?_ A/\: -"BJ']NZ1_P!!6Q_\
M"$_QI/[=TC_H*V/_ ($)_C0!H45G_P!NZ1_T%;'_ ,"$_P :/[=TC_H*V/\
MX$)_C0!H45G_ -NZ1_T%;'_P(3_&C^W=(_Z"MC_X$)_C0!@^-$U-IK3[*+TV
M7V:[\P6>_?Y^P>3]SG&=_MG;GM4L.IR&"PCU>]BM1:1Q?;Y3($$MUL#&,'N!
M@NV/8=-PK;>[%]93?V3=VLL^-JN'#JA/<XSG YQWQC(ZUC:IX8E;^R9-,:)G
MT_SQY=RY E,L;*SLP!.[<<DXYRWK0!TRLKJ&4AE(R"#D$4M9^@Z8=%\/:;I9
MF,QL[6.W,I&-^Q0N?TK0H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ***CN+B"T@>>YFCAA09>21@JJ/4D\"@"2BJD>JZ=-8-?Q7]J]FN=UP
MLRF,8ZY;.*G@GANH$GMY8YH7&4DC8,K#U!'6@"2BBB@ HHHH **@N[VTT^ S
MWMU#;0@X,DT@10?J>*9+J=C#9+>27D MF^[+O!5OH>_0]* +5%0VEW;7]I%=
MV<\5Q;RKNCEB8,K#U!'6H+K5],L9A#=ZC:6\I&X)+,JMCUP3TH NT4R&:*XB
M$D,J21DD!D8$'!P>1[@T^@ HIKND4;22,J(H)9F.  .Y-16=[:ZC:1W=E<17
M%M(,I+$P96&<9!'6@">BH;J[MK&!I[NXBMX5ZR2N$4?B>*C;4[!;$7S7UL+,
MC(N#*OEX]=V<4 6J*;'(DT:R1.KHPRK*<@CV-.H **@N[ZTL(?.O+J&WB)"[
MYI @R>V3WIMIJ%E?[OL=Y;W&T MY4@?&<XSCZ'\C0!9HHHH ***H7.N:59&[
M%UJ-K ;1%DN/,E5?*5L[2V>F<''TH OTQ(HXL^7&B9Z[5 S3E974,I!4C(([
MBEH *0@,"" 0>"#4-U?6MB(3=7$4(FE6&+S& WR-]U1ZD^E3T  &!@=****
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M@GUN"WC.H7CV]B&885BTFU"^.2%\QC].*N:GX;M-2U*WU-)KFRU*!#$EW:L
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MN[ZVL41KB79O;:@ +,QP3@ <G@$\=@364?%ND'6=.TR*Y$LM_ UQ"Z9*% 5
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M9FUNY+W'B8PR-L3+*+R0>G3*@XZ<8Z<4 >MU4U+5+'1[%[W4;J.VMDQNDD.
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M>E:?JUAY6I&06T3B8E)WAP5SU92#CKQTJ?2[NQOM+MKG3)(Y+%T'D-$,(5'
MQ[<5SCO>O\6$@^WRBT31S,+?:NW)F"GMGG Y]JYGP-J6J:9HO@6 W,3Z?J23
M6[6XAP4VQR2*P;.2<I@CI@^V2 >J45Q.@ZYX@UM=&UFWB7^R[[+7,4IC"Q(P
M.SRR"6+ X!#=><!>E=#XCN[^QT*XN=,MGN;E"A\J, N4WC?L!X+!-Q /4@4
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M[HL)H91&(X8SD(8]K;BP(4$'@\XV\4 =U17F'_"1^+!\/Y/$YU.Q+AVA%O\
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ML:;KU@\>DV3ZE]KO+VT6>&7R&3[2H4$R 8P.H..V15EM=T]83+YLC#S7B"I
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M8A&4+EMK#!Y8C;UXSWK=O]=T[2RRWER5:.+S9-D;/Y:<C>^T':O!Y.!P?0T
M0_\ ".61NUGD>XE1+HWB022;HTF.?F ZCJ>,XR<XSS5[4-/M-5T^XL+Z!9[6
MX0QRQOT936?=^*]#LIU@FU&,S/;_ &I$C5I&>+(&Y0H.[J.G;GI69K.LZM<Q
M6EYX9D@N+&?3+NY$OEEPT@1#!CZECQWQ0!KV6@6ME)YRS7,UPL'V>.>>3>\<
M><[03[@$D\G R3@5)HFBVGA_2XM-L3*+6'/EK(Y<KDDGD\]2>M2VUS)#HL-U
MJ3)'*ENLERV,*I"Y8^PZUFZ;XACET*TUF_D\B+42K6D 0L^UQE%P 2SE>2!T
MY]": +5UH%E=ZS#JS&>.]B@: 213,H*$YP0.#@\C-4[3P;I5E#I$,!N5CTAV
M>S4S$["P*G/][AF'.>M78O$.ESV<-U#<F6.:1HD$<3LY=<[EV ;LC:<C'&.:
MNVEW!?VD5U;/OAE7<C8(R/H>: ,32_!>CZ/J3WED+J-6D:5;4W+FWC=L[F2+
M.T$Y/;C)QBM?4;"+4K0VTSRHN]) T3E&5E8,I!'N!]:YG5O%?_%1^&[33+P-
M!>WTD$X\@E956*0G9(1@X90#M)K<'B+2CJ$5C]KQ/*SI%F-@LC)]Y5?&UF&#
MD D\'TH YSQ)X7E>32/[-MKJ>3^VH]0OKE)463Y8F3><D#(&P8 Q@=/79O/!
M^CZAIEW8WL,DXNY5GFG:0B5I5P%<,,;2H4 8P !7,3^*;K4[36-0B\0-H5KI
MUY+;LT^G&1/*50-WS 'S-QSC/3@KWKJK_P 6Z'I5Q-;7FHHMQ;Q":6-8V9E0
MY^;"@\<'Z8H KS>"-'N=%&F7)O)P)EG6ZENG:X65?NN)2=P(Z#''YU-)X2TV
M73[6SD>[=;>Y2[$KW#-(\RD%7=SDL1@<'C@#& !5J[\0:796L=U+=;H9(?/5
MH8VE_=8!WX0$A>1\W2HM0\0:?!8>9%?*6FMC<0O#&TW[O'$F%!^7D<GB@!\>
M@6L.L7NJQRW"W=[&L4S"3@JN=H Z#&X]/6LR7P#HDFE:;IZB[A&F$_8IX+EX
MYH >H#@YP1P0<U;\&ZI<ZOX)T?5+Z16N;FSCFF<*%!8KDG X%067BG2;;2[>
MXO-?AN4NKN6&"X,7EAF#M^[  _A *Y[[<T 2W'@_2IGT^5/M4%S8!EAN(;AU
ME*L<N&;.7#'D[LG//6KVB:'9>']/^PV E$'F/+B65I#N=BS<L3C))/XT_2M8
ML-;MGN-/N/.CCD:)\JRLCCJK*P!!Y'!'>N9D\27-WXRU30$U2WTR]M5C-C;S
MPAA=AD#%\D@LNXE=J$$;22>> #6U'PAI>I:E/J#FZ@N+F#[/<FVN&C$\?. X
M'7&3@]>W2JT_@'1)1IQC-];2V$ M89[:]ECE,(_Y9LX;++['IVQ6@=:BTS2K
M636)#'=FV$LZ11-(5( WMM4$A03UZ"G7/B71[2T2ZDO5:!X/M(>%6E'D]?,.
MT'"?[1XH 0^';#^UK'4D\V.:QA-O;JCX1(SC*[>ASM7\JIZ?X*TC2]2EO++[
M7$))&F%L+ES;QR-U=8B=H;D]N.U21^+=.E\1-I$?FL5LUO#<")C$48G:0P&"
M,*3G..W7.%TK7+,>'["ZFU8:C]IRL5Q';D-<$$GY8U!/ !Z#H,T 1_\ "&:5
M_P (TWA_-S_9S2&4IYQW9W^9][KC?S_]:IM1\*Z;JE^E[=?:?M MC:.T=PT?
MFQ$YVN%(R,\_B:<_BS08[.UNWU.!8+J4P1,<C,@SE",9!&#D'&,<U;TK6;#6
M[>2?3[CSDBE:&3*,C(XZJRL 0>1U'<4 4+/PEIEA-I4L!N=VE0-;VN^=FVQM
M@,#GKG:O7I@8Q6CJNFV^LZ5=:;=[S;74;12A&VED(P1GMD<5R?B;Q1<V_BFV
MT.UUBVT9W5=LU]I\DL=S(Q.$1]RJ" !W.2V.U=)XAUF+P[X;U#5YU,B6=NTI
M4<%R!P/;)P/QH C7PW9KJ-K?K+<BYM;5K2)_,Z1MC(QC!.54Y/H*KVW@W2K2
MUTFVA-RL6DR&6S7SB=C$$')_BX9ASGK52WUO4[#7-)TS4GAGEU:SEFC*IL$4
M\85F3C/R$-P3DC:>N>%TR[UU/&%UI5[?VE[:_8A<-)!!Y3VLA?"IC<V01N(S
MS\OO0!9D\%Z5+:W=L[71BN[U;^8><1NF4J0WMRBG X^45?@T*RMM<N=8B\X7
M=RB)-^];8^T85BN<9P<9Q4.BZNU]=:EIMSM^W:;,(IMHP'5E#HX';*GD=B&J
M]J.HVNDV$U]?2^5:PJ7DDVDA%'4G /'O0!!K6B6FNVD=O=F5?)F6>*2&0H\<
MB]&4CH>2/QKD_$O@Q8M*>+1;2\N)[S5+2[NL7?S8C="S NXPVU.HY)KJYM?T
MNVN)8)[Q8Y(K;[6X92,0YQOSC!&3CBH+#Q3HNKW,=II^H)+/-;_:(AL8!TX^
M920 V-PR <C/.* +5AI4%C/<70,DEW<[?.GF(+L%!VKQP ,G@#&23U)-,U70
M[+6);*6Z$HELI3-!)%*T;*2I4C*D<%2016/X3\1277A"TU#6+CS+J6XN(08X
M26D*32* J*"2=J=@> 36I%XETB>TANH+OSHY@Y00Q.['8</E0"PVD@'(X) /
M6@"$>$M*%Q<.J2B"YN!=3V@D/DR3 @[ROKD D#@D9(-;E9<GB+2HDC<W)9'B
MCF#)$[!4?A&8@':#SC..AK4H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#B]'T.ZN]-\8:=J%K-:1:M>W#1.Y4[HI(
ME3<,$^AX.*K6_A[4=53PI9:E:-!%HD;&Z<LI6600F)1'@Y(.XMD@8&!UR!VM
M_?6VF6$]]>2>7;0(9)7VEMJCJ<#)I]M<17EK#<P-OAF19$;!&5(R#@^U ' 6
M/A?4FT/POX=N;=DCT2_CGFNB5V21PEC%MYR2QV9&.,-GMGK)]/6\U;RQ:K%:
M(5FG<( ;F0'**?4+]X^^T?WA6Q1D9QGF@#AO#MAKL'B.WDNUG&T7_P#:$SGY
M)]\ZFVV^N$SC'W1P<9Q5^^L]0L?B!#KD=K+=V$VG&RD2$@O XDWAL$C*MD@X
MZ$#M7552?5K&/6(=)>?%]-$TT<6QOF12 QSC'!8=^] '"+X:U33]%T"WCL99
MGC\0-J4\43IBVB9Y6V\L <!U&%SSG%=/XXTV[UGP-K&GV,7F74]LRQ1E@NYN
MN,G@5T-!('4T <:L.HS^.5U=](NHK8Z*UN=S1DK(90P0@,><#Z9[US>D:+KN
MA67ANYN- NK^.'25T^[LX)T66"16W!QEPK*<D'YNP->DZ=J]CJINQ93^:;2<
MV\XV,NR0 $KR!GAAR..:NT 9VCVJ:;HEO;QV$5FD:$K:08(C!).T=B>?IFN9
M^'_AM;#1@VK:'%;ZG%>7$J2S1QM(%>5F4AU)Q\I ZUV]% 'F=YIOB"ZU2UFD
MT.XW6?B'[3^XEB2%K?#@.J[AN8AE+%ANSG'I5ZVT/5)_"'C?3VL)(+G4KB^>
MU61DQ*)4PAR"<<^N,5VL]_;VUY:VDKL)KHL(0(V()5=QR0,+QZXS5F@#AC8Z
MI>:UX0N6TNZMH[2TN(KEF>,F!GC15SACGE3TSVSBE\&1:Q8Z9IFB:IX>,<ND
M1F'^T&:-HI$52JM%AM^YAC.0,9.3VKN*K27]O%J,%@[L+F>-Y(U$;$%5(#?-
MC ^\.">: /,8K6]T?3?!<%]ITZ7$?B&ZD,&49BKBY=2,-@_*P.,YX]:T;C1M
M8MM1O]7M-*=XM1UB&:2W3R_/BA2'RS*FXA5=F'/.X*>QZ=O?Z-8ZG<V=Q=Q.
M\MG)YMNPE==CX(SA2 3@D<]B:LW5W;V-K)<W<\<$$8W/)(P55'N30!YI:Z%K
M<-M:PMHUT!#XJ?426FC<^02YW9+Y)&X>Y.:GU+0M9FM_$[0Z7,S3:Y9W]NF]
M 9XHC!OVY; /[MN#CM7<VNN:==W:VL<S)<.I>.*>)XFD4=2H<#<!ZC-:- '.
M>*+#^V-(LXI[&^R;A)"]G,$GLV"MB12#@D' (&>&/!JQX4AU:WT%(M9D\VZ6
M64+*45'DCWG8SA> Y7!..Y]<UKSSQVT$LTK$)$A=\ D@ 9Z#D]*2UN8KRTAN
MH&+0S(LB$J5)4C(X/(X/0T 0:M9OJ&CWUE')Y3W%O)$LG]TLI /X9KD?"EK>
M#["=4\*/9W^F0&)[R29)5<[=I\C#$X; )R  ..:[JB@#S(:+K7_"H8]&_LBY
M_M(7*N;??'G:+KS<[MVW[H]:OZK8:A#XLO[F7P[<:SI>K6T4>V.9$,#J"I21
M68 HP.<\XYX.:[+^U; ZO_90NXCJ'DF<VX;+B,$#<1V&6'YU8N+B&TMI+BXE
M2*")2\DCMA54=22>@H X2WL-7T+7M4M?^$=74M,U6.W\GR'C$-NR1+$T<@<@
MB/Y000&X)X)JRVG:I;^(/%;_ -G230ZE8PB":)D"ETB="F"V0<D8XQCO72KK
MVF-97=V;M8X;1=]P95,9B7&[+*P! QR..:IZ1XR\.Z]>FSTK5H+JY"&0QQYS
MM! )Z=.1^= '//H&L+X&\*S65J(_$&B1VX6&5@ WR"*:,L"1@J2>/[HJ77M'
MU#3-0T'4+'3I]7M;.":UN[>&41S-YA1O-7+*&.Z/D9_BKM(+F&Y,@A<.(W*,
M0.-PZC/0X/!QT/%)+=0PSPPRR!'F)$8/1B!G /3.,G'7@^AH XLZ/=1:KX2F
ML]"-G:VMU<SW$,3(1;B2)U&[YN6+,"=N>2>3U,MOHL\'Q!O((70Z/-Y>JS0]
MTN?F0#']UBHD_P!Z/WKL);F&&:*%W DE)"(!DG'4X'8<9/09%<UX8U#P;9W<
MVA^'KFT2XW-*T,;,3(0<$AF^^![$XH M^+UU%M(A_LVR^UR+=PM*BJAD6,."
MS1[_ )=XQD9Z=1S7/:7X6NK_ $?Q?I&HV5Q9Q:E>M/;333+(PS%&$;(9CN5T
MSSW P37=6UU#>0^;!('3)4]B"#@@@\@@]0>:FH X>:U\1_\ "$)<SZ?%<:[<
MS6\MY @C<HJL@;RM_P N]57<,\!LFL2^T#6Y=!\:VD.BWA?4KJ":T$MQ&[.-
MD0(+%SR"C9R<= ":]3HH X;6;'69?%&K7]AI(G67P_\ 98/M.PQ23[W;RV4G
MIA@#GCMFL>30=<OYM:*Z3>QC4?#1LD>[GBR)_P!Y\I"L0H.\8"C:/:O4:* .
M+M-,O+[6/#NHRZ?/:+HUE*D@EV[Y'=%7RU )R!M))SC.W&><<]IVB:]H^C>%
M;N30[F[.GV]Q:7MA'.BRJ)'5A(AW!6QL (W=#[5ZK10!EZ!9I9Z.D2:;'IJN
MS2?9$(.S<2?F()!8YR<$C)/)ZGF_!]IJ7@O2SX;GTNZN[2UED-C=VQ1EDB9R
MP5P6!5AN(.1CWKN** .1O;35H/&>E^(39O/;?8IK*XMX6#/;[W5U< D;ON!6
MQ[8R*Q;?PUJEG=Z1.+&5E;Q%<ZI-&K)_HT4B2*H/S<G+*2%SR3UQ7I%% 'F>
MH:)K$WAKQ;:Q:3<-/?ZTEU;)NC'F1AH3NSNP/]6W!P>E.=)K[6/B)IL.FRW$
MM\L$*9VA-S6JJ Y)X SDG\LGBO2JH6>C6-AJ%Y?6T3K<WK*UPYE=MY P#@D@
M8  X[4 <''X>U'1=2N;"YT&77]-OK6WB25)U54>.%8F6568?(=H;(!ZG@U-?
MZ'JA'CF&'2G*ZAI,-I9^64"2.L,B$#+94 N.N.*]%HH \XO=%U=IK>]TJVO[
M#5XX+:(DNCVMVBXW),A) *Y?YA@X/!/2HM1TWQ!=:G'(VAW!-IXA2Z0P2Q)"
M]N"0' W LY!!8L,]<''%>F44 >::IH>MR>%?'.DQ:3-)-J-W+-:.LD>V82*@
M&,MD8VG.0/QK9CM=2TWQ;K6H/ID][8ZO:P>6J%-T4D:LIB<%A@'=D'IG=FNR
MHH \\\,>&]3\.ZSX?CGMI;B&PT"2SFN4*E?.,D;[0"<D84@''I6]X L+S2_
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M2AD.0%P#NR"%)XZ&NDHH XW[#J6I^(-&UFZTZ:'^QK&?,)9-TUQ(JJ53YL8
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M8)8<CY1D]Z]!HH \VOM%\12QVM[!!/9^(X[&WBDDMV1K*[(^_%+&3@*I+?,
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MM.MK686MU$89%>ZE<B,_P*Q8E5]E(%%[X(T#4$L!/:2AK"/RK>6.ZECD2/\
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MOY]]"(+DI/(HD4 @9 8#."1N S@XS3/^$5T@1Z>L<$L3:?%Y-K)'<2+)'&0
M4WAMQ7 '!)Z#TH X[3_$OB#5;GPY:M?+:O<W5_97CQ6Z$2F .!(FX'!)7/<9
M[$<5T_@K4KW4=%N!J%Q]IN+2_N;,SE%0RB.5E5B%  . ,X %7?\ A&=($VG3
M+:LCZ;N^R[)G41[AAC@'#$Y.2<YS4^EZ/8Z+#-%81/&DTSSR!I7DS(YRS?,3
MC)YH P;C_DKFG?\ 8#N?_1\-1_$LR?\ ",6RC/V=]3LEN?\ KD9TSGVSBNA?
M1;"36X]9:.3[?'$84D$S@!"02NW.W!(!Z=J:^@Z;)_:0EMS*NI8^U)([,KX4
M*, G"\ =,>O6@#GO+\WXP7,6P/;MH,33J1E2XN&\LGW^_BH]:U">"'Q?XAMN
M7TK3WM;0XSAU0RR,/^!%%/O%756.E6FG/-);H_FS;?-EED:1WVC"@LQ)P.P]
MSZFB/2;*/39]/$(-K.93*C$G?YC,SY)]2Q_.@#FTFETOPSX7LK*],+3K'&5C
M0//< 0EB$W KN) 9F;C&[D&LBZU6_P!5^#>L:C>3'^T++[4T<VU58/;3/Y;$
M+QN_=KG'&:Z6#PI:S:5INGZFKS-I+ 6=U%.\4FT+M!+(00=O##.#U[X#+GP?
M8?V+-H=A;BVTZ]G,MX/,9LJ6W.B@DXW'(P, !F(YH S_  I?RZWXP\1W%TI!
M@M[*"*,_P(\/FMCZL_/^Z/2M"YTV#5?%&D3P1HEMH;2$2*  9&3RQ$OL 23[
MA1ZXN_V*+?Q#<:E; !+Z!(+N,,5/R9V.I'0@,5/M@C[N#5L/ GA[3;N&YMK:
MY$D+[XQ)?3R*&]=K.5)YSR.O- %6PN)+;XIZSIR?\>]SIMO?,.RR[WB)^I54
M_P"^176U@+X:@O9=8N=30M)JL:P2)'(5,<"@A4#*0<Y9F)'=L=@:W418XU1<
M[5  R<\4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***YOQAXIG\,0
M:;]ETI]3NM0O%M(8%G6++%6;[S#'\- '245Q'_"5^-O^B<S_ /@WMZ9!XYUR
M+7]*TS6?!\NF)J4S0Q3MJ$4H#!"W1.>@H [JBBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L3Q=
MXC@\)^&+S69XS+Y"@1Q X,DC$*J_B2/H,UMUQ'Q8T:[UKP!=I8Q--<6LL=VL
M2C)D","P'J=N<#N10!D>/?$6O^&)/"48UA86U&^6WOW$,>Q5)7<4W*=H&3C)
M/ &<U8\)^)-=USQ1XDTB*^2]TFS"_8M:2%<&3"DQG:-CXR0< ?=/3(PWQ_HV
MI>++KPAJ6AVGVRTLKV._DD$J*'CRK +N89) ^GO3] \*ZG9?$S6O%UQ'%I.E
M7%L(_L8E4F0@+F23;\@^Z3U)Y^N0#I_!_B1?%&@+?-$(;F*5[:ZA!R(YD.&
M/IW'L16]7"_"G3+BR\-7][<(T?\ :VIW&HQ(PP5C<@)D=LA0?QKNJ "BBB@
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M%% !1110 4444 %%%<IJ6KZ^WC0Z%IATU(_L"W@DN8W8C]Z$9?E8=LX/;WH
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MK.XBN+>0926)PZL/8C@UYY<W^HZK9_#B[ADM+47DJ3-"MNQ17-I*W #CY1G
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MB^3Y%8I*Z@*"23\J9ZGH:TY_$FAVT$$\VL6$<5Q&987:X4"1 ,EE.>0 "<T
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M<(B D#=\YW<9 VYSR,S:/;I>:9"UUX8UBUU;3=/EMGDN6D:-"8]I6'YB) Q
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M/&:ZV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUWD3RH?+8JH4@<D#U8<9^N.*Q_"7C&#4+&WM]6U"V_M6:[NH$C1=@?RYI%4
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M<2D$D@A@4/&/0].:T;ZPOY]2\<3#3+G;J.DPP6V4!\R01R@KP<<%U'IUYP*
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MSC;%&Y^]&QSE<D84<C.*8='UB^NM<9-*U!1J/AK['')=M&O[X>;\I56PGWU
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ IKHLB,CJ&1@0RL,@CT-.HH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "L/Q#H#ZO-IE[:W(MM0TRY^
MT6\C)N4Y4JZ,,CAE)'!R.#[5N44 <=J/@J?48;^8WL,=_?WMK=32>2615MV4
MI&HW _P\DG^(\= $U/P//JMWKL\FIB!M1%J]N\,/SVTMN=R/DG#<\D8%=E10
M!S]O_;>EZ5<7&K7L.HWY39!#:6YB1F .  68EF/4Y  '0 $U'X:\/WWAW1=!
MTN&\A^S65NR7B&(EII" <JV1M 8L>AR#VKI** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIB(C=P<8.>$(ZBMF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!117$ZYXH\21^-6\.^']*T^Z:.P2]DDN[AH\!G9,# /H/SH [:BN(_M'XE?]
M"_X?_P#!A)_\14WA?Q-KNH>)]2T+7M-LK2XL[>*X#6D[2!@Y8=2!_=H [&BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWN#;RB3R[K"&-MC!2.&)!ST! Z&IK[68;.^AL$@FNKV6)IEMX-N[RU(!8EF
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MV\,[E[A''#\H-N /N9P.QQQ5[PYI]I<^+]5U;3+^*ZT=F6:)86#Q"[=<2LK
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M4 (JA1A0 /0"C:-Q; W$8SCG%+10 4444 %%%% !1110 4449 QSUH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0@,I! (/!![U';V\%
MI D%M#'#"@PL<:A57Z =*EHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-2\9;F70XVL=)AD.>C$&7'T "D]1@]@:ZK2O^2R^(O\ L%VG_H4E ';T444
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MEL;86[B&QN6NX5$K?ZUM^XL<_-GS'R#GK6U110 4444 %%%% !1110 4444
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MO"JCNB2$GC^'T %>H44 >;1S6]IXHOM1L]*N1:Z'H;&U)@?=<.Y+LW(R3^[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%0I=6\DPB2>)I2F\('!)7.,X],\9J5F5$9W8*JC)). !0 M% .
M1D=** "BBB@ HHKSO6H]9UKXH2Z+:>([_2K.'2([K;:JAW.974YW ]@/RH ]
M$HKB/^$&UW_HH.N_]\0__$5!X2.K:?X_UO0[_7;S5;>"RMYXFN@@*L[.#]T#
MT% '?4444 %%%% !1110 4444 %%,EEC@B:6618XU&6=S@ >I-,M+RUO[=;B
MSN8;B!L[9(7#J<=<$<4 345#]JM_M?V3SXOM.SS/)WC?MSC=MZXR1S[U-0 4
M451N=:TJSN#;W6IV<$P&3'+.JL!P,X)SW'YB@"]1110 445%)=6\,T,,L\22
MS$B)&<!I"!DA1WX!/% $M%%% !111TH **K6FH66H"0V5Y;W(C;:_DRJ^T^A
MP>#5F@ HHJ.XN(+2!Y[F:.&%!EY)&"JH]23P* )**165U#*05(R"#P12T %%
M%1?:K?[6+3SXOM)0R"'>-^T$ MMZXR1S[T 2T444 %%12W5O!-##+/%'+,2L
M2.X#.0,D*._ SQ4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWFBX1F,\BQ"5E&&&T!649YY)XXYV?#NA1>'-'338+F>XB1W=6GV[AO8N1\H
MZL>U<WXM\)'^S_$NI:;>:BDVI6$B3V%LJNES+Y11#C:6!/ .TC.!GO0!;@\3
MZA-J5S9^7:C9HD6IQOL;AV+ J1NY'R>W6J5QXSU0>&+#5XX;*(SZ*-2*,K2E
MY-@8QJBL&50#RYR!D9J[!X534([#4?MM_8SMI:6-S$BJOF1@9VL'4LI!+<C!
MYIB?#NSBMX((]6U-(TTL:3( T?[V 9V@_)P1N/*X/K0 P^)M>U#6[/3]*MM.
MC6ZTE-15[IG.W+J"IV^S''Y^QI:3XGU6VLKZ2^GBN[B?7IM-M@D#*$*L1G&\
MY 5"0O!)[\YK?TOPC#I>J65^FI7LTEI8#3U67R]K1@@Y.$!SD#H15:Y\ Z?<
MV>H6K7U^J75\=0B*2*K6DY;<7C(7.<_WL]<4 4;WQ3XETZV3[1I5LLCZM;V4
M4TFZ-)XI6 W!=S%2"2#DGID9Z5U^F_V@+"/^U#;&\Y\PVH81GDXQNYZ8_'-8
M4W@T7=A;07FM:E<7$%W%=FZ?RM[O$=R+C9M"@]@!G)R>:W/L4G]K"]^VW'E^
M1Y/V7Y?*W;L^9TSN[=<8[4 6Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<1VT* XW22,%4$]ASDGT!Z]*9;:K(FE7-[J]I_9HMC)YN^4.FQ?XPPZJ1SR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HZOI-IK>FRV%ZA:)
MR&!4X9&!RK*>S @$'VJ]10!'%&RPQI,XFD0#,A4#)]<=C]*I3Z-;W6MVVJ7)
M,LEHK+:H1\L1889_=B.,]AG'4YT:* "BBB@ HHHH *8\,4AR\2,>F64&GT4
M1?9;?_GA%_WP*<D4<>=D:+GKM&*?10 4444 %%%% !3/)B#%A$F2VXG:.OK]
M:?10!'';PQ.SQPQH[_>95 +?6EFABN(_+FB21,YVNH(_6GT4 ,>*.0 /&C8Z
M94'%.V@KMP-N,8I:* (_L\/'[F/@8'RCIZ4CVUO)%Y3P1M'G.PH",^N*EHH
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MD\LLUQ-;);A0KEXB1(.2!QM/.?I0!NT5S2>+1/XETS2X=/NC%?6+WGFL@4H
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MK>D^*[7X@OXAT"STVZAETQ+-TN[AHR"LC.2,*?45WE% '#_VA\2_^@!X>_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%A_X#)_A1_PC^B_] BP_\!D_PH N?:K?_GO%_P!]BC[5;_\ />+_ +[%4_\
MA']%_P"@18?^ R?X4?\ "/Z+_P! BP_\!D_PH N?:K?_ )[Q?]]BC[5;_P#/
M>+_OL53_ .$?T7_H$6'_ (#)_A1_PC^B_P#0(L/_  &3_"@"Y]JM_P#GO%_W
MV*/M5O\ \]XO^^Q5/_A']%_Z!%A_X#)_A1_PC^B_] BP_P# 9/\ "@"Y]JM_
M^>\7_?8H^U6__/>+_OL53_X1_1?^@18?^ R?X4?\(_HO_0(L/_ 9/\* +GVJ
MW_Y[Q?\ ?8H^U6__ #WB_P"^Q5/_ (1_1?\ H$6'_@,G^%'_  C^B_\ 0(L/
M_ 9/\* +GVJW_P">\7_?8H^U6_\ SWB_[[%4_P#A']%_Z!%A_P" R?X4?\(_
MHO\ T"+#_P !D_PH N?:K?\ Y[Q?]]BC[5;_ //>+_OL53_X1_1?^@18?^ R
M?X4?\(_HO_0(L/\ P&3_  H N?:K?_GO%_WV*/M5O_SWB_[[%4_^$?T7_H$6
M'_@,G^%'_"/Z+_T"+#_P&3_"@"Y]JM_^>\7_ 'V*/M5O_P ]XO\ OL53_P"$
M?T7_ *!%A_X#)_A1_P (_HO_ $"+#_P&3_"@"Y]JM_\ GO%_WV*/M5O_ ,]X
MO^^Q5/\ X1_1?^@18?\ @,G^%'_"/Z+_ - BP_\  9/\* +GVJW_ .>\7_?8
MH^U6_P#SWB_[[%4_^$?T7_H$6'_@,G^%'_"/Z+_T"+#_ ,!D_P * +GVJW_Y
M[Q?]]BC[5;_\]XO^^Q5/_A']%_Z!%A_X#)_A1_PC^B_] BP_\!D_PH N?:K?
M_GO%_P!]BC[5;_\ />+_ +[%4_\ A']%_P"@18?^ R?X4?\ "/Z+_P! BP_\
M!D_PH N?:K?_ )[Q?]]BC[5;_P#/>+_OL53_ .$?T7_H$6'_ (#)_A1_PC^B
M_P#0(L/_  &3_"@"Y]JM_P#GO%_WV*/M5O\ \]XO^^Q5/_A']%_Z!%A_X#)_
MA1_PC^B_] BP_P# 9/\ "@"Y]JM_^>\7_?8H^U6__/>+_OL53_X1_1?^@18?
M^ R?X4?\(_HO_0(L/_ 9/\* +GVJW_Y[Q?\ ?8H^U6__ #WB_P"^Q5/_ (1_
M1?\ H$6'_@,G^%'_  C^B_\ 0(L/_ 9/\* +GVJW_P">\7_?8H^U6_\ SWB_
M[[%4_P#A']%_Z!%A_P" R?X4?\(_HO\ T"+#_P !D_PH N?:K?\ Y[Q?]]BC
M[5;_ //>+_OL53_X1_1?^@18?^ R?X4?\(_HO_0(L/\ P&3_  H OI(D@)C=
M6 _NG-.J"ULK2Q1DM+6&W5CDK%&$!/X5/0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI1+6-O,5(A.TJ.0 6*JQ5<G@'N>:L>)O$*>';""00&XN[NYCM+2W#;?-F<X
M)[ 8))[ &B23Q#:FU9Q87:23(DZPQ/&T2$X+#+-NQ_P'CGMB@"CH%DFH>(+O
MQ5)I-SIT]Q;1VJQ78"RD*269E4D#.54=\)Z$4ZP\%6VF:G-<6NIZBEE+.;G^
MS?,7[.LI.XL!MW ;OFV[L9[5M?VOIOVX6/V^V^UDE1!YJ[R0,D8SG..<5 ?$
MFABX2 ZSI_G23&W2/[2FYI1C* 9Y;D<=>1ZT -T#0HO#]G-:P75Q.DMQ+<DS
M[<AI&+MC:HXR2:K_ /",02:A;75S>7-R+2[DO+:.4)^Z=]P(#!0VT;S@$^G7
M I4\7:$VI:E9/J5M$^G!?M#2RJBJ2,D9)[<9/;..M+-K]E<W%K%INMZ26^UB
M&='E#L_RDF- &&'Y4\YXSQ0!J7ME;ZC87%C=QB6VN(VBE0]&5A@C\C6!IG@U
M=.T^:R?6]5O(F@:V@-S(C&WC(P0ORC)Q@9;<>/KF'0/&$%S=7UEK&H:=;WJ:
MG-9VL(D$;3*FW!"LQ)//:MV36])BBN)9-3LDCMG"3NTZ@1,>S'/RGV- &#)X
M"M1!I'V/5M3LKO2[86<-Y \8D>  #8X*%6' /W>O-37G@FVFU"TU"SU/4M/O
M8(/LSW%O(I:XC+;B)-ZL"=Q)SC.2:O?\)1I+:W>Z.+Z!+RTA2602. %W;CCK
MS@)D^@(J2RU:"+0[*\U'4]/<RQKFY@?;#*V,Y3).1P3U/% $/_",6T>MVVJ6
M]U=P2P6?V,HC*5DC!W+NW DD'G((SWS5"V\"6-GI^EV\%]>K/I<TDUI=DH9$
M\PDNI^7:5;<<@CTYX%;;ZYI,4-O-)J=DL5R"T#F=0)0!DE3GD  GCL*(=;TJ
MXT]+^#4K26S=MBSI,K(S9Q@$'!/!XH RI_!EE<11 W=VDRZBNI23+LW33+@*
M6RI&  !@ < 5?TS0HM+U35+^.ZN)9-2E665)-NU65 @VX4'[JCJ3TK0MKJWO
M+=+BUGCGA?[LD3!E;G'!'6BXN8+.$S7,T<,0P"\C!0,\#D^] &?K6A1:V^G/
M+=7$!L+I;N,0[?F=00-VY3QACTQ65=^ M/O8=226]OQ)?7J7XF1U5[>=5"J\
M9"C& H'.>_K6W_;FD_9$N_[3L_L[R>4LOGKM9\XV@Y^]GC'6I;34K&_LOMMG
M>6]Q:_-^^AD#I\IP>1QQ@T 8<W@V.ZL[2*ZUC4IY[>[CO/M3M'OD>,Y0$;-H
M4>@ ZGN2:?J?A"&_UU=8M=4U'3;QHA!<-9R*!<1@D@.&4C(R<,,$9/-0Z/KF
MK^)M'_MG2ELH+*4M]CBNHW9YT4D!F8,/+W$<##8&#[5-HOC71]5T6WU">Z@L
M'E,B/;W4RJT;QY\Q>3SMVDY].: &:AX*M+V\N)X;^]LTN; 6%Q# R[98UW;,
MEE+ C>W((SWJ2R\(06%]:WD.I7QDMM.&FQ[_ "R/*!!!/R?>R!STXZ5+>>,=
M!L]/LK[^T[66VO;A+>"6*565V+8)W XP.23VQ5JTU%;C5-00:CI\UO!'$PBA
M;,L.0Q)D.XC!P,<#H>M &):^ +/3X](-AJFH6USI<#6L5RAC+R0$Y,;@H589
M (XR#3/^%=V4>FV5O;ZKJ=O<V-Q-<6M['(@EC,K%I%^[M*L2<@@UT4.MZ3/'
M/)#J=FZ0*&F99U(C4]"QSP#ZTEGKND:A=&ULM4L[FX$2S&*&=7;RSC#8!S@Y
M'/N* * \*0#4=)OCJ%\\^F^859V1O.:08<R97/(], =@!5G3K"]MM:U6YFOK
MF:TN3&8()F4B$@$-LP.%/R\$DY!I_B+4;C2/#>I:E:PQ32VEM).(Y7*JVU2W
M4 ^E6=,N7O=*L[N155YX$D8+T!90>/SH JZ_H4/B'3TLI[FX@C6>*?=!MR6C
M<.OWE/&Y13(M CB\3RZ]]MNFN);9+5HCL\O8K,P_ASG+,>O>H;[6[NT\9:1H
MXMX3:WT%Q(9=Q+@QA.,8P!\_J>G:L[Q9KOB/0;2\U>TL;"72K !YHI783S(,
M%F0CY5QDX!SG';B@#JKBWAN[:6VN(EE@E0I)&XR&4C!!'IBL#_A$(3I T5]3
MOGT@+Y7V0LO,7_/(OMWE,<=<XXS5Y]7\W7HM)M0#,(!=7#./]5&3M48_O,0V
M/0*3Z SQ:OIUU<O9VVHVLET W[M959AM."=H.3@\'TH YBYTRY;XEV\EI]JL
M[2+1FMA-#;@Q!O,!"9*E1\HR/ICVK37P;I\+Z,UK/=6S:5YHB,;*3*),>8'R
MISN(R2,'/0BAO%EO::9JDU\FVZTN803PQ]7=MICV9_O[TQGH3C/!-/UJY\16
MFD-<6*Z6)X86FF:YW^6<#.Q<$'I_$?RYX *S>!;![.Z@>\O6>;4?[4CGW('M
M[C.=R87&.V"#P2.]/U#P7::I8:C!=7MV9]1,7VBZ38)"L9RB#Y=H4')Z9Y/-
M2R>(IK70]*UF_M?LUM<K"+N)_OVK2[0"3W 9@IX&,Y[8KH* ,FVT&.W\1W&M
M_;+F2XGMH[9XWV;-J%B" %!SEV[]Z77="BUZ.SCFNKB 6MU'=IY&SET;<N=R
MGC-5?&/B)_#?AR]OK:!;F\CMY9H86. 0BEF9O10!S[D#J144OB"YN-8T[1K$
M0+>W%B;^:25"R11@JH 4$$EF;CG@*>M &S)9/)J=M>"]N52&-T:W4CRY2V/F
M88SD8XP1U-5++08K'7]2UA+NYDEU!8UEB?9L41@A=N%!_B/4FL2Y\9W!^'-]
MXEL[.$W=E'-YUM+(0J21,5<9 R>5..F1CI6YJFLKIME9ML#W5[,EO;Q9P&D8
M9Y]@ S'V4T (F@Q)XHEU_P"UW)GDM5M3"=GE[%9F'\.<Y8]ZR!X2B>QU_0+@
M2C3-5GDNHY86PT328+K[$."P.,$-CMS8@U^X@\6ZIINI3V<=C9:?!=^?M,>W
M>TBMN)8@ >7GVS5VYUR.TU'3E=XI+'4G\FWGC.<2[2P4GH0P5L'U&.<C !5M
M/#W]C:E>:TE[J&H7UQ;1P21RM&!*4+;#\J@*?G(XP.^,\UG6G@Y]'MM NK<B
M>_TR6:2XV\>>)\F;;G_:(89_N@=\UK^+/$ \-:$=081X,\4'F2DB.+>X7>Y'
M\*YR?ICC.:?87>J"]9;Y[&?3S;^='>VRLBL<\@@LP Q@YW'.>V* $N-!-_+<
M_:]4O9["Y*LUBZQB, 8^7(0/M..03Z]B13-0TI]6\2Z7<RJ5M-*9YUW?\M)F
M0HN/959CGU(QT-78M=TF>">>'4[22*W4-*R3*0@/0GG@'MZU@>'/%,^KV%KK
MMQ?:5%I%S;[C%N*RV\I(*H6W$-\I.> <C@8/ !L^'K"]T[3G@OKZYNW,SO&]
MRRM(J$\*Q4 'OTZ @<XS6E-$L\,D3]'4J2.N#3;6[MKZUCNK2>*XMY!E)8G#
M*P]01P:P/#VMZCJVK^(;*X^RHNF7(MHFCC;+DHK[FRW^UC ].M $\7A.QM])
MT:QMY9XWT=56SN<J9%PFPYXP0RD@C'Y$#%BW\/VUKHUWIT$LR?:VD>>X^4R.
M\A^9SD8R<^F , #BLSPKXGDU3P_+JFKRV=JJW<MLNW*+\DAC'+$Y+$<#WQS6
MR=>T=;:&Y;5;(03,4BD-PH5V'! .>2,'([8H R+[PBI\'V.BVEP[RZ6;>2QE
MN,9#P%2@8J!P0NTG'0FGZCX5LO$5X-1OS=*9+&2Q>T<)L".5+9^4G<&12"#C
MCBJ4/CJQ3Q+>PW>K:5'HRV=O<6MWYP4.TCR*1O+;6_U?&,=ZZ:ZU73[&%)KN
M^MH(I!N1Y)0H88R2"3R,<YH P+_PS+=:!9>&GN[N\M!+$US=794N88V#!,@#
M<S%0N<=,DG.,]56==Z]H]@B/=ZK90+)&94,MPJAD SN&3R/>K\<B31)+$ZO&
MZAE=3D,#T(/I0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *Q?$KP&Q@M;S2GU*PNYO)NHU@,V
MR/8[;RHR2-RJ.!GFMJJM[J5AIL:R7][;6J,=JM/*J GT!)H \RBT>\T32_$E
MKHNGW^H^'?(A-GI]_%(2DI?]X(D;#LBKM;'<C /6K20WS-X\<V6K2KJ&G1_9
MI9K0JT[>2Z8"A1@Y(&, COBO0+/6-,U"9H;+4;2YE1=S)#.KL!ZD ]*NT >:
MS&\TZ;PSJ-SI>L7.G)I/V*>.RCE$UM,?+.6C7#%3MP>#C KM/#EC:Z5X=M;6
MSL);&UC5C';2.SO&I8L <DG/.<9.,X[5K44 >>^#]'M_*\1W&IZ9>(\FLW5Q
M'YD$JEXF;*LHQSGVYK+\-1:AIG@[P3:SZ-?QRVS3)<3K9,\UFQ5@,*1QNW8W
M$$ ?7(]6JM_:-E_:7]G?:H3>^49OLX<;P@(&[;UQD@9H \OT/3;M+;P7;WFC
MWZFQU2^:X$UHS"-6\[8Q(!&"73GIWZ#-:=]I21ZOXSMIM$FG34K6"*R6.T+)
M(!#LV[P-J8;'WB,=?>O1J* /.M$TZ^\.:G>VNMVUSJ%M=:19V\<\$#SJS0QL
MDD;;0=N68L,X!W'FJ_AGP]>:=KGABUU>REN#:^'I+6:5H#)&DIDC*H7P5X56
M'7M[UZ;10!C>*2W]@3*D,TKF2/"0Q-(QPZD\*">@-<WI_A^^L/%^H0K&?^$9
MFF36$ 4Y%P<AHMN,XW@2^Q '<UVL5]:SWEQ:17$;W%MM\^)6!:/<,KN';(Y%
M(-1LCJ1TX7<)OA%YQMPXWA,@;BO4#)'- 'F6@)?Z=X*\-V\^BWRR0ZK<//)]
MB=YK,,\Y618\<Y#@9P0H8Y%)8V6I6NDZ2TNE:E_H/BJXN95-N6?RG,^' 7[P
M_>+DCCGV->KT4 >?:5Y\.H:GHFL>';R[FEU=[^UN3!NMV1G#1NTO16C  QU^
M48S65>Z?=-X?\3!-+O3<S^)(KF'%G)N>-983O'R\@!7Y_P :]6HH \Q\16-W
M<M\15ATZ]D-_IL$=KMM7(F<1R*0O')!9?\BK=Y:*?$<LC6=Y#I[>%Y+:26.!
MHPIW9VAB JL%W8R1BO0ZK:AI]MJNG7%A>Q>;;7"&.5-Q&5/7D<C\* ///"-Q
M#+K.A2:E#J-K>VNF?V?;K-I<T$<A(5B3(PVYQ'P,^OJ -CXD6TEYI^BPI97-
MVB:Q:SS)#;O+B)'RY(4'C%;NG>'K?3Y4D-W?W;1_ZK[9=-+Y?&,@$]<$C)R>
M3SR:UZ .)OH]/73M<M]'T:]5KO3I!*?L4L:$JK*BJ&4;G)?H.PYQWH:=8/'K
M'@21M,N46STF:*=C:.!#(4B #?+P<J_^37HM% 'D&GPBQ?P7'J&GW">7K6I-
MY,EH^X*PG="$QDC#*>!Q^%7+K1+JVTW4)K73[I;:]\3VM]!;1V[EDB1XO,D*
M 97)1VP0.,>M>@:AHEOJ.J:=J$LLZS:>[20!& 4,RE6R".<J2/Q]:N7=Y:V%
MNUQ>7,-O"O62:0(H_$\4 >>WEC??V=XYT:\TZZN;C5I9)K"5(&9)5>%4C4N!
MA"C*!\Q&, U;UG2-5TS4=$N=/FWWE_;+H^H2;L%AL++./5DVR'W#>U=O+>VD
M-G]LENH8[7:'\YY $V^N[ICWJA::1I[:M+KD,\]S)<*-A:Y:2%!@ F-<[5R
M,D#^9H Y'6+-=,\47,%[HNJWNAW^G0V<']FB1EBV;PT3JA&%(<8)XZ\U9T;2
M([?QZ0VD2Q6D6A6MM$9(FD1'CD=BGF$$,0"G.><>HKNZ* .1\>Z/?:A;Z/J6
MFP&YNM'U&.]^S @&9!D.JYXW8.1GT]ZV;/7(]0\M;6SOPS$;Q<VDL C'?)=0
M"?89R?;D7)M1LK>]MK*:ZACNKDL((6<!Y-H).T=3@ FK- 'EMOI.J7'@FS\-
MSVETFN6FK),;LPMY?%SYK3B7&TY0MQG.21BH]0TVY;P[XP2/2KPW-SX@BN(
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MEE@>2"5!)&(D4E>!GD'CK7;6>HV6HB<V5W#<""4PRF)PP1P 2IQW (X]ZLT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAA9$$@=581DGYX_F&&QSC.3GCLZY:V\#V-BT5Q#?:J]Q;V#V,<ANL-Y1Q@=
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M3.C--O(&]=I.%VKQGGYSP,<@%"Y\0>(KR343H5E'<G3;U;5HG"*LVT(9,L9
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M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<4&L6MK(U\MNR2IN,Q'WHE&1AN1SSCTKDH_"NJZ7X$TN6TM]VLZ3>O?VUL&
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MR0X+!##*F<$CNZUR^JZ5J,^A>-HH],NFGO\ 589[91$<RHH@&0?8QOU]/<4
M>@7FN:9I\ZPW=[%"[,J?.>%+'"ACT4D],XSVK0KS>YTZX.N:YIVI^'M1U6RU
M:X6YM9HIV6#!C1=DR[QLVE <X)(Z<@"O2 , "@ HHHH **** "BBB@ HHHH
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M,\\\DT ;]Y>VNG6DEW>W$=O;QC+R2,%5>W4U!8ZSIFI:;_:5E?V\]D Q,Z2
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MJG>0-O3!.3T%R#5]8UTZM+IEY:VC:9?+;"&8!HY%54:0NV,C(=MNW'0$YSP
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MS6;KS+ZZEN(U$4)+2E)''RH@)X5><#ZUI/XOT!(K"4ZE$5OT9[7:K,90H).
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,T$4:%5RSH5'+$ #)]:3PSI%MIFBV4O]DPVE^+2.*?;&@D)51D%EZ\^];M%
M'FNCZ;X@T[1?#EI+HEQLAN+S[8(9(1/&'=FC*OO^52&^8J0W 'KEGAW0M<LE
M\&1W.CSQC2Y[W[2WFQL$5U<(WWLD$L/?UKTVB@#F?!5C>V%EJJ7UG);--JMW
M<QJ[*=T<DI93\I/8]*SM'CU;2_%?BN_DT&^E@U"XADMC')!\X2%4.<R#'(/6
MNWHH \RE\&ZXD<VOO''+K$^MP:I/8PR#!AB4HL(8X!8*<Y. 6'XU-K_AK6-7
MOM6UW3K8PSE; V]G.X3[2UO,93OP2!G(49].<#FO1Z* .%U^WU;Q'X1U"2'P
M])97;R6LJV\SQ>?.8IED8$JQ7&%PN3Z]*S-:TK7=67QK)%H5TG]KZ5!;VB/+
M$&+J)00WSX!^<'J1COGBO3:* .1CM-07Q[;ZH=,N!:)HK6S/NCXE,BOLQNST
M!YZ>]<KI&A:]H5AX;N;CP_<7R6^GO8W=E%<1K+"WF;ED7YPK ]"-WH>U>L44
M </8Z-=V'BS1;FWT,6FGVVEW,+1V[)LA>22-U3&[).%.2!C)K,T/0]<TZT\&
M22Z1-YFFS7B74(EBW1B4-M;.[!7D9P2?:O2Z* *EA=7%TMP;BQEM#'.\2"1E
M;S4!XD&TG /H>:MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1167XDUE/#OAK4M8D3>+.W>
M4)G&X@<#\3@4 :E%>*?$:[U.T^"NF:S_ &C=1ZM=RP7$UQ#,T9S(I8H,'A1D
M #IQZ\UJ>*]5O? WC?PC+I]Y=/IVLR_9+RRGG>5,Y0!TW$E3\_; .T>IH ]7
MHKCM%UF6U^(>K^$YI&DA6UCU"R+G+(C':Z9/4!N1Z XZ 5V- !1110 445GZ
MWJ)TO2)[I K3 !(58X#2L0J GL"Q% &A17&_#_4;HP:GX?U*\^V:AH]T8VN"
M>9X7^>*3\02/;;76W4:S6LL;@[64@X)!_,4 2T5XWX4FU:YT+P+=:3-J\VH3
M3*=4DF:9X'MOF\PN7^3=]W;CG/2N]A\8;M;L-.GTZ6W:_:X6W5Y )OW6XY>,
M@;58*2IR<\9QF@#IZ*\\U#X@:M)X0O=:T[0&ABB$D:W%Q<)A9%F\DC:,D_WO
M3@C/KM3:S9VOB\+J%BUO=0Z/-=/=B<M&L*R)N4+W.2#D@'CB@#J:*P+77[NZ
MDB#Z)<BWN;,W4$J.&&.,1R= CD,"!DCKSQ6)I7B^"#1O#-KI&@W3IJEF\EI"
M;A3L"*#M9V.>A')_4\4 =U17)Z?XU.IZ?'+#I4\5TMU-:7<4[A8[.2)2S>9(
M 0%/&"!SN%1V_CU+VVT"6TTFXF.LM-'&!*@$;Q*Y8$YY&4//IS[4 =A17#77
MC:_GL-+DLM.2*XFUHZ7=Q33?ZIT9MP4A2&!V=>P/3-=P"VS)7YL<@'O0 M%<
M4GQ =K:VNSH-T+6;4FTUF$T9=9A(T:X7.""RXSD8SWJ];^+9Y5U.!]&N!J%A
M<PV[VT3B0-YNTH^X#A0&RQQ\H4]: .GHKC9?'R1Z+J.HBP$J:;?"SO#%<!D0
M$(?-#8^9 '4G@$8/'%=)!J#3ZO<V20@QV\4;M.'R-S9^3&.H !//1E]: +U%
M8GB+Q = &G8L)KMKZ[2T01NJ[68$C.3['^N*R[SQP]E:SF72B+VSA66\LOM*
MF1<Y.R/ (D;:,XX'(YSP #KZ*YR'Q9')JUY8RVQMUAT]=0BFE? EB.><8R-I
M&&STR.N:</$ES-/)9VFEF74+>TCNKJW:<+Y0?=MCW8.7.UN.!QUY% '0T5YS
M+XGTZ\\6^&->M[B46=[I5V4C=F!9]\*JFSGY]Q*X )SZUTUUXE>R%G;W-K!!
MJ5U$\RV\UT%5%7;G<X4\Y=1@ \GT!- '045F:!K*:_HMOJ*6T]MYNX-#.N&1
ME)4CW&1P>XP:FU?5+71-(N]3O7*6UK$TLA R< = .Y/04 7:*YR3Q3)9ZI%I
MVH:8\%S<VLES:+'*'$OE@%XR3C:X!!QR,=#Q571O&YU6XT-9-)FM;?6K9I[6
M5I5;E5#E2HZ<'@]\=!0!UM%5=2O#IVF7-X+:>Y,$32""W3?))@9VJ.Y-9NB^
M(UU76-2TJ2!(KK3UB>3RIA*A$F[ S@$,"C @CTH W**Q?$?B >'H+*0V,]W]
MKNX[15A900SG ZD?Y]*PI_B&;*SU<WVAW4%]I4L"SVHE1\I,P$<BL."">H'(
M(H [>BN=B\27DM\NF?V08M4:.2X^SRW*[5A5@JN74-@L3P,=CG&.:D'CVRO(
MM.6WB6.ZOFGC$%W,(=DL+!7B+8(+Y/ [@$YH ZVBN3NO&%]'J3:9:>'+NYOE
MT^.^,1GCC&UB05R3U!4CW/MS3(?B!8W^F6EUIL2RRW-H;L07$PA*J&*[2<'Y
M]RL .GRG)'&0#KZ*Y>#QC_:-J'TK3+BXN5L5OI;:8^4\:MN"IC!S(2C@#I\O
M49&66WB34[KQDNG+IWEV?]E1WVR1]LV78C#*1@,"I&,]R2: .KHKB-%\4VEK
MH'AR2TTJ6WT[4[EK5#)<%C;N6? 8G).XJ0.>I K7NO%$5HY22*-6ENVM+5GF
MVK*RJ6=B<?*JX93P>1CTH Z"BLCP]KHUZRGF^RR6TD%P]O(C\J67^)&XW(00
M0:YW6;J]LOB?:26%E-?3/HL^+<7 C4D31<DL<#N,@9YH [FBN3MO&XO](M;Z
MTTR8>8LYG%T_E):O"P5HY'P0&+'"CO@GC%(GCNVN[;2WL;8//J5@;ZWMYYA$
MTB\?NTX(9^>GZT =;17)WFOV&G>)M4EN-.N5N++11>23+)N\R$,YV*F<9!#<
MD _A6QHVK-JT;2B* VY1'AN+>X$T4H;/1L#D8Y^HH U***YD>+PNN6.G7&GR
M6XOKF:V@,CXE)C#'>8R,A&V-M8$YXX&: .FHJMJ%['INFW5],KM%;0O,ZH,L
M0H)( [GBL6#Q1+<:5)J%OIWVR(K";=K&;SUF,C;>H48V\%C@X'- '1T5YQXM
M\0IKG@#Q.L8,-QIDZ0.T%QN1FS&P*N,9!#X((ZY&*Z'7_%XT![B2?3Y/LELT
M*O,[[#(9&Q^Z!&)-N06Y&/>@#IJ*YAO%-[+XBO\ 1[#09[F2Q:'S96N(XU"R
M!B&YYQ\O3KUX]7Z7XL_M;2]-NHK$I->73VKVSR_/ R;]^[CJNP\?3GF@#I**
MK:A=_8-.N;OR7F\B-I/+0@%L#.!G KF;/QPUSI]C>7&E-9IJ21-8F>Y0++OC
M,C;B,E H7J1SD8'.* .OHKE;+QK'?1V\*6$B:E/>2VB6[OA&,:[FD#XYCVX(
M8#G(&,U@^&]>ET?^US=VDC?:?%)L=IN"YB,B1 $$_>7//;@].U 'I%%<U)XP
M@AN]4M9K5Q/97D%G&JN#Y\DRJR =,?>&<],'KBJ.O^*M8T[39C'H_D7,6HVM
MH7EE)BD25T&^-MOS?>VG(&#GKC! .SHKDI_$&G:9XDU:;4+.2UGLM(CNKBY\
MXNC1;G^55SU#!^< GCVJV/%$D&J6>GWVFO!-?V[S6824/YA0!FC;H%< Y[C@
M\\4 =%17'Z+XZ_M:70B^D3VUMK43M;3/*K'>J%RI4=!M!P?;IWKJ+ZZ^PZ?<
MW?D33^1$TGDP)NDDP,[5'<G& * +%%<HGCBVA;64U&V\A]*LEOIQ#*)?W9#?
M+T&'!0@J?4<T[_A,)8]3.GS:/*9O[..HJ89T9?+Z8);;\V<# R.1S0!U-%<?
M8^.6NM-L+Z?2FLXM22(V#3W*8F+QM(V<9*!0O4CG(P,G%26WCFWGMT5[7[/>
MM=26JQ32[8F*+N+B3',>",$#.2!CK@ ZRBN.A\>>?_9D::+=^??7<UGL+J%2
M2-&;(8XW*0N0PXP<^U1CQ]*EC)>3Z'/%#:Z@-/OF\]#Y,AD5 5[N,NI/ X/?
M!H [6BN5U+QQ;6,\_E6QNH+6Z6UN/*DS*&)4%EC RRJ6&>0>#@'%5KKQ\UJN
MIS-HEQ]ETR_2SNI3,F5#>7AU7)S_ *P<>G?M0!V=%<YI6MZC?>,M=TR:VA2S
ML! (V63+'>K-DC;WX&,\8[YK5U6_DTZU22&SENI))DB5(QPNXXW.<':@ZDX.
M * +U%<+>^.KJ?28;C3+2 S#7(M*GW3[D&9%!*,%^8,& S@8SG'&*[A"QC4N
MH5R!N .0#]>] #J*YB/Q@#K=AIT^G2P&_EN(K<2.!+F(,=S1D#:K!&*G)SQT
MS52R\>M=#3IY-%N(+.\U"33O.:9"4E5W0?*.H)0\]L]^M '945S,'BUI;;5M
M^GF.\TZ\2T-J9AND9]NP@XX5MXP?KG&*Z49P,@ ]P#0 M%%% !1110 4444
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M-2SNQP% Y))]* .(L_!&KVM[I=P^KVDIT^_GN@[6K>9.LJNI\QM_+ /@'&
M.#TI\/@K4(M(TZQ^W6I:SUAM4+^6V'S(\FS&>.7(S[=*ZH7LT\E@]I;">RN4
M+R7'F!?*7;E#M(RV>G;%7: .*LH-,\1>/!KFF7$DD-G"T%WA"L<LZL5C!R!E
MD#2Y]-R>U=K110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7$_$>&Q,7ARYU".W,$.M0>9).J
M[40A@<D\ $XSVZ5VU(0",$ CWH \C\13V2I\3DCN54+IEL\:B4C:WE28P,\<
MXX]Q6A%IV@R^/[>TD^SO:7F@M/<Q--E)W61-KN,_,0K-R<_I7IFT>@HVCT%
M'B^CZU:MH?A./7]0B319]-FA%Q=*)8?M"N %D+<!O+'!/^UZUZCX5MHK/PQ8
MV\%Y=7L$:%8KBZ_UDB9.T^XQC!],5K/&DB;7167K@C(IU 'EGB6[L[#4OB':
MW,T4,EUHT4UK$QPTK"*;+(.Y# 9(Z8S4<=MH6K^*HX-8N(Y+&?PQ;3%9+DJC
M,'<%^N,@ ?3&:]5:.-SED5C@KDC/!ZBL4>'V/C"77I+B-T>S2T%N8/NA79PV
M[=URQ[>E '!^&9;G[3X>L?%Y\RQET1_LYOQ\LDPE/W]W'F>3Y9YYQN]ZKZ="
M)K_P9:ZM</)"]WJ,=N)YCNFM0KB'=S\P*XQGJ".N:]>>-)5VR(KKG.&&12X!
M["@#C_AO+"="U"UMY5>WM-6O8(%5]PCB$S;%'MC&/:J/B&STN]^)]A:ZNZFT
MN-%N T4LQ1)&$L6 1D \9/X9[5WX '08K#N/#[7'BZWUQ[F,QPV;VGV9H,[E
M9T<G=NZY0=O6@#S73;&">?P9INK3O-:S3ZE# D\[!IK7#B'/.2"N,>HQ5^\6
MV_LSQI97Q\G5[%S_ &1\Q\Z.(0K]F\@]>7!'R]6)!ZUZM@>@I#&C.KLBEU^Z
MQ'(^E 'E$NGZ;J'B#Q);^*)@LPT>RF=6N"H27;+O=!GJ#C&.F?>JJ77F)9Z5
MX\U 6#7.A6WV>6Z0',N&$NUF^[,"8_?@5Z/:>'VM_%6I:U)<1RB]CAC$)@P8
M_*W;2&W'GYSGCTK::-'V[T5MIR,C.#ZT >;:?I>F7_Q%^PWLTUX8=#LIE%S,
M1*TJ2O\ .R@C#X"D\=_>NU\4&,>$]7,K[$%G*2V[;CY3CGM6K@9S@9I>M 'D
M6FF/3[GPC-HLL?\ :5_X;N-_[W<9Y5CA,0;)YPVX#TY'05:TMH;NS\#W>DN&
MU:258M67/[QX_*;[1YXZDB0#ENC$8ZUZEM'H*18T5V=44,WWB!R?K0!XQ"=*
MLOANL<+6UM=6_B-4F6,B-D_XF!PK 8Z)G /0>U;S7VC7NOZ]IGB.=XM634(Y
M=."-MG> *AB^SGJ<L&R%[EL]:]*VKSP.>>E(8T+ARBEE& V.10!Y8T^GZGXA
MU&QUC59+'7K;5C)9QQQJ+F2(,#%Y1/)1DX(''WB<9)KU.2-)HGBE17C<%65A
MD,#U!'<4&-#()"B[P,!L<@?6G4 >->&KFSM/#O@V!EMTTDWD\.K;5 59L.(5
MF_X%CAN^SVKN/!D<D.I>)(;=MVB)?+_9^#E%S&IE5/\ 8#D@ < [AVKJS&C(
M4**5;J".#2JH50J@ #@ =J .(\7Q:<GCOP?=:A%;>7ONHO,G12"QBRBY/?/0
M>O2N/+:;'8SZLD\(O(O&A5)Q-RJ-= .!SPI0G/J.O2O9R <9 ..11M7T'Y4
M>51SZ?JGB"]L]6U:2S\06NL,]K%'&HN)(@^81&3R8VCP"!Q]XG'6O5))$BC:
M21U1$!9F8X 'J31Y:&02;%W@8#8YQ]:=0!Y?KUG>^(O"NH>)=/NK'<LRZCI\
MIR61;?/E -G # .<'IYK"K-WXLTW6M0\(W]U-"/#M_!,TAE8>4MUM79'*3P"
M 9, _P 0]0*]&P,8P,4C1HZ%'164]B,B@#Q:U?2OL%E!#<Q) OC69%6.?:/+
M)? X/3&W'X4:U;:5::%X_-L\49TN]273U27 M7,43$QC/RDONZ>XKVH(H& H
M SGI1M'H* /,]>N;(^*O%H%VFQ_#"2\3_P 6Z;D<\<;.GMZU%X?&FV?B+P@U
MO/&AU#P_+]K/G9,Q40%2QSR1E\>@R!TKU':/0?E1M'H* /(-'=[GP/X:-C?:
M9-<QF]9;'4FS#=J)3N&[^%P""#SP3VS5[27T:?QCX?O;JQBLDNO#0$*76/,#
M+(F '/+,%[CG'/ KT]XHY%VO&K+Z,,TXJ"02!D4 >.:(NA67PUT35YR7FN[F
M*UFN&NB(^)V8"<G(\L8Y&.<@9&<U!))ITV@WB74EG-;6'B^!\[ (H(&>(D@$
MD)&<MWP03VKVHHK*5*@J>Q%&U2"-HYZ\=: /+[V6RN_^$SM]39(KJ"-9-((.
MUD@\E?*:W[Y\P-]WG=@>@I^DV$&J^/H[?7BLNH)H-C<3PF8C%TLCEFV@]00O
MX?6O3&C1F5F12R_=)'(^E+@9S@9H IZ7J^GZW:&ZTR[BNH%D:,O&<@,IP17'
M^)[32[OXC:5%K7E?89-(ND(FDV([>9"=IY / )Q[9[5VEG90V22"($M+(9)'
M.,NQ &3CV 'T J=XTD $B*P!SAAGF@#R726_L6Y\(7.I7)AT];S48+>YNY,9
MMB'\A79NQ4?+GMBJ:/I4^EZ3/=BU:VMO&-U&[3J-L,3-/A3N^ZI^3@X'2O9F
M17 #J& .1D9YI=BXQM&,YQCOUH 0;3&,<)CCM@?TKQM)K&30=-C:\&P>,YH@
M1<D'R_/DXR#G&-OZ5[-2;5]!^5 '&>!OLMMKGBW3;)XUM;;4D,4$;96,-!&6
MP.PW;OQS3O'*S-=Z8;6XTUKE(YY!I^I\0W: )NPW\+KD8.#PS=LUV. .@I'C
MCE&)$5QZ,,T >8:?J6FQ^(=.GN8_L%IJ'A=%BM[MOFD<./DY^^X4J/4C'%9O
MA_6M,73O"D/B6YA_L6XT )'+=,/)-T" X8G@/LQC//WL=:]A9$8J6525Z$CI
M2-%&R!&12HQ@$<#'2@#S866BW/C;1=-N)'N+%/#TZJE]*=\B"6+:7R<G(!//
MIG&1QT'PSNC>?#K19&G\]E@\LN7W'Y6( )]@!75X!["E  Z"@#SC6;W1YO%^
MO:1XKN/LT<UO =+=V*L4VG>8#_SU$G]WYC\O7%8WC#5+%9]:>.?[/J%A<Z>2
M;R3-PHW1$F+D>6@5CN;)!)?IU/KS(C,K,BDJ<J2.GTH*(2254DC!..M 'G$U
MUY/C5+J,V6K6=UJ<4?RG;>6$I0  ?WXL#<1Q@,3SBJ?A:?3]6U#39+S59(?%
M5G=R"[LXXU6=SE@ZR9Y:'!!!Z !<<@"O4_+C\SS-B[\8W8YQ]:!&@D,@10Y&
M"V.2* ,?Q==Q6/@_6+F<77DQVDA?[(VV4#:>5/8^_;K7*>"[RT'CK5;6TNK%
MK>?3;2:**Q/[HD-*K,O.&( 4%P!GC(!XKT7K2*BKC:H&!C@=J .,^))@72=(
M,\WE9UFR&1*8S@S+NY!';/TKE;^[BT2X\7VVFOY>FVVHV$MU#;_/Y4#*GGL$
M'8X^8=QNSWKUX@'J,TF!Z"@#S%M#TW5_#FO7'AG4AJ#[XKVU6%5%M'<1C=MC
M"\ OM <?[7/6HK*2;4/$#RQV#)IGC"U22,&/!A$>/,+'^'?&Q8>^.^:]21$C
M0(BJJCH%& *4*!C ''3CI0 (BQHJ(H5%&%4#  ]*\IL[\:9>W$DPBU.TFM+Z
M>#4M-;;>(H^=XYE[N#A5;/! &!FO5Z:L<:,S*BJS=2!@F@#RGPUJ6GQ>)6%K
M>626EQX<60);R94LK'EVZ/(%/S-@'GD"J>GWVES>%/"=A<20^:_AUS&;IMT!
M.(U*JG\<V1@8(*@MUSBO8@B*  BC P,#M2[%)!VC(Z<=* /']&72_$M]X(M]
M2N1=K=>&Y%N$:Y;][(/(X.#R<[_?(/<5N2Z6^F>*+[PS!:DZ9X@*W:2!<K"$
MP+A">P(";?0R'%>B!5  "@8Z8%96FZ1<VM_<7M_J<E_,Q9(-\21B"(MNV *.
M>BY)Z[10!J!52/: %0#  X %>/6<-M!X'US7-/\ ,FO;75+F&26&5I)$M/M@
M,BJ,]/+!/YD=:]CI  .@H \DO[K3+31=0U;P[J[W>F7%Q9_VF+% L$$'F 2L
MH0?*Y3.['..3CBJ^N?V//?>.%T-K.19?#<4T0LV4J74S\IMXR/E/%>Q)&D:;
M$157^Z!@4)''&,(BJ,8PHQQ0!Y3J>MBZUV[N/#=Y%<7LGA28V[6[AO,F5U(Q
MCAG [=:L3'PIKOA/6;O06%S-)H,J3P1G<JD+N4S+_P ]@W0GYN#7IR1I& $1
M5 &!M&.*%C1,[$5=QR<#&3ZT >9V=QI8UGX>'3I[8));7 "PN CMY [#@G=D
M9ZYR*I6$TMYX9T"ZA<+XPCU9([P9Q.6\TB=)!U\OR\G!X"A<=!7K050  H '
M3CI2"-!(9 BAR,%L<D?6@#QF<:;#H^L:FEPGVRS\6HMO,;@EHE,\08#)X!4M
MGU YZ5[0"" 0<@]"*3:OH/RI: "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME06RW/0@$5@>#/B#?ZI>64BWMQ.;+3;F;Q#;7856CE0?*T8P,9;(PO '4 T
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M+,2PF#44N[R1FG0\<%@QR!CJ0,JM>D44 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M],@9 ^F>] '644R(2"%!*RM(%&\J, GO@=A3Z "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#&U_7CH7]FG[&]PM[?0V98.%$9D;:&/<_0#\JV:Y#X@2QQVV@[W5<:W9N
M<G^%9 2?H!U/:NO!!&0<@T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>exhibit1034b002.jpg
<TEXT>
begin 644 exhibit1034b002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MR$7=UO5HS^[9N%VN-YP</TXK1TKPY<SZQ<7-EIEQX3MFL%MG%N8/,DE$@8,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !5*ZTC3+ZZANKO3K2XN(?]5+- KNG?Y21D?A5VB@ HHHH **** "
MBBB@ ID,,5M D$$2111J%2-%"JH'0 #H*?10 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6=JVI2Z<MMY-
MHUPT\OEEBVV.$!68O(^#M7Y<9QU('>M&L+Q%HM[JT^ESV=Y#";*Y\YX;B(R1
M3#:5^90PY4G<.>"!0!2LO&]M?Z;I,\%L?M.IWDMG%"9!M#Q;]Y+@'Y<1L00,
MG(X]*I\?LMF9CHER775ETEU69"/-+["0<\C.,9 SGM6#K.ES^&M*TS3;K6+*
M,-JMQ?1WMU9N(8\EW"NZN"C[I>"&7(4CGD'0L=(U'7=(MK>.?24@L]2AOX[N
MSAD\JY*N7889B22W5]S [O4&@#4N_&LUG;SK-I034;6#[1<V1NE+ $MM5"H(
M=R$) XZ@9R:+_P >VUO;S3V=F]U]G@BGF@9_+FPZAPB(02SA2"5..H&<])=0
M\.ZPGB9]:T+5;:T:[A2"]@NK8S(^PG:ZX92& 8CK@\5%)X8UJS\03:CHNMQ1
M1WL44=]'>6QF+,B[1*A#+ARN 0<CC..U #;SQS+%)K2VFB3W"Z5:Q7DC/,L>
M^)U=N <D$!#P>O?'>>#QK%_:$45[826=I<:?)J%O<O(K;HH]I?<H^Z0'4]3Q
MZ'BH[CPG>2W7B25;Z+;K%A'9KOC):+8KKN)S\Q/F$]NE,D\&374VDB[NX7MK
M/2IM,FC2,@RK(J*S Y^7B,<<]30 L?CH--L_LR21)+)[R%X)0_"@$QR< (^#
MD<D'!YXIVE^-)M2N=*B;1WMQJ^GM>63R7"D.55&*-@$KPXP><^@Z4FF>'?$5
MMH\FE7^NVUW;Q6S6]JZVI1V!7:&E.XAL#L ,GDFET_PE>6=QX5D:]@=="LGM
M& B(,P9$3<.?EXC!QSU- %SP1K-_X@\*6>J:A#%%+<AG B?<,;C@=!C'3OTJ
MIJ?C*XLKW7+6WT26X;2+:.ZE8W"('C8.3MZ\X0X'?V[Z'A+0[GPWH$&DSW<=
MREN66%TB*'9DD;LDY//48'M5&\\+7EQJ/B2Y2\@5=8L8[-5,1)AVJXW$Y^;_
M %AXXZ"@!]GXP-QJEK:RZ7/##?6+WUG*'5VE5-NY2@^ZV'4@9.?8\5'9^,9K
MN_DTX:45U#^SAJ$=M]H&_&0#'("!Y<GS+QR.>M0OX/OWDT9EU..$Z=I<VG^9
M%$0Y,BHOF*<_*1Y8('/7K5?3O#MUX8NK37-2U6R%KINE/:7"P6;+N0,K[_O$
M[LKD\'.>G>@#8TGQ0NL6.B7-K:@_VFC2,AEYMU4?-NXY(;"$?WB/K5CQ)K__
M  CNGPW9LI;H2W4-MMC95*F1P@/)]6'_ -:LOP;I=I'>:OK5D\ILM0N#)9I(
MI4(A ,C(" 0'DW-[X!K2\4:)/K^FP6D%Q' T=W!<EG0MGRI%<+@$=2H&: ,\
M>-HX%U:/4=/DM;K3YX(1 LJR><9L"(*>!DDX([8ZXYJ'6O&5UI=OK=JVGQ1Z
MM8::^HPH9RT4T2Y!8-M!RI&"I ZCGG(9JG@:;5KO79YK](3J#6LMLT<1+6TM
MORC')PP)ZCCT]ZLWWA*;6CJ5QJ=S"MY=Z5)I:&W0[(D?)9N3DDG:<=@N.>M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 445R/C:Z>UOO#INL#1'ORFH,WW #&PBW]MGF;<YXSC-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"
M RE6 (/!![TM% "!550H4!1T ' I:** $P!V%!564J5!!X((ZTM% " !0
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MK2<MM[ GN??O4R1QQ)LC147T48%.HH 3 ]!2!%5F8* S=2!R:=10 T(JEB%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS'M"L.X)P2.M2:#XKOM:U&XTZ31TM;NRD>._1KDD0]/**G8-X<98=, '/84
M=517,^"M7U/6=-O;C4X[=62_N($,,A;B.5DQ@J, ;1SDYZ\5F:EXZU6S77IH
M/#T=Q;:%/MNV%[AFB\M9"R+LY(5LD$CIP3V .YHKC]7\<'2Q]I^PHUCOMA&[
MS[9+A9BH+QI@Y"[QG)&>1QWLR>+);;5-=L+NPCADTZV6ZM\7!8W<;;@"!L&T
M[EVD<\D>HR =/17)_P#"3ZRWB.71TT2V\RWM[>YN)#?85(Y&96Q^[Y*["0.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/-+"0;2-_'^L;GZ?B@\#W TU+3^U8_EUG^U]_P!E/WO-\W9C?TW'&?2NRHH
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M9[*B@#$AT&2/Q9?:V]TCQW=I':M;^3T5"Y!W;N?OMGCTK-L/! L]/L-)DO\
MS](T^Z6YM8&AQ(-K%HT9]V&56((^4$[0">N>MHH XZ[\#S76C^(=..J(JZS>
M_:V<6W,1P@V@;^>(UY]S5WQV&_X5WK\;$/+)ITT:A%^^YC(  Y.2>@YKI**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBJU_?VNF6,U[>S+#;PKN=V[?XDG@ <DT 6:*Q!XHLQKJZ.]M?
M)=&Q-\<P$J$SC!(S\WM_6H])\7Z9J]CIMW&MS;Q:D66V-U%Y99U)!0^C?*2!
MW XS0!OT444 %%%% !52ZU73K*417=_:V\A&X)+,J''K@FK=><7VA:5KOQJN
M8=6TZUOHH] B=$N(@X4^>XR : .U_P"$AT3_ *#&G_\ @2G^-6+74K&^9EL[
MVVN"HRPAE5\?7!K#_P"%=^#/^A6TC_P$3_"L'POI.G:+\6?$5IIEE;V=M_9M
MJWE01A%R6?)P* /1**** "BBB@ HHK)UOQ#9Z%ILU],DL\4$T<,JP;69&<J%
MR"1_?7\#0!K4444 %%96JZ]%IDXMDM;F]O# ]R+:U"F0QH5#-\Q ZL !G)SP
M.M6-*U ZI8+=&RN[/<S 17<823 . 2N3@'J,\T 7:**8DT<CR(CJS1MM< \J
M< X/X$'\: 'T55U&^33--N;Z2.22.WB:5UC +$*,G&2.U+IM]'J>EVFH0JRQ
M74*3(KCY@K*&&<=^: +-%%% !116,?$<+ZE]DM[*]N42Z^R37,$8:.&7:&PW
M.X#!&6Q@$X)H V:*IW^I0:?:7<[AI3:PF>2*+!?9SR 2/[K?D:=IE_%JNE6>
MHP*ZQ7<"3HKC#!64, <=\&@"U1110 4444 %%,DFCBV>8ZKO8(N3C<3V%/H
M**** "BBF/-'&\:.ZJTK;$!/WC@G _ $_@: 'T5F:+KD&MK?&"&>(V=V]I*L
MP .]0"2,$\<UIT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M OT444 %%%% !7CM];PP^"O&@2:82?\ "0! 'G9\ 3P<X8D9Y'./2O8JSIM
MT:Y:X:?2;"5KEE><R6R,967[I;(Y([9Z4 <%J^JWOAJ\\7Q6U]=O;V]O87 :
M>5YC;B65TF=<DD (N[ X&.,5TWAN!HM7O)(O$":A:7$,<B6J.\HA/(WAV=B
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M1/"4@C>2^O[6S9P9&9VFE"D]22>6[?A41T>]DU:&-WL8]"M"DEK:00%9-ZC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNQ24/)$'. 7<;R>@Y Z<G?M-+N[OQD=<N(?LUK:V1LK. D;FWLK.[ < ?(@
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M-;DN-"?4]2O=\5U>S"RW*H8PARL:@*!N)"[NA/-:Z:WILMI%=1W2-%-(T4>
M2SNI(90N-Q8%6R,9&#Z5Q[Z'J=AK.@"&QO7TJSTHV<<=G+")(),J-S;R!RB@
M;E.0<X/.3<M=*O-&\717$6C22Z<NFK;VJVTJ,+:0R,TN[>P)+_(2W.=ISSU
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M\Z-3&TBNPZ<A.5_AW#DU0L?'-]?OI[1:;;F&\U:73U<3DED3?F11MYXC9CG
MY Y.< '<TU)$D+!'5BAVL <X/H:261(8GED8+&BEF8] !U-<O\.[18O":7X@
M6%]5GEU%D5=H42L608]DV#\* .GFGBMX_,FE2-,XW.P _,U)7$/J"7/C#Q'?
MW^#IWAVS6.-&Y7S'C\V5\>NPHOL"WJ:PX/%XT7X:V-G-J,$&J6^CI//YDRB5
M,QY2-03DR-P/]D<GL" >I @C((/;BD1U==R,&'(R#FN%L_,M+7POX.L;DOYU
MG]JOKN.3<6A4+N(8=Y)' W ]"Q'.#5Y/%OVB40:':PW,45XMFL2'YF57"RN
M.$1!NP3]XK@#D$@'17&GV-[>07,\22SVA/EDDG83@GCIGA3STX(JWN4,%R-Q
M!(&>2!_^L5S^F7YF\<Z_8Q_ZFVMK1V]I7\W=^.Q8OTHUV_-KXE\,6T7^MN[N
M9''K$()&;\-PC/X"@#H:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(
MLO#EG::%=:23)-#=M.]P[D;Y#,S%R2,?WB![ 5KT4 <_8>&;BQT6+3?[=OY%
M@1(X)"(U9%0@@'"@,<* 2<\=JP]?T%EO+:QMDN6?6-5BO-0N([9C$BPH"N<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***R?$6OV_AW3%NID,L
MLTR6UM IP9IG.$0'MD]3V )H UJ*Y@^([JV\6'3+V;1X[&'3_M-S+]L598Y
MW.8R<A,<[B,>_:M>/6],NK:&6TU6PD6Y8Q6TBSJZR2#/RK@_,1@\ YXH T**
MQ_#^OQ:Y#=J8_)O+&X:UNX-V=DB^A[J000?0^N16Q0 4444 %<MKWCW2?#^L
MC2;BWU*XO# +@I9V;S80L5!.WIRIKJ:X>#_DN%[_ -B]%_Z/>@ _X6CI/_0'
M\1_^"F7_  K5\.>-M+\3WUU96<-]!<VJ+))'>6S0L%8D @-]#71UQ&E?\EE\
M1?\ 8+M/_0I* .WHHHH **** "BBJBZKISWWV%;^U:\Y'V<3*9.!D_+G/ -
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M553PC=76L?$;7=9;1M5TZTEL+:&,ZA:F$LRL^<9X/4=Z]"HH **** "BBB@
MKRH?;9=9T68:/J-M]E\0W#SVT5D_EQJZS 2[R/GWE@2P.T;L''&?5:* //\
MPQ!J-EXBM8K?[5<:/(D[F*^M&CFTYBP8HLA WHS= <G !!(%:>J?:K#XB:?J
MD\$\VE-ITMJ'AB:3R)C(K98*"0&5<9QU4#O76T4 >6_V3?:=X>TF$V5V8CXH
M^VP6\=N[FVM3,S+N"@[0%(.#TSCM77>/;2XU'X?:[:V<,DUQ-92".)%)9SCH
M!US[5TE% '"C;?\ Q!L]1DTV\-F-"EC$DUC( KF53M.5X8J&XZXXKFM$6_T7
M3?"UQJFEZTU@NDM8RK:P2F6VFW@_/&!NVLH R ?NBO7Z* ,GPY8VVE>'+.TM
M+.:SM84/E6\KEW1<D@'))S@].<=.U>?SVEU+\*]7M/[,OVNGU>6:.$V<F]E:
M\\P,%VYQLYS7JU% '$6-C#+\0O$MW<:7*\4EI9FWEDM6"NR>:6VL5QN&4Z<]
M/2L"#3M8_P"$=UG2+5+K4-.?P_/'9-=VC0W5LY7:MLQ( DXZ'&1MYZC/JU%
M&'8O<WO@N,6:S6UVUCY<7VB)HF239@$JP!&&]17#Z7)+*GP_@.C:E#=:3*T-
MZ'LI (6^S.A._;@JSX.X$CD$UZI10!Y5H7VR37O"5RVCZC9QP&]BGM19.L5F
MS@87<1E@<9+Y*D],=*V]!TBZL/%-UH7EK_8EA,=3M"#]TS;@(L>BOYS#T^2N
MXD02Q/&2RAE*Y4X(SZ'L:H:-HUOHEF;>"6YG9FW23W4S2RR' &69N3P /PH
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M>J>*KSXA2>']!U"PLH(M,2\9KFU,I9C(R$###T% '>T5Q']E_$C_ *&;0_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ***BDN;>%MLL\:-C.&< T 2T57^WV?_ #]P?]_!4D5Q#,2(
MIHY".NQ@<4 24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<C D!"C)PIRP(P: /0*:\B1[=[JNX[5R<9/H*\Y@O]>D_P"$ET^SF#W%IJ<
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MG^[[=*OT4 8MIX1\.V%I=VMIHMC!;WG%Q''"H64>C#N.3QTYJZ='TXK9*;*
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ME10!#=6EO?6LMK=P1SV\J[9(I5#*P]"#UJG_ ,(_I)L)K%M/@>VGP)HW7<)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!#G!QU[9K)SXB_N:7_ -]R?X5KT4 9&?$7]S2_
M^^Y/\*,^(O[FE_\ ?<G^%:]% &1GQ%_<TO\ [[D_PHSXB_N:7_WW)_A6O10!
MD9\1?W-+_P"^Y/\ "C/B+^YI?_?<G^%:]% &1GQ%_<TO_ON3_"C/B+^YI?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA_WZN?\ &JAUWQQH_B?0;#7/^$?DM-4N'@)L8Y@Z[8V;/S-CM[UZ%7$>-?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\R,%Y!60#D#&3UQSJ77C":SC\2B738S+H5K'=2*ER2LJLC.0#L&" A'3GVH
MZJBN4?Q;?RZ['I5CH9N)'LH;[>UTJ 1N^T]1U&"<=\=J2T\:_;KW3OL^F33:
M??RM''<Q;V:/&=KNNS"HV.NXXR,@9X .LHK*\0ZY!X=TDZA<!?*$L<19VV(F
M]@NYVP=JC/)Q5 ^*)XKK1H9["+9J=T]LDL-UYB@"-I%<':-RD)[8S0!TE%>;
M>(];?5X-.F6P*W.G>*8K,1I-GS"O/!(  .1U]*LZSXO2;PYXEMM<\.YGTM(V
MNK$709)HGY1UD ''RG/&010!Z!17+ZUXO.FSW\-CISW\FGHC7$4;,')8;ML8
M"-N;;@X)7J!GKATWBJ>9;V32=(EOTL7B2X3S/+EW.JN51".65'4D$KZ=: .F
MHKFM%UG5+_Q?XAT^XAMUL]/>&.(I*2WS1[\D;>2=W//&,<]:/$.LZI8>)/#=
MA8PV[PW]Q,DQEE*DA(7<#A3@9 .?8#OF@#I:*Y*Z\<);:9/K0LO,T2WNS:S7
M(F^==LGEM($VX*!\C[V< G%=;0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6=J]A=WZVHM;N&
MW\FX29_,@,F\*<X&&7'UYK1H)P,GI0!SNM>#]/UGQ%HVO,/*U'2Y=R2JO^L0
M@@HWMSD>A^IKGM2^%D-\NM62:CY6DZS?QWUW#Y.9 ZG<RH^[ #$ \@XYZ]N@
MM/$5]J!UV&UTV%KK3+M;=$:ZPLP*(^[=M^7Y7Z8/3K71;@#@D9]* .0/@1!X
MTU'74O@+74;%;*ZLS#DE5  VON^7@ '@]^1V7P7X1U3PGIRZ2^O"[TRW+_9$
M^RA)4#$G#ON(8#)Q@#GVXKKLC=MR,]<5#=231VD[6L237*QL8HF?8'8#@%L'
M )P,X.,T 9_AG2]2T?14L]6UB35KM79C=21",D$Y P">E0>,/#TWBGPW<:/%
M>I9B=HV:5H#+C8ZN,#<O=?6MJ&1VMXWF58Y"@9U#;@IQR >,@>M/R,XR,]<4
M 8?B'0KG7;+3X5OHK>2UO8+QG-N7#F-@P4#>, D>IK)U'P+/J%SK=P=7\B>_
MN;>[MI(;?#6LL*@(>6(<?+R,#J:ZFSFNI/M'VNWC@V3,D6R7?OCXVL>!M)_N
M\X]:L@@C((Q0!FZ-9ZI:P.VKZE'>W3X&88/)C4#T7<QR<\G//'3%8GB'P==Z
MW?ZG-%JR00:CIAT^2.2V\UH@=WS1MN&W.[YA@YVCD<8Z2]U&TTZT^U74Z1P[
ME0,3U9B%4#U)) I1+=_VFT)MHQ9B$,L_F_,9,D%=F.@&#G/?&* .?A\,:E9Z
MLFI6VJV_VAM-BL)C):$K\C,RNH#C'WSP<]N?5+7P8NGZAX>EL;Q8[71K>:!8
M9(2[S>8%W,7#  Y7/W>YKJ0020"#CK[4!@3@$9H XL>!KP:(FG?VQ!N76?[5
M\S[$>OG^=LQYG][C.>G:KSVL?A;5=<\1WNHXTZ]:&26%;5G>-U18@05))4X'
M&W@]\5T]5C?VJZFFG&9?M;PM.(L\[%(4L?098#\_2@#!\$:'#H^EW$D*S)'=
MW$DL$<P(:& NQCC /*@ E@IY&\BKOB/0YM;CTYK:[2UN+"]2\C>2'S%8JK*5
M*AE/(<]ZV0P)(!&1U'I5:_U&TTS3[B_O)TBMK="\KD\*!0!S,G@F40:YI\.I
M*NE:U*TMS$T.9$:0 2[&#  -C/(^4DGGI76+$(;80VX6,(FV,$9"X&!QD<?C
M43RW8U**);:,V;1,SSF7#*X(VJ$QR""3G/&/>K&X$X!&: .,L/ ]W8Z;X9L_
M[7A<:'<-,&^QD>=E'7&/,^7B0\\]!37\#Z@)99H=:@$CZR=5"/9%HSE-FQU\
MSYL8# Y&",X].UR-VW(SZ4M '"'X?7,EK':SZM;SVZZS)JC)+8Y$@??NC/S@
M<^8W./3CUD/@2^&@1:7'K[*;"\%UI$_V;+V@7(6-LN?,4*Q7G'!KMZ,@4 9^
MD6NHVULQU2_2\NW.6>*'RHU Z!4R<>Y)).?3 &7?^'-0N/&5MX@M=3MH3;V;
MVBP2V;29#LK$EA(O.5':NCW KNR,=<UC:)KKZMJ&LVDELL)TVZ%ON67>) 8T
MD#=!CAQQSTZT 9[^![:_DU:YUF[>]O=3LS8O*J>6L$!S\D2Y.WD[B222:GT?
M1?$%G9O#J?B&._:.$PV[BS\O_@<H#_.W'8J.OKQT092H8$$'H<TH((R#D4 <
M/'X$O[30?#]O8ZXD.J:$ICM[O[)F.2,J%9'CW\@@#D,,$ BM*7PUJ-QJFA:C
M<:Q'+/ILLLLN;4XF,B%"% ?Y% / ^;W)YSK:WK5GX?TF;4KYF$,> %1=SNQ.
M%51W8D@ >]4I=8U:UA@GNM$412S11,L-T'DB#N%W.-H&!G)VENGIS0!#%X:N
M8]5\1WAU,*NL1HBB&$H]N5CV!@^XY..>@YJAHW@W4M+U'3[Q]8M9&L],;3MD
M=B45EW*RM_K#@Y7)]>V*['(W;<C/7%8_BO77\-^&KW5X[9;EK6,R>2TOE[@.
MN#@_RH 7PMHDGASPS8:/)=+=&TC$0F6+R]P'3Y=Q_G5(^&KJP\17NL:)?0VY
MU#:;VUN(3)'(ZC D4AE*MC@]0<=,\UTFX<9(!/09ZTM '.:QX9N-7M[.6340
MFIV5VEW;SK%^[1E!7;Y>[.TJ6!^;/.<\ "EJO@F;5K353)J$,5_J;VQEF%L6
M1(X&#(BKO!ZYR2?XNG2MK6M<729M/M4B6:\U"<P6\;R>6A(4N2S8.!A3T!).
M!BI-,U&[N[F[MKRP^R2VQ3E9?,20,"=RG ..,<@'(/'J 8>J>"YM6N?$,D^I
MQK'K.G)8E4MB#%M#X?)?GF0\8'0<U:M/#FH1>);+6KK5+>9X-/>RDB2T*!]S
MJ^X'S#MY0#&#WYKHPP894@CU%5KW4;33[=9[F=(XWD2)6)^\[L%4#W)(% ',
M7'@>>YLM=@;58PVIZC%J,;"U.(7C,152-_SC]TN?N]34VI^#?[<MM8.I7B_;
M=1L18"6&+:D$8)884DDG<V3D\X XQST2RW9U.2%K:,68B5DG$N69R3N4IC@
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MK+4;VYMGDLKO[3!/';%)U3G]SOW'*$GGCIQCO6KXDTA]?\-ZCI$=RML;VW>
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M'\L<L9C."N_YE/E# R" >IJ35?!FH7]QK;0:Q##%K6GK:78:TW,'5'4.AW@
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M=-*/^^B;[0,!1U";=V<<8!)Z5[9VXK'\/Z&="COD-U]H^UWDMX3Y>W:TC;F
MY/&>G]: .!8Z9J/B+4=-UR^O;77H=6\^RCAA02RQ!@83$Y0G;M^5N<#YLXR3
M4$>F02Z1XZO]'MDEUJTU&Z-F\)_>QJT,8;R\="1O QU(]17K:LKJ&1@P]0<T
MZ@#S"^O-$O\ PWJNK^"XIWN38Q1W"V2%0(UD!9"O3S=AD'0MQ],Y&O1^&KSP
M3XFU30]0FNX[BSC615B2.!9%8;,*J+^]P2#WP!G'%>S44 >4ZY8Z:FM>+K'3
M8+=HKOPOYQAB 833@S8<C^)\%3GKT-5K^[T.XTRQLK>*W4R>'93#(\1>*1B
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M%V8<-WP8UX]R.<\:UCHCQ:P^L7URESJ#6RVJO'%Y2)&&+'"EF.2QR3GL.G<
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M]I<:==&XC=8P^<HR,"#[.>>Q]: .)TS6;GPP?$]U;Z=;R:<GB/9<'S=CJ)!
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MZM)K7@;Q?#9VEO+::<CV\LDSD,90JLQ08.-FX<GJ01QC)V+CP1)<:5K%@=4
M74]174'?[/RC*T;;1\W(_=+^OX1:CX!ENXM>M;766M;#7 7NK?[,'VRE0K/&
MQ8;=V!D'/L10!U_FI!9^=*VV../<S>@ R:P]+UW5=473;R+24.FZC;-/'-Y^
M&@!4-&)!C^,'^'.T\<]:W$MQ]B%M.WG Q['+ #?Q@Y ]:Y[PYX4O/#T45H->
MGNM.M 5LK:2%08EP0 [CF0*#@#C]!@ Q=+\63P:!X;&D^'[.%=5N;BW2V6Y*
M) Z^:W9.02A).,\G@UK)XEUFY@O/L6C0W-UISQ0WENES@M*RH[I&Q !"JX.3
MC)R..M16/@>2QM-!MUU0,-'NY;I&-OS(7#@@_-QQ(WZ?C8F\(W">(KW4M.UN
MXL;?4=AOK5(E;S&50NY&/,9*@ D9Z9X- %;4_&MSIUGXKF_LZ*1M *';YY G
M5HUDZ[?E.&QWZ4[4O%>JP:KK-A9:5:RMIUC'?!Y;ME$BMYF5P$.&_=G';GKV
MINM>!9-5EUY8M8>UM=;A1+F(6ZN0ZH$#*Q/ V@9&.W45<;PK.VHZI>G4@7O]
M/CL6#6_W0F_#<,,G]XWZ?B 5;'QC=W&H:0L^EI'::O8/>6ACG+RC8J,5==H
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MJ0Z7=22,%01-DGZ5Y]X:UE;'X1:;I\%K<7>K?V?Y"6,<+%_,(( ?C"#)Y+8
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MXB> 9)D5P5&.O/2G)<0R-(J31LT9PX5@2A]_2O)_&5DE[:^,KW3D6;2KK2X
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M8P0=O7-:XN[8QF07$1C4X+!Q@'ZUYW'9V.G77@B'3A=BP34KF6,W2D,J/#*
M=N!L4LP ! ZBK5OH\UCXMN_#<5HIT2_G76 P4;8]I'F1?C*(F ]&<=J /0.M
M0+>6KM*J7,+-%_K ) 2GU]*?.YCMY'"-(50D(G5N.@]Z\J\+2P3>)/"\D=I+
M%;2:1<VSV_V63;"=T1\IW89=A\V23C(S@9Y /5!<VY5&$\15SM4AQACZ#UHC
MNK>6:2&.>)Y8_OHK@LOU':N(\)Z7<V-Y-H5Q:-]@T"YDDL9"O$JR#,0![E%>
M13[[36!X=N8)?$'A*XCM)[:W^S7T$ML;:4BW+%&\N21AEFR&))..,X'4@':Z
MCXAU'2[32I)[6RDDO-42QD,,[,L:M(55A\O+8 R.,'/6NA^U6XN?LWGQ>>1N
M$6\;L>N.M>3V 2#P+X;A5/+$/B<N4"D;(_M4K!B.R[2ISTP13M2NXWUF*2*S
MN;9[7Q2CS1+;2R.PP4,S/@_*PQM5<#'KV .\\/>(CJ_V]+Q+>UGM]0FLXXUE
MW>8(\<C(!/7TJ33-;GO?$^MZ3+;QQIIRP-'(KEC()%8Y(P,8V].?K7G5_HEK
M?:7XHM%LE'B636I)=.8Q8G3+H8Y%;&1&.26'&,UH:Z+Y]2\>#3XYIK@P:>PC
MB7YID0DS*F>&.S(QSRP'>@#TN"Y@ND+V\\<R@[28W# 'TXJMJ.L6&DFV6]N4
MB:ZF$,*LP!=CZ?09)^E<YX0_L:_U2\UG29M0F:XACCN))X/(3*YVKMV*"X!(
M)&<# ]*/'T4>[PU=36YEAM]9B:9A"9-B&.09( )QDJ/RH ZQKJW29(7GB660
M91"X#-]!WJ6O*K^*2YT+QII=[!)_;L]Y)-I@V$22J0OV9HC_ +) !Q]W!SBO
M4+99DM(5N'#S!%$C#H6QR?SH YK3/$NJZK>ZS;0:78I_9=T;9WEOF <[%?=Q
M$<##"M^&] LH9KWR[29H1++$\@_=\#<,\9 )QFO.-*ATB[U3QJFI7MU;)=:@
MWE-'<RQ+(AA1=RA2 _((Z'.,5HR#3-7^)-A?7-E&;:;0YBQN80 ?WL93>&'!
MVAF /(&?2@#O%N;=I5B6>(R.F]4#C)7U ]/>D%W;&58A<1>8V=J;QDXZX'M7
MDF@V=I;:'X G2V2.\34I(YW\O$BQ>7,NUSU"\QC!X^[[57LM'TV^\,M%IEM"
MOB*#Q'(;5XTQ+"JWA+'/41B/?G^'MUH ].T77)]2U?7K&>WCA&F7*0JR2%MZ
MM$LFXY Q][I6HE[:20&=+J%H0<&19 5SZ9KS#5Q>/-XT:SAEGC&KV,UQ#&I+
M3VR1PB8*/XAA6! ZX(]JV1H]EXB\7ZHUNJ3:!?Z,MO>&,?NY9RYV$=BZIG)Z
MC*^U '<B>$LBB6,F090;A\P]O6DBN8+AI%AGCD:,[7"."5/H<=*\ZL+37]1\
M*ZLCQ%=8TBPN-)LI5P#+*!S*I[;@L..F#NJ@5MM;T34-0\-IJQUJ/2'M7@>W
M%N(AD'R3B-0S\$+C..?7D ]3BN[:99&BN(I%C)#E'!"D=<^E.@N(+F/S+>:.
M5,XW1L&'YBO,U3P_K=CJ&IV5WK,+2V4=I<3&S$0M\2J4#1^6H=E).<9PH(/!
M%=-X)GOI%U6._CLY)4NA_P 3"R4K%>YC3YP,G#  *<$C(H Z9[B&.3RWFC5\
M9VLP!QZXIGVN!HPT<\+;CM7]X,,WIFN8\:6LUI=Z/XDL;)KJ[T^X\F2&, M+
M!-^[91]&*-_P$UF>$-'O=,U&;0K^!#8Z1.U];SA L;F920%]D9IQ[?)0!T?A
M7Q%_;^BP7=RD%M=2RW$?V=)=W$4SQY&<$_=SG'>MDW, N1;F>/SR-PBWC<1Z
MXZUY'I=K:P:'X5NUMT2_7Q+.9)?+Q(L32W'4]0A5D]OF'K5B2WNKOP?>:5)&
MR>+XM9,T3%2)"YN=R3*?^>8B(&>@4$>U 'K-11W5O-+)%%/$\D?#HK@E?J.U
M.F<QP2.$9RJDA5ZMQT'O7DOAV>TDUSPQ,;62"R;2;NWEMVM9-D',3>5([C+L
M,-N+''&<#/(!ZNMW;.'*W$+!%W-AP=J\\GT'!_*G0SQ7$2RP2I+&WW71@P/X
MBO(-,L(M+^&'AG5+?3I$>&6#^UWMK8-<>2N_[RE26".4;!!P!QTKO?!T&F+#
MJ%[I$EY+;7MQY[2W$?EK)(5 9D3:N!P,G&"<T =%+/#!_K98X^"WSL!P.I_"
MD>YMX[?[0\\:P8#>87 7!Z'/2N-\0V5A<_$SP\UW;02QBQO!,9(P5ZQ% V>.
MSD ^AQ7->&Y)+&V\(37<;+HUM-J,,NY3LMI#*WD,X_A79D*3P-P]10!Z;?ZU
MIVFQVLEU=Q(MW*L,'S#]XS=,>O'/T%7P01D'(->23Z:UI:P7,EJS:0OBP7%J
MHA+B.V9"&(4#(C,A8CC'(/0BO64(,:E00"!@$8Q^':@!U%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4QY8X\>8ZKGIN.*?7#_%>*.3P;&7@$Q74;/"D DYG0$#/'(X_&@#M&GA7
M&Z5!D9&6'(H2>*262-)4:2(@2*K E"1D9';CFO/_ !6_VSQ9X)6XT::V"ZFP
M5I_)8$>2YP-CL>H!].*N7/BO^QV\9WC:5;"32Y( 6A.&N-T:E6D;'\(8 ]<
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M8R&QD9)QD#CG@ [ZBN,N_$WB"XUK4M-T;3M/=K6Q@O(VN9G'F"3?\I '!^3
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M**2[F? W'&TA5_#CZ]L$ [)YXHY8XGE19),[$+ %L#)P._%25YO;:TGB77?
M.MM:"VGF-\DL9Y,;)&RLN>X#*:TE\;W!T73/$?V>%M%O[M+?:,^;$COY:2DY
MP<G;E<# ;J<<@';45R$/BC4=VM6%Q#:IJUE=Q06\2AMLR2X\N3KG!^;./N[&
MZXI+GQ7J;RW+Z5IQO8[.]%I-"L+[Y,$"1U?[J[23\ISD+U&: .PHKCSXKU&Z
MN!-IFFM=V::@UE+&L3A]J.8WE$GW.&!.WN!U!XJ71?%C:OKT^G;[6*>WFE2>
MQD5DN(D4D)(,G#JP .5&!N'7K0!U=%%% !1110 4444 %%%% !1110 4444
M%%%% !65H^B+I)GD>_O+^XF(#3W;AG" DJ@V@  ;CVSS6K10 4444 %%%% !
M1110 4444 %%%% !1110 4444 (02" <'UK+\/Z%'X?L9;2*YFG22XEN"TP7
M(:1R[?= XRQK5HH *J:G9/J.G36D=[<V3R 8N+8J)$P0>"P([8Z=#5NB@"MI
M]C%IME':PEV5<DO(V6=B269CW)))/UJS110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M" WFF0$.7/J<D\8Y/X5'9^";2SM8=.%U*^D6]V+N"R91B-@^]5W=2@?Y@.O
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MH U**X_P)X]LO%V@:==7,UE::G>"1EL%N 7VH[+D*>2,+GI72:K<RV6DWEU
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M.%B):':)!NSG#?ZP\<=!0!!;>,;BTFBTZ^T6:VD>P:ZLI'G5EN1&H+J=N=C
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MLX/%=E=P&ZLI[<2-&98V0.O5<C&1]* ..?XDV37=DEG83W5M?:C_ &;;7".
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M'@$9P<X.T=!@8QDU9M[N;4/A;?+%<7'F>+/$7V=&E=F\B%G Y9O]E#D_[0H
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MEX5!/E++'L60C^ZIZGMF@#HAJU]#?V-K>Z48Q>2,BS03"1(R$9\/D*03MP,
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M Y^;Y4)/7H:T/$US903-?Z2=*U+3X["(RZ7PD@C,CXEM6'&XG((Q\Q5><XH
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MB6^\8>![^\T]["[D2\$L$C!FCQ%T+#@CN#[]JNKXX!T_3-8:Q']BZA=+;17
MFS(F]BD;LFW 5CC^+(##CK@ ZU8T0$(BJ"<D 8YI=H]!^5<O8^,X;ZYO0J6Z
MP6,DZ7@^T?O[<1[OF>+;]UMN0<]QU[.TKQ7=:CJME;OHMS':7MNTT=TJR%8B
M "%ER@"D@\$,1D$>A(!TNQ-^_:N\C&['.*=@9SCFL_6]8MM T2\U6\W>1:QF
M1@HRS>@'N3@#ZUF_\)%>6^O6VC7^GPP7-[;236;)<EXY&CQOC8[ 5(W Y ((
MSZ8H Z'"_=XX'2C:OH/RKA?A]9#5-+MM?U*S@.IK/=A+M)6,CAII%96X'R@
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MZ$CD4ZN1U'QN\/VN33-)N-3ALYDBF$"R&1RP5CY85"&VJX."PS@^V>N!R,T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9TAO'U,.BK%M8Q,(",$#H2&('L3V->QT4 >4:W#]AUOQ7#X;@53-HUK,8K(
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M/>J*R^$O^%D2>-'T;Q.UR44I;_V/($67:5,AXY.,8]#D\GIM:AXDC\5>-?"
ML-)UF);2]DEFDNM/DB15,3 ?,1CK0!ZE1110 4444 %4M7U%=)TFYOC&TIB3
M*1)]Z1SPJ#W9B /<U=KG-7:74_$-EI=O,8!:@WDLCP%T9QQ&G8'&6?KD%5H
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M,@%XS,P..0$Y)'&#UK8M9;?^U]<T37M)O+F[N-5%Y9,L$A2>,;#$PE4879M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %3
M3]-MM*@>"S0Q0%V=8@?E0DY(4=AG)QTYXJW110!4L--MM.$Q@0^9<2&6>5CE
MY7( RQ^@ '8  # %6Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** ,SQ!H<'B/1IM+N9YX8)BI=H"H;Y6# ?,".H
M':M) 515+%B!@L<9/OQ2T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF=IA"7VDDG8I<L$!/)"@A1GL!6O10!R6A^'-=T.Y>QAU:U?01</<0QM WVA
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M+H7*I#"4V'RT0CECQ\@Q56?PYK5KXIO]4T74[6"VU18_MD5S 9&1T78)(R&
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M99@H. "<9/)[#FK5 '"ZIX*U>^O+^1-4LRLVHV]]"\]NSR((F1A"2&'R H2
M.['ZU@7=WYWB?66CU#P_YK7J9T_4%FBFD>)5"GRE?$F67<K;&)^7K@ >H?;H
M_P"T_L'ES>;Y/G;_ "F\O&[&-^,;O;.<<U8P,YP,^M ',Z=H-U)K&LZE?B)(
M=8M8(I+922\.Q&!!;H<[S],=ZJZ3X5UN+1G\/ZQJ]O=Z.EL]I$88"D\D90H!
M(Q8KPI[#D@'/4'L:* .1TW0?$T6BRZ7J6L65U%';-;6\D=NT;R97:&E.XC('
M90,GG-)9>%;^TG\*.;BV8:%9O:N!N'G;HU3</[OW <<]<>]=?2,P52QS@#/
MR?RH X)/!&L6<%K=:?J=I#JMG?W=U$TD3-#)'<.6>)QD'TP0?X16M+H&K76K
M:!J5U>VTLVGRS2SA8V17,D9CVH,G: #GDDD^F:VM'U>SUW3(]1L'=[:1G56=
M"A)1RAX/(Y4]:O4 <./!>I+9H$OK5;F+7GUB,F-F3#E\QD9!X#GGOCH*[=00
MH#')QR<8S2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&[9&RH2NX\\Y/RG!!-/FE\26-[H&G7>O!GGU:>VD:W".WD^0\B*Y9!\ZX'(
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MCOI!+=(97Q*XQ@MSST'Y#T%68]%TZ+53J:6J"^:)8FG))9E7.,YZD9//7DT
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M>(\[7!7D9V\\ \UZ162WAG1V(_T)501I"8D9EC9$^XK(#M8#L"*UJ "BBB@
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MV/,AY&X@'G'<=_I56P\(ZEIVIZ!<K%$X@O[V^O=DF AN ^%3/WMNX>F<9]J
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M_O?#IW%&*D9F&<$<B@#<M?$=K>ZA%;6]O=R12M*D=VL686>)BKKN!RI!! +
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(H!D? &X^IP!5FBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:ZS)>0*EOB.0&5FCE$P3[@0A2"W1=N.@H ]0JN;ZS69(3=0"5V**AD&YF'4
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MI\5W<6UV2X$LF\+$"I&.8VR_;(X/.&6NI:[/X_>RE>WA@31XKHVA4G9([LK
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M# :0Y8CW/?Z]:X+0KR;2;?Q1)9Q6R@^)&C=YF")$C)"&?&1N(SPH.22!4O\
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M!+K:-H8Y4E&QP2I!QZ=:@U'P!;7AUF.WU.]LK/68RMY:PB,HS[=F]=RDJ2
M<=<"M[^W]'^S7-PNJV3PVR>9.Z3JPC7U;!XZ&GZ/JUGKFDVVI6,JR07$:R+@
M@E<@'!QT(SR* )/L9&F?8A<2$^5Y7G,%W],9X&,_ABL*P\%P:<V@&+4;IAHE
MN]M;A@GSHP"G?\O)PHZ8K=.IV"WPL3?6PO&Z6YE7S#QG[N<].:0:IIYOOL(O
MK;[7S^X\Y?,X&3\N<].: *OA_0X_#VG/917,TZ-/+/NE"Y#2.78< <98U43P
MN++5KR_TC49[#[<_FW5NJ(\4DF,&0*PRK$ 9(.#CD$UIIJ^F20W$R:C:-%;G
M;.ZSJ5B/HQSQ^-++JNG07,-M-J%K'/-CRHGF4-)GIM!.3G':@#.O_"\%[)I]
MT+NXCU&PF::&\^5G)8;7##&"K# ( &,#&,54O/ ]E=VX87=S#J0OAJ"ZA'M\
MP3[=N<$;2NP!=I&,#UYK:_MK2OM0M?[3LOM!=D$7GKOW*-S#&<Y Y([#FI;3
M4;&_W_8[RWN=F-_DRJ^W/3.#Q0!S,_P_M;R+5/M>JZA+/J$\-SYZE$>":)55
M)(]JC!&T>HK=T?2YM,MV%UJ5UJ-R^-]Q<! 2!T 5 % &3V[G-6+S4K#3@IOK
MVVM0V=IGE5,XZXR?<4RZU?3+$D7>HVEN1&93YTZIA!@%N3TY'/3F@"C+H-S]
MKOYK76;NW6^</)'LC=8R$5,QY7*G"CKD9[5FS> ;.$Z7)HVHWNCSZ=;"S26V
M*,9(,YV.'5@W/(..I)JWJ_B"6UU'PXMBUK/9:K=&!Y02WR^4\@9"#C^#WZUJ
MIK&ERVLEU'J5F]O$VV299U*(?0G. : ,2[\%QOJEOJ6GZOJ.G7B6XM9Y861S
M<Q@EOGWJPW9).[&>35P>&88M>BU:VO+F"2.R6R,0*LDB*2R%MP+9!8]",]ZV
MBZJA<L @&2Q/&/6J*Z[I#VTURNJV+6\!VRRBX0K&?1CG /UH Q+3P):V%AH\
M-M?W2W6D/(;6Z8(6VR9WHXQAE.?0'@<\5--X,M94ML7EPDT6I#5))0$S-.!@
M;N,;<8&!C@#FM.3Q%HD27+R:SIZ):N$N&:Z0"%CT#\_*?8U)<ZUI5FF^ZU.S
M@7RO.S+.JCR\@;^3]W)'/3D4 5])T)-)U#5;Q+J:5M2N!<2K(%PC!%3Y< <8
M5>N:=KN@VFOZ5+I]SNC21XW+Q@!LHZN.2#W4?A5'5_$$MKJ/AQ;%K6>RU6[,
M#R@EOE\IY R$''\'OUK7;5-/6^6R:^MA=L<" S+YA.,_=SGIS0!3UO08];&G
MAKJ6W%E=)=QB(+\SI]T'(/'/;%7-0T^#4K"YM)AA;B)HF< ;@&!&1GOS2)JV
MFR)<.FH6K);$B=EF4B+'7=S\OXTDNKZ9!)!'-J-I&]QM\E7G4&3/3:"><]L4
M 8DWAM=-NO#U]8*\AT>%K-TXWRP,JJ3QU8%$;WPP')%:=[H%CJ&N:;K$P?[3
M8+(L>#@,' X8=P" 1Z$9JU/JFGVUW%:3WUK%<RD".&295=R>F%)R>AI?[3L/
MMHLOMUM]K)($'FKYF<9^[G/3GZ4 95]I+:OXITV\F0BTTM960,/];-(NS@>B
MJ6^I88Z&J.F^%(E\)MX5OEE^SVC_ .BW$9PP0/OB93V=/E'/=<XP:Z6YOK2S
M:);JZ@@:9MD0ED"EV]%SU/L*B&L:88[B0:C:%+8[9V$ZXB/HQS\I^M %2/31
MIUS=:L_FW^I2PI #M"Y122J*!PH+,22?7T  PK/P?)HMOX?O(2)[[39)WNMG
M'G"XR9MN?1RK#/9<=ZNZ9XLC?6]9L-5NM/M1:WT=K:$R;#-NB20#YC\S?/CB
MMVZU33[&5([N^MK>1\;%EF5"V3@8!///% $-EIAMM3OM0:[FF:\V?)(J@1*H
M.U5P <<D\YY)K.T_01X;N=8O[.>[NCJ,YN6LR$""8@#*X VYP,DG'>NBJE#K
M&EW)E$&I6<IA7?*$G5MB^K8/ X/7TH Y_2O#%_HUKH%K:ZC,@M7EEOP@7RKA
MI"6?<"-WWB=N,8SST .OKF@P:V+-VFEM[JRG%Q:W$6-T;@$'@@@J02"#U!_&
MIXM<TB>.62'5;&1(51Y&2X0A%<94D@\ ]CWJQ:7EK?VZW%G<PW$#9VRPN'4X
MX.".* ,*]\&VE_I]_#-=W N[ZXAN9;Q H<21%3'M!!4*-@XP>^<DYI)O!T<\
MVLROJ=XSZM9)93DB/A%# ,OR_>^=O;GIQ6W-J=A;74=K/?6T5Q*0(XI)55W)
MZ8!.3G!I)=4T^"\2TFOK:.Y<@)"\RAV)Z84G)H YU_ RI=V=YI^MZCI]U#:I
M9S20>6?M,2?=WJRE=PR<, ",FM.S\.0V/B&75XKJ<M):1V?D-@H(XRQ7G&[.
M6;DGG-:":G822W$27ULTEL,SH)5)B_WAGY?QJ.;6=+MXX9)]2LXDG ,+/.JB
M3/3:2>>HZ4 0:]H4>NPV:O=3VTMI=)=PRP;=RNN1T8$$88CI63>>!;>^M-?M
MI=2O FMNC7! 3*;55!M.WT1>N:WI=9TN&Z^RRZE9QW!=(_*>=0^]L[5QG.3@
MX'?!IT.J:?<7DEG!?6TMU&"7@296=0#@DJ#D<\4 <WJ/@&'47U3?K&H11ZE)
M!/-''Y>!+%LVN,H3_P LUXSCVJ:[\$07L7B"*74KPKKD:17)PF5"IL&WY>I7
MKG-.O_%*Q>+=#TBRN;&XCO99H[E5DW2Q;(F88 /'*X.1ZU8\4:U=:&FE26ZP
M&.ZU&"TF,P/RH[8)&".1[T 7-4T2#6/#=SHEW-*8;FW-O)(A"O@C&1QC/X8K
M$G\!I=G4'NM;U&674-.&G7+D1#<@W?, $P#AV'ISW-;J>(-%DLOMJ:OI[6GF
M>5YZW*%-_P#=W9QGVJV+NV-R+87$1G*>8(MXW%?[V.N/>@#!DT--)OHM?\Z^
MNY=/TUK1;:&-&::/*L<# )<E%Q@@4>%M*BANM6UL6,UE+JTZS&";AT55"C<N
M2%+'<Q'^T,\YK9O=4T_3@IOKZVM=P)7SYE3..N,GW'YU;!! (.0>] ''^+K:
MZN/$_A-K5;I1;WDLDL\-NTBQ P.HW<$ %B!]#VZU:NO!EK=V$ENUY<++/?QZ
MA/<*%W22HRE>H("C8@P.R]>I.Y%J=A/>/9PWUM)=("6A252Z@'!RH.1S20ZI
M87-R]K;WUK+<H"6B2969<'!R <CGB@#G+OP#!=2WC#6-1BCN=0BU+RD\LA)T
M*'<"4)(.P<$D#TI]WX&M[RQUNTDU*\$>L7"3SD!-RLH0 +\O3"+US6>?&6K+
MX>:_,%EYT>O?V7(H5MIC^TB'</F^]@Y]/:NPGU33[6[BM+B^M8KF4@1PR3*K
MN3TP"<GH: &ZGID6KZ)>:5=NYAN[=[>5DP&PRE21Z'FLJU\*_9M4L-1;5;N:
MYLK-[-#(L>&5BI)("CG*+C&.GN:V)=3L(;Q+.6^MH[J0@)"\JAV)Z87.3T-8
MTGBS3[[3]7;2M5TV.XL)&A,MY(!"K@*26P0=N6QGCD&@"G8^ +?3AIOV;5]0
M1K&&:W##R\RQ2N'96RF!\P'(P:ET_P #6^FQZ (=4O\ =HL4D$3GR\R1/MRC
M?+T^1>1@\=><UT*ZA9-=O9B\MVNHUW20B4;U'J5SD"HIM;TJWM8[J;4[*.WD
MSLF>X4(V.N"3@T 0:_H<>OVEO;2W,T"PW,5T&B"Y+1N'4'(/&0*JS^%X[R]M
MYKR\FN(K:\^W01NBYBDYP%;&=N3G'7WQQ6XQ9H2860L5RA/*Y[=.U<YX/\6V
M_B'1-.DN[JQCU:Y@,SV<4HW 9(R$)+8XZT 7?$/AV+7XK1A=W%E>64XN+6[M
M]N^)\%3PP((()!!'-<KIOAI]5E\7:;?2ZC&MQJ%O<07TD.QW:..$B125"G$D
M9X Q@=,5V\>JZ=-=O:1:A:O<H&+0K,I=<<'*YR,=Z9#KFD7#,L.J64K)&TK!
M+A&P@)4L<'[H(()Z9&* .>N? $-X=3DN-9U%[C4/LS22CRQM>!MT;@;,=>W3
M';/-.N? ,%Y;:[!/J^H.-;2-;ICY6<JH7*X3 )"@>GH*Z&+6-,G$AAU&TD$2
MEI-DZG8!R2>> *@N=8M9='O;K3=3TTO"C 3RS!H8WQD>85/ Y&>0<4 1#P_C
MQ&NN&^G-RMD;+9M385W;MV,9W9'KCVK-7P- OA:+0/[3O#;170NED(CW[A-Y
MV/NXQO\ ;IQ6U+KFF64(-_JMA ZQ++(7G5 %.!NY/"DD8/N*2>_/]I:='!>Z
M>()U=WCD?][*NW*F+!P0.IX/% &5+X,3^W;K4;75]0LXKXJU]9PE/*N& "[N
M5)0D  E2"<55U#X?6UZFLV\.K7UI8:N_G75K$(ROFG&YU+*2N<#(SUKHHM=T
MB>YAMH=5L9)Y]WE1)<(6DVDAMH!R<$$''3!I\VKZ9;3F"?4;2*8'!CDG56SC
M/0G/3F@ OM.BU+1[G3+MWDAN8&MY6X#,K*5)X& <'TK M?!/D7=O=RZYJ$]Q
M!8/IZNZQ &)BIY 3&1M!SUSUR.*ZB26.*)I9)%2-5+,['  ]2?2H+;4["\AE
MFM;ZVGBB.)'BE5@G&>2#QQS0!@VO@FUMDT"/[=<R1:+;O;0HZH1*C($(?Y>?
ME '&*K6?@"*SCTJW36]1-GI-U]HLH&$1\L;64(6*990'(&3G'YUT2ZYI#K(R
M:I9,L8W.1<(0HQG)YXX(H77-(>&:9-4LFBA(65Q<(50D9 8YXR"",T 8VE>#
M$T:\D^R:OJ TPRM/%IK%##%(Q+<';NV@G(7.,UI^'="C\.Z5_9\-S-<1"624
M-,%W NY=A\H'&YC5EM6TU;!+]M0M!9N,I<&9?+;Z-G!Z4U]:TJ***634[-(Y
M8S+&S3J Z 9+ YY '.: *;^'4?Q?'XC^VSB>.T-F(0%\LQE@Q[9SD#G-+K?A
M]=8N].O([ZXLKO3Y6>&:$(QPRE64AP000?3@@59BU[1YI+6.+5K&1[M2ULJ7
M"$S =2@S\PX/3TJ5]4T^.^2QDOK5+M_N0-,HD;C/"YR>.: .9;X>6@L%B@U;
M48;N+4)=0MKQ&3S())"2X'RX93N((;.:OMX3$D^DW,VJWLUSIUPUSYKA,SR,
MA0E@%P!M) "@8XK2&NZ.UQ%;C5;$SRR&*.,7";G<=5 SDD>E1Z=XBTO5=3O]
M/L[N*6XL7\N9%<$@X!.!WQN )]>* *-[X.L-0U'5;FYFN'@U6V6VN[3*^6X4
M,%;.-P(#'H?0]JFT_P .+:W=E=7=]/?SV,#06KS!045L;F.T#<Y"@$_H,G.H
MU_9I<O;-=P+.D9E:(R ,J#^(CJ![U VMZ2D4<KZI9+'*C21N;A '5>2P.>0,
M')H J:[X=37;K2YY+R> Z=="[B6(+AI "HW9!XPQX&*2/PU%:^(;K6+&\N+6
M2\15NH$"F*5U&!(01D/CC((R ,YK0&J:>VGIJ"W]J;)P"MP)E\MLG PV<'FL
M7PUXG_M>VUFYO)[)+:QU%[6.>)\1M&%0ABQ)&27^G2@"FOP]MH-*TFVL]6O[
M:\TEY#:7R>69%60Y=&!7:RGT(["KDO@Z*2_L[U=6U!+F"WEMII-R,;A)&#-N
MRI .5'*@8' P,8UAK>DFVBN1JED;>5BL<OVA-KD=0#G!/%31ZA92V OX[RW>
MS*>8+A908RO][=G&/>@#G]*\$0Z3)HTD6J7DATFS>S@$HC(*/MSNPHZ;%Q].
M<YK4\.Z''X=T>/38;B:>*-Y'5Y@N[YW+D?* .K&K$>KZ9+)!''J-H\EPN^%5
MG4F5?51GD?2L74_%2V7B+1K:*YL&TR[^TBYN&D_U31)N/S9VCGKGIB@"*7P+
M!)'<;-5O8Y9=5&K)*HCS', %P 5P5P,8(-6K/P?9VVG:W837=U=V^L2223K/
MLX+J%?&U1UQGV[8J[<ZK'+;Z?<:=J6F&&YN$422R[EF0GD1$'!<]NH]JMR:G
M80WJ6<M];)=2'"0-*H=CUX7.3T- &5:>$=-L]2TN_C$AN-.M'M8W9LF0-C+/
MZM][G_;;UK?KF- \5I>W%_:ZK=6%M=1:G-96T0DV-,$"XP&.6;YNU=/0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8/C:P
MU#4_!.L66EDB]GM72( XW''*Y[9&1^-;U% ' W,?]M:]HVK6=A=6\%IIMS'>
MI):NAVNJ!(=I&6(8$X&<;?<9U/AUIZ6/@715:P-I>+9117"R0&*3<HY#9 /4
MG\S7544 >>ZM%=0ZWXY0V%[(-0TF(6SQ6SNLA6.52H901NRRC;UYZ8S5*.UF
MM;OP]+;Z)=2^5X9N8)H1;/&'D(B*Q,VWY2Q5^O\ 6O2(+RUNI)X[>XBE>W?R
MYE1P3&V =K8Z'!!Q[U/0!Y5I4-[=:Q%(FGZBL<_AA[1!)8O!'#*&!$(W $ #
M@;B<]B:[;P0[GP1HL4MO<6\L%E#!)'<0M$P=8U##:P!Z@C/?''%;]% 'GOAM
MB"F@ZSH5[-JEGJLUVER]NWDMNE=EG$N-N=CXQG.1C'IFV^FZE<^"K+P_-:W2
M>(;35TF-P86V BY\QIQ)C:08RW?))V]>*]4HH XJ71KVV\<75M;VY;1M95+R
MZ<?=BEBPKK_VT'E CN ]9%S:K+K.NZ)KND:Q=B^OENK.2V$GD3+A-@:1>(RA
M0 EB. .M>F57-_9B_6P-U#]L:,RBW\P>84! +;>N,D<^] '!VFDVDTGCUKW1
M[IDFG=XBEHRR2QFU5&\EBO+$^8!CN?>M7P<-6BU#48+^9K^UCBA^S:E+:FWF
ME'S_ +N12!N9./F 'W^><XZ^B@#C9?-T_P ?:M/J=I<7&FZAI\,5M)';M,J;
M#)YD1"@X+;P>>#T[5S_AO0[O2]7\'Q:I8SR/9Z1=1RRFW:1869XS'&7 (W!
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M>OIQ5ZRM5FU.ZT77-'UB>\36'OK69!(+:13*7CD\P?*NQ2 03GY< 'I7<_\
M"2:%G']M:=GI_P ?2?XUIT >2RZ=(N@:L8M(O!<-XKCNH]MC(',0N$;>/ESM
MVACGZ^M==X:6:V\7^*XYK6Y1;F[BN896A81NGV>)>'Q@G<I&,YXZ5UE'09-
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MY8E1I$C9E5WVJ2!D GL/>L&?P58RZ]<:I%>ZC;?:RIO+2"?;!<D# +KC.<
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M222MM,.[=(2S$-Y>1DD]#QVJ9O"%D;C5)4NKN/\ M&T2SE1"FU8D#!0N5)!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJQ//#:P//<2I%#&-SR.P55'J2>E<;X+TN]L[RZL;MA)9Z&[V6G2;LEXWVO\
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M3?*+/3)[*X!C&8I&$."PSPOR-R?3W%=SXFC>;PKJ\,43RR2V<L:1HI9F9D(
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M'?C=M8_+C.3R,$D5]%M]5?7?"MW/H5]:"VDO([B!(%2"U+C@)SRO??SGMZ
M[;2?%>D:QH_]J072+;>8T8+G!R'91QURVW('7FKB:WI<FGI?QW]N]K(VQ)5<
M$,V<;1CJV01CKD5YO:66LZ;X<T!WT;4YETC4+G[9:P$I*Z2&4"2+# O@.#QU
M#'WQ?>QETW5-"UW3] U"+2UO+J:[MB&EN-\T:J)VC))SD,"!D@-G&210!TG@
M[7KC7X-7EFEMY4M=2EM89+=2JM&JJ1U)YY.>:UK_ %G3=+(%]?06YV&3]XX&
M$'!8^BC(Y/'-8/@>&YA;Q"]Q87%HMQJ\UQ#YZ;-Z,J88#KU!K+\;0:C=W^JV
MEOI-S(ESH<D,5S:1*S32'?\ NG<_=49# <;BQY/0@'9W6L:=9.J7-[#$S!6&
MYNS'"D^F3P/4]*N]*\PN[+5A;VM[I-OJ5KJRZ?;0R6=Q;>9:WRC/[N3@B-ER
MWS9& WUQZ1?>8-/N?)@6>7RFV0L<"0X.%)]^E %>RUK3-1G,-G?03RA!)M1P
M24)QN'JN>,CBK-S=06</FW$JQID+ECU)X 'J3Z5YWX6M]1'BK0KV;2=0@A&B
M26D@>!8HK:3?$WEJN?E0!6 )R3@<FNJ\7V27^F6\+_V@A%TCI<Z>"TMLP#$2
M8 .X9X(P>&H GN-9MII-,-EK%A&EQ<M'MDPS7 4,&2/YAA@PY/.-IXIP\4Z
MUS';KK-@TTLQMT03J2T@_A'/7G&/7BN/-OKDUKX6_M&UDGGM->>:2>&T,>^
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MPZ]I-R\B0ZC;.T<9F8"0?ZL=7'JON.*=%K>ESV=O>0ZC;26MPXCAF24%)&/
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M&SKR* ->\\5@^,= TO3[RTFMKUKA9U +/^[C9@5;.,;A@\'D=:W8M:TR>_\
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MBI*\WU+7;^_^#]QK\S1C5-.>25)8UV@R6\[)N SP&"$$>C$=*]%AD$T,<H!
M=0V#VR* *$.A6,.MSZP%F:\F 4F2=V1. /D0G:I( R0!FM*N7DU;4=5\0ZYI
M&F7$=K)I4$+*SQ[_ #99%9ANS_   .,$DGD8K!TWQ9K_ (HN]&CTV>STY-2T
M5[X^;;&4Q2))&A'WAN!W''3CGF@#T4D*"20 .23VIL,T<\2RQ.'C<95AT(]1
M[5RWCN[DBM-%T]3B+4]7M[.?'>([G9?HP3:?9C4\^JWFH>*[[0;"X6S-E91W
M#2F,.7>1F"C!_A 3GN=PP1CD Z'SXOM'V?S%$Q3>$)Y*YQD>O_UQZU)7F^I^
M)KF_^&NE^+3 L%_:7T)=$)P3]H^SRJ.^U@6_,>E=EXBOI]/TM9;>>W@=IXHR
M\P+':S@,$4 EI,$[5QR<4 7-0U.RTJV%Q?W45M"75 \C8!8G  ]23VJU7E^M
MZS>:OX!\11WH.^PUJ"T1F0*[()K=U+ <;OGQQCIT%;U]XFN;+Q>-+O97T^.6
MYA2QDD@W6]VA"[U\P?=EW;P <=%X.<T =E17G\WC+4O^$2;Q? T;6<=\T+V)
MCY, G\DG=U$G\7IVQWK>\;:MJ&A^&VO]-: 3K<V\9$R%@5DE1#T(P?FZ\_2@
M#HJ*\\O_ !;KGAG5=4T_5)+6_(MH+FSGB@\H)YLX@*NI8Y 9@1\PR,Y/<2:]
MK?BS0]%UN\*0B&".*2SEND0R$E@LB,L;XP,@AO?!!H [^BN+N[SQ-9>)M(TB
M35+&1=1%VYE6Q*F(($*@#><XW'T[=>E9EGXH\1?V=I5_<W5G(C:V=)N(DMBO
MFCSVB\S.[Y3P#@<=?7@ [ZWO[2[N+JWMYTDFM7$<Z*>8V*A@#^!!_&K->9^)
MM<UB30?&D*WD<#:=>V\$4D$6TF*18B0<D\_O",^W&*ZKQA=:AI?@#6KJTE9[
MZ"QE=)57!#!3\P [CK^% &A)X@T>&:2&35+1'C;;(&F4;&]&.< ^QYK0C=)8
MUDC8,C ,K \$'O6%X5L+ >!-)LXHXY;.6PCW C(E#H"Q/KNR2?7)KG_$OB"_
M\.6U[_9T\#P:9#:^3;HGF$H6VMYS'&W(QM .3R<$4 =_5:_O[32[*6]O[F*V
MMHEW22RMM51]:X2^U^^T+Q#XVU.:Z:XMM-LK5X;5E 7YA(0,CD#<<D]?R JW
MXQCUF'P=XG6\O;6ZL'T29D(39*LNQMV .#'@KC))!ZDT =NCK+&LB'<C ,I'
M<&JU_JNG:5&DFHWUM:([;$:XE6,,WH"3R:Y33=<U'3-=73]2F2XLCHPU!!;V
MK;XMC*I4 $E\AAVSD=.<51\;:S::WX5LKFU2Z6*+6[%6^TVLD!_UR'.)%!(Y
MZ]* .ZNM3L+)(7NKVW@29@L32R!0Y/0#/4FK58_B'F/3AW.H08_[ZS7&ZCXF
M\5PZ9XGU6WNM.,6@7[J;<VS#[1"L<;E2V_Y3ACSSD^@H ZW_ (1'2UOI[J-K
MZ$7$AEF@AO94AD<]6*!L9/?'7OFK"^(="B!C75+%$C^3B90JD?PYZ9&.E<_\
M3]2N[;X6ZI>6+20R211J77AHXW=5<^Q"L?I72MI.FRZ -)\B+^S3 (5C&-H3
M&!CZ<8- &A17#WGB;5+G3?%&J:;)#&N@SR1+;R1Y%QY4:O)N/49W$+C&, G.
M<"I<^)]?O9M<?3[JUM;>TT>WU.W$EJ7?YUD;8WS?[ !/Z=Z /0ZK7]_::792
M7E].D%O'C?(YP!D@#]2!7&6&HZIJOCG3I$OA#!/X>6[6W,89$=W7/<$]!W[=
MN:SH_$WBD_#8>*I;[3V:6*(K;BS.$)FV,=V_G((QQQCOUH ['2;?1X?$.M/8
MWGG:A*T;W\?F[MC;=J9'\)VKC'MS6Y7G5PFMGQOXPDT2]M;6>*TLI/\ 2(#(
M)"%E(7[PV@]SR:MZ+XMU'6[R+&R"&Z\/1:HB;,M%*S$$9[KQWH [>:)9X)(7
MW;)%*MM8J<$8X(Y'U%9?ARVTBTTZ2VT>4RPPSO%*[3-*YE7Y6#,Q))& .3P
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MS_PE^J6$E[I=W+!/>+KEOI<%T(=B[9HTDW,H/506 YY.V@#T"BO._$/BS6=
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MC-;E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSNPB?B3<%VXQG.X@?7B@#4HK,N/$.E6MU]GGO%1A*L+,5;8LC8VHSXVJQR,
MD'D>HHO?$&E:=/Y-W>+$P=$=BK%(V<X4.P&U"<C&XC.1ZT :=%9;>(M)2_%D
MUXHF,_V8?*VSS=N[R]^-N_'.W.:YS0_'%I'=ZC9:]JMNETFKRV=L-FP;1M"
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MT;;8V?&T.V,(3D8#$=16I0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 >8^!CJ/A?P]XFL8M+EU'4K+697^R)(J/+%)L99 6XP5)(]=I%:/ASPG#
M:>/[WQ39:<^D65UIZPR6CJJ&28ON9RBDA<!5'N23[GM_LL'VL7?E*+C9Y?F
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MX-S_ +F="<8&2=V!C><$]*[EF"J68@*!DDG@"DCD26-9(W5T<!E93D$'H0:
M/-]=T75[RU^(44.F3N^JQ1)9D%<3%80AQD\ ,#UQ47BO3M>U6+7;:+0[EEE2
MT>T:!HHQ+MVE_-.X,S@AE .5P!CUKT^B@#B9;+47\4>([W^S;@0W>CPP0G*'
M=*OFDIPW7]XO/3KS6YX0MKBR\&Z+9W<#P7-M8PPRQOC*LJ!2."1U%;5% '->
M,K&[NX]%GM+5[G[#JL-U-'&1N\M5<$@$C)&X<=:YK6?#>KW%YJGB&PL6:26_
ML[A-/:4127$<*,K9(.%9MYQD_P "YQT'I5% &#X9@3;=WRZ'+I3W3*76Y96G
ME*C&Y]K,.F .<X%5_B)_R3?Q)_V#I_\ T UT(NK=DC=9XBLC;4(<88^@]3P?
MRJ'4],M-8TV?3[^,RVLZE)8P[)N4]02I!Q0!PNM>&[WQ88);2"33S%H=U9^9
M, I>294"IQG*KM8D].1C/.$^QWVK>']2>;PC<V6K#2Y[,R33I(9'=<;(3O/R
M$\DG:.!UYQZ%!"EM!'#'NV1J%7<Q8X'N>3^---W;BZ%J;B(7#+N$1<;R/7'7
M% '&WFG:A)IW@9(]-GW:?=0R72?+^Y58'C.>>?F8=,UE:GHNKS^'?&EM%I5P
MT^H:JEQ:J"@\Q (1NSNX_P!6W7';UKTVF1RQR[O+D1]K%6VG.".Q]Z .%U31
M]3U#5O&1AL95CU+0X[6UD<J \H6;*]<C_6+R>.M/M[/5O[;\)Z@=(NDC@TZ>
MRN%+Q[H&;R<,WS8Q^[;ID]..<5W5!( R3@4 >:^&]#U%=.L]#U+P_-%?Z9&T
M46KO.'A "E5EB&_<'((XVC&3SV,>G6.NC3O!.G3^'[J.;0[M4NI%>(QE%@DC
M\Q#NR0=RGIGGUKTT.K?=8'Z&EH *\Z\0>&]8U.[\:V5M;.BZO:6YM;HNOEEH
MT(*-SN&2 .F,&O0IIHK>%IIY4BB099W8* /<FECD2:-9(G5XV&593D$>H- '
M)QV=[K?BS0M:EL)]/73[2X2=9MN6>4(!&,$[@-K'/3IC/..NHHH \QO-&U>7
M1M=@72+EY+GQ+#?1)\GSP*\+%N6QTC;@\]..:Z6:TNW^)=CJ(LI39)I4UNT_
MRX61I(V QG/13SBNF>6.-D5Y%5I#M0,<%CC.!Z\ T^@#SO1-(OK:]_L?5/#<
MUW]GU)[NWU-YPUN4,K2+(5+960;B,!3SSG!)K6M?#][:>-KYD5?["NG342,]
M+L HRX]#A),_WE]ZZLS1"41&1!(1D(6&2/I3P00"#D'O0!YK<^'=7E\+^)?"
MTMG)))J-]--:WN08S'+('#L<Y#)SQC)VC&:OV=MJ^E:SK>ESZ$^IV>I7HO+:
M]9HVB7*H")@Q##:4!& <\8Z5W=% 'F6IZ=K]UJ0<Z%<$VOB&.[3[.\20R6X/
M#XW M(1@L6'&#@CI4MWX=U*]T/Q5X>?3I5DU;4I)H;D[3$L;E/WF<YRNTG&,
MY ^M>C.Z11M)(ZHB@LS,<  =2335GA=U194+LF]5##)7U'MR.: .7L-*FE\9
M>*&O;&0Z=?VMM"CR8*S!5D5QUS_&.H&:C\":=?6UK,=0F6X^PL^FV4N<EX(G
M(#'_ &CPK?\ 7,&NDU32[/6=.ET^_A\ZUEQO3>RYP01RI!'('>I[:V@LK6*V
MMHEB@B4(B(,!0.U $M>5VVE^(+;PUHN@S:'=S76E:U%/)<H\?ESQ+,7,BDN#
MD@\@C.<UZBDT<CR(DB,\9PZJP)4XS@^G!!I] 'G6EZ1?6^HW&D:GX;FO4&IR
M7MKJ+3J;<(\IE#,I?(D4L0 %.2!R!S5G0]*U/3?$<4]E#?6^F2&>2]T^ZVR1
MPN<E7MVSD;F).T'&"<@'BN\HH \IM;/4M'\/^#D.DWC:SI\]S(;>$Q.ZQD.&
M)0NH93O09##!(^ALQV<EQIVE6]CI.J+<6WB%=0OTNHT1UWEW9P Q7;E^ I)X
MKNM5\/Z9K4D$M];LTUOGRIHI7BD3.,@.A# ' R,]JM65A;:=;^1:Q[$SN)+%
MF8^K,22QX'))- ' W%CKEO>ZY/;Z-++'<ZY;W((6)I/($*(TD08X#AD[X."2
M.:JIH6MQ:9> :-=YB\3PZFD;3QN\L 9"<$ORP .<GZ$UZC3)98X(S)+(L:+U
M9S@#\: //)-*U!=:UFQU#PS-JEEJMPMS!-]H7R8R40%)U+C 4IG(#9&,=*]&
M' HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KG_ !1KM[HC:2ME90W+7]\MG^]F*;"RLP/"
MGCY>?3T-=!7'^/8KB=_#2VJW&^/68IFDBMVE$:!) 68 <+D@'..M %$^.=5M
M#?6FH:=:IJ&GZC:6LPBD9HY(KAE5)$) ((R<@CM5C7/&M]I,7BHQV-O.VBI!
M(FZ0IYBR GG@\C'X^U7[[P9!J%CJ*S7DBW]]<0W+W<: ;'A*F(*IR-J[1P<Y
MR>>:J7G@'[?#KB7&M73OK,4,=PWE1C'EC@J .#^F/4\T &J>+-1T.YM[;6%T
MRP:Z,IM[EW=K<E=NR)WPH1VW-R>/EXSG GD\3WT6H:Q9-;6XDL=+BU!&W$AB
MWF90_P#?OJ/6M'5M#FU:%H9;Y?(EMFM[B&2W#QR _P 6TGAASCJ.>0>*S9O
MT0F!L=3NK2)M+32YHPJN9(D#;#N(R&&YLD=<]NM %/4?&M_:^'8=72SMDC;1
MQJ6V20L9GV[FB15^88')<@@9'O4]UXJUB76)-/TRPLC_ ,2E-2CDN)F'WF(V
MD!?;U]\]C&WP\C-J;9-;OEBDTA=(G&R,F2)0P4@[?E/SG..O'?FK]KX2>UU
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ML8N6G^U7DMXQ9 NUI&W,!CMGI0!!=:U<S>(;C0]+6W^U6UHMU+)<9*_.S*B
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M.35+S58K6XFM=<NS!+L.^-U8QY!/0;1@>PK7T[PH+/\ LM;F_DO8])4K8B1
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MQPC/L<#:I4/T/7!Z<$]?VKEG\&R)KEU?V6NW]I!?%6O[6-8RL[A0NX$KF,D
M E<9[8/-=30 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !44MS!#)''+/'')*<1JS@%SZ =ZEKD
MO'BND.@WODRR0V6L03SF*-I"D>UU+84$X!8=!0!TG]HV6QG^V6^Q9!$S>:N
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MNF(WJ6*A4 Y)^4DGMQP<\2>#Y;V;PY$VH6<-K<^;,'6!66.3]XW[Q5;D!_O
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M6?EQLWF2)$8S%P.&X0\]F/H< &G/K^MW]I9W_AS3K"YTZXM4N?M%]=M!PPR
M J-T&"2<=?8T_3O$UQ>Z5H9EM8H=3U>,RQP*Y9(XP-Q<D@$@ KQ@'+ <=10C
MT>[TGX::5X:^9KJ:"'3Y6CYV!@!*P(Z83>0?4"I+BW:U^+&DRE=MK)HMQ;0
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MAT.TM@@L%##KG /K4'AJ*>UMOAW+=V-YLM[&[M9P;9R8G81[5<8RO"GDX'%
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MN*2[L]HF17!*DY./J.,^F17G7BZ:2ZDU]+?3;Z*07NGS@PVDLANT5H3YN_!
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M,-H"XYYY;IQSG:-X@U)?#FF:5HMLDMW::%9W+>9$75V="$3AUV_ZLY;GJ.*
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M*C@ =_4DXUCH4^I^)_&,5S)J%M8:A)"G^IV+<1B!4?:Q7CD,I(/3IC@UWE%
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M&N3;+JED9Q*(#$+A=WF$$A,9SNP#QUXJ4:KIYOQ8B^MC>'($ E7?P 3\N<\
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MHK+7Q+H3W,5NNLZ>TTTIACC%RA9W'50,\GVK4H **** "BBB@ HHHH ****
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M&7YN./GQS^/O7J-% 'EUFM]929.C7PB;Q)>3_:5LG>6WC=6V21H1T;)4M@@
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M8 'G%6KFV:PFTSQ'I'A[5/L*:F]S>VL@D>YE+PF/S_*8ELJ2..I&3CO7I=%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVKE[GPOJ<7B6\U31]=^PP:B$^VV[VPERRJ%#QL2-C;0!R&' .#74HH1%4$D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!ZJK!AE2"/4&EKE_ MQ+<:5>B>QM+6:.]='>Q8FWN&PI,D6>BG."/[P:NHH
M1F50"S 9.!DUEZQK(TR;3[6.-9+O4)S! KMM4$(SDL<'  0]NN/K7-:C)9_\
M+ O[?Q*L']F3Z;&M@UUCRB0S^<H)XWG*''7 'I7.V]H%MOAS'XA2*2[%Q,)#
M>*#)Y/DS>4'W<]#&.?XO>@#U'3)[VYT^*74+-;.[.1) LHE"D$C(8 9! !Z
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M'Y< \^E:EZ^EZEX@UC2]>O;^WU1K])]-%M$GF31 (8C!(4)'((." ,MG&2:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!LA'J5U-<PM$@>5(S;N4D8;5W,,[<<#[WM6[X>U2[U?2A<7VG3:?<K(\;PR
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M EGI\=K#*^AF]AN,YW[=H.TX" @GG'3CGT^B@#F=-B\1R7FDSW-Z! D<JW<
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MG*R8+D]SM&:J_;]9D\#W.KM;W,5]8Q1V,T<88D^5*%N9$ ()RH;:1S\IP>:
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M, YD.> "X<9Z L!2Z5KEOX9T:]EO;F*UFU?5;RYLO/!PL32';(PZ[<?-CON
M[Y !U<7BG3;JRTZYL6DN_P"TD9[6*)0'=5&6.&(V[>AR1R0.I K1T^_MM4T^
M"^LY!);S+N1L8X]P>01T(/0UPNG1Z;IOB#PYJ5G<;M"32[FQCNI/E42^9&VY
MB<??V/ST)''45N> +.XLO"%NMS&\;S3W%PL;C!1))G=01V.UAQVH Z>BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(@R<*R\+U-:.O^.XK/P?9OH6LSWMY>ZK%ID]U/'LEA<D[_W94!" , ;>^>:
M/4ZH7&C:?=:G;ZE/;*][;@B&8D[HP>H7GC/?UKB?#^M:SK.L>,/"T.I&";3+
MJ-;:]DC$DD<,@)Q@\,PVD MZ\YQ@Y_AGQ5K/AS3/&TWB2_?5K#0;CR[:[9 C
MS-@YCXXR"4'L6- 'I-_I5CJBQ+?6L<_DOYD1<<QMC&Y3U!P3R.:6QTNRTT2_
M9( C3-NE<L6>0XP"S$DGCCDUP7A[Q;>:OHE_(MZT_BPZ<U[#I3P/!'$&7,:H
MK >8,E06RW/0@$5@>#/B#?ZI>64BWMQ.;+3;F;Q#;7856CE0?*T8P,9;(PO
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M48C^$GC.,\]*]3HH \F@^%-[I^@:!);7%O)K&F:L=4E0L1%+O92\8;&1\JJ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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-** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>exhibit1034b003.jpg
<TEXT>
begin 644 exhibit1034b003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MR$7=UO5HS^[9N%VN-YP</TXK1TKPY<SZQ<7-EIEQX3MFL%MG%N8/,DE$@8,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !5*ZTC3+ZZANKO3K2XN(?]5+- KNG?Y21D?A5VB@ HHHH **** "
MBBB@ ID,,5M D$$2111J%2-%"JH'0 #H*?10 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%<[X]U*YT?P%KE_9L5N8;-S&XZH2,;A]
M,Y_"@#;MKRWO/--M*LJQ.8V9>1N'49Z'!X..A!'446M[;7R2-:SI*L4K0N4.
M=KJ<,I]P:Y?1[D:'\+]&-HA:=M/@2!50N7E=!S@<GDECCG )KB_AY=MX2^)>
MM>$)Y+HV6IYU'3WNT9'=L?.,, 23@\_],_>@#URTO+>^B,MM*LBJQ1L<%6'!
M4@\@CT-3UP&FW<MK\<M:TR(G[+>:1#>RKV$JN(P?J5P#ZX'I7?T %%%% !7
M?$^SBU*3PGI]R9/LUUK4<4RQR-&64QR9&5(-=_7#_$'_ )"O@K_L/1?^BY*
M%_X5'X-_Y\;S_P &5S_\<K!U/P?HWA3QQX-ET>*Y@:YOI(Y=]W+*&40L0,.Q
M'6O5-P]17$>-2#XR\"X/_,2E_P#1#T =Q1110 4444 %1SS16UO)/,ZQQ1*7
M=V/"J!DDU)7/>*9&N4M='2TENQ>.6N8HBN3;I@O]Y@,,2B$9Z.?2@#<MKB&[
MM8KFWD62"9!)&Z]&4C((_"I:X?X;7,MG9ZAX6NXY8I]%GV0I,07-J^6A)()!
MP,KP3]VNXH **\XU3Q'JMQX4UC7K/4I+62SU-K.*W2.-E5$G6$[]RDEF!+=1
MC(]\R:WX@UFSM/B T&HNKZ1%'+9-Y49,>80Y'*_,,^N3[T >AUGKK=@^J7>F
MK*YN[2%9YH_*?A&S@@XPV=IZ9Z5Q?BSQ'JNGP:M=6&HN[V$5J_DQ1)LA+,"P
ME+#+%P> O(&#QD$W9VE3XB^(7AE,4JZ!;LDB@$J1).0<$$4 =/\ VW8C3+74
M#)((;H+Y"F)A(Y89 "8W9QDXQD8/I46B^(M-\0I,^G23.L+!9#);R18;GCYU
M&2""#CH1@UPTT]]K.F_#._N-1G6YNY8Y)6C2,9D-I*Q?!4C/48Z<]*N:CXHU
M/2;OQ6KW8DBM+NP@MFE556W6?8&8D+T&\G)!Z#K0!Z%5&#5[*YU>ZTJ*5C>6
ML:231F-EVJ^=I!(P<[3TSTKCM4U7Q'X<$RWE];/#?WEI;6;EP\MKYK[)&;$:
MJ5'5<@\\'(JWH=O+;?%'Q DMW+<YTRR*M*%W*-\_'R@9YR?QH [2BBO/=+U_
M59_$&@Q?VE)=6>J+>!YUBC6)]GS(T(QN 7IEN&Z\]: /0J0$$D @XX/M7G>E
M^(]9N-$\&74VH,TNH:E+:W?[J,"5 )R.B\$>6O3%4]+U>_TG3)%_M&YEDU#Q
M5+IOG3!&,*^:XW#Y?O$(%&<@$C [4 >HT5YIXF\0:]HL7BNQ@U&1FL+.WOK2
M[:*,N@D=D:-OEVGE"0<9P>IQ6C<OKG_"7:EHJ^(KI(#I:7\<BP0[X9-[H57*
M8V< X8$\?>H [JDR,@9&3SBO-3XHU?4/"MA>Q:BR7K^'C?R06L2;A+M!$KEP
M5"9! 4<DYX..+6F7-[JOCO1;J74+B/S_  V+EH8PGEAFDBW8!4XSQ[\#G% '
M<6%_!J5K]HM_,\O>Z?O(VC.58J>& /4'ZU9KSK1/$^IWEKX>L;N_83ZE?7\4
MEV$0,5@DD"HHQM!("\XZ*>YR.TT6*]M[)X-0U!+^XBF=?.6,(=N<H& XW!2,
MD 9]* -&BL+QAK4F@>&YK^)E1_-AA\UQE8A)*L9<_P"Z&S^%8^OZCJOAB"9F
MU<7,=Y=VEO;F6)/,M!)($D=B  PYRN1P?4<4 =K17G7B77-;T*?Q'80:C+(L
M&A/JEK<O%&7AD0E2A^7:RG (R,_>]L/GO]9@U2]T^76;B6.Y\/27ZL(XT:WE
M5@O[LA<@$-_%N(QUH ]!!# $$$'D$5DZCXETO28=1FO99HHM.1)+E_L\C*JL
M"000OS=.<9QWQ7$Z=+K*Z;X#TVTUZYMX]2TQC*YAB=E*VZ,NW*=B>^?>HO%E
M[J+:#\0],O+Y[J&RTRW,)>-%(+QN7/R@=2 : /40<@$=#2UYYJM_X@T'5Y[3
M^VI;N"[T>ZO(B;>(-:2P[,;<+@H=X&&W'CK5NSUC5+O5?"EL^H2+%JNBRW%P
M$CC!\U5APZG;P?WC<=.G% '77>H6]E]G\XN?M$P@C\N-G^<YZ[0<#@\G %6J
M\M\/:CJEEX#\"W$>J7#M?WT$5R)51MZ.'+#.W/5<YSGD\U<OO$^K2>%=?\2V
MEVT<FDW\T26)13&\<+A2C\;MS#)R",$C''4 ]&HKS/7=:\00KXVN;;6IH%T6
M*&YM8?(B/6'S"CDJ25SD=C[UZ3"_F0QR$8W*#CZB@!]%<_XAO+B+4=+L[:]D
MB:X:4M;VZ*9I@J_PLWRJJD@DGV'?!Y'3]=\0ZS8^#%&L/:RZHMW%=21P1DL8
MT?:X!7 ;*Y]/:@#TZBN!L[C7#KWB"&X\3.EKHI@8-+;1!9 ;?>_F$*"%W'/&
M"/6J]EKVM&^FM6U"X=)/#QOXYY88U)F5@/,10.%;/W6&1CH* /1J*\^\/ZOK
M7]H>$'N]4DO(];TAYYX7BC14D2.)@R%5!&=[9R2/0#I2:'JOB35;GP[(UU<H
MTQG.L0_9T\N IG:JL5X!8;1@DL#G/&: /0J*X+0-3\1Z_:Z-KT-_:Q6%VS?:
MK=Y%.U6R%5!Y>1(K8'+$'G/;&98:SXCET3PQJ3Z[*TNH:I)I\\9MXMA0M, V
M N=X\M<<X]0><@'J%%><+XEU:P:]TN6_-S*OB"/3(;R<(CK&\"RC)5-N<Y0'
M;_$.*EU.[\5Z1%;0W&KP!IM;MH(F0)*_V>4X*R911D$'! !(ZT >@DA022 !
MR2:6O*O$-[JW]A>*=-FUBZE.FZK8QQ7&V-)'CE,!*-M4 @>8W0#/ .1Q7J42
M-'$B-*\K*,%W RWN< #\@* 'U1TS5[+6%N6LI6D%M<-;2[HV0K(N,C# 'C(K
M*U[5IX?$N@:'!,UN-2,[R3* 6VQ(#L7((!)8<XZ*<>HX_1M3O=)DO--AN=TV
MH>*;FV:ZE*H<"'>!G:5#,5 ^[W. #C !ZG17!W-YXMTBQ NF.I+#>R&5=-9'
MNQ:[,IE610S*S#(4 D;??)IGB"?Q%?6VE6.N2*K:.+U+U8462=VD:/)5EP-I
M7E0!RV.@P0#O*R+GQ-I=FKM<2S1JEXEB2UO)CSF*A0#MZ$L!NZ>]<T9?$%WX
MLM-&'B,Q*='%S-+;6T15IEE5&*[@< \\'/7C%9&M7^H:AH.L0W-X97M/%=I;
M6[O&OR()+=E!"@9P6/N?6@#U.BO-=2\1:YX6U/5M-N=2.H0B.RF@O+F-(VMO
M/N#"P<HH7 P6!*_7-6]3U7Q'X=\U+R^MGAO[VTM;-RX>6U\U]DC-B-5*CJN0
M>>#D4 =C;ZO97.KW>EQ2L;RT1))HS&R[5?.T@D8.=IZ9Z5>KB]"MY;;XG^(T
MDNY;G.G615I0NY1NGX^4#/.3^-=I0!6LK^"_69H/,Q#,\#[XV3YE.#C<!D>X
MX/:K->:/K^O?V4&356$Z^*O[-\QH(SN@\X(%(VCMW&#72>%[V_;6_$>E7M])
M?+I]U$()ID17VR0H^T[%4'!)QQ0!T]93^(]+2:>(7#R&W8K,\,$DB1,.H9U4
MJI'<$\=ZL:NUTFBW[6()NQ;R& #^_M.W]<5SWPP,!^&F@M;L&W6P,ISR923Y
MF???NS0!U%G=V]_907EI*LUO/&LD4B]'4C((_"I20JDG. ,\#-<BEX]UXKF\
M-:==MI]I9Z:EQ&ULJ$NSNR\;@PVKLZ#N<=L5D^&O%FJ>)+K2-+NIC9SO97-Q
M<S0*H,[13^0-FX$ '!<_@.F<@'<:3JUEK=@+VPE,MN7>,,49#N1BC## $892
M*NUY7X5U._M=*T70K>X EOKS56>X9UC9S%<-\H^1@"=Y;IT4XQ7?>'!JT>DB
M'6[FVN;Z*1T:6W.0RYRN[Y5 ;:1G  S0!?O+RWL+26[NYDA@B7<\CG  JI9:
M]IU_>FRAEE6Z$9F\F:"2)]@(&[#J#C) S4'BO2K;6_#ESIUS=O9K.T:QW$?W
MHY?,4QD>OSA>.]<C%XDUWP_?SV7BFPM[O4+?3;FXT_4K3(2[2,*SHR?P-PA.
M./3W /1Z*\\N-;\2:5H;>)C>6=YIQTJ2Y,#2@EY@F]&CVQKA< Y!)XYZ@YMZ
MZFJQ>%]5O8_$CRV\NB2S1A8T63S57=YD;*!A"" 1@XR""#0!UTNH6\-Y:6K%
MS)=[O**QLRG:,G+ 87CIDC/:K5<+9WNH:=?>"+)-0FEM;RTE\^)XX_GV0AEY
M"@C!/Z#-4K?Q1J\WA30?%<=TT@O[^*&>PV)L$<LOE[5XW!TR.<\D'(] #T>B
MO,9=;\006.H:F=:E<6'B-;%8#!$%E@::.,JYVYR YP01SUS7IU !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!?6=OJ-A<6
M-U&)+>XC:*5#_$K#!'Y&IZ* .<T?PNEGINEV5^[7#:.=EC.DSH=@4JI95(&X
M(2IZ@\GC) LZEX3T75]8M-6OK-I;^T_X]YA/(IC[\;6 K:HH P=(\/\ V77M
M3UZ\*-J%^$C 0Y6&%!A4!/4DY8GU/M6]110 4444 %9.O^&='\4V<5IK5DMW
M!%)YJ(SLN&P1GY2.Q-:U% '$?\*A\!_]"_'_ .!$O_Q=7-+^&G@_1=3@U+3]
M%C@NX"6BE$TC%201T+$=":ZNB@ HHHH **** "J8TNT75FU,))]K:,1%_.?;
ML!SC;G;UYZ5<K"\6^(3X;\/7E_%!]INHX))(8,XW;%+$D]E &2?H.I% %M=
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MGR?LLNS[9]OQ]IE_U^<^9G=USS]:O6>CV-A?WE];1.MS>LK7#F5VWE1@'!)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/C^5O\
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M]-;PO9VEK8VDNKRR+=12HS>3*8GF8C##/S Y'?U&<U0_X2_7AIMN -.:]7Q
M='F<Q.$==QQ(J[\J<8R"3WYKH3X3MWNM/NI=0OY;BRN7NEE=D)DD=2AW?)C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAB$5"F#M!)S\H(X8C)XK0'C2XMS=Q7VCW$,J7,-O:N(Y1'=&0$C:60-E<-N
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M.0CR,6VY[[5VKGVK+D\#SR:9>V1U6,?:M675"_V4_*PD639C?TR@Y],UV5%
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MDDYSC@8I]WX0O]5T1K;5?$,TVHI+'-;7L%NL0@DC.598\D$\G=D\@XXKK**
M,W1["_LK=CJ>J'4+I\;I1"(4 '0*@)QU))R2?H  :?IL]KJ6HWMQ=).UVR[
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MC3==:PENX8XK^-;99%FV9"NFX_(P!(S\PZ<'%=510!7FMW;3WMH) C>7L5Y
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MC>_U);Z0BT!PN%5H^6/!5 -W49)KI*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM)$H5$7)^8ACR0.V1SC.<@ '9T5SGASQG8^*5CETVVNFM7:91<-LVJ8V"D,
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M<W;FP&4G:#UXS@@=4#D9% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]+<VRZ=+X@NGEE$A,A5+HN5"XQDE0,[N >E=;H>BWNDZYKL[RV[V6H70NXP
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M3?5K>+Q3IZVIM#:'+HJ_NVD"GDKY8DSGC]*]#MK:*SM(;6! D,*+'&H_A4#
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MM([Q*H&Z-00_S#@D?, O! %=//X=U#6=2U34)O)M(M5T-+#RV8M)"_[PDD8
M.#(1C/\ #[\=:;>%IQ.88S*HP)"HW ?6I* .5T_P[?FXT.?4OLBMHMNT=ND$
MC,)9&01[V)4;1MSP ?O=>.<BT\&>(-+TG0I-/O-/75M):X3;*7,%Q#,^YE)
M#*00I! /*^]>@U6O[^WTVPGO;EG$,"[I#'&SL!_NJ"3^ H 33DO4LU_M&6*2
MZ8EG\E2$7_97/.!ZGKUXZ#'\;Z'>^)/#<FEV+V\<DDT,A>=F  CD63L#G.W'
MXUT0.1FB@#'9==GN49X-/MXE1]P2X>1I3@A5R8UVKDY)Y/ KGM+\(:II]IX-
M@>2S?^P=XF(D;]Z#$T7R_+Q][//ICWKN:* /+]9TK4-$_LSS6LVFO/%PO(5$
MK;<.DGRL=O!XQD ]>E;.L>#;_5-.\0NLEK'J&L26^078QQ1PD;1G;EB<,<X'
MWL=N>E@O-'UJXN887M;R6R<1RC:'\IB,XSZXQ5F]U"UTZ))+J78'<1H I9G8
M]%51DL>#P!V- '.-X=U6TUG6[S3Y+1HM:B3SHYW8&WF5/+W+A3O4KC@[>5Z\
M\9&KZ)I)M= \)Z9JGEZOI9B2,1L#,MN4*3%AV#1[N?[VSVKO+.]M]0M5N;65
M98F) 8=B#@@CJ""""#R",57L=3TS48)K^SN(98HW>&2=> "A(8;O0'/M0!B:
MQH.LQ>(;76O#D]BDBVOV*XM;P,(GB#;E*E.0RDGM@@]JANM!\2VNOQZUI-_I
M\MQ<6J6U_#>(ZQOM9F5X]N2"-[#:>V.<\UUD$\=S DT1)C<94E2,CUYIJW4#
M7;6HD G5=Y0C!*^H]1VXZ4 <AK_@^]UV2)I6L_M< B-KJJ,T5S;.#\Y4*/F4
M\D*6QR<UVM%% '/:[X9_MC6M*U!)_)^S;XKI<?\ 'Q;L QC/L71/PW>M4=.\
M'3:5X7UK2K>X25KL30VAD)"P0-N\N/(!.%WM^>*Z^J-MJ]E=ZK>:9#*6N[-4
M:>,HPVA\[3DC!SM/3/2@#EF\&7MTVC17CVWV6TT:?2[D1R-N?S%C4LN5](^_
M][VYGL/"VHO;>';/5IK62'0I!)%-"S;[ADC:.,LI "<-DX+9(':NJN+J&U$?
MG/M,C[$4 DLW7  Y/ )^@)[5!I>KV6LV\L]A*98XIG@<E&0AT.&&& /!XH N
MUP=UX.U:XT77;%9+(/J.L)J,;&5\(JO$VT_+U_=?^/>W/;074%RTJQ2!FB?9
M(N,%&ZX(/3@@CU!!Z5-0!P&I>#M>O[ZXG:ZTZ0_VK!?V\TP<R)'&R-Y'3"J-
MIQCKGD DFMV[\,&X\8VFN+<!(A;^5>0 <7#(P:$_\!8N?RKHJ* .170?$6G>
M(=2ETF^L!I6IS"XF6X1C-;2;51C'CALA0<-C!]>_7444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7O$^G65T+B6UTZUEL8YA&F)7,H/S8 R=BXSQGVK \1ZP^M_#3Q8IO=2AN;5
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M!9K2=#')$W1E/;CI^%<WJ_@JS&DZA_9%E&^H75JMH[7ES*PFB!Y5F)8[MK.
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MGVJ7B;=OWYW9SNY^O-+>Z6--FOM:T;3([G5[@('CDNFB27&%R?O*&"CKMR<
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M!<+=(3<RE_-7&UV?=N8C QDG&!3Y_"FC7/\ :GG6TCC5%"WH-S+B8 ;0#\W
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M'Z):VL-M;V\\,,,30(L=W,,1L<E3\W(SZ].U;,$,5M!'!!&L<,2A$11@*H&
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M*7'F>8).3_?&<<=QQ0!C>,]8U&Q?45T[4'26TTF2[%O;Q(S(XW8DD+@C9\N
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4=&\;Z7/&;/^V;F62VF+JPVM#&@R%)(Y0Y'H: .DM?$.G7]XEA%--#<SP&>
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MG^1NSC=OS\_7';'>NCT?3[KPYIFGZ=:6,<\<ES*]P4E"):K(SR':",LH9@H
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M?#^MVBZ:WG7?B!-0B'G1X,(FB<DG=P<1GCU(KT8'(!((]CVH 6BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)YSUYS0!Z%17.>"O$C^)M#DFN$1+ZSN9+*\1/NB:,X)'L1@^V<5T= !1110
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M))P!R>PH [.BN6/Q T0W^A6L1N)4UQ=UC<(@\I\=022"".,@C/..M6IO%UC
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MSM.2?XAZDUK^)_']C>^!;O4M.U2_T>2UOEM+F1;1))K:16Y1D+8YZ9!/7ZT
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M+M=%9>#AAD4 <5\,-(N=/T/4K^ZC>)]8U2XU%(G&&2-R-@([$@ X]Z[>BB@
MHHHH *QO%NEW&N>$-7TJT*"XN[22&,R'"[F4@9/I6S10!Y?+HOC>[MM*BO\
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MG#"$OPVTXST)'). <#% &3K\M^/'_A>V@OFBMIDNG>$("&9%7!/X.1[5F_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY&-2A#6<7G3[LJ%CSC>"1AER,9&1FN1UC1M6N8/B''%ILSOJMO''9D;0)F$
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MLR[@"JDCCOTKC['1M4O].\&V%SI\EE<:%/&]U,2NPB.%H\1D'Y@Y*GV&<X.
M>OU^*6?P[J4,$32S2VLD<<:XRS%2 .>.IH S/#'BNPU?3M/AEOXGU-]/BNIU
MQM!RJ[V!Q@@,<''3H<5=@\4:-<K(8;S=LM_M7^J<;H?^>B\?.ONN17(PZ5K,
M4GA-XM)9I+#0KBUF68KL69HX@J-SR"8R"1D4OAG3M8C\5:3J%WH]Y!%_8SV=
MPTKQ!(I=\;;51&PJ84A0H[#([T =I;ZWI]U;6%Q!<&2&_/\ HKK&V)."W''
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MSJPD>-7&5 QE1G/7/:M+2?%9U7Q#/IBM:Q36]Q+%/92Y2XC120DHR<.KX4Y
MP PY- '4D@ DG '4FEKD_B;#'-\-/$(D4,$LI'7/8A3@UU%O_P >T7^X/Y4
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M^[N8^^.]36/@Y]-U>XFM-:O8M,N+DW;Z:%0Q^:3N;#XW!2W)4'&<]B17444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1145Q<0VEK+<W$BQPPH9)'8X"J!DD_A0!+17GOB;XBW>B> H?%UOIL
M4MK<2IY,$SE7:)_N.2!P2.=N.A'-6X/'%['X^A\(:A80)<W=D;NUNK>4NF/F
MX=2 5^Z>Y[>M ';T5D:!KT.N070">3=V5PUK=P%L^7(OH>ZD$$'N#V.16O0
M4444 %8OB3Q3IGA2TM[G5&F"7$P@B6&%I69R"<84$] :VJX?X@_\A;P5_P!A
M^+_T7)0 O_"UO#O_ #[ZS_X*I_\ XFI].^)?A[4]6M-,B&H17-VY2$7%C+$K
M$ DC+ #H#785Q'C7_D<O O\ V$I?_1#T =O1110 4444 %%%<Y'X@NSX\N=
MDBMUMH+!+[S]QW$,[)MQT&-I.<_A0!T=%5(-5TZZN%M[>_M99FC\Q8XYE9BG
M]X './>G0ZC8W-S);07MO+<1YWQ)*K,N#@Y .1SQ0!9HJFVKZ:KSQG4+0/;J
M7F7SES&HZEAG@#WK.MO$5OK%CIM]H][8-;7,X5_/DPS(03A #]_[IP>V: -V
MBJBZKISPS3)?VK10G$KB92J'T8YX_&EDU*PBN8K:2]MDGFQY432J&?/]T9R?
MPH M45B>+M:G\.>%=0UFWACG>SB,IBD) <#J,CH:H6GBJZC\46.A:K90QR7]
MHUU;3V\I93MQN1@0"I ((/(/M0!U5%5(=5TZYCED@O[65(1F5HYE8(/]H@\?
MC6?>^+M L'MTFU:S+W$RPHJSJ3N8;LGG@;><GMCU% &W15"UNY9+^_62XLFM
MX=AC$3DR("N6\SL.>F.U0WFKQ2:-=W6E:AIK21*0LLTP,"/_ +94\"@#5HJG
M<ZMIUB&^V:A:6Y0*7\V94QGIU/?M3KK4K"R$9N[VV@$GW#+*J[OID\]1^= %
MJBJEUJFGV._[7?VMOL7>WFS*FU<XR<G@9XS56X\1Z3;:Q9Z5+?0B\O(S)"GF
M#E1@9Z]R0!Z\XZ4 :M%5H=0LKFX>W@O+>6=,[XTE5F7!P<@'(YXHDU&QAG:"
M6\MTF1/,:-I5#!?[Q&>GO0!9HJG_ &E:2PQM;WEJ[3Y6 ^:"LC#L".OX5D^$
M/%$7B'0=.N;F6TBU&Z@\]K2.0;@NXC(4G...M '145674;)KTV2WEN;H#)@$
MJ[Q_P'.:R_%.M76AV=C/;10R"?4+:UD\TGY5DD5"1CN,T ;M%5(M4T^>UENH
M;ZVDMXB5DE292B$=02#@8IO]L:7]F6Y_M*S\AGV"7SUVEO3.<9]J +M%0F[M
MA,T1N(1(J>8R;QD+_>(]/>FVE_9ZA&TEE=P7**VUFAD#@'T)'>@"Q15.XU;3
M;1G6YU"TA9&56$DRJ5+9V@Y/!.#CUQ3[O4+*P"&\O+>W#G"^=*J;OID\T 6:
M*S+CQ#I=MKMMHTMY$M]<1-*D1< [05'YDL,#O@^E&J^(-+T6XLH+^\B@EO93
M%"KN!DA2Q//0 #K[@=Z -.BJS:C8I>I9->6ZW;C*P&50[#KPN<FHVUG2U=D;
M4K,.H8LIG7(V_>SSVR,^F: +M%43K6E*)RVIV0%NH:;,Z_N@>A;G@'WIMQ?.
M9]--I=6!@N9#N\R3YI4V$CRL<,<X/IC- &A15,:MIIGC@&H6AFD9D2,3+N9A
MU &<DCN*>=1L1>BR-[;B[/2#S5W],_=SGIS0!9HK*T[Q)I&JO?K9WT$@L96B
MG82# ( )/7H,XSZ@U;AU*QN+1[N"]MI;9,[YDE5D7'7+ X&* +5%<[H7B-M9
M\1ZY8(UK):V'D>3-;OOW[U8G)Z9!7'%;-SJ-E9RQ175Y;P22G$:2RJI<^@!/
M- %FBJ=QJ^FVC.MSJ-I"R,JL))E4J6SM!R>"<''KBGIJ-C)// EY;M-;C,T:
MRJ6B'^T,Y'XT 6:*IP:II]U.;>UOK6:X\L2B*.96;8>C8!S@Y'-9?AGQ"^J^
M'Y=2U+[-:F*[N+=RK80".5HP<MZ[1^= '0453.KZ:MM%<G4+002G;'*9EVN?
M0'.#3YM1L;9I%GO;>)HU#N'E52JG@$Y/ ]Z +-%4'UO28TN'?5+)4MG"3LUP
M@$3'H&Y^4^QJ:ZU&QLH%GN[VWMX7^[)+*J*?H2: +-%5+C5=.M QN;^UA"Q^
M:3+,JX3(&[D],D#/O56Y\2:3::I8Z=+?0"ZOE+P)Y@^90/O=>A) 'J3QWH U
M:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KFOB%9W5_
M\/-?M;-6:XDLI-JKU; R0/J 1^-=+10!XQX_@GUCX!Z%;:7:7%Y-+!9LD5M"
MTC86,9X4'&*MZ=IE]!\7;"]\,V-]%I4UF!J\]W#(J,0#@*THW%ON\+QT]Z]1
ML-.MM,A>&S3RH&=I!$#\J$G)VCL"<G XYJRZ[T90Q4D$;EZCW% ' >!89F^(
M7C^^4'['+>V\,9[&2.,B3'TW"O0:K6%A:Z9:+:V<0BB4EL9))8G)8D\DDDDD
M\DFK- !1110 5PGQ+:>W;PO?Q6%[>1V6L)/,EG TSA!'("=H^HKNZ* .'_X6
M=9?]"UXK_P#!/)6-?^(6\5>-/"/V/0M>MX[.]DEFEO-.>)%4Q,!\QXZFO4:*
M "BBB@ HHHH *X; /Q9U*>:UG:S;0XX#*UNYC9UE=F3.,$X(XKN:* /)?#-@
MUC9?#=AIEQ#<6_GK=_Z*RM'F!UQ(<<9;:.?:F:7]MN=1\,2VNGW]@R6M_;^0
M;*58[*1PNU2[+EN026)P2.,=*]=HH \_\'2VM_IVC6=SH5[#K>DVC6T[W%N\
M:P,4"N0Y&V3>R@\$DYS6/IL,G_"(?#R%].O$NM/U"%+@/9R!H@L4BN3E>%W%
M1GI[\5ZQ10!Q#:/>6GC>]L8+9CHNL[+^=P/EBECPLBG_ *Z8BX[C?61/!'/K
M6MZ'KUAK$TMUJ*W=D;>)_)G4;#&?-48C*%0#DC 'O7IU% '*_$J.6?X=:Y;P
M0S3SS6K1QQ0QL[.QZ   FF2Z+IL&@7FLP:7<:AJ#:6\0CFFE:61=A)B7>24W
M'C"XYKK:* /(0LES<ZA)]BOY8+GPK]GC!TZ1(UD4OB)5*YXR,;B2<\$UJ3Z=
M#9>&?!%W;Z5(A@O;22]\FS8R@"WD0EU"[CAF Y'>O2J* /*]8L]0>Z\</IVF
MW,A>XT^X\E82OVN./89D4XPQ(#*0,YSCO5OQ0VG^(/ _BB_TK1;TW%[:)&7D
MLY$DGD4$*JQL-Q*Y^\!CGJ<''I-% 'F]S'HDOQ(U7^T[%)X9]"MCM:U+ELR3
M C&,[B, #J<>U83:?J6G^%ET.\TZ]%^?"[0"XBMWG:9COQ;9 *)M^7)/)R,$
M8Y]1AT*&'Q)<:X+FX-Q/;I;O&2OEA$+%<#;G.6;OWK4H \ST^U@NO%%M=76F
M3-&?#"1.\]D_^L#'*G*_>V]NN#47AF*ZM)?A]-=6-Z!%HTUG+FV<F*4^1A7X
M^7[C<G XZUZC10!Y]X-2^L]9L[6-I;W2/L4AADN[9HKG3_F3]P[$ .#VXS\G
M<<G3\6V=];:QI&NZ3:_:+N-GL)X\<-#,."W^RLBQL?;=7744 <+X,TF]TB2?
M3+])#8:#))'83LN?.20!PP [HI*<#N17/>&]/>TTWX>,--N(+F"XG%TQM'5H
MPT,J_O/ER 6*#GVKUNB@#RJRL=0NO!^AZ-);7$7B/3]6CEFD:)AM(F+23;\8
M*NA;G/S;L=>*ZCXAPFYT33X1;2W .JV;R)'$TGR+,K.2 #P%!S76T4 >6ZB#
M9:IXL:/1II[22^TV1 MK(8UV[ TP5 #)L*@E5Z[>>*GT[0WUZS\;Z5,M[&UY
M>+<6MS<VQB^?R(BD@^4#(=,X SQS7I=% 'G=^FNZKX GUB739TU:9K62:QC
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M]ZMT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445R/CO6]9TA-$M]#>S2[U+45L]]W&SHH*.V< @]5% '74
M5Q'V/XF_]!CPS_X!3?\ Q=4FU?QOHOBCP_9:S>:+<V>IW+P,+2VD1UVQLV<L
MQ':@#T2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***"
M0!DG H **9YL?_/1/^^A1YL?_/1/^^A0 ^BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.P'("@@\ 59@N-4OM+\86)U:XT^;3[P"RG\WS6AS#&X1CC+C<Q&.3S@$X!H
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M-:)X>\[^R-,MK/SCF3R4QGV^G)XZ<U--HVGW&J0ZG+;*U] "L4Y8[D!Z@<\
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M JCK6JP:%HE[JMTLC06<+32+& 6*J,G ) S^-7JYCXC?\DV\2?\ 8.F_] -
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC>*2V6963<6!7)&ULGKS].N4F\"I<^*[O6Y]4N)!<Z9_9IBV ,J'.3O]R<X
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MMI$L0D*!=V!UP.E<E:_"J&+PU::)<ZQ-<6\6J#4;@F%1]I(8ML89[YY//04
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M<X C5O;/4UZ/<:7'<W-@Q;;;69+I;JN%+XPA/LHW8'J0?X165<:&W_"QK+Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** ,F]UV*#7K/1+=!-?W$;3LF[
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MTEJDDE[-;M#;QQ*6<N_RY '/&<_A0!%X%\;2>,='N=6FL(=/LHYWABD-SO\
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M$?#OPK):9N=4U(WMT98<-Y:YDEX(R.&5??;W%>YW$UIHNE/)L6&UM8OECB3
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M9IV!W*#TVXW  ?Q$\$DFLC2?#KW/@KPEI\.F^7?ZSK7VV^G%KM$<:%GQG'
M*X'3.X#O0![7KFJWMA;VKZ781ZC++=I!)&;E8O+0G#-D]2/[O7FL[1O%QU?Q
MAKNB_98HH-+>.);CS\F>1EW%0N!C:.O)KC+K0-/TOXKZ%86.F7(L-*M;G569
M4>4RSRMMQN.<D8W=?;K7.Z#X<N-=C\/3)9%=<NM=?6]4NRF&LX@[8B9NQ;Y<
M)UXR1@9H ]Z\Z+>R>8F]1EEW#('O5.ZUG3[/4+*PFNHQ=WI(@A!RS@*6)QZ
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M"G>:7;7MW:7<BE;FT8M#,APR@\,ONI'4'V/4 BY110!3M]+MK?4+G4 I>[N
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M_"6 (![8/?%9_A&XU#QMX+U18M8O+&V;5KB.UO(G)G%JK J%=LG.>,G/ (H
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M\LMA,YVJ#P!Z#UR: +5AX5M;36O[7N+N[O[Y(WBADNG5O)1W+%5  ]0,G)P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@Q@[E4=2,$D\]*T-<\._VY;)I;K!!INT1RLG,SQ=XE./D4]"022,CC.1T%%
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M*UW74T*.Q>2VEF6[O8;,&,J C2,%#')Z<]LUK4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !6?KLMC#X?U&74XQ)8);2-<H
M1D-&%.X?EFM"D95=2K*&4C!!&010!YOIEO?^#_$&AZ?IFK_VQX<U-V2WMIV$
MDUF!&S!XY!]Z, 8YZ @=ZI^&[\:O'IFH_P!NQ)XC@>5+K3T4B::7#!HI5+GY
M >0=H  &,5Z9!IUE:SR3V]G;PS2?ZR2.)59_J0.:<EG:QW4ETEM"MQ(,/*J
M.P]">IH X'P?<Z+K]AHEV^J32:T]M)%J%JLWSRR%<2B=.H"L#MZ 9 '! K#T
M"2WA\ _#\V=T4D.J6\5PL4Y )*OE74'!^Z.#Z5ZW%9VT$\L\5O#'-+S)(B ,
M_P!3WIC:=8LJJUG;D*Q< Q+PQY)Z=30!YE?WEW=^%O%%_P"?+%XET[5)$M0K
MD.F'401JO='4KQT;<3UJ'Q'$SI\1;E[R[6?3H(+BV"7<@$$OD;\J-W][MT].
MIKU5K*T>[6[:UA:Y4;5F,8+@>@;K3&TVQ=I&:RMF,G+DQ*=W?GCF@":W<RVT
M4A()9 V1WR*X?QII6AWS7VI65^MMXJL(@();:Y_?*^-T<31@_,&) VD<[O>N
MZCC2*-8XT5$48"J, #Z5%]BM?M?VO[-#]IQM\[RQOQZ;NN* .<\7&35?!NLZ
M'#-"=;GTF1_LB.-YRI7@=<%LKFL"_,VKZCX(DT5@TMOIUU=97_EFK6XC3/IE
MV Y_NGT->C>3%Y_G^6GG;=GF;1NVYSC/IGM38;6WMVD:""*)I6W2%$"ESZG'
M4T >7^&(;C2]"\!OI%Y=-+<2?9]1LY)2R$>6[3,4/",DB]1@Y.#G->H733):
M3/;H'F6-C&IZ,V.!^=)':6T4\D\=O$DTGWY%0!F^IZFIJ /+=-NI[C0?!6KV
M-S*^LW5['#J(+G=*"&^TK(O^P02,CY=H Q6YX'M+2'7_ !@\*@.FK&,88G"^
M1"<=?7-=?'96D-S)<Q6L*7$GWY5C 9OJ>IHALK6VD:2"VAB=OO,D84GZD4 <
MK\4H8I?AWJ9E4%8_*?D\#$B\_EFL;4['3=2\;ZC"LI:U3PTC)Y%PRCB:7!W*
M<G!]\?I7I$D:2QM'(BNC##*PR"/0BJYTVQ+%C96Y8KM),2Y*XQCITQ0!Y=:Z
MT-0MM LM?U:"TMKWPY;S0W%X2%DN"")6#[U D V$9R1DXQS7I6@(T>@6"->R
MWQ6%5%U*N&F '#GZCGWJ=]-L)8$@DLK9X8VW)&T2E5/J!C@U:H X'6P'^+^D
MH-0>R;^Q;@^9'Y>3^]CX^=6'Z=JYNRU"'3(/&\%Q>375L-1M0=:MY!&]S)(5
M!C=_N*$X1BH "D\ UZQ-IMA<2F6:RMI9#U9XE8G\2*E-K;M;&V:"(P$8,10;
M2/3'2@#RZUNYKF7Q/I5CJ^G12IJ=JUI TA:V;,4;-#P<A&;*G'!)/'.*E?4'
MFT[0";>YTRXB\3K:W%M]J+Q[OF+*I& Z=, CCIQBO2&T^R='1[.W9' #*8E(
M8 8&>.<"@Z=8F*.(V=N8XO\ 5H8EPGT&.* ."TG4--U:_NTU75);7Q!9:XZI
M!'-LF9 Y$4:H>L31E<X&#\QSU->C5#]CMOM?VO[/#]IV[/.V#?M]-W7%3=:
M/,-$T&/Q._CC3)]0FBL9M=D6XB@VAI%$<61N() .,''IVJ;6[FTT?Q/XGD:6
MXMK>V\,0#=9D"6-1). 4ST(XP3TKT*"RM+5F:WM886;J8XPI/Y4&RM&F>8VL
M)E<;6<QC<PZ8)[T >27VH)%!XUM;?488HQX>CNH(K*\8A)0LV65@1EOE3<0!
MGC(]>ET.-;'X@64$%Q.T=YH'VB=9)V<22+)& ^"3@X9AQV^E=G_9MCY?E_8K
M;8$";?*7&T'('3IGG%.2PLXI5ECM($D085UC *CT!Q0 7Y"Z==,Q  B<DGMP
M:\\\-ZWINF_!#3#=31R,^F>3';*=TD[E2!&JCDDDXQ7I$L4<\;1RQK)&W57&
M0?PJ*#3[*U??;VEO$_3='&%/Z"@#S3PG8W5A=Z%X6\1@B"/P^KPQ.Y"M/YA\
MP9!Y9$V >@R14.BZW*LGA^S\57I_LF>"]6WN+J3:ERZ3 0F1CP3Y62,]<YY.
M*]2NK.UO8Q'=VT-PBG<%EC#@'UP:6XL[:\A$-S;0SQ @A)4#+D=.#0!P$$UC
MI7B?PQ&-6GFTR73+V,7-[<9%QM>+:6;@-\I;![KS6-H-P-2M/ B/J%S();_4
M()E6[<%U"SD*V#U V]>0*]8FM+:X\OSK>*7RF#Q[T#;&'0C/0TS^S[+]W_H=
MO^ZYC_=+\G.>...: /*'C%GX;U&]AO+H3:7XG6VLV-TY$,1N8U*8)P1M=ASG
MCZ"M"2]BU76=6M;_ %^/3-7LM5'V:/:?M!B!4QK&"X#*Z\$!3DL<\UZ+_96G
M;"GV"UVD[BODK@GUZ5(;*T:YCN3:PFXC7:DIC&Y1Z ]0* /)]27R='\6ZFM[
M=_:M.\11"V<W<A$0)MP1@M@@AF&#V.*Z'2)](TCQ_P"-+J\N+>U*&VE+RR[<
M(806;D],]Z[,Z7IY# V-L0QW,#"O)]3Q[FEN-/MKB&5##$IDC\IF\I2=GIR"
M"/8Y'M0!/#-'<0QS0R+)%(H='0Y5E(R"#W%>6?$+5H(G\2FWOFBO["UMG0S3
M[3"V2P^SJ,')'WFSV P><>H6=K#8V4%G;IL@@C6*-?15& /R%)+96L\C22VT
M,CLGELSQ@DI_=)]/:@#S37(H-0U3QY)]NN7BM]&M[JV\N\<*C[)R'7#8_A4C
MM5R]O;K1)?#_ (K"SWD5]8I9W4*L6!F= T,@7H"SCRR?]M?2N];3K%V=FLK<
MLXPY,2Y8>_'/05G/HMU)K$4CWT0TB#:\.GQVP7$BYP2^>1D[@,#D YXY +FC
MV!TO2;:S:0R21H/,D))WOU8\^ISQVKD_%0>3XG>"XX;GR)3!J&&VAC]R+L?H
M:[JH)+&TEG$\EK \PQB1HP6&/>@#A+[2M)\*MI>GM=S23:GJ4]W/)=S+'#<R
MF-BYF(7&!P50 9*KZ$US^DW U72O!5M/JD\H?5KZTG\J[==\:BXVJ<-GH$QG
MG&,&O7IK>"Y"B>&.4(P=0ZAL,.A&>]1'3K%F5C9VY*L6!,2\,3DGIUSS0!Y[
M8Z=IFF>+?%]G'(T,B:;:B FY<2D"*4%@Q;<2 HYSVJKH^L6K0>$;'Q#>"+3+
MOPW')')<3;(Y;G";MS$\N%Y&?4GK7I\EI;2NSR6\3LR;&9D!)7K@^WM4;Z;8
MRVZ6\EE;/ C;EC:)2JGU QC- '%(L</BSP=:V^IWUU:R:=>)YD]PQ:=5$>US
MC )P20P&2#FN<T2WE/AWP?K5EJ%[+J\FK"VEW7;R"6#S7$J,I)& @+9QD%<U
MZW+:022"?R(3<(,1R/&"5].>M8WA+PQ'X:T:"TD-M<746\&ZCM_+9U9BV#R3
MQG'7L* .&TW6;27Q-X:N;74B(;R^OH9C/<YN)AMD*B4# 4!E 1<$@!>0<BHM
M*!@T?PUJBWMVUVWB6:S,DET[[HC/.I0@G!! '7G@5ZL+"S#%A:0 ES(2(QRY
M&"W3KCO3/[+T\*%^P6NU3N \E< ^O2@#B?!MYHFA?\)/)=7EK9[-;G5S-,%V
MJ2NW.3W)Z]\UZ#5#4='LM3L[FUG@C\NYP)\(N9 /4D=??J.V*O@   < 4 >>
M7-Q<VGC%9ITCU#3KK5%MX[FWF*7%E*4V^5(G\4?&[C&,[L=ZY^UM93X7L]7L
MM1OI-<@\0/;0!KR1]Z&\96B92V"/+)8Y&<#.<"O6OL%JMRUTEK;BZ((\[RQN
M_/K6/X6\,)X>LWCF:VN;DSS2BY2WV-B21I"N22< L1UH XF\O;R[\(Z]J*S2
MQ^*;'5WC@4.0Z-YP$,07NCQE1CHVXGKS4?B?4ELK#XCV[WQ@GB:"6TC\\JR$
MV\9)C&<@;MYX]_>O5#96C7BW;6L)N5&T3&,;P/3=UI);"SGF:::T@DE9/++O
M&"2N<[<GMGM0!P6L7LUOXD;41Y.J:2;NSC9K><K<V#MY>S:.DD3EE) P3N/7
M%9?]MVO_  D6C7MKJ6P2>(+FVG-Q<#SW3;,"CJ,!8PRJ%4Y.-IX/7U$V%F;H
M71M(#<+TE,8WCC'7KTH%C:"0R"U@WLXD+>6,EQT;/K[T <UX&8&?Q5@@XUZ<
M''^Y'4OC2]M;6/1X+J5T%S?JB*THBAD(1VVS,0?DXSCJ2%'K7106EM;%S!;Q
M1%SEC&@7=]<=:=/;P74?EW$,<J9#;9%##(Z'!H \DM[\7/A6PA:]CN/LWC%(
M4(DW!8Q=G8!DDA<=.3Q4E[=1Z'<>/[FS?RKN/4+9Y-A)D6V9+?SG"@@XVESD
M8/H17J3Z?92@B2SMW!<N0T2G+'J>G7WJ46\(E>40QB1U"LVT98#H">XH \H\
M0?8X_"?B*_TCQ*MQ#)';2>7I\A2&W;S -P(=L%@>5Z'&2*VM1T.RM?'?A_38
MI[X6EY!?RSPM?S,)&_='NWNW3U/:NV72]/2V^S)8VRP;M_E"%0N[UQC&:>UA
M9LZ.UI 6C7:A,8RH]!Z"@#R_1M3M9-$\-V%_?,[M/J21B[N,0-'%,R R$\NR
MJ5VKD=SD8S570;JTU ?#F^U&[2>017D,D\LW.Y4^522>O3KR:]973K% @6RM
MU"/YB 1*-K?WAQP?>G"SM0D:"VA"QMO0!!A6]1Z'D\^] 'FWAZ]BUJ\L;BYU
M^.UUZUU*1+FR13]HD^=@8F4OS'MP00N %!&,&O3W4.C(<@,,'!(/YCD5"MG:
MK=M=K;0BY9=K3!!O(]"W7%3/NV-L(#8X)&1F@#Q[1;>4^'/"&LV6H7LNKR:L
M+:3==O()8/.<2HRDD8" MG&1C.:L:=K-G-XF\-W%MJ/[B\O[Z&?[1< SS+ME
MP)0,!0&4!%P< +R#D5W7A+PQ'X:T>&TD-M<74>\&ZCM_+9U9BV#R3QG'7L*V
M!8VBL72U@5RYEW",9WXQN^OO0!PFE6]Q;Z[<^#)OM#PPW@U..Y=V):T)+!"Y
M.21*/+P3R@JEI%[%K.HQ/>:_'9:]9ZQ(DMHBD7#J)& B(+_-$8RIR%P -W4$
MUW.B:5>V/FW&J:BNH:A*JH\Z0"%0BY*J$!..68DYY)^@K0^QVHNS=_9H?M)7
M:9M@WX]-W7% 'FWAJ]BUJYTV[N=?CMM>M[Z1+NQC4BXD.Y@T3J7.8P.0=N%"
M@C'->E7CS1V4[VR!YUC8QH>C-C@?G2+9VJ7;W:VT*W+KM:8( [#T+=2*GH \
MNTZYFN-"\$:M87,SZO=W<<&I9D.Z8%6^TK(O^P02/[N !BM?X>Z?!+%>ZF]Q
M=3W4.HWUJC2W<CA8Q.V%VEL'A1R>?>NRCL;2*XEN([6!)Y>))%C 9_J>IIUO
M:6UJK+;V\4(8Y(C0+G\J ,CQ>EQ+H)BM+VWM+EYXA$USGRI&W@B)\<[7QM./
M[W?I7"277VUM @N(KS2)/^$ADLKRVCOF\LDV[DJC*1E"=N.A4D@8Q7JD]O#<
MQ&*XACEC/5)%# _@:P=;\+KJD^B^0UK!::;=&X-NUON67*.A7 ( &')Z'F@#
MAC-=Z%>76FQW-P?#"^(H+=II)F;RHWAW/'O)SY8F*J>>Y!ZFG^)&NM.@\7Q6
MD\J:79RZ?- RR$"VE:1?.5#GY5V;6*]!O/K7J0M+9;7[*+>(6^W;Y00;,>F.
MF*2.RM8K3[)';0I;$%?)6,!,'J-O2@#SN^U&*[\3^++6QUV"V$EA8F&5I2T2
MR&213P#P#\BL1T!J$:Q%#!_9VJV3:9>C6HH98([L?8I7,&X#>1Q$54-LQG=@
M=S7I"Z=9+$8EL[<1E0A01+@J.@QCH/2@:=8BU%J+*W%N&W"(1+L!ZYQC&: /
M*8+];CPK;0M>QW'V7QC'"FV3(6,7?R 9)(7'3GI7K]5GT^RE!$EG;N"Y<AH@
M<L>IZ=?>K.,# H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "JFJ1K)I-VC9P86Y5B"..Q'(JW5>^BEN+">&%D622,HK."0,
MC&3B@#QR'6GMOAKX9O;.\U6#7)VMA]MN7G6V)+#>9G?]VRE=P[DG&*]"UOQK
M;Z3+?)#;?:SIY07,:2@2Y8!L1I@[R%8$C(Z\$G(&6? >I7/@*U\'76JVHT^.
M*.&::*V;S9(U(.%RV%)P.<'Z5H/X8UBP\0W=[H6KV]M9:@(_M=O<6YE9'1 @
M>([AABJJ/FR,C//2@"'4?'S63:XT6B7,\.C1QS7$GFHF8F3?N4'DG;SCV.<<
M9M:QXVMM--V+:W%XUG$DL\:RA9&##<%C7!WMMYQQU&"3TK:AX.O;Q?%:+?0J
MFNVR6ZED8M"%C,>3S\Q(.>U*/#&NV.M/J&CZO:0+>0117T-Q;-*N^-=HDCPP
MPVW P<C@=: *6I2R^(?'$>DW%F)])DT<W"QF8QL"\BCS ,9#@# Y!&3R,FK7
MAO7["'0=.MM,L)XYKR[NH(+:XN2[;HY'\QWD.XXRI/?E@!6HFA7<?C%-;6ZB
M>%=.%CY3J=Y^??O+=,]L8_&L./P+J=KING-9:K;Q:MIM]<W=O,T!:)UG9F>-
MUW9Q\^,@YX!H NWVNQSC0FU/0[R&:75_LT:M+M$4RAP),@@NA 8CC!R,@59D
M\8"WUFSL;C3Y(8[R]DLH6D?;(S*K'?Y9'^K.Q@&!/;CFDU#P]JFI1Z,]SJ-N
M]S9:@M_,PA*HY"LNQ%W$J,-U)/3WK,_X0C5OM<$IU>T<6^LMJ:2/:L99%8.-
MCMOYVB3:N   H^E $Z^.+^>TU*[M/#%U-;Z=)<13-]IC#%X3@A5R22><8XXQ
M6Y9:ZNH3Z<MM$DL5Y9_;#*DF1&IV[>W.[=QT^ZWI6=IL$?@O2-7O-9OH1:37
M\MXTJ1L!'YK_ '2.2<$@9_04G@;1(=)TRYFA,OD75P[VJ2C!BMM[&- #R%^9
MF /(WX[4 7]>\0'0Y]+B%A-=-J%U]E0QNJA6V,PSD^BFL.3Q_-;V%]=W&A3H
MFF7HM+_%PA$62F&3N_$BG&!6UX@T6XU>[T::">*(:=?"\8.I/F81TVC!X^^3
MGGI6+?>"K^\TGQ+8B^MD.M7JW0?RF/D@",;<9^;_ %0YXZF@#0U?Q>-'O2EQ
MI\BVJWD%GYTC[&D:7: T:D?.JEU!((Q\W!Q3O^$L\NYU^VGL3%/I$:RA#+DW
M","49..Y!7_>!%9.J^"=7U&;5&&K6@6\N[:[C:6V9WB,31MY6[>/W>4)  '+
M&I)K?3O$GCFRGL[F22?21)#J12,JCE65HXVR.2) '&"?NGUY .O>Y%O8M=7>
MV%8XS)+\VX( ,GGOBN=L/%L.KZE:Z<UFXAU"V:6&:&;?M  )67:!Y;$'(P2.
M#SD5T5Y:17]C<6<X)AGC:)P#C*L,']#7/>'-$\1:1;165]K5M>VEG'Y=KMMC
M')( ,+YK;B#@>@&3SF@#$\&^(TL/ 7AFV=XYK^ZLFF7[3/Y:E4(#%G()SEE
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ML+JT1Y;.SC8R99D.V4;@ ><9Y''4<CN ;=OXOBU95_L*U-^_V&*^=6D\K"2
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MEXSQRY&?;I5P^$I+CQ1::U</:I=6EQ+(MU;QE)IH6#!89.Q5=R\G/W!@#)-
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MZUU:@A0&.6 Y.,9H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH"54@AL9R.AS[56U+QI/H\FK6MYIB?;;'36U.)(KG*3PKD/AB@*L".F.X_
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M%/#&I:WI5M=/?:I$L;).1Y+L[;7 *_P\@#)[<T >BTT1H  $4 #&,=JY2_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGOCN(2=VUH]_!!Y!#>M=Y10!ST7ANYC\2V&L/J?G&ULY;5TD@^:7S'5V;<&
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M<,)08U\L2^K[\XW<\-Z55\.WNG3O\.(_E>2UL)[6[S&?W3"!5,;G'&#G(/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9ED24JOG#&=JAFQAASM/(XK:\.:,/#OAZRT=;@W$=G$(HY&7:2HZ9QWK"O\
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M;!S\YVKGH.,8&3EJ:,_AN]F\27>HW^H2)81VDL%O:*2ZHS%2J(,\;SP/Y<4
M+%XTBET>TU=%C>R_LR34KQESNB50,*!_>)WC!_N-4$GC.]T\7%UJ.DR_V?'8
MM=_:(HI%".,?N3O4;B<\,...@JQX>\,6(T?5UFLY8H-:EF>2VFR&CA?/R8_A
M!W.^WL9"*2R\$N-&N-'U?7+W5=/>W:UBBF1$,<9&.649=@. Q_*@"YI.M:G=
M:Y+8W>FNMM]G$T=XD4B(&W8,1#J"3R"".",\#%/N]:N)/$+Z%IJ0&[BM!=RO
M.3L4,Q5%P.<DJV3V '!S1X?T*_TE0+_7KO5?+3RH3/&B;$XZ[1\[<#YCZ=LG
M*WOAXR^(HM>L;O[+?"V-K+NC\R.:+=N *Y!RIR00>YSF@#GX?'FHZHNB)I6D
MV_VC4UND9+JY*B":#AE.%.5R.HZ^@[=S"93!&9U19BHWJC94-CD X&1FN;MO
M!D%C>Z)/:7;HFE>>0C(&,[3<R,QXY)R> ,$^G%=/0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !16?>:Q;VFIV>F@-+>W>YDA3&51<;G;T49 ]R0!5YRP1BJ[F X7
M.,F@!U%4-)U>UUFT>>U+ Q2M!-$XP\4BG#(P]1^1X(R"#5^@ HHHH **** .
M;G^('A"VN)()_$NEQRQ,4=&N5!5@<$'GKFF?\+'\%_\ 0T:3_P"!2_XUA_#7
M2M.N]$U26YL+6:0ZS>C?)"K''FGN179_V#H__0)L?_ =/\* )=-U.QUBQ2]T
MV[AN[60D)-"X96P<'!'N#5NN'^$BA? $*J  +R[  [?OWKN* "BBB@ HHI&)
M"$J,D#@9QF@!:*YKP;XR@\:65S>V=C<V]K!.T DF*_O&7&=NTG(YZUTM !16
M3XFUZ#PQX>O-9NHGE@M5#R+&0&(R!QD@9R16+IOQ#L+[6;'2;G3[VQN[^Q%_
M:B?85DCP3C*L=K8!X..G6@#L**PO"/B:'Q?X>BUJVM)K:WF=UB68C<RJQ7=Q
M[@_E6[0 445SGC#Q?;>#K"TN[FTN+H75RMK'';E=YD8$CAB,]#0!T=%<[H7C
M&SUS7=5T3[-<VFI:85\^&;:0589#*RD@C!'H>:Z*@ HKFO$7C2PT#2HKZ.)]
M0$UZMA&ELR\S$D;<D]B"#C.,'TKI: "BL3Q#XJTWPV+6.Z,LUY>2>5:6=NN^
M:=O11D#'/)) 'K2VVMWCZQ;Z;=Z-<6SW$+SK,)4DC54*@JQ!R&RZ\8(Z\\4
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M(UE-(M+5KJ^-N;IT\Q45(]VT$D]R<@ #L<XJSI.H_P!JZ>+K[+/:GS)(VAG
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M8Z4 >'QZ5;VU_P""?#=I-MM=(L)-=U*9&+?.%VAUSD9WAB.W(//?M/@T9I_
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ME+@F4B%D15 Y&=^3G&,8&<YH U_"VOO'H4TFJ7<UU<-J]W96^0#)*5F<*H
M'"K[  $G %:$_C72;:RGN9A<K]FN5M+F(Q?/!(Q 4..P.Y<-]WD<USEKX4UN
MVAL;Y(8Q>Z?K=U?K;F4;9H9S("H/0.%DXSQD=><UJ-H%F[^)KW7VAM;?7A'
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M3)($22X,8BN#GYV !WC!7 [$'IG- &E<^,M*M[M;1%O+F=[,7L:6UJ[[XB0
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M=K>U_P!7'D] <#)]3@9.:YB[T#5S>>+K>&VADAUX*(;@RC;"/(6)MZ]3C!(
MSGH2.M &WJ?BO3-+@FN)FEEMK=$DN9X$WI C<AF([8YXR0.3P169;:TUMXV\
M0?;-2/\ 9-KIEK=KO*^7"&,VY@0.A" \YK+3PIJ>B:Y<+8Z1IFKZ;>0P()+U
MPKVKQQ+%DY4[U*HIP,'.?K4FM>#;_6KWQ)!E(+;4M*M[."X!'RR1,[9*CHI+
MCIZ&@#HQXIL?M+VTD-W#<BV-W'!)#AYHAU9!W(R,KPPR,CFFVGBW3+Z;2(X/
M//\ :\!N+-RF%=  3DYX(!!P>>?8U3ATO4M6\0Z)K&IVJ6<FEV\RLBRA_-EE
M"J=N/X %)YP22.!BL&3P#JL-J_V&\BBN-.U+SM$8]((7;=*K>N1(ZX]$6@#O
M;"^CU&V-Q$DBIO9!O7!)5BI(]L@X/?KTJU6'>>%-.O8K.)YM0B2TB$42VU_-
M -HZ9", QXZFMR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *@O+N.QLI[N8.8X4+L$4LV ,G '6IZHZS_R ]0_Z]I/_030
M!#9:Y!?V^DW%M;W3P:G#YT4@BRL:E X\P_PY!P/>K]U:V][:RVMW!'/;RJ5D
MBE4,K@]00>"*\]T&[NX(?AG!%=RI;7.F%9H 1L?;:J5)XSP?>JZ:E?F"_P!.
MUEKZ*]FTJZE@NH+IGMKY1M82QD',3 8^4 <-WXH ])M([:&SACLDB2U5 (EA
M "!<<;<<8QZ5*S!$+$$@#. ,G\J\TTB\E6V\)^'X[EXH;O0UN%+WDD32RA8Q
MM5QD_*I)VC Y]JNZ3>ZA<^(=/\,ZKK#7)ATN2X>ZM6,)NI1,8^JX/R*O('!+
M9/:@#K]$UFUU_28=3LA(+>4N%\Q=K?*Q4Y';E36A7(?#!=GP^TY2Y<K)< L>
MK?OY.33?$IO9_&WA_3(=5O+2TO;:\,R6[*I8H(RI!QD'YCS^6#S0!V-%>7Z+
MK>KG4M+\.ZC?7$UL^JZA:?;BVR2X2!08U+KCDDMDC!/E?6FWFIZW&TVG+JEV
MD5IXGMK&*Y4@O)!($8HQ(.XKOQGOQG- 'J!D02",NN\@L%SR0,9./Q'YUFZ7
M!I]R[:S#I9M+RY!61YK<1SL%) #=\=QGL:Y6PTD67Q.:V;4M1G,>B(RRW%T6
M8DSN.1]T]N,=AG)JAX?U[4+VS\&Z?>WMPR:FU\;BYWE7E:)FV)N&",C)XP?D
MQTR* /3:*\NN-3UM&_L\:K=I%:^*(;".Y4J7E@=%?8Q(.XKNQGOCG/-6X[G7
M(QXBTO3[N2^DL=6A6"*ZNBDLT30I*\*R]0>6P?PS0!Z-16!X/U*/4]#:1/MR
MR17$L4L-]S+"X8DQDY.=N0 <G(Q5;6=0F?QOHV@O++!975K<3LT3F-II$* (
M&&",!F8X/.!VSD WM0U"VTNS:ZNGVQAE08&2S,P55'N6( ^M1Z9J:ZG'.PM;
MJV>"8PR1W,>Q@P .0>0P((P02*\UU26]U'PK+;ZC<W$O]G^*8+*"X\PJTT0N
M8L%MN 6&2N?5<]:]5BC$421J6(4  NQ8GZD\F@"C9:W:7^KZCID(E%QI_E^=
MO0JOS@E=I/7@&K!O -3%C]GN,F$S>?Y?[H<@;=W][G./2O-M?6YCU7XAW]IJ
M%U:3V.GVUS$;=PN72&1EW<<CCIT.3GMC9EU/4G\6%$U$P1R^&WNE63'DQ3;U
M D(QVSWSQ0!W-%<=X.U*ZDU.]TW5;>^L]4AMX7DMYYS/"XRX\Z*0DY#'@CC&
MT<5T^HWT>FZ=<7LH)2%"^U>K'LH]R>![F@!EKJUC>:E?:=;W"O=V)07$8ZQ[
MUW+GZBKM>7"*]\*>+-#UR]LS;IJ6=/U67S597FD8R1OP> )"R@GHK =JV9KR
M;6M9\46#ZU+I4^E-#]F>-\"*,QK(967(#@DLIW9&%['.0#N**X6*_EUVZ\1A
M]:FTRYTF^C2+82!%"$C?<T9(#^9EQ\V?;D51O]9U"[\/^,M7COI[74-$O)DM
M8E<A%2)%90R='$G)R03\W&,"@#TBBO-K_6=12W\>.]U<6SVFDP7=O'YI!MY6
MAD8[3_O*..G&*DEDU'4O$,MHVM:A#;MX<BO L$@3$I9AN! S_"#_ /6XH ]
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M&BM7/1"%+%C] , ^I6H].\86MSX!C\5312^2EJ9[F*)=S1L@/F+C_9*L/PH
MWK6TM[*#R;:)8H\EL*.I)R2?4D\DGK45_IEEJ:1K>VT<WE/YD98?-&W]Y3U!
MY/(KF+CQU(;W2(;30M2,>H77DK),B1[U\EI04W.,YQWQT/? -RV\0:9;7>O2
MM-?E[:\B@EBGY E=$")"OHVY>/5B: -6?0=)NK*&RGT^W>UA</'"4&U6!R&
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MMA ]RVW?(5Y?;RN[^]CMG..U1ZCK$,%W_9L<-S<WCP-,8K7;O2/.-Q+$ 9/
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M0#N: !08X0O+LJX[#<<?E7-:=X2MXO$HUV:SLK5X4=+6VM8P A?[\CL -SL
M!TP!GKDFK%AXOLM0FTN)++4HCJ0E$;3VK(L;Q[MT<A_A?Y'X_P!DUT% '/\
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MMJ%@)'9T8Q1+&4E&T8# 'IG&?:K>HZ)XAUC2;,36VE6MS%J-K=-;PS-L5(9
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MT9G: .IE50Y3/(4D@''IP?RJ&]NWLXXG2TN+DO*D96  E QQO.2/E'4]\=J
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M_&@#DK[P9J]U>:I>QR6<=P=9M]5L096*L8HUC*2?+\H8*W(SC(]*EUWP=?\
MB"#Q!=N;>VO]1TZ.QMXO,+(@1F?+MCJ6;' . !USBN@G\1PQZD]E!97MX8;B
M.WN9+9%9;=W 8;AG=@!E)(!P&&>^-J@"&U:X:UC:[CBCN",ND3EU4^@8@$_7
M ^E%Y;+>V5Q:NS*DT;1L5Z@$8X_.IJ* //;#PSXGAM?"MC<QZ8\6@7(_TA;A
MP9X5A>)3LV?*V&&1D\@\U=\+Z!X@T(1Z1,FER:7:NQM[Y2WVAX\DJC(5P".A
M;=T'3/([6B@#@]*\'ZAI]S=W-M#:V'VJPDBNK*WN6-M-<MC$JJ5_=@?-G YW
M=.,G*N+74-(D\):3 ^EC6M*TIDD+WS0%DPD?R.8V#*2C$J5X(!R,<^HU5O=-
ML=15%OK*VNE0Y43Q*X4^V10!Q.DZ7>7Q\,RV6G65E::)=S"6-+UIE<-$R9C?
M9\_,A))P<AA[TL7ACQ);!PG]GR02ZU<7UQ:&Z=5GAD!VJS"/.58@E<$-BN]1
M%C1410J*,!5& !3J //++P;KMAIFD11C36FTS6I[Y$$KHCQ2>=WV':1YH^7!
M'R]>:O:5H'B#2-6O+6)-*FTFYO9+Q+N0M]H@$CEW39M(;YBV"6&,\@XQ7:T4
M >;OX0\20>'YO#UL-.FLH]42^M;F6X='\O[2)RCJ$/(.X;@>>.*]'&<#( /<
M YJGJ>J0:7% TP=WN)E@@B3&Z21LD*,D#H">3T!I=+OSJ5BMRUG=6;[F1H+I
M KJ5)!Z$@CC(()!&#0!<HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *K:C_R#+O\ ZXO_ .@FK-1SP0W4#P7$22Q.,-'(H96'
MH0>M 'C7AU'72?A\_B"57\/K%%)9M$NQ8;X ^7YQ.2003M((&[@CI76W5U-J
MNM>,;.ZOKJR;3((FLC#.T7EH8B_G<$!OGW YR,+CUSUPT;2AIITX:;9BQ;K;
M"!?*/.?NXQU [4DVB:3<-"TVF64C0KLB+P*2B^@XX'M0!P?AN6;4/&^DZCJI
MDAO[CPS#-*GG,@\PR 'Y<X[_ '<8R>F:S_!@FL-/^'4T%[=XOUF@N(6G8Q,@
MAD=0(\[00RCD#/J37J-QIMA=W$=Q<V5M-/&K(DDD2LR*W# $C(![^M0QZ%H\
M(MQ'I5B@MB6@VVZ#RB>I7CY?PH QO%^K'3K_ ,/6\]PUKIU[?&&ZG5S'C]TY
M1-XP5#.%Y!'3'>LB>Z-AK.A:/%K%W=:7>ZC=+-.TYRC"/?';B4')&2>^?EVY
MZBNXO;&TU*T>TOK6&ZMI.'AGC#HWU!X-1-H^F-IR:<VG6AL4QLMC"OEK@Y&%
MQ@8- 'F^H76JP27>GIJ5\MI:>)K*VMK@3MO,<OEM)$6.=X4N1\V?0]*K^)$:
M/1?&NF/>7DMI8W]A) )[N1VC\SRBPWEMQ7))P20,UZ>^C:7+;16TFFV;P0OO
MCB:!2J-G.0,8!SWH;1=*;[5NTRR/VL8N<P+^^'H_'S?C0!R0L3??$>ZT\:MJ
M:V4&F6MRD45])CS!-*"2<Y((0 CH>_.*P+AY[S2+>&XOKE]GC5K=)7E+.B+*
MRJ QSC X%>G0:1IMM<BYM].M(K@1B(2QPJK!!T7(&<>U1_V%I'V2:T_LJQ^S
M3/OEA^SIL=O5AC!/N: /-]7DU'0X?$]K:ZMJ+V-C=Z;);S37;N\+22J)HS(3
MEEVE3AB<!Z7QG<FZ@^(]D;V:2"#2K:6.$7#%8W(EW8&>,X7(Z'C(KTS^R]/_
M +/?3_L-M]BD!#V_E+Y; ]<KC!S44&A:1;1O'!I5C$CQ>0ZI;H T?]PX'*\G
MCIS0!RUY<SV'C#1(M.N;F>%M)O9/LYN7D261#%MSDG)RS#/OBLRQU&^FT'P3
MK=I?W4][J5U%#?QM,S)*'1C,-A.%*%21@#&TBN^BT;2X);>6'3;..2V3RX'2
M!08E_NJ<?*/84Z#2--MKJ2ZM]/M(KB0DO+'"JLQ/7) R<]Z /,[.:]AT_3=2
M_M;4I+A?%4EAB2[=D: W+Q[&7.&XQ@D$C P16U8W]]:^,(+?4_M$]M>7UREE
M?VMVS1/@2'R)8B<(4"D!@""4[$FNM_X1_11$L7]D6'EK)YP3[,F _P#>QC[W
MOUJ6#2=-MKIKJWT^UBN'9F:6.%58EOO$D#.3W/>@"6.RMHO*\N!%\D$1X'W<
M]<?6N<\07,UMXV\)HES-%!<2W,<R"4JDF(&905S@G(R._%=556_TRPU6!8-1
ML;:\B5PZI<1+(H8=" 0>?>@#S&+4+N[L=/$>L7NUO%\]EOCNV):WW2[4)R<C
M"KC/X5(^LW6D+?:8=0NQ8#Q1%8-<37#O)!;O"DA7S&)8 N=N2<@/P1Q7HAT'
M1R03I-B2)C.";=.)"<E^GWCZ]:5M#TEHKJ)M+LC'=G-RAMTQ,?\ ;&/F_&@#
MS6_OO^$<UKQE):W<D<0N=+2>:25I#;PN=LC9)W  $]^,\8P*LZ^EUI^@:Q<6
M7BN6X5[FP>%+:5S]EWS*C8D9V+*X).TG ].:] MM!T>SCECM=*L8$E3RY%CM
MT4.G3:0!R/:F1^'-#BT[^SX]&T]++?YGV9;5!'N_O;<8S[T 36&F1Z?8O:+<
M7<R,SMON+AY)!N). Y.0!GCGBO*=,MH3X&\&11W$RO)X@ <B=F9?FN!QDG;T
M/3'KUKV)55%"J J@8  P *S_ .P-&X_XE%AQ,9Q_HR?ZT]7Z?>]^M 'GCZS=
M:-#J5B^I3II\7B5+)KJZG>1K>!X%DP9"VX+YA"Y+<!NM=GX6MI+3^T8CK@U2
M$W&^,#<WV8%03'O9V+>N"<@,.V*T_P"Q=*,5U%_9EEY=WS<KY"XF_P!\8^;\
M:FL;"STRT2TL+2"UMD^[#!&$1?H!Q0!P@L[S4/B9XMM+2]CM#+IEG&\C0^8P
M!\T97Y@ ?J#]*?\ V59>&/%7@S3+5G6TL=,OT5G.6P!"2Q]^IKM8M*TZ&^DO
MHK"UCO)/OW"0J)&^K8R:=+IUE/>17DMG;R740(CG>)2Z ]0&QD4 ><:!J<LW
MB#P^BZI=2V>J:3<2L\UX3).0T6R1DSMB8[FP%/ X[8$7A6YOEC^'U_)JFH3S
M:HLT5V)[IW251!(X^0G;D,@^8#/J37H4/AW0[?9Y.C:?'L+E=EJ@VEQAR,#C
M<.#ZT^/0M'B%N(]*L4^S$M!MMT'E$]2O'R_A0!:MKNWO8?.M;B*>+)7?$X9<
M@X(R/0\5Y/>6UQ'HOC76+#4[^VU&QUJ5[1()V5'DVQ81HQP^\D+A@>O&*].T
M?1[31;62"SABB665IG6*,1IN.,X4< <#^9R233_['TPWYOSIUI]L)!-QY*^9
MD<#YL9H X&XOKK6;_7H9?$B:+J.FWJ>4F7)CC"HRD1B15D5\L.5.<X[#'3^.
MM6FT7PP]Y'(T,?VFWCN)TZPPM*JR./0A2>>W7M6M/HVEW6HPZC<:;9RWT'$5
MS) K21_[K$9'X5;EBCGA>&:-)(G4JZ.H*L#U!!ZB@#@->ODT2UEETW6[F>SN
M]0L8[G-P918P.^UV60DE=P'KQG(QFL_Q?<:EI(\7V=A?WJV46AK?1R?:7+VU
MQN=<*Y.X!@F<9[<=:]$MM%TJRTY].M=-LX+)\[[:*!5C;/7*@8.:0:)I*V+V
M(TRR%I(<O!Y"[&^JXP>@H XJZ^VV'B75;"TUJYA%SX?-R)KRX>1(9]Y02 $_
M(.1D+@<=.*S-7U;4(_!WBJ&=-1TG6;"*"1U2_>6/#,0KQ2$YVMALJ<8QS7I#
M:'I#N7?2K%G:+R"QMT),?]SI]WVZ4'0](-G)9G2[(VTA!>$VZ;&(Z$KC!Q0!
MQ>LWO]K:GXVTV]NIX%T[3D-K%'.T64:%F:7 (W?-\O.0-N.YSF:=?/J-OI^A
M3:TNEQ_\(Y9S6;^:\99BK!W4JZ9*[4X.?U->BW>@Z/?R0R7FDV-Q) FR)I;=
M&,:^BDC@>PI+CP]HEW!;07.CZ?-#:G,$<ELC+%_N@C"_A0!QME:W.I>-8;&Y
MU_49X4T.UNR]O.\"S2B5P9-@/ 8*,KT.:K>'M0NM8MM+UP>(@FH)-*MWI@WL
MTK_,&@,9DPI4C((7( ST)KT,:;8K?F_%E;"\*[#<")?,*^F[&<>U1PZ-I=OJ
M4NI0Z;9QW\HQ)=) HE<>[ 9- 'F<%W'JVD?#_79[^6:]NM61K@-.VP2&*7<H
M0G:NT_*,#C\37IVHZ5I^KQ11:A9PW20RK/&LJ[@DB]&'N*@'AO0ENFNAHNG"
MX:7SFE%JF\R<_,3C.[D\]>:TZ .)\1K9^']2TF"SB33[;7-6QJ-S ?+:1O+9
ME!88(+LJC(YZ^M<U-J \/ZGXI6"]:&V?7K*&YNI96<PQ/!'DEMVX#=A,Y& >
MHQ7J=[8VFI6CVE]:P75L_P!^*>,.C?4'@U7BT'1X()X(=*L8X;A0DT:6Z!9%
M P PQR, #F@#C)K;5K:WN(M*\00ZJSW\<L5B\\D8*^4Q>W6?>S G;Y@!/&,'
MY34=KJTEU/X,EMIM3MEDU2[MKJVNKAF8%8YRT;G)#A67 ))X KMD\/Z-%816
M$>DV*6<3^9' MN@C1_[P7& >3S[U(='TQOLV=.M#]E.8,P+^Z/JO'R_A0!P"
M-JNKWS6T>HW'VV+7W6:6"]*1&S5CE  W4+A< 9W@GU-4M6EO8=-\8ZBFK:D)
MM+UF+[(!>.$C!6 E2N<,IWL-K9'/ '-;:?#YKB69-3M= NC)(\AU+^S\7AW,
M6SNSPXSPP/&!QVKK7T#1I$G232;!TN'#S*ULA$C#H6XY/N: ."\3:S+%?W]W
M8ZG<[K36K&U;?<F-8]S1!XDB'#J5=B6;'4XSMXK7E\-#N/'^I6ES*DJ7MKE_
M.=]D3QP^9(%W<[59B#V XP*]%E\/:+/+++-H^GR23*J2,]LA+JN"H)(Y P,#
MM@58_LVP^U377V*V^T31B*67REWR(/X6.,D>QH \ZUC4+C0-/OKZR\3K=V5V
M]FLBQ,\@LHWE"/,LC.Y7<I.!TR,CH:V-(M[>T^+&J1P3R2*^C6S@2SM*1^]E
MZ%B3CH?QSWKI[30M(L+&6QL]+LK>TFSYL$5NB1OG@[E P<^]%CH6D:7()-/T
MJRM'">6&@MT0A<D[<@=,DG'O0!RGC-;I_'W@M+*:*&Z/V_RWFC+J#Y'=003^
M=8NF:C/HWP_\6W]LDH\6P-)+JB289EGQ@.H  \O9\R<8P.YS7I5QI6G75W%=
MW%A:S7,/^KFDA5G3Z,1D4ITVQ-\;XV5L;PIL-P8E\S;Z;L9Q[4 <9>^9!X@T
MBWTV]N[K3=5TRY:Z5[J23Y41"DRL3E22^W((SN'I7/:':P3Z/\+H$N)QYJN9
M&2X;<I-D^0#G*?1<8SQ@\UZE9:5IVF[OL%A:VN[AO(A5,_7 ]S44>@:-#Y/E
M:18)Y#%XMML@\MCU*\<$^HH QO <\[Z7J=M-<SW"V6JW=K"\\AD<1K(=H+-D
MM@'&2<UDV&H1:S=ZJ][KES8:CIVM&)88YRO[I6 C3RLX82*>N"26XZ#';VFG
MV6GK(ME9V]L)&+N(8E3<QZDX')]ZC;1]+?5%U1].M&U!%VK=&!3*!Z!\9Q^-
M 'G5YJVIW/@[7M<AN[J/7=.U62**W69@@VS!8X3'G:P9"O49)?/I4/B26]CA
M^(-W'JVI1R:289[)4O'58F\A'(P#@J23\IR.>E>F-I.FM?\ V]M/M3><?Z08
M5\SCI\V,\5')H6D2_:?,TJQ?[40;C=;H?-(Z;N/F_&@#B+F&-/&WC&=;FXAG
M_L:VDB*73J=VVXY W8XQD#MR1WJL8KJR\$^%M536-4DNK^ZTDSF2\=E8,4#
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MQ8S.))2;=#O8=&;CDCU- &5X0N8=5TGSI+6\AN;2[FCDAO9?->"7)W*'R=P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BF&6,2K$742,"50GD@=2!^(_.H_MEKME;[3#B%MDIW
MCY&XX/H>1P?44 3T444 %%%% !114-U=VUE#YUW<16\6<;Y7"+GTR: )J*SH
M]?T:618X]6L'=CA56Y0DGZ9JU9WMKJ%LMS97,-S Q*B6%PZD@D$ CC@@C\*
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MU)H =14-K=V]];1W-I/%/;R#*2Q.&5AZ@C@U-0 4444 %%%% !1110 4444
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MU2XTZ.1SEFC0C9D]R <?A7<5SW@SPV?#.AO;S2))>W=Q)>7DB?=::0Y;'L.
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M@ZX/9VF^*M<U"+3-8CTU&T.[1Y9VPJO;Q;2R.&\P[^@!&T'GCIST%]X?@O\
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M:&YGN3#&$\ZX;=))@8W,<#)/>K% !1110 4444 %%%% !1110 4444 %%%%
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M*8VK:,D"SO P7>)F<KDC@X(/_P!>@#?76M,;45T\7T!NV+!8MXRQ7[P'J1W
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M$[0@/][((Q[5I5Q/AHRZ78Z@+K1[Z7[1X@G>)%M^5224E9B&QA1U)ZCTKMJ
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M 4444 %%%% &;)H5A-KL>L2+*]W'&$0-,YC7&>1'G;N^8C.,\UI444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 445G:GKNG:.\:7TSQM("5VPN^<?[H.
M* -&BN?_ .$VT#_G[F_\!)O_ (BC_A-M _Y^YO\ P$F_^(H Z"BN?_X3;0/^
M?N;_ ,!)O_B*/^$VT#_G[F_\!)O_ (B@#H**Y_\ X3;0/^?N;_P$F_\ B*/^
M$VT#_G[F_P# 2;_XB@#H**Y__A-M _Y^YO\ P$F_^(H_X3;0/^?N;_P$F_\
MB* .@HKG_P#A-M _Y^YO_ 2;_P"(H_X3;0/^?N;_ ,!)O_B* .@HKG_^$VT#
M_G[F_P# 2;_XBGK?:/XJC-G#<W)\ITF/EB6 _*P(^; R,CD4 ;M%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!F:[KEMX>T[[==Q3O#YB1'R5#$,[!5X)'5F _&DTS7K+5;R\
MLHO-BO;(J+BVF3:Z!AE3Z$'G!!(XK!^*#HO@MT:4(S7MGMY&>+B,DC/H 3^%
M9_B_1;?2M%U+6TU.[;4+^YLE>Z$PC(C69 $79@;=K.3USDD]. #T*BO,M:^R
MV&M3Z#=:I=:;936B/I<^9IG:0N[2>6^[)D!*X!SQ@ 8R*['[=JU@\USJBZ?%
MI$$1<S^<WG\#^)-NT'KP&/M0!=BUJPFUVXT5)P;^"!+B2/T1B0/Y<_4>M7Z\
MOU/[9HCZ-XUN#:@?:C]M,3$N\%P57:>S>7B/&.T?UJ+Q 8;W4O&(CU:\6\AM
MK>?2HX+UP?.,1*^6@;#9;:,8(Y]Z /5:*\CU=9[B7Q<C:G>)KMJ;:33H8KQQ
MBX,"'")NPP9\C&" ">F35R[2^DE\<7FG7%W/J^GN&LHH[J1@A:U0/L3=AOF+
MX!! 8< &@#U"BN!BM8=;UJ6UT6_G_L:]T=A/)#.Q\FXW*(G!SE9,%R>YVC-5
M?M^LR>![G5VM[F*^L8H[&:.,,2?*E"W,B $$Y4-M(Y^4X/- 'I%9VEZQ!JTN
MH1PQ31M8W1M91* ,L%5LC!/&'%>?R:G;6UM#J%CK$UWX?N]3@^W21(Z06T?E
MN"%))*J7$6_G R<XR:W_  "UI]H\4+92!X#J[/&58L"I@BP0>ZY! QQQQ0!H
MIXNM9)-15-/U)UTZ8PW3)"'V-M#<*K%F^5@?E!ZUL:?J%IJVGP7]A<)<6LZ[
MXY4.0PKBO#6MZ9I^K^,I+F]A3=JV]$#;GD'D1#Y5'+<@C@'D8KG-.%UX>T[3
M8=>8Z7I&I2W]QMGC<I;R22JT4<FUAL.PN1DX!)[@8 /3]4UJ+3)(H!;W%U=3
M1R21VUN%+NJ ;B-Q XW*.O4BI]-OCJ-BET;.ZM-Y8"&Z0+( "1D@$XSC([X/
M:N%@M;6/QCX2CN+ZXNI$TNZ'VBZ<I+)AH?+9AD8) )YY.#GD5G:;<"Z3PO!-
MJ5TR2:WJ4,O^F."\7^D; QW9(_U>"?48ZT >K57OKM;"PN+QT=T@C:1EC +$
M 9.,D5Y7:ZU]FT_2X-2U IHGVG4K5KF??*BNMQBW5V# @>7NVDG'3O@U8N;J
M.W6ZTG6]2NY;7^PA_9=Q=L8VN9,R!V[9EP(L#[V#GN: /2+34[:ZT:#5=WDV
MLMNMSNE(78A7=EN<# ZUGIXHMGLXKX65_P#8)F017/E#:X<@*VW.\*<CDJ!C
MGI7/7^FW>N_ ]=/TTDW<^C1)&H."Q"+E/J<%?QK?TKQ+HVI:=;K;S1F9D56L
M>/.C.,%&C/*D=\@ 8STH WJ*\S6\OKB!2L\J>*(=>\M[?S"";<SXQMSS%Y!W
M9QC(S]ZJME.L4]A>+J5RTW_"4W-KE[QV!MRTH"D%L%<;,$_[//2@#U.*:*=6
M:*17"L4)4YPP."/J""*RM8\0Q:):7UW=6-XUM9I&[2QJI#[B1A<L,D8&<XZC
MK7G-G':0:9IEBMU/;/\ \)1<PW4<=R\9\LR7!"M@C@C8?Q![@U9\10^1#XUT
MNUFN988-+L1%$\[S%-IDW$;B3G 4G\">M 'JM,FFBMX6EFD6.-1DLQP!7ENN
M1O:P^(;G0K^[FTA;2VN#*EW),J7 FRY1RQ/^J&6 .,$9ZU%XBO;758_%C17+
M7%E'-IEQ$5D8QA?,7S'7MC&22..] 'J:7+/?36QMIE6-$<3L!Y;[B?E7G.1C
MG('45/7F6M:C=VVH>*?[&N+F4)INGR1QQRN[+'YD@F,8SD-Y>#QSG!ZD57\3
MW+1VGB";1=1D_L=M-MY%DM[EMJ7)E(PC ]2F"RCV)'/(!ZK7/7_C&PT[4+^T
MGM;XG3X%N;F2.(.L<3;L/P<D?*W0$C'2J7AMXX/&GB.QM[J22V$5K/&CSM+A
MV#AR"Q)YPF?P]:RYK&/6OB/XET[^T9;:.XTFU@D^SE-S#=-O4%@<$!ATY&[Z
M4 =99^(;*_U==/MO,D+V27T<XP8Y(G.%*G.>WI6M7FFL_8O#^LZE;6WVF*WL
MO"RPQK9OB9%61@-A.<,!@YP<=:R[W4_]$\0Q0:DR0B\TR6V-I/(L85WC$FQL
M_,I ;/8X)QUH ]?HKDO"CI#XC\4:?#<226T%S"\*23M+LW0H7P6).-V>_7-;
MA.LY.%L,=LL_^% $NI:G;Z7!').6+2RK##&@RTDC=%'OUZ\  DX JNGB'33I
M=QJ$LWDQ6TK0SK(/GCD!QL(&<MDC &<Y&,Y%9/BZ"5=1\,:D_P#QZV.I;[H_
MPH'ADC#GV#,O/;.:Y&;3IKC71JMRTB:#<>)6N&='*C:MJ(HY=PZ*95^]_NG/
M0T >ER:BL.FO>S6T\049$3A=[$]  #U)( !QR>U4U\36AU^+2)+>\BEGW_9Y
MI(2(IB@RP5O4#)Y R!D9K"\/M?7<QT^ZN);JSBU*:>UFE;<TEM'MV MU;$K<
M,>HCZFI+NZ74O&.C7VC:LEXL$TMM>6:A'6%-C;GR!N1@RHO)YW8'4Y -J'Q+
MI\]Y' AD\N6X>UAN"H\N69,[D4YSD;7[8.TX)I=0\0P6$DT2VE[=S1D+Y5K%
MYC,2NX@#/& 5))P/F4=3BN!L+66+PWX9T-SMU#3=;:>\4GF...25VD;T5E*X
M/?>/6NKFU^S\.:%#>:A+'#=ZE(TJ),2/F?D!CV"+M4G_ &0!R0* +UMXLTR]
MTRPO;0RS?;Y&BMX FV5G7=O4JV-I78V<D 8^F4F\5V2:=#>6UM?7WFEQY%I
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM9CL[+4GUN\FD7Q0^G&-]FQX#<-%A@%&3C&#VP,=Z /4J*** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@RB,N$W$EAP">?;UJII?B6Q^PV_EOJ%S->7]S;0Q3A/-,B-(77J%"J$;&3T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>exhibit1034b004.jpg
<TEXT>
begin 644 exhibit1034b004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3W;[<TD>V3S+9XUV!6+<F0.VX#!7N: /2=/\0:/JMS+;:?JEI=31#+QPS*Q
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MR$7=UO5HS^[9N%VN-YP</TXK1TKPY<SZQ<7-EIEQX3MFL%MG%N8/,DE$@8,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !5*ZTC3+ZZANKO3K2XN(?]5+- KNG?Y21D?A5VB@ HHHH **** "
MBBB@ ID,,5M D$$2111J%2-%"JH'0 #H*?10 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !111VXH \V^*_B36="LK2]T92T.EW4-UJ6#@M$S%53W!.<^GRGO6]XI2'
MQ-X)C>PO985OFMOL]W;R%'022( P(.>C=*)O!L.I:9JL6LP:=>WE^9/])^S8
M*JPVJ.22-JX (/;/!JEX;\&:SX?\'6GA]M8M;L6EU'-%,]NRD1K()-F-WJ,
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MV'POJ&K6GDQ-'F^2!O-=4Z93=@,>YW?A4_B#P)>:OXG\.:Q:ZE;P#0P1'%)
M7\W.,Y(88Z4 :WA"VMY+'^V;1KI(-3ABE%M/*[^41NZ;B=N05R!W%=)6-I>G
M:I;ZE/<7U[;/;^6([>VMH#&L7)+,26.XGY?3&/<ULT %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#Q5FO*]0O=03P_XG:/5;Y)+;Q1!!#(+AMR1LUL"@S_#AVXZ<]*LW]SJ6D_\
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M;2C!<6(CO'"1,8$<\ X922?E.5YZ5H:S?'69?'-C>W4\']G:>OV6&.=HAL:
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MD'!XYP,YYR >O45Y1J>H:IX7U#7;"WU&^FTA;C3M]S<3M*]DLTA68"1B3]T
M]?EW@U:\5SZCI,WBJSL+^]6R3P\U^C_:79[:X!<+M<G< P4G&?X3ZF@#TVF/
M-'&\:.ZJTK;4!/+'!.!^ )_"N$GACLKO1[+^U]3FGU".6Z>&>^=(WVQH&8R
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M: EN@$V>N_CYNIZ^M7Z* ,V'P]HMOIC:9#I%C'8,P=K9+=!&6!!R5QC.0#^
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M?3;YN,57C\*WL6GM81W.B)9/]ZW710(S]5\S%=510!RLGA:^EM(;22ZT5K:
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MCFNKHH Y9?"]^D%S MUHJPW1+7$8T8!9B>I<>9\WXTA\+7QL6L3=:*;1VW-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3SGKD#G@5#9Z-?VND7.G2Z=XCO$FMVM5EN;ZT=X8B,%5^8#TY()X'/%>@44
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M+Z.[M4F1$^ZJ8;"@9;M_$:[*VDDFMHY)8'@D89:)V4E3Z$J2/R-2T4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[A8;D6TLT90K&Y0-\PW;@,$#..I].:HQ>.](FU2QLU+E+^5H;:X#(R.ZY."
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M]*19;J$+$2L)4L) ?,VD85N =W!XJ6\\;VT%ZUG::5J>H3_8DOT6UB0[X6)
M(+,.>#P<'TS0!U%%<.=>BUGQ1X+U'3+RX_L_4(+MVCWLJOM0$;DSC<I)'UJ_
M#X]TJXU"RM(4ED%_O%G*CQE9F4%L8W97< 2"P /M0!U-%<?HOCE+WPW8:E?V
MC6\]])(L$)DC&\*6/#%@  J\DXYZ#D5;L/&^F:I:VS6<5Q+=7%Q+;+:#;YBO
M%_K,G=MP!@[@2#D8R2!0!TM%<C\/[NXO+'6FN6NB8]8N8D2ZD+O$H( 3.3P/
M8D59NM;L[+Q3J"O%J37-II:W+QJX,+Q!VY12V-^0P)(!P!0!TM%<WI/C*TU:
M^TZV%A?6PU*S-Y9RW"(%E4!2P&&)!&]>H /8D5+XJU^XT"WTY[>R>Y:[U""T
M.UE&T.X!ZD9)&0.V>M &_17G@\42>'_$GB^YN[?5+JQM?LLSHCAQ:(8MSG#.
M!C)R0F3Z#%;^M^-]+T,7)E$DXM(UEN/)9,QHW(.&8%CCG"@G'U&0#I**@^VV
MWV#[=YRBU\KSO-)XV8SN^F.:YR#QYIUQ?+9Q6MT\\UJ]U;(AC8SJN,J '^5L
M$':V/SR* .JHK#L/%-EJ.G:5?P0S^1J,33(6V#R4"Y+2?-P!P#C."0*HP^/M
M*GOK>U2*X9KNWDN+4J8V\]4&X@ /E6VG(#!>/<$4 =517+:7XYM-5FTM(]-U
M")-5M6N+*65$"S;5#,GW\AL'N #@X)JUX/U^X\2>'X]2N+)[5I))0JEE(($C
M*,$$]  #D#GI0!OT5Q6K>(;RZN_%FCK:7%O'IVFI+'=Q2JK!V25MV0VX?<7&
M!V.<9J3PQXMA:PTC3]0AO()I-(2[6[N=NR=41/,;.XMD%@3N SG/- '8T5S>
MG>-=,U+6;73$66.6[@:>V=F1EE5<9'RL2K8(.& X]P15+XCWD]AHEA<6]U<V
M['4[6&1H)&4M&\@5Q\O7(/U]* .QHKE[6^T^UNK^ZM+C59TL;3S)[:5Y6W!B
M2I7S3]X"-NG'S5';^.[>YDTU(]'U0G4[3[58DI'^_ 56*CY_E(##EMHZX)XR
M =917*+X^L'L]-G73]19[^YEM$@6-"Z3Q[]T;?-@',;#()'<D#FLC7_%2ZSX
M3EN;'[?IM[8ZO:6MS;R-Y4L;&>,,K;6(965_4@@T >A45@:CXLM-/&HR"UNK
MF#3,?;IH%4B#Y0QX+ MM4ACM!P#Z\5);>)[*ZUN72TBG#K9K?1SML\J:%C@,
MAW9//7(&./44 ;=%<O<^.=/MK&.X:VN3(UH+UK9FB25(CG:2&< D[6P 2>.U
M-7QY97%[;VUAINI7S7%G%?1M;QIM,,C;0WS,,8.<@\\=#0!U5%9?B'7(/#>B
MSZK=0SS00[=ZP*"PR0 <$CN167-XU2&\O[+^P]6:\LX%N?)"Q9DA.X>8I+XQ
ME2-I(;VH ZBBL&+Q79W<=E_9T%Q?2W=DM_'%%M5A"V-K-O8 9)P!GJ#Z$TVV
M\7Z;J-KI[Z>L]U+J"R-% @"R*(SB0ON("[6(4\]2,9H Z"BO-O#^M*/#]B^I
MOJ[--XCFMH2)SO1A.X1)3NR4 &".1Q5NZNKK7/%GB#3;A-8M[;3H+9X'L;E8
MF1CYC%N'^;?M4 $'@<A<F@#OJ*Y+3?%>EVWAO1FM3=S_ &NS\^WCN9T\YHP!
MR[R.!GYE'7))] 2)+;Q[IFH6-O=:;!=7AFLWO!!&$60(K%6&UF&6# C ST]Q
MD ZFBF2R+#"\KYV(I9L DX'L*YVV\9VEQ(T;6%]%*=._M*.-U3=)#D#@;N&&
M1PV.OUP =+17+Z;XWM=3FTZ./3-1B&IV1O+)Y5C G 569!\^0P##[V ><$CF
MK.G>++34]*L+^WL[S%[<M:I"P02(ZE@VX;L#&QB>2>.E &_167X@UVW\-Z2^
MI7<,\L".B,(%#,-[!0<$CC+#I6++\0;&U36!>:9J=K<:7;?;)+>6- \L'/[Q
M,/@C@YR01TQ0!UU%<E<>([>ZNM'^U:?K5F)M1$5JQ*QI*QB9@7 ?)C*[N".J
M\@8JU<^,]/M89+MX;DZ;%=?9);]0IBCDW;#GYMVT/\I;& ?;F@#HZ*YZV\61
MW>OW.D0:5J3R6MP(+B;8GEQ%H_,5B=V=I!'0$\\@<5H:MK5IHZVXN#F6X<I#
M&&52Q +'EB   .I/H.I H T:*X#4?$\.N)X:OM,GNK<?V^+&ZA\S;R$DW(X4
ME6&54@Y(Z8K8N?'>D6M_#;N7:*6\^PBX5D*K-DK@KNWXW KG;C/MS0!T]%8*
M>*K:6>V$-C>S6MS<O:Q7<48:,R+NSGG<%RC#<1C(ZX(-8*^+EU+PG)J.J6&I
M6D(U06H-I,JL"MSY:997SC<%#>N3C(H [RBL#4?%EIIXU%Q:W5S!IF/MTL"J
M1!\H8\%@6(4AB%!P#Z\56O?'%I;75U;V^FZA?-;V27Y:V6,J\#;L.I9P#]T\
M<$]@: .HHKEX_$":WXCT[3K&5Q:2:<-4ED7*LZ.P6)?4 _,Q_P!T#H35ZRU^
MWU>4PV]M<O;/+-;&Y1E"J\9*L#AMRG(..!^'% &U16!X:U:6\GU;2[IR]WI5
MWY#2'K)&RJ\;'WVL ?=2>,U8OO$$5K>W%E;V=S?75M MQ/%;!<QHQ(7[S#).
MUL <\?3(!KT5RDGC[3V-@-/L-0U+[?9O>VWV2-3YB*5##YF&&&X<''IUXK;U
MK5XM#T*[U:XAFDAM86FD2( OM49. 2!P/>@#0HKF!XT1]1_L^/1-5>[DM?M=
MM&%B'VB/(!()?"X)&0^T\BGP^,[.[TVPO;*RO;D7MM)=)&J*I1(\!PQ9@H8$
M@8SR?;F@#I**X2X\1V\_BKPQJT%[.FEWVDW-R8V<A6'[DH2F<;OG(]<G%;UQ
MXHM[2WM#<VEQ;W5VK/%:3O$DFU0,DDOM&-RCKG)'% &[17+V7CO3-3M;273X
M+FYEN899EMEV+(!$P5QAF +!CC )]>G-=)',)+=)MK*K('P1R.,T 245S^E^
M+;35-1M;(6EW;O>6C7ML9U4>9$&4$X!)4_,IP0.#]15K7?$$&@"Q-Q;74PO+
ME;6/R$#8=LXR"0<<'IF@#6HKFX/&E@]G=S7-O<V<]K>"RDM;@QA_-(#* 0Q7
M!5@<[L8SGI5:/X@Z6Z.?LMWNBOX["<+Y;"%Y,;&9@^"C;AR"?<"@#K:*Y]/%
MMJ\FL0BRO//TJ:.&6(B/=(T@!39\_(.X8SCTZUO@Y )!'L>U "T444 %%%%
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M]/M_$=KH,DV+^Z@>XC3U5" ?Q.3C_=;TJ_)/%%+%$\BK)*2L:D\L0"3C\ :
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MN@F9D16)9G9MF3R1@ ?P]>>.PN+2VO(Q'<V\4Z Y"RH&&?H:E5510J@*H&
M, "@#F=6T34]0'AIHQ:*VF7B7-P&E;! C=,(=G/W\\XZ5E'P3?G0-2\+M+;/
MHUY>-.LY=A-'$\OF/'LVX)SN ;=WSCC![RHYYXK6WDN)Y%CAC4N[L<!0.230
M!AZ)I%]I_B+Q#?W/V;R-2GCEA$<C,RA(ECPP*@<[<\$]:9XIT75+^?2]3T2>
MV34=.E9DCN]WE3(Z[71BN2.Q! ."*Z.HX)XKJWBN()%DAE0.CJ<AE(R"/PH
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M4$=#@TES86=["L-U:03Q+RJ2QAE'T!% ' >*KJYDUW7]/%]B>32XO[,\N]6
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M^[C'7FK$,,5M"D,$211( J(BA54>@ Z4 >:>&KPZZVEZA-XD2WU1+N2*]T]
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M0N-1O;A+>[26[>1)X2KF3*$[<KMSD#.1SDFO5DMH[2S,%C!#"J@[(U78@/T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY;N<4 /HIDLT4";YI%C3(&YC@9)P/UI] !115&\UC3=/GB@O+ZW@EE9519)
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MVLEU=SQ06\2[I)97"JH]23P* )J*9#-'<P1SPNKQ2*'1U.0RD9!%/H ****
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MV,_+R<<\<5=A\2:I:OX7N;O[-+9ZZ5B:.&,J;>1HC(FTY.Y<*0<CWXZ5N_\
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MCR'+;O,Q@1KA1M.<DYZXQ76:SI$&N:+=:5=R2BWNHS%*8R Q4\$9QQFL;4/
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MQ:\[?L[LJD[N0",XXR<'C%=A9^#[6TTFZT]M2U2Z6XA-N9KJY\V1(B,%5)&
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MGP'H=S>W N)Y[&&0OMP3E%//)R<YYX^E<E:ZI<Z-:^+=0O#:WCKX@2"%)("
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M2717)A/5!L"@9/)(&2<<\#%2R\%65GI-UIQU'5+F*>W:U#W5SYC11,,%$R,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** ,.\\9^%].O)+2]\0Z7;W,1Q)%+=(K*?
M0@G(J#_A8'@W_H:=&_\  V/_ !JKX3@BDU;Q<7B1C_;1&64'_EV@KI_LMO\
M\^\7_? H PO^%@>#?^AIT;_P-C_QH_X6!X-_Z&G1O_ V/_&MW[+;_P#/O%_W
MP*/LMO\ \^\7_? H PO^%@>#?^AIT;_P-C_QH_X6!X-_Z&G1O_ V/_&MW[+;
M_P#/O%_WP*/LMO\ \^\7_? H PO^%@>#?^AIT;_P-C_QH_X6!X-_Z&G1O_ V
M/_&MW[+;_P#/O%_WP*/LMO\ \^\7_? H PO^%@>#?^AIT;_P-C_QH_X6!X-_
MZ&G1O_ V/_&MW[+;_P#/O%_WP*/LMO\ \^\7_? H PO^%@>#?^AIT;_P-C_Q
MH_X6!X-_Z&G1O_ V/_&MW[+;_P#/O%_WP*/LMO\ \^\7_? H PO^%@>#?^AI
MT;_P-C_QH_X6!X-_Z&G1O_ V/_&MW[+;_P#/O%_WP*/LMO\ \^\7_? H PO^
M%@>#?^AIT;_P-C_QH_X6!X-_Z&G1O_ V/_&MW[+;_P#/O%_WP*/LMO\ \^\7
M_? H PO^%@>#?^AIT;_P-C_QH_X6!X-_Z&G1O_ V/_&MW[+;_P#/O%_WP*/L
MMO\ \^\7_? H PO^%@>#?^AIT;_P-C_QH_X6!X-_Z&G1O_ V/_&MW[+;_P#/
MO%_WP*/LMO\ \^\7_? H PO^%@>#?^AIT;_P-C_QH_X6!X-_Z&G1O_ V/_&K
M.J:A::??6.GQ6"7%]?>888@%4;4 +L6/0#<HXR<D<=<2:3<PZFMT)-*:SEMI
M_(>.9$))VJV05)!4AA@_RH I?\+ \&_]#3HW_@;'_C1_PL#P;_T-.C?^!L?^
M-;OV6W_Y]XO^^!4-S_9]HL9N$@C$DBQ)E!\SL< #WH R/^%@>#?^AIT;_P #
M8_\ &C_A8'@W_H:=&_\  V/_ !K4A0R7UU#+ID<4$>SR9R5(FR/F^4<K@\<]
M<U9^RV__ #[Q?]\"@#"_X6!X-_Z&G1O_  -C_P :/^%@>#?^AIT;_P #8_\
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M^\7_ 'P*/LMO_P ^\7_? H PO^%@>#?^AIT;_P #8_\ &C_A8'@W_H:=&_\
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M6W_Y]XO^^!0!A?\ "P/!O_0TZ-_X&Q_XT?\ "P/!O_0TZ-_X&Q_XUN_9;?\
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M]!%6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/_!U<?\ Q==310!RW_""6?\ T&O$G_@ZN/\ XNC_ (02S_Z#7B3_ ,'5Q_\
M%UU-% '+?\()9_\ 0:\2?^#JX_\ BZ/^$$L_^@UXD_\ !U<?_%UU-% '+?\
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ME_UP3_T$5;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#EO"'_ "%?%_\ V&C_
M .DT%=37GFCQ>)I/$'BPZ->Z3!;_ -KG<MY:22N7^SP9(*R*,8QQCUYK:^S>
M/?\ H*>&_P#P73__ !^@#J:*Y;[-X]_Z"GAO_P %T_\ \?H^S>/?^@IX;_\
M!=/_ /'Z .IHKEOLWCW_ *"GAO\ \%T__P ?H^S>/?\ H*>&_P#P73__ !^@
M#J:*Y;[-X]_Z"GAO_P %T_\ \?H^S>/?^@IX;_\ !=/_ /'Z .IHKEOLWCW_
M *"GAO\ \%T__P ?H^S>/?\ H*>&_P#P73__ !^@#J:*Y;[-X]_Z"GAO_P %
MT_\ \?H^S>/?^@IX;_\ !=/_ /'Z .IHKEOLWCW_ *"GAO\ \%T__P ?H^S>
M/?\ H*>&_P#P73__ !^@#J:*Y;[-X]_Z"GAO_P %T_\ \?H^S>/?^@IX;_\
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MZ"GAO_P73_\ Q^@#J:*Y;[-X]_Z"GAO_ ,%T_P#\?H^S>/?^@IX;_P#!=/\
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M;Q[_ -!3PW_X+I__ (_1]F\>_P#04\-_^"Z?_P"/T =317+?9O'O_04\-_\
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MM/</O<J.@] .>PY[U?KEOLWCW_H*>&__  73_P#Q^C[-X]_Z"GAO_P %T_\
M\?H ZFBN6^S>/?\ H*>&_P#P73__ !^C[-X]_P"@IX;_ /!=/_\ 'Z .IHKE
MOLWCW_H*>&__  73_P#Q^C[-X]_Z"GAO_P %T_\ \?H ZFBN6^S>/?\ H*>&
M_P#P73__ !^C[-X]_P"@IX;_ /!=/_\ 'Z .IHKEOLWCW_H*>&__  73_P#Q
M^C[-X]_Z"GAO_P %T_\ \?H ZFBN6^S>/?\ H*>&_P#P73__ !^C[-X]_P"@
MIX;_ /!=/_\ 'Z .IHKEOLWCW_H*>&__  73_P#Q^C[-X]_Z"GAO_P %T_\
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M?]"AXD_\!XO_ ([1_P )E<?]"AXD_P# >+_X[74T4 <M_P )E<?]"AXD_P#
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MF5Q_T*'B3_P'B_\ CM=310!RW_"97'_0H>)/_ >+_P".T?\ "97'_0H>)/\
MP'B_^.UU-% '+?\ "97'_0H>)/\ P'B_^.T?\)E<?]"AXD_\!XO_ ([74T4
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M_P =H_X3*X_Z%#Q)_P" \7_QVNIHH Y;_A,KC_H4/$G_ (#Q?_':/^$RN/\
MH4/$G_@/%_\ ':ZFB@#EO^$RN/\ H4/$G_@/%_\ ':/^$RN/^A0\2?\ @/%_
M\=KJ:* .6_X3*X_Z%#Q)_P" \7_QVLOQ)XBOM7\+:OIMOX1\1">\LIK>,O!$
M%#.A49/F=,FN]HH KV$;0Z=:Q.,.D**P]" *L444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/4A=0RV\VGW,-M-&[)C?+M\LAL[<'>,DD8P:V["\>\CD:2TFMGCD,927:<X
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M(8LI;)YSR",#';G&<4V?Q)/!XX&B-9,+1-/:[DN2Z8'SA<G)!"C!SWYZ8&:
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MW)BU.)YH\[,Q(N,E\-ZD#C/)K=H **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC.#Z'!'YT^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^?\ UMS'HC+(^>N6$^3G]:MW>D:]?VLEK>:EHMQ;R##Q2Z0[JP]"#/@UT-%
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MI6#2/(3+(SG+$D@$DX&3P.@' H GHHHH **** "BBB@ HHHH **** "BBB@
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MR!+E@SR29P=@)+\\=<5T% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !6?K>BV7B'29M,U%9'M)QB5$D*;AUP2.<5H44 8H\*Z6;VTN[A;
MBZFLVW6_VFYDE6)L8W!2<;O?&15>PL;O4O$8UG5-)BLI;*.6VM/WRRO(KL"7
M) ^4$(N!U^9LUT5% %2#3H;;4;R^1IC+=A!(&E9D&P$#:I.%Z\XQGO5NBB@
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MNKZ.)538AL+5(&D'F+(#+G<KG*CC:!RW'S8%_3O#<EE;:3!-?O<K832S$R(
M79@P7I@#&\]J@LMR:_;#5Y]*@BGN;Z"W^T/%$%Z9 V[F(7=R#@GH0>XS0;Q@
MJZ5/J7]B:F8()9(I<-;Y!0@''[W#?-E1M).01Z9+3PH^GZY-J5MJMRWF13+Y
M4RHP#R.&W9"@D CH3V S@8JTN@*NE:/IWF@P6,D3R@K_ *[RU.WZ'S-K_P#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^$.\-?\ 0!T[_P !U_PK;HH Q/\ A#O#7_0!T[_P'7_"C_A#O#7_ $ =._\
M =?\*VZ* ,3_ (0[PU_T =._\!U_PH_X0[PU_P! '3O_  '7_"MNB@#$_P"$
M.\-?] '3O_ =?\*/^$.\-?\ 0!T[_P !U_PK;HH Q/\ A#O#7_0!T[_P'7_"
MC_A#O#7_ $ =._\  =?\*VZ* ,3_ (0[PU_T =._\!U_PH_X0[PU_P! '3O_
M  '7_"MNB@#$_P"$.\-?] '3O_ =?\*/^$.\-?\ 0!T[_P !U_PK;HH Q/\
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M (#K_A1_PAWAK_H Z=_X#K_A6W10!B?\(=X:_P"@#IW_ (#K_A1_PAWAK_H
MZ=_X#K_A6W10!B?\(=X:_P"@#IW_ (#K_A1_PAWAK_H Z=_X#K_A6W10!B?\
M(=X:_P"@#IW_ (#K_A1_PAWAK_H Z=_X#K_A6W10!B?\(=X:_P"@#IW_ (#K
M_A1_PAWAK_H Z=_X#K_A6W10!B?\(=X:_P"@#IW_ (#K_A1_PAWAK_H Z=_X
M#K_A6W10!B?\(=X:_P"@#IW_ (#K_A1_PAWAK_H Z=_X#K_A6W10!B?\(=X:
M_P"@#IW_ (#K_A1_PAWAK_H Z=_X#K_A6W10!B?\(=X:_P"@#IW_ (#K_A1_
MPAWAK_H Z=_X#K_A6W10!B?\(=X:_P"@#IW_ (#K_A1_PAWAK_H Z=_X#K_A
M6W10!B?\(=X:_P"@#IW_ (#K_A1_PAWAK_H Z=_X#K_A6W10!B?\(=X:_P"@
M#IW_ (#K_A1_PAWAK_H Z=_X#K_A6W10!B?\(=X:_P"@#IW_ (#K_A1_PAWA
MK_H Z=_X#K_A6W10!B?\(=X:_P"@#IW_ (#K_A1_PAWAK_H Z=_X#K_A6W10
M!B?\(=X:_P"@#IW_ (#K_A1_PAWAK_H Z=_X#K_A6W10!B?\(=X:_P"@#IW_
M (#K_A1_PAWAK_H Z=_X#K_A6W10!B?\(=X:_P"@#IW_ (#K_A1_PAWAK_H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ***I:EID.J)!'</,(XI?-VQ2M'O\ E88)4@D?-G'J!0!=HKSWP/I<=]%J
M]Q+<7K366OW20-]KD.(XY/E3!;!7&1@^M(GB>:VT?3GT32DMUO-?DLIX[BY)
M97\U]Y!PWWBC?0'B@#T.BN#M=4AT/Q;XSO;MG\F*.P.S>6^=U90JYX&6('8<
M]JU;7Q7<W<FJ6L&D-/>V<*S0I!.#%<ALX596"@,",$$<9!YH Z>BFH6:-69=
MK$ E2<X/I3J "BBB@ HHHH *\>\17EUI?Q01)IY&T[5(VCC1FRL4Z$GCTW+^
M9KV&O)OB3ILNHV=XUJ/].M)?M=J0.?,1B0!]1D?C7S^?.-J<9[2;7I=:/Y.S
M-Z.S,GQ!>75QXAT;1+&>2%Y'-U=/&V"($['V9CC\*CM/$&F:=IVM7HBN52#4
MI(70L9&EFRHP@)X!)&!QBF>$!+JMYJ/B6Y@DA>\98;>.089(4X_5MQ_"N?ET
M^\DT?6+B&UEE>T\3->^2JG=+&I7.T=^.?PKYV%&FW["6G+9/S;>OW;?(T;>Y
MU]EXBFDU.+3]2TFXTZ:=&>!G=)$<+R1E2<$#G!JG_P )FSV<NIV^C7D^D1%M
MUXK(-RJ<,ZH3N*C!YJ:+Q);Z[=#3M+@GGBEA?S[HQM&MOQ\H.X#+$GH.E<;I
M<&FV'A]=-U6?7X]1A5H9-/@EFQ*<D (!\I5A^'-*EAJ<KN=.STTU>CO=VO=;
M+?UV:!R?1GJ,$\5S;Q7$+AXI4#HPZ,I&0:XNPLKK7?$GB%)M:U6WCM+E8XH[
M:XV* 4!Z$&NMTNUBLM*M+6&.2***%42.0Y90!P"?45QVF>&K'5O%'B6;4;:<
MXNT$;+-)&"-@_ND9K#"N$/:N]DEH[)OXEYCE?0LZ=JMWHVKZ]IUS>3:E::=:
M+=I))M\U."3&S  $\9&:O6_C"&31I]9N+"YMM.2)'BF<J3,6XVJH.>N ">N?
M2I+W1+#2/"6L6^F6:Q"6UF+!<LSML/4G))K&U72[J^^%FFP6\,K3P6]K,88\
MJ[! I8#_ &L9_$5LEAZ[4FK7DE?;IJ[+1-BU1LP^)IH[VT@U31[G3TO'\NWE
MDD1U+XR%;:?E)[4V3Q1/+<WJ:;HEU?0V4IAGE21$^=0"RJK'+8S6%;Q:!J6H
MZ?%;W&OZA*LZS;)9I2MNR\AGWX P>/7FDU231$U*_F6XU?0M5\QLBW1\7)'W
M7V@%'!_/UJEAJ7/;D=[;6=M][7YOZV#F?<Z!]3LKGQ!H9,%VL]U;S20[R4"
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MSL7?R2" >!CFBMAZ-G*U[WU[/FM;>VW2U^H)LN'QUC2(=9_L6\_LE@IDN2Z
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M_78+NYKVGB2\FEM#<Z!>V]K=L%BG#))C(R"ZJ25'OV[T2^)II;^[MM*TBXU
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX]ZZRB@"I81W\8N/M]Q#,6G=H?*B*;(C]U3DG+#N>,^E6Z** "BBB@ HHHH
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M[[_P&M__ (W6W10!G6%A?6LY>YUFYO4*X$<L42@'URB@_P#ZZT:** "BBB@
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MM6_Z&>^_\!K?_P"-UMT4 8G]C:M_T,]]_P" UO\ _&Z/[&U;_H9[[_P&M_\
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M=&N+V\1MDDA'*HJD9]SGBA9OF.O,XJS:U7:U_P T')3['K/_  D-A_>;]/\
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MBADDN4U=G\B6")G7:J,Q.0#W &.O)/8U??Q!I<>H16+W:K-+(88\JP1Y ,E
M^-I;@_+G/!XH TJ*J6.I6>I"X-G.LWV:=[>;;GY)%^\I]Q5N@ HHHH ****
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M9TSQMJ%G=,%EN-/M&BR?O"-2C8]>:L>'6%UXS\47L)#6Y>WMU<=&=$.X?AN
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'VSQ/_T!=+_\&C__ !BMNB@#$^V>)_\ H"Z7_P"#1_\ XQ1]L\3_ /0%TO\
M\&C_ /QBMNB@#$^V>)_^@+I?_@T?_P",4?;/$_\ T!=+_P#!H_\ \8K;HH Q
M/MGB?_H"Z7_X-'_^,4?;/$__ $!=+_\ !H__ ,8K;HH Q/MGB?\ Z NE_P#@
MT?\ ^,4?;/$__0%TO_P:/_\ &*VZ* ,3[9XG_P"@+I?_ (-'_P#C%'VSQ/\
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M?;/$_P#T!=+_ /!H_P#\8K;HH Q/MGB?_H"Z7_X-'_\ C%'VSQ/_ - 72_\
MP:/_ /&*VZ* ,3[9XG_Z NE_^#1__C%'VSQ/_P! 72__  :/_P#&*VZ* ,3[
M9XG_ .@+I?\ X-'_ /C%'VSQ/_T!=+_\&C__ !BMNB@#$^V>)_\ H"Z7_P"#
M1_\ XQ1]L\3_ /0%TO\ \&C_ /QBMNB@#$^V>)_^@+I?_@T?_P",4?;/$_\
MT!=+_P#!H_\ \8K;HH Q/MGB?_H"Z7_X-'_^,4?;/$__ $!=+_\ !H__ ,8K
M;HH Q/MGB?\ Z NE_P#@T?\ ^,4?;/$__0%TO_P:/_\ &*VZ* ,3[9XG_P"@
M+I?_ (-'_P#C%'VSQ/\ ] 72_P#P:/\ _&*VZ* ,3[9XG_Z NE_^#1__ (Q1
M]L\3_P#0%TO_ ,&C_P#QBMNB@#$^V>)_^@+I?_@T?_XQ1]L\3_\ 0%TO_P &
MC_\ QBMNB@#$^V>)_P#H"Z7_ .#1_P#XQ1]L\3_] 72__!H__P 8K;HH Q/M
MGB?_ * NE_\ @T?_ .,4?;/$_P#T!=+_ /!H_P#\8K;HH Q/MGB?_H"Z7_X-
M'_\ C%'VSQ/_ - 72_\ P:/_ /&*VZ* ,3[9XG_Z NE_^#1__C%'VSQ/_P!
M72__  :/_P#&*VZ* ,3[9XG_ .@+I?\ X-'_ /C%'VSQ/_T!=+_\&C__ !BM
MNB@#$^V>)_\ H"Z7_P"#1_\ XQ1]L\3_ /0%TO\ \&C_ /QBMNB@#$^V>)_^
M@+I?_@T?_P",4?;/$_\ T!=+_P#!H_\ \8K;HH Q/MGB?_H"Z7_X-'_^,4?;
M/$__ $!=+_\ !H__ ,8K;HH Q/MGB?\ Z NE_P#@T?\ ^,4?;/$__0%TO_P:
M/_\ &*VZ* ,3[9XG_P"@+I?_ (-'_P#C%:EH]U):HUY#%#<'.Z.*4R*.>,,5
M7/&.PJ>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!-15?[=:>>D/VJ#S7)54\P;F(Z@#OBL\Z_:WB:M;Z5=V<M_8!D99I<1K)M#
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MKV\$4 '^AI(!!(P8,K.N,D@@=\<4 /T.QDL=+C6=5%U*S3W.WIYKG<V#Z G
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M6!/KC@'&0*U* /+8/#VBIXC\)62Z;)+IRV5\FR^AW':[(8UD!' /SE58#'3
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M/*JX9@IX / + ]JABB9=(#2VEX\=IXP-Q(TEFX(A9R=VW:.#D$X'&>:]@HH
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M@!F POU.!5B^U.WTY[9)Q*3<R^5%Y<3/EL$X.!QP#R>.* +E%%-#H79 REU
M)7/(!Z?R/Y4 .HHJ*YN8K.TFNIV*Q0HTCD G"@9/ Y/ H EHKG?^$UTG[=]A
M\O4OM?D?:?(_LV??Y><;L;,XSQ5S2_$>GZS?W-G9M,TEO##.Y>)D!24,4(SC
M/"F@#6HJLUZJZE'8^1<%GB:7S1$3$,$#:7Z!CG('H#Z59H **** "BBB@ HH
MHH **** "BBLY-:M'\02:(/-^V1VPN6S&0NPMM&&/!Y]* -&BBB@ HK.U'6K
M32KO3[:Y\T27\_V>#;&2N_:6P3T'"G\JT: "BBLM-?LY=3U+3HUN'N=.A2:9
M!">5?=MV?WC\AZ4 :E%0VMP+NSAN1'+$)8U<)*A1UR,X93T([BIJ "BFET$@
MC++O()"YY('4X_$?G3J "BLZXUJTMM<LM'D\W[7>1R218C.TJF-WS=,\CCWK
M1H **HC5;=8]0EG2:VAL6(EEGC*(5"ABZD_>4 ]1W!]*CTS6H=3N)X$MKN%X
M523]_"5#HX)5E/0]#QU'<"@#2HHHH ***SM3UJTTFXL(;KS=]_<"VAV1EAO(
M)P3T' /7TH T:**SM5UJTT=K);OS<WMREK%LC+#>QP,GH!]: -&BBFAT,AC#
M+O !*YY .<''X'\J '4444 %%9U_K5IINH:=8W'F^=J$K0P;8R5W!2YRW0<*
M:-*UJTUEKX6GFYLKIK2;S(RG[P*K' /.,,.: -&BBB@ HHHH **** "BBB@
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M(=-L=<;6Y;6?[?-#<VWWD(#N@@V9^5A\AW?>XST-<]837FE_#=KRSU*\2?\
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MG !X'6O0:S&\.Z2\@=K)"=B1D$G#JG*JPSA@.P.<5IT %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZQBCL9HXPQ)\J4+<R( 03E0VTCGY3@\T >D5G:7K$&K2ZA'#%-&UC=&UE$H
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MV7<7;&-KF3,@=NV9<"+ ^]@Y[F@#TBTU.VNM&@U7=Y-K+;K<[I2%V(5W9;G
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M6T\049$3A=[$]  #U)( !QR>U4U\36AU^+2)+>\BEGW_ &>:2$B*8H,L%;U
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "LRRT6.RUO4M46YF>2_\
M+\R-]NQ-@PNW ST/<FM.B@#,T_18]/U;5-12YFDDU%TDD1]NU"J!!MP >@'4
MFM.BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ%;!)QEB, 'UH ]#HKROQ;XW&B:SX<GDOKI?!E[;,6U&U)=FF(.W<V"V ,'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0!ZDT +12$A1DD >II: "BBB@ HHHH **** "BBDWKNV[ANQG&><4 +1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,=Q25BQ+ _5V/X^PH \RFT\P^%/BC]M"37@)>24C.'-JCG:3R%#$X'88K?\
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M[8QQ0!MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %9NNW=Q:Z5(MD5%]<$06NX9 D;@,1W"\L?936E63?Z0=
M2UBVFO$M9]/@C?;;RQ[CYK8P_/' ! X_B- &';>(+S5/A=>ZEYK6NK6MG/'<
M% -T5S$K!^""/O+GIT(IVDZC?2^*]*MY;N5[>;0/M#Q-C'F[XQNZ9S@GO2+X
M.N;9O$]O8W%I;Z=K41"6RPD"WE,?ELXP<'(P2,#D=:O:?X>N[37=/U"2XA9+
M72_[/9%4@L=RMO!SQ]SI[]: +%]XF@LM=71Q87]S=-$L_P"XB#*(RX3<26'
M)Y]O6JFE^);'[#;^6^H7,UY?W-M#%.$\TR(TA=>H4*H1L9/0 <FKIT>X_P"$
MR_ML31>1]A^R>3M.[._?NST]L8_&N.U?2[G0;#3+62[MTD_M6ZOUO'M9FBCW
MEVV%HV#(<RD Y 8*0>N" :%SXMDOM3\-7FFK?_9+BZNK>6TV(&F:.)^.3V=2
M,E@,@YXYK0B\:)>WF@QV.GW+PZHTX9GV*T)BR'4@MU##G&1@'&:I:-HU]=_V
M)=;;*WATJYF=!#'(JW*R1E2P#_,IW.Q).=Q&<\YJ;3O!U]8-HTBW]N9-/NKN
M5OW)(D2X=G('S<$%L \CCIVH W-(UZWUM$EM(9_LTD?F17#;2D@SCC#$@^Q
M-5;CQ=9V^L7FG/:7I-DJ/<W C'E0HRLP=FS]W"'/%5] \*OI&LS:FSV\<L\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 8WBKQ%#X7\/W>J20M</#
M&[QP(<-(54L1GL  23V /7I6I;R_:+6*;;M\Q ^,YQD9K@?B%I_B*31_$EW
M--FLFTR6&)7\SSHXS'EPH QN8_GA?2NST,78T*R%^(1<^4N\0YV>V,\],?C0
M!H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
<0 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>exhibit211001.jpg
<TEXT>
begin 644 exhibit211001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IS3WL>J6L4=L
MDEE*KB64-AHG RO'=3R,]CCUXN44 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^\AB@VL0K 89R22.>VVLKPAXTFU+QB;F?PGK*:OJ<JP-=7,!2&UME.1&IZX
MR2>-S'/ P!+\1=\WQ9\$7$,,TL%E,3<RQQ,R0Y9<;B!@=#0!Z]7F.M>(O$%G
M\;_#GA\ZC'_9-W#).T$4&PG"2@!F));!4'C ]JZK4O%C6'B_2-"32+RYCU&-
MG^W1+F*+&>I_#GD8R.N:X3Q0S/\ M ^%[](IGLK6T>*>X6)C'&Q$PPS 8'WA
M],T >OT4=:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P *-WBC_GGH_P#WW+_A0!MT5B;O%'_//1_^^Y?\*-WBC_GGH_\ WW+_ (4
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M 4444 %%%% !1110 4444 %8MU_R.VE?]@^\_P#1EM6U6+=?\CMI7_8/O/\
MT9;4 ;5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 ,E_P!2_P#NFLKPG_R)NA_]@^#_ -%K6K+_ *E_]TUE>$_^
M1-T/_L'P?^BUH V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#%\)?\ (M6W^]+_ .C&K:K%\)?\BU;?
M[TO_ *,:MJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** ,70_\ D+>)/^PDO_I+;UM5BZ'_ ,A;Q)_V$E_]);>MJ@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *Q;K_D=M*_[!]Y_Z,MJVJQ;K_D=M*_[!]Y_Z,MJ -JBBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &2_ZE_]
MTUE>$_\ D3=#_P"P?!_Z+6M67_4O_NFLKPG_ ,B;H?\ V#X/_1:T ;%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!B^$O^1:MO\ >E_]&-6U6+X2_P"1:MO]Z7_T8U;5 !1110 4444
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MG'.<5O3>(1;?$B"SN=8N884T9KJ2R-NIA<!B3-Y@.X$8(VX[>] &Y]K\3?\
M0&TK_P &DG_QBC[7XF_Z VE?^#23_P",51T?Q_H^M:M::=;I<I+>VGVVT>15
MVSQ9()4AC@\'A@#5;3?B5I.L7 @T_3]6N)/M,EJ^RURL4B+N(9L[1GH.?R'-
M &O]K\3?] ;2O_!I)_\ &*/M?B;_ * VE?\ @TD_^,54T/QQIOB'3;>^T^WO
M'CGO#9A&15=) "QW#=P  3Z\=*Z:@#$^U^)O^@-I7_@TD_\ C%'VOQ-_T!M*
M_P#!I)_\8K;HH Q/M?B;_H#:5_X-)/\ XQ1]K\3?] ;2O_!I)_\ &*VZ* ,3
M[7XF_P"@-I7_ (-)/_C%'VOQ-_T!M*_\&DG_ ,8K;HH Q/M?B;_H#:5_X-)/
M_C%'VOQ-_P! ;2O_  :2?_&*VZ* ,3[7XF_Z VE?^#23_P",4?:_$W_0&TK_
M ,&DG_QBMNB@#$^U^)O^@-I7_@TD_P#C%'VOQ-_T!M*_\&DG_P 8K;HH Q/M
M?B;_ * VE?\ @TD_^,4?:_$W_0&TK_P:2?\ QBMNB@#$^U^)O^@-I7_@TD_^
M,4?:_$W_ $!M*_\ !I)_\8K;HH Q/M?B;_H#:5_X-)/_ (Q1]K\3?] ;2O\
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M7GV^:SDO#:*L?F>5&,N_+A?< ')].#0!H?:_$W_0&TK_ ,&DG_QBC[7XF_Z
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MUTE]X5\03?$.'Q%;?88UBT-K!=\K-MF.Y@V-O* D#L3Z5TW_  BNF?WM1_\
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MF?WM1_\ !G<__'*/^$5TS^]J/_@SN?\ XY0!M45B_P#"*Z9_>U'_ ,&=S_\
M'*/^$5TS^]J/_@SN?_CE &U16+_PBNF?WM1_\&=S_P#'*/\ A%=,_O:C_P"#
M.Y_^.4 ;5%8O_"*Z9_>U'_P9W/\ \<H_X173/[VH_P#@SN?_ (Y0!M45B_\
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MC_A%=,_O:C_X,[G_ ..4 97B;PQ=WWC'PYXFL=DDNDF9);9WV^8DB%<J<8#
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MDMY><@9&&0Y]<C X-=#_ ,(KIG][4?\ P9W/_P <H_X173/[VH_^#.Y_^.4
M<_X8\ ?8F\1WVN-#/?\ B%W^U1PDF.*(Y C4D GAN3@9XXXK$L/A++;:;X32
M6]#WFE74ANY@Q_>V[*08Q[;5C7'H6KN_^$5TS^]J/_@SN?\ XY1_PBNF?WM1
M_P#!G<__ !R@#F?$'A'6-1^(;:];+:FT_L673PKS%7,C;R#C:1MRP'6N?B^&
MFOV7A[P:T4>FW6I>'I)UEM9I"8;B.5B3ABO!QZC^7/HW_"*Z9_>U'_P9W/\
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MKE;;P7X6T9T@L[:>S:Z<X2WO9T\Q@"22%?T'4UH?\(KIG][4?_!G<_\ QR@
MT/\ Y"WB3_L)+_Z2V];5<]X8M8K*\\0V\)D,::DN/,E:1N;: \LQ)/7N:Z&@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *Q;K_D=M*_[!]Y_P"C+:MJN;UF\-CXOTB46MS<YL;Q=ENFYA\]
MOSC(XXH WKO_ (\Y_P#KFW\J\C^&^KM8V7AJV\10B*TFLXUT2Y#9@\P@AE?^
M[,><$\%>%P2<^AW&MK<V\D$NB:UY<B[6VP[3CZA@1^%8LNG:#-X;3P]+X6UE
M])0@I;,KD+@Y&#OS@'MG% %S6=2U6\\3W&@:7<K:S1:<MVDFY0S,[N@.&1LJ
MI09P!]X<UGWFLZWI5]IHU;4T2&_TZ6(FR1'2.^C ;Y"RY;< ^%/=<=Z??Z;H
M6I+9B[\-:[(]F"L$VZ42JIZKY@DW$'T)(K2FN["X@LX9?#.IM%92)+;)]E $
M3(,*0-W&,\4 97A_Q%J6HZ*DMWJ"V]YI=I.-6,R)Y:W"DJ-V%&%^1V^7'&WK
MFJB>(=;CDU*W-_<,%\._VC#--!$K>:"PW*H7A&P/E<9'M6_]HT_RM1B_X1G4
M_+U)BUXOV48F)0(<_-W50*H6>GZ%83QS0>%]9,B6QM TJO(3"?X#N<Y'89Z#
M@4 26.LZI<ZWX:MFO6$6I:)+<S 1I_K5$.''&1_K&XZ=.*R?#GB#7IHO!=_>
MZJURNL^=%<V_D1J@*Q.ZLN!N#93!YP0>@K0LM-T/3IK6:V\-Z\LMK$\,$C-*
MS1QMC* F0G;\HP.@[8J6VM-&M(M-C@\-:VB:8S/9J/,(B)!!Q^\YX)'.>":
M*^B:SXAU6QTCQ(EU;'3;F-Y+JU>1> 0=JQXC!#JPVD%CGGVJ?PWJ'B+5AH.M
M&]M&TR_MR]S TBG#,FY1%A <J000S'@'N*33['0]*U674K'PMJ\-Q*[2'$;&
M-7;[S*A?:I/.2 #R?6C2K'0]$OY;W3O"VKP2R,S8$;%$+?>*(7VH3_L@4 2>
M/O\ C_\ !W_8P0_^BI:W/$NHG3M!NYH[Z"RN!$3'-,A<*<A<[1RQRP &#R0.
M<UD:NVG:ZULVH>']<D-K*)H"@>/RW&0&&QQSR>?>JTUEHUS;W4%UX<UZY2ZC
M$4OVEI93M!W  M(2O(!^7'('I0!@>)=5U&Z\,^.=.O'F:.SCM6@^TK&)%$@!
M(;R^",C([\UO/)XDM_%5UH*ZV9Q>Z7)=VMPUM&K6DR.JXP%P4.\?>R>#SWH7
M3]! O0WA;6)/MT*PW1E1W,JKTW%G))_VNOO6A8W=IITCRP:%KC3.JHTTR-+(
M5&<+N=R<#)XSU)/>@#F;'QW="ZT.^O+J?^SI[-X+^/RX\17RJQV9"YW'RI1M
MXY*>N*OZ]JFN:9IT\2ZO(^H6FC/>21P0Q%EE&3O<LNWRQM*@##'!ZXR-$G2C
M \/_  BVI>6]X+YA]E',X8/YGWNN0*BU*#1]7O6O+[PSK$L[VYM7(C91)$<G
M8P5P&&22,@X)XH BN?$M[I&I:-JFIWC#1-2L#NC6-=L-T$$@YQN(90X SU'N
M*ZK1TO4TFV&I3-+>,@:8D*-K'DK\H P.F<<XKBYI[B:>ST5?"5\GAZR:&>.9
MP9)&:,[E38>F&"DL6.0"._'3/X@\Q&0Z+K(##!VP8/X$-D4 <7XS^W7LEQXE
ML-.NYIM!N5>QE0IL9(B1<CEMWS9=#@<^6N*Z+7_$-VEAI6JZ6EW<:1<1--</
MIZH]PJ%5*.J,#N49.X 9Z>X,MK=V=EI7]F0:#K:VFTIL*,Q /7YB^[]:I6EG
MH]A:VEM9^'O$%O%9JZ0"-Y08U?&Y0?,S@[1QT&.* &P>(KIM:T;RM8BGTZZT
M&:\:9XE5'D0Q8E/ ('SL2.,4>&=<U2X\3VEA=7<MS;7.C"]\R6%(P\@=5+Q@
M ,$(;@/SP/QE^SZ-YMNX\+ZL/L]JUG$@B8(L+ !DV[]I!P,Y'85'IUCHFDW=
MK=6?AG6TGM83;PR.'D*QG'R?,YR!@8!Z=L4 'C,S+XT\$&!$>7[;<[5D<HI_
MT=^I ./RK$U7PY?Z)"+N34V@N=8\36L\T=GCRT!=0%^9?F(V@DX&3U%=-?RZ
M?J>H65]=^'];>YLF+6[JKIY9(P2 K@<CCGM4FJWEGK5F+6_\/ZS+$)$E7;$4
M974Y5@RL""".H- &9/J?B+5)M9&C7UM!)I-XL&VZ=51U5$9S*/+)^8,V"I4#
M ]#GNZX>XT[0;G6$U63PKJWVQ51"RQLJR!?NAU#[7QVW UIVVH6UG>7EW!H.
MLK->.KSL8B0Q50HP"V!P!TQ0!1'_ "6M_P#L75_]*#3O'+S//X=BMM0GM]VM
M0Q3+"5YRCL-V0>A4$#I['BFW4.EWFKG5I=!\0K?F+R#/%)+$?+SG;\L@&,\X
M]:22VTB6P%G)X<UQXEN1=AF\PR><.C^9YF_...O3CI0!S_BW4;O7_ OC*87T
MD,.GW3V2VZHA#B,IN+DC.6))&",#;[Y]4K@[W2?#^H37DMQX6UK_ $U56YCC
M#QQS;> 619 I(P.2,UJV][:6M_+?0Z#K0N)8DA=FC+91,[1@OC^(\]3WH Z>
MBL7_ (2(_P#0%UC_ ,!A_P#%4?\ "1'_ * NL?\ @,/_ (J@#:HK%_X2(_\
M0%UC_P !A_\ %4?\)$?^@+K'_@,/_BJ -JBL7_A(C_T!=8_\!A_\51_PD1_Z
M NL?^ P_^*H VJ*Q?^$B/_0%UC_P&'_Q5'_"1'_H"ZQ_X##_ .*H VJ*Q?\
MA(C_ - 76/\ P&'_ ,51_P )$?\ H"ZQ_P" P_\ BJ -JBL7_A(C_P! 76/_
M  &'_P 51_PD1_Z NL?^ P_^*H VJ*Q?^$B/_0%UC_P&'_Q5'_"1'_H"ZQ_X
M##_XJ@#:HK%_X2(_] 76/_ 8?_%4?\)$?^@+K'_@,/\ XJ@#:HK%_P"$B/\
MT!=8_P# 8?\ Q5'_  D1_P"@+K'_ (##_P"*H UY?]2_^Z:RO"?_ ")NA_\
M8/@_]%K44GB(F)_^)+J_W3_R[#_XJLSPQKYB\)Z-'_8^JOML8%W);@@XC7D'
M/2@#L**Q?^$B/_0%UC_P&'_Q5'_"1'_H"ZQ_X##_ .*H VJ*Q?\ A(C_ - 7
M6/\ P&'_ ,51_P )$?\ H"ZQ_P" P_\ BJ -JBL7_A(C_P! 76/_  &'_P 5
M1_PD1_Z NL?^ P_^*H VJ*Q?^$B/_0%UC_P&'_Q5'_"1'_H"ZQ_X##_XJ@#:
MHK%_X2(_] 76/_ 8?_%4?\)$?^@+K'_@,/\ XJ@#:HK%_P"$B/\ T!=8_P#
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MJR_ZE_\ =-97A/\ Y$W0_P#L'P?^BUH V**** "BBB@ HHHH **** "BBB@
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M *E_]TUE>$_^1-T/_L'P?^BUH 9_8NI_]#1J?_?BU_\ C5']BZG_ -#1J?\
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MZ"ZM*LD[AYH_*64[<+@-M)Z\<8YZT =#_8NI_P#0T:G_ -^+7_XU1_8NI_\
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M$,4UU+=2+J*YFE50S?Z-!U"@#VX':NAK%T/_ )"WB3_L)+_Z2V];5 !1110
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MP 3QU'X5>EA\'/'#*GBBSCU**^;4%OENHMYF8;6R.A4KA-OH!SD9KT#-&>:
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M_3/_  *3_&MJB@#%_P"$O\-?]!_3/_ I/\:/^$O\-?\ 0?TS_P "D_QK:HH
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M+JGQ+>.^-M<6LF@,SH\@,;?O1@D9P>.?PSVKJ/\ BJ/31_SEH_XJCTT?\Y:
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M%O$G_827_P!);>MJN>\,?:OMGB'[9Y/VC^T5W^3G9_Q[08QGGIBNAH ****
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M.Z[U#JS2G:.#S^]//M^- &R?%UNFK6EE+97427=Y+8P32 +NDC#$G:3G8=K
M-CGZ$&NBK@O^$-UQM1M+J6^T^5[76'OA<21N998F$BA&.>-@DP ., =._>T
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MXSC/3.!^57J* ,7_ (0_PW_T M/_ / =?\*/^$/\-_\ 0"T__P !U_PK:HH
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MW7C]*VZ* ,7_ (0_PW_T M/_ / =?\*/^$/\-_\ 0"T__P !U_PK:HH Q?\
MA#_#?_0"T_\ \!U_PH_X0_PW_P! +3__  '7_"MJB@#%_P"$/\-_] +3_P#P
M'7_"C_A#_#?_ $ M/_\  =?\*VJ* ,7_ (0_PW_T M/_ / =?\*/^$/\-_\
M0"T__P !U_PK:HH Q?\ A#_#?_0"T_\ \!U_PH_X0_PW_P! +3__  '7_"MJ
MB@#%_P"$/\-_] +3_P#P'7_"C_A#_#?_ $ M/_\  =?\*VJ* ,7_ (0_PW_T
M M/_ / =?\*/^$/\-_\ 0"T__P !U_PK:HH Q?\ A#_#?_0"T_\ \!U_PH_X
M0_PW_P! +3__  '7_"MJB@#%_P"$/\-_] +3_P#P'7_"C_A#_#?_ $ M/_\
M =?\*VJ* ,7_ (0_PW_T M/_ / =?\*/^$/\-_\ 0"T__P !U_PK:HH Q?\
MA#_#?_0"T_\ \!U_PH_X0_PW_P! +3__  '7_"MJB@#%_P"$/\-_] +3_P#P
M'7_"C_A#_#?_ $ M/_\  =?\*VJ* ,7_ (0_PW_T M/_ / =?\*/^$/\-_\
M0"T__P !U_PK:HH Q?\ A#_#?_0"T_\ \!U_PH_X0_PW_P! +3__  '7_"MJ
MB@#$'@[PTHPN@Z<!Z"V7_"E_X0_PW_T M/\ _ =?\*VJ* ,7_A#_  W_ - +
M3_\ P'7_  H_X0_PW_T M/\ _ =?\*VJ* ,7_A#_  W_ - +3_\ P'7_  H_
MX0_PW_T M/\ _ =?\*VJ* ,7_A#_  W_ - +3_\ P'7_  H_X0_PW_T M/\
M_ =?\*VJ* ,7_A#_  W_ - +3_\ P'7_  H_X0_PW_T M/\ _ =?\*VJ* ,7
M_A#_  W_ - +3_\ P'7_  H_X0_PW_T M/\ _ =?\*VJ* ,7_A#_  W_ - +
M3_\ P'7_  H_X0_PW_T M/\ _ =?\*VJ* ,7_A#_  W_ - +3_\ P'7_  H_
MX0_PW_T M/\ _ =?\*VJ* ,7_A#_  W_ - +3_\ P'7_  H_X0_PW_T M/\
M_ =?\*VJ* ,7_A#_  W_ - +3_\ P'7_  H_X0_PW_T M/\ _ =?\*VJ* ,7
M_A#_  W_ - +3_\ P'7_  H_X0_PW_T M/\ _ =?\*VJ* ,7_A#_  W_ - +
M3_\ P'7_  H_X0_PW_T M/\ _ =?\*VJ* *MAIECI4+0Z?9P6L3OO9(4"@M@
M#)QWP /PJU110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>exhibit231001.jpg
<TEXT>
begin 644 exhibit231001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%RERT2V\J.I9 JD-A@#U8C\*ZF@ HHHH **** "BO!-,^.GBW6WG72/!)O\
MR"/,^S>9)LSG&=JG&<'\C78^"_'?C#7_ !%'8:UX*N=)LVC=C=212J 0.!EE
M YH ]*HKBO"?BW7M<\4:SINI^'9M.L[-F%O=/&X%P Y4$%@ <CGBNUH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLIMEY&^UV4QN4;</X@5/S#T!Z\UQOA]$\"6M]HGBKX;-JU^LK-:W0M1(),@
M+NP<KD9!&>IXKT'P_I.K'X1>*)[[PMIVCWU]I\R16VGVABEE41-MWKDG)+'
MZ^W- '+> =!\8_$?P7+<7/C;4K2WMIGBMU61V>63 8M(^[)4;@ /8].^K\(]
M6\0>-O!'B/0+O7+N&[MFC2WU#<S31!]W&[()QL/?/-=+\!["\TWX=M!?6D]K
M-]ME;RYXRC8PO.",XK _9\TK4=,D\4?VAI]U:>;) 8_M$+1[\>;G&0,]1^=
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M,9&UB<C!)/'K69X'T#QC\1/ KWESXUU&UBMI)(K6-9'9IG'S%I'W9(R0H'.
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MKQ'X9GUH^'_#4VM_:#%YWE([>5M+[<[0>N3U]*][\ >+?$WB6>^37_"\^BI
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'BW6DU/4=4M[>*QL94M;6\D@6.22-BS?*0<@CIT]0:Q[2XUW7_#GA:X>2?6
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M1L001R"/6N#U>#4=(LO#&G6=WK%\^NS>;?-_:)CDE*P[]B.Q B#'DA<<+@4
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M78V<'&'VG)X]:YK4Y?$GAN32Y/$%QI7B+26OX(DD>U\FZBE9MJ2* 2C$$YX
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M*'+<;<G^$\4 >L45C^%-0@U7PIIE[;W4]W%+;KB>X4+(Y'!+@<;L@YQWK8H
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M=$&CMIJ_8A-]HVB5P_FYSYGF [RW^UG-9MUX],7]H7=KH=[>:/ILKQ7=_&Z
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M!VNI'&1CDUKZIJ5KH^EW6I7LACM;6)I97"EL*!D\#DU9CD66))%^ZZAAGT-
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MJ5HEI=Q1".2))1(!MX!# #.0 ?;-:E%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<;\0'9U\/Z=
M+-)!IU_JB6]Z\<A0LFQV$98<@,RJ#CZ=Z[*JVH:?9ZK8RV6H6L5S:RC#Q2J&
M5OP- 'E=['H_A'Q1XN-M=WEM9PZ! 7%I+OEMF:20;8RV=I.0P[ MGBH[.PDT
MOQ]X8M3I":1%J*7,4\(U5[B6Z00DYD7&." =P).37H]GX1\/6$$\-KHUG''<
M1>3.OE ^:F2=K9^]R3UIMAX.\.Z7-#-9:/:0S0MOCE5/G4X*\,><8)&.G)H
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MZBMO,9$GG\P*=V"-VU<'';=FNZK.U?0=*UZ&.'5;""[2-MT?F+DH?53U'X4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6TS5[F_A21V\J6.5Y,H6 RI*2=<'!'>@"[<^/I-+M-9&L:,]IJ.F68OOLR7
MD2>$DC<D@ Z$8((&.*Z#0-3U#5;)[F_TA]-#-F"-YUD9XR 0QV_=//W><8KC
MM8\(>(/$\.O7]_'8V=]>:4=-LK6.=I%C4MO9I)-HY)QP!P!WKT.)2D*(>JJ
M: /(]5\3>(7\(>.I[E9K?[#JJ16\L%Q\\8#0?NEV@'H2<YYWD5V5MXRN(=8%
MAKVC/I(DM);R"4W*S!DCQO#;1\K ,#CD>]8^H^#]=N;#Q;I<261MM6ODO[:=
MIF#!LP[D9=O&!$2""<Y%;GB3PO+K_B"PG9T6Q33[VSN/F^?]^J*"HQC^%OTH
M I6GC^:0:;>WNAR6FCZE*D5M=-<H[@R?ZLR1@?(&X[G&1G%;_B37D\.:8FHS
M6[2VPN(HIV5L>2CL%\P^H!(R/2N$T?X?7EF^E6<OAKPM#]AEC,^K1Q!Y;A$Z
M;8S&-CM@98L<')&:[[Q'%IEQX=O[;6+B&WL+B!H9I)G"JH88SD\9YXH SM7\
M:66C:AJ4%Q#(UOIM@MY=3H<[2S%8XP.[-@D<^GK4%AXOO&U>PT_6=$.FG40W
MV1UNEG!=5W%'  V-M!/<<$9KF?#/A&Z\2_"F^35;G_B9:^B2M<,F?E0*L!(/
M;$:L1_M&KNB>#;R+6K*Z?PSX9T46B.9+BQC666:0KM4IF-?+4$D]2>WO0!?N
M/'>H62VU[?>&I[72;BZ2V6::X59UW/L5V@(R 21QG.#G%7;+Q9>ZEXKOM'L]
M"D>UL+GR+J^:X553,8=2JXRQYP1VX/?CA_\ A6^MR:1;VLFDZ+_:D%S%-/K$
MMR\L]WLE#G!*90D#GD^F,'(]"\/:+=:7JOB*YN&C,>HWXN8=A)(7RD3YN.#E
M30 OB'Q(=%N;"PM;)K[4K]G%O;^:(EVH 7=W/W5&1V))( %8UQ\1$L='U*XO
M-)F34--N8+>YL8I5D)\YE",CCA@0W'0Y!!Q4GC?PB^O:AI.JPV&G:E)I_FH]
MAJ Q%/'(!G#;6VL"H(.#WK)7P)?R:#?11:9HFE375_:3I:6*!5CBAE5R'D"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "HXH(H PAB2,,Q=@B@98\DG'<^M244 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M"$!E*L 01@@]Z;%%'!$D4,:QQH JH@P% [ #I3Z* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *ANK2VOK=K>[MXKB%B"8
MYD#J<'(X/'6IJ* $      '0"EHHH **** "BBB@ HHHH **** "BBB@"-X(
MI)8Y7B1I(L^6Y4$ID8.#VR*DHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN[J5I;B?3[>261NKLT:DD_4FLN2]\3ZS8:AI]YX6%@D]I,B3?VC'+\Y0A1@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUS26CU71]8O=9@OQ-).^H)]E\L-P(8@P&<>HX Z]J^AQR*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
&444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>exhibit311001.jpg
<TEXT>
begin 644 exhibit311001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 ST# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\^0?*<";"ECL.,/\H)^7/% &E1679^(=,U!('M9WECN 3#((7"R8!/RL5P>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS4M1\)ZA ZZI,\GA18Y$EAF^:[PRL,$<N3P<<GWQ0!Z=!J5K<ZA=V,4C&XM
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 (RAE*GH1@X.*1$2*-8XU5$4!551@ #H!5:YU.UM+ZSLI
MI&6>]=D@78Q#%5+D9 P/E4GD]JMT %%%% !1110 451N=7LK35+/39I'6ZO
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M)V'&U@H9<D;B2@/-0:HVJV>HZNT,.J2:>E]:^8L<<DA,'E8?R@?O /M+!<Y
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MU!)$ZNXW,HVF,,6<[&W< ?=*]2"=U-!TR.]:[6VQ*\HF;]XVUI NT.5SM+8
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MEO([*8!G"$$\XR<$\C)P:DM_#&DVJV@B@ES:2F:%GN9&97*E"2Q8EOE)7DG
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M:/>S9Z \G@9  XZG;T?5+J\U#5M/NXX_.T^9$$L2D)(KH'!P22",X(R>@/?
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MJ16D=A&XU>RM#(;<Y=)4CY;##<PW8!] !3X/$NK/#;PR"(RF^O+26YAMV?\
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M\FBTNR26]!%TZP*#.#UWG'S9]Z ,"_O=8@UW1+8ZE:F*;4Y(V\F,Y>+[+)(
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MCY^/FXXY[5'9Z/86%]<7EK;10RSQQQ/Y:*HVH"%' YQD]>U %^BBB@ HHHH
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M;!Q[]:KWW@^[NKVXOXM6CANR]K-;L+4E8Y(0P^8;_F5@[ C@C/6@":;Q2O\
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MSPI#%#N;S(20ZDYQVZYP?6I8_%FFW%K;W-J+BYAFAAG+0Q%C'',<(S#KSSP
M2 "3@52L/![Z??6]RFHA_(N;FX5&MP!F8<C@C@'.*CTGP7-HC6GV+698T2SA
ML[E1"I\]8L[&!)^1L,02,Y'8$ T 78O$=O$+UF:[N3'>R0;! %,92,.PSP-H
M )W,><X]*;I^MOJ/B>-+:<2:9<:3%>PC9@Y=R <]>5QQ4$GA"22XEE&ILJRW
M\EX\?D J=\83:03R1@%6['L:GT+PNVBSV4GVXSBUTR/3@#%M+*AR&R#U[8H
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M%+;49VW=/O$R-VQTP!B@!8O%T0NM2ANK5X?LVH?88"9$'G-Y*R]2P X+'G'
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M"L>006##\QFF/X<U>;0ML6FO;7:^'KC3[J,2)_I=PRJ$(.[! (D.YL']Y[G
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MLC /3/;H] M+Y?$6KZE<Z:;&*\AM@B-(C-N0,&!V$CN,'TH V(]0CQ,;EX(
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M_=,L4C] #D_NR",C&:YX>&=6L=!_L:UCMYK:QU""[L':3:TD:3)(8Y./OC#
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M1110 A (((!![&EQ@8%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2;1NW8&<8S2T4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M);NAP/F^ZPC'O44_@2XE2[,%Y#:/*\<XB1&>W>=)?,\QHB<+NQM8+C.2>N,
M&])XFTU[&26VNMTH\U53R)&=7C^_NC W *2,YQU'J*71];%SX1TK6=09(FN[
M6WED"*<;Y N%4<GEF  Y/(K,'AC4HK^TU*"YT^*Z6":VN(8[8K"4D*'* -D,
M"@Y).<GIQBW#X<>/P-9^'IS:W9@MH;>0RQ'RY53:#QDD$A>#V.#VH MMXDTJ
M,2;[AT,<$ERX:"0$1QMM=L%<\'@CK3Y/$&EI-#";L!YG2-#Y;%=[C**6 P"1
M@@$@\CU%<Y+X*U$6B10ZHK,;"[L'-T'E*1S.&0!B06V !<MU'/M5_2?#VK:/
MJ,SPZE;/971AEN(VMSO$J1I&=AW8"L(UZ@D<XZ\ #_"_BF+6;:""ZD1=2D$S
M[$A=$98Y2A*DY!Q\N0&)&:=XJ\2#1--N&M71[V'RB4:%Y%57<*-Q7A<\XR1T
MJOI'A:[TZZTB62YA=;!+M&"J07\^17X],;<>^>U1:UX3U"^NM7-G?V\=OJJP
M&59HF9HGBP,K@C(( X/0C/>@#7AUVU%Q>I+=K(8KS[*D45M)O5Q$LA0CDN<9
M;*C&"/0FI&\1:4LD$9NL&=HT0^6VW=(,HK'&%)XP#@\CU%8MWX0EO#J8N#:S
MQWNHK>A27C:/$"Q HZG*."@;<.Q(]ZFTCP[K&D:B[IK$=Q;7(@>[,\!,KS1Q
MI&S*0V '$:YR#CG'7@ ET?Q,LVDB?4W07)N;R();0NQ9()WCW!!N;&%7)Z98
M>HK137],E\KR;KSEF2.1&AC:12LF=ARH(&[!QFL/3_"E]IEY:W\%W US"]Z'
M1E;8\=S-YV/4,K!1GN >F>([3P-]@FTDVMPL;:>D2"ZCW)*Z*Q9XV .UT;)P
M#]W)(S0!L_\ "5:+]F2X^V'RGM'O5;RGYA0@.W3L67(Z\]*1O%FBK9O>-=2+
M;H"SNUO( J\?.?EX3G[Q^7KSP:YZ/P/J26:6IU&U,4.F7FFQX@;)69D(<G=U
M&P9'?\>+]WX5O9+^SO()]/++9)974=W:^<I522KIR,,"S<'(.1Z4 ='=7]M9
M)&T\A'FMLC5%+LYP3A54$G@$\=@35 ^*M$%G'=_;E-N\*S^:J,52-B0K.0/D
M&0>6Q]T^AIFNZ/>7LFFW>FW44%YI\QD3SXRT<BLA1E8 @C@Y!'0BL^]\*7EW
M)JF;^)EUBP6RO=T1&P@.-\8R>TC#:?0')YR :C>)](746L&NF%PMP+9AY$FU
M964,JEMNT9!!&3SGC-4X/&^C26<=S*UU")9IXHD:TE+.8F96P I)X4G'^!JK
M)X2N?M-R\5Q"L4NIVM\BD$E5A2--A/<GR@<]L]\4ZP\*WME>Z<YO()(+*]O+
ME0(RK,L[.<$Y(R-YY[XH V4US3Y[M;.&Z7[1*9$B+1ML=TSN"M@!BN#D YX/
MH:S_  _XHBU'0=*N;YE6]O+:&:2.")RJ&0[5Z9V@L"!D]CZ57L?"<UI_9]O)
M<QRVNF7LUY:'!$C%Q( CGIA?-;D=<#@<YIVG@BXM[;1(_M4*7&F0PPI>0;HY
M<(^74C.'1UP-K< Y/- '2ZGKNFZ-_P ?]SY7[IYCA&;;&F-SG:#A1N7)/ S4
M+^)](CU%K![IA<+.ELP\F3:LC@%%+;=HW C&3@YP*S_%WAJ^\26\UK#?PPVL
MUC<6KQ2Q%P'D "R###)&#USUR.:AG\*W\]Q=S-=VVZXU"SO3A& 'D"/*]3][
MR_PSWQR 6[KQ(/\ A)-(TZS=)8;J:>&=C"^ 8XV)VO\ =)#+@CGOTQ5G4_%>
MBZ-<R6]_>-#)%&DL@\F1@B,2 [$*0%RI!8\#N163IWA/4+"\TM3J%O)9:;=W
M$\(,+>:Z2A_E8[L94N>>^!Q46K:;=:KXOUJQC CMKW0XK22=XV(7,DV[:<8+
M!7!VY_B'X@&X_BG1DO+FU:[82VQQ-^YDVH=JL 6VXR0RXY^;/&:E3Q!ICB3;
M<-YD<P@:$Q.)1(5W!?+QNSM^;ITYZ5BS^#I)K36[9;M(5O;BWN;9@I8PM L0
M3<,_,,PJ3TZD>]-O/"=_-JG]NVUY;P:N+F.8*R,\!18FB*'D$Y$CG=Q@XXXY
M -<^*M%6SBO/MP-M*J.)1&Y559MJER!\@+ CYL<@^AJIJ?B9;?6M(LK-EE2Y
MOI+6Y/D.V-L$DAVN/EW!D (Y/)[BJ]SX7U"76UU'[7I\QN+=(+M;BRWX*,S!
MHOF^7[Y&&ST4G.#F.V\)ZA;7EBJZA;M8V6K3:E$&A8R$2K-N0G=CAIFP?3''
M'(!J/XMT-+(7C7O^CFR-^'$+D& 8R_W>@R,CJ,]*>_BG1XH#/)<ND2G#L]O(
M F6*!FRORJ6!PQP#@D'%<O\ \(#J1T8Z:VIVGEIHTVD1L(&SL<KAS\W4!>16
MQJ'AJ\N=?74H9K#;/;1V]U%=6OG;=A8AXCD8/SL,$$=#VY -RWU2SN[IK>"1
MGD7>,^6P4E&VN V,$AN" :I0^)M/DNM1MW\Z)K&Y6U<O"WSR,B, O'S'YQP.
M>_3FJ^F>')+#Q'<ZHLJ0I<"7SH8"P2=F<%'9#PKJH(+#EMV3TQ52\\)W<VIW
M=[#?1(SZG#J<"M&>'2%861CGE2JGD#(+9YQ@@&_;ZE!J.GS7%A,K["Z9="-D
MBY!5E.""#U!P:Q/#?C33]8T6RFNKA(K]M.BO;B+RG10&4;BFX?.H8X^4G!P.
MM:>D:/\ V=%J#.X,U_<O<S;1\JLRJN!]%5>>YR>,XKG#X"EN-#LM/NKZ-9=.
MTS^S[2:*+/0Q,)'4GGF&/Y>GWN3G@ ZRQU2SU+[0+64LUO)Y4R.C(T;8#8*L
M 1P0>G((-8L?BN&7Q*EM'-&=,.FR7IG:%USM=%!5CPRD,>@/;GFKNFZ1.FDW
M-MJ!LEEN5*2?V?!Y* %<9&223[D^GISSI\"ZE<V4-I>:K;;;?2VTZ.2*W.XX
M:-DD(+8R/+&5Z'GUX .E'B;26,JBX?S(I#')#Y$GFJP7><IMW?=(.<8P134U
M^S6ZOO-OHC% \*",0.KHT@&T$G[Y8D8VCVYK'N?"5WJ&F)#>C2Q<!BX>RA>V
M\I]N%DC=26#CGO@@X]S2UW0[VQM+VX:8W,EU/8E9EM9)6B:'!,C+'\W)7JO0
MGGC)H Z+_A+=%_=XN929)I($5;64LTD8)=  N=P"GCV(I[^*=%2PAOC>C[++
M$DPE$;E51CA6? ^09R,MCH?0UAZ-H]]<MIMXT=O"+*^GNB1'*AN3+&RLV'&Y
M3ND8\\?*,8'2&R\#7U@UHT=WI\N+1;2Y6YM/-!57=U>/)^5OWC @Y!X]* -C
M5?$HMM7TFRLW23[1J'V2X+0N0O[IW(5QA0P*CCGJ>.*Z*N0C\):A#>P"/4+<
MV,&KR:I&'A8R?O!)OC)W8^](Q!],<<<]?0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5;S4;6PDM8[F0HUU
M,((<(2&<@D#(''"GKZ5F/XPT9(XG$UP_G"<QK':2LS>2^R08"YRK<8_'I4^N
MZ3-JL5DUM<1P7%G=I<QM)&74D @@@$'HQ[]<5D6/@^[LY;20ZG#(;<WY_P"/
M8C=]ID\S^_\ PG\_:@!_B/Q=#9>'9[W2IDGG$$5PA\EI$$<API;&,9&<9^N,
M5J7'B72K6]6TEN&$K.T2D1,RLZJ7* @8+;03CV(ZC%<ROP_O8-(FTZVUB$17
M-A;6DYDM"QW0J%5TPXQE0,J<].M:UIX9OK+4[V2+4+4V5S*]P(WL\RI(X^8"
M3=]S=EL8SSC- &GIFOZ?J^FMJ-K)(+,()/.FA>)2A4.&!<#(P>HXZ^E5W\6:
M/&DC2W$D>Q(Y2'@<$I(VU7 QDJ3QGMWQ19^'4B\$P^&KN?SHET\6$DL:["R^
M7LR!DX./<UEW?@NXU"R87>HQM>I8K90SI 0HVNK[F7=SED3(!&,'UX -:Z\5
M:1:-*DLTV^*[%DR);2.WG%!(% "G.58$8X.<#FKDVK6MO!:RR&4?:B!#'Y3>
M8QVE\;,9!"J3@C/'K7/KX2OFOY+N74[=GDU6+4F5;4@92!82@^?H=N<]O>M7
MQ%H::_91VLHMVB63>RS1DG." 492"C D$,#GJ.^: #_A*-)PY-Q(-DT$#9@<
M;7FVB,'CN67GH,\XJ&#QCH=Q?):+=2(\DDL2M+;R1QF2(MO3>RA=PVL<9S@$
MUE2^"K]MRIK2NLCV$TLD]N7D>6V9#N)#@8;RQGCJ3S572O#4FMZ?/!J8DAM(
MM7O[A(F@:.1Q(\RJ<M_#ME+ @<Y'H<@&_)XRT.(2>9=2*4,.5-O)DB9MD; ;
M<E2W&?7KBIK?Q/IES]H"M<I);QQ22Q2VDL;JLA(3Y64$Y((P.XK(3PEJ;Z''
MIUSJMF[PSVSQS1V&PLL,J2#>-_+'8 2, <\5L7F@QW?B&RU?SF1H(FBEB ^6
M<9#)N_W&!8>Y- $<'B&S#W2R79G9;Q[=(H[5U=2J!V3')<@9.X#!R /=4\06
M2WMZ)+X&.%;?$/V=U96ER%P?XRQP  .,5EW?@MKV&_AGN+::.[OGO%#0,&A8
MHJ*4<.&5EVYW#&<D<=:)_!=Q//-<-JQ:?_0GAE>')$EN2=S_ #?,&W'(&.O6
M@#3;Q9I"M&AFF,LD[VPB6VD9Q*B%V0J%R#M&1GJ.1D5I:?J%MJNGP7UG)YEO
M.@>-BI4D>X/(/L:P5\)RC6X-6^V1"X%^U].HA.UR;8VZJOS< +SGG)].TV@Z
M5JFAI8Z=]J@N+"&"02L("C&0OE2#O/&"1C';.>U $X\3V(U+4;.59HOL+Q1L
M[1MB1Y,;57 Y)W* .ISTXS5^PU.TU..9K:0DP2F&9&4JT;C!*L#R#@@^X((X
M-8.H^$9KW4;Z\BU!8C-<6UW"# 6\N:' &3N&Y2!@C /)YK4TW1ELY-3GF<23
MZE,)IR@*J,1K& !D_P *#GN2>G0 %63QGH,*RM)>,%CB2?/DN=T;-M#K@<KN
M(&1TR,\$5/%XGTN8/LDF\Q+AK8PFWD67S GF$;"-WW"&Z<@BL.'P5J">&Y-$
MDU:U:)(XX;>5;':_EHRL/,(?YVPH&1M'4D'M/?>#'U"75#<7%K-%?WBW6QX&
M#0LL"1*4<."K#8&##'4COF@#6/B?25\S=<./+F@@?,+_ "O,5$8Z="649Z#/
M.*C@\6:1<F0127!V2M#DVLJAI%9E9%)4 L"C9 Z 9Z<UD7'@N^D:0)K*,DKV
M$TCSVY>1Y+9T;)(<##;!GCJ3S4LG@^Z.D+!%J4*WD.J3:G;RO;;HPTCR$HZ;
MOF&)77((/0]J -2;Q-IZ>%KKQ# SW%E;PR2L(T.X^7D,N#R""I!STP<UF)XP
MCM]?O8+\M%8K;V<D+"VDRC3/(I\PX.!E%Y(4<UJW6BR7WA6\T:YN8Q)=VTL$
MDT,.Q5,BD$JF3@#/ R>G)[UCWG@^]OEU$RZG;B2]M;2W)6U("&!V?.-_.=Y&
M,\8[T :\GB?2XYYH?-E:2-9FPL+'>8L>8%.,$C(X_P #@B\267_"*1^(KD2V
M]D;9;E]T3%D4C/0#)QZX]^E9/_"'WLFM"_N=5BE >Z S;'S/*F'";M^,)@ <
M8P.F3FK<WAJXG\ -X9DOHO-:Q^Q_:5@(4#;MW;-W7'^UUH F/B_1UN'@>6X1
MXYX[>3?:2J$:0@)N)7 #%@ 3P3]#2S^+-*@6Z/F2R-;PSS;4A;]X(&"R[3C!
M*L0#SW].:I:AX4NK^;4Y/[0A0WTUG+C[.3L\AU;'W^=Q7VQ[U6/@F\FOY+FZ
MU:*4O!>VS/\ 93YC1W#*0"V_^#8 .,8["@#5_P"$MTJ.SMKBZE> 3)$S!HV_
M=>8=J[CC@%N,G'KTJ&?Q=ILJ,MM=S0F.[CMGFDL)FC#^<(S'G  8GY<YXW \
MCK5M?">H6FH0W*:G:,KVT4%VKV.[<8\@/$2_R$@X.=PX!Q4C^%+E]%N-/_M"
M+=+JPU(2?9S@8N%GV8W<\KC.>G:@#1;Q#933S6=K/_I82<Q[XFV,T1"O@\ [
M6(!&?ZU5M]==OAU;Z_>7"6LCZ6EW+.(&E6)C&&+; <D G.,]!UJI%X2OUUM=
M2EU6&9T^UJI>U.\I,055FW_P;0!@ 8'3)S5M_#,C_#P^%?MB!SIG]G_:O*.,
M>7Y>[9N].<9H L2>*M)AOS8R3RB=)X[=S]FDV+)(!L!;;@;L@ YQDXK/M_$T
MEQK5ZK2B"UL[[[%Y#6KE[@F%'&P]FW,>,'Y5SQUI+KPE=7,][*=1A4W-[97>
M/LY^4VY0[?O\[C&.>V>]+)X1N&O)KU=0C%Q_:PU. ^0=J'R1"T;#=\P*9Y&,
M$Y[8H NR>,-&1(")KB1IVE1(XK65WW1G#J5520R]P>>_2FIXRT:25(XY+IWD
M>6.,+9S'>\3%70?+RP*GCK@$]*@M/"CVFL6FHK>(7CN+FYN%\D_O'F 'R_-\
MH 4#OG%,L_"ES:7-A-_:$+_9-0O+W'V<C?YYD.W[W&WS#SWP.E %X>+=%:"W
MG6Z9HKB.*57$3X59'V(6X^7+<<],'.,&JX\4VUS-)$DDMH8=36P+36KN)FP"
M5!& N<D D\8!QR*QF\ 7YTRWL#K4#PPPQ(@DLRP22.8R[U'F<%AA3U.%&"*T
MW\)W33RLNHQ")M6CU,*;<Y!4#<A._G)'!QQ[T :8\2:69UA%PV7\WRV$3E93
M'G>$.,,1@\#DX.,X-&D^)-+UN0)8S2.S6\=TGF0/'OB?[K+N R/ITK*M/!SV
MT-C;->I);:;///9 Q'>ID610'.[Y@HE8< 9X].9]!\+S:-<:=(]]',MGI4>F
M[1"5+["/GSN.,XZ?K0!;;Q3I*WMU:&6<26LGE3'[-)M1\(0N[;C)\Q,#/S9X
MS5%_%4=QK.EQ6,\9M)9[B"\$D;*\;QQE\<XQV/0Y!!!Q27OA*:\@UU/[06-]
M1O8;Z!U@SY$D2Q!=P+8<9A4D<9R13F\-ZC/+IUQ-J5M'<VK3.QM;/8N7C\L;
M 7.,=>2V3Z#@ #[GQKI4.GO=P_:)PC6P*+"X;;.P6-\$?=.?TQUXJ0^)["UN
MKM;F\=@MW':I$ME*&CD>-6"'@[B<Y!P!R!R:QH_ EZ+>[635K=I[B*R!D6T8
M9EMI3(';,A+;N_.>^:O3>$[J;4Y[PZC"/-U&WOROV<\>5&J;?O\ ?;G/;T-
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METVJASO/\(.1CKSD=*KZOX4N-3O=4G2_BB%\EF@4P%MGD2M)UW#.[<1VQ[T
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MZB\+0;RLT31G*MN&%;RER"#SR#VH T(_%&GRO H6?=-<3VRCR\GS(=V]>/\
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M!/J<>O%=3&'$:B1@S@#<P&,GUQ0 ZBBB@ HHHH **** "BBB@ HHHH ****
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MK.>[@7:C-,(F57555B=V77&>#GK3E\:VKD)%97$\IU#^SBL+QLOF^3YP.[<
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M>)J&GV]Y''+&D\:R!)D*.H(SAE/0CN* +%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!F:AHR7VHVE^MW<6US:QRQ(\.TY23
M;N!#*>Z*0?:JL7AV"'4=(\F,166CPNELF<EG90F?P7<.>26]N=VB@#'N?#ZS
MZ\=8CU&]M[DVOV7;%Y14)NW=&0G.?>J;^"[%+>T%C=WMA=6TTDZWD+JTKO)_
MK"^]65MW&<CL,8P*Z2B@##D\,6T]]:7<US<RO:2"6#S"A,;[-A(;;NP<Y(S@
MG\17.W_A*ZM9-,L;(:C-8V5H889XOL<C;F;+"19DQC"I@H,]<C@9Z_4M433Y
M+. )YES>S>3!'G 9@K.23V 56.>?UKE=$\57-OH6V>VO-0U'S[^0PH"[^7%<
MN@7*@@MC:HZ XZB@#4?PBE[%</?:A=&ZO/LKW+0[ OF0$,"H*< L.<Y_"E'@
MNR,.HV<M[?2Z9?><6L&=?*C,N=Y4A0PR68X+$ DD#I@_X2RWN;F]LXH)1+;P
M^9)"7$=PJF,.&\ML''.W/]X$'I57_A,[:STB&5+6ZN1%IUK>2AG'F%)B43&>
M';*G/3]<4 :NE>'AIFHRW[ZG>WMQ+:Q6KM<^7RL;.RGY47G]XV3WS574/!>G
MZI+=2WD]S))<6\]MYGR*Z1RL&(#!<D*0-H;./>F'Q>%U22T?3+E(XM0CT^29
MG3"R/&CJ< DD?.![4P>-[80&[?3[T6#V_GP70B.R7+*JID@ ,Q9=HS@@]1@T
M +-X)M[AIYI-5U$WLMQ%=+= QAXI8TV!E 3;RI((((()XJ>Z\)6]YYC3ZA?N
M\MA+82.6CRR2'+M]SALCC' ["F:!>7UQXD\107A95@D@$47F;U0-'D[3@<$^
MHZTU?&,3) WV&8F6>\@VJZDA[<N&ZXX/EG!^F: -*_T*'4=%ATR6YN$BB>%Q
M(A7>3$ZNN<J1U09XJI'X3M8[J"X%Y>%H=1DU)02F#(Z,A!^3[NUVXZ\]:IV_
MCJVDMS-<V%Q;[[2VNH%+*QF$[;$48/#;\#GU!]<5K'Q%=6FM:W;7J2RSMJ"0
M6EN&+JH^S)(<%5SM^\?NYR: +D/@BWM%LC9:OJ=K+:(\*2QM'EH68-Y3 H00
M".#C</7FK%QX1L[BTUFV:\O%CU9U>;#)E-J(@V$J?X47KFH[/Q7+?:A:64>A
MW\<LUNMQ(+C;$85+E#D$Y.",].1TJ?5?$\.F/J 6VDN!IMLMU>;" 4C;=]T'
M[S81CCC@>I H CG\(V\VJ/J(U&_CN&NTN\H8\!UB,6,%",%3WR<\@BG:1X3M
M-&FTZ2"\O)/L%FUE$LI0@QLRMSA0<C8HS[=Z8OBZW:5T6V=E34H]/WJPP3)&
MDBN/;$B^_6K6@Z[)KL<TPTZ:VMTDDB625T.]XY7C884DC!3.?>@!O_".1)KT
M^JPWUY"+DH]S:HR^5,Z *K'*E@<!0=K $*,YJFG@C3TT];#[3=FVA@FM[5"4
M_P!&2488(=O.%^4;LX%,B\;6L\#3Q0;XEO(+-PLH\R-Y9?* =.JL"5)!['@F
MG2>,#]K2SM]*N+BY>[GM%59$52\2;R<DC (]O_K@#Y_!EG.L^Z^O@TL%I#N!
MCRGV:0R1L/DZ[B2<Y!]*D?PC9RV>H6\MU=O]MNTO3(60/#,FS:R$*,8,:GG/
M3T.*I0^/+>[L4N;/2[^X=8EEN+>*(O+$#(\97"@@L&CDXR.%X)XI]QXR>"#5
M+K^QKDV>FS-%<3F5 !M*Y; ). K;B?13WXH NR>%;669+B2ZN3<B]CO9)AL!
MD=$V*"-N H7L,?7.:M7VB17FJ6VI1W,]K>01/")8=OS1N02I# @\JI'H1[D&
MG?ZRBW^GQ&*X$<FI"UCEAD 5V\IF.[U7@C _B7VK/E\86M_HD]Y$DWDQW%O&
MQMIU$L;O,%V2 X*,#C<O/#<9H UE\+Z6B:,D<3(FD<6P5OX=N-K>HR%;_>53
MVJ)?"\46HWMS!J5_#!>,9);-&3RO-*X+C*E@>^,[2><4Q_%ENLT9%O(]H]^V
MG+.K#_7@E<%?[N\%,YZ]L<TW0?%J:Y<VD7]GSVHO+)KR!I'5MRJRJP(!.""Z
M_7/M0!K:7IL>DZ-::9!-*\5K L$<DFTOM48&< #. .U9=IX1M;.#288[Z](T
MOS/(9C'D[U*G=\G. QQC'XU9\2:M<:-I]O<6UND[RWMM;%7?: )950GI_M57
M_P"$KM_/A)MW^R27YT[[0&!Q."5P5_N[P4SZ]L<T 5#X!T_^SH+(7^H".#3E
MTZ,AH\B-65@3\G+94=>"."#FK-OX/M[>_BO/[1OWECO7OAO,>#(T1B;.$'&T
MGCU/X5)K/B.73-26PMM)N;ZX:TDNP(G1051E5A\Q'/SC_/3.C\?VDT$]Y%87
M3:=!;174ER60?))&73"[LDGA<>I].: )[?P/:V36CV>J:E;R00M;NZ/'F>(N
M7V/\F!@LV"NUAD\U/-X1MI;^6]34+Z*>2^2_RACPKK#Y. "A!79CKDY&00:B
MOO%ZZ:;^.[L'6>Q6&:95D!402,5$H;'(4JVX8R-I//&9[[6D34M-B>.X6.74
M6MHY8I $=EAD<[QU*_*PQ_>7VY #2/"=KHT]A+!>7DGV&T>SB64H08V96.<*
M#D%% .>W>I+GPO97CZP;B:Y=-5C2.9-P4)M&%*$ $'ODD\BL*7Q:3K6F:J3-
M%HDVD7=Z &!\Y4:$JVWJ&VL2!GHPZ'(KI-+U:74);N*73KJU>W*X:2-@DH89
M!1F R1R".Q]B#0!B7_A[4DN?#PBO[^_:UOS//>3M#O2/R)8QP JGEQG"Y().
M<XJZG@ZQ@E$UK<W5O.T4L,\J%2TXD<R,6RI&=[,P( QN(Z<57M/&9O+6"9=)
MN8_M3LEJKL&,A0OOR$W%0-G7!^\/<A\GC..&.QDGTR[MENC;J4N0(Y%::3RP
MH0\G:V-W3 8$9S0!:B\):? NH11O.MO>V4=BT *[(XD5E4)QD'#'J35:Y\%6
MEW!/%/J6H-Y]@E@[YB!,:,6!^YC=\Q]O:A?&MBQNL(&,%R+3RUD'F"9I1$B.
MAP4W$@@GC;S1+XP6&Z^PG3IVOEOEL7B1UVAFB,J,&)&5*CTSG.1Q0!4\0^&K
MAO/GLFOKAKV\BGNEB:WWH(X]JF-95V'E4R&],CFK^C:5JMM]@,U_,MO!Y@-N
MZ0J71@-H<1J%W*P)!4@8XYSFJMQXZ@MM!75I+"98ECG>96D4%#"^QT7^\V0Q
M Z$*3D55B\37.E:YKB7D%U<Z?'J\%L+@.F+82P0;1MSDKODYP.-W?G !M:AX
M6L]0N[Z=YKB--0MUMKV&,KLG09QG()!PS+D$<'V!%S2](ATJ2^>&::3[9<&Y
M=9-N$8JJX7 '&%'7-<WI?B2>UM+F"1;G4;UK[4/)C )8Q0S%<< ]-R*..XZ=
M:Z&;6/+T6#4A:3J)A&?*G'E-%O(_UF?N[<_-UQ@]: ,\^#K;9J<"ZCJ"6.H>
M<SVB2*$B>4$2.AV[@268X+%023BH_P#A"K<K.3JFH&>6:WN!-^Z!22$ *R@1
M[>0H!!!'H!38O'%G-#I[+#LDO3,L:2RA SQ2>6R(QX9L@D#@D#/M1)XVM4@U
M&>.#S4L)3%.BRCS4(D$?S(>5SG<.Q7G- "R^![*?3)].GO;R:TN)9Y98Y/+.
MYI7WDCY,@@YVD8(R?;$P\'V>_48WO;U].OS*TVG,Z^2&E!$C#Y=XSN8XW8R2
M<9QAEYXO%K>3VD>FSSSQZ@NGA4= &=H1,IR2,#:P'L<TI\7+'J2V,^G313.D
MI6/S$+[HT#D$9P 03@YYQVH L:3X;72M0^VMJ=]>3?9$M,W'E_<1F*YVH,GY
MCSWJ'4?!NGZM-<R7TUQ,T]O/;9^0,D<PPRA@N2!V!)Q^6*UIXYMYX8Y)["XM
M_/M;6YME9U8RB=Q&B\'@[R!SV.?7%NY\2RVN()-)N3?MYS);KEO,2+;EU*@Y
M!WH!D#D\XZT 5YO!%O<?:)9M5U%[R5X)5NLQJ\4D60CJ FW."00000>E6IO"
MT-Q-%//J-]),EG/:&1C'EUF*EV/R8S\BXQ@#'2I=0\0KI^@6VK-87;+</;H+
M=E"2H9G5 &#$8(+@$557Q3(;I+<Z/>M(D\=M=K$ID^SNZJPR5!4J Z%CG@-G
MG!P 6[KP[;W7AJ+0GN;E;>..*,2J5\PB,@C)*X_A&>*@;PG:M<R3F]O-SZBN
MI$9CQYJH$ ^Y]W:HXZ^]5H?&D4\D0ATVZF2>VNKF$Q%2S+ P1@5)&&+,H YZ
M\XP::?&T6QUBL)+B=+^.PVP3(R%WC612&)&1A@.G4'MS0 __ (0JWB^SO9ZK
MJ5I/;2SO#-$T994F??)%AD*LA;!&02,#GBI[GPC9W-MK-N]Y>^7JUNMM/\Z$
MJ@0I\I*DY()R3FLN_P#$5W>W&C-:136T/]KK9W/[U3EPC;T('50PVY!ZJ>,<
MU-9^*R(K:&VTZ^N9[JXOD19IH\JT,K*REL],CC&<#% %RY\(6]S?O??VC?QW
M#303;D,> T2LJ\%"""&.<YYP1C I^E^$[72;C3YH;R\D-C#/!$LK(05E=7;.
M%!."BXY[=ZI3>/+-=+CU"&SN)8SIL.INF0KB*0X4 'AFX.1D=.O(K2UW6+K3
M(M,-O:+(]Y>1V[+))M\L,"3TSD\8_6@ ?PY%_;\NK0W]Y;FX"?:;:)E\J<IP
MI;*E@<<':1D  YJO#X-L(8([=;BY^S0-,UK$2I%N90P8J=N> [@;LX#'VQE:
M'XJDM ]OJHG>)K[4D2]=U.%@ED.T@<X"+UQ_#6_I&N/JMS+$VFW=LJQ)-'++
M&P216SQD@?.,<CGJ,$T 4'\#V$EH]LU[?%&TZ+3L[H\B.,DJP^3[V3]/:K$W
MA*RN8=6BNKJ[G&I^69BS("K1J KH548(VJ>XR.E5X_&&]ILZ7<I&MV]E&[,K
M>9,K$$!5)., MG!X![\&NNN7EYXAT=A;WUHDMM?":RE787>)HPK#.,@Y)4\
MAATH T)_"EM=;Y)[RZ>Y>XMIWN!Y89C P:-<;<;0V3P,\GFKNHZ-%J%]97PG
MFM[NS+^5+%MSM< ,I# @@X4_516%;>,;>VT/1KDV]T]O=VUHZRW$JF1O.947
M_?9207Z8!!&<XJ#1O$UU:W4EK?V]U/;SZQ<V<-X70A6#ML0KG(&%P#CKCZT
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M!M/S'<N/7-07?B*.YM[&XC@:6TFO;2..:"Z9-QD"L#P!N4;EX/#9.<8H :/
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M^)9-1E TW3FN(XS;BX)F"-&)5#Y /#;592>1WQDC% $4?@FR@:UDM[_4;>>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA_3I;VYO#'.EQ<JJS/'=2H7"YV@[6' R<?4U:&FV0GM)OLT?F6B-';MCF-6
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M,>..2)6#LIV/C<O!&0=J]>X![4 <II_BN\T^R2RNK:%Y4M-.-NT;GYOM#-$
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M >>0 .@H YQM:DTOQ1JMQ)&OG75OI,*Q"0M&DLTLR9SW R.1C./>K5YXPNK
MW\-Q: -878AN+J*%Y(UC:(2+(47Y@.0K==O7I6[-X=TFX-R9;)&^TQ1PRC<<
M%(R2@ S@;2201@@G(IQT'3B@7RI =YD+B>0.S%=I+,&W-\H Y)X ]!0!A?\
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M&.^:OV&JZY/XKLK2[-E';3:?+=&*%68GYXPN6..0&],=?48TU\,:.EO-;K9
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\Q)XA;3.I90Y Z [23R <]JSM(<Z9>X$,$UZVJSZ=92^6<PQI%G;\T@W#;&
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M)./3- '-V_BW4-4.S2I+%W@MH+F5KA&A617=@_!.Y,!".APW!]X$U*77-?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7I098UE6(R*)'!*H3R0,9('MD?F*X&YU.36=7T*\>5$6W\1W%F+?:,IY<4Z
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MKM[R.2R5</"84E9<'KG]UM;.>6&,=" =Y17%MXFN(+2PN&U:SGMM2DM469$
M^S>8&+,><;2554SR"3G=BFWOB#4]/DGA?4+6?R])O;I9DC 4R0R*$[^C88>H
M.,4 =M17!7'B'7GBUFYM[RTCCT[28;Y8S:EO,9XI6()WC W(#^E27.MZY%,-
M/34M-2]:Q^WQ2W0\F-\MC81\Q*KCYB"#\Z^G(!VSRQQLBO(JESM0,<;CZ#U-
M/KSRXU276]2T.\DDCC%OXCEL_LP4939%,N23SEL;O3#+QW/H= !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR,_<P"3'CN?]GG).+MMKVI/J6G0SS2"TNXXHUFM!&P25K<OMD4C<IS\X897
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MF*G[V..>U6)-*TZ7/F6%J^8O(^:%3^[_ +G3[OMTKB-$U:76=6\+75S<137
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M6>*>,,4+Q.&&X'!&1W!!!J:N;\%D'3-1P1_R&+_I_P!?,E=)0 4444 %%%%
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MFZ0G:516N)$FD52,G8GSGZ#/&!70Z#>W<^JZS:R7/VNRMWB^S7.%R=R99"5
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MK)8+?231R&-8V8[8F8$;U/((%84/B;4;I=2GAUFRBO+..]6739\%HFCW>4[
M*&11M4EB2&#<=10!W5\]E#;_ &B^,"PQ$'?-C"DG Y/3DBG)9VL;*T=M"C+]
MTK& 1]*\]?Q+?/H.KZI:Z_&\,*VOD 26TK(S%1)NV C!)P,GUQQBCQ'KFIFS
M\36OVN7:-.OY+.:S=&3,8'RL,;XW7IW#;B00<  'HDMM!,298(Y"1M)= >,Y
MQ^=--E:%)$-K"4D&'7RQAA[^M<--K=PMWKLL7B67[%IFEPW<9BAAF!+),"Q
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M]#7G5[XLOK73+RW&N_Z9;R:DL,CK$IE\G;LW-MV[AN VA<M[ '/0>'KZ._\
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M4Q:S>PV\YPIGB6"4*W& 3SMR!@D9[UZ!0 4444 %%%% !1110 4444 %%%%
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M?)D;2Q_@!R!P!4%AJ<M]J7A\7-QYKV_B"\C0LQ.(_L\X0;B 6&&4 GDY7UH
M]%$:!RX10Y&-V.<4%$))**2>N17+ZI+>2^-[:RAU&XBB&GO<BWB95$DB2IM!
M)!."-P(],URW]OWTWAB;5(?$<ZSK%:K>6_V;:UK,9D63<7SM.&8;0 /ER/<
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M/E7(7H6 &,UV4.MV=Q+<10B>1[:[%G,%@<[)"JMSQ]W#J=W3GK5]'20$HRL
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M(L;'<B%0V"!@G+KQUYH \VU'4M;L=$EA^UZHUQ#!=RV,S!R98UF_=%MHR[[
M/O<;3D@Y-:NIZKK<6HZHVG>;>L\$[V@A9P\#+&,(\+?*02,JPQDG!'-=Y!<1
MW$:,NY6=%D\MP5=0>F5/(_'TJ6@#SN/5I$:SNHM4O[C0[J^5;J4PS1_9AY3X
M7<Q+A3((]QSA2<<9.+WAYKZU^'&I'2XI9-0BEU%K59U.YW\^9H\[NN<J??-=
MM10!YKJ5_J!@:;2M0O\ ["\%DSNSL7CG-PH=?FY!,9;>G1< X&>>G\,2W'_$
M\MFGFG6VU!TMC/(7/EF-& W'DC<7&>>F.U='4+W"QW,,!24M*&(98R57&/O-
MT'7C/6@#S2>^\07/AI)[.>^.IMHUVVI0AFW0W:H"FU?X&\S<%4<,O8@"K.HZ
MS=75QJ#V=_?);&[THQ2)O4;'E FVDC&-F2>W&:]%2:*39LE1O,7>F&!W+QR/
M4<CGW%/H YGQ,L^F^'+&*TO;M72^LXS-YI:1HS.@?<QZC86)SV!)K @N+^UU
M&$Q7]]+Y6O26B1S3LZFW,+-AL_>&\C#')&  >U>BU!>7D%A:O<W,@2)2 3C.
M22  !W))  ]30!Y_:W^L3Z;8S)?74%U)I5Q_:_FJSBUN0%PP3^$AR^%7&Y>1
MG -.M)KJZUK09[^*ZC\F_N(6>&ZEG@=O)!5D;J4)R/FZ'>O2N[M+^&[M1< 2
M0J7,96>,QL&#;<8;WZ'H>,9S2:=J=KJD,LMHS,D4TD#[D*D.C%6&#SU!H Y_
M5Q=S^-+>W@O+M(UTZ2=88Y2B/,LB% V/4;@1W&:YVUUG43HO]II?:G,0MLFJ
M6OV257ML2#SF&XDAMI8$)P ,@#C/IM% 'GFI:@\9M((]6U2+2+Q+CR;]H979
M9BRE%!7#8 +[=V0V#G/%1BZU*+4YY9-2OW>'6K.%5=BJ&)X8O-R@XQN,GJ%(
M.,8->CU"+A6O'MMDH9(UD+F,[""2,!NA/R\CJ,CUH YGPBDUMX=U.*%9VO8K
M^^VI<,YY\^0Q\L>A4J<CKG/>L.QDU36-!NKS3]5U)]0BMHI7LY(I80MS&=S1
MDL>K\H57Y0,$ <$^C%T$@C+*'8$A<\D#&3C\1^=.H X/6M0NVTVUN$?4X)-2
M6>>)%,@$?[O]VI"Y8-C!" @%MV>@%9=U?7T@N]3B>Y6[_L'396DC5E;<LTC2
M\ =E;)'H1ZBO4*IW6JV=FUL)I&Q<S_9XV1&=?,Y&&(!"\C'..>.M '$MK,TV
MH7T1N-1^R2ZTJ02*)501-9JV-P&[89-Q 4C+8&0#699W=_/96^HW4VHKJ$GA
M7B3]XG^DKG=QT#9QVY./:O5:J6&IVNI&Z^S,S?9IVMY=R%<.H!(Y^HYH X2Z
MU+69;2^6.>Y348[6TETE0S!;ABHW@CHY+[E8'.U<'CK4L=W?1Z\)OM]ZP'B%
MK;RVE8Q_9S!DC;TV[\8/8C /6O0:* .5\074Z:ZMK<7%S::=)I\K0SP,RYN0
MPX)'5@O*J>&^;@XJCX;2[E\7I=:J)$U)]!LS<J)&""?=+YB[<[>,@X[9SWS7
M6WVI6NG/:)<LRFZG%O%A"P+D$@$CIT/)JW0!P/B2^U"'4O$$=O?7<2I'IK0>
M6Q^1FG<2[?\ @&W=[8)JK-YQU"&.:XOYK6R\2A$?SI680M:9&2#EE\UB 3G!
MX]J[F]UBTL+E+>3S7F8*Q2&)I"JE@H8A02!DXS]3T!(DU+4[72;/[5>,RP^8
MD>50M\SL%7I[D<]* /-Y]3U6Y\-:Q=C4]1AUBWTZX6XLT@D41W /R%6)(!R,
M+L^\&Z''%SQ(+RS?5DL=7U1EBT.:\MB+ECNN-S,F,=>P"]",#&*]!AN%G>=%
M253#)Y9+QE0QP#E2?O#G&1QD$=JFH X ZU=/XQLO*GOA =2\B=&5RGE-9LRD
M #:$\P*0QR22>0!BK>C2ZA;?"^ZDTR)GU&..\:WCVY)D\R0KP>I/&!WR*[)W
M2,9=E4$@9)QR3@#\20*=0!P?]J(\FGW-C>ZK)HES=JM[).9%^SCR7P S .H,
M@3<<X!P.,D52$NJS3VEO>:C?QVY@U/8Z2M&TD:2I]G9F'.[;N(/5@,\\UZ34
M5Q<PVD#33N$C! SUR2<  =R20 !U)H \LGN[\6.IZBUQJ$6HW'A[3Y8Y(VD&
M909?,P/N@@E<C'!/3DYV-7EU&R;6K.WO;_S8K!9]%<RL_P!HG)D8KGHYW>6N
MTYPN,=S7?@Y .",]C2T <UX<W_\ "1^)S* ':Y@)QT/^CQ@X]1D$?A6/IMSJ
MM_<Z6LD]VE])=W4.K6^]E$4.)-C*.BX(B"LOW@W?DUWM% 'GXN]?M?"T\TXO
M6NM+:.RF<!W:=%F7S9PH.6S%AAC!!+ =!3(_/O+S1[>+7M3EL;RZN?WJ>9"1
M'Y654,Q+$!^C$]>.@KT.B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^[DC?@.,_>3@@#@#%=/=7,=G;27$V1%&-SD#.T=S]!UJ565U#*0RD9!!R"*
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MQM:^5)?/=O(6^WJ0I_A$>3G'2K]S;:M)>7L<<5VE^FJ6SV$ZJ_E"S_=!U+=
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M-#2XM]26-=0U-9TD60*(F>7RMW;&TH%/ITKMK?3K6TN[JZAC*S7;!YVWL=Y
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M:FZ-9ZF+?3;36]*U*Z5M-M8[>1&(:VN(V;?O;(*$_NSO_B"XYZ$ ]$@G,S3
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M=16H,>/E9V"@G)'&3VR:T*\_71[F6QBN+70KZSEEU2RGN()I(<@1.-[A4;8
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M;F/\3$*H^I) _&O-KC0=7FN;UET&6-9[#5+9T5XBC/)(C0G)?<VX!CD_=)P
MHI]UX5N_*OD@T/\ <O%I,OE#RQYLL,Y:?@MC?L(&3][&,F@#O[?4EGU.]L3;
MSQ-:"-C+(!LD#@D%2"3Q@@Y _+FKO6L;Q#8M>^'I+:&.XC=FA8"V";XRKJ<X
M;Y6"XR5YR 1WK-%GJ:_#RYLY=,MYKXQS+]EA_=),"[8. WREE.XKN&"2,B@#
M;OM7AL;_ $RU>*1SJ$S0QR)C:C+&\GS<YY"-T!J>YNY+=UVVDLT9C=V>-DPI
M4#"X)!).3C''')%>?Q>';U[A/MNBS3:?'KKW;0RB$[H7LS'G8K8XD;D8[D\\
MU:TSPY?Z7=Z,18N8;>'45 5E/V>.60-##G/.%&WC(&.N* .ILM?@O-)M=5:&
M2#3Y[%;XW$K*%C4J&VL,YS@YSC''6M56#*&!R",BO,6\+:K/X<BL6THBX_X1
M!]-;>T>/M.U0J$Y]5)!Z>]:L^BHVNV2V=G!;Q:I:BWU2T8(&6.(AU8A<CD,T
M9Y_Y:*?X: .TFNH+=X4FE5'G?RXE)Y=L%L#\%)_"ILC)&>17.^)],DO;OP_/
M%IXNULM1\V5 $RL9AE3(W$# 9D./;/:LC0M#U2&^T22YMFAO+&2Y&H7>5Q=H
MX;;R#EMS%'Y^[M(XXR =SD9QFDW#!.1@=:XS6/#D^H^)M9NX;)$FDTB.*QO7
M"XCNE,_S#G<& D3YL=,C-9D>E:@EM#J-OX<O8G6Z@;4-/DEA_P!)1$D4[%4[
M#M9D8$X+;!Z"@#T;(XY'/2ER,XSS7GMUX>NF2]@CT1Q8W6EF&QM_,5C93[Y&
M.26.PMOC.5)"^7@'A<Q77A74G3Q#.E@DVJ-';_9KIMBF?;&JS!6SE"X#*2<9
MR* .WLM6BO=4U"P2*17L3&'9L;7WKN!7!/'UQ6@2 ,DXKBM+>;1M5U?4?^$?
MN[:TOI[1(T00J02H1F*A^QQG')[ T[Q79V5YXOT"*^TT7\,EM>*\)C5PPQ%C
M(/49_(G/O0!V>0#UH!!Z'->:Z?X-U% ([BV4WL6@QV]M?2E7\FZ4R;2#G=N0
M,HW8['FGW&@ZS):&YTW3&LW73[>*YL6=%%U(DR.R9!P?D61-QX/F#GK@ ]&W
M+C.1CUS1D9QGGTK@-0TJ>3[)/;^&[Q=+G>X%WIR/"90T@C"R['8H/NN"%;(#
MY[D4IT#4;75(FMK.XEMUA$4L4\BNR@6I0/#/G<&SA"&R"26XY- '? @]#F@D
M#&3UKC_#OV[P^GV2[L9)H;F[2*&Y2&.*0CRP-TR*V"1MV[E'(&< #-2>)],O
M[K6;.[L(#*\(C!CF1'@E'FAB#R&C=<!@PX/0@\"@#K:3</45YY8Z)J-O?V,$
MFB2F"TO-39Y 8MC13/(T>T;LD$,HQC@_2LV+P9=?V!%;R: #<?\ "+BTD!$9
MS>*H"9.[EA\V'[9ZB@#U7(SC/-&X8SD8]:\WOO#5[=OJ-R^BN]S)=:;-#(3'
MOQ&T?G$'=P=JL#TSTYJ1] OHC=6<6@L;%]5GEA$9CQ%&UN%#*A8+@OO!R#C)
M.,G( /1"<>Y]/6H[65Y[2&:6![>1T#-"Y4M&2.5)4D$CV)%<%X=\-S&\@N=9
MT,M)%H5E!NG$<A^TQB4/T8_-AU&?0XSUJK:^'+R?2_#NGZEX>=H=/TZW-V?W
M3/<31KA8<[N$5@6/8Y Z;J /2\C.,\^E+7%:#I-Y'XC>;4M-NA=VUQ<LFH>;
M&(989&)4?*=['&P;6&%V<'@9[6@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M80*/.95DEMY?,*DJ,A6Z!AR,YQ73Z=IT\.AWJ-806EU=F21H8YVE!=E RTC
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MDL16(G:C%$RI/F,<D'.#TQ7HM( !T %+0 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPZ9I,4VFSK)!X;NK*094XF8Q;5X/<(WZ9Q6UK>FWUU\)[G2H+21[^72?LRP
M@'S#'MQG..O?.*Z^B@#EE@NQX[34C97'V0:/Y!DP/]9Y@;;C.<X_#WJQX%LK
MK3? VBV%] \%U;6B12QL02K*,'D$@UT-% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M +(3@XYYQ0!T]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8DG5T!91&YPKLP&%4GH3@<'T-5_$FK)IULD'E7AEN@T8FM[&6X$(QRQ$:M^
M/4^V2..O='D33/$5GIUC=?9]5T.WLM,1X74KM62,(P(RF-ZM\V."?0X .W?Q
M'I<6LQZ5).Z74K%(RT#B-W W%!)C86P"=N<^U/M=>TZ\U673899/M<<9EV/"
MZ!T!VED9@ X!(&5)'(]:Q;B_M+K7K'3KBVU%OL$ZLKC3IRDLVTJ&\S9L"+N)
M)W<GZ<RVQFO?&D.I6<US)9&TE@GCN;4QB%@ZE=A95;+'=D9((4'C H Z>BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ IDD22A1(@8*P8 C/(Z&GT4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>exhibit312001.jpg
<TEXT>
begin 644 exhibit312001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 ST# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **1F5$9W8*JC
M)). !6=%K^F3M"([@MY^?(/E.!-A2QV'&'^4$_+GB@#2HK+L_$.F:@D#VL[R
MQW )AD$+A9, GY6*X/ )X]*2Q\2:1J4L,5K?([SAC"&!7S=IPVW<!NQWQG%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** .=\>6%[JG@;5[/3T:2YEAPL:G!D (+(/\ >4%?QJY9ZSI.HQ02
M6\B/L&_85VM;_*0=X/,9P2,''7%:U% 'GWP_N([7PWH$<VJ.T@MVC:P9%S&V
M<[C@!E"JK?>/?UQ61X8CD@/AJ^U0L^F037:VY1-OV6Y>20!I>Y5D8@'@ GG.
MX$>L44 <IB/_ (6B%PNS^Q3'C'&?.SM^N.<>E<OK!#^'_'"*Q#RZY T>T9+
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF0W!*%9>J2!-NTOD%6/09->F44 <SXIM)+[5?#]O_I_V5[J5;K[*\J+Y9@D
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M1E=5"Y,3 @MQG.#ST'J5% '#6R75_P"*9HKXZU#-'=.\)BB=;>:V9, %\;0
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M$L-0OK>]N$E-S;*RPR1W$D90-C=C:PZX'Y54;PCH3Q11FP 6,RD%975F,O\
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MB5_MMQ>6^E/+(=)M+M?+9I'*22."-@ZE?F; Y;IZ5L1>$]%@6-8K1U6.&6!
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ME$S?O&VM(%VARN=I; 'S8SP/2J]MX2T2R6=+:T:%9GWE4GD 0[@_R#=^[^8
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M[!TS[<]V+4"62197 =@C.H 5RF=I8 #G&>!Z"HX/#.D6YMS':M_HYE,8:9V
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M9&+!+B!W7:!QPXC<COD8[BM?5=7O-)\/0:A-;1&Y,EO'-"&.U3)(B$ ^V_\
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MU"$[<1L64$ X.ULD9Z'GK40\.:)-;(GV&&6(>68R26VA"2FTYX R< <<GUH
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M\$"M"3P_I4SRO+91R-+,D\A?+%I%&%;D]0 !]..E36FEV5C(9+> (Y!7.2<
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M#/',5B*$8=, JS*&;:>2,;CTSWP'MH>F.M\CV43I? "Z1QN64!=HW \= !]
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MIV9Y42,!9&;[Q8 <D]\]:K_V!H_E^7_9-CL\C[-M^SICRO\ GGC'W?\ 9Z4
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MR7485CQU Z'M61K7@ZSU-K?R+?2TBC>222WN=/6>&1WQF0J"I#\'YL_Q'.:
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M3V?]BZ7F _V=:9MT$<.(5_=J#D*O' ! ./:FOH.D27YOGTNR:[+K(9V@4ON
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MQL^_G:'^]C)P,^M5K'P1<Z= BP:K&9&T\Z?.S6QVNF]F5E7?PP\QQU(.>V*
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M.Y2WD218V*[9VVPDG'&YN!^N*+;Q7I%U?)9QS2B1Y985:2WD1#)%G>NYE R
MK''H":Y\> ;Y=,T^P_MN&2*Q@L8XO,LR=CVT@?<H\SY=X4!N_'7'%71X,E:2
M#SM1C>*/4+J]=%MBI<3I(A3._C E//? XH N7GBK3OL$\D-X]N4CBF69[21U
M,<C;58#C()!&<\<$\8S=&O6$FI?V=',PN6=XD+1-L,B*&9<]"0"#U]?0XQAX
M4U67PJ^A7>N0RHB1PP3"S((1&!!<;_F;"@9&T=>*>/"M]_PD<.K2:K#*8;J6
M:,/:DN$>,IY>[?\ =7.1@#WR3F@"WH.O&X\$V&N:K)'&TEJLT[(I"@D=AR>O
M:I)?$]I%JEE8F&Y#7(F8NT+*(Q'C=GC_ &ASTQSGIEEAX>DL?!D&@-<V]P8H
M! 9);;='(HZAHRW((X(SWK/MO!<UD;(V>JM#]E^TK&IC,@BCF"_+&6;*[2@(
MSD<G@#& "W<^--+BLC<1+<38EM8R@A8,%N'"QO@CH<_7C'7BK4WBG2+>[6VE
MN6$CEU7$3$,Z*69 0.6 !X]B.H(K!C\"7BPW._5[<SS+8L9%LV&9;:7S [9D
M);=T/.>^:T+3PQ?6=W?"/4[<V5S)+.L;6>98Y),EAOW\IN);&,\XW8H >?'6
M@BV:X,UUY2VJ7A;['+CR&&?,^[]T8.3V_*KUQXDTJVOX[.6Y(EDE$"D(Q7S"
MN\)D#&2O(_ =2!6$W@:X;2FL?[5BPVA?V-O^R'IC'F8W^G\/ZU=L?#5]I^L3
MW,6I6[6EPZSR1/9YD64(JG8^_A#M!(()ZX(SP *?'6BMI]Q>0-<RK%927RK]
MFD0RQ)PQ3< #@D ^F1FM&TU^SNY884$OG2!=R^4W[MF4N QQQP"><=O45@1>
M!)5T^VLY=51DBTFZTPE;4J6$Q0[_ +YQC8..<\\BK2^$YSJEEJ4M[ +RU55\
M^WMFB>1 A4QM\YW(2=V&SCL>X .BO;R#3[*:\NGV00J7=L$X ]AR?PK+?Q7I
M,9C5GN/->Y>T$2VTC-YRH9"F #SM&1Z]J62QU?4?"CV5S?K:ZG+$5:Z@C("G
M/!VALC(QD!N,G![UE6?@RYM+^&Y&HVH2+5&U'RH[(HN6MS 4'[S@<EL__KH
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M> <X%67\8:+'IR7[7$H@:*:9CY#YC2)@DI88RNUC@YY_*JLOA.XDU6:]&I1
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MU;@Q(0"L<K(O&2<X45D2^"[Z6XM';6(72U>U>)7M"2AA #!3YGRJ^,GC.>Y
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M?VVH%I=1EN+06ZQB.1$'[P$Y<;5&,C@CZ8 QR :=%%% !1110 4444 %%%%
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M&XX(VN1MR%S@&G>,M+U34-2=K+29)@L-J\5Q%)'DLEQO9#O8;<* 05&23R<
M"@#N-R[MNX9],UGOJ\*>(8-'\J0RS6TMR) 1M 1HU*GG.?WBGIBN-3PW?QZL
MM[!I'D7']ORW(N!Y>Y;=H&3.=V=N\C*_CBI?"^DZG;:SH,]YHLEO-::3/97U
MT7C82S%X2'R&W,&*2-DC.6Y[T =7%K44OB.XT06\XG@MDN6E.WRRCLRKCYLY
MRC=NU:6Y=VW<-V,XSSBN>MK*\7XAZAJ#6KK92Z;;VZ3EEP7225F&,YZ.O./6
ML;4=+U2;QA%>1Z/)Y,.J1S&>.2,B6'[,8RQW-N!#'&T # S@DT =R9$ )+J
M.ISTIQ( R3@5YI:>&;S3-#TF5/#[.Z32KJ-K!Y(FE0E_+;+':^T-T)X#''3%
M;NM:#))\/8M(L].DD:/R!';/,'=%613@NQQD*#W^F: .LWIE1N7YNG/6@.I)
M 89!P>>E<-<>'7C\1-;C0Y)-+=H)K*2TDCB2S9#N*L,AE&[+?(#G<0>]8NK:
M/>V5A(;JQ:6S>_TYHQ.D?VA7-ZF8MZG$BX8X9L'YL$G)P >I[TV;]R[?[V>*
M4LJ]6 ^IK@+7PU>:=JJW-OIW_$D;4Y9_[+4(/*1H%0.$SM_U@=MHZ"3.,Y%9
MTO@R_:RE@GTH77_$GO8(-QC;RGDF+P1<MU1,*#T&.#0!Z@74';D;L9VYYK*M
M-=6XU1=.FLYK6X^QQW3"1D(7<Q79E6.2"#[>A-<[%I&J#Q#!>-9R2P.%%W%=
M+&X_X]MI>)P<J<_(4.0<D\=:QH?!]Y+HEA:ZCH7VB1?#D5@H=HV\BY3/.=WR
MXR"&7/0]^" >@VNK176L:AIPBD1[)8F=WQM<.&(Q@_[)ZXJ_O79OW#;C.<\8
MKS^_T37HY]1DBMI;O"Z?N(D13>"+=YH&X\'D$;L D8KI-&TZ*T\.S0)IDT$<
MS2R_8YW1W!<DD$ E%R23M!P,T 6='UM=8MDNX[66*SFBBFMIY&7;,D@R, '(
M.,9!'<>^-/<H.,C)[9KSK3/#E_::3HUK>Z+Y]LF@BQFM5,9,5R NYC\V#NQC
M<"<;1ZUH^%O#-Q8ZY+=:O9I<745E9QQZ@X5B\R1NDK*<[@3NP20,B@#M"RA@
MI(!/09ZU#<7MK:('GGCC4R)$"Q_C9@JK]22!7)7VD7ESXOF-WIES=VDD]O<6
M=W%.B+;&,#*ODAQA@6&W(;>0>]8[>&=5-G)&=,-U;I<V%PD=PL0N ([C?)$7
M#;9 J%B&."=Q!)- 'HEY>)9V=Q<%6D\B-I&C0C<0!GC) [=ZSKOQ';VGA-O$
M)@ED@6U6Y:)"N\*5#8Y(&<&N3.B:O-K[3KHTELC&_B9EDB*%9 /+;.XN<[1D
M=%. !@9JI)X0OAX>O!8:.;6XET$6,]NIC4W5SD88X;:=N&^8GG?[4 >DK.YN
M)TDA:..,*5E9EVOGK@ Y&/<#VJJFL0OK\VD&-UDBMH[CS21L979E '.<Y0]1
M7+ZAH=]<ZMK<J6EU;QW4UI)#<0>4Q#1JV6*,<, < J>HZ<@5D:AX8UB^T^\\
M[0X6N_[#BM[;R?+5$N%DD(V M\A 93G.!R 3B@#TJ.=WGGC>!HTC90DC,I$F
M0#D '(P>.<=*D\Q F_>NWUSQ7 ZGX>O;O5-1D_L=I()]8L;I<F/#1HJ"1L;O
M]E@1U/O5*2PN]--I9II4KL-1OYX;!!"ZM;/D;A&9%& 9%[Y&XC'- 'IM-#H5
M#!UVGH<\5R4-EL^&,>GZ782W1BMA;BVN,1O(5;:^[# %LAC][#'O@YK'M/#=
M\^J6?VS19)+2+6;BY;S_ ""/)DMF7E5;',A&0!UY]Z .XUK5H=$T.]U6:-Y8
MK2!YV2,C<RJI8XR0,X!JZKAHU?H& //O7E+>&]='AF]TVYT.2Z$^@O96<?F1
M'[),&EXY; #!HL$9_P!6!Q@5V?B;39]4T?2XDL#.\5_:321$IE$612^<G!^4
M$<$Y]Z .C#J<88'/(P>M17-PT5K++!";ET'^JC=06/IEB /Q-<#;>&KRROK.
MXM-#$;P:Y<S*RM&FVU>*4  @Y"EW4[1[G%9Z^&]9DT;5X/[!FB-UI%E#'!OA
MVK/$\FY1\Y/ 9,,Q)(')S0!ZIN7.-PSZ9J&WO;6[A,T$\<D0D:+<IXW*Q5A]
M0P(_"N%N/#MVVO7VH1:,1(^O6MW#,#&&$(AB25@=V1DJ^1U.>AS5"X\-:FNC
MSZ;%X>)WR:KB:-X?^6LC-"0"V-I5L$D;EVX &<T >E"=S=RPM RQ)&K"8LNU
MB2V5QG(Q@')&/FXZ&DGG>-8VBA:?=(J-L91L!."QR1P/0<^U>?:GX?U6]CU1
MO['E9[K3=-C 9XLM-%+(TF3NZA67GOC@U8?P]>175TMMHY2V'B&VO;=$\M56
M%8HA(P&[CYE?CJ<].: ._#*3@,"?3-"LK9VD'!P<'O7FUAH,^C)9WTVFM8)
MNJ&\N4>)&CBDD9X\L&Z8P1UVX[5>\#VAMM322]TVYM+]M+@@4R0Q*C)$?F8%
M)'RQ,BYSC(4<<4 =7J>KPZ7-8Q2122->7*VZ["/D+ D$Y.<<=LU:M[AI(B\T
M)MV\QT"NZG(#$!N"1R!G'7GG!KAIM'U9]90SZ1)<2Q:\+U+Y6CP;8J0HR6#
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MM0GM19VW6.1[F*177^]N1B /QJGIMK?Z>?$<[Z<9C<WQN((?,0><GE1IC.<
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MI*-@[6SCG&<;L$'!KE8O!>LKHUU926]J9'T.YTV-A.6&^1V*DDJ#MP1GO]:
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MPS;)G@9%A=GWH,L H&3@<Y Q6/#XTLQKES%/<Q'3&M;.>TN(H7;/GM(N789
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MG-,_X272-KM]J("20Q,3$XPTV/+SQ_%N'/3GFLB^\'G47O+BZ6VDGO+B.61
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MH]Y>!K*RAN8+>2-2)2LR-&-W;*HY'^T<'C&*GN_#FNZCI5FM[J6GRZA8SI-
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M>H6YL8-7DU2,/"QD_>"3?&3NQ]Z1B#Z8XXYZ^@ HHHH **** "BBB@ HHHH
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M-=A9?+V9 R<''N:R[OP7<:A9,+O48VO4L5LH9T@(4;75]S+NYRR)D C&#Z\
M&M=>*M(M&E26:;?%=BR9$MI';SB@D"@!3G*L",<'.!S5R;5K6W@M99#*/M1
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M #C&!TR<U;F\-7$_@!O#,E]%YK6/V/[2L!"@;=N[9NZX_P!KK0!,?%^CK</
M\MPCQSQV\F^TE4(TA 3<2N &+  G@GZ&EG\6:5 MT?,ED:WAGFVI"W[P0,%E
MVG&"58@'GOZ<U2U#PI=7\VIR?VA"AOIK.7'V<G9Y#JV/O\[BOMCWJL?!-Y-?
MR7-UJT4I>"]MF?[*?,:.X92 6W_P; !QC'84 :O_  ENE1V=M<74KP"9(F8-
M&W[KS#M7<<< MQDX]>E0S^+M-E1EMKN:$QW<=L\TEA,T8?SA&8\X #$_+G/&
MX'D=:MKX3U"TU"&Y34[1E>VB@NU>QW;C'D!XB7^0D'!SN' .*D?PI<OHMQI_
M]H1;I=6&I"3[.<#%PL^S&[GE<9ST[4 :+>(;*:>:SM9_]+"3F/?$VQFB(5\'
M@':Q (S_ %JK;ZZ[?#JWU^\N$M9'TM+N6<0-*L3&,,6V Y(!.<9Z#K52+PE?
MKK:ZE+JL,SI]K52]J=Y28@JK-O\ X-H P ,#IDYJV_AF1_AX?"OVQ YTS^S_
M +5Y1QCR_+W;-WISC- %B3Q5I,-^;&2>43I/';N?LTFQ9) -@+;<#=D '.,G
M%9]OXFDN-:O5:406MG??8O(:U<O<$PHXV'LVYCQ@_*N>.M)=>$KJYGO93J,*
MFYO;*[Q]G/RFW*';]_G<8QSVSWI9/"-PUY->KJ$8N/[6&IP'R#M0^2(6C8;O
MF!3/(Q@G/;% %V3QAHR) 1-<2-.TJ)'%:RN^Z,X=2JJ2&7N#SWZ4U/&6C22I
M'')=.\CRQQA;.8[WB8JZ#Y>6!4\=< GI4%IX4>TUBTU%;Q"\=Q<W-PODG]X\
MP ^7YOE "@=\XIEGX4N;2YL)O[0A?[)J%Y>X^SD;_/,AV_>XV^8>>^!TH O#
MQ;HK06\ZW3-%<1Q2JXB?"K(^Q"W'RY;CGI@YQ@U7'BFVN9I(DDEM##J:V!::
MU=Q,V 2H(P%SD@$GC ..16,W@"_.F6]@=:@>&&&)$$EF6"21S&7>H\S@L,*>
MIPHP16F_A.Z:>5EU&(1-JT>IA3;G(*@;D)W\Y(X../>@#3'B32S.L(N&R_F^
M6PB<K*8\[PAQAB,'@<G!QG!HTGQ)I>MR!+&:1V:WCND\R!X]\3_=9=P&1].E
M95IX.>VAL;9KU)+;39YY[(&([U,BR* YW?,%$K#@#/'IS/H/A>;1KC3I'OHY
MEL]*CTW:(2I?81\^=QQG'3]: +;>*=)6]NK0RSB2UD\J8_9I-J/A"%W;<9/F
M)@9^;/&:HOXJCN-9TN*QGC-I+/<07@DC97C>.,OCG&.QZ'(((.*2]\)37D&N
MI_:"QOJ-[#?0.L&?(DB6(+N!;#C,*DCC.2*<WAO49Y=.N)M2MH[FU:9V-K9[
M%R\?EC8"YQCKR6R?0<  ?<^-=*AT][N'[1.$:V!187#;9V"QO@C[IS^F.O%2
M'Q/86MU=K<WCL%NX[5(ELI0T<CQJP0\'<3G(. .0.36-'X$O1;W:R:M;M/<1
M60,BVC#,MM*9 [9D);=WYSWS5Z;PG=3:G/>'481YNHV]^5^SGCRHU3;]_OMS
MGMZ&@#13Q3I,EG#<I-(RRF8+&(7\S,1(D!3&X;2"#D=<#N,E_P");*S\*R>(
M8UEN+,0B:/9&P:13T(!&0#D<XZ<URFK:'>Z;)9PI*7W75]=?:H].GF"^>^XQ
M$0N''WVYSM.T=\5T<NC3:MX&;1I1#8R2VWD+Y49V1@<(0A.0, ?+G(Z9[T 7
M)O$>F02[)9W3$D<3LT3!8WDQL5SC"D[EX./O#/4974M:BT[4M-L&BE:74)'C
MC=8RRIM0MEL?0?J>U9,WA"6X;4HIKZ-K34[B&ZNHQ"0?,0(&V'=PK").#DCG
MDYXU=5TF:_U'2KV"Y2&2PF>3#Q%PZM&R$<$8/S9SSTZ4 97AOQC;:CH]O)J4
MPBO?L;7<Q\ATC**V&9">" 2N<$XR*V]/UFRU.2ZCM9&,MJX2:-T960D!AP1T
M(.0?\#7+KX D?3K6RGU12D&F7&GEXX-K$RNCAQEB!M,:\<YYKI-%L;ZRM6&H
M7-I/<-@;K6U\A,#OMW,<GOSCT [@%:V\7:1>1&6"2X9-VQ";65?,;+@JF5&X
MCRVR!TQSBFGQGH/V);Q;TR6YBCF9XX7;8CL40L ,C+*1@C.0?0UG'P=>1Z-I
MUO!J5N+W3[N6YBEEM2\3B0N61X]^<8<\A@<@'VK)UC3;\:\R+$DA-K!&P;2Y
MWANF5WD W1.%10S  29QSR022 =5#X@M!>7L4EV9&2[6VC@%JZ.CF$2;.?OD
MKE\@#@X[5!)XTTJ"XO5G%S%!:6L%R\[6[[=LI;;P%R/N]_4^AJM<^$9+]M2:
M[>TFBU"[CNI+>2!CLVPK'A7# A@55@XP1@C'-5[CP1>2V=W;C6MYN]/MK.66
MX@+NS0ECYA.\9W;SD'GWH V1XJTHR1QM)<1L[QQXEM9$*-([1H&#*-NYE(&>
MO!Z$9;%XNT>>X\B*6X:0M,BC[+( SQ$^8@)4 L-IXZG%4M;\*WVL:D+G^U(4
MC62UFBCEMC)Y3PRB0[3O& ^ #QG@<XXI+;PC<0W-G*^H1,MOJ%W>E1 06\_S
M/ESNXV^8>>^.@H V]#U6+7-#L=4ACDCCNX$F5)%(*AE!Q[]>O0U2NO$=CIU_
MJ(O+TB*U2WWQ"UD)C,K,JMN&=P8@#@?+M.3SQ'H&F:MHD&EZ4]U;W.GV=@MN
MSK;F-RZ;50YWG^$'(QUYR.E5]7\*7&IWNJ3I?Q1"^2S0*8"VSR)6DZ[AG=N(
M[8]Z -&'Q-IEQ$S123%UG:W,)MW$OF*NXC81N^Z0W3H1ZUF/XOMXM3>XDN$_
ML0:4FH"587+@%R,D=<8QQM!'.:CE\(Z@FJS:K9:K!%>F_:[C\RU+Q[&A2)HV
M <$\1JP((P:EU;PC/J[7QGU)?]+TIM/9A!R&)+>9][&,G[OZT :\FOZ=%-<P
MM.WG6TL<,D?EMN+N,JJC'S9![9[^AK$T?Q1)>R1+=W"Q.^I7=M'$+.3,R1*Y
M"]?D8!=W.<X( YXCG\'ZC<7LVHOJUNM^;NWO(BEJ1&KQQF,J07R5968=00><
M]JFM/"=[;WEI<OJ4#O!J5Q?D"V(#&5'3;]\XQO)S[8]Z +EKXST*[MWN([MU
M@6T^V^9+!)&K0]V4LHW8XR!SR*T+'6+/4;JZMH&E\^T95G22%DV%@& R1@Y!
M!X]:XZ\\'W6F^&TB$ZWWV717TORX[,L9-[)^\V[^<!<[1DGG'.!6SX1BNT-[
M)<)&ZS%'^T?9)[>21@-N&6=F<X55YZ<_6@"1/%-M'>V]LTDMTUWJ,UDC16KI
MY)2-G*L#DG&W&>,YST!K6T_5K35 6M'=TV+(KF-@KJV=I4D8(.T]/ZBL./PG
M<Q7D%TNH1>9#JTNHJ#;D@K)$\93[W4!R0WJ.E6?#WAHZ%=7<XGC N43S(+=#
M'"9 6+2A"Q"LV1D+@?+GF@"T_B728I722ZV*BS.961A'B(XD^?&/E[\]CZ'$
M<WBO2+9)VN)I8F@:)9$>WD#KYK;8SMVYPS<9Z9!!P0:S!X.NGTC4]"GU4-H]
MUY_DHD&V:+S69L%]Q#!2Q(^4'IDG'+K_ ,(W6J&6YNM0@^WR):1&5+<A-L$W
MG?=W9RS>_ Q^(!I)XJTJ2%I$EF++))$T7V>02AD&YAL(W< @].XQUJ67Q#ID
M-R()+@@^<EN7\MMBRN 51FQ@,0R\'^\!U(SAWO@F2^74$FNK9UN[Q[M"8&5[
M=S&B*R.'!#+LSD8SN(J4>#7VW5K)J!EL+J]@OI5DCS+YL9C) ;.,,T2D\<9;
M'48 ':;XAGN+B.&\NH8I7U>YLHU2V8B98U<A<YPC87=D]=I '/"3>+X%\0VJ
M),O]D-IMU>RSM XR(FB 96Z,N';H#T!Z$4)X1G%Q;2/?QE(=6GU(J(""PDCD
M39G=Q@2$[O8<52@\$:K!9V5M%KZ1C3]-N--M9H[4B54D\O8Q._&Y1$O( SST
M[ &Q<>+M/@:)$2YDE>^6Q>,0.&BD9/,^88S]P@C'7(]\3/XJT6.X>&6]6,K'
M++N=6",L9Q(5;&#M)&<5CP^"[N*>2==1M$D;48=058[,A%9(1$RX\S)! SG.
M0>N:8/ UPVDW^CR:I$+"42?97CM )XBS;@'?=APIZ# ) &30!K:-K<^I>(]9
MLF4K;VB6[1!H&C<;PQ.[=UZ#H!Z=<UO5AZ/H]_9ZO?ZE?WMO/+>10QLD%NT8
M4QAN>7;KNZ>U;E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 4M0U.WTW[,)MS27,ODPQJ0"[[6; R0
M.BL>O:J+^*M/B6<R+<)Y#VZ2!H\%?/($?&?4@'N*GU[1H]=L5LYA;O 7S)'<
M0>:KC! XR"""000<@BL.;P-(T;0Q:S*(I([)93-$))'>V<,K%LC[V.>.O.>Q
M ':-XN7[5+9:JTPD?4KFT@N/LY6([&;:FX<;MJD^^/7BKLGB:TN+.QN8);B&
M&YN+=8I1"'699&^49!( /0G@CZTV+PH$G/F7A>W6_DU"*,18997W=6SRH+D@
M8';)..:D/@9( 3%=QPL]W;7<B0V^R)GB;<6";L*SG&XCK@<9YH FNO$CR>(M
M$M[$R-8W-Q<PRR>6"LACC<D*>O#KCIS@XS3K;Q=80Z+9WD\US<121+*UR;?9
MA6?8&8=N3T&3QG%1V/@^:PN[ Q:INM-/NI[BV@:WRRB4."C/NY +G' /8YJE
M+\/I)-+@T_\ MAO*BM/LPW6P;!$F\.H+?*3P&]0!TH T-1\7626VJK&U] ;
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M6MUM&EG>8!BBKAHQYGEG<I(/#@@X!Q@YQ5/_ (1%UU9]5BU )>?;VO(R8<J
MT*PLC#=R"J*<Y!!'IQ44G@:VD2V0W"_N;@W0E\G$R3-,TLC1N""FXL01R, "
M@#3M/%&EWVK+IT$Q::19&B88*R>60KXP<C!(Z@9'(R.:2Z\4Z79ZHEA+*?-:
M=;8E0"%E9=RJ1G=R".<8Y S3=#T&YT5WA&JR3Z<KNUM;-$ 8@Q)VE^K 9('
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7\ZFYCM(VR Q MY#(AR>I+,<YZCTK,UWPY>QR;[+[9.+G43?S/;+ 7A?R1$
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MQQ?*H;*L?D()]3CUXKJ8PXC42,&< ;F QD^N* '4444 %%%% !1110 4444
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M;;6-H?(+(KMW^8<< 9 RH)]2 =Y17+Z?XVM]1MDG32]042Z>FHP(51FFC;'
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MR[3GL%8G..AZUC:AXEOK77;&?[#?_9SIM]+-IY$:MNAEA ?)(R,,V.<$$<4
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MF7*1Q:A'I\DS.F%D>-'4X!)(^<#VI@\;VP@-V^GWHL'M_/@NA$=DN6553)
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M]INS;0P36]JA*?Z,DHPP0[><+\HW9P*9%XVM9X&GB@WQ+>06;A91YD;RR^4
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MJW!<)NPN5(\ML@;O8FFR>+=166WMQH+)=3174@2:X,:XA*\@E,[6#@@[0>Q
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MTD[>9(7)=V+L<GU))J]110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD)D"8QM'3Y3W'7VJW;:!IME<F>VMS#(;5+3Y)7 $29VJ!G QN;D#/)YK2HH
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M@<J3G!_PP5G\6ZK"^KWL<=M+;016+06[Y4CSCR2PSD_-Z=A[YZ9_#FDOMS:
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M<'%6M-\27>LR,=/DTZ2*V:U%PS,P$JRHKEXSV&'&T$')!''6M;^P]+DEDG2
M"2242M)'(RG>JE <@\$+E>.W%(OAO15OK>]73;=;BWC6*)U3&U%^Z,#CCMZ=
MJ .6\.:I-;SMHED(8YKF^U6=))D+(JQ7.W:%!&3F0=^ IJQ9^-KF[_LB2:U6
MQAOTB"RR1M)&9FD9&CWJ1L/ *EAA\XX-=%_PCVE!546@4K,\ZLKL&61\[V#
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M%;Q704B(J\,DH)7.=W[IEQNYRI[XK>;1=-D%\)+2.1;_ /X^E?+"7C;R#QT
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M6^[C;E3GYAUXY[.XTRRNK%;*:VC>V7;MCQ@*5(*D>A! ((Y&*B;1-.9;=3;
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M<I LUA$WD%S&W(8;_O\ (.3N_BSU[YJ9M&TU]&_L=[*%M.\H1?9BN4V#H,4
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MCR02'8X(&T"0 '!SANE>B5D7/A?1+R<S3Z; SE8U;C 8(<ID#@[2.,]*U^E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6'$?V83*53G)W$*>#\N3CN(/^$A\1M!:V,\VF6.K/IQO<W),<3MN(VD?,<
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M+K>I:'>221QBW\1RV?V8*,ILBF7))YRV-WIAEX[GT.@ HHHH **** "BBB@
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MN1D#)%+0 455MM0M;RYN[>"4M-:2".=2I&QBH8#D<\$'CUJU0 4444 %%%%
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MW4XMXL(6!<@D D=.AY-6Z .!\27VH0ZEX@CM[Z[B5(]-:#RV/R,T[B7;_P
MV[O;!-59O..H0QS7%_-:V7B4(C^=*S"%K3(R0<LOFL0"<X/'M7<WNL6EA<I;
MR>:\S!6*0Q-(54L%#$*"0,G&?J>@)$FI:G:Z39_:KQF6'S$CRJ%OF=@J]/<C
MGI0!YO/J>JW/AK6+L:GJ,.L6^G7"W%FD$BB.X!^0JQ) .1A=GW@W0XXN>)!>
M6;ZLECJ^J,L6AS7EL1<L=UQN9DQCKV 7H1@8Q7H,-PL[SHJ2J89/+)>,J&.
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M!7H=% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY5\JWF/@KO[;2.1P<GWJ+PJ^I#5KV.[$\\#1B2.ZD$D9Y=OW<D;\!QG[R<$
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M.DBR!1$SR^5N[8VE I].E=M;Z=:VEW=74,96:[8/.V]CO( 4'!.!P ./2K5
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %5XKR&6[FM02L\(5F1NNULX8>H."/P-<?\0;74;V"6"PL
M+J:4Z9=>1-#\VV?Y2@ R K<9#GG@@<FM,+-<?$&SN(T=(H]'D%P&&"&>6,Q@
M^_R2_K0!KZCJ]EI3V:WDXB-Y<+;0Y_BD8' _''\J;>:O!9:E;6#Q3/-<Q2RQ
M[ ,$1@%AR>OS#%<_XCT:Z\3C5(5D-JD$/DV[R6S,WF963S4((Z,J <'E#V/+
M(I]1U._\,ZG=Z;=6\R65R+R,Q']S*RI\OXE6QZT =1I6HP:QI%GJ=L'$%W D
M\8<8;:RAAD>N#4KSE+F&$02L) Q,B@;4QC[W.><\8!Z5RVG6%TGPKTS3I5N[
M:ZCL+>&01Q;I(W4*&RA^\ 0<CN,CO6=:V^I03Z1->6YM$MX]0$T]LC1Q!204
MDVN?W>?F(#'CUQ0!Z!4-Q.8%0B"6;=(J8C )7)QN.2.!U/M7E,=I<W?A^^C-
MIJ<6J2:/#!'!]GE3S7C;YY=W0NQ=,\D_+U/;;N-,NX;Z]CM+.\6U_MRQN80J
M/MV 1^:P]LJV?4Y/4T =5+X@B6^>UM[&]NS'.+>62W162)RJMALL" %<$G&.
MW7BM>O.Y](FCM-=:VTV:.>7Q!:W$1B@*L\*O;EV! Y7"R\?7U&91!?F/5_M.
MBZC/J\!OFBN(IC$EQ$^XQ*L@/7;L4#JI7/;) ._J-YHHY(XWD57D)"*3RV!D
MX_"O-HM,U"2X:)M/ODLWU:TG15B:)!%Y(63" DJ,@Y!Y]>35K2='N(=5T.:;
M2YFAM+[4HXR\63#$\I: \\A=H&/3@=>* .XU748M(TF\U*X21X+2%II!& 6V
MJ,G )'8&K,;B2-)%SA@",^]<)XWLKZ]EUJVDTZXO;6ZT1X;#RH]XCN?WF[('
MW2P,6&/'RD9]2TL;R?Q+C4;+5%>.XBN+2XB""$0^4JM&[8W#!WY3N2".N0 =
M-#X@BN;Y+>VL;V>)I9(OM4:*85:-BC@G=D88$=.>V0#6E<S&VM99UAEF,:%A
M%$ 7? SA<D#)^M<!IND3VEAI(@TV:WD3Q#<SRA(2F(&DG*,V!RN'CZ]/PJ#^
MS[^Z\#:K#+I&HQ>(!I,MI/-N(%S<8^5EP?G);+!OX0<<=* /2P<@'&/:BN%6
MSNKGQ7*;^TU7*W,=Q9W, 58O(\I0R,V-R\[\IW)!'7(Q;31M<MM,M?[.M;R'
M4)-$O(9F<LI,_F1F)68]&VB3:>V>V: /3KB<P",B"67?(J'RP#MS_$<D<#O4
MU<+-:_:+>QNM.T?4;$/JMM-+#(K+M"\.?+!(4  9/\1R>>II6>F7T]M=_;8-
M;M]4CAEM[FXB2,Q3!G!#J ,R],@'H-R\9P0#T>BN4LH]3A\$:I'+IX>\5+@0
MQVFZW^T\':R@G,18]L\'D=JYV+3+^2Y:)M/OELVU>TG15B:)!%Y*K)\@)*C<
M#D'GUY- 'I<K^7$\FUFVJ3M7J<=A5;2]1@U?2+/4[8.(+N!)XPXPVUE##(]<
M&N#L+*_MI+.WO=,NY]&674HE@$1;RRT^ZW8KUV^5N53T7/..UPZ=?_\ "G-/
MT[[)=)?Q6%M$8%!$BNNP$<?0T =W39)$AB>61U2-%+,S'  '4FO/+C1IH-4O
MIK.PNU$>MV4UJ51\+"1$)RH[ XDW>OOD51O=*U74/[5B&CW:+=Z7JENT<BY5
MIC(K0[F)^<D;MK= #@8P: /4E8.H93E2,@^HJ*XG,"(P@EFW2*F(P"5R0-QR
M1P,Y/L*X,6%S/K,,4^FZK%;E;:73Y+5(T6#9C>CG&8_F!)'\2MCD\5';:'/#
MH-M.EE>"_P#[=#R$^86^SK>M(I(/\(C;/XXZT =_>W26-C<7<BNT<$;2,$&2
M0!DXI;.ZCOK&WNX@PCGC650PP<,,C/YUYW#::JVHWDITJ^ACGT_4895*E@93
M*K1Y;)+DJ6VGH <#H:Z2?1Y]2^'T&G*##?+91>3O&#'.B@KGVW  ^HR.] '3
M45PFE:5K;WUY)+:I;172C4X=V#]GN61HQ"?7;@.3_>)Q5"TL[L:1]H.CZR+I
MOLL-]#/MV%DD!:0(F#-CG)S\RX!SS@ [R;5((-9M=+=)//NH9)HV &W$94,"
M<YS\Z]JO5Y0^F^(%MM+$6GW3/9C4TEBE3'FP-<(R1*RG"EHE(4C@8 XX-7]>
MTR>]N=7NK+3;U =,LC8H(W7RYTEE+;5Z!@K1\_7WH ](HK@$L;V?6[YKVUUD
M7<,UQ)!<VVQ(Y('1@B[\;B0"HV'HRAO>J3:9K(TN2 0AFAF9X)3I[B*\'E*N
MV:$',;=MZX&1G')% 'IE%<!;V>H3>('.I6&JQW,<R7%K-;,AA6+RE4QF3&[@
M[P4Z,<,.N1J^"[6^LTNH;N+=$J1"&Z> P22\'(D0\%UXRXX;/L: .DMYS.CL
M8)8=LC)B0 %L$C<,$\'&1[&GS316T$D\TBQQ1J7=V. J@9)->>VNCSS7VGQW
MMC>/:+JFI/*KJY4PN7,>X=U.5P*N2Z7J%]\%Y-+GM99M2.DF+R)AES*$P!\W
M?(&#0!U=MJD%UJM]IR)(LUF(VD+ ;2'!(P<_[)J]7G&J:5--J.IWUII=U&XD
MTU[/;"RE0DN9-H' PA(/L2/:M'P[979\0--J%KJ<>H6\MP))SL6WGB=R4.X#
M+\;<*>4P1QW .HU;5(-&L#>7"2-$)(XSY8!(+N$!Y(XRPJ]7GGBBRU"[O=8A
MFTNZNV>XLI=-EBCWJD2/&9%!_@8,)"<XR".N.%73[VXU#4OMUKK<=]$UZ4N;
M7RU26"0/Y85L99@I0!2>&4'H* .\FG,4D"""602OL+(!B/Y2=S9/3C'&>2*F
MKS^QLM5BO-&,]K\MOK#NUQ;V[P++";1EWO$?N?.44CH2-PP*Q[.&6[L9S)%J
M7VM]+NK>V<P2 7LCY=)"X^7?M!Q@G.YL'I0!ZQ17)>%K":PUR]'V:XAM9=/L
MVS(K;6G'FB4\_P 6#'D]\#TJBFGZK)J">;#.FH0ZS),]V%.R2Q.XA=PX(V%4
MV=0P!QQF@#NZ*Y7P=I,UAX/CVPR6^J2PE96N-Q;>-P4MGTS^5<GJUCJ,7@ZY
MNO)NK.6W\-W4>J;R5,MTJH4;=_&P*RG>,\'KS0!ZM17F]YI6H6EY=WNDVE^V
MCR/:/<V8&9)F'F^:R))U^]"3_>V'J>MJQT!?[=TG=9:D]A%97+*MVQ!20SQ2
M1*VW 7&U]H_A  ..!0!W<TT5O"\TTBQQH,LS'  ID<YDN)HC!*@BQB1@-KY&
M?EYSQT.<5Y6=(U2\TC48GT6\"3:79M]GECS^_CF<R#YB2\FTK\YY?&>F*VKJ
MSU)=3U"6UL;D:>U]922P;"/,MUCPZJO?#;25'4*1@YP0#T"BO/(]#N7UFS%S
M:W,FD&_NY(X2K[8K=H0 K+V!DWD*1P"!@=*T(+;7/^%46UK"EP-7CLHT:.1B
MLK%<;UW'^(J& .>I!SWH ZJ_OX--LVN;AB(PR( !RS,P55'N68#\:BBU%I;.
M.?\ L^\1FF\IH710Z?-M+'G&T=<@GCD9KB-7T::[AU%[?3IFTV:\TV6WM&MR
M"CI,K3N$(^4%  >!DJW7//2>*+:66PTM;."5O*U*TDVPJ?EC612Q('8*#Q0!
MT-1PS17$*30R+)$XW*ZG(8>HK@--T>XBUBQF>QNOFU74%N&D1R#:N)3&&S_
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MBTJXFLQ>:9=K&T1;<5D'GL W5MN-W<\]>: /2:HW^J0:=<6$,R2$WMQ]GC*
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M#SHVM$AW#G&Y7!;#8R.>M4U\&W:7*-)IL<\)M-418R8R(?M$R/#&,GLJL..
M6P#B@#T02(9#&'4R !BN>0#T./3@_E3/M,'V@V_G1^<%W&/<-P'KCKBL/0!+
M;26EC<Z9Y=U%ID"RWFY&+%>#&Q!SP22,\'+8Z&L:?1M7D\5PWC:6IM8M1FE?
M9)'MEB>V,8;!.XMG (.!P, \F@#M8KJWG+"*>*0J S!'!P#R"?K61H-_ILE]
MJ>FZ99V]O#:.CL]OL"2M("Q;"]\CGOFN*@\&ZU!H%I:6MA%;7*>'TLICYB!9
M)E="48J22&"N-V/XOK76^'[2\37]:U"XTQ[&*]6W**[QLV40JV=C$>G?I0!T
ME%%% !1110 4444 %07EE::A;FWO;6&Y@)#&.:,.I(.0<'C@@&IZ* "BBB@
MHHHH **** "BBB@ JC;Z-I=K>R7MOIMG#=2$EYXX%5V)ZY8#)J]10 4444 %
M%%% !1110 4444 %01V-I#>37D5K EU.%$TRQ@/(%&!N;J<#IFIZ* "BBB@
MHHHH **** $(!QD XZ5#)96DUW%=R6L+W,((BF:,%T!ZA6ZC/M4]% !1110
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M-RD#%90/*#*Q#GVPIH UZ*KMJ%DEJERUW +=_N2F0;&^AS@U5US5AHNG+>&
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M2'8(YHI;"_W<%K609;'^T&4 >F\FLX>'=6DTG1DU"..\O8=0AENW!7:T<:E
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M);W$7AR?39)6=<+,WD;0<')7]T^2/[P]ZT9K+5;MK.]7P];V<[7:O=*DR-,
M(7CWAON_Q!>YV9P,X [&B@#RQ/!>KMX;ELY=+B-W_P (TNF1MYB'$Z[@#G/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *, XR.G2BB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#,NO$&GV>I_V;*]P;OR?/\N*UED_=YQNRJD=>*M6&H6FJ6:7=
MC<)/;OG:Z'(R#@CV((((/(-<W=3&U^)2W<EO=FW&D-$98[621=_FAMN54\X&
M<5S36FJ6D&H2_9=3MAJ]_>7=O'"LA\H>4JIYBQ_,'<J6 ) !.3R,4 >H!U+E
M PW@ E<\@'.#^A_*G5Y>SZM#)>:G%:ZJUW/I6ENY6*7<ZK(_VD <#>$/W>&Y
MXY.:Z?0UMO+M)#=:Q.LM[)):F>*:,+F,Y5E/(C'S8\SOC'\- &YJ&K66EM:K
M>2.ANIA!#MB=]TA!(7Y0<=#U]*NURWB;S+_6]"T^W@G:6VU"*\E?RF\L1!)0
M3OQC(('&<_,OK7/P7&J+):6DG]M;X;C58YR%G(V%Y#!\W\7RE-I!..!Q0!Z3
M2,P52S$  9)/:O,('UZQTT/;)K,LCZ-837*RB9V,@E_?A-W23R]WRJ0<X[XK
MLO#3)'I5S<)<:A/;O,TL?VN"1'5<#*HCC?MSG /.2<<8H L6WB72;I;]EN6B
M%@@DN1<0O"8T()#X<#*D*V&'!P:N66HVNH>:+=V+0L%D1T9'0D C*L 1D$&N
M%UG3M0UBW\13Z<]S=6MY:6\D:3V_E2;XY"QA3*JQ4J#PV<,QYY-:UI=)8^)=
M9UNX2Y2PO/L=G"?L[DLZ[\L5QD+^\4%B !M/I0!NZOKEAH<"S7SS!2"<0V\D
MQ"C[S$(I(49&2>!D4V7Q%I,0B9KQ"DL23JZ LHC<X5V8#"J3T)P.#Z&J_B35
MDTZV2#RKPRW0:,36]C+<"$8Y8B-6_ 'J?;)''7NCR)IGB*STZQNOL^JZ';V6
MF(\+J5VK)&$8$93&]6^;'!/H< ';OXCTN+68]*DG=+J5BD9:!Q&[@;B@DQL+
M8!.W.?:GVNO:=>:K+IL,LGVN.,R['A= Z [2R,P < D#*DCD>M8MQ?VEUKUC
MIUQ;:BWV"=65QITY26;:5#>9LV!%W$D[N3].9;8S7OC2'4K.:YDLC:2P3QW-
MJ8Q"P=2NPLJMECNR,D$*#Q@4 =/1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4R2))0HD0,%8
M, 1GD=#3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>exhibit321001.jpg
<TEXT>
begin 644 exhibit321001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 ST# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7T%N\[!8UE<+N).!^I ^IKA]/OI[O5] FO-1GD5=4U.W#F3:K[97$((7 )V
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MF$J%&>>N.O/K0!T+:G:*EHYD;;=L%@_=M\Y()].. 3SV!HO-3M+!XTN)2))
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MLH3^U%D!;IM%M"-WTRK#/J#Z5S'A6.6TA\$ZG<AAI]O87-M*S# MIG92K/\
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MCGC-:E>7QH=5^&WA#1K!&DU6,:>^44G[&8MC2.Y_@(567!Y). *]0H ****
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MV:6D4D-JD*+#'(A1E0 !05/(.,<'GUJW0 4R:&.XA:*5=T;C#*>A'H?:GT4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %4Z
MC9C4ETXW,8O6C,H@S\Y3.-V/3/&:M5Q&MW(@\?2NER(94\/7!5P1E6\Q".O&
M>,_A3O"&I7D^J1V]SJ4MVL^C6EXPE*G;*Q</C &. N1_CR =K17#C7+J;4]4
MA2\F76K*>?R=+V_+/"(SY1Q_=)VMO]<KGM61J'B#4UT22[T[5IGB?1Q/<2G:
M6M[K>@"X(^4L&D!3'&S@#G(!Z?17G5QJM]%J\^G1ZY<>4NMV\*R%HRYBDMPS
M+G;TWYQQQT]JJ)XBO'M+>RO->:QB=[^"#47CW[I8[ADB#$8!;RPI /#\\&@#
MU"H7NH([F*V:0":8,R+C[P7&?RR*Y"PU:6^UZ?3[[5+BUU*"Y41VJ1[/M%N8
M5^8*<\%BS%LY4KMSV.'H^L:E9Z#X?2PNY;JZ;2KQWM96W&2YC5"JG/S9W%AC
M/KWH ]1HKS/4=>U%-)NKK3-7FDM6TJ.=YSM9H;DR*-O(^4LI;*?P[> ,UU/A
MN[FDU7Q!8RWTEW':W:"%Y&4L%>&-B,J!QN+8].G:@#HZA6Z@>ZEMED!FB17=
M<=%;(!_\=/Y5Y^=3\06.HI WVNY2TNYK"=V^[*9OGM9.!_""B,1@#?GMPGB:
MZNHY-<L'U2Y:"T@TJ4'>%*YN'$S$@#@J%+9_E0!W]M?6MY)<QVTZ2O;2^3,%
M/W'VAMI]\,I_&II)$BC:21@J*"23V KS>.]>S\1:E<VFI2*DGB*VA:/<I26-
M[2!6)R,GD'G/!7ZUT&OR+!XTT"2:ZDAMS;W8(\PJC./+*@CH3C?^ /O0!TEI
M=V]_907EK*LMO/&LD4B]'4C((^HJ:O)-$UC4='\+Z<EI>33#_A'+>=H2HD,!
M5D1RB@9RJ%CMYR5'O7;Z!?"32-0O8M9_M6SW-);RQ0D^6NP91223)@@G\=O:
M@#I**\MM/%]Y'#<.=0DFL1'ITTLX/F-%%(SK-)D#C[J[@,A,MCI6G<ZVD5Q;
M6DOB"XCTR[M[AK+4PH^:;>-B!L8?:I^4'[^#G=0!W]%<%<:UJK7=ZB7$D>J6
M^IVT5M9, !/:OY09BO<$-*Q8?=*8Z @U-.U&^NKO2TFU^ZV75_J5K-AXQ^ZC
MDD\LCY>#A5Y]#]* /2**\EBU_5K_ $O<WB*X@NUT".[@6,1YEN0\B_=VY8L5
M4%1USQBMC_A([S_A*K&WEOGA+:A]EO(6( B!LV< +@C;Y@!#DY))'04 >A5#
M<W4-G#YUPX2/<J;B,\LP4#\R!7GGAZ^U758M.M6UZY^T:EH4DS2G9F&=70*R
M@+P?F;([X]JLS:WJLOA4ZO)-/I\\=S:6;Q$C!=9U2X(W#D$EUSZ)GO0!Z!17
MGT&KWRZ]$[:O-)&?$$EB8&*;/),#,!@ 'APN#GV[G+_!^O3ZOK,"2Z[!+(EI
M)]JM%GC+2S"3AU3[Z(%SP=O5<C.: .ZFN(;94:>5(P[K&I=L99C@ >Y-25Q?
MBVRG\4-=:98/;[]/B$RR/.4,-U]Z)^%/W-N><#Y_:J8\2/XA'AV>#4Y;"&^L
MKE[J*%D!25%3@D@D$$M_.@#T"BO)V\2:M/HTE^=9F2>+P_I]\(TV!3<,T@D!
M&W/.%ROO]*V+CQ#<6^N7%D=299%U^WCCB+ G[+)!&3_P N7PWKQGM0!W-[>6
MVG64UY>3)#;0(7DD<X"J.I-,O-2LM.LOMEY<QP6PQF61L*,\#)[9XKS"Y\0S
M:CH?B"$W[SV]QX>N9564_/YH+J05Q\C8*@H"<<=S74>.Y4_X5O<,LB8=;?8Q
M.0?WB'\: .HL]1LM0$AL[J&?RFV2>6X8HV,X('0X[&K->;?;[G1IO%5W.W_$
M_F,,F^&/,<MFIPLD*<DE4,A898[AZ%:>VJ2O/I A\6O+I=_J$L?VB%50*GV9
MVV"1]V[#KG/;=CJ. #T:CI7F-MKFM_V?<6^I:C-!-'ITLNFW04*;R19I55B,
M8=BBP'9CGS"<=,&KS:MJ6D>,?/U*\BN+/3 Z65NRA5D:V)9>!N.'Z<YH ].J
M*YN8;2$RSN$3(7.,DDG   Y))(  ZU@:YJ<EEX:L[NPG:2V>XMUFNE.\I;LX
M#R9]-I^]V!SVKF]2N)KAX8[B^D>PA\0P)8W/FX,D1C5F^;^(*Y90WMSR* .W
M&O:4;:SN/MT(BO&V6[%L>:W/RC_:X/'7@^E6;>_M;N>X@MYTDEMWV3*IR8VQ
MG!]#@@_C7)?$87#P>'X;*\BM+QM57R9I5W"-O)E 8CN 2/S%5%\5K;>%;RVA
MA^PZOILT::A;C,S1J9%\V93UD&QF?=U]>: /0**X$WU_!I]IJEIK,^L:>UZ\
M)^S)C,<J[8PK9)<K*5&[/1CG.VF0:OJ=OX:,^K75S!/9S0Z;<2_=6603!7E+
M$85'4K\X^Z&; R!0!Z#17F^G>)+K.G&]U)EA>;5+21BW#-'*1 N2 2^P<=VZ
M\UG?\)'JLNAM>_VW.LT/A[3[X(NP!KAFD$F1MR<[5ROO]* /6:*X%]<U"XUZ
M^AM]4$6I6D\IBTLP%OM4'EDQD<@;22&WCH<KGM6CX,U)M5,EVFMF_B>"/S;=
MH"IMIN=VXD_*QXRF!C;D8S0!OMK.FI>?9&O81/Y@B"%NKGG9_O8YQUQ5JXGC
MM;:6XF;9%$A=VQT4#)->?M,^EZ^&TF^BOK&\U;;=:/< >=!*9</-"1SM##>0
MP(QD@BDB\07%WX8U6^36+B'6+;3KG[79!!_HTZDE3@CY<8VJ/XP<\D9H ]$1
MUD174Y5AD'U%+7 0ZW=7GB!+.36_L,\<MM);0>27^V6[1(7(YP<L9 6P=FT'
MIUSK/5=3N+2U#:Q=7$E]8:F&4,H(>.0"(KM (;!/3K^ P >E?:X/M7V;S!YW
ME^;M_P!G.,YZ=:J66O:7J-ZUG:7B2W"IYAC (.SC#<CH=PP>ASQFN&MM1+Z6
M+--3D>S/ACS@/,'$@X)#=<]NO:@ZOJ.EZ=I\>EW,MP1X9EN$MQB0F53#M(&,
MD@%\+[8Q0!Z56?/KFEVTDJ37T"&$XE);Y8SZ,>BGD<'GFJGAR\M+^*XN=/U:
M34;.1E:-F^81G: RANIY&2#T)QQT&#X(NK.U\(1Z)K$D8U6-IH[ZTE/[V61G
M8LP7JX?.01D$&@#N:*X1=9U.;455;ETOX]:>UFLB1C['EMK[3T&S;)O]>,XX
MK-L]0OWT[PW=7/B:\1-2OIK:Z<M$JJJQW!&#L^4DJGY"@#TVBO-['6-5,,5I
MJ^IS6T)M+IK34/E0W#I.RQL>,%O*".%Z-N)P<<)#K&KO!J][J6IWMI<6.DVU
MR]I;1QMY4SPOY@VD9.UL'!/! R<4 >DYQ4-O=0W2R-"X<1R-&W!X93@C\Z\V
M.K2WEY&L^I/]EM?$,2(\5P640O:!UR^!O4R,<$]^!VJ_::]=O>PVU]J$BZ?)
MJ5_!+=[PFPH?W,98 !01N(/&2H'.<$ ] IDLL<,32RNJ1J,LS'  KRJYUW7Q
MI-]-<:O<0W5KH;7D2HJ+YDBRR"-R-O\ &JQDK_M=!79^)YI'F\-JAS:SZK'Y
MY4Y!41R.GX>8L?XXH W+G4+2R6%KF=8A/*L,>_@L['"KCU-6:\QU9@-9UBWD
MOIDD/B+3VC5I,[(RD!W*#D ;M_MP?0T\^(KJ**.SO=;:ULC>7]K_ &E(,E72
M1?(5F& ,J7()^]L .<\@'I$DJ1;=[A=S!5R>I/:H)]2LK:!9IKF-(W?RT);[
M[<_*OJ>#P/2JJ:='J>D:<NINUS-#Y4_G!6@+2J/O[0<KGG*Y[D'-<S<V5IX:
M\<:1<R P:(+.YBCDED9HX+F21&Y9B=@90P'0#&!C.* .RM+^UOA(;6XCE\IM
MD@4\HV =K#L<$<'UJQ7*ZMJT":GIA@F$6F7LSI>7T3;5+",^6OF#H">-P/50
MN>U<[_:VM31PQ7>KW%NW]DZA,K1[$,IBG58)3\O5H_FXX//&,T >F45Y=>>(
M-3M[.X==;F!DT_3;LN?+/EO).4EV_+@#;MX[<'OS=.JWEI=364NL7$]A)J7E
M6EV[JOF VY=HS*HZ!_N[1DL-GK0!Z)17DI\3:M<^'FU#^VIDN(O#=I?[$" &
MZR^\$;<\E0"OO771S:DGBJ;23/<26MTZ7]O<@\) HQ)%GI]_9[E9?]F@#7M_
M$VAW?E_9]6M)?,A,Z;)0<QAMA?\ W0W!/:M6JBZ;9H.(%("NOS$D8<Y?KZGK
M7(6&J:G:?"*POX_,>Y2WAS)MW.(-ZJ9,<Y(BRW?IWH [JFNZQHSN<*HR3[5Y
M]=ZKJ U06]IJ\O\ 94FJ6T4%RCHY97C8R1AR#N (4YZ_-C/&*Z+PEJ$ESX<D
MEN[OSS;W=W!Y\C#)2.=U0L1Q]P+SWZ]Z -"SUW2M1:%;/4+><S*6B\MP?, [
MKZCZ5HUYIX;EU>P^$5GJ%E,MS);Z4/(MT@!>)P.3WW,!NXQ[8YJ;5-9O8KF5
M=.UF1M)>YTWRKM71\-+,5FC#$'(V!7/]W=Z<4 >BT5YOJ=]J.GW.JQ1^(+P_
M8+K3HHC(T9)61T63=\OS?*6/MU[5T_A6[FF?6K6:\>Z6SU%H8GD(+;/+C;!(
M SAF8?ACM0!L0ZA9W#7(ANH9#:MLGVN#Y38!PWH<$'GUI;2_M;^-GM)TF53@
ME#G&0"/S!!'J"#7!:M#-?Z=\1K6QS+<22IB.,Y9Q]EA#*!W)PR_7BM.VN+Z7
MQ9K&IZ);07MH]G9PC=<>5&\BF9F(8*W(5XP>._M0!TC:QIR7%U UY");2,2W
M"%N8D.<,WH.#S[&K5O<0W=O'<02+)%(-R.O1AZBO,M6N+Z/QQK-\D,-S:VUE
M8RZCIRO\TR+YY8(W 8H2&*D8;@'&<'T&RU73]9T@7UE>*]I(F?-1MI48YSGE
M2/0\B@"2SU6QO[B:"UN4EEB56=1G[K9 8>JG:W(XX-7*\P\-7[P>'/#5A/J,
MME92Z%YBW7F 8N5"#9D]U&2$/7G(.*UO#-[K&JZ^BZK?W%O-%I5C=2V*;%43
M.)A*I&W..$)&>"1[4 =S1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% %34=3M-)L)[V]E\NW@3S)6"EBJ^N "<5;KS;QK;L+[Q9\MVQN?#\2
MP!3(R.X><, !\N>8^/\ :'<U)>ZG?:;J&H1)=7LFDIJ,!FF/F3-%"]N22I4A
MMGFA,[3A<GH,B@#T0D*"20 .236;8Z_IVI7?V6TDE>3R_-!-O(J%#C#!RH4@
M[AC!YYQT.,Y(V_X0*X2:\NKO-M-MGE5HI'7YMO&=W3 &>2,9Y-<[;2W5I9Z/
M;VU]=6T3>&9R['?*(IAY.QBN<[A^\PO7 ('2@#T:BO.(]8O5>VAU87MMITDE
MS!-=6,\LZ&;9$8FCD WA"#+P>CC'.!4L^IWT/B.RBCGU8B&]MHIO/C?]Y$T!
MR=J*$P6(R3D[P0,!10!W&GZC:ZI9BZLY#)"7>/<5*G<C%&&" >&4C\*M5S'@
M^'S_  K<0,TL>^^O^48HZAKF4@@]1D,"#[@UBI>:_#X:NYY1=O=:48[&4IN=
MKA5E7SIU4'+$Q8(QA@2P':@#T&BO,]2O[J/2&6QU/5[E;F.\FM)A%,BJPC0J
M@ZR,=Q;:&('W\YV@5M>'I+C4_$US<7%[?;(K6TECA+LD9=HW$F4X!ZJ<=C@T
M =E17$W-Y>3>,I[&XO;VS>*[ADM$B@D9+BWV+O!8'9C=YF21E< @]*P8M0UZ
MUTRWN;"YO[K4)M.U+]U,[2 R)(OD?(> V-V.[#UH ]*BU&UFU*YT^.0FZMHX
MY)8RA&%?<%.2,'.QNGI4UQ/':VTMQ,2L42EW(4G  R>!R:\SEU!K?5=7U'2&
MU":UDL]-,L[1S2NL0FF$N,_-D*P) .1EL8(J::\G"M:7&H:E<:1<V5T]I<^7
M+&7F)&V/.2Y 4MMW'YN>N!0!Z+:W,-[:0W5N^^">-9(VP1N5AD'!]C3;:\MK
MSSOLTZ2^3*89-ASL<=5/N,UA:;?G3/A]IDYC(F6P@C2.12I\PHJ@,.H&>I[#
M)[5C:3:7'AGQ7+I\V!:ZS:>:9(68XNHP%9V.!M:12#GN8SW- '>U4N]2M;$O
M]H:10D#W#,(G90B8W'(!&>1QU/.!P:\L@O=8E\%Q:E8ZOJ5S)<>%WFNF,S,8
M[P)&82G]UV)D&!UP"<DY/1ZJ);2_DM8;V\N+2?0KV1A+,TBM(6C*=>,X+X'I
MD#@4 =BVI6B::NH-+_HKHLBN%)+!L8PN,DG(XQFJ\.OZ7<:;#J$-VLEM,YCC
M**Q9G!(*A<;MP(;(QD8.>E5M.O+>Q\(Z;-=3&",6L*&3;G8Q4#G@XY]>!WKE
M[&QOK*YT*[O'\VRM-5O&:Z\L1EUE23;,X' RS,N0 #N!Z&@#L+2SL[G5/[?M
MKEY3<6J0C:08R@8L,<9SECWHN?$.DVFJ0Z;<7J1W<S!$1@<%B,A=V-H8]@3D
MUC^#IUL-/BTV[+Q7EW/>7L$#QL,0O<.ZC., [74[3S[<4:[J>E7.KV^D7/F@
M17,-S)LMI&\R16#1J"JD?>"DG/  '<X ->ZO;#4&FTI=0DAG;<F^!BC*P )"
MOC&X Y(Z@=JKZ1KF@R036MA?(RV48>0/N#;#G]YEN6!()W#()SS7*VEA<HFD
M:?*C?:K+7[R]NW93@0-]H8.3Z,LJ ?4CL<:^FZWH]]K5WK):=7BM/+4-:2KY
M<*MDL25ZLQ'') 4?[6 #H-.U6PUNVF>RG,J(YAE&UD=& &5((#*<$'MU!J'3
M-!ATQ84%U=W,=NNVW2XD#"$8QQ@ GCC+9.._)K'T:\72;C5KF^N_.LKW4(_L
MUYY&&E9T5=IV#!"[54/@# P3Q3/'=[=6\,<%I)?1S26=T\3V^_;YBJNT'8-Q
M?D[1D#AB<X H ["J.HZQ8Z4H-Y*RDHS[4C:1MJD!FPH)VC<N3T&17*Z?J>HR
M^)K$O)+<VUQLW*K/$]LWV?<=\9^5XB>=W!#D#FKFH0PM\1K.6229%72;D,ZS
M.JJ3)%@<' . QQWVY[4 ;MMK-C=75O;122">XMOM<<;PNA,60,G<!@Y9>#SS
MTJ_7EMO>ZP=-T>^B6XGU<>%)"Q92TAGW0DC!ZR?*YP>20:OQZI(DEE<QZEJ-
MQH5W>@7,IAFC^S_N6PH9B9 ID"Y.< G&<$B@#N=/U"UU2S6[LY#) S.@8J5Y
M5BK#! /!4C\*M5R7@ZT:?P*]EYEW;LT]XBRG<DJYGD*L"<'."#FLG1YO$5SJ
M%I%>QWL<-Y MO,WFOB&:V8"5QSE1+\P!'78#_%0!WD-W#/YFPN/+D,1WHRY8
M<G&0-P]QD5G)%I_B-M,UBWN9F2SFD>$JNT%\/$P8,N>[CM7(LT\^K:?-=37T
MD-MXEN$W!Y#LB-M($^[_  [\ 'ISCN:7PD9[34-&5)[D171U(3PN[>6,3[HS
MM/"G!8@\$@GK0!W6HZG::592W=[-Y<$0!=@I;:"< X )ZU;KS;QG PU+Q1Q=
MEKC1[00!3(R,PEF# #E<@%./?/?F2[U.^TV[U&$75Z^E1ZM$)9CYLS10/; D
M@J=^SSL9VGY<D= 10!Z#<7$-I;2W%Q*D4,2EY)'. J@9))]*K6>JV=_-+# \
MGG1*KO')$\;*K9VG# '!VMS[&L?R()/ 4MOJ<M[J5K) Z2.T3+-+&20"%'S9
MVD8_B. >IKF3?Z[I4&H007TFLV%NMLXU)("UQ'$9L21/LQYC*FYLKA@">Y!H
M ]+HKSPZ@\#6<=SJFK2Z)>"Z\N]BAF1XY3Y?E+GE]H!EVELY( YP*;J&I:A9
M7EY;_:-3,@O=+D@!5RQA9XUF)"C&#\^X#C)Z=* ._N;F.UC627?M9UC&R-G.
M68*. "<9(YZ#J<"B:[A@,8<L2\@B&Q&?#'D9P#@>YXKS])+V/0GU :EJ37(U
M]8 K3N5%N+_'W?[ODDDGNOL!2VS7%C/(D4M]%*WB8B8,\A#0L21UX*XQTXZ>
MU 'HM%>;VE_J5Y:W4LFK7MGJ<44D-W;R6DIBBD,@VL26P%[ QX)5B?X<C>L=
M1O!X&U&ZFM[M+J!+G MY3<.Y7<0T+,,L#_#D>@YH ZJFR2+%$\CYVH"QP"3@
M>PY->:1ZAJ$LDL"WU^L!U:R\MU:7_4/&OF .XRRYW9/'<X%2V6I7:W$%CJ%Q
M?_V7YNHPI<!Y"YD68"!6<?,1Y9;:2?FP.IQ0!W']M:=_82ZW]H_XEK6XN1/L
M;'E%=VXC&0,<].*?::K:7LJQ0F;>R>8HD@>/<O'(+ 9ZCIZBN/5'_P"%#" Q
M2+,?#ODB)D(<O]GV[=I&<YXQ5R&XM_[*FAEUF_E$E@@'DJ%>V*\$JRJ,,2R
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M2W&KPQ726WF_,[,CN(\Y^\<!>O7CUK)U6\OMD\NDW]__ &:ZZ>PD,CL\<K7
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MA3TK44@C 8''!^M>46.IWUIHOAV*$ZG#);6FD+)&8I-I0N$FP@7!^4D,6SC
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M1P&5E.00>A!IU<MX$MYM&\+:5HE^&CU".V:8PX)$2%SA-WW<J&5<9[>E=30
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M+%<;4$9*J=Z#_6#@8W;2>>:==:;J2WFHM!<:L-6,%B;&8EX_/=1AC(%^1O\
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MJ" S&U_TR6W,+ [XRN9 LA3G;D@$X.* /2:KRWD:$!%>8^:L+B(;BA.#EO0
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M0$OY D;L=I0<\^O>MWQ3?((#I4EEJ,T%Y$RW$EK:22A8SP5RH.&89'L,GTR
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MKZC!QR >ET5SV@VEO:+IT6S5I)5MYO)FO2Q*QF13M?&%#?=V@C<%4CL:Z&@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HJH;^+^U!I\8WSB+SI,'B-"2%)]R0V/]UO2J-MXACN=.U"]%I.B6-Q)#
M*C8+XC^\P )SZ@9R?KQ0!LT5$+J!K5;H31_9V0.)=PVE3R#GTI@O[,H7%W 5
M"[RWF# 7.,]>E %BBH7NH$F2$S1B9P2D9<!G^@[U0T'78-=TV&Z0+%+(I9K<
MR!G0!BN3CZ4 :M%8EQK\L?B"?1X; S30VB79?S@JE&9E Y[Y0^W3FM.*]A<P
MQR.L-S*@<6[N-XXYX]OZ4 6**KC4+(D@7=OD'!'F#CJ/7V/Y'TI8KZTG=$AN
MH9&=/,0)("67.-PQU'O0!/16=J6K)IMWIL#P2R?;[G[,KKC"-L9\MDYZ(>@-
M4Y/%%K'?21>6QMXKU+"2XR,+.X!5<=QEE7/]Y@,=2 #=HK+U[61H5C%=-;M.
MLES#;[58 AI'6-3SVRPS[5+8:DU_<W"QVY^RQ'8MSO!65NX4=P#D$],CC/.
M"ZL:(S,J*"YRQ ZGIS3JB>Y@CG2!YXUED^Y&S@,WT'>LJV\0)?ZW<6%E"D\=
MI-Y%U*LR@Q-Y:R [?XE^95R#G<>F 30!M45@3>+=.6[L8K>6*XBN+R2SDF24
M;8'2*20[O;]VPK8>]M8XXI'N8528@1L9  ^>F#WS0!/55=.M4U.34EC(NY(E
MA:3>W* D@8SC@DGIW-0ZOK$&D10&5'EFN9EM[>"/&Z60Y.!G ' ))/0 T0ZA
M.+EX+VS-N$B\WSQ(&B(S@C=P<CJ<@=>">< &A14'VZT\A)OM4'E/DJ_F#:V
M2<'O@ _E2)?6DA(2Z@8B,2D"0'"'HWT]Z &WVG6NI1Q1W<9D6*59D =EPZG*
MG@CH0#5JH%OK1XY9%NH&2(XD82 A#[GM2-J%DD*S/=VZQ,I97,@"D#J0<]*
M+%%0F\M@SJ;B$,B[W&\95?4^@JGK&MVFC645S/(F)IHX8@7"AF=@HY]!G)/8
M ]: -*BJ5CJ'VB.-+E8[:]92S6WG*[  XR,=0>"#COS@\5/%=6\^_P FXBDV
M<ML<';]<=.AH FHKGX_%^F3ZC:003PR6ES#<2B\$R^6IA=$8'ZF08/\ C6V]
MU;Q2QQ23Q))+_JT9P"_T'>@"6BH9[JWM5W7%Q%"N"<R.%&/Q^HH>ZMXGB22X
MB1ICB-6< N?;UH FHJE<ZE%&A%N\$TRNBM&9U4@%PI/X<\=R,58%S ;DVPGC
M,X&XQ;QN ]<=<4 2T5DKKT$GB9=%C"R.;62X:1) =I1T4J0.0?G!_"M%KF!+
MA+=IXUG<$K&7 9AZ@=30!+14,5Y;3R&.&YAD<+N*HX) Z9P.W!K-L?$-K?:G
MJ=HC1B*P2)VN!*I1@X;TZ8VF@#8HK/U#5[6PTB74?-BDB6,O'B50)< D!3T.
M<5/I]V-0TRUO0A07$*2A2<[=P!Q^M %FBLK1O$%EKBWQM2P^Q7+6\N\8Y !#
M#_9*D$'N#5U;^S=9&2[@98\%R) 0N>1GTS0!8HK'U37ET^QOKV**.ZM[6SDN
MLQSKE]F<J!^!Y]>*NR7<O]G+<V]J\\KHK)"K $D^I/ 'O_/I0!;HKG[;Q3'=
M66GLME-'>WT\MO':RL 5>(N)"6&1M&P\C.<KZUIZ3J<&L:9#?6VX1R9!5Q\R
M,I*LI]PP(/TH NT5AZCXB?3-3MX)M+NC937$=K]M!7:LCX"_+G<5R0N['4_C
M38/%5I-<PJ(I!;7%Q-:V\XY\V6+=O4 <_P $F#WV'VR ;U%8%GXDGGO[NPGT
M:[MKR&!;B*)GC;SHV8J,,&(!!&"">/4U=T75FU>TFDDLY;2:"=X)(I"&PRGD
MAAPP]_\ "@#2HK*UG78-(>S@8Q-=7LIBMXY)1&I8(SG<V#@80C.#R0.]3QZF
MDFG)<;4$[P>;]G\U6;('*Y!(.#QD9% %ZJDNF64VI0ZA);H]W A2*4]4!ZX[
M?C[FLC3/%D&H26 D@^S17FEIJ0DDE&$#%1L/O\PYK>6>)WV)*C-M#;0P)P>A
M^E $E%1+<P-<-;K-&9U&YHPXW >I'6FI>VDL9DCNH7C5MA99 0&],^O(XH G
MHJO'?V<K1K'=P.TNX1A9 2^WKCGG'>HYM3MDM[AX)8IY(8C*8DD&X@ _EG'6
M@"Y167I>L?VE;6=R(5BAN;)+O+2@LNX [2OH ?O=*M_VC8_9EN?MEOY#':)?
M-7:3Z9SCL: +-%1R3PQ%!)+&A<[4W,!N/H/6H6O[<P&2&>"4D-L E #D#)&?
MY^E %AXTE0I(BNAX*L,@TZN>U/Q=9:9IEY,3%->V=FEW-9QS*6"MG'/?H>?;
MWK=BGAN QAECD",48HP.&'4''>@"2BL!O%VFM>6,5O-#/;W,T\+W*RJ$A:)6
M+9_[X(K9>\MHQ$7N(5\X@1;G WD]-OK^% $U%13W,%LNZ>:.)3GF1@HX&3U]
M@3^%(MU;O<&W6>)I@N\QAP6V^N.N* )JJ:AIEEJD,<-];I/''()%1^FX9QD=
M^IX/%.74;%RP6\MV*ML;$JG#>AYZTV>]5!&8/*FS.(7_ 'P79GK]2/[O6@"W
M15<W]F%D8W< $8RY\P?*,D9//'((^H-#W]FBHSW<"JX!4F0 ,#P".>] %BBH
M1>6ICE<7,)2$E96WC"$=0WH?K3&U"R2)97O+=8V7>KF50"N0,@YZ9(Y]Q0!9
MHJE_;&G?;[BQ^VP"YMHUEFC+@%%;."?3[I_3U%6HIHYHA+%(DD;<AU8$'\:
M(KZQM=2LWM+R!)H'QN1QQD$$'V((!![$4VQTZUTZ,I;1E0WWF9V=F],LQ)/Y
MU6U+7].TW1;G57N8Y+> ')C<'<W]T'.,U+:7[/9/<WT<5JBN0'\]7C=?X7#<
M<'/< T 7J*@-Y:@P@W,(,_\ J@9!^\_W?7\*BNM5T^QBN9+F]@B6VC,L^Z0
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MT4<TL@42%20Q&>V5;'J!GI4G]JP#4;6T)4K>1-);2JVY9-H!(^N"".N1GTH
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M7;<1[X]1GM9[6[#J/LOEA 003GY2A=< Y+GIUK8T&QN;/5O$,UQ;&*.\OQ/
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MN9;K5_[-TR..&ZT*6SC$9C0&9V8X(S_M9)^M=*S7%MHL"BPEN9-B1R01R(K
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M%Q&JQ7UZMQ"0^3M$$47([',9/T(K:J*WNH+M':WF254D:-BC9VNIPRGW!!%
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M,J*69@J@9))P * /,]1T&YTGPT[7R00PQZ#;::S^?L43J_#%L'"98'<1CKD
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MWD<N7EB*,-F,# )()!X^7C-=$2 "2< =356SU&RU$2FSNH9_*;;)Y;AMIP"
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M\NWJ &V\*.,Y/&3B6+PYJ,=_!,+>)537Y=18B09\IH7C_P"^LN./0'FNUHH
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MUIR@&2UN PR#A04Q\R[6R3MR#P2>Q\M,YV+GKTJ.:6VLH);F=XH(E&Z25R%
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MI'7CUJUIVI6>K627=C.L\#$@,O8@X((/(((((/(- %JBFB1#(T8=2Z@,5SR
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M/T&Z2V$][XRAU.UDO#9_9)8+B*[M#$(R&4IY>Y%;).[/)! 'HM=/10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA6:&/:27"_>(P.V1GTR/6JJ^)-(>WAN%O 8IYS;1.$;#R@D%!Q][((QZ@^E
M&K1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/.<U=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>exhibit322001.jpg
<TEXT>
begin 644 exhibit322001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55 ST# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7T%N\[!8UE<+N).!^I ^IKA]/OI[O5] FO-1GD5=4U.W#F3:K[97$((7 )V
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MW*Q):$"=Y 55"0" 2>.A'YCUKD;Q;'QS'HDPE>SN9;&6YMI!Q+:3AH2#@_Q
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MF\Z>,[D4LT9 R."<(QP.1QZC/,JUUI'B/2?$UQ%"D.K,UK>F.4NVU_GA9AM
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MB;/5%DBM=2U^ZN[-"3')$ABDV2+W0[_G'NP[G%=#X5?6/[7U*VUN+-U:P6\
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M/T&VFE\8^(=8166PNDMH82P(\YXP^Z0 ]OF50>^WTQ0!K?V]IWVH6XG8N9C
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M@>IH V;;7],N[AX(;G,B6Z73;HV4+$^=KDD  '!_(^E%OKVFW,L,<<[9G4M
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MM.O;B*&WG9VF#&)C$X24#J48C:P]P3VHT699;25!<SW?ES.#<31["^3N &
M0 P7(&./8UQN@&31]2TZ+3KF>XT"6.262QO(&\[2L(2-K$;MI/R!&R>?ER,T
M =XE]:R7\UBDZ-=0QI))$#\RJQ8*3]=K?E6>?%&C+=2VSW9CDBG6VD,D3JBR
ML 50N1M!(9<#/.1ZUR;+>Z;K>C^*WB4K?RM;WJ1*S2"&7!CW#'_+(H@)[ L:
MS[^SN;C4_$,\D=Q<Z.NMP3WEG%$=\\*P08D0XRP61,E5ZA2!SP0#O[CQ'I=I
M=W-K-/(LMK&LLX$$C"-&SAF(7 'RMSG'!]*M7&IV-KIO]HS7<266U7\_<-A5
ML8.?0Y'YUPNH'[5XK\22Q:E>645QI-K'%/;VWF^8P,^0 4)) 9>!@_-4MEI\
M^M^%-&\.7FFPVBQZ:IO+.3?M4%/+1 3G)'+8))4JN: .SU#5K'2OL_VZX$"W
M$JPQNRG:7;@*6Q@$GIG&:2[U>RL'E6YD=##";AR(G8",=6R!BN.LW77O".G:
M3X@A,\T-V;&\$B,!-L#IYH/]U@%8,.YZY%1M;:S8V>NZ9J0ENHK72)8[._(W
M-<HV=JMCK*N-I]>#WH ["#7]-N(_,6:1(C UR))H'C0QC&6W,H&/F!Z]ZEL]
M8LK^<P0/+YHC$FR6!XSL/ 8;@,BN4TU[;_A%TM;V:_U&)]'\N>Q-O]Q1'\X^
M55.3G;@Y.<8[TFA?VU8ZE<:?87JZS8QVF^UN;]622W;>H\B20+ELKD]-PV_-
MU!H Z^[U.TLI8H9I#YTH)2*-&D=@,9(503@9&3C'(]:J7/B;1[/2QJ4]YML_
M,\II1&[!'SMVL ,J=W&#CGBL.!+W3O';ZKK*1QPW>EQVZS1,6BAD21V9"Q Q
MN#J02!DJ1V%5;2%4'B:6\LVEL]>OA':6<J,!*/*2)G88RBLRDDGL >I (!UM
MQK-C:RW$<TDBM;0"XFQ"Y"1G/)(&.QXZ\'TJ6'4;6XTQ-1B=FM7C\U7\MLE,
M9R%QGI[5PVF-<:5X=\1>&M0\V>]M+>0QWI1C]MC:/"')SF11A"N2>!CK6QHN
MK6H\)Z=98F^T+IJB13"X\O;$,[B1P<X&.N30!K6WB/3+RWAN+>2=X9X_-BD%
MK+MD7;NRIV_-QR .32P^(M+N-*MM3@N6EL[IU2&1(7;>2<#  SU]JYOP&YMM
M \-VTM[>O,--CA>SD@ 6%Q&I))"@C&TK\Q/6I= T]+/QQK5G'Y@T^#9=VD)7
M]VDTV\3;#CM@' Z>:WK0!V3,J*68A5 R2> !5:#4;.XTR/4HKF)K&2$3K.6P
MGED9W9/08YJAXAD>:"#2X=OF7TGEL7!VB,#<^2.FX#9]6]JX:YT[4O\ A%/$
MOA*"W:22TN$N;2.)2$FMFD65H5)X)&)$QZ%?6@#O&\2:4D:2/-*B2*6C+VTB
M^8 I8[<K\W )XSFBV\2Z7>7;6L,LYF240N'M94".5#!6)4!3M(.#ZCUJ2TU6
MPU7R3;AY2/GPT+*83@_># %3SC!YYZ=:R/"X_P")_P"+2R,%DU-)(RRD!U%O
M"N1GJ-RL,CN* -Z[U.TLIHX)I&,T@+)%'&TCE1C)VJ"<#(YQCD>M5I?$>E0V
MEO<M=%HKB;[/$4B=R9<D;" "0V01@X.016.4?2_B)>ZE?9%C>:=##!<$?)$\
M;N60G^'.]2,]<'TKF;RPN_->\Q<6UO?^*(;JW"Q_/'$L:HTI5@=H+*3\PZ$$
M]: /2+;4;6ZAFEC=E2%BLOFQM&4( ;D, 1P0<^]4K/Q/HU]%>20WRA;)0]QY
MJ-$8U()#$, =I .#T..*MPQ?8--<7=S)=!-[R2R("S*23@A1@X'' [=*X357
MA\3:;K%[80W;W\D=M^Y:TEC(MX9A(4RRC<[9DX&>H';) .W&MZ?]FDG-QM6.
M5875HV#K(V-J["-VX[EP,9.1ZU7O/%&C6%C'>W%YM@??AEB=RNPX<L%!*A3P
MQ(&#P<5R-[8W5SXL?78E=M+CU6S=B <.J02HT@'=0TJ9/^P3VJ:"\72M+U.*
MZ6XB;6-0NI('6UDD\J!CC>0JG&>6 /7<.V< '?121S1)+$ZO&ZAE=3D,#T(/
MI3JIZ4EM'H]E'9(\=HD"+"KJ58(% 7(/(XQP>?6KE !3)(8Y2AD7=L;<H/3/
M8XI]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS&J%5)QNSN+ C/<YYH ]1HKS34O$FHPZ3=76G:RTML=)BN6N2(R8;@R*-O3
MW ME3TV<8KJ/#=]-/JOB"PEU!KQ+.[187?9O57AC<CY0!C<6QQ[=J .CJ%;J
M![N6U653/$BN\8/*JV0I/UVM^5< =:\0V.HI;R/=7*VMW-87#&-0LK2_/:R<
M+V!16P0 7!/3AOB;4+R&77-/?6)C%9P:5+NRBLFZX=9F) '!55)SP/H<4 >@
M6U[:WCW"6T\<K6TODS!&SY;X#;3Z'# _C4KR)%&TDC!$4$LS'  '<UYO%J3V
M7B/4KFUU4B.7Q';6[Q90K*CVD"DGC.<CL1ROUKH-?G%OXST RWKV]N]O=@J7
M"H[@1D YZG&[\ ?>@#I+6Z@OK2&[M95FMYD$D<B'(=2,@CV(J:O)-#UZ_P!&
M\+::EK?O<)_PC=M<^455S!M9$=E"C)VH6.#GE/K7;Z#J'FZ3J%ZFM1ZI:!FD
M@F@3?Y:[ 2@8?ZP@Y/KSM[4 =)17EUIXUNDAN'?5!-9B/3II+D%':&*5G6:0
MX&%^ZN1R$R>>*T[G7UBN+>RD\3F&PN[>X>SU7:FV27>-B!L;7VJ>!_'@]<4
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M<ZDQLX?$4$5G=!D!EC,:L1G&&V.67/MSD@T =R-<THV]I<?VC:B&\;;;NTH
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M=/LB^9QL/R\$+M;KG"Y[53CU+5)-/O!'=:LJM#I<L+/YV]6,Y6?YF R=H&X
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MY_>!-X')&XD<\S:3#=6]U%'+9:BNB2:AJ!E3R9@VYF4PL1C<4QYG/0$KT(%
M'I%-61&=D5U+)C< >1]:\F:UU:=+RPOKK6&U5="BEM%AFE#+/YLXB9MIVA\"
M,-NX.#GH36C<P:EINHZS-]CU!UEU*VFNVM87?S8#;(K&,?Q8E'*KD[01C'!
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M&(RZG:XP #]W:'&X*#[T =%1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !155K^+^TUT],O/Y?G
M2 ?\LT)(!/U(('KM/I5&W\0PW&G7]Z+6X2.QGDAF1@"W[O[S  G([XZD>_%
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MWMZ+8W%O:VDER6BE7+;,Y4 GT'7IVJW)>.-.6Z@M9;AW162&,J"<^Y( ^I-
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M &F'RF.%DWC:3Z T 344QY8X]N^15W'"[CC)]JC:[B\HM$\<K8;8JR#YR!G
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MC0!+138Y$EC62-U=&&0RG((^M.H **** "BBB@ HHHH **** "BBB@ HHHH
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M=OJFD2WD+VMEB9;T)]DFA R' 8$@,-P*YR20<=:]!BECGB26&19(W 970Y#
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MV=+9IVGS\H(904'J?G!/;MUSBT-0C?5GT^(;Y8HEEF.<",,2%'N3M;CT'TR
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MCT^/PXNFWC2RQ[%?Y 5SN_V3S]*W/!UM=C2A=ZA-'<74BB!9T_Y:0QDK&W_
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M0R,6.6."1E6YRK!2">QUI-(UJZ^'EYI;M!%JLL<RJR*(U?+L06"DA2ZXW8R
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M## QD9-= TB(RJ[JI<X4$XSQGBJMKJNG7L1EM+^UN(UD\LO%,K@/_=R#U]J
M.0TK2M2@\.:%IL5O%+-I=U)%=;W"2*NV10Z,0<;@P)(YVL<<TNDZ+?V\7@;3
M;A$6XT6$O=F-]R@+;M"!G_:+Y ]%/I7=8YSWJ&"ZMKB2=()XI7A?9,J."4;
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M,P!<@9( [X )H EHJ&6[MH+B""6XBCFN"5AC9P&D(!8A1WP 3QV%34 %%%%
M!1110 4444 %%17%S!:1B2XFCA0NJ!I&"@LQ"J,GN20!ZDU+0 4453_M;3M^
MS[?:[O/^S8\Y<^;@'R^OWL$''6@"Y1110 4444 %%%% !1110 4444 %%%%
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MMW,.$.,YSCGD"JO]N7+Z<;W2_$=KJ=M+<Q^7$S^1G]TY>(3'.'RH?# 8QM.
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MWD>6UBN1--:[8Y@3EE)4,-WN00?QJS110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !16;=:]I]GJ/]GRO,;ORO/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME=PR#Y"C'USQ7J-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
( !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481573008896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Jun. 26, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--04-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-5286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">KEWAUNEE SCIENTIFIC CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">38-0715562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2700 West Front Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Statesville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">28677-2927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">873-7202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common&#160;Stock&#160;$2.50&#160;par&#160;value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KEQU<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,907,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,879,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text">DOCUMENTS INCORPORATED BY REFERENCE: Those portions of the Company's proxy statement for use in connection with Kewaunee Scientific Corporation's annual meeting of stockholders to be held on August&#160;23, 2023, indicated in this report are incorporated by reference into Part&#160;III hereof.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000055529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481573011040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">FORVIS, LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Charlotte, NC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">686<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481573189872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 219,494<span></span>
</td>
<td class="nump">$ 168,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">183,906<span></span>
</td>
<td class="nump">144,652<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">35,588<span></span>
</td>
<td class="nump">24,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">30,224<span></span>
</td>
<td class="nump">26,828<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating earnings (loss)</a></td>
<td class="nump">5,364<span></span>
</td>
<td class="num">(2,608)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionExpense', window );">Pension (expense) income</a></td>
<td class="num">(71)<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income, net</a></td>
<td class="nump">939<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,734)<span></span>
</td>
<td class="num">(632)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (Loss) before income taxes</a></td>
<td class="nump">4,498<span></span>
</td>
<td class="num">(2,485)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">3,139<span></span>
</td>
<td class="nump">3,518<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (loss)</a></td>
<td class="nump">1,359<span></span>
</td>
<td class="num">(6,003)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: net earnings attributable to the non-controlling interest</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">$ 738<span></span>
</td>
<td class="num">$ (6,126)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="num">$ (2.20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="num">$ (2.20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">2,824<span></span>
</td>
<td class="nump">2,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">2,902<span></span>
</td>
<td class="nump">2,786<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost (reversal of cost) for pension benefits. Excludes other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481570719184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (loss)</a></td>
<td class="nump">$ 1,359<span></span>
</td>
<td class="num">$ (6,003)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Change in unrecognized actuarial loss on pension obligations</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss), net of tax</a></td>
<td class="nump">1,659<span></span>
</td>
<td class="num">(6,168)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less comprehensive income attributable to the non-controlling interest</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">$ 1,038<span></span>
</td>
<td class="num">$ (6,291)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481570688192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Apr. 30, 2021</a></td>
<td class="nump">$ 41,241<span></span>
</td>
<td class="nump">$ 6,915<span></span>
</td>
<td class="nump">$ 3,807<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="nump">$ 34,149<span></span>
</td>
<td class="num">$ (3,577)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="num">(6,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(165)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="nump">744<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Apr. 30, 2022</a></td>
<td class="nump">35,694<span></span>
</td>
<td class="nump">6,983<span></span>
</td>
<td class="nump">4,483<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="nump">28,023<span></span>
</td>
<td class="num">(3,742)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation</a></td>
<td class="nump">677<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Apr. 30, 2023</a></td>
<td class="nump">$ 37,409<span></span>
</td>
<td class="nump">$ 7,084<span></span>
</td>
<td class="nump">$ 5,059<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="nump">$ 28,761<span></span>
</td>
<td class="num">$ (3,442)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481570644464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 8,078<span></span>
</td>
<td class="nump">$ 4,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">5,737<span></span>
</td>
<td class="nump">2,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, less allowance: $476 (2023); $357 (2022)</a></td>
<td class="nump">46,081<span></span>
</td>
<td class="nump">41,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">21,889<span></span>
</td>
<td class="nump">23,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Note receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">6,135<span></span>
</td>
<td class="nump">6,164<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">87,920<span></span>
</td>
<td class="nump">91,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">16,402<span></span>
</td>
<td class="nump">15,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">9,170<span></span>
</td>
<td class="nump">7,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">5,406<span></span>
</td>
<td class="nump">4,514<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">118,898<span></span>
</td>
<td class="nump">118,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="nump">3,587<span></span>
</td>
<td class="nump">1,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityCurrent', window );">Current portion of financing liability</a></td>
<td class="nump">642<span></span>
</td>
<td class="nump">575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of financing lease liabilities</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,967<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">23,599<span></span>
</td>
<td class="nump">27,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and amounts withheld</a></td>
<td class="nump">4,304<span></span>
</td>
<td class="nump">4,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">4,097<span></span>
</td>
<td class="nump">3,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">1,772<span></span>
</td>
<td class="nump">3,336<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">40,053<span></span>
</td>
<td class="nump">42,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityNoncurrent', window );">Long-term portion of financing liability</a></td>
<td class="nump">28,132<span></span>
</td>
<td class="nump">28,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term portion of financing lease liabilities</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion of operating lease liabilities</a></td>
<td class="nump">7,136<span></span>
</td>
<td class="nump">6,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_AccruedEmployeeBenefitPlanCosts', window );">Accrued pension and deferred compensation costs</a></td>
<td class="nump">3,546<span></span>
</td>
<td class="nump">4,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">943<span></span>
</td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">455<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">80,413<span></span>
</td>
<td class="nump">82,593<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">7,084<span></span>
</td>
<td class="nump">6,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">5,059<span></span>
</td>
<td class="nump">4,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">28,761<span></span>
</td>
<td class="nump">28,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(3,442)<span></span>
</td>
<td class="num">(3,742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Common stock in treasury, at cost: 3 shares</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Kewaunee Scientific Corporation Stockholders' Equity</a></td>
<td class="nump">37,409<span></span>
</td>
<td class="nump">35,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">1,076<span></span>
</td>
<td class="nump">486<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Stockholders' Equity</a></td>
<td class="nump">38,485<span></span>
</td>
<td class="nump">36,180<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 118,898<span></span>
</td>
<td class="nump">$ 118,773<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_AccruedEmployeeBenefitPlanCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the aggregate carrying amounts of the noncurrent liabilities for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans and deferred compensation arrangements representing currently earned compensation under cash arrangements (such as a rabbi trust) that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_AccruedEmployeeBenefitPlanCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481570768608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for receivables</a></td>
<td class="nump">$ 476<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 2.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">2,833<span></span>
</td>
<td class="nump">2,793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">2,830<span></span>
</td>
<td class="nump">2,790<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569334976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (loss)</a></td>
<td class="nump">$ 1,359<span></span>
</td>
<td class="num">$ (6,003)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings (loss) to net cash used by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">2,867<span></span>
</td>
<td class="nump">2,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt provision</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation expense</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment', window );">Provision for deferred income taxes</a></td>
<td class="nump">516<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Receivables</a></td>
<td class="num">(4,947)<span></span>
</td>
<td class="num">(8,464)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">1,907<span></span>
</td>
<td class="num">(7,279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and other accrued expenses</a></td>
<td class="num">(5,558)<span></span>
</td>
<td class="nump">11,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">568<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other, net</a></td>
<td class="num">(1,508)<span></span>
</td>
<td class="num">(3,096)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used by operating activities</a></td>
<td class="num">(3,790)<span></span>
</td>
<td class="num">(7,885)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="num">(4,148)<span></span>
</td>
<td class="num">(1,908)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(4,148)<span></span>
</td>
<td class="num">(1,908)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">60,599<span></span>
</td>
<td class="nump">59,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments on short-term borrowings</a></td>
<td class="num">(58,601)<span></span>
</td>
<td class="num">(64,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ProceedsFromFinancingLiability', window );">Proceeds from sale-leaseback transaction</a></td>
<td class="nump">13,629<span></span>
</td>
<td class="nump">15,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_PaymentsOnFinancingLiability', window );">Repayments on financing liability</a></td>
<td class="num">(575)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments on long-term debt</a></td>
<td class="num">(121)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">14,931<span></span>
</td>
<td class="nump">11,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, net</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="nump">6,921<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents and Restricted Cash at Beginning of Year</a></td>
<td class="nump">6,894<span></span>
</td>
<td class="nump">5,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents and Restricted Cash at End of Year</a></td>
<td class="nump">13,815<span></span>
</td>
<td class="nump">6,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure of Cash Flow Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">1,862<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">3,158<span></span>
</td>
<td class="nump">1,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability', window );">Assets obtained under new finance or operating leases</a></td>
<td class="nump">$ 3,902<span></span>
</td>
<td class="nump">$ 366<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred income tax expense benefit net of rate adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_PaymentsOnFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments On Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_PaymentsOnFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ProceedsFromFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ProceedsFromFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-Of-Use Asset Obtained In Exchange For Finance Or Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481578795504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kewaunee Scientific Corporation and subsidiaries (collectively the "Company") design, manufacture, and install laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's sales are made through purchase orders and contracts submitted by customers through its dealers, its subsidiaries in Singapore and India, and a national stocking distributor. See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i1de8d1053c4044f7aa1eb1bfb086781f_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 12</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details on the closure status of the Company's China operations. The majority of the Company's products are sold to customers located in North America, primarily within the United States. The Company's laboratory products are used in chemistry, physics, biology and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government and health care markets. Technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's consolidated financial statements include the accounts of Kewaunee Scientific Corporation and its international subsidiaries. A brief description of each subsidiary, along with the amount of the Company's controlling financial interests, as of April&#160;30, 2023 is as follows: (1) Kewaunee Labway Asia Pte. Ltd., a commercial sales organization for the Company's products in Singapore, is 100% owned by the Company; (2) Kewaunee Scientific Corporation Singapore Pte. Ltd., a holding company in Singapore, is 100% owned by the Company; (3) Kewaunee Labway India Pvt. Ltd., a design, installation, manufacturing, assembly and commercial sales operation for the Company's products in Bangalore, India, is 95% owned by the Company; (4) Koncepo Scientech International Pvt. Ltd., a laboratory design and strategic advisory and construction management services firm, located in Bangalore, India, is 80% owned by the Company; (5) Kequip Global Lab Solutions Pvt. Ltd. is 70% owned by Kewaunee Scientific Corporation Singapore Pte. Ltd. All intercompany balances, transactions, and profits have been eliminated. Included in the consolidated financial statements are net assets of $16,786,000 and $13,127,000 at April&#160;30, 2023 and 2022, respectively, of the Company's subsidiaries. Net sales by the Company's subsidiaries in the amounts of $72,778,000 and $42,024,000 were included in the consolidated statements of operations for fiscal years 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the years ended April&#160;30, 2023 and 2022, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits.</span></div><div style="margin-bottom:7pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows. The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows at April 30 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"><tr><td style="width:1.0%"></td><td style="width:59.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,078</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,737</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Receivables are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to the Company, or a project dispute makes it unlikely that all of the receivable owed by a customer will be collected, a specific reserve for bad debts is estimated and recorded to reduce the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, a reserve for bad debts is estimated and recorded based on past loss history and an overall assessment of past due trade accounts receivable amounts outstanding. Accounts are written off when it is clearly established that the receivable&#160;is a bad debt. Recoveries of receivables previously written off are recorded when received. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the allowance for doubtful accounts for each of the years ended April&#160;30 was:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.008%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">357</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts written off (net)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">476</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unbilled Receivables</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accounts receivable include unbilled receivables that represent amounts earned which have not yet been billed in accordance with contractually stated billing terms, excluding retention, which is included in other assets. The amount of unbilled receivables, net of unbilled retention, at April&#160;30, 2023 and 2022 was $13,459,000 and $9,287,000, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's inventories are valued at the lower of cost or net realizable value under the first-in, first-out ("FIFO") method. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is determined for financial reporting purposes principally on the straight-line method over the estimated useful lives of the individual assets or, for leaseholds, over the terms of the related leases, if shorter. Property, plant and equipment consisted of the following at April&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,147</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44,180</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-10&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61,368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,326&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44,966)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,402</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the carrying value of property, plant and equipment for impairment annually or whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value. There were no impairments in fiscal years 2023 or 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other assets at April&#160;30, 2023 and 2022 included $1,191,000 and $1,293,000, respectively, of unbilled retainage, $2,352,000 and $2,480,000, respectively, of assets held in a trust account for non-qualified benefit plan, and $111,000 and $110,000, respectively, of cash surrender values of life insurance policies. Life insurance policies are recorded at the amount that could be realized under the insurance contract as of the date of the Company's consolidated balance sheets with the change in cash surrender or contract value being recorded as income or expense during each period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for uncollectible accounts receivable, self-insurance reserves, income taxes, and pension liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Interest Entity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On December 22, 2021, the Company entered into an Agreement for Purchase and Sale of Real Property with CAI Investments Sub-Series 100 LLC (the "Buyer"), for the Company&#8217;s headquarters and manufacturing facilities (the "Property") located in Statesville, North Carolina (the "Sale Agreement") in exchange for $30,275,000 in sales proceeds, $14,864,000 of which was payable in redeemable preferred shares in CAI Investments Medical Products I Parent, LLC ("Parent"), an affiliate of Buyer. At April 30, 2022, the carrying value of the redeemable preferred shares was $13.5&#160;million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sale Agreement was finalized on March 24, 2022 and coincided with a 20-year lease, effective on such date between the Company and CAI Investments Medical Products I Master Lessee LLC ("Lessor"), an affiliate of Buyer, for the Property (the "Lease Agreement"). At the same time, the Buyer and its affiliates formed a new, debt-financed affiliate CAI Investments Medical Products I, DST ("Trust") and contributed the Property to the Trust. According to the terms of the lease, the Trust leased the Property to its affiliated Lessor, which in turn sub-leased the Property to the Company (together with the Sale Agreement, the "Sale-Leaseback Arrangement"). For additional information on the accounting for the Sale-Leaseback Arrangement, refer to </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i1de8d1053c4044f7aa1eb1bfb086781f_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company concluded as of April 30, 2022 that Parent and its direct affiliates, including the Trust, are designed primarily to acquire and manage the Property and constitute a variable interest entity because the Trust lacks sufficient equity on its own to finance its operations. The Company evaluated its lease arrangement and redeemable preferred shares in Parent as variable interests. Based on its evaluation, the Company concluded it should not consolidate Parent or its affiliates under the variable interest model or the voting interest model of ASC 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the redeemable preferred shares as a Note Receivable, classified as held to maturity at amortized cost, on its Consolidated Balance Sheet, rather than as an investment in preferred equity, due to the mandatory redemption feature of the preferred shares.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 22, 2022, the Company had fully redeemed all shares and converted the Note Receivable to cash. The Company's maximum exposure to the Buyer and its affiliates as of April 30, 2023 was limited to the Company&#8217;s lease payments and right to use the Property. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A financial instrument is defined as cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company's financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, a note receivable and corresponding sale-leaseback financing liability, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Expanded disclosures about instruments measured at fair value require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows:</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#160;&#160;&#160;&#160;Quoted prices in active markets for identical assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#160;&#160;&#160;&#160;Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring and nonrecurring basis as of April&#160;30, 2023 and 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:50.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,358</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,358</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,358</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:50.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,003&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,003&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">The Company maintains two non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">Plan liabilities are equal to the individual participants' account balances and other earned retirement benefits.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company recognizes revenue when control of a good or service promised in a contract (i.e., </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. Sales taxes that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Certain customers' cash discounts and volume rebates are offered as sales incentives. The discounts and volume rebates are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and contractual obligations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of customer deposits and advance billings of the Company's products where sales have not yet been recognized. Accounts receivable includes retainage in the amounts of $235,000 and $523,000 at April&#160;30, 2023 and 2022, respectively. Shipping and handling costs are included in cost of product sales. Because of the nature and quality of the Company's products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company's consolidated financial position and results of operations and are expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Concentration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs credit evaluations of its customers. Revenues from three of the Company's domestic dealers represented in the aggregate approximately 36% and 38% of the Company's sales in fiscal years 2023 and 2022, respectively. Accounts receivable for two domestic customers represented approximately 23% and 21% of the Company's total accounts receivable as of April&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains a self-insured health-care program. The Company accrues estimated losses for claims incurred but not reported using assumptions based on historical loss experience. The Company has also purchased specific stop-loss insurance to limit claims above a certain amount. The Company adjusts insurance reserves, as needed, in the event that future loss experience differs from historical loss patterns.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In accordance with ASC 740, "Income Taxes" ("ASC 740"), the Company uses the liability method in measuring the provision for income taxes and recognizing deferred income tax assets and liabilities on the consolidated balance sheets. ASC&#160;740 clarifies the financial statement recognition threshold and measurement attribute of a tax position taken or expected to be taken in a tax return. Under ASC 740, the Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC&#160;740 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The Company did not have any significant uncertain tax positions at April&#160;30, 2023 or 2022. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Experimentation Expenditures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and experimentation expenditures are charged to cost of products sold in the periods incurred. Expenditures for research and experimentation expenditures were $1,012,000 and $990,000 for the fiscal years ended April&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advertising Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Advertising costs are expensed as incurred, and include trade shows, training materials, sales, samples, and other related expenses and are included in operating expenses. Advertising costs for the years ended April&#160;30, 2023 and 2022 were $226,000 and $175,000, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements of subsidiaries located in India and China are measured using the local currency as the functional currency. Effective May 1, 2022, Kewaunee Scientific Corporation Singapore Pte. Ltd. transitioned to using the U.S. dollar as its functional currency. The financial position and operating results of Kewaunee Labway Asia Pte. Ltd. are also measured using the U.S. dollar as its functional currency. Assets and liabilities of the Company's foreign subsidiaries using local currencies are translated into United&#160;States dollars at fiscal year-end exchange rates. Sales, expenses, and cash flows are translated at weighted average exchange rates for each period. Net translation gains or losses are included in other comprehensive income, a separate component of stockholders' equity. Gains and losses from foreign currency transactions of these subsidiaries are included in operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Basic earnings per share is based on the weighted average number of common shares outstanding during the year. Diluted earnings per share reflects the assumed exercise of outstanding stock options and the conversion of restricted stock units ("RSUs") under the Company's various stock compensation plans, except when RSUs and stock options have an antidilutive effect. There were 33,900 antidilutive RSUs and stock options outstanding at April&#160;30, 2023. There were 44,750 antidilutive RSUs and stock options outstanding at April&#160;30, 2022. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic to diluted weighted average common shares outstanding:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:65.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,824</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,902</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting for Stock Options and Other Equity Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, "Compensation&#8212;Stock Compensation." Forfeitures are accounted for in the period in which the awards are forfeited. The Company granted 87,969 RSUs under the 2017 Omnibus Incentive Plan in fiscal year 2023 and 67,750 RSUs in fiscal year 2022. There were no stock options granted during fiscal years 2023 and 2022. (See </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i1de8d1053c4044f7aa1eb1bfb086781f_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note&#160;7</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options and Share-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments," which replaces the current incurred loss method used for determining credit losses on financial assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December&#160;15, 2022. The Company will adopt this standard in fiscal year 2024. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued&#160;ASU No. 2019-12,&#160;"Income Taxes ("Topic 740"): Simplifying the Accounting for Income Taxes." This update simplifies the accounting for income taxes through certain targeted improvements to various subtopics within Topic 740. The amendments in this update are effective for fiscal years and interim periods beginning after December 15, 2020. The Company adopted this standard effective May 1, 2021. The adoption of this standard did not have a significant impact on the Company's consolidated financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574301616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Obligations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a distinct good or service or bundle of goods and services that is distinct or a series of distinct goods or services that are substantially the same and have the same pattern of transfer. The Company identifies performance obligations at the inception of a contract and allocates the transaction price to individual performance obligations to reasonably reflect the Company's performance in transferring control of the promised goods or services to the customer. The Company has elected to treat shipping and handling as a fulfillment activity instead of a separate performance obligation.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary performance obligations identified by the Company:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Laboratory Furniture</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company principally generates revenue from the manufacture of custom laboratory, healthcare, and technical furniture and infrastructure products (herein referred to as "laboratory furniture"). The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. Customers can benefit from each piece of laboratory furniture on its own or with resources readily available in the market place such as separately purchased installation services. Each piece of laboratory furniture does not significantly modify or customize other laboratory furniture, and the pieces of laboratory furniture are not highly interdependent or interrelated with each other. The Company can, and frequently does, break portions of contracts into separate "runs" to meet manufacturing and construction schedules. As such, each piece of laboratory furniture is considered a separate and distinct performance obligation. The majority of the Company's products are customized to meet the specific architectural design and performance requirements of laboratory planners and end users. The finished laboratory furniture has no alternative use to the Company and the Company has an enforceable right to payment for performance completed to date. As such, revenue from the sales of customized laboratory furniture is recognized over time once the customization process has begun, using the units-of-production output method to measure progress towards completion. There is not a material amount of work-in-process for which the customization process has begun at the end of a reporting period. The Company believes this output method most reasonably reflects the Company's performance because it directly measures the value of the goods transferred to the customer. For standardized products sold by the Company, revenue is recognized when control transfers, which is typically freight on board ("FOB") shipping point.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All orders contain a standard warranty that warrants that the product is free from defects in workmanship and materials under normal use and conditions for a limited period of time. Due to the nature and quality of the Company's products, any warranty issues have historically been determined in a relatively short period after the sale, have been infrequent in nature, and have been immaterial to the Company's financial position and results of operations. The Company's standard warranties are not considered a separate and distinct performance obligation as the Company does not provide a service to customers beyond assurance that the covered product is free of initial defects. Costs of providing these short term assurance warranties are immaterial and, accordingly, are expensed as incurred. Extended separately priced warranties are available which can last up to ten years. Extended warranties are considered separate performance obligations as they are individually priced options providing assurances that the products are free of defects.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Installation Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sometimes performs installation services for customers. The scope of installation services primarily relates to setting up and ensuring the proper functioning of the laboratory furniture. In certain markets, the Company may provide a broader range of installation services involving the design and installation of the laboratory's mechanical services. Installation services can be, and often are, performed by third parties and thus may be distinct from the Company's products. Installation services create or enhance assets that the customer controls as the installation services are provided. As such, revenue from installation services is recognized over time, as the installation services are performed using the cost input method, as there is a direct relationship between the Company's inputs and the transfer of control by means of the performance of installation services to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Custodial Services</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the laboratory and healthcare furniture industries for customers to request delivery at specific future dates, as products are often to be installed in buildings yet to be constructed. Frequently, customers will request the manufacture of these products prior to the customer's ability or readiness to receive the product due to various reasons such as changes to or delays in the construction of the building. As such, from time to time Kewaunee's customers require us to provide custodial services for their laboratory furniture. Custodial services are frequently provided by third parties and do not significantly alter the other goods or services covered by the contract and as such are considered a separate and distinct performance obligation. Custodial services are simultaneously received and consumed by the customer and as such revenue from custodial services is recognized over time using a straight-line time-based measure of progress towards completion, because the Company's services are provided evenly throughout the performance period.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment Terms and Transaction Prices</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with customers are generally fixed-price and do not contain variable consideration or a general right of return or refund. The Company's contracts with customers contain terms typical for Kewaunee's industry, including withholding a portion of the transaction price until after the goods or services have been transferred to the customer (i.e. "retainage"). The Company does not recognize this as a significant financing component because the primary purpose of retainage is to provide the customer with assurance that the Company will perform its obligations under the contract, rather than to provide financing to the customer.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allocation of Transaction Price</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts with customers&#160;may cover multiple goods and services, such as differing types of laboratory furniture and installation services. For these arrangements, each good or service is evaluated to determine whether it represents a distinct performance obligation. The total transaction price is then allocated to the distinct performance obligations based on their relative standalone selling price at the inception of the arrangement. If available, the Company utilizes observable prices for goods or services sold separately to similar customers in similar circumstances to determine its relative standalone selling price. Otherwise, list prices are used if they are determined to be representative of standalone selling prices. If neither of these methods are available at contract inception, such as when the Company does not sell the product or service separately, judgment may be required and the Company determines the standalone selling price using one, or a combination of, the adjusted market assessment or expected cost-plus margin approaches.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients Used</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected the following practical expedients:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The portfolio approach was applied in evaluating the accounting for the cost of obtaining a contract.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payment terms with the Company's customers which are one year or less are not considered a significant financing component.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company excludes from revenues taxes it collects from customers that are assessed by a government authority. This is primarily relevant to domestic sales but also includes taxes on some international sales which are also excluded from the transaction price.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company's incremental cost to obtain a contract is limited to sales commissions. The Company applies the practical expedient to expense commissions as incurred for contracts having a duration of one year or less. Sales commissions related to contracts with a duration of greater than one year are immaterial to the Company's consolidated financial position and results of operations and are also expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregated Revenue</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of net sales transferred to customers at a point in time and over time for the twelve months ended April 30 is as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"></td><td style="width:52.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.080%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,716&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"></td><td style="width:52.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,848&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,024&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closing balances of contract assets included $13,459,000 in accounts receivable and $1,191,000 in other current assets at April&#160;30, 2023. The opening balance of contract assets arising from contracts with customers included $9,287,000 in accounts receivable and $1,293,000 in other assets at April&#160;30, 2022. The closing and opening balances of contract liabilities included in deferred revenue arising from contracts with customers were $4,097,000 at April&#160;30, 2023 and $3,529,000 at April&#160;30, 2022. The timing of revenue recognition, billings and cash collections results in accounts receivable, unbilled receivables, and deferred </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue which is disclosed on the consolidated balance sheets and in the notes to the consolidated financial statements. In general, the Company receives payments from customers based on a billing schedule established in its contracts. Unbilled receivables represent amounts earned which have not yet been billed in accordance with contractually stated billing terms. Accounts receivable are recorded when the right to consideration becomes unconditional and the Company has a right to invoice the customer. Deferred revenue relates to payments received in advance of performance under the contract. Deferred revenue is recognized as revenue as the Company performs under the contract.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended April&#160;30, 2023, changes in contract assets and liabilities were not materially impacted by any other factors. Approximately 100% of the contract liability balance at April&#160;30, 2023 is expected to be recognized as revenue during fiscal year 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574229536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following at April&#160;30:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.557%"><tr><td style="width:1.0%"></td><td style="width:75.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,412</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,380</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials and components</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,097</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table>At April&#160;30, 2023 and 2022, the Company's international subsidiaries' inventories were $2,740,000 and $2,811,000, respectively, measured using the lower of cost or net realizable value under the FIFO method and are included in the above tables.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574241632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt and Other Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-term Debt and Other Credit Arrangements</a></td>
<td class="text">Long-term Debt and Other Credit Arrangements <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;6, 2013, the Company entered into a credit and security agreement (the "Loan Agreement") consisting of a $20 million revolving credit facility ("Line of Credit") with Wells Fargo, National Bank, which originally matured in May 2018 and was extended numerous times until it was terminated in June 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 19, 2019, the Company entered into a Security Agreement  with Wells Fargo, National Bank, pursuant to which the Company granted a security interest in substantially all of its assets to secure its obligations under the Loan Agreement. On December&#160;13, 2019, the Company entered into an amendment to the Loan Agreement and the Line of Credit to effect a change to an asset based lending arrangement based on eligible accounts receivable and inventory, with the available amount not to exceed $20 million through January&#160;31, 2020, and with such maximum amount reduced to $15 million thereafter. This amendment replaced the prior financial covenants with new financial covenants, including minimum monthly liquidity and EBITDA requirements. Additionally, a requirement for the repatriation of foreign cash and restrictions on the payment of dividends were added. The Security Agreement was amended several times during fiscal years 2022 and 2023 as the Company was finalizing the Sale-Leaseback financing transaction discussed in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i1de8d1053c4044f7aa1eb1bfb086781f_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note 5</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Financing Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These amendments were primarily driven by requirements and timing of the Company's new credit arrangement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2022, the Company terminated the Credit Agreement with Wells Fargo, National Bank. At the time of termination, there were no borrowings under the Credit Agreement, and the Company did not incur any material termination penalties as a result of the termination. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2022, there were advances of $1.6 million and $716,000 in letters of credit outstanding, leaving $2.4 million available under the Line of Credit. The borrowing rate under the Line of Credit at that date was 4.75%. Monthly interest payments under the Line of Credit were payable at the greater of the Daily One Month LIBOR interest rate, or 0.75%, plus 4.0%. At April&#160;30, 2022, the Company was in compliance with all the financial covenants under its revolving credit facility.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2022, the Company entered into a Credit and Security Agreement (the "Credit Agreement") with Mid Cap Funding IV Trust, as agent (the "Agent"), and the lenders from time to time party thereto (collectively, the "Lenders"). The Credit Agreement provides for a secured revolving line of credit initially up to $15.0&#160;million (the "Revolving Credit Facility"). Availability under the Revolving Credit Facility is subject to a borrowing base calculated in accordance with the terms of the Credit Agreement and on the basis of eligible accounts and inventory and certain other reserves and adjustments. Pursuant to the Credit Agreement, the Company granted to the Agent, for itself and the Lenders, a first priority security interest in all existing and future acquired assets owned by the Company. Subject to the terms of the Credit Agreement, from time to time the Company may request that the initial revolving loan amount available under the Revolving Credit Facility be increased with additional tranches in minimum amounts of $1,000,000, up to a maximum borrowing availability of $30.0&#160;million. The Agent and Lenders must consent to any such increase in their sole discretion. The Revolving Credit Facility matures on December 19, 2025.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to Term SOFR (Secured Overnight Financing Rate) plus 4.10%. The Company is required to make monthly interest payments on the Revolving Credit Facility, with the entire principal payment due at maturity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2023, there was $3,548,000 outstanding under the Revolving Credit Facility, with remaining borrowing capacity under the Revolving Credit Facility of $10,286,000. The borrowing rate under the Revolving Credit Facility was 9.02% as of April&#160;30, 2023. At April&#160;30, 2023, the Company was in compliance with all financial covenants under its revolving credit facility. In addition, the Company's International subsidiaries have a balance outstanding of $39,000 in short-term borrowings related to overdraft protection and short-term loan arrangements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2023, there were foreign bank guarantees outstanding to customers in the amounts of $5.2&#160;million, $142,000, $3,000, and $233,000 with expiration dates in fiscal years 2024, 2025, 2026, and 2027, respectively, collateralized by certain assets of the Company's subsidiaries in India. At April 30, 2022, there were bank guarantees issued by foreign banks outstanding to customers in the amounts of $8.2&#160;million, $111,000, $9,000, $3,000, and $249,000 with expiration dates in fiscal years 2023, 2024, 2025, 2026, and 2027, respectively, collateralized by a $6.0 million corporate guarantee and certain assets of the Company's subsidiaries in India.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574256720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale-Leaseback Financing Transaction<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityAbstract', window );"><strong>Financing Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionDisclosureTextBlock', window );">Sale-Leaseback Financing Transaction</a></td>
<td class="text">Sale-Leaseback Financing Transaction<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2021, the Company entered into the Sale Agreement with the Buyer for the Company&#8217;s headquarters and manufacturing facilities located at 2700 West Front Street in Statesville, North Carolina.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and the Buyer entering into the Lease Agreement. The Sale-Leaseback Arrangement is repayable over a 20-year term, with four renewal options of five years each. Under the terms of the Lease Agreement, the Company&#8217;s initial basic rent is approximately $158,000 per month, with annual increases of approximately 2% each year of the initial term.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the Sale-Leaseback Arrangement as a financing transaction with the Buyer in accordance with ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as the Lease Agreement was determined to be a finance lease. The Company concluded the Lease Agreement met the qualifications to be classified as a finance lease due to the significance of the present value of the lease payments, using a discount rate of 4.75% to reflect the Company&#8217;s incremental borrowing rate, compared to the fair value of the leased property as of the lease commencement date. In measuring the lease payments for the present value analysis, the Company elected the practical expedient to combine the lease component (the leased facilities) with the non-lease component (property management provided by the Buyer/Lessor) into a single lease component. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presence of a finance lease indicates that control of the Property has not transferred to the Buyer/Lessor and, as such, the transaction was deemed a failed sale-leaseback and accounted for as a financing arrangement. As a result of this determination, the Company is viewed as having received the sales proceeds from the Buyer/Lessor in the form of a hypothetical loan collateralized by its leased facilities. The hypothetical loan is payable as principal and interest in the form of &#8220;lease payments&#8221; to the Buyer/Lessor. As such, the Company will not derecognize the Property from its books for accounting purposes until the lease ends. No gain or loss was recognized related to the Sale-Leaseback Arrangement under U.S. GAAP.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 30, 2023, the carrying value of the financing liability was $28,774,000, net of $708,000 in debt issuance costs, of which $642,000 was classified as current on the Consolidated Balance Sheet with $28,132,000 classified as long-term. As of April&#160;30, 2022, the carrying value of the financing liability was $29,350,000, net of $768,000 in debt issuance costs, of which $575,000 was classified as current on the Consolidated Balance Sheet with $28,775,000 classified as long-term. The monthly lease payments are split between a reduction of principal and interest expense using the effective interest rate method. Interest expense associated with the financing arrangement was $1,316,000 and $147,000 for the years ended April 30, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will depreciate the building down to zero over the 20-year assumed economic life of the Property so that at the end of the lease term, the remaining carrying amount of the financing liability will equal the carrying amount of the land of $41,000.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remaining future cash payments related to the financing liability for the fiscal years ending April 30 are as follows:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.293%"><tr><td style="width:1.0%"></td><td style="width:67.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Liability Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,774&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for sale leaseback transaction. Includes, but is not limited to, terms and conditions of transaction and gain (loss) from transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 40<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209073<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888253<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574306208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") was signed into law, which contains several income tax provisions, as well as other measures, aimed at assisting businesses impacted by the economic effects of the COVID-19 pandemic. The CARES Act includes a broad range of tax reform provisions affecting businesses, including permissible net operating losses ("NOLs") carrybacks up to five years, changes in business deductions limitations, and deferral of Social Security withholdings. The Company applied the NOL carryback provision of the CARES Act with respect to its estimated NOL for fiscal year 2021 to years that had higher enacted tax rates. The Company also applied the deferral of Social Security withholdings in accordance with the CARES Act; 50% of these deferred withholdings were due and paid by December 31, 2021, with the remainder due and paid by December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 1, 2019, the Company elected to revoke the indefinite reinvestment of foreign unremitted earnings position set forth by ASC 740-30-25-17 for multiple foreign subsidiaries. As a result of this election, the Company recorded a tax withholding expense imposed by the India Income Tax Department of $406,000 and $240,000 for the years ended April 30, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the Tax Cuts and Job Act amended Internal Revenue Code Section 174, effective for tax years beginning after December 31, 2021. This amendment to Section 174, effective during fiscal year 2023 for the Company, eliminated the current year deductibility of research and experimentation expenditures and required the Company to deduct these expenditures over five years. The impact of this tax regulation required the Company to record a new deferred tax asset of $1,558,000 as of April 30, 2023. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's accounting policy with respect to the Global Intangible Low-Taxed Income ("GILTI") tax rules is that GILTI will be treated as a periodic charge in the year in which it arises.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:64.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">691</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,736</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,624</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">515</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">515</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reasons for the differences between the above net income tax expense and the amounts computed by applying the statutory federal income tax rate to earnings before income taxes are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"><tr><td style="width:1.0%"></td><td style="width:66.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">945</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal income tax benefit </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits (state, net of federal benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(457)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of differing US and foreign tax rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">413</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign subsidiary income to parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,667</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items comprising deferred tax assets and liabilities as of April&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee benefit expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,156</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits (state, net of federal benefits)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">170</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">638</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;E Addback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,558</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial loss, defined benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves and capitalized costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">201</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">249</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,558</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,078</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,758)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of Sale Leaseback property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid pension</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(919)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APB 23 Assertion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,318)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(976)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt Issuance Cost on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,453)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,568)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,901)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(943)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities) classified in the balance sheet:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(943)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(943)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to evaluate the realization of the deferred tax asset and any requirement for a valuation allowance in accordance with ASC 740-10-30-2(b). This guidance provides that the future realization of the tax benefit of an existing deductible temporary difference or carryforward ultimately depends on sufficient taxable income of the appropriate character within the carryback or carryforward period available under the tax law. The Company evaluates all available evidence, both </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">positive and negative, to determine the amount of any required valuation allowance. The valuation allowance totaled $8,568,000 and $6,901,000 at April&#160;30, 2023 and 2022, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2023, the Company had foreign tax credit carryforwards in the amount of $638,000, which are subject to a full valuation allowance, and which will begin to expire in 2028.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal, state and local tax returns with statutes of limitation generally ranging from 3 to 4 years. The Company is generally no longer subject to federal tax examinations for years prior to fiscal year 2019 or state and local tax examinations for years prior to fiscal year 2018. Tax returns filed by the Company's significant foreign subsidiaries are generally subject to statutes of limitations of 3 to 7 years and are generally no longer subject to examination for years prior to fiscal year 2017. The Company has no unrecognized tax benefits.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574381520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Stock Options and Share-Based Compensation</a></td>
<td class="text">Stock Options and Share-Based Compensation <div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's stockholders approved the 2017 Omnibus Incentive Plan ("2017 Plan") on August&#160;30, 2017, which enables the Company to grant a broad range of equity, equity-related, and non-equity types of awards, with potential recipients including directors, consultants and employees. This plan replaced the 2010 Stock Option Plan for Directors and the 2008 Key Employee Stock Option Plan. No new awards will be granted under the prior plans and all outstanding options granted under the prior plans will remain subject to the prior plans. At the date of approval of the 2017 Plan there were 280,100 shares available for issuance under the prior plans. These shares and any shares subject to outstanding awards that subsequently cease to be subject to such awards are available under the 2017 Plan. The 2017 Plan did not increase the total number of shares available for issuance under the Company's equity compensation plans. At April&#160;30, 2023 there were 149,007 shares available for future issuance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2017 Plan, the Company recorded stock-based compensation expense of $845,000 and $701,000 and deferred income tax benefit of $199,000 and $165,000 in fiscal years 2023 and 2022, respectively. The RSUs include grants with both a service and performance component vesting over a 3 year period and grants with only service components vesting over 2 and 3 year periods. The recognized expense is based upon the vesting period for service criteria and estimated attainment of the performance criteria at the end of the performance period based on the ratio of cumulative days incurred to total days over the performance period. The remaining estimated compensation expense of $812,000 will be recorded over the remaining vesting periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RSU granted to employees was estimated on the date of grant based on the weighted average price of the Company's stock reduced by the present value of the expected dividend stream during the vesting period using the risk-free interest rate. The Company issued new shares of common stock to satisfy RSUs that vested during fiscal year 2023. The following table summarizes the RSU activity and weighted averages.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.839%"><tr><td style="width:1.0%"></td><td style="width:48.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,841)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,640&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stockholders approved the 2008 Key Employee Stock Option Plan ("2008 Plan") in fiscal year 2009 which allowed the Company to grant options on an aggregate of 300,000 shares of the Company's common stock. On August&#160;26, 2015, the stockholders approved an amendment to this plan to increase the number of shares available under the 2008 Plan by 300,000 shares. Under the plan, options were granted at not less than the fair market value at the date of grant and options are exercisable in such installments, for such terms (up to 10 years), and at such times, as the Board of Directors determined at the time of the grant. At April&#160;30, 2023, there were no shares available for future grants under the 2008 Plan. Under the 2008 Plan, the Company recorded no compensation expense or deferred income tax benefit in fiscal year 2023 or 2022. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to determine the fair value of stock options on the date of grant, the Company applied the Black-Scholes option pricing model. Inherent in the model are assumptions related to expected stock-price volatility, option life, risk-free interest rate, and dividend yield. The stock options outstanding have the "plain-vanilla" characteristics as defined in SEC Staff Accounting Bulletin No.&#160;107 (SAB 107). The Company utilized the Safe Harbor option "Simplified Method" to determine the expected term of these options in accordance with the guidance of SAB&#160;107 for options outstanding. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued new shares of common stock to satisfy options exercised during fiscal years 2023 and 2022. Stock option activity and weighted average exercise price are summarized as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:40.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.34</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of options outstanding, exercisable, and their weighted average exercise prices were within the following ranges at April&#160;30, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.717%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$15.85-$23.62</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining contractual life</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574296800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">Accumulated Other Comprehensive Income (Loss)<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's other comprehensive income (loss) consists of unrealized gains and losses on the translation of the assets, liabilities, and equity of its foreign subsidiaries, and additional minimum pension liability adjustments, net of income taxes. The before tax income (loss), related income tax effect, and accumulated balances are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum<br/>Pension<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,357)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,577)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,543)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,199)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,742)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(290)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(290)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">590</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">590</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,833)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(609)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,442)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574329920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Leases, Commitments and Contingencies</a></td>
<td class="text">Leases, Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes lease assets and lease liabilities with respect to the rights and obligations created by leased assets previously classified as operating leases. The Company elected to:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Record the impact of adoption using a modified retrospective method with any cumulative effect as an adjustment to retained earnings (accumulated deficit) as opposed to restating comparative periods to reflect the effects of applying the new standard.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elect the package of three transition practical expedients which alleviate the requirements to reassess embedded leases, lease classification and initial direct costs for leases that commenced prior to the adoption date.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Elected to use the short-term lease recognition exemption for all asset classes. This means, for those leases that qualify, the Company will not recognize right-of-use ("ROU") assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets.</span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating type leases for real estate and equipment in both the U.S. and internationally and financing leases for equipment in the United States. ROU assets totaled $9,170,000 and $7,573,000 at April&#160;30, 2023 and 2022, respectively. Operating cash paid to settle lease liabilities was $2,278,640 and $2,019,000 for the fiscal year ended April 30, 2023 and 2022, respectively. The Company's leases have remaining lease terms of up to 8 years. In addition, some of the leases may include options to extend the leases for up to 5 years or options to terminate the leases within 1 year. Operating lease expense was $3,344,000 for the twelve months ended April 30, 2023, inclusive of period cost for short-term leases, not included in lease liabilities, of $1,065,000. Operating lease expense was $3,067,000 for the fiscal year ended April 30, 2022, inclusive of period cost for short-term leases, not included in lease liabilities, of $1,048,000.</span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At April&#160;30, 2023, the weighted average remaining lease term for the capitalized operating leases was 5.1 years and the weighted average discount rate was 5.0%. At April&#160;30, 2022, the weighted average remaining lease term for the capitalized operating leases was 5.8 years and the weighted average discount rate was 4.1%. For the financing leases, the weighted average remaining lease term was 3.1 years and the weighted average discount rate was 6.8% at April&#160;30, 2023 as compared to 3.8 years and 6.6% at April&#160;30, 2022. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"><tr><td style="width:1.0%"></td><td style="width:60.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.221%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.198%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Lease Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in certain claims and legal proceedings in the normal course of business which management believes will not have a material adverse effect on the Company's consolidated financial condition or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574306208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Benefits</a></td>
<td class="text">Retirement Benefits<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has non-contributory defined benefit pension plans covering some of its domestic employees. These plans were amended as of April&#160;30, 2005, no further benefits have been, or will be, earned under the plans subsequent to the amendment date, and no additional participants will be added to the plans. The defined benefit plan for salaried employees provides pension benefits that are based on each employee's years of service and average annual compensation during the last ten consecutive calendar years of employment as of April&#160;30, 2005. The benefit plan for hourly employees provides benefits at stated amounts based on years of service as of April&#160;30, 2005. The Company uses an April&#160;30 measurement date for its defined benefit plans. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in projected benefit obligations and the change in fair value of plan assets for the non-contributory defined benefit pension plans for each of the years ended April&#160;30 are summarized as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation, April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,867</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">251</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,732</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status&#8212;under</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(636)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,155)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in the Consolidated Balance Sheets consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(636)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,155)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actual loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,526</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,064)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax actuarial loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,462</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Benefit Obligations at April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pri-2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pri-2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projection scale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MP-2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP-2020</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended April 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net periodic pension (income) expense for each of the fiscal years ended April&#160;30 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,604)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">628</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-769"><span style="-sec-ix-hidden:f-770"><span style="-sec-ix-hidden:f-771">Net periodic pension expense (income)</span></span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated net actuarial loss for the defined benefit pension plans that will be amortized from accumulated other comprehensive income into net periodic benefit cost during fiscal year 2024 is $580,000.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's funding policy is to contribute to the plans when pension laws and economics either require or encourage funding. The Company expects to make no contributions during fiscal year 2024. There were no contributions made to the plans in fiscal year 2023 or 2022.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following benefit payments are expected to be paid from the benefit plans in the fiscal years ending April&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029- 2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected long-term portfolio return is established via a building block approach with proper consideration of diversification and rebalancing. Historical markets are studied and long-term historical relationships between equities and fixed-income securities are preserved consistent with the widely accepted capital market principle that assets with higher volatility generate a greater return over the long term. Current market factors such as inflation and interest rates are evaluated before long-term capital market assumptions are determined. Peer data and historical returns are also reviewed to check for reasonableness and appropriateness.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a Yield Curve methodology to determine its GAAP discount rate. Under this approach, future benefit payment cash flows are projected from the pension plan on a projected benefit obligation basis. The payment stream is discounted to a present value using an interest rate applicable to the timing of each respective cash flow. The graph of these time-dependent interest rates is known as a yield curve. The interest rates comprising the Yield Curve are determined through a statistical analysis performed by the IRS and issued each month in the form of a pension discount curve. For this purpose, the universe of possible bonds consists of a set of bonds which are designated as corporate, have high quality ratings (AAA or AA) from nationally recognized statistical rating organizations, and have at least $250 million in par amount outstanding on at least one day during the reporting period. A 1% increase/decrease in the discount rate for fiscal years 2023 and 2022 would increase/decrease pension expense by approximately $231,000 and $271,000, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a total return investment approach, whereby a mix of equities and fixed-income investments are used to attempt to maximize the long-term return on plan assets for a prudent level of risk. Risk tolerance is established through careful consideration of plan liabilities, plan funded status, and corporate financial condition. The investment portfolio contains a diversified blend of equity and fixed-income investments. Furthermore, equity investments are diversified across U.S. and non-U.S. stocks, as well as growth, value, and small and large capitalizations. The target allocations based on the Company's investment policy were 75% in equity securities and 25% in fixed-income securities at April&#160;30, 2023 and April&#160;30, 2022. A 1% increase/decrease in the expected return on assets for fiscal years 2023 and 2022 would increase/decrease pension expense by approximately $181,000 and $207,000, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan assets by asset categories as of April&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:49.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,724</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,732</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,867&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the assets in the Company's defined benefit pension plans at April&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small/Mid Cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,743</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">702</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquid Alternatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">627</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,732</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small/Mid Cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquid Alternatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,867&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1 retirement plan assets include United States currency held by a designated trustee and equity funds of common and preferred securities issued by domestic and foreign corporations. These equity funds are traded actively on exchanges and price quotes for these shares are readily available.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Contribution Plan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a defined contribution plan covering substantially all domestic salaried and hourly employees. The plan provides benefits to all employees who have attained age 21, completed three months of service, and who elect to participate. The plan provides that the Company make matching contributions equal to 100% of the employee's qualifying contribution up to 3% of the employee's compensation, and make matching contributions equal to 50% of the employee's contributions between 3% and 5% of the employee's compensation, resulting in a maximum employer contribution equal to 4% of the employee's compensation. The Company's matching contributions were $932,000 and $967,000 for years ending April&#160;30, 2023 and 2022. Additionally, the plan provides that the Company may elect to make a non-matching contribution for participants employed by the Company on December&#160;31 of each year. The Company did not elect to make a non-matching contribution in fiscal years 2023 and 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574300032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are classified into two business segments: Domestic and International. The Domestic business segment principally designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. The International business segment, which consists of the foreign subsidiaries identified in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="#i1de8d1053c4044f7aa1eb1bfb086781f_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note&#160;1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, provides the Company's products and services, including facility design, detailed engineering, construction, and project management from the planning stage through testing and commissioning of laboratories.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intersegment transactions are recorded at normal profit margins. All intercompany balances and transactions have been eliminated. Certain corporate expenses shown below are net of expenses that have been allocated to the business segments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows revenues, earnings, and other financial information by business segment and unallocated corporate expenses for each of the years ended April&#160;30: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:49.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146,716</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219,494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,604</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,822</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11,426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,394</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">191</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,867</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,408</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,382</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,498</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">621</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">621</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,408</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,511</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">738</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38,898</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118,898</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,856</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,292</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,559</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75,337</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,401)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574256720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Costs</a></td>
<td class="text">Restructuring CostsIn December 2019, the Company initiated a restructuring, which included the closure of the Company's subsidiary in China, a commercial sales organization for the Company's products in China, that was completed in March 2023. The Company incurred operating expenses of $32,000 in its international operations related to the closure of the China subsidiary in fiscal year 2023, offset by the recovery of bad debt collections of $51,000 that were originally written off when the Company initiated the restructuring. The Company incurred operating expenses of $28,000 related to the closure in the prior year period. The Company reflected all the expenses as operating expenses in the Consolidated Statement of Operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481672508784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">Principles of Consolidation The Company's consolidated financial statements include the accounts of Kewaunee Scientific Corporation and its international subsidiaries. A brief description of each subsidiary, along with the amount of the Company's controlling financial interests, as of April&#160;30, 2023 is as follows: (1) Kewaunee Labway Asia Pte. Ltd., a commercial sales organization for the Company's products in Singapore, is 100% owned by the Company; (2) Kewaunee Scientific Corporation Singapore Pte. Ltd., a holding company in Singapore, is 100% owned by the Company; (3) Kewaunee Labway India Pvt. Ltd., a design, installation, manufacturing, assembly and commercial sales operation for the Company's products in Bangalore, India, is 95% owned by the Company; (4) Koncepo Scientech International Pvt. Ltd., a laboratory design and strategic advisory and construction management services firm, located in Bangalore, India, is 80% owned by the Company; (5) Kequip Global Lab Solutions Pvt. Ltd. is 70% owned by Kewaunee Scientific Corporation Singapore Pte. Ltd. All intercompany balances, transactions, and profits have been eliminated.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the years ended April&#160;30, 2023 and 2022, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits.</span>The Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text">Accounts Receivable and Allowance for Doubtful Accounts Receivables are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to the Company, or a project dispute makes it unlikely that all of the receivable owed by a customer will be collected, a specific reserve for bad debts is estimated and recorded to reduce the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, a reserve for bad debts is estimated and recorded based on past loss history and an overall assessment of past due trade accounts receivable amounts outstanding. Accounts are written off when it is clearly established that the receivable&#160;is a bad debt. Recoveries of receivables previously written off are recorded when received.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy', window );">Unbilled Receivables</a></td>
<td class="text">Unbilled Receivables Accounts receivable include unbilled receivables that represent amounts earned which have not yet been billed in accordance with contractually stated billing terms, excluding retention, which is included in other assets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories The Company's inventories are valued at the lower of cost or net realizable value under the first-in, first-out ("FIFO") method.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, Plant and Equipment Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is determined for financial reporting purposes principally on the straight-line method over the estimated useful lives of the individual assets or, for leaseholds, over the terms of the related leases, if shorter.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentImpairment', window );">Property, Plant and Equipment, Impairment</a></td>
<td class="text">The Company reviews the carrying value of property, plant and equipment for impairment annually or whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_OtherAssetsPolicyTextBlock', window );">Other Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other assets at April&#160;30, 2023 and 2022 included $1,191,000 and $1,293,000, respectively, of unbilled retainage, $2,352,000 and $2,480,000, respectively, of assets held in a trust account for non-qualified benefit plan, and $111,000 and $110,000, respectively, of cash surrender values of life insurance policies. Life insurance policies are recorded at the amount that could be realized under the insurance contract as of the date of the Company's consolidated balance sheets with the change in cash surrender or contract value being recorded as income or expense during each period.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for uncollectible accounts receivable, self-insurance reserves, income taxes, and pension liabilities.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company concluded as of April 30, 2022 that Parent and its direct affiliates, including the Trust, are designed primarily to acquire and manage the Property and constitute a variable interest entity because the Trust lacks sufficient equity on its own to finance its operations. The Company evaluated its lease arrangement and redeemable preferred shares in Parent as variable interests. Based on its evaluation, the Company concluded it should not consolidate Parent or its affiliates under the variable interest model or the voting interest model of ASC 810, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the redeemable preferred shares as a Note Receivable, classified as held to maturity at amortized cost, on its Consolidated Balance Sheet, rather than as an investment in preferred equity, due to the mandatory redemption feature of the preferred shares.</span></div>As of June 22, 2022, the Company had fully redeemed all shares and converted the Note Receivable to cash. The Company's maximum exposure to the Buyer and its affiliates as of April 30, 2023 was limited to the Company&#8217;s lease payments and right to use the Property.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A financial instrument is defined as cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company's financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, a note receivable and corresponding sale-leaseback financing liability, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Expanded disclosures about instruments measured at fair value require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows:</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#160;&#160;&#160;&#160;Quoted prices in active markets for identical assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#160;&#160;&#160;&#160;Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.</span></div><div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company recognizes revenue when control of a good or service promised in a contract (i.e., </span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. Sales taxes that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Certain customers' cash discounts and volume rebates are offered as sales incentives. The discounts and volume rebates are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and contractual obligations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue consists of customer deposits and advance billings of the Company's products where sales have not yet been recognized. Accounts receivable includes retainage in the amounts of $235,000 and $523,000 at April&#160;30, 2023 and 2022, respectively. Shipping and handling costs are included in cost of product sales. Because of the nature and quality of the Company's products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company's consolidated financial position and results of operations and are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Credit Concentration</a></td>
<td class="text">Credit Concentration The Company performs credit evaluations of its customers.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReservePolicyTextBlock', window );">Insurance</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company maintains a self-insured health-care program. The Company accrues estimated losses for claims incurred but not reported using assumptions based on historical loss experience. The Company has also purchased specific stop-loss insurance to limit claims above a certain amount. The Company adjusts insurance reserves, as needed, in the event that future loss experience differs from historical loss patterns.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes In accordance with ASC 740, "Income Taxes" ("ASC 740"), the Company uses the liability method in measuring the provision for income taxes and recognizing deferred income tax assets and liabilities on the consolidated balance sheets. ASC&#160;740 clarifies the financial statement recognition threshold and measurement attribute of a tax position taken or expected to be taken in a tax return. Under ASC 740, the Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC&#160;740 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The Company did not have any significant uncertain tax positions at April&#160;30, 2023 or 2022.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Experimentation Expenditures</a></td>
<td class="text">Research and Experimentation Expenditures Research and experimentation expenditures are charged to cost of products sold in the periods incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising Costs Advertising costs are expensed as incurred, and include trade shows, training materials, sales, samples, and other related expenses and are included in operating expenses.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The financial statements of subsidiaries located in India and China are measured using the local currency as the functional currency. Effective May 1, 2022, Kewaunee Scientific Corporation Singapore Pte. Ltd. transitioned to using the U.S. dollar as its functional currency. The financial position and operating results of Kewaunee Labway Asia Pte. Ltd. are also measured using the U.S. dollar as its functional currency. Assets and liabilities of the Company's foreign subsidiaries using local currencies are translated into United&#160;States dollars at fiscal year-end exchange rates. Sales, expenses, and cash flows are translated at weighted average exchange rates for each period. Net translation gains or losses are included in other comprehensive income, a separate component of stockholders' equity. Gains and losses from foreign currency transactions of these subsidiaries are included in operating expenses.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share Basic earnings per share is based on the weighted average number of common shares outstanding during the year. Diluted earnings per share reflects the assumed exercise of outstanding stock options and the conversion of restricted stock units ("RSUs") under the Company's various stock compensation plans, except when RSUs and stock options have an antidilutive effect.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for Stock Options and Other Equity Awards</a></td>
<td class="text">Accounting for Stock Options and Other Equity Awards Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, "Compensation&#8212;Stock Compensation." Forfeitures are accounted for in the period in which the awards are forfeited.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments," which replaces the current incurred loss method used for determining credit losses on financial assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December&#160;15, 2022. The Company will adopt this standard in fiscal year 2024. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued&#160;ASU No. 2019-12,&#160;"Income Taxes ("Topic 740"): Simplifying the Accounting for Income Taxes." This update simplifies the accounting for income taxes through certain targeted improvements to various subtopics within Topic 740. The amendments in this update are effective for fiscal years and interim periods beginning after December 15, 2020. The Company adopted this standard effective May 1, 2021. The adoption of this standard did not have a significant impact on the Company's consolidated financial position or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_OtherAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_OtherAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for assessing and recognizing impairments of its property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for treatment of receivables that are billable but have not been billed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -URI https://asc.fasb.org/topic&amp;trid=2196771<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481572902096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock', window );">Cash and Cash Equivalents and Restricted Cash</a></td>
<td class="text">The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows at April 30 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"><tr><td style="width:1.0%"></td><td style="width:59.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.919%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,078</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,737</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,815</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock', window );">Schedule Of Allowance For Doubtful Accounts</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the allowance for doubtful accounts for each of the years ended April&#160;30 was:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.008%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">357</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debt provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts written off (net)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">476</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment consisted of the following at April&#160;30:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Useful Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,147</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-40&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44,180</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5-10&#160;years</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">61,368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,326&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(44,966)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,402</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Fair Value Hierarchy for Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring and nonrecurring basis as of April&#160;30, 2023 and 2022 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:50.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,358</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,358</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,105</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,358</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,463</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:50.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities held in non-qualified compensation plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,371&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-qualified compensation plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,003&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,003&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">The Company maintains two non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt">Plan liabilities are equal to the individual participants' account balances and other earned retirement benefits.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic to Diluted Weighted Average Shares Outstanding</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic to diluted weighted average common shares outstanding:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"><tr><td style="width:1.0%"></td><td style="width:65.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,824</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options and RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding&#8212;diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,902</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of bad debt provision charged against earnings and the amounts of accounts receivable written off.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481658685664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of net sales transferred to customers at a point in time and over time for the twelve months ended April 30 is as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"></td><td style="width:52.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.080%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,716&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,778&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"><tr><td style="width:1.0%"></td><td style="width:52.180%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.260%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Over Time</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point in Time</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,848&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,024&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574445472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following at April&#160;30:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.557%"><tr><td style="width:1.0%"></td><td style="width:75.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,412</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,555&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,380</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Materials and components</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,097</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,796&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574457024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale-Leaseback Financing Transaction (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityAbstract', window );"><strong>Financing Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock', window );">Schedule of Remaining Future Cash Payments for Financing Liability</a></td>
<td class="text">Remaining future cash payments related to the financing liability for the fiscal years ending April 30 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.293%"><tr><td style="width:1.0%"></td><td style="width:67.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Liability Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,774&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Remaining Future Cash Payments for Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481578072224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Income Tax Expense</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:64.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">691</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">197</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,736</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,624</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">515</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">515</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Income Tax Reconciliation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reasons for the differences between the above net income tax expense and the amounts computed by applying the statutory federal income tax rate to earnings before income taxes are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"><tr><td style="width:1.0%"></td><td style="width:66.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit) at statutory rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">945</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(432)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local taxes, net of federal income tax benefit </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits (state, net of federal benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(457)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of differing US and foreign tax rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">413</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign subsidiary income to parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,667</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other items, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant items comprising deferred tax assets and liabilities as of April&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued employee benefit expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,156</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits (state, net of federal benefits)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">170</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax credit carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">638</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 174 R&amp;E Addback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,558</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized actuarial loss, defined benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,064</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory reserves and capitalized costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">201</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">249</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,558</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">254</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,078</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,462&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,758)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book basis in excess of tax basis of Sale Leaseback property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid pension</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(919)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APB 23 Assertion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,318)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(976)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt Issuance Cost on Sale Leaseback</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,453)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(8,568)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,901)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(943)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities) classified in the balance sheet:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(943)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(943)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481576164640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Summary of RSU Activity and Weighted Average Exercise Price</a></td>
<td class="text">The following table summarizes the RSU activity and weighted averages.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.839%"><tr><td style="width:1.0%"></td><td style="width:48.306%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.621%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,827&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,315)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,841)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,640&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity and Weighted Average Exercise Price</a></td>
<td class="text">Stock option activity and weighted average exercise price are summarized as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:40.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Number<br/>of&#160;Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.34</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14.54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of options outstanding, exercisable, and their weighted average exercise prices were within the following ranges at April&#160;30, 2023:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.717%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$15.85-$23.62</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining contractual life</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,900</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19.97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574471200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Before Tax Income (Loss) Related Income Tax Effect and Accumulated Balances</a></td>
<td class="text">The before tax income (loss), related income tax effect, and accumulated balances are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Minimum<br/>Pension<br/>Liability<br/>Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,357)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,220)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,577)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,543)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,199)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,742)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(290)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(290)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in unrecognized actuarial loss on pension obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">590</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">590</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,833)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(609)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,442)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574308256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturity</a></td>
<td class="text">Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"><tr><td style="width:1.0%"></td><td style="width:60.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.221%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.198%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Lease Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Finance Lease Maturity</a></td>
<td class="text">Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"><tr><td style="width:1.0%"></td><td style="width:60.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.221%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.158%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.198%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">($ in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Minimum Lease Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed Interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481672518000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock', window );">Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in projected benefit obligations and the change in fair value of plan assets for the non-contributory defined benefit pension plans for each of the years ended April&#160;30 are summarized as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:74.439%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.413%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Benefit Obligation, April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Projected Benefit Obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected benefit obligations, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,368</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,867</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">251</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual benefits paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,732</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status&#8212;under</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(636)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,155)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in the Consolidated Balance Sheets consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(636)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,155)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actual loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,526</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,064)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After-tax actuarial loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,462</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Benefit Obligations at April 30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortality table</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pri-2012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pri-2012</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projection scale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MP-2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MP-2020</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended April 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Summary of Components of Net Periodic Pension Cost</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net periodic pension (income) expense for each of the fiscal years ended April&#160;30 are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:73.247%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,604)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">628</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-769"><span style="-sec-ix-hidden:f-770"><span style="-sec-ix-hidden:f-771">Net periodic pension expense (income)</span></span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Summary of Expected Benefit Payments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following benefit payments are expected to be paid from the benefit plans in the fiscal years ending April&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029- 2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock', window );">Summary of Plan Assets by Asset Categories</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan assets by asset categories as of April&#160;30 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:49.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,724</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income Securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,732</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,867&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock', window );">Summary of Fair Value Assets in Defined Benefit Pension Plans</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the assets in the Company's defined benefit pension plans at April&#160;30:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small/Mid Cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,326</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,743</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">702</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,845</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquid Alternatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">627</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">163</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,732</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:62.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large Cap</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Small/Mid Cap</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liquid Alternatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,867&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of additional asset categories and amounts within a category that is useful in understanding the risks associated with each asset category.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574478768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Apr. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows revenues, earnings, and other financial information by business segment and unallocated corporate expenses for each of the years ended April&#160;30: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:49.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Domestic</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146,716</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219,494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,604</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,822</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11,426)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,394</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">191</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,867</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,408</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,382</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,498</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,139</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">621</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">621</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,408</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,511</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">738</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38,898</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118,898</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,856</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,292</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,559</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75,337</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fiscal Year 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,401)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (loss) attributable to Kewaunee Scientific Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for segment assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (excluding intersegment) from customers in foreign countries</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481570009344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 22, 2021</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 219,494,000<span></span>
</td>
<td class="nump">$ 168,872,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Unbilled receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,459,000<span></span>
</td>
<td class="nump">9,287,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Property plant and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Sale agreement for property</a></td>
<td class="nump">$ 30,275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1', window );">Portion of sale agreement payable in redeemable preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,864,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Carrying value of redeemable preferred shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">13,457,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityTermOfContract', window );">Term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionContractorReceivableRetainage', window );">Retainage included in accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 235,000<span></span>
</td>
<td class="nump">523,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,012,000<span></span>
</td>
<td class="nump">990,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226,000<span></span>
</td>
<td class="nump">$ 175,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive options exclude from computation of earning per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,900<span></span>
</td>
<td class="nump">44,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72,778,000<span></span>
</td>
<td class="nump">$ 42,024,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,716,000<span></span>
</td>
<td class="nump">126,848,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,786,000<span></span>
</td>
<td class="nump">$ 13,127,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Restricted stock units granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,969<span></span>
</td>
<td class="nump">67,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Sales Revenue, Segment | Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Accounts Receivable | Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_UnbilledRetainageCurrent', window );">Unbilled retainage included in other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,191,000<span></span>
</td>
<td class="nump">$ 1,293,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other Noncurrent Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrust', window );">Assets held in trust account for non-qualified benefit plans included in other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,352,000<span></span>
</td>
<td class="nump">2,480,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueOfLifeInsurance', window );">Cash surrender value of life insurance policies included in other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,000<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember', window );">Kewaunee Scientific Corporation | Kewaunee Labway Asia Pte. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of controlling interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember', window );">Kewaunee Scientific Corporation | Kewaunee Scientific Corporation Singapore Pte. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of controlling interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember', window );">Kewaunee Scientific Corporation | Kewaunee Labway India Pvt. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of controlling interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember', window );">Kewaunee Scientific Corporation | Koncepo Scientech International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of controlling interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationSingaporeMember', window );">Kewaunee Scientific Corporation Singapore Pte. Ltd. | Kequip Global Lab Solutions Pvt. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of controlling interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Term of Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_UnbilledRetainageCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled Retainage, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_UnbilledRetainageCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=77885760&amp;loc=SL35686385-199418<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 205<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=118262037&amp;loc=d3e9915-115836<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604008-122996<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874367-224272<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueOfLifeInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueOfLifeInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionContractorReceivableRetainage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer withheld under retainage provision in long-term contract or program when right to consideration is unconditional.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126937589&amp;loc=SL119991598-234733<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionContractorReceivableRetainage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the noncash (or part noncash) consideration received in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=kequ_KewauneeScientificCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=kequ_KewauneeLabwayAsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=kequ_KewauneeLabwayAsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=kequ_KewauneeScientificCorporationSingaporeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=kequ_KewauneeScientificCorporationSingaporeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=kequ_KewauneeLabwayIndiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=kequ_KewauneeLabwayIndiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=kequ_KoncepoScientechInternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=kequ_KoncepoScientechInternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=kequ_KewauneeScientificCorporationSingaporeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=kequ_KewauneeScientificCorporationSingaporeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=kequ_KequipGlobalLabSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=kequ_KequipGlobalLabSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481576231728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Cash Equivalents Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 8,078<span></span>
</td>
<td class="nump">$ 4,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">5,737<span></span>
</td>
<td class="nump">2,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 13,815<span></span>
</td>
<td class="nump">$ 6,894<span></span>
</td>
<td class="nump">$ 5,731<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569797504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance at beginning of year</a></td>
<td class="nump">$ 357<span></span>
</td>
<td class="nump">$ 636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt provision</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Doubtful accounts written off (net)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(371)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance at end of year</a></td>
<td class="nump">$ 476<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481570173392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">$ 61,368<span></span>
</td>
<td class="nump">$ 60,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(44,966)<span></span>
</td>
<td class="num">(45,205)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net property, plant and equipment</a></td>
<td class="nump">16,402<span></span>
</td>
<td class="nump">15,121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">$ 17,147<span></span>
</td>
<td class="nump">$ 17,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building and improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building and improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">$ 44,180<span></span>
</td>
<td class="nump">$ 43,121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569167520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($) </div>
<div>compensation_plan</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($) </div>
<div>compensation_plan</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">$ 2,463<span></span>
</td>
<td class="nump">$ 2,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Financial Liabilities</a></td>
<td class="nump">$ 2,910<span></span>
</td>
<td class="nump">$ 3,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag', window );">Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</a></td>
<td class="text">Total<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_NumberOfNonqualifiedCompensationPlans', window );">Number of non-qualified compensation plans maintained | compensation_plan</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag', window );">Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</a></td>
<td class="text">Total<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=kequ_TradingSecuritiesMember', window );">Trading Securities Held in Non-Qualified Compensation Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">$ 1,105<span></span>
</td>
<td class="nump">$ 1,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CashSurrenderValueMember', window );">Cash Surrender Value of Life Insurance Policies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">1,358<span></span>
</td>
<td class="nump">1,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=kequ_NonQualifiedCompensationPlanMember', window );">Non Qualified Compensation Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Financial Liabilities</a></td>
<td class="nump">2,910<span></span>
</td>
<td class="nump">3,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">1,105<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Trading Securities Held in Non-Qualified Compensation Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">1,105<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">1,358<span></span>
</td>
<td class="nump">1,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Financial Liabilities</a></td>
<td class="nump">2,910<span></span>
</td>
<td class="nump">3,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Cash Surrender Value of Life Insurance Policies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Financial Assets</a></td>
<td class="nump">1,358<span></span>
</td>
<td class="nump">1,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Non Qualified Compensation Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Financial Liabilities</a></td>
<td class="nump">$ 2,910<span></span>
</td>
<td class="nump">$ 3,003<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_NumberOfNonqualifiedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of nonqualified compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_NumberOfNonqualifiedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=kequ_TradingSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=kequ_TradingSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CashSurrenderValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CashSurrenderValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=kequ_NonQualifiedCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=kequ_NonQualifiedCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569142016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">2,824<span></span>
</td>
<td class="nump">2,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive effect of stock options and RSUs (in shares)</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding-diluted (in shares)</a></td>
<td class="nump">2,902<span></span>
</td>
<td class="nump">2,786<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481573079232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">$ 219,494<span></span>
</td>
<td class="nump">$ 168,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Over Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">214,772<span></span>
</td>
<td class="nump">162,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember', window );">Point in Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">4,722<span></span>
</td>
<td class="nump">6,859<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">146,716<span></span>
</td>
<td class="nump">126,848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Domestic | Over Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">141,994<span></span>
</td>
<td class="nump">119,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Domestic | Point in Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">4,722<span></span>
</td>
<td class="nump">6,859<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">72,778<span></span>
</td>
<td class="nump">42,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">International | Over Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">72,778<span></span>
</td>
<td class="nump">42,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">International | Point in Time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales transferred to customers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481570626832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenueRecognitionLineItems', window );"><strong>Revenue Recognition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets in accounts receivable</a></td>
<td class="nump">$ 13,459<span></span>
</td>
<td class="nump">$ 9,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">4,097<span></span>
</td>
<td class="nump">3,529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenueRecognitionLineItems', window );"><strong>Revenue Recognition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_UnbilledRetainageCurrent', window );">Contract assets in other assets</a></td>
<td class="nump">$ 1,191<span></span>
</td>
<td class="nump">$ 1,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerDurationAxis=kequ_FiscalYearTwoThousandTwentyFourMember', window );">Fiscal Year 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenueRecognitionLineItems', window );"><strong>Revenue Recognition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage', window );">Contract liability recognized as revenue percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract with customer, liability, revenue recognized percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_RevenueRecognitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_RevenueRecognitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_UnbilledRetainageCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled Retainage, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_UnbilledRetainageCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerDurationAxis=kequ_FiscalYearTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerDurationAxis=kequ_FiscalYearTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569230544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Summary of Inventories (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 3,412<span></span>
</td>
<td class="nump">$ 4,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">2,380<span></span>
</td>
<td class="nump">2,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Materials and components</a></td>
<td class="nump">16,097<span></span>
</td>
<td class="nump">16,348<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 21,889<span></span>
</td>
<td class="nump">$ 23,796<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569301136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=kequ_ForeignSubsidiariesMember', window );">International Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FIFOInventoryAmount', window );">Inventories measured using FIFO method</a></td>
<td class="nump">$ 2,740<span></span>
</td>
<td class="nump">$ 2,811<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FIFOInventoryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of FIFO (first in first out) inventory present at the reporting date when inventory is also valued using different valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FIFOInventoryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=kequ_ForeignSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=kequ_ForeignSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481568928608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt and Other Credit Arrangements - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 19, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Jun. 27, 2022</div></th>
<th class="th"><div>Feb. 01, 2020</div></th>
<th class="th"><div>Dec. 13, 2019</div></th>
<th class="th"><div>May 06, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Loan agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity', window );">Collateralized debt instrument, borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Unused and available credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,588,000<span></span>
</td>
<td class="nump">$ 3,587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=kequ_InternationalSubsidiariesMember', window );">International Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember', window );">Expiration Date, Period One | Bank Guarantees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Bank Guarantees outstanding to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_AdvanceAmountOneMember', window );">Advance Amount One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_AdvanceAmountTwoMember', window );">Advance Amount Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 716,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_AdvancesMember', window );">Advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at period end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt, variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt, variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember', window );">Term Loan B | Expiration Date, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Bank Guarantees outstanding to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,200,000<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember', window );">Term Loan B | Expiration Date, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Bank Guarantees outstanding to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,000<span></span>
</td>
<td class="nump">142,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember', window );">Term Loan B | Expiration Date, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Bank Guarantees outstanding to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember', window );">Term Loan B | Expiration Date, Period Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Bank Guarantees outstanding to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">233,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember', window );">Term Loan B | Expiration Date, Period Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Bank Guarantees outstanding to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 249,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Credit Agreement, Mid Cap Funding IV Trust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Loan agreement</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Credit facility outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,548,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Unused and available credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,286,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at period end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.02%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Additional tranche available, minimum amount</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption', window );">Maximum borrowing availability</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Credit Agreement, Mid Cap Funding IV Trust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt, variable interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Asset Based Lending, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=kequ_InternationalSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=kequ_InternationalSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsByNatureAxis=kequ_BankGuaranteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsByNatureAxis=kequ_BankGuaranteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=kequ_AdvanceAmountOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=kequ_AdvanceAmountOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=kequ_AdvanceAmountTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=kequ_AdvanceAmountTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=kequ_AdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=kequ_AdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=kequ_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=kequ_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=kequ_CreditAgreementMidCapFundingIVTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=kequ_CreditAgreementMidCapFundingIVTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=kequ_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=kequ_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569667840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale-Leaseback Financing Transaction - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($) </div>
<div>renewalOption</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityAbstract', window );"><strong>Financing Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityTermOfContract', window );">Term of agreement</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityNumberOfRenewalOptions', window );">Number of renewal options | renewalOption</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityBasicMonthlyPayment', window );">Initial basic monthly rent</a></td>
<td class="nump">$ 158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityAnnualIncreasePercent', window );">Annual rental increase, as a percent</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDiscountRate', window );">Discount rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gain (loss) on sale leaseback agreement</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiability', window );">Financing liability</a></td>
<td class="nump">28,774<span></span>
</td>
<td class="nump">$ 29,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs on financing liability</a></td>
<td class="nump">708<span></span>
</td>
<td class="nump">768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityCurrent', window );">Current portion of financing liability</a></td>
<td class="nump">642<span></span>
</td>
<td class="nump">575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityNoncurrent', window );">Long-term portion of financing liability</a></td>
<td class="nump">28,132<span></span>
</td>
<td class="nump">28,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_InterestExpenseFinancingLiability', window );">Interest expense on financing liability</a></td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityLineItems', window );"><strong>Financing Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">$ 61,368<span></span>
</td>
<td class="nump">60,326<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityLineItems', window );"><strong>Financing Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (in years)</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityLineItems', window );"><strong>Financing Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property plant and equipment gross</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityAnnualIncreasePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Annual Increase, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityAnnualIncreasePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityBasicMonthlyPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Basic Monthly Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityBasicMonthlyPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Number of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Term of Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_InterestExpenseFinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_InterestExpenseFinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of finance lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128295416&amp;loc=SL77919786-209982<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481579326336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityAbstract', window );"><strong>Financing Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidYearOne', window );">2023</a></td>
<td class="nump">$ 1,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidYearTwo', window );">2024</a></td>
<td class="nump">1,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidYearThree', window );">2025</a></td>
<td class="nump">2,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidYearFour', window );">2026</a></td>
<td class="nump">2,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidYearFive', window );">2027</a></td>
<td class="nump">2,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaidAfterYearFive', window );">Thereafter</a></td>
<td class="nump">33,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityToBePaid', window );">Total Minimum Liability Payments</a></td>
<td class="nump">43,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiabilityUndiscountedExcessAmount', window );">Imputed Interest</a></td>
<td class="num">(15,143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FinancingLiability', window );">Total</a></td>
<td class="nump">$ 28,774<span></span>
</td>
<td class="nump">$ 29,350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, After Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityToBePaidYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, to be Paid, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityToBePaidYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FinancingLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FinancingLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481575877872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2020</div></th>
<th class="th"><div>Dec. 22, 2017</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod', window );">CARES Act, NOL carryback period (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility', window );">Section 174 expenditure deduction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxAssetsSection174REAddback', window );">Deferred tax asset, Section 174 addback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,558<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax asset valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,568<span></span>
</td>
<td class="nump">6,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Foreign tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 638<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FederalStateAndLocalTaxReturnsPeriod', window );">Federal, state and local tax returns period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ForeignSubsidiariesTaxReturnsPeriod', window );">Foreign subsidiaries tax returns period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_FederalStateAndLocalTaxReturnsPeriod', window );">Federal, state and local tax returns period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ForeignSubsidiariesTaxReturnsPeriod', window );">Foreign subsidiaries tax returns period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_MinistryOfFinanceIndiaMember', window );">India Income Tax Department</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_TaxWithholdingExpense', window );">Tax withholding expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 406<span></span>
</td>
<td class="nump">$ 240<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Coronavirus Aid, Relief And Economic Security Act, Net Operating Loss Carryback, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxAssetsSection174REAddback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Section 174 R&amp;E Addback</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxAssetsSection174REAddback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_FederalStateAndLocalTaxReturnsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Federal, state and local tax returns period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_FederalStateAndLocalTaxReturnsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ForeignSubsidiariesTaxReturnsPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign subsidiaries tax returns period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ForeignSubsidiariesTaxReturnsPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Section 174 Research And Experimentation Expenditures, Period Of Deductibility</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_TaxWithholdingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Withholding Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_TaxWithholdingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_MinistryOfFinanceIndiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_MinistryOfFinanceIndiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481579328112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 691<span></span>
</td>
<td class="nump">$ 1,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">1,736<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current tax expense</a></td>
<td class="nump">2,624<span></span>
</td>
<td class="nump">3,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">515<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred tax expense</a></td>
<td class="nump">515<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Net income tax expense</a></td>
<td class="nump">$ 3,139<span></span>
</td>
<td class="nump">$ 3,518<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569484128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income Tax Reconciliation (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax expense (benefit) at statutory rate</a></td>
<td class="nump">$ 945<span></span>
</td>
<td class="num">$ (432)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and local taxes, net of federal income tax benefit</a></td>
<td class="num">(119)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">Tax credits (state, net of federal benefit)</a></td>
<td class="num">(433)<span></span>
</td>
<td class="num">(457)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Effects of differing US and foreign tax rates</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount', window );">Net operating loss adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(286)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount', window );">Return to provision adjustment</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary', window );">Impact of foreign subsidiary income to parent</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Increase in valuation allowance</a></td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">4,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other items, net</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Net income tax expense</a></td>
<td class="nump">$ 3,139<span></span>
</td>
<td class="nump">$ 3,518<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Net Operating Loss Carryback, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Return To Provision Adjustment, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569996656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits', window );">Accrued employee benefit expenses</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Deferred compensation</a></td>
<td class="nump">1,156<span></span>
</td>
<td class="nump">1,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits (state, net of federal benefits)</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign', window );">Foreign tax credit carryforwards</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxAssetsSection174REAddback', window );">Section 174 R&amp;E Addback</a></td>
<td class="nump">1,558<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits', window );">Unrecognized actuarial loss, defined benefit plans</a></td>
<td class="nump">1,064<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory reserves and capitalized costs</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">249<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback', window );">Proceeds on Sale Leaseback</a></td>
<td class="nump">6,963<span></span>
</td>
<td class="nump">7,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxAssetLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">1,558<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">14,078<span></span>
</td>
<td class="nump">11,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Book basis in excess of tax basis of property, plant and equipment</a></td>
<td class="num">(1,417)<span></span>
</td>
<td class="num">(1,758)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty', window );">Book basis in excess of tax basis of Sale Leaseback property</a></td>
<td class="num">(1,106)<span></span>
</td>
<td class="num">(1,122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxLiabilitiesPrepaidPensionCost', window );">Prepaid pension</a></td>
<td class="num">(919)<span></span>
</td>
<td class="num">(949)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DeferredTaxLiabilitiesAPB23Assertion', window );">APB 23 Assertion</a></td>
<td class="num">(1,318)<span></span>
</td>
<td class="num">(976)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use assets</a></td>
<td class="num">(1,526)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts', window );">Debt Issuance Cost on Sale Leaseback</a></td>
<td class="num">(167)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(6,453)<span></span>
</td>
<td class="num">(4,989)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(8,568)<span></span>
</td>
<td class="num">(6,901)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">(943)<span></span>
</td>
<td class="num">(428)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax assets (liabilities) classified in the balance sheet:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax labilities</a></td>
<td class="num">(943)<span></span>
</td>
<td class="num">(428)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">(943)<span></span>
</td>
<td class="num">(428)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax assets (liabilities) classified in the balance sheet:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax labilities</a></td>
<td class="num">$ (943)<span></span>
</td>
<td class="num">$ (428)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxAssetLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxAssetLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxAssetsProceedsOnSaleLeaseback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Proceeds on Sale Leaseback</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxAssetsProceedsOnSaleLeaseback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxAssetsSection174REAddback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Section 174 R&amp;E Addback</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxAssetsSection174REAddback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxLiabilitiesAPB23Assertion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, APB 23 Assertion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxLiabilitiesAPB23Assertion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxLiabilitiesPrepaidPensionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities Prepaid Pension Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxLiabilitiesPrepaidPensionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DeferredTaxLiabilitiesSaleLeasebackProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Sale Leaseback Property</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DeferredTaxLiabilitiesSaleLeasebackProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481573118448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 26, 2015</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Aug. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (515)<span></span>
</td>
<td class="num">$ (121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandTenAndTwoThousandEightPlanMember', window );">2010 and 2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandSeventeenOmnibusIncentivePlanMember', window );">2017 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandSeventeenOmnibusIncentivePlanMember', window );">2017 Plan | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 845<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Remaining estimated compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandSeventeenOmnibusIncentivePlanMember', window );">2017 Plan | Service Components | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandSeventeenOmnibusIncentivePlanMember', window );">2017 Plan | Service Components | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandAndEightPlanMember', window );">2008 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized under stock option plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in number of shares available under stock option plan (in shares)</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=kequ_TwoThousandAndEightPlanMember', window );">2008 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Terms of award (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_ShareBasedCompensationDeferredTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax expense benefit related to deductible temporary differences from share-based compensation expense stock options at exercise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_ShareBasedCompensationDeferredTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kequ_TwoThousandTenAndTwoThousandEightPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kequ_TwoThousandTenAndTwoThousandEightPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kequ_TwoThousandSeventeenOmnibusIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kequ_TwoThousandSeventeenOmnibusIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=kequ_RestrictedStockUnitsRSUsServiceComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=kequ_RestrictedStockUnitsRSUsServiceComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=kequ_TwoThousandAndEightPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=kequ_TwoThousandAndEightPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569848656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details) - Restricted Stock Units (RSUs) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of RSUs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">144,827<span></span>
</td>
<td class="nump">125,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">87,969<span></span>
</td>
<td class="nump">67,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(50,315)<span></span>
</td>
<td class="num">(31,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(22,841)<span></span>
</td>
<td class="num">(16,197)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of year (in shares)</a></td>
<td class="nump">159,640<span></span>
</td>
<td class="nump">144,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of year (in dollar per shares)</a></td>
<td class="nump">$ 11.94<span></span>
</td>
<td class="nump">$ 12.24<span></span>
</td>
<td class="nump">$ 12.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollar per shares)</a></td>
<td class="nump">13.43<span></span>
</td>
<td class="nump">13.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollar per shares)</a></td>
<td class="nump">13.86<span></span>
</td>
<td class="nump">12.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollar per shares)</a></td>
<td class="nump">15.37<span></span>
</td>
<td class="nump">21.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at end of year (in dollar per shares)</a></td>
<td class="nump">$ 11.94<span></span>
</td>
<td class="nump">$ 12.24<span></span>
</td>
<td class="nump">$ 12.71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569484256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of&#160;Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of year (in shares)</a></td>
<td class="nump">47,400<span></span>
</td>
<td class="nump">84,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled (in shares)</a></td>
<td class="num">(7,850)<span></span>
</td>
<td class="num">(35,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(5,650)<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of year (in shares)</a></td>
<td class="nump">33,900<span></span>
</td>
<td class="nump">47,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of year (in shares)</a></td>
<td class="nump">33,900<span></span>
</td>
<td class="nump">47,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of year (in dollar per shares)</a></td>
<td class="nump">$ 19.97<span></span>
</td>
<td class="nump">$ 19.34<span></span>
</td>
<td class="nump">$ 18.56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled (in dollar per shares)</a></td>
<td class="nump">20.08<span></span>
</td>
<td class="nump">17.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollar per shares)</a></td>
<td class="nump">14.54<span></span>
</td>
<td class="nump">8.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of year (in dollar per shares)</a></td>
<td class="nump">19.97<span></span>
</td>
<td class="nump">19.34<span></span>
</td>
<td class="nump">$ 18.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of year (in dollar per shares)</a></td>
<td class="nump">$ 19.97<span></span>
</td>
<td class="nump">$ 19.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569734128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price range lower limit (in dollar per shares)</a></td>
<td class="nump">$ 15.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price range upper limit (in dollar per shares)</a></td>
<td class="nump">$ 23.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">33,900<span></span>
</td>
<td class="nump">47,400<span></span>
</td>
<td class="nump">84,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price (in dollar per shares)</a></td>
<td class="nump">$ 19.97<span></span>
</td>
<td class="nump">$ 19.34<span></span>
</td>
<td class="nump">$ 18.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life (in years)</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options exercisable (in shares)</a></td>
<td class="nump">33,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average exercise price (in dollar per shares)</a></td>
<td class="nump">$ 19.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569485088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">$ (3,742)<span></span>
</td>
<td class="num">$ (3,577)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Change in unrecognized actuarial loss on pension obligations</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(3,442)<span></span>
</td>
<td class="num">(3,742)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(2,543)<span></span>
</td>
<td class="num">(2,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(2,833)<span></span>
</td>
<td class="num">(2,543)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Minimum Pension Liability Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(1,199)<span></span>
</td>
<td class="num">(1,220)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Change in unrecognized actuarial loss on pension obligations</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">$ (609)<span></span>
</td>
<td class="num">$ (1,199)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481568885504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets</a></td>
<td class="nump">$ 9,170,000<span></span>
</td>
<td class="nump">$ 7,573,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">$ 2,278,640<span></span>
</td>
<td class="nump">2,019,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LesseeRemainingLeaseTerm', window );">Remaining lease term (in years)</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LesseeOptiontoExtendTerm', window );">Option to extend, term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_LesseeOptiontoTerminateTerm', window );">Option to terminate, term (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 3,344,000<span></span>
</td>
<td class="nump">3,067,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_OperatingLeaseShortTermExpense', window );">Operating lease, short term, expense</a></td>
<td class="nump">$ 1,065,000<span></span>
</td>
<td class="nump">$ 1,048,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, weighted average remaining lease term (in years)</a></td>
<td class="text">5 years 1 month 6 days<span></span>
</td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease, weighted average discount rate (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance lease, weighted average remaining lease term (in years)</a></td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease, weighted average discount rate (as a percent)</a></td>
<td class="nump">6.80%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LesseeOptiontoExtendTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Option to Extend, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LesseeOptiontoExtendTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LesseeOptiontoTerminateTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Option to Terminate, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LesseeOptiontoTerminateTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_LesseeRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_LesseeRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_OperatingLeaseShortTermExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Short Term, Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_OperatingLeaseShortTermExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481570163600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 2,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">1,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">1,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">1,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,380<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total Minimum Lease Payments</a></td>
<td class="nump">10,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Imputed Interest</a></td>
<td class="num">(1,533)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">9,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Financing</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total Minimum Lease Payments</a></td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Imputed Interest</a></td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total</a></td>
<td class="nump">$ 233<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569829312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated Benefit Obligation, April 30</a></td>
<td class="nump">$ 18,368,000<span></span>
</td>
<td class="nump">$ 20,022,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in Projected Benefit Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations, beginning of year</a></td>
<td class="nump">20,022,000<span></span>
</td>
<td class="nump">22,942,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">845,000<span></span>
</td>
<td class="nump">710,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial loss</a></td>
<td class="num">(1,113,000)<span></span>
</td>
<td class="num">(2,218,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Actual benefits paid</a></td>
<td class="num">(1,386,000)<span></span>
</td>
<td class="num">(1,412,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Projected benefit obligations, end of year</a></td>
<td class="nump">18,368,000<span></span>
</td>
<td class="nump">20,022,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in Plan Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, beginning of year</a></td>
<td class="nump">18,867,000<span></span>
</td>
<td class="nump">21,459,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">251,000<span></span>
</td>
<td class="num">(1,180,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Actual benefits paid</a></td>
<td class="num">(1,386,000)<span></span>
</td>
<td class="num">(1,412,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, end of year</a></td>
<td class="nump">17,732,000<span></span>
</td>
<td class="nump">18,867,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status&#8212;under</a></td>
<td class="num">(636,000)<span></span>
</td>
<td class="num">(1,155,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Amounts Recognized in the Consolidated Balance Sheets consist of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Non-current liabilities</a></td>
<td class="num">(636,000)<span></span>
</td>
<td class="num">(1,155,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract', window );"><strong>Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Net actual loss</a></td>
<td class="nump">4,526,000<span></span>
</td>
<td class="nump">5,116,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits', window );">Deferred tax benefit</a></td>
<td class="num">(1,064,000)<span></span>
</td>
<td class="num">(1,202,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">After-tax actuarial loss</a></td>
<td class="nump">$ 3,462,000<span></span>
</td>
<td class="nump">$ 3,914,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Weighted-average Assumptions Used to Determine Benefit Obligations at April 30</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost for Years Ended April 30</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term return on plan assets (as a percent)</a></td>
<td class="nump">7.75%<span></span>
</td>
<td class="nump">7.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569324416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 845<span></span>
</td>
<td class="nump">$ 710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(1,402)<span></span>
</td>
<td class="num">(1,604)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Recognition of net loss</a></td>
<td class="nump">628<span></span>
</td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense (income)</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="num">$ (355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Pension Cost (Reversal of Cost)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Pension Cost (Reversal of Cost)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList', window );">Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Pension Cost (Reversal of Cost)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes expected return (loss) on plan asset component of net periodic benefit (cost) credit for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes interest cost component of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes settlement and curtailment gain (loss) component of net periodic benefit (cost) credit for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481568786560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Benefits - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear', window );">Defined pension benefit plan, net periodic benefit cost</a></td>
<td class="nump">$ 580,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Anticipated contribution in the next fiscal year related to pension plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate', window );">Increase decrease in the discount rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations', window );">(Decrease) increase pension expense</a></td>
<td class="nump">$ 181,000<span></span>
</td>
<td class="nump">$ 207,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions', window );">Age limit of employees to be eligible for contribution (in years)</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod', window );">Minimum service period of employees to be eligible for contribution (in months)</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Employee's compensation (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount', window );">Employer matching contributions</a></td>
<td class="nump">$ 932,000<span></span>
</td>
<td class="nump">$ 967,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution', window );">Matching contributions by company (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Contributions by employer per employee's compensation (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employee's compensation (as a percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution', window );">Matching contributions by company (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Contributions by employer per employee's compensation (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity Securities | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined benefit plan, Plan asset percentage</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Fixed Income | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined benefit plan, Plan asset percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=kequ_YieldCurveTechniqueMember', window );">Yield Curve Technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate', window );">Increase decrease in the discount rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations', window );">(Decrease) increase pension expense</a></td>
<td class="nump">$ 231,000<span></span>
</td>
<td class="nump">$ 271,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=kequ_YieldCurveTechniqueMember', window );">Yield Curve Technique | Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Par amount outstanding</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedBenefitPlanPercentageChangesInDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined benefit plan percentage changes in discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedBenefitPlanPercentageChangesInDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan age limit of employees to be eligible for catch up contributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedContributionPlanEligibilityMinimumServicePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan eligibility minimum service period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedContributionPlanEligibilityMinimumServicePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedContributionPlanEmployerMatchingContributionsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Employer Matching Contributions, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedContributionPlanEmployerMatchingContributionsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan employer matching percent of employee contribution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost (credit) included in accumulated other comprehensive (income) loss expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for pension and other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=kequ_YieldCurveTechniqueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=kequ_YieldCurveTechniqueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481573649232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Benefits - Summary of Expected Benefit Payments (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 1,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2025</a></td>
<td class="nump">1,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2026</a></td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2027</a></td>
<td class="nump">1,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2028</a></td>
<td class="nump">1,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2029- 2033</a></td>
<td class="nump">$ 7,030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481573078368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, Plan asset</a></td>
<td class="nump">$ 17,732<span></span>
</td>
<td class="nump">$ 18,867<span></span>
</td>
<td class="nump">$ 21,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Defined benefit plan, Plan asset percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, Plan asset</a></td>
<td class="nump">$ 12,724<span></span>
</td>
<td class="nump">$ 13,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Defined benefit plan, Plan asset percentage</a></td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">73.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Fixed Income Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, Plan asset</a></td>
<td class="nump">$ 4,845<span></span>
</td>
<td class="nump">$ 4,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Defined benefit plan, Plan asset percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, Plan asset</a></td>
<td class="nump">$ 163<span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Defined benefit plan, Plan asset percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481573339104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 17,732<span></span>
</td>
<td class="nump">$ 18,867<span></span>
</td>
<td class="nump">$ 21,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">12,724<span></span>
</td>
<td class="nump">13,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4,845<span></span>
</td>
<td class="nump">4,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">17,732<span></span>
</td>
<td class="nump">18,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">7,326<span></span>
</td>
<td class="nump">7,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Small/Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2,326<span></span>
</td>
<td class="nump">2,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,743<span></span>
</td>
<td class="nump">2,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">702<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Liquid Alternatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">627<span></span>
</td>
<td class="nump">897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4,845<span></span>
</td>
<td class="nump">4,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Small/Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Liquid Alternatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Large Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Small/Mid Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Emerging Markets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Liquid Alternatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Fixed Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanEmergingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanEmergingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanLiquidAlternativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=kequ_DefinedBenefitPlanLiquidAlternativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481574406496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 30, 2023 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569385712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 219,494<span></span>
</td>
<td class="nump">$ 168,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenuesIncludingIntersegmentMarkup', window );">Intersegment revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">2,867<span></span>
</td>
<td class="nump">2,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (loss) before income taxes</a></td>
<td class="nump">4,498<span></span>
</td>
<td class="num">(2,485)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">3,139<span></span>
</td>
<td class="nump">3,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings attributable to non-controlling interest</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">738<span></span>
</td>
<td class="num">(6,126)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">118,898<span></span>
</td>
<td class="nump">118,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Expenditures for segment assets</a></td>
<td class="nump">4,148<span></span>
</td>
<td class="nump">1,908<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">75,337<span></span>
</td>
<td class="nump">43,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (loss) before income taxes</a></td>
<td class="num">(6,292)<span></span>
</td>
<td class="num">(5,891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">889<span></span>
</td>
<td class="nump">2,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="num">(7,181)<span></span>
</td>
<td class="num">(8,230)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenuesIncludingIntersegmentMarkup', window );">Intersegment revenues</a></td>
<td class="num">(11,426)<span></span>
</td>
<td class="num">(4,401)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_DomesticOperationsMember', window );">Domestic | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">146,716<span></span>
</td>
<td class="nump">126,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">2,394<span></span>
</td>
<td class="nump">2,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (loss) before income taxes</a></td>
<td class="nump">3,408<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">3,408<span></span>
</td>
<td class="num">(229)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">80,000<span></span>
</td>
<td class="nump">91,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Expenditures for segment assets</a></td>
<td class="nump">2,856<span></span>
</td>
<td class="nump">1,613<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_DomesticOperationsMember', window );">Domestic | Operating Segments | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">2,559<span></span>
</td>
<td class="nump">1,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_DomesticOperationsMember', window );">Domestic | Intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenuesIncludingIntersegmentMarkup', window );">Intersegment revenues</a></td>
<td class="nump">1,604<span></span>
</td>
<td class="nump">882<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember', window );">International | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">72,778<span></span>
</td>
<td class="nump">42,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">282<span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (loss) before income taxes</a></td>
<td class="nump">7,382<span></span>
</td>
<td class="nump">3,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">1,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings attributable to non-controlling interest</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss) attributable to Kewaunee Scientific Corporation</a></td>
<td class="nump">4,511<span></span>
</td>
<td class="nump">2,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment assets</a></td>
<td class="nump">38,898<span></span>
</td>
<td class="nump">27,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Expenditures for segment assets</a></td>
<td class="nump">1,292<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember', window );">International | Operating Segments | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">72,778<span></span>
</td>
<td class="nump">42,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember', window );">International | Intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_kequ_RevenuesIncludingIntersegmentMarkup', window );">Intersegment revenues</a></td>
<td class="nump">$ 9,822<span></span>
</td>
<td class="nump">$ 3,519<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_kequ_RevenuesIncludingIntersegmentMarkup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenues including intersegment markup.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">kequ_RevenuesIncludingIntersegmentMarkup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>kequ_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=kequ_DomesticOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=kequ_DomesticOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=kequ_InternationalOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140481569057904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs - Additional Information (Details) - Facility Closing - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring costs</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Recovery of bad debt collections</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>kequ-20230430_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:kequ="http://www.kewaunee.com/20230430"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="kequ-20230430.xsd" xlink:type="simple"/>
    <context id="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i58b08545b7074cb3a201d2e0553c4643_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="ieed3ef2aaf314496a20674e2d53f2bb0_I20230626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2023-06-26</instant>
        </period>
    </context>
    <context id="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="ib43bd0d59c2a4929843b0a5e1ef18ece_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i18873af196c74589a636521ad47359ea_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i33b2837f1a254ad8887f32c8e8b57bd2_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i9d828b49d10a4704808daece2df60079_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i72d2e48957c54d558de63a0798e40ea8_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="ia08ef11dead048c8b9c14a66f2f30b19_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i915042cddaaf43d0b7ae1684758c4070_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="id640e7a42f774176b13620cd072a3127_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i4cbc0049851e457db78badf31b1e8567_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i53f6e6d09b0c4d3bb0bc3f7cca2b19b7_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i5c9f52a76719413ca2b86f14caf73d43_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i98d4566e618a454691c20203db06f3e1_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ic873590b7746431d91d9e534c1f4f8ef_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ia6cb154cb71b4be8aeb4451ec6960761_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i47eb375d52294ca48f7e189e4064efc2_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i2ca2ebd535504440b59023a1e53f9d80_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i39375c07149c4105a5bb96993a610b54_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="id90398c44c124e6fb0320813aaf37e69_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i81381b39a97b4ea58fac780296922591_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i936dc2381cd44b90a8a4da43b0dc2458_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i69f3a0aef45846feb5cfcd30de4b3a46_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="if150932ec89044d5a2fe26428a616330_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ic49c2c59bb514ba9a98eea71a4532d83_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ie7d7a5379c3946afbbfd4db4209a9259_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="iffed0786ff994d8b887d069e8f55bdc6_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i4d12676382c14aefb358f5cf0f5ca1e0_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeLabwayAsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="idb5014da29064620a8625170da6db109_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeScientificCorporationSingaporeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i035c81617bd64b739231dde89d9e390b_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KewauneeLabwayIndiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i42a4784036154c0598d9e7d078cc620b_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KoncepoScientechInternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i96f00904ca244286a10a749a0fce2507_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">kequ:KewauneeScientificCorporationSingaporeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">kequ:KequipGlobalLabSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ief738c90b80a46dcae563091eb90527b_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i7a204790b1a14821b1916e1824956a58_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i90242fcce5d84297ba58ac37f58d01eb_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="id2c67af89acc4cceb16bae291f0b924f_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i6e8f56e78063401992e2639148b52a7c_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ia1e6cacd2bfe41289beb4377632e046c_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i57303180faa04cc888c13c4f5bcf55a0_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="ieb6a852f1dc64a4c8ae4e54a59cf843c_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i8dd046eeca6c43a49013acada8280e5c_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="iadc7ed37eabf46289e1b3ede5bfd6780_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i3b6a962e78384b8cbbb043ce06b35ea2_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i0e8b0570b6534fad8da8843f53a91fcb_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i83a554db45cd44afb12954d7dbcb3262_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i3defb6f321ab4a0ba12e8290a4c594fa_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="iadd284a39a98417ea0c4e5f5d3eed853_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="ie12e2507d8404c55843b1ee785732570_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i1252e42ba8f94788b9c2e9526358c016_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i31ecee99cb564fb4853c3bcd51ee186d_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ic6b14126cfd04589a48a1267cb447516_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i18837955ad44418ebb8430792c895f28_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i86c6fb5e15db485f849df283bb68dec9_D20211222-20211222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2021-12-22</startDate>
            <endDate>2021-12-22</endDate>
        </period>
    </context>
    <context id="idbabd4cac86145e9800da3c3c2fc57ed_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i3433d8e1e195426ea3058452dac64693_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="iba363eb7d56e476996da5c8c0716bbf4_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ia33e90d485ca4a4fbfa0aaa236176d1d_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i234054f8708d43f4811f8f93244fe91c_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i251e9520bea74e6991781ef0e97f7a97_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i24354820914d4aee9f7707f52e56f2ff_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i99d113f3a4a845649deeb8980f67ebc1_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ib1a86d35001449868ca80f5a24ebfdbd_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i0adeca8c17f64dfeb440b21d5c2d6c40_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">kequ:TradingSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ie91fc5afe2074e3683df40b73a01966b_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="if70f929642694c0ca07d208b0d16e645_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CashSurrenderValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ie732b5f45f464e6ca8f0b1fb3c13d76a_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="id38d9bc0dc4a4764ba3d1d2f6e881e3a_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iaf90038df3a74e6d8e1591581aa2c4dd_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i2592da14edd14d3a9802f6465c8990d2_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">kequ:NonQualifiedCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i0ffefcfa990f4dd792c6f71caefc049c_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i55120ad7d22e4ad3a0aff429b22a6b6b_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i1396e4dd472c434789f1f0126457631e_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i8e80065eb8da4baab97a3125ae4f02ba_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i67f1ba03114040909ce8cdfc2a78ea6d_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i6751dceadb374681b0c6d52cd75ece45_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i6a8537ecb2f1436aaeb85e43dc13d546_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i76d8faf2554a4789a61384dd2757d22e_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i9b8a41ff0b9c49e69f759968f6dd33fb_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="ic868b6191e614d7d9d37a313030673f7_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i64432110caef45faafd30217f99ab7e5_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i29c25bca73914a2e8b0740a217a19a70_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="ieb71661af8d5440999566d760f9a4987_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i4523e07e76d34e0986ee2172ffc114c8_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="ic72bb0d6c18f493c8331dbd53a1be173_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i7066198457634c5c84c33711657d5762_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="if62c92cef71f4d728c84fa5dbdb324b6_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="if0d0017306a14071a889803879b2857a_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i158c57bc39694f63be232317e782c90e_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i12df3466c7ff493e867302751a24bada_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i6a02acdd018f43b8b0f5cc560820651a_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">kequ:FiscalYearTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="ieb2d1acd7b3446289e9ad791d76db1de_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ia4ff3442856846399487d370b1773546_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:ForeignSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i6a43198092b94ea889724f8b5846813b_I20130506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2013-05-06</instant>
        </period>
    </context>
    <context id="i6ffdef1e14f34eb8bad803398261c99d_I20191213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2019-12-13</instant>
        </period>
    </context>
    <context id="i442be4c6913b49a4b50ea772baaab2d6_I20200201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2020-02-01</instant>
        </period>
    </context>
    <context id="i1b182470888b4bfbbed867265f9c5935_I20220627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <instant>2022-06-27</instant>
        </period>
    </context>
    <context id="i9ae780b25bd64b349ff3f0cdb52c391c_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:AdvanceAmountOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i7e3cd898d91a4be8995d0dc84050feba_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:AdvanceAmountTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ie1cc410519c54218bd0491e4a36cd2ea_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:AdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i8817c527703e49429894104cdd1d7ecc_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="id54523868cb9492da803a3fdb87635d5_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i546d1702d5294252997efbcc4760c0d2_I20221219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-19</instant>
        </period>
    </context>
    <context id="i77d740aedb144bb0ad536168beb98a3c_D20221219-20221219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">kequ:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-19</startDate>
            <endDate>2022-12-19</endDate>
        </period>
    </context>
    <context id="i68739a09bcb74732ad67255efa20ec71_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">kequ:CreditAgreementMidCapFundingIVTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ibc3c4ae466f84e8aa27fac57a2ef3a4a_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">kequ:InternationalSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i5ee2c5a57bb34a47b58f57f8e3d1c42d_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i3e58a0cf3d454dedbd6523de24bb050f_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i18991e1526b14ffd876d57c01cbb0bde_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="if7d1f7a7276349cca788e17cd7c0ef20_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i040d62d3dd79442993ccc580b1141db5_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="id3242c4e7dfc44caa5252683fd462cbc_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i07a66023f9b1454788d7c1753ac27d49_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ia2bdb86fad2b464f9159d4e51f919a4b_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i2e3b5ea3288d445dbfb4e15eb2d7eff1_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">kequ:TermLoanBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i68ff7bf3b6ef494bb98b7aeeb082d754_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GuaranteeObligationsByNatureAxis">kequ:BankGuaranteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i63ec6c47db8041f29ab17eb138d30e46_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="ia4b416d20e6c41dca68290de29b3950c_D20200327-20200327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2020-03-27</startDate>
            <endDate>2020-03-27</endDate>
        </period>
    </context>
    <context id="ia09ed2386bef4571af63546d7275fed5_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfFinanceIndiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i76e58b3cdbee43328d425bf866be46cb_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:MinistryOfFinanceIndiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="ic4fc91d4336742bca6f7d1456d6b6290_D20171222-20171222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2017-12-22</startDate>
            <endDate>2017-12-22</endDate>
        </period>
    </context>
    <context id="ia90c11936dba4904a9531ab5d52fbbd5_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="id553a2e4e4c34c41aad075cfe7d7e942_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandTenAndTwoThousandEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i0df14ac1694242918bf120280e13b5e4_I20170830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-30</instant>
        </period>
    </context>
    <context id="id145fd41da7a42d8bf28d16bf42e6e73_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i856a73272e2d43a39d425e3dec7e46cd_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="ie0f4be86b27e4b73ba9843141170627d_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="ie3d01a1650ac43cca9d9a27d1d799fb8_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kequ:RestrictedStockUnitsRSUsServiceComponentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i63348bc16c724f1f8d2b204017cbb09b_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">kequ:RestrictedStockUnitsRSUsServiceComponentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i7f51b34728494fe387a9da7cbaaecf7f_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandSeventeenOmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="idadad6c5f93d416caf379a3ec3da9055_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="if60aac1ba48e4bd790f9b0fafdf6e109_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i81ebd11ae8384005a4122c79a54d0388_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ib7bce12c1c32423e8650a7aa2cca14a6_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i4ca44f1ca15a49c686f4c491a93f8591_D20150826-20150826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-08-26</startDate>
            <endDate>2015-08-26</endDate>
        </period>
    </context>
    <context id="i93b7e975c5f64cc6b08cfc1e4e83c167_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="iabe50ea0d70a4c4395aa06274568ff1c_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">kequ:TwoThousandAndEightPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i0587fe00cae74bec97d95dac2c6e3805_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i58cc8871d7854cf58997cb98992e51f7_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i375a69d8f72741c3b852a98fd7b2e36d_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="ie4fb45c9d24746b3a2e1197cf86d9d3a_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i09cf305d1de04959b7bda23aa95706a3_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iceca130826c3475f9ab063adc1f5f5cb_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i302d0d54469e442197359aabf6bc4272_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i0ccfacb4e2c84a068c3ca01af64454f4_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i474fdf01402c4320988de23ca2856814_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="id6ebb0ed884a4d85b16577907b09659a_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i169a6334517a4b19877902820dba5e96_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">kequ:YieldCurveTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ib5dbb92c8fb44dc2ba4e9a4183b0e326_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">kequ:YieldCurveTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="ibb15b53ace4d4cc89a084c541d351ce9_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">kequ:YieldCurveTechniqueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i472a2c8c23a648a2a20e3abd4d4c0d6c_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="id18cf987103643748c6db3d293c21a14_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i8c34d5d2c07b404c96ed13f48c0378f7_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i2618157cd36a473eb1be555923af9434_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i461991f9a104434190673d6c11e374a4_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i7564e3aaefde4cc68eb4d66be4958117_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i4021b8377b114d78bbf1ef3499af7718_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i3bc3127d271f40c68917d5dfd4db4ba5_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i000d0b9b003247e49169b92e76d8a09a_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i03d983ee673f413c90842b0da9ff9f43_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i923a5fb9c22b4ca38cc73db048a7825c_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i312a8cb23fc94a6da460c8f4222f0639_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i8a4fccb41c0d41d9bad0908cc0d8c23b_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i9cc3a1c0b4c54acd9b37831a3bb584a3_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="if2aaffec262844dfacd06946a041d076_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i79fc58d8bcb0411fbe11a081e6d072a8_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i896cff42816940eaaee621949ddb6194_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ia0eb4dc2bb954fe79a558072049a1831_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ib7de646a2dc541ca9f756667c74e21e8_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="iadfc70c5513e41bb947fe21e6b0966c1_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i897db272c7af4c3197ac2a1529dc2f8a_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ic212c7fd02eb41fe97da02135a2a32b5_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i84d2c48142ac411eb496c07b85230a6d_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i93f86e2de3e8488eb7824809bf0d34e8_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i425180d6d80c4d73ad2fa942d6d8e85f_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="iaba8749a1a26404e9c8bf4ea4a8c9546_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ieb3130ef4af74fbabeb2632567506974_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i1d2b508c96c041a5999e41c866d6dac5_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ib1c69c8ad78245338093ee6b28093169_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i789bb8f7d31e4310960e2e37137bb32a_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="if9efb8d4ca2d493eb707565a176dce6d_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="ib241eb5a32fa4fea9b004f728e78a69c_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="id1f810c2a94b4f1aa8f0d78dbbca6e8f_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iec155c938875403a9cd89d027b15e0c1_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i4f78266f81774c8cb5cfab7eb95904c0_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i854a8abfd519441d95b99eb28db921d7_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i2b825859a1f84c25a9245c562c9110c8_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iab1212417875461884b453615e64caae_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i08c47e380ee54dabb1754d7ccb46e86a_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ie7b52ce2fc2241eb9007387adf55e35a_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i43427226e74849a88e0eb5b4a25adf12_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iffc659a9402841f48ab3f91f0d5a48a4_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iec243beb997e4e3d9e2437b00cb92051_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ibe6caf6ca2e04c14b416ef5a51d235c1_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanEmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="icee3a5c7b5744ec2a0b78771afc9000d_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i517e6442cdb945718bfb4a5054667765_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i0449597eea9b4e8bb4321131eeadb7d3_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="iad9200d2ce534be78d4a456fc4ef6b6c_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i9d0fa294085541439c1c28e09b131ee3_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i7ecc70cd0abb4a2dbf24582b226b6ab8_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">kequ:DefinedBenefitPlanLiquidAlternativesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i912b55bb462d4adcad4393d6753058e8_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i1115530ba0114611bc42e50e7b6324a4_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i55beed59b26e4f22a06bf6565cb3b9a4_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i3f2aaa221eb94ad69d94ee9d5db0943a_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="ib99cbe4793c040dd859880b6ce8c5d6c_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i66409b457de24b8ea9db0e15adf2f1c1_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i17f99b083fb44457829907146d217534_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="iba68a35a7cbd4325912b37c8a42846b6_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="ie729b60a90844b3893420d0d57361c11_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i34c4fe4e054c42a0be6b9bb2053335ca_I20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="i23df5675029345c288bde9f193ac67d7_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="ia5465457d161440f8737d4f3e58f566a_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="iaeefffc08f9c430ebb298fa36e4c30b8_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i68f7a9301a3f4938978283aee47bfa00_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i93a0af5a5c704ae09f78421067a08c16_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i3f86e115975447b7b8aae1019a860422_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i4d8e2f8f245e4158ba91b25300e91af8_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i07eb9ad716994fadacba37a96ffddb15_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ib6a0995d858b40708d0b3419cfbc2624_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i7e3c49b7bdf74b079553da120ca298d9_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:DomesticOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i40c6621adfc5456994955d1968018f4e_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">kequ:InternationalOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="icc0cd04d9ec24d0e82564984d27f29ff_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i7e800b6ee23a4e2894c72aa7f8abe31f_D20220501-20230430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="i72a92bc417734dbfa6b9630d85382b62_D20210501-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="compensation_plan">
        <measure>kequ:compensation_plan</measure>
    </unit>
    <unit id="renewaloption">
        <measure>kequ:renewalOption</measure>
    </unit>
    <unit id="segment">
        <measure>kequ:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-31">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-32">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-33">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-34">0000055529</dei:EntityCentralIndexKey>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-769">http://fasb.org/us-gaap/2022#PensionExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-770">http://fasb.org/us-gaap/2022#PensionExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-771">http://fasb.org/us-gaap/2022#PensionExpense</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList>
    <dei:DocumentType
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-3">2023-04-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-4">--04-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-6">0-5286</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-7">KEWAUNEE SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-9">38-0715562</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-10">2700 West Front Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-11">Statesville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-12">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-13">28677-2927</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-14">704</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-15">873-7202</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-16">Common&#160;Stock&#160;$2.50&#160;par&#160;value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-17">KEQU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-19">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-23">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-24">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-25">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-26">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-27">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i58b08545b7074cb3a201d2e0553c4643_I20221031"
      decimals="0"
      id="f-28"
      unitRef="usd">37907714</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ieed3ef2aaf314496a20674e2d53f2bb0_I20230626"
      decimals="INF"
      id="f-29"
      unitRef="shares">2879785</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-30">DOCUMENTS INCORPORATED BY REFERENCE: Those portions of the Company's proxy statement for use in connection with Kewaunee Scientific Corporation's annual meeting of stockholders to be held on August&#160;23, 2023, indicated in this report are incorporated by reference into Part&#160;III hereof.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-35">FORVIS, LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-36">Charlotte, NC</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-37">686</dei:AuditorFirmId>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-38"
      unitRef="usd">219494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-39"
      unitRef="usd">168872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-40"
      unitRef="usd">183906000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-41"
      unitRef="usd">144652000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-42"
      unitRef="usd">35588000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-43"
      unitRef="usd">24220000</us-gaap:GrossProfit>
    <us-gaap:OperatingExpenses
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-44"
      unitRef="usd">30224000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-45"
      unitRef="usd">26828000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-46"
      unitRef="usd">5364000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-47"
      unitRef="usd">-2608000</us-gaap:OperatingIncomeLoss>
    <us-gaap:PensionExpense
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-48"
      unitRef="usd">71000</us-gaap:PensionExpense>
    <us-gaap:PensionExpense
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-49"
      unitRef="usd">-355000</us-gaap:PensionExpense>
    <us-gaap:OtherIncome
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-50"
      unitRef="usd">939000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-51"
      unitRef="usd">400000</us-gaap:OtherIncome>
    <us-gaap:InterestExpense
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-52"
      unitRef="usd">1734000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-53"
      unitRef="usd">632000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-54"
      unitRef="usd">4498000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-55"
      unitRef="usd">-2485000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-56"
      unitRef="usd">3139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-57"
      unitRef="usd">3518000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-58"
      unitRef="usd">1359000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-59"
      unitRef="usd">-6003000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-60"
      unitRef="usd">621000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-61"
      unitRef="usd">123000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-62"
      unitRef="usd">738000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-63"
      unitRef="usd">-6126000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="2"
      id="f-64"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="2"
      id="f-65"
      unitRef="usdPerShare">-2.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="2"
      id="f-66"
      unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="2"
      id="f-67"
      unitRef="usdPerShare">-2.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-68"
      unitRef="shares">2824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-69"
      unitRef="shares">2786000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-70"
      unitRef="shares">2902000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-71"
      unitRef="shares">2786000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-72"
      unitRef="usd">1359000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-73"
      unitRef="usd">-6003000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-74"
      unitRef="usd">-290000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-75"
      unitRef="usd">-186000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-76"
      unitRef="usd">590000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-77"
      unitRef="usd">21000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-78"
      unitRef="usd">1659000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-79"
      unitRef="usd">-6168000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-80"
      unitRef="usd">621000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-81"
      unitRef="usd">123000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-82"
      unitRef="usd">1038000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-83"
      unitRef="usd">-6291000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ib43bd0d59c2a4929843b0a5e1ef18ece_I20210430"
      decimals="-3"
      id="f-84"
      unitRef="usd">6915000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18873af196c74589a636521ad47359ea_I20210430"
      decimals="-3"
      id="f-85"
      unitRef="usd">3807000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i33b2837f1a254ad8887f32c8e8b57bd2_I20210430"
      decimals="-3"
      id="f-86"
      unitRef="usd">-53000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9d828b49d10a4704808daece2df60079_I20210430"
      decimals="-3"
      id="f-87"
      unitRef="usd">34149000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i72d2e48957c54d558de63a0798e40ea8_I20210430"
      decimals="-3"
      id="f-88"
      unitRef="usd">-3577000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430"
      decimals="-3"
      id="f-89"
      unitRef="usd">41241000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i915042cddaaf43d0b7ae1684758c4070_D20210501-20220430"
      decimals="-3"
      id="f-90"
      unitRef="usd">-6126000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-91"
      unitRef="usd">-6126000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id640e7a42f774176b13620cd072a3127_D20210501-20220430"
      decimals="-3"
      id="f-92"
      unitRef="usd">-165000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-93"
      unitRef="usd">-165000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4cbc0049851e457db78badf31b1e8567_D20210501-20220430"
      decimals="-3"
      id="f-94"
      unitRef="usd">68000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i53f6e6d09b0c4d3bb0bc3f7cca2b19b7_D20210501-20220430"
      decimals="-3"
      id="f-95"
      unitRef="usd">676000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-96"
      unitRef="usd">744000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="i5c9f52a76719413ca2b86f14caf73d43_I20220430"
      decimals="-3"
      id="f-97"
      unitRef="usd">6983000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i98d4566e618a454691c20203db06f3e1_I20220430"
      decimals="-3"
      id="f-98"
      unitRef="usd">4483000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic873590b7746431d91d9e534c1f4f8ef_I20220430"
      decimals="-3"
      id="f-99"
      unitRef="usd">-53000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia6cb154cb71b4be8aeb4451ec6960761_I20220430"
      decimals="-3"
      id="f-100"
      unitRef="usd">28023000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i47eb375d52294ca48f7e189e4064efc2_I20220430"
      decimals="-3"
      id="f-101"
      unitRef="usd">-3742000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-102"
      unitRef="usd">35694000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i39375c07149c4105a5bb96993a610b54_D20220501-20230430"
      decimals="-3"
      id="f-103"
      unitRef="usd">738000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-104"
      unitRef="usd">738000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id90398c44c124e6fb0320813aaf37e69_D20220501-20230430"
      decimals="-3"
      id="f-105"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-106"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i81381b39a97b4ea58fac780296922591_D20220501-20230430"
      decimals="-3"
      id="f-107"
      unitRef="usd">101000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i936dc2381cd44b90a8a4da43b0dc2458_D20220501-20230430"
      decimals="-3"
      id="f-108"
      unitRef="usd">576000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-109"
      unitRef="usd">677000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="i69f3a0aef45846feb5cfcd30de4b3a46_I20230430"
      decimals="-3"
      id="f-110"
      unitRef="usd">7084000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if150932ec89044d5a2fe26428a616330_I20230430"
      decimals="-3"
      id="f-111"
      unitRef="usd">5059000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic49c2c59bb514ba9a98eea71a4532d83_I20230430"
      decimals="-3"
      id="f-112"
      unitRef="usd">-53000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7d7a5379c3946afbbfd4db4209a9259_I20230430"
      decimals="-3"
      id="f-113"
      unitRef="usd">28761000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iffed0786ff994d8b887d069e8f55bdc6_I20230430"
      decimals="-3"
      id="f-114"
      unitRef="usd">-3442000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-115"
      unitRef="usd">37409000</us-gaap:StockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-116"
      unitRef="usd">8078000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-117"
      unitRef="usd">4433000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-118"
      unitRef="usd">5737000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-119"
      unitRef="usd">2461000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-120"
      unitRef="usd">476000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-121"
      unitRef="usd">357000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-122"
      unitRef="usd">46081000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-123"
      unitRef="usd">41254000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-124"
      unitRef="usd">21889000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-125"
      unitRef="usd">23796000</us-gaap:InventoryNet>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-126"
      unitRef="usd">0</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-127"
      unitRef="usd">13457000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-128"
      unitRef="usd">6135000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-129"
      unitRef="usd">6164000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-130"
      unitRef="usd">87920000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-131"
      unitRef="usd">91565000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-132"
      unitRef="usd">16402000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-133"
      unitRef="usd">15121000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-134"
      unitRef="usd">9170000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-135"
      unitRef="usd">7573000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-136"
      unitRef="usd">5406000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-137"
      unitRef="usd">4514000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-138"
      unitRef="usd">118898000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-139"
      unitRef="usd">118773000</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-140"
      unitRef="usd">3587000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-141"
      unitRef="usd">1588000</us-gaap:ShortTermBorrowings>
    <kequ:FinancingLiabilityCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-142"
      unitRef="usd">642000</kequ:FinancingLiabilityCurrent>
    <kequ:FinancingLiabilityCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-143"
      unitRef="usd">575000</kequ:FinancingLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-144"
      unitRef="usd">85000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-145"
      unitRef="usd">126000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-146"
      unitRef="usd">1967000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-147"
      unitRef="usd">1319000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-148"
      unitRef="usd">23599000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-149"
      unitRef="usd">27316000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-150"
      unitRef="usd">4304000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-151"
      unitRef="usd">4504000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-152"
      unitRef="usd">4097000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-153"
      unitRef="usd">3529000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-154"
      unitRef="usd">1772000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-155"
      unitRef="usd">3336000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-156"
      unitRef="usd">40053000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-157"
      unitRef="usd">42293000</us-gaap:LiabilitiesCurrent>
    <kequ:FinancingLiabilityNoncurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-158"
      unitRef="usd">28132000</kequ:FinancingLiabilityNoncurrent>
    <kequ:FinancingLiabilityNoncurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-159"
      unitRef="usd">28775000</kequ:FinancingLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-160"
      unitRef="usd">148000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-161"
      unitRef="usd">228000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-162"
      unitRef="usd">7136000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-163"
      unitRef="usd">6179000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <kequ:AccruedEmployeeBenefitPlanCosts
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-164"
      unitRef="usd">3546000</kequ:AccruedEmployeeBenefitPlanCosts>
    <kequ:AccruedEmployeeBenefitPlanCosts
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-165"
      unitRef="usd">4159000</kequ:AccruedEmployeeBenefitPlanCosts>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-166"
      unitRef="usd">943000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-167"
      unitRef="usd">428000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-168"
      unitRef="usd">455000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-169"
      unitRef="usd">531000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-170"
      unitRef="usd">80413000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-171"
      unitRef="usd">82593000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      id="f-172"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      id="f-173"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="2"
      id="f-174"
      unitRef="usdPerShare">2.50</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="2"
      id="f-175"
      unitRef="usdPerShare">2.50</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-176"
      unitRef="shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-177"
      unitRef="shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-178"
      unitRef="shares">2833000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-179"
      unitRef="shares">2793000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-180"
      unitRef="shares">2830000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-181"
      unitRef="shares">2790000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-182"
      unitRef="usd">7084000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-183"
      unitRef="usd">6983000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-184"
      unitRef="usd">5059000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-185"
      unitRef="usd">4483000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-186"
      unitRef="usd">28761000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-187"
      unitRef="usd">28023000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-188"
      unitRef="usd">-3442000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-189"
      unitRef="usd">-3742000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-190"
      unitRef="shares">3000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-191"
      unitRef="shares">3000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-192"
      unitRef="usd">53000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-193"
      unitRef="usd">53000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-194"
      unitRef="usd">37409000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-195"
      unitRef="usd">35694000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-196"
      unitRef="usd">1076000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-197"
      unitRef="usd">486000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-198"
      unitRef="usd">38485000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-199"
      unitRef="usd">36180000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-200"
      unitRef="usd">118898000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-201"
      unitRef="usd">118773000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-202"
      unitRef="usd">1359000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-203"
      unitRef="usd">-6003000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-204"
      unitRef="usd">2867000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-205"
      unitRef="usd">2769000</us-gaap:Depreciation>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-206"
      unitRef="usd">120000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-207"
      unitRef="usd">92000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-208"
      unitRef="usd">886000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-209"
      unitRef="usd">729000</us-gaap:ShareBasedCompensation>
    <kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-210"
      unitRef="usd">516000</kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment>
    <kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-211"
      unitRef="usd">120000</kequ:DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-212"
      unitRef="usd">4947000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-213"
      unitRef="usd">8464000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-214"
      unitRef="usd">-1907000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-215"
      unitRef="usd">7279000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-216"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-217"
      unitRef="usd">-955000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-218"
      unitRef="usd">-5558000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-219"
      unitRef="usd">11886000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-220"
      unitRef="usd">568000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-221"
      unitRef="usd">406000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-222"
      unitRef="usd">-1508000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-223"
      unitRef="usd">-3096000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-224"
      unitRef="usd">-3790000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-225"
      unitRef="usd">-7885000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-226"
      unitRef="usd">4148000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-227"
      unitRef="usd">1908000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-228"
      unitRef="usd">-4148000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-229"
      unitRef="usd">-1908000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-230"
      unitRef="usd">60599000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-231"
      unitRef="usd">59359000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-232"
      unitRef="usd">58601000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-233"
      unitRef="usd">64598000</us-gaap:RepaymentsOfShortTermDebt>
    <kequ:ProceedsFromFinancingLiability
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-234"
      unitRef="usd">13629000</kequ:ProceedsFromFinancingLiability>
    <kequ:ProceedsFromFinancingLiability
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-235"
      unitRef="usd">15893000</kequ:ProceedsFromFinancingLiability>
    <kequ:PaymentsOnFinancingLiability
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-236"
      unitRef="usd">575000</kequ:PaymentsOnFinancingLiability>
    <kequ:PaymentsOnFinancingLiability
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-237"
      unitRef="usd">0</kequ:PaymentsOnFinancingLiability>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-238"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-239"
      unitRef="usd">377000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-240"
      unitRef="usd">121000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-241"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-242"
      unitRef="usd">14931000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-243"
      unitRef="usd">11031000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-244"
      unitRef="usd">-72000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-245"
      unitRef="usd">-75000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-246"
      unitRef="usd">6921000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-247"
      unitRef="usd">1163000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-248"
      unitRef="usd">6894000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430"
      decimals="-3"
      id="f-249"
      unitRef="usd">5731000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-250"
      unitRef="usd">13815000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-251"
      unitRef="usd">6894000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-252"
      unitRef="usd">1862000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-253"
      unitRef="usd">480000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-254"
      unitRef="usd">3158000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-255"
      unitRef="usd">1006000</us-gaap:IncomeTaxesPaidNet>
    <kequ:RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-256"
      unitRef="usd">3902000</kequ:RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability>
    <kequ:RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-257"
      unitRef="usd">366000</kequ:RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-258">Summary of Significant Accounting Policies&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Kewaunee Scientific Corporation and subsidiaries (collectively the "Company") design, manufacture, and install laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's sales are made through purchase orders and contracts submitted by customers through its dealers, its subsidiaries in Singapore and India, and a national stocking distributor. See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i1de8d1053c4044f7aa1eb1bfb086781f_127" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 12&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for details on the closure status of the Company's China operations. The majority of the Company's products are sold to customers located in North America, primarily within the United States. The Company's laboratory products are used in chemistry, physics, biology and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government and health care markets. Technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's consolidated financial statements include the accounts of Kewaunee Scientific Corporation and its international subsidiaries. A brief description of each subsidiary, along with the amount of the Company's controlling financial interests, as of April&#160;30, 2023 is as follows: (1) Kewaunee Labway Asia Pte. Ltd., a commercial sales organization for the Company's products in Singapore, is 100% owned by the Company; (2) Kewaunee Scientific Corporation Singapore Pte. Ltd., a holding company in Singapore, is 100% owned by the Company; (3) Kewaunee Labway India Pvt. Ltd., a design, installation, manufacturing, assembly and commercial sales operation for the Company's products in Bangalore, India, is 95% owned by the Company; (4) Koncepo Scientech International Pvt. Ltd., a laboratory design and strategic advisory and construction management services firm, located in Bangalore, India, is 80% owned by the Company; (5) Kequip Global Lab Solutions Pvt. Ltd. is 70% owned by Kewaunee Scientific Corporation Singapore Pte. Ltd. All intercompany balances, transactions, and profits have been eliminated. Included in the consolidated financial statements are net assets of $16,786,000 and $13,127,000 at April&#160;30, 2023 and 2022, respectively, of the Company's subsidiaries. Net sales by the Company's subsidiaries in the amounts of $72,778,000 and $42,024,000 were included in the consolidated statements of operations for fiscal years 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the years ended April&#160;30, 2023 and 2022, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows. The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows at April 30 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.560%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.918%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.851%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,737&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Receivables are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to the Company, or a project dispute makes it unlikely that all of the receivable owed by a customer will be collected, a specific reserve for bad debts is estimated and recorded to reduce the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, a reserve for bad debts is estimated and recorded based on past loss history and an overall assessment of past due trade accounts receivable amounts outstanding. Accounts are written off when it is clearly established that the receivable&#160;is a bad debt. Recoveries of receivables previously written off are recorded when received. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity in the allowance for doubtful accounts for each of the years ended April&#160;30 was:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.005%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;357&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Doubtful accounts written off (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;476&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unbilled Receivables&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Accounts receivable include unbilled receivables that represent amounts earned which have not yet been billed in accordance with contractually stated billing terms, excluding retention, which is included in other assets. The amount of unbilled receivables, net of unbilled retention, at April&#160;30, 2023 and 2022 was $13,459,000 and $9,287,000, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's inventories are valued at the lower of cost or net realizable value under the first-in, first-out ("FIFO") method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is determined for financial reporting purposes principally on the straight-line method over the estimated useful lives of the individual assets or, for leaseholds, over the terms of the related leases, if shorter. Property, plant and equipment consisted of the following at April&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.209%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,147&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10-40&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44,180&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;61,368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(44,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,402&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the carrying value of property, plant and equipment for impairment annually or whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value. There were no impairments in fiscal years 2023 or 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other assets at April&#160;30, 2023 and 2022 included $1,191,000 and $1,293,000, respectively, of unbilled retainage, $2,352,000 and $2,480,000, respectively, of assets held in a trust account for non-qualified benefit plan, and $111,000 and $110,000, respectively, of cash surrender values of life insurance policies. Life insurance policies are recorded at the amount that could be realized under the insurance contract as of the date of the Company's consolidated balance sheets with the change in cash surrender or contract value being recorded as income or expense during each period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for uncollectible accounts receivable, self-insurance reserves, income taxes, and pension liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Variable Interest Entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On December 22, 2021, the Company entered into an Agreement for Purchase and Sale of Real Property with CAI Investments Sub-Series 100 LLC (the "Buyer"), for the Company&#x2019;s headquarters and manufacturing facilities (the "Property") located in Statesville, North Carolina (the "Sale Agreement") in exchange for $30,275,000 in sales proceeds, $14,864,000 of which was payable in redeemable preferred shares in CAI Investments Medical Products I Parent, LLC ("Parent"), an affiliate of Buyer. At April 30, 2022, the carrying value of the redeemable preferred shares was $13.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sale Agreement was finalized on March 24, 2022 and coincided with a 20-year lease, effective on such date between the Company and CAI Investments Medical Products I Master Lessee LLC ("Lessor"), an affiliate of Buyer, for the Property (the "Lease Agreement"). At the same time, the Buyer and its affiliates formed a new, debt-financed affiliate CAI Investments Medical Products I, DST ("Trust") and contributed the Property to the Trust. According to the terms of the lease, the Trust leased the Property to its affiliated Lessor, which in turn sub-leased the Property to the Company (together with the Sale Agreement, the "Sale-Leaseback Arrangement"). For additional information on the accounting for the Sale-Leaseback Arrangement, refer to &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i1de8d1053c4044f7aa1eb1bfb086781f_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 5&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale-Leaseback Financing Transaction&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company concluded as of April 30, 2022 that Parent and its direct affiliates, including the Trust, are designed primarily to acquire and manage the Property and constitute a variable interest entity because the Trust lacks sufficient equity on its own to finance its operations. The Company evaluated its lease arrangement and redeemable preferred shares in Parent as variable interests. Based on its evaluation, the Company concluded it should not consolidate Parent or its affiliates under the variable interest model or the voting interest model of ASC 810, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded the redeemable preferred shares as a Note Receivable, classified as held to maturity at amortized cost, on its Consolidated Balance Sheet, rather than as an investment in preferred equity, due to the mandatory redemption feature of the preferred shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 22, 2022, the Company had fully redeemed all shares and converted the Note Receivable to cash. The Company's maximum exposure to the Buyer and its affiliates as of April 30, 2023 was limited to the Company&#x2019;s lease payments and right to use the Property. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; A financial instrument is defined as cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company's financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, a note receivable and corresponding sale-leaseback financing liability, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Expanded disclosures about instruments measured at fair value require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#160;&#160;&#160;&#160;Quoted prices in active markets for identical assets or liabilities as of the reporting date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#160;&#160;&#160;&#160;Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company's fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring and nonrecurring basis as of April&#160;30, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities held in non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities held in non-qualified compensation plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt"&gt;The Company maintains two non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt"&gt;Plan liabilities are equal to the individual participants' account balances and other earned retirement benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company recognizes revenue when control of a good or service promised in a contract (i.e., &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. Sales taxes that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Certain customers' cash discounts and volume rebates are offered as sales incentives. The discounts and volume rebates are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and contractual obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue consists of customer deposits and advance billings of the Company's products where sales have not yet been recognized. Accounts receivable includes retainage in the amounts of $235,000 and $523,000 at April&#160;30, 2023 and 2022, respectively. Shipping and handling costs are included in cost of product sales. Because of the nature and quality of the Company's products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company's consolidated financial position and results of operations and are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit Concentration &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs credit evaluations of its customers. Revenues from three of the Company's domestic dealers represented in the aggregate approximately 36% and 38% of the Company's sales in fiscal years 2023 and 2022, respectively. Accounts receivable for two domestic customers represented approximately 23% and 21% of the Company's total accounts receivable as of April&#160;30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Insurance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company maintains a self-insured health-care program. The Company accrues estimated losses for claims incurred but not reported using assumptions based on historical loss experience. The Company has also purchased specific stop-loss insurance to limit claims above a certain amount. The Company adjusts insurance reserves, as needed, in the event that future loss experience differs from historical loss patterns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In accordance with ASC 740, "Income Taxes" ("ASC 740"), the Company uses the liability method in measuring the provision for income taxes and recognizing deferred income tax assets and liabilities on the consolidated balance sheets. ASC&#160;740 clarifies the financial statement recognition threshold and measurement attribute of a tax position taken or expected to be taken in a tax return. Under ASC 740, the Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC&#160;740 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The Company did not have any significant uncertain tax positions at April&#160;30, 2023 or 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Experimentation Expenditures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Research and experimentation expenditures are charged to cost of products sold in the periods incurred. Expenditures for research and experimentation expenditures were $1,012,000 and $990,000 for the fiscal years ended April&#160;30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Advertising costs are expensed as incurred, and include trade shows, training materials, sales, samples, and other related expenses and are included in operating expenses. Advertising costs for the years ended April&#160;30, 2023 and 2022 were $226,000 and $175,000, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The financial statements of subsidiaries located in India and China are measured using the local currency as the functional currency. Effective May 1, 2022, Kewaunee Scientific Corporation Singapore Pte. Ltd. transitioned to using the U.S. dollar as its functional currency. The financial position and operating results of Kewaunee Labway Asia Pte. Ltd. are also measured using the U.S. dollar as its functional currency. Assets and liabilities of the Company's foreign subsidiaries using local currencies are translated into United&#160;States dollars at fiscal year-end exchange rates. Sales, expenses, and cash flows are translated at weighted average exchange rates for each period. Net translation gains or losses are included in other comprehensive income, a separate component of stockholders' equity. Gains and losses from foreign currency transactions of these subsidiaries are included in operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Basic earnings per share is based on the weighted average number of common shares outstanding during the year. Diluted earnings per share reflects the assumed exercise of outstanding stock options and the conversion of restricted stock units ("RSUs") under the Company's various stock compensation plans, except when RSUs and stock options have an antidilutive effect. There were 33,900 antidilutive RSUs and stock options outstanding at April&#160;30, 2023. There were 44,750 antidilutive RSUs and stock options outstanding at April&#160;30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic to diluted weighted average common shares outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,824&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,902&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting for Stock Options and Other Equity Awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, "Compensation&#x2014;Stock Compensation." Forfeitures are accounted for in the period in which the awards are forfeited. The Company granted 87,969 RSUs under the 2017 Omnibus Incentive Plan in fiscal year 2023 and 67,750 RSUs in fiscal year 2022. There were no stock options granted during fiscal years 2023 and 2022. (See &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i1de8d1053c4044f7aa1eb1bfb086781f_112" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note&#160;7&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options and Share-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments," which replaces the current incurred loss method used for determining credit losses on financial assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December&#160;15, 2022. The Company will adopt this standard in fiscal year 2024. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued&#160;ASU No. 2019-12,&#160;"Income Taxes ("Topic 740"): Simplifying the Accounting for Income Taxes." This update simplifies the accounting for income taxes through certain targeted improvements to various subtopics within Topic 740. The amendments in this update are effective for fiscal years and interim periods beginning after December 15, 2020. The Company adopted this standard effective May 1, 2021. The adoption of this standard did not have a significant impact on the Company's consolidated financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-259">Principles of Consolidation The Company's consolidated financial statements include the accounts of Kewaunee Scientific Corporation and its international subsidiaries. A brief description of each subsidiary, along with the amount of the Company's controlling financial interests, as of April&#160;30, 2023 is as follows: (1) Kewaunee Labway Asia Pte. Ltd., a commercial sales organization for the Company's products in Singapore, is 100% owned by the Company; (2) Kewaunee Scientific Corporation Singapore Pte. Ltd., a holding company in Singapore, is 100% owned by the Company; (3) Kewaunee Labway India Pvt. Ltd., a design, installation, manufacturing, assembly and commercial sales operation for the Company's products in Bangalore, India, is 95% owned by the Company; (4) Koncepo Scientech International Pvt. Ltd., a laboratory design and strategic advisory and construction management services firm, located in Bangalore, India, is 80% owned by the Company; (5) Kequip Global Lab Solutions Pvt. Ltd. is 70% owned by Kewaunee Scientific Corporation Singapore Pte. Ltd. All intercompany balances, transactions, and profits have been eliminated.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i4d12676382c14aefb358f5cf0f5ca1e0_I20230430"
      decimals="INF"
      id="f-260"
      unitRef="number">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="idb5014da29064620a8625170da6db109_I20230430"
      decimals="INF"
      id="f-261"
      unitRef="number">1</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i035c81617bd64b739231dde89d9e390b_I20230430"
      decimals="INF"
      id="f-262"
      unitRef="number">0.95</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i42a4784036154c0598d9e7d078cc620b_I20230430"
      decimals="INF"
      id="f-263"
      unitRef="number">0.80</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i96f00904ca244286a10a749a0fce2507_I20230430"
      decimals="INF"
      id="f-264"
      unitRef="number">0.70</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:AssetsNet
      contextRef="ief738c90b80a46dcae563091eb90527b_I20230430"
      decimals="-3"
      id="f-265"
      unitRef="usd">16786000</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="i7a204790b1a14821b1916e1824956a58_I20220430"
      decimals="-3"
      id="f-266"
      unitRef="usd">13127000</us-gaap:AssetsNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430"
      decimals="-3"
      id="f-267"
      unitRef="usd">72778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430"
      decimals="-3"
      id="f-268"
      unitRef="usd">42024000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-269">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash and cash equivalents consist of cash on hand and highly liquid investments with original maturities of three months or less. During the years ended April&#160;30, 2023 and 2022, the Company had cash deposits in excess of FDIC insured limits. The Company has not experienced any losses from such deposits.&lt;/span&gt;The Company includes restricted cash along with the cash balance for presentation in the consolidated statements of cash flows.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <kequ:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-270">The reconciliation between the consolidated balance sheet and the consolidated statement of cash flows at April 30 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.689%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.560%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.918%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.851%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.919%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,737&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</kequ:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-271"
      unitRef="usd">8078000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-272"
      unitRef="usd">4433000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-273"
      unitRef="usd">5737000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-274"
      unitRef="usd">2461000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-275"
      unitRef="usd">13815000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-276"
      unitRef="usd">6894000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-277">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Restricted cash includes bank deposits of subsidiaries used for performance guarantees against customer orders.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-278">Accounts Receivable and Allowance for Doubtful Accounts Receivables are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts. The Company evaluates the collectability of its trade accounts receivable based on a number of factors. In circumstances where management is aware of a customer's inability to meet its financial obligations to the Company, or a project dispute makes it unlikely that all of the receivable owed by a customer will be collected, a specific reserve for bad debts is estimated and recorded to reduce the recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer identification of potential bad debts, a reserve for bad debts is estimated and recorded based on past loss history and an overall assessment of past due trade accounts receivable amounts outstanding. Accounts are written off when it is clearly established that the receivable&#160;is a bad debt. Recoveries of receivables previously written off are recorded when received.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <kequ:ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-279">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity in the allowance for doubtful accounts for each of the years ended April&#160;30 was:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.227%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.005%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.008%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;357&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debt provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Doubtful accounts written off (net)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;476&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</kequ:ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-280"
      unitRef="usd">357000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430"
      decimals="-3"
      id="f-281"
      unitRef="usd">636000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-282"
      unitRef="usd">120000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-283"
      unitRef="usd">92000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-284"
      unitRef="usd">1000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-285"
      unitRef="usd">371000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-286"
      unitRef="usd">476000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-287"
      unitRef="usd">357000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-288">Unbilled Receivables Accounts receivable include unbilled receivables that represent amounts earned which have not yet been billed in accordance with contractually stated billing terms, excluding retention, which is included in other assets.</us-gaap:TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-289"
      unitRef="usd">13459000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-290"
      unitRef="usd">9287000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-291">Inventories The Company's inventories are valued at the lower of cost or net realizable value under the first-in, first-out ("FIFO") method.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-292">Property, Plant and Equipment Property, plant and equipment are stated at cost less accumulated depreciation. Depreciation is determined for financial reporting purposes principally on the straight-line method over the estimated useful lives of the individual assets or, for leaseholds, over the terms of the related leases, if shorter.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-293">Property, plant and equipment consisted of the following at April&#160;30:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.209%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Useful Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,147&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10-40&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44,180&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5-10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;61,368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(44,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,402&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i90242fcce5d84297ba58ac37f58d01eb_I20230430"
      decimals="-3"
      id="f-294"
      unitRef="usd">41000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id2c67af89acc4cceb16bae291f0b924f_I20220430"
      decimals="-3"
      id="f-295"
      unitRef="usd">41000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6e8f56e78063401992e2639148b52a7c_I20230430"
      decimals="-3"
      id="f-296"
      unitRef="usd">17147000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia1e6cacd2bfe41289beb4377632e046c_I20220430"
      decimals="-3"
      id="f-297"
      unitRef="usd">17164000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i57303180faa04cc888c13c4f5bcf55a0_D20210501-20220430"
      id="f-298">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ieb6a852f1dc64a4c8ae4e54a59cf843c_D20220501-20230430"
      id="f-299">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8dd046eeca6c43a49013acada8280e5c_D20210501-20220430"
      id="f-300">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iadc7ed37eabf46289e1b3ede5bfd6780_D20220501-20230430"
      id="f-301">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3b6a962e78384b8cbbb043ce06b35ea2_I20230430"
      decimals="-3"
      id="f-302"
      unitRef="usd">44180000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0e8b0570b6534fad8da8843f53a91fcb_I20220430"
      decimals="-3"
      id="f-303"
      unitRef="usd">43121000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i83a554db45cd44afb12954d7dbcb3262_D20220501-20230430"
      id="f-304">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3defb6f321ab4a0ba12e8290a4c594fa_D20210501-20220430"
      id="f-305">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iadd284a39a98417ea0c4e5f5d3eed853_D20210501-20220430"
      id="f-306">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie12e2507d8404c55843b1ee785732570_D20220501-20230430"
      id="f-307">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-308"
      unitRef="usd">61368000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-309"
      unitRef="usd">60326000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-310"
      unitRef="usd">44966000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-311"
      unitRef="usd">45205000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-312"
      unitRef="usd">16402000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-313"
      unitRef="usd">15121000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentImpairment
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-314">The Company reviews the carrying value of property, plant and equipment for impairment annually or whenever changes in circumstances or events indicate that such carrying value may not be recoverable. If projected undiscounted cash flows are not sufficient to recover the carrying value of the potentially impaired asset, the carrying value is reduced to estimated fair value.</us-gaap:PropertyPlantAndEquipmentImpairment>
    <us-gaap:AssetImpairmentCharges
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-315"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="INF"
      id="f-316"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <kequ:OtherAssetsPolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-317">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other assets at April&#160;30, 2023 and 2022 included $1,191,000 and $1,293,000, respectively, of unbilled retainage, $2,352,000 and $2,480,000, respectively, of assets held in a trust account for non-qualified benefit plan, and $111,000 and $110,000, respectively, of cash surrender values of life insurance policies. Life insurance policies are recorded at the amount that could be realized under the insurance contract as of the date of the Company's consolidated balance sheets with the change in cash surrender or contract value being recorded as income or expense during each period.&lt;/span&gt;</kequ:OtherAssetsPolicyTextBlock>
    <kequ:UnbilledRetainageCurrent
      contextRef="i1252e42ba8f94788b9c2e9526358c016_I20230430"
      decimals="-3"
      id="f-318"
      unitRef="usd">1191000</kequ:UnbilledRetainageCurrent>
    <kequ:UnbilledRetainageCurrent
      contextRef="i31ecee99cb564fb4853c3bcd51ee186d_I20220430"
      decimals="-3"
      id="f-319"
      unitRef="usd">1293000</kequ:UnbilledRetainageCurrent>
    <us-gaap:AssetsHeldInTrust
      contextRef="ic6b14126cfd04589a48a1267cb447516_I20230430"
      decimals="-3"
      id="f-320"
      unitRef="usd">2352000</us-gaap:AssetsHeldInTrust>
    <us-gaap:AssetsHeldInTrust
      contextRef="i18837955ad44418ebb8430792c895f28_I20220430"
      decimals="-3"
      id="f-321"
      unitRef="usd">2480000</us-gaap:AssetsHeldInTrust>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="ic6b14126cfd04589a48a1267cb447516_I20230430"
      decimals="-3"
      id="f-322"
      unitRef="usd">111000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:CashSurrenderValueOfLifeInsurance
      contextRef="i18837955ad44418ebb8430792c895f28_I20220430"
      decimals="-3"
      id="f-323"
      unitRef="usd">110000</us-gaap:CashSurrenderValueOfLifeInsurance>
    <us-gaap:UseOfEstimates
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-324">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The presentation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from these estimates. Significant estimates impacting the accompanying consolidated financial statements include the allowance for uncollectible accounts receivable, self-insurance reserves, income taxes, and pension liabilities.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i86c6fb5e15db485f849df283bb68dec9_D20211222-20211222"
      decimals="-3"
      id="f-325"
      unitRef="usd">30275000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationReceived1
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-326"
      unitRef="usd">14864000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationReceived1>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-5"
      id="f-327"
      unitRef="usd">13500000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <kequ:FinancingLiabilityTermOfContract
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      id="f-328">P20Y</kequ:FinancingLiabilityTermOfContract>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-329">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company concluded as of April 30, 2022 that Parent and its direct affiliates, including the Trust, are designed primarily to acquire and manage the Property and constitute a variable interest entity because the Trust lacks sufficient equity on its own to finance its operations. The Company evaluated its lease arrangement and redeemable preferred shares in Parent as variable interests. Based on its evaluation, the Company concluded it should not consolidate Parent or its affiliates under the variable interest model or the voting interest model of ASC 810, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded the redeemable preferred shares as a Note Receivable, classified as held to maturity at amortized cost, on its Consolidated Balance Sheet, rather than as an investment in preferred equity, due to the mandatory redemption feature of the preferred shares.&lt;/span&gt;&lt;/div&gt;As of June 22, 2022, the Company had fully redeemed all shares and converted the Note Receivable to cash. The Company's maximum exposure to the Buyer and its affiliates as of April 30, 2023 was limited to the Company&#x2019;s lease payments and right to use the Property.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-330">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; A financial instrument is defined as cash equivalents, evidence of an ownership interest in an entity, or a contract that creates a contractual obligation or right to deliver or receive cash or another financial instrument from another party. The Company's financial instruments consist primarily of cash and equivalents, mutual funds, cash surrender value of life insurance policies, a note receivable and corresponding sale-leaseback financing liability, term loans and short-term borrowings. The carrying value of these assets and liabilities approximate their fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Expanded disclosures about instruments measured at fair value require the Company to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#160;&#160;&#160;&#160;Quoted prices in active markets for identical assets or liabilities as of the reporting date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#160;&#160;&#160;&#160;Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities as of the reporting date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:67.5pt;text-align:justify;text-indent:-49.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#160;&#160;&#160;&#160;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-331">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company's fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring and nonrecurring basis as of April&#160;30, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities held in non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,105&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,358&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities held in non-qualified compensation plans&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-qualified compensation plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt"&gt;The Company maintains two non-qualified compensation plans which include investment assets in a rabbi trust. These assets consist of marketable securities, which are valued using quoted market prices multiplied by the number of shares owned, and life insurance policies, which are valued at their cash surrender value.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:16.52pt"&gt;Plan liabilities are equal to the individual participants' account balances and other earned retirement benefits.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:DerivativeAssets
      contextRef="idbabd4cac86145e9800da3c3c2fc57ed_I20230430"
      decimals="-3"
      id="f-332"
      unitRef="usd">1105000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i3433d8e1e195426ea3058452dac64693_I20230430"
      decimals="-3"
      id="f-333"
      unitRef="usd">1105000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iba363eb7d56e476996da5c8c0716bbf4_I20230430"
      decimals="-3"
      id="f-334"
      unitRef="usd">1358000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia33e90d485ca4a4fbfa0aaa236176d1d_I20230430"
      decimals="-3"
      id="f-335"
      unitRef="usd">1358000</us-gaap:DerivativeAssets>
    <kequ:DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-336">Total</kequ:DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag>
    <us-gaap:DerivativeAssets
      contextRef="i234054f8708d43f4811f8f93244fe91c_I20230430"
      decimals="-3"
      id="f-337"
      unitRef="usd">1105000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i251e9520bea74e6991781ef0e97f7a97_I20230430"
      decimals="-3"
      id="f-338"
      unitRef="usd">1358000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-339"
      unitRef="usd">2463000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="i24354820914d4aee9f7707f52e56f2ff_I20230430"
      decimals="-3"
      id="f-340"
      unitRef="usd">2910000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i99d113f3a4a845649deeb8980f67ebc1_I20230430"
      decimals="-3"
      id="f-341"
      unitRef="usd">2910000</us-gaap:DerivativeLiabilities>
    <kequ:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-342">Total</kequ:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag>
    <us-gaap:DerivativeLiabilities
      contextRef="i251e9520bea74e6991781ef0e97f7a97_I20230430"
      decimals="-3"
      id="f-343"
      unitRef="usd">2910000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-344"
      unitRef="usd">2910000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets
      contextRef="ib1a86d35001449868ca80f5a24ebfdbd_I20220430"
      decimals="-3"
      id="f-345"
      unitRef="usd">1219000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0adeca8c17f64dfeb440b21d5c2d6c40_I20220430"
      decimals="-3"
      id="f-346"
      unitRef="usd">1219000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie91fc5afe2074e3683df40b73a01966b_I20220430"
      decimals="-3"
      id="f-347"
      unitRef="usd">1371000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="if70f929642694c0ca07d208b0d16e645_I20220430"
      decimals="-3"
      id="f-348"
      unitRef="usd">1371000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie732b5f45f464e6ca8f0b1fb3c13d76a_I20220430"
      decimals="-3"
      id="f-349"
      unitRef="usd">1219000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id38d9bc0dc4a4764ba3d1d2f6e881e3a_I20220430"
      decimals="-3"
      id="f-350"
      unitRef="usd">1371000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-351"
      unitRef="usd">2590000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="iaf90038df3a74e6d8e1591581aa2c4dd_I20220430"
      decimals="-3"
      id="f-352"
      unitRef="usd">3003000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2592da14edd14d3a9802f6465c8990d2_I20220430"
      decimals="-3"
      id="f-353"
      unitRef="usd">3003000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id38d9bc0dc4a4764ba3d1d2f6e881e3a_I20220430"
      decimals="-3"
      id="f-354"
      unitRef="usd">3003000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-355"
      unitRef="usd">3003000</us-gaap:DerivativeLiabilities>
    <kequ:NumberOfNonqualifiedCompensationPlans
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="INF"
      id="f-356"
      unitRef="compensation_plan">2</kequ:NumberOfNonqualifiedCompensationPlans>
    <kequ:NumberOfNonqualifiedCompensationPlans
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="INF"
      id="f-357"
      unitRef="compensation_plan">2</kequ:NumberOfNonqualifiedCompensationPlans>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-358">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products. The Company recognizes revenue when control of a good or service promised in a contract (i.e., &lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract. Sales taxes that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Certain customers' cash discounts and volume rebates are offered as sales incentives. The discounts and volume rebates are recorded as a reduction in sales at the time revenue is recognized in an amount estimated based on historical experience and contractual obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue consists of customer deposits and advance billings of the Company's products where sales have not yet been recognized. Accounts receivable includes retainage in the amounts of $235,000 and $523,000 at April&#160;30, 2023 and 2022, respectively. Shipping and handling costs are included in cost of product sales. Because of the nature and quality of the Company's products, any warranty issues are determined in a relatively short period after the sale and are infrequent in nature, and as such, warranty costs are immaterial to the Company's consolidated financial position and results of operations and are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ConstructionContractorReceivableRetainage
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-359"
      unitRef="usd">235000</us-gaap:ConstructionContractorReceivableRetainage>
    <us-gaap:ConstructionContractorReceivableRetainage
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-360"
      unitRef="usd">523000</us-gaap:ConstructionContractorReceivableRetainage>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-361">Credit Concentration The Company performs credit evaluations of its customers.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0ffefcfa990f4dd792c6f71caefc049c_D20220501-20230430"
      decimals="2"
      id="f-362"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i55120ad7d22e4ad3a0aff429b22a6b6b_D20210501-20220430"
      decimals="2"
      id="f-363"
      unitRef="number">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1396e4dd472c434789f1f0126457631e_D20220501-20230430"
      decimals="2"
      id="f-364"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8e80065eb8da4baab97a3125ae4f02ba_D20210501-20220430"
      decimals="2"
      id="f-365"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SelfInsuranceReservePolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-366">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Insurance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company maintains a self-insured health-care program. The Company accrues estimated losses for claims incurred but not reported using assumptions based on historical loss experience. The Company has also purchased specific stop-loss insurance to limit claims above a certain amount. The Company adjusts insurance reserves, as needed, in the event that future loss experience differs from historical loss patterns.&lt;/span&gt;</us-gaap:SelfInsuranceReservePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-367">Income Taxes In accordance with ASC 740, "Income Taxes" ("ASC 740"), the Company uses the liability method in measuring the provision for income taxes and recognizing deferred income tax assets and liabilities on the consolidated balance sheets. ASC&#160;740 clarifies the financial statement recognition threshold and measurement attribute of a tax position taken or expected to be taken in a tax return. Under ASC 740, the Company applies a more-likely-than-not recognition threshold for all tax uncertainties. ASC&#160;740 only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the taxing authorities. The Company did not have any significant uncertain tax positions at April&#160;30, 2023 or 2022.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-368">Research and Experimentation Expenditures Research and experimentation expenditures are charged to cost of products sold in the periods incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-369"
      unitRef="usd">1012000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-370"
      unitRef="usd">990000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-371">Advertising Costs Advertising costs are expensed as incurred, and include trade shows, training materials, sales, samples, and other related expenses and are included in operating expenses.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-372"
      unitRef="usd">226000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-373"
      unitRef="usd">175000</us-gaap:AdvertisingExpense>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-374">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The financial statements of subsidiaries located in India and China are measured using the local currency as the functional currency. Effective May 1, 2022, Kewaunee Scientific Corporation Singapore Pte. Ltd. transitioned to using the U.S. dollar as its functional currency. The financial position and operating results of Kewaunee Labway Asia Pte. Ltd. are also measured using the U.S. dollar as its functional currency. Assets and liabilities of the Company's foreign subsidiaries using local currencies are translated into United&#160;States dollars at fiscal year-end exchange rates. Sales, expenses, and cash flows are translated at weighted average exchange rates for each period. Net translation gains or losses are included in other comprehensive income, a separate component of stockholders' equity. Gains and losses from foreign currency transactions of these subsidiaries are included in operating expenses.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-375">Earnings Per Share Basic earnings per share is based on the weighted average number of common shares outstanding during the year. Diluted earnings per share reflects the assumed exercise of outstanding stock options and the conversion of restricted stock units ("RSUs") under the Company's various stock compensation plans, except when RSUs and stock options have an antidilutive effect.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-376"
      unitRef="shares">33900</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="INF"
      id="f-377"
      unitRef="shares">44750</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-378">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic to diluted weighted average common shares outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.994%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,824&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&#x2014;diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,902&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-379"
      unitRef="shares">2824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-380"
      unitRef="shares">2786000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-381"
      unitRef="shares">78000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-382"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-383"
      unitRef="shares">2902000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-384"
      unitRef="shares">2786000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-385">Accounting for Stock Options and Other Equity Awards Compensation costs related to stock options and other stock awards granted by the Company are charged against operating expenses during their vesting period, under ASC 718, "Compensation&#x2014;Stock Compensation." Forfeitures are accounted for in the period in which the awards are forfeited.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430"
      decimals="INF"
      id="f-386"
      unitRef="shares">87969</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430"
      decimals="INF"
      id="f-387"
      unitRef="shares">67750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="INF"
      id="f-388"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-389"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-390">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;New Accounting Standards &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments," which replaces the current incurred loss method used for determining credit losses on financial assets, including trade receivables, with an expected credit loss method. This guidance is effective for fiscal years, and interim periods within those years, beginning after December&#160;15, 2022. The Company will adopt this standard in fiscal year 2024. The Company does not expect the adoption of this standard to have a significant impact on the Company's consolidated financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued&#160;ASU No. 2019-12,&#160;"Income Taxes ("Topic 740"): Simplifying the Accounting for Income Taxes." This update simplifies the accounting for income taxes through certain targeted improvements to various subtopics within Topic 740. The amendments in this update are effective for fiscal years and interim periods beginning after December 15, 2020. The Company adopted this standard effective May 1, 2021. The adoption of this standard did not have a significant impact on the Company's consolidated financial position or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-391">Revenue Recognition&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a distinct good or service or bundle of goods and services that is distinct or a series of distinct goods or services that are substantially the same and have the same pattern of transfer. The Company identifies performance obligations at the inception of a contract and allocates the transaction price to individual performance obligations to reasonably reflect the Company's performance in transferring control of the promised goods or services to the customer. The Company has elected to treat shipping and handling as a fulfillment activity instead of a separate performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the primary performance obligations identified by the Company:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Laboratory Furniture&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company principally generates revenue from the manufacture of custom laboratory, healthcare, and technical furniture and infrastructure products (herein referred to as "laboratory furniture"). The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. Customers can benefit from each piece of laboratory furniture on its own or with resources readily available in the market place such as separately purchased installation services. Each piece of laboratory furniture does not significantly modify or customize other laboratory furniture, and the pieces of laboratory furniture are not highly interdependent or interrelated with each other. The Company can, and frequently does, break portions of contracts into separate "runs" to meet manufacturing and construction schedules. As such, each piece of laboratory furniture is considered a separate and distinct performance obligation. The majority of the Company's products are customized to meet the specific architectural design and performance requirements of laboratory planners and end users. The finished laboratory furniture has no alternative use to the Company and the Company has an enforceable right to payment for performance completed to date. As such, revenue from the sales of customized laboratory furniture is recognized over time once the customization process has begun, using the units-of-production output method to measure progress towards completion. There is not a material amount of work-in-process for which the customization process has begun at the end of a reporting period. The Company believes this output method most reasonably reflects the Company's performance because it directly measures the value of the goods transferred to the customer. For standardized products sold by the Company, revenue is recognized when control transfers, which is typically freight on board ("FOB") shipping point.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All orders contain a standard warranty that warrants that the product is free from defects in workmanship and materials under normal use and conditions for a limited period of time. Due to the nature and quality of the Company's products, any warranty issues have historically been determined in a relatively short period after the sale, have been infrequent in nature, and have been immaterial to the Company's financial position and results of operations. The Company's standard warranties are not considered a separate and distinct performance obligation as the Company does not provide a service to customers beyond assurance that the covered product is free of initial defects. Costs of providing these short term assurance warranties are immaterial and, accordingly, are expensed as incurred. Extended separately priced warranties are available which can last up to ten years. Extended warranties are considered separate performance obligations as they are individually priced options providing assurances that the products are free of defects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Installation Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sometimes performs installation services for customers. The scope of installation services primarily relates to setting up and ensuring the proper functioning of the laboratory furniture. In certain markets, the Company may provide a broader range of installation services involving the design and installation of the laboratory's mechanical services. Installation services can be, and often are, performed by third parties and thus may be distinct from the Company's products. Installation services create or enhance assets that the customer controls as the installation services are provided. As such, revenue from installation services is recognized over time, as the installation services are performed using the cost input method, as there is a direct relationship between the Company's inputs and the transfer of control by means of the performance of installation services to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Custodial Services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is common in the laboratory and healthcare furniture industries for customers to request delivery at specific future dates, as products are often to be installed in buildings yet to be constructed. Frequently, customers will request the manufacture of these products prior to the customer's ability or readiness to receive the product due to various reasons such as changes to or delays in the construction of the building. As such, from time to time Kewaunee's customers require us to provide custodial services for their laboratory furniture. Custodial services are frequently provided by third parties and do not significantly alter the other goods or services covered by the contract and as such are considered a separate and distinct performance obligation. Custodial services are simultaneously received and consumed by the customer and as such revenue from custodial services is recognized over time using a straight-line time-based measure of progress towards completion, because the Company's services are provided evenly throughout the performance period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Payment Terms and Transaction Prices&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's contracts with customers are generally fixed-price and do not contain variable consideration or a general right of return or refund. The Company's contracts with customers contain terms typical for Kewaunee's industry, including withholding a portion of the transaction price until after the goods or services have been transferred to the customer (i.e. "retainage"). The Company does not recognize this as a significant financing component because the primary purpose of retainage is to provide the customer with assurance that the Company will perform its obligations under the contract, rather than to provide financing to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Allocation of Transaction Price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's contracts with customers&#160;may cover multiple goods and services, such as differing types of laboratory furniture and installation services. For these arrangements, each good or service is evaluated to determine whether it represents a distinct performance obligation. The total transaction price is then allocated to the distinct performance obligations based on their relative standalone selling price at the inception of the arrangement. If available, the Company utilizes observable prices for goods or services sold separately to similar customers in similar circumstances to determine its relative standalone selling price. Otherwise, list prices are used if they are determined to be representative of standalone selling prices. If neither of these methods are available at contract inception, such as when the Company does not sell the product or service separately, judgment may be required and the Company determines the standalone selling price using one, or a combination of, the adjusted market assessment or expected cost-plus margin approaches.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Practical Expedients Used&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected the following practical expedients:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The portfolio approach was applied in evaluating the accounting for the cost of obtaining a contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Payment terms with the Company's customers which are one year or less are not considered a significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company excludes from revenues taxes it collects from customers that are assessed by a government authority. This is primarily relevant to domestic sales but also includes taxes on some international sales which are also excluded from the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company's incremental cost to obtain a contract is limited to sales commissions. The Company applies the practical expedient to expense commissions as incurred for contracts having a duration of one year or less. Sales commissions related to contracts with a duration of greater than one year are immaterial to the Company's consolidated financial position and results of operations and are also expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregated Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of net sales transferred to customers at a point in time and over time for the twelve months ended April 30 is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.080%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Point in Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.260%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Point in Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The closing balances of contract assets included $13,459,000 in accounts receivable and $1,191,000 in other current assets at April&#160;30, 2023. The opening balance of contract assets arising from contracts with customers included $9,287,000 in accounts receivable and $1,293,000 in other assets at April&#160;30, 2022. The closing and opening balances of contract liabilities included in deferred revenue arising from contracts with customers were $4,097,000 at April&#160;30, 2023 and $3,529,000 at April&#160;30, 2022. The timing of revenue recognition, billings and cash collections results in accounts receivable, unbilled receivables, and deferred &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;revenue which is disclosed on the consolidated balance sheets and in the notes to the consolidated financial statements. In general, the Company receives payments from customers based on a billing schedule established in its contracts. Unbilled receivables represent amounts earned which have not yet been billed in accordance with contractually stated billing terms. Accounts receivable are recorded when the right to consideration becomes unconditional and the Company has a right to invoice the customer. Deferred revenue relates to payments received in advance of performance under the contract. Deferred revenue is recognized as revenue as the Company performs under the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal year ended April&#160;30, 2023, changes in contract assets and liabilities were not materially impacted by any other factors. Approximately 100% of the contract liability balance at April&#160;30, 2023 is expected to be recognized as revenue during fiscal year 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-392">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of net sales transferred to customers at a point in time and over time for the twelve months ended April 30 is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.080%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Point in Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.798%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.260%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Over Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Point in Time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67f1ba03114040909ce8cdfc2a78ea6d_D20220501-20230430"
      decimals="-3"
      id="f-393"
      unitRef="usd">141994000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6751dceadb374681b0c6d52cd75ece45_D20220501-20230430"
      decimals="-3"
      id="f-394"
      unitRef="usd">72778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a8537ecb2f1436aaeb85e43dc13d546_D20220501-20230430"
      decimals="-3"
      id="f-395"
      unitRef="usd">214772000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76d8faf2554a4789a61384dd2757d22e_D20220501-20230430"
      decimals="-3"
      id="f-396"
      unitRef="usd">4722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b8a41ff0b9c49e69f759968f6dd33fb_D20220501-20230430"
      decimals="-3"
      id="f-397"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic868b6191e614d7d9d37a313030673f7_D20220501-20230430"
      decimals="-3"
      id="f-398"
      unitRef="usd">4722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64432110caef45faafd30217f99ab7e5_D20220501-20230430"
      decimals="-3"
      id="f-399"
      unitRef="usd">146716000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29c25bca73914a2e8b0740a217a19a70_D20220501-20230430"
      decimals="-3"
      id="f-400"
      unitRef="usd">72778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-401"
      unitRef="usd">219494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb71661af8d5440999566d760f9a4987_D20210501-20220430"
      decimals="-3"
      id="f-402"
      unitRef="usd">119989000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4523e07e76d34e0986ee2172ffc114c8_D20210501-20220430"
      decimals="-3"
      id="f-403"
      unitRef="usd">42024000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic72bb0d6c18f493c8331dbd53a1be173_D20210501-20220430"
      decimals="-3"
      id="f-404"
      unitRef="usd">162013000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7066198457634c5c84c33711657d5762_D20210501-20220430"
      decimals="-3"
      id="f-405"
      unitRef="usd">6859000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if62c92cef71f4d728c84fa5dbdb324b6_D20210501-20220430"
      decimals="-3"
      id="f-406"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0d0017306a14071a889803879b2857a_D20210501-20220430"
      decimals="-3"
      id="f-407"
      unitRef="usd">6859000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i158c57bc39694f63be232317e782c90e_D20210501-20220430"
      decimals="-3"
      id="f-408"
      unitRef="usd">126848000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12df3466c7ff493e867302751a24bada_D20210501-20220430"
      decimals="-3"
      id="f-409"
      unitRef="usd">42024000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-410"
      unitRef="usd">168872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-411"
      unitRef="usd">13459000</us-gaap:ContractWithCustomerAssetNet>
    <kequ:UnbilledRetainageCurrent
      contextRef="i1252e42ba8f94788b9c2e9526358c016_I20230430"
      decimals="-3"
      id="f-412"
      unitRef="usd">1191000</kequ:UnbilledRetainageCurrent>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-413"
      unitRef="usd">9287000</us-gaap:ContractWithCustomerAssetNet>
    <kequ:UnbilledRetainageCurrent
      contextRef="i31ecee99cb564fb4853c3bcd51ee186d_I20220430"
      decimals="-3"
      id="f-414"
      unitRef="usd">1293000</kequ:UnbilledRetainageCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-415"
      unitRef="usd">4097000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-416"
      unitRef="usd">3529000</us-gaap:ContractWithCustomerLiability>
    <kequ:ContractWithCustomerLiabilityRevenueRecognizedPercentage
      contextRef="i6a02acdd018f43b8b0f5cc560820651a_D20220501-20230430"
      decimals="INF"
      id="f-417"
      unitRef="number">1</kequ:ContractWithCustomerLiabilityRevenueRecognizedPercentage>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-418">Inventories&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following at April&#160;30:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.557%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,380&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials and components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,097&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;At April&#160;30, 2023 and 2022, the Company's international subsidiaries' inventories were $2,740,000 and $2,811,000, respectively, measured using the lower of cost or net realizable value under the FIFO method and are included in the above tables.</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-419">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following at April&#160;30:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.557%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.483%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.535%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,380&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Materials and components&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,097&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-420"
      unitRef="usd">3412000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-421"
      unitRef="usd">4555000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-422"
      unitRef="usd">2380000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-423"
      unitRef="usd">2893000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-424"
      unitRef="usd">16097000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-425"
      unitRef="usd">16348000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-426"
      unitRef="usd">21889000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-427"
      unitRef="usd">23796000</us-gaap:InventoryNet>
    <us-gaap:FIFOInventoryAmount
      contextRef="ieb2d1acd7b3446289e9ad791d76db1de_I20230430"
      decimals="-3"
      id="f-428"
      unitRef="usd">2740000</us-gaap:FIFOInventoryAmount>
    <us-gaap:FIFOInventoryAmount
      contextRef="ia4ff3442856846399487d370b1773546_I20220430"
      decimals="-3"
      id="f-429"
      unitRef="usd">2811000</us-gaap:FIFOInventoryAmount>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-430">Long-term Debt and Other Credit Arrangements &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;6, 2013, the Company entered into a credit and security agreement (the "Loan Agreement") consisting of a $20 million revolving credit facility ("Line of Credit") with Wells Fargo, National Bank, which originally matured in May 2018 and was extended numerous times until it was terminated in June 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 19, 2019, the Company entered into a Security Agreement  with Wells Fargo, National Bank, pursuant to which the Company granted a security interest in substantially all of its assets to secure its obligations under the Loan Agreement. On December&#160;13, 2019, the Company entered into an amendment to the Loan Agreement and the Line of Credit to effect a change to an asset based lending arrangement based on eligible accounts receivable and inventory, with the available amount not to exceed $20 million through January&#160;31, 2020, and with such maximum amount reduced to $15 million thereafter. This amendment replaced the prior financial covenants with new financial covenants, including minimum monthly liquidity and EBITDA requirements. Additionally, a requirement for the repatriation of foreign cash and restrictions on the payment of dividends were added. The Security Agreement was amended several times during fiscal years 2022 and 2023 as the Company was finalizing the Sale-Leaseback financing transaction discussed in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i1de8d1053c4044f7aa1eb1bfb086781f_106" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note 5&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale-Leaseback Financing Transaction&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. These amendments were primarily driven by requirements and timing of the Company's new credit arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 27, 2022, the Company terminated the Credit Agreement with Wells Fargo, National Bank. At the time of termination, there were no borrowings under the Credit Agreement, and the Company did not incur any material termination penalties as a result of the termination. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At April&#160;30, 2022, there were advances of $1.6 million and $716,000 in letters of credit outstanding, leaving $2.4 million available under the Line of Credit. The borrowing rate under the Line of Credit at that date was 4.75%. Monthly interest payments under the Line of Credit were payable at the greater of the Daily One Month LIBOR interest rate, or 0.75%, plus 4.0%. At April&#160;30, 2022, the Company was in compliance with all the financial covenants under its revolving credit facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 19, 2022, the Company entered into a Credit and Security Agreement (the "Credit Agreement") with Mid Cap Funding IV Trust, as agent (the "Agent"), and the lenders from time to time party thereto (collectively, the "Lenders"). The Credit Agreement provides for a secured revolving line of credit initially up to $15.0&#160;million (the "Revolving Credit Facility"). Availability under the Revolving Credit Facility is subject to a borrowing base calculated in accordance with the terms of the Credit Agreement and on the basis of eligible accounts and inventory and certain other reserves and adjustments. Pursuant to the Credit Agreement, the Company granted to the Agent, for itself and the Lenders, a first priority security interest in all existing and future acquired assets owned by the Company. Subject to the terms of the Credit Agreement, from time to time the Company may request that the initial revolving loan amount available under the Revolving Credit Facility be increased with additional tranches in minimum amounts of $1,000,000, up to a maximum borrowing availability of $30.0&#160;million. The Agent and Lenders must consent to any such increase in their sole discretion. The Revolving Credit Facility matures on December 19, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as set forth in the Credit Agreement, borrowings under the Revolving Credit Facility bear interest at a rate equal to Term SOFR (Secured Overnight Financing Rate) plus 4.10%. The Company is required to make monthly interest payments on the Revolving Credit Facility, with the entire principal payment due at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At April&#160;30, 2023, there was $3,548,000 outstanding under the Revolving Credit Facility, with remaining borrowing capacity under the Revolving Credit Facility of $10,286,000. The borrowing rate under the Revolving Credit Facility was 9.02% as of April&#160;30, 2023. At April&#160;30, 2023, the Company was in compliance with all financial covenants under its revolving credit facility. In addition, the Company's International subsidiaries have a balance outstanding of $39,000 in short-term borrowings related to overdraft protection and short-term loan arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At April&#160;30, 2023, there were foreign bank guarantees outstanding to customers in the amounts of $5.2&#160;million, $142,000, $3,000, and $233,000 with expiration dates in fiscal years 2024, 2025, 2026, and 2027, respectively, collateralized by certain assets of the Company's subsidiaries in India. At April 30, 2022, there were bank guarantees issued by foreign banks outstanding to customers in the amounts of $8.2&#160;million, $111,000, $9,000, $3,000, and $249,000 with expiration dates in fiscal years 2023, 2024, 2025, 2026, and 2027, respectively, collateralized by a $6.0 million corporate guarantee and certain assets of the Company's subsidiaries in India.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6a43198092b94ea889724f8b5846813b_I20130506"
      decimals="INF"
      id="f-431"
      unitRef="usd">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <kequ:DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity
      contextRef="i6ffdef1e14f34eb8bad803398261c99d_I20191213"
      decimals="-6"
      id="f-432"
      unitRef="usd">20000000</kequ:DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity>
    <kequ:DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity
      contextRef="i442be4c6913b49a4b50ea772baaab2d6_I20200201"
      decimals="-6"
      id="f-433"
      unitRef="usd">15000000</kequ:DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity>
    <us-gaap:LongTermDebt
      contextRef="i1b182470888b4bfbbed867265f9c5935_I20220627"
      decimals="-3"
      id="f-434"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LineOfCredit
      contextRef="i9ae780b25bd64b349ff3f0cdb52c391c_I20220430"
      decimals="-5"
      id="f-435"
      unitRef="usd">1600000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i7e3cd898d91a4be8995d0dc84050feba_I20220430"
      decimals="-3"
      id="f-436"
      unitRef="usd">716000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-5"
      id="f-437"
      unitRef="usd">2400000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="ie1cc410519c54218bd0491e4a36cd2ea_I20220430"
      decimals="INF"
      id="f-438"
      unitRef="number">0.0475</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8817c527703e49429894104cdd1d7ecc_D20210501-20220430"
      decimals="4"
      id="f-439"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id54523868cb9492da803a3fdb87635d5_D20210501-20220430"
      decimals="3"
      id="f-440"
      unitRef="number">0.040</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i546d1702d5294252997efbcc4760c0d2_I20221219"
      decimals="-5"
      id="f-441"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <kequ:LineOfCreditFacilityAccordionFeatureIncreaseLimit
      contextRef="i546d1702d5294252997efbcc4760c0d2_I20221219"
      decimals="-6"
      id="f-442"
      unitRef="usd">1000000</kequ:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <kequ:LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption
      contextRef="i546d1702d5294252997efbcc4760c0d2_I20221219"
      decimals="-5"
      id="f-443"
      unitRef="usd">30000000</kequ:LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i77d740aedb144bb0ad536168beb98a3c_D20221219-20221219"
      decimals="4"
      id="f-444"
      unitRef="number">0.0410</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCredit
      contextRef="i68739a09bcb74732ad67255efa20ec71_I20230430"
      decimals="-3"
      id="f-445"
      unitRef="usd">3548000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i68739a09bcb74732ad67255efa20ec71_I20230430"
      decimals="-3"
      id="f-446"
      unitRef="usd">10286000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i68739a09bcb74732ad67255efa20ec71_I20230430"
      decimals="INF"
      id="f-447"
      unitRef="number">0.0902</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:ShortTermBorrowings
      contextRef="ibc3c4ae466f84e8aa27fac57a2ef3a4a_I20230430"
      decimals="-3"
      id="f-448"
      unitRef="usd">39000</us-gaap:ShortTermBorrowings>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i5ee2c5a57bb34a47b58f57f8e3d1c42d_I20230430"
      decimals="-5"
      id="f-449"
      unitRef="usd">5200000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i3e58a0cf3d454dedbd6523de24bb050f_I20230430"
      decimals="-3"
      id="f-450"
      unitRef="usd">142000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i18991e1526b14ffd876d57c01cbb0bde_I20230430"
      decimals="-3"
      id="f-451"
      unitRef="usd">3000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="if7d1f7a7276349cca788e17cd7c0ef20_I20230430"
      decimals="-3"
      id="f-452"
      unitRef="usd">233000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i040d62d3dd79442993ccc580b1141db5_I20220430"
      decimals="-5"
      id="f-453"
      unitRef="usd">8200000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="id3242c4e7dfc44caa5252683fd462cbc_I20220430"
      decimals="-3"
      id="f-454"
      unitRef="usd">111000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i07a66023f9b1454788d7c1753ac27d49_I20220430"
      decimals="-3"
      id="f-455"
      unitRef="usd">9000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="ia2bdb86fad2b464f9159d4e51f919a4b_I20220430"
      decimals="-3"
      id="f-456"
      unitRef="usd">3000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i2e3b5ea3288d445dbfb4e15eb2d7eff1_I20220430"
      decimals="-3"
      id="f-457"
      unitRef="usd">249000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue
      contextRef="i68ff7bf3b6ef494bb98b7aeeb082d754_I20220430"
      decimals="-5"
      id="f-458"
      unitRef="usd">6000000.0</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:SaleLeasebackTransactionDisclosureTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-459">Sale-Leaseback Financing Transaction&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 22, 2021, the Company entered into the Sale Agreement with the Buyer for the Company&#x2019;s headquarters and manufacturing facilities located at 2700 West Front Street in Statesville, North Carolina.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sale Agreement was finalized on March 24, 2022 and coincided with the Company and the Buyer entering into the Lease Agreement. The Sale-Leaseback Arrangement is repayable over a 20-year term, with four renewal options of five years each. Under the terms of the Lease Agreement, the Company&#x2019;s initial basic rent is approximately $158,000 per month, with annual increases of approximately 2% each year of the initial term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the Sale-Leaseback Arrangement as a financing transaction with the Buyer in accordance with ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as the Lease Agreement was determined to be a finance lease. The Company concluded the Lease Agreement met the qualifications to be classified as a finance lease due to the significance of the present value of the lease payments, using a discount rate of 4.75% to reflect the Company&#x2019;s incremental borrowing rate, compared to the fair value of the leased property as of the lease commencement date. In measuring the lease payments for the present value analysis, the Company elected the practical expedient to combine the lease component (the leased facilities) with the non-lease component (property management provided by the Buyer/Lessor) into a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The presence of a finance lease indicates that control of the Property has not transferred to the Buyer/Lessor and, as such, the transaction was deemed a failed sale-leaseback and accounted for as a financing arrangement. As a result of this determination, the Company is viewed as having received the sales proceeds from the Buyer/Lessor in the form of a hypothetical loan collateralized by its leased facilities. The hypothetical loan is payable as principal and interest in the form of &#x201c;lease payments&#x201d; to the Buyer/Lessor. As such, the Company will not derecognize the Property from its books for accounting purposes until the lease ends. No gain or loss was recognized related to the Sale-Leaseback Arrangement under U.S. GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of April 30, 2023, the carrying value of the financing liability was $28,774,000, net of $708,000 in debt issuance costs, of which $642,000 was classified as current on the Consolidated Balance Sheet with $28,132,000 classified as long-term. As of April&#160;30, 2022, the carrying value of the financing liability was $29,350,000, net of $768,000 in debt issuance costs, of which $575,000 was classified as current on the Consolidated Balance Sheet with $28,775,000 classified as long-term. The monthly lease payments are split between a reduction of principal and interest expense using the effective interest rate method. Interest expense associated with the financing arrangement was $1,316,000 and $147,000 for the years ended April 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will depreciate the building down to zero over the 20-year assumed economic life of the Property so that at the end of the lease term, the remaining carrying amount of the financing liability will equal the carrying amount of the land of $41,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remaining future cash payments related to the financing liability for the fiscal years ending April 30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.293%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Minimum Liability Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SaleLeasebackTransactionDisclosureTextBlock>
    <kequ:FinancingLiabilityTermOfContract
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      id="f-460">P20Y</kequ:FinancingLiabilityTermOfContract>
    <kequ:FinancingLiabilityNumberOfRenewalOptions
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="0"
      id="f-461"
      unitRef="renewaloption">4</kequ:FinancingLiabilityNumberOfRenewalOptions>
    <kequ:FinancingLiabilityRenewalTerm
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      id="f-462">P5Y</kequ:FinancingLiabilityRenewalTerm>
    <kequ:FinancingLiabilityBasicMonthlyPayment
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-463"
      unitRef="usd">158000</kequ:FinancingLiabilityBasicMonthlyPayment>
    <kequ:FinancingLiabilityAnnualIncreasePercent
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-464"
      unitRef="number">0.02</kequ:FinancingLiabilityAnnualIncreasePercent>
    <us-gaap:LesseeFinanceLeaseDiscountRate
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="INF"
      id="f-465"
      unitRef="number">0.0475</us-gaap:LesseeFinanceLeaseDiscountRate>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-466"
      unitRef="usd">0</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <kequ:FinancingLiability
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-467"
      unitRef="usd">28774000</kequ:FinancingLiability>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-468"
      unitRef="usd">708000</us-gaap:DeferredFinanceCostsNet>
    <kequ:FinancingLiabilityCurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-469"
      unitRef="usd">642000</kequ:FinancingLiabilityCurrent>
    <kequ:FinancingLiabilityNoncurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-470"
      unitRef="usd">28132000</kequ:FinancingLiabilityNoncurrent>
    <kequ:FinancingLiability
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-471"
      unitRef="usd">29350000</kequ:FinancingLiability>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-472"
      unitRef="usd">768000</us-gaap:DeferredFinanceCostsNet>
    <kequ:FinancingLiabilityCurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-473"
      unitRef="usd">575000</kequ:FinancingLiabilityCurrent>
    <kequ:FinancingLiabilityNoncurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-474"
      unitRef="usd">28775000</kequ:FinancingLiabilityNoncurrent>
    <kequ:InterestExpenseFinancingLiability
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-475"
      unitRef="usd">1316000</kequ:InterestExpenseFinancingLiability>
    <kequ:InterestExpenseFinancingLiability
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-476"
      unitRef="usd">147000</kequ:InterestExpenseFinancingLiability>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i63ec6c47db8041f29ab17eb138d30e46_D20220501-20230430"
      id="f-477">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i90242fcce5d84297ba58ac37f58d01eb_I20230430"
      decimals="-3"
      id="f-478"
      unitRef="usd">41000</us-gaap:PropertyPlantAndEquipmentGross>
    <kequ:ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-479">Remaining future cash payments related to the financing liability for the fiscal years ending April 30 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.293%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.222%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Minimum Liability Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</kequ:ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock>
    <kequ:FinancingLiabilityToBePaidYearOne
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-480"
      unitRef="usd">1931000</kequ:FinancingLiabilityToBePaidYearOne>
    <kequ:FinancingLiabilityToBePaidYearTwo
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-481"
      unitRef="usd">1970000</kequ:FinancingLiabilityToBePaidYearTwo>
    <kequ:FinancingLiabilityToBePaidYearThree
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-482"
      unitRef="usd">2009000</kequ:FinancingLiabilityToBePaidYearThree>
    <kequ:FinancingLiabilityToBePaidYearFour
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-483"
      unitRef="usd">2050000</kequ:FinancingLiabilityToBePaidYearFour>
    <kequ:FinancingLiabilityToBePaidYearFive
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-484"
      unitRef="usd">2090000</kequ:FinancingLiabilityToBePaidYearFive>
    <kequ:FinancingLiabilityToBePaidAfterYearFive
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-485"
      unitRef="usd">33867000</kequ:FinancingLiabilityToBePaidAfterYearFive>
    <kequ:FinancingLiabilityToBePaid
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-486"
      unitRef="usd">43917000</kequ:FinancingLiabilityToBePaid>
    <kequ:FinancingLiabilityUndiscountedExcessAmount
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-487"
      unitRef="usd">15143000</kequ:FinancingLiabilityUndiscountedExcessAmount>
    <kequ:FinancingLiability
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-488"
      unitRef="usd">28774000</kequ:FinancingLiability>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-489">Income Taxes &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act ("CARES Act") was signed into law, which contains several income tax provisions, as well as other measures, aimed at assisting businesses impacted by the economic effects of the COVID-19 pandemic. The CARES Act includes a broad range of tax reform provisions affecting businesses, including permissible net operating losses ("NOLs") carrybacks up to five years, changes in business deductions limitations, and deferral of Social Security withholdings. The Company applied the NOL carryback provision of the CARES Act with respect to its estimated NOL for fiscal year 2021 to years that had higher enacted tax rates. The Company also applied the deferral of Social Security withholdings in accordance with the CARES Act; 50% of these deferred withholdings were due and paid by December 31, 2021, with the remainder due and paid by December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective August 1, 2019, the Company elected to revoke the indefinite reinvestment of foreign unremitted earnings position set forth by ASC 740-30-25-17 for multiple foreign subsidiaries. As a result of this election, the Company recorded a tax withholding expense imposed by the India Income Tax Department of $406,000 and $240,000 for the years ended April 30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 22, 2017, the Tax Cuts and Job Act amended Internal Revenue Code Section 174, effective for tax years beginning after December 31, 2021. This amendment to Section 174, effective during fiscal year 2023 for the Company, eliminated the current year deductibility of research and experimentation expenditures and required the Company to deduct these expenditures over five years. The impact of this tax regulation required the Company to record a new deferred tax asset of $1,558,000 as of April 30, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's accounting policy with respect to the Global Intangible Low-Taxed Income ("GILTI") tax rules is that GILTI will be treated as a periodic charge in the year in which it arises.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;691&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,736&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,624&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;515&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;515&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,139&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reasons for the differences between the above net income tax expense and the amounts computed by applying the statutory federal income tax rate to earnings before income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit) at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local taxes, net of federal income tax benefit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits (state, net of federal benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of differing US and foreign tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;260&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;413&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign subsidiary income to parent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,667&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;307&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,139&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant items comprising deferred tax assets and liabilities as of April&#160;30 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued employee benefit expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;153&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits (state, net of federal benefits)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;170&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 R&amp;amp;E Addback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,558&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial loss, defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,064&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory reserves and capitalized costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;201&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;249&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds on Sale Leaseback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,558&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book basis in excess of tax basis of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book basis in excess of tax basis of Sale Leaseback property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APB 23 Assertion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt Issuance Cost on Sale Leaseback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (liabilities) classified in the balance sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to evaluate the realization of the deferred tax asset and any requirement for a valuation allowance in accordance with ASC 740-10-30-2(b). This guidance provides that the future realization of the tax benefit of an existing deductible temporary difference or carryforward ultimately depends on sufficient taxable income of the appropriate character within the carryback or carryforward period available under the tax law. The Company evaluates all available evidence, both &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;positive and negative, to determine the amount of any required valuation allowance. The valuation allowance totaled $8,568,000 and $6,901,000 at April&#160;30, 2023 and 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At April&#160;30, 2023, the Company had foreign tax credit carryforwards in the amount of $638,000, which are subject to a full valuation allowance, and which will begin to expire in 2028.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files federal, state and local tax returns with statutes of limitation generally ranging from 3 to 4 years. The Company is generally no longer subject to federal tax examinations for years prior to fiscal year 2019 or state and local tax examinations for years prior to fiscal year 2018. Tax returns filed by the Company's significant foreign subsidiaries are generally subject to statutes of limitations of 3 to 7 years and are generally no longer subject to examination for years prior to fiscal year 2017. The Company has no unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <kequ:CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod
      contextRef="ia4b416d20e6c41dca68290de29b3950c_D20200327-20200327"
      id="f-490">P5Y</kequ:CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod>
    <kequ:TaxWithholdingExpense
      contextRef="ia09ed2386bef4571af63546d7275fed5_D20220501-20230430"
      decimals="-3"
      id="f-491"
      unitRef="usd">406000</kequ:TaxWithholdingExpense>
    <kequ:TaxWithholdingExpense
      contextRef="i76e58b3cdbee43328d425bf866be46cb_D20210501-20220430"
      decimals="-3"
      id="f-492"
      unitRef="usd">240000</kequ:TaxWithholdingExpense>
    <kequ:Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility
      contextRef="ic4fc91d4336742bca6f7d1456d6b6290_D20171222-20171222"
      id="f-493">P5Y</kequ:Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility>
    <kequ:DeferredTaxAssetsSection174REAddback
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-494"
      unitRef="usd">1558000</kequ:DeferredTaxAssetsSection174REAddback>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-495">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;691&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;197&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,736&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,624&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;515&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;515&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,139&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-496"
      unitRef="usd">691000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-497"
      unitRef="usd">1899000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-498"
      unitRef="usd">197000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-499"
      unitRef="usd">490000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-500"
      unitRef="usd">1736000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-501"
      unitRef="usd">1008000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-502"
      unitRef="usd">2624000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-503"
      unitRef="usd">3397000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-504"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-505"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-506"
      unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-507"
      unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-508"
      unitRef="usd">515000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-509"
      unitRef="usd">121000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-510"
      unitRef="usd">515000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-511"
      unitRef="usd">121000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-512"
      unitRef="usd">3139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-513"
      unitRef="usd">3518000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-514">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reasons for the differences between the above net income tax expense and the amounts computed by applying the statutory federal income tax rate to earnings before income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.270%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.846%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.538%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (benefit) at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local taxes, net of federal income tax benefit &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits (state, net of federal benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effects of differing US and foreign tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;260&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;413&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of foreign subsidiary income to parent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,667&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other items, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;307&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,139&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-515"
      unitRef="usd">945000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-516"
      unitRef="usd">-432000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-517"
      unitRef="usd">-119000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-518"
      unitRef="usd">-29000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-519"
      unitRef="usd">433000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationTaxCredits
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-520"
      unitRef="usd">457000</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-521"
      unitRef="usd">260000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-522"
      unitRef="usd">22000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-523"
      unitRef="usd">0</kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount>
    <kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-524"
      unitRef="usd">286000</kequ:EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount>
    <kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-525"
      unitRef="usd">413000</kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount>
    <kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-526"
      unitRef="usd">0</kequ:EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount>
    <us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-527"
      unitRef="usd">-99000</us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-528"
      unitRef="usd">-74000</us-gaap:IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-529"
      unitRef="usd">1667000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-530"
      unitRef="usd">4170000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-531"
      unitRef="usd">307000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-532"
      unitRef="usd">456000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-533"
      unitRef="usd">3139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-534"
      unitRef="usd">3518000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-535">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant items comprising deferred tax assets and liabilities as of April&#160;30 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued employee benefit expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;153&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits (state, net of federal benefits)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;170&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;638&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 174 R&amp;amp;E Addback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,558&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized actuarial loss, defined benefit plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,064&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory reserves and capitalized costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;201&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;249&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds on Sale Leaseback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,558&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;254&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book basis in excess of tax basis of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book basis in excess of tax basis of Sale Leaseback property&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APB 23 Assertion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,318)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt Issuance Cost on Sale Leaseback&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(8,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (liabilities) classified in the balance sheet:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-536"
      unitRef="usd">153000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-537"
      unitRef="usd">228000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-538"
      unitRef="usd">114000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-539"
      unitRef="usd">142000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-540"
      unitRef="usd">1156000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-541"
      unitRef="usd">1196000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-542"
      unitRef="usd">170000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-543"
      unitRef="usd">170000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-544"
      unitRef="usd">638000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-545"
      unitRef="usd">638000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <kequ:DeferredTaxAssetsSection174REAddback
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-546"
      unitRef="usd">1558000</kequ:DeferredTaxAssetsSection174REAddback>
    <kequ:DeferredTaxAssetsSection174REAddback
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-547"
      unitRef="usd">0</kequ:DeferredTaxAssetsSection174REAddback>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-548"
      unitRef="usd">1064000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-549"
      unitRef="usd">1202000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-550"
      unitRef="usd">201000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-551"
      unitRef="usd">110000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-552"
      unitRef="usd">249000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-553"
      unitRef="usd">112000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <kequ:DeferredTaxAssetsProceedsOnSaleLeaseback
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-554"
      unitRef="usd">6963000</kequ:DeferredTaxAssetsProceedsOnSaleLeaseback>
    <kequ:DeferredTaxAssetsProceedsOnSaleLeaseback
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-555"
      unitRef="usd">7215000</kequ:DeferredTaxAssetsProceedsOnSaleLeaseback>
    <kequ:DeferredTaxAssetLeaseLiability
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-556"
      unitRef="usd">1558000</kequ:DeferredTaxAssetLeaseLiability>
    <kequ:DeferredTaxAssetLeaseLiability
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-557"
      unitRef="usd">0</kequ:DeferredTaxAssetLeaseLiability>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-558"
      unitRef="usd">254000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-559"
      unitRef="usd">449000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-560"
      unitRef="usd">14078000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-561"
      unitRef="usd">11462000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-562"
      unitRef="usd">1417000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-563"
      unitRef="usd">1758000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <kequ:DeferredTaxLiabilitiesSaleLeasebackProperty
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-564"
      unitRef="usd">1106000</kequ:DeferredTaxLiabilitiesSaleLeasebackProperty>
    <kequ:DeferredTaxLiabilitiesSaleLeasebackProperty
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-565"
      unitRef="usd">1122000</kequ:DeferredTaxLiabilitiesSaleLeasebackProperty>
    <kequ:DeferredTaxLiabilitiesPrepaidPensionCost
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-566"
      unitRef="usd">919000</kequ:DeferredTaxLiabilitiesPrepaidPensionCost>
    <kequ:DeferredTaxLiabilitiesPrepaidPensionCost
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-567"
      unitRef="usd">949000</kequ:DeferredTaxLiabilitiesPrepaidPensionCost>
    <kequ:DeferredTaxLiabilitiesAPB23Assertion
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-568"
      unitRef="usd">1318000</kequ:DeferredTaxLiabilitiesAPB23Assertion>
    <kequ:DeferredTaxLiabilitiesAPB23Assertion
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-569"
      unitRef="usd">976000</kequ:DeferredTaxLiabilitiesAPB23Assertion>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-570"
      unitRef="usd">1526000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-571"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-572"
      unitRef="usd">167000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-573"
      unitRef="usd">184000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-574"
      unitRef="usd">6453000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-575"
      unitRef="usd">4989000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-576"
      unitRef="usd">8568000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-577"
      unitRef="usd">6901000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-578"
      unitRef="usd">943000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-579"
      unitRef="usd">428000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic6b14126cfd04589a48a1267cb447516_I20230430"
      decimals="-3"
      id="f-580"
      unitRef="usd">943000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i18837955ad44418ebb8430792c895f28_I20220430"
      decimals="-3"
      id="f-581"
      unitRef="usd">428000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-582"
      unitRef="usd">943000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-583"
      unitRef="usd">428000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-584"
      unitRef="usd">8568000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-585"
      unitRef="usd">6901000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-586"
      unitRef="usd">638000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsForeign>
    <kequ:FederalStateAndLocalTaxReturnsPeriod
      contextRef="ia90c11936dba4904a9531ab5d52fbbd5_D20220501-20230430"
      id="f-587">P3Y</kequ:FederalStateAndLocalTaxReturnsPeriod>
    <kequ:FederalStateAndLocalTaxReturnsPeriod
      contextRef="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430"
      id="f-588">P4Y</kequ:FederalStateAndLocalTaxReturnsPeriod>
    <kequ:ForeignSubsidiariesTaxReturnsPeriod
      contextRef="ia90c11936dba4904a9531ab5d52fbbd5_D20220501-20230430"
      id="f-589">P3Y</kequ:ForeignSubsidiariesTaxReturnsPeriod>
    <kequ:ForeignSubsidiariesTaxReturnsPeriod
      contextRef="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430"
      id="f-590">P7Y</kequ:ForeignSubsidiariesTaxReturnsPeriod>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-591">Stock Options and Share-Based Compensation &lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's stockholders approved the 2017 Omnibus Incentive Plan ("2017 Plan") on August&#160;30, 2017, which enables the Company to grant a broad range of equity, equity-related, and non-equity types of awards, with potential recipients including directors, consultants and employees. This plan replaced the 2010 Stock Option Plan for Directors and the 2008 Key Employee Stock Option Plan. No new awards will be granted under the prior plans and all outstanding options granted under the prior plans will remain subject to the prior plans. At the date of approval of the 2017 Plan there were 280,100 shares available for issuance under the prior plans. These shares and any shares subject to outstanding awards that subsequently cease to be subject to such awards are available under the 2017 Plan. The 2017 Plan did not increase the total number of shares available for issuance under the Company's equity compensation plans. At April&#160;30, 2023 there were 149,007 shares available for future issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2017 Plan, the Company recorded stock-based compensation expense of $845,000 and $701,000 and deferred income tax benefit of $199,000 and $165,000 in fiscal years 2023 and 2022, respectively. The RSUs include grants with both a service and performance component vesting over a 3 year period and grants with only service components vesting over 2 and 3 year periods. The recognized expense is based upon the vesting period for service criteria and estimated attainment of the performance criteria at the end of the performance period based on the ratio of cumulative days incurred to total days over the performance period. The remaining estimated compensation expense of $812,000 will be recorded over the remaining vesting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each RSU granted to employees was estimated on the date of grant based on the weighted average price of the Company's stock reduced by the present value of the expected dividend stream during the vesting period using the risk-free interest rate. The Company issued new shares of common stock to satisfy RSUs that vested during fiscal year 2023. The following table summarizes the RSU activity and weighted averages.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.306%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.773%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The stockholders approved the 2008 Key Employee Stock Option Plan ("2008 Plan") in fiscal year 2009 which allowed the Company to grant options on an aggregate of 300,000 shares of the Company's common stock. On August&#160;26, 2015, the stockholders approved an amendment to this plan to increase the number of shares available under the 2008 Plan by 300,000 shares. Under the plan, options were granted at not less than the fair market value at the date of grant and options are exercisable in such installments, for such terms (up to 10 years), and at such times, as the Board of Directors determined at the time of the grant. At April&#160;30, 2023, there were no shares available for future grants under the 2008 Plan. Under the 2008 Plan, the Company recorded no compensation expense or deferred income tax benefit in fiscal year 2023 or 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In order to determine the fair value of stock options on the date of grant, the Company applied the Black-Scholes option pricing model. Inherent in the model are assumptions related to expected stock-price volatility, option life, risk-free interest rate, and dividend yield. The stock options outstanding have the "plain-vanilla" characteristics as defined in SEC Staff Accounting Bulletin No.&#160;107 (SAB 107). The Company utilized the Safe Harbor option "Simplified Method" to determine the expected term of these options in accordance with the guidance of SAB&#160;107 for options outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued new shares of common stock to satisfy options exercised during fiscal years 2023 and 2022. Stock option activity and weighted average exercise price are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.08&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14.54&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of options outstanding, exercisable, and their weighted average exercise prices were within the following ranges at April&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.717%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$15.85-$23.62&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining contractual life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="id553a2e4e4c34c41aad075cfe7d7e942_I20230430"
      decimals="INF"
      id="f-592"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i0df14ac1694242918bf120280e13b5e4_I20170830"
      decimals="INF"
      id="f-593"
      unitRef="shares">280100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="id145fd41da7a42d8bf28d16bf42e6e73_I20230430"
      decimals="INF"
      id="f-594"
      unitRef="shares">149007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i856a73272e2d43a39d425e3dec7e46cd_D20220501-20230430"
      decimals="-3"
      id="f-595"
      unitRef="usd">845000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie0f4be86b27e4b73ba9843141170627d_D20210501-20220430"
      decimals="-3"
      id="f-596"
      unitRef="usd">701000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i856a73272e2d43a39d425e3dec7e46cd_D20220501-20230430"
      decimals="-3"
      id="f-597"
      unitRef="usd">-199000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie0f4be86b27e4b73ba9843141170627d_D20210501-20220430"
      decimals="-3"
      id="f-598"
      unitRef="usd">-165000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i856a73272e2d43a39d425e3dec7e46cd_D20220501-20230430"
      id="f-599">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie3d01a1650ac43cca9d9a27d1d799fb8_D20220501-20230430"
      id="f-600">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i63348bc16c724f1f8d2b204017cbb09b_D20220501-20230430"
      id="f-601">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i7f51b34728494fe387a9da7cbaaecf7f_I20230430"
      decimals="-3"
      id="f-602"
      unitRef="usd">812000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-603">The following table summarizes the RSU activity and weighted averages.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.306%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.773%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="idadad6c5f93d416caf379a3ec3da9055_I20220430"
      decimals="INF"
      id="f-604"
      unitRef="shares">144827</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="idadad6c5f93d416caf379a3ec3da9055_I20220430"
      decimals="2"
      id="f-605"
      unitRef="usdPerShare">12.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if60aac1ba48e4bd790f9b0fafdf6e109_I20210430"
      decimals="INF"
      id="f-606"
      unitRef="shares">125217</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if60aac1ba48e4bd790f9b0fafdf6e109_I20210430"
      decimals="2"
      id="f-607"
      unitRef="usdPerShare">12.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430"
      decimals="INF"
      id="f-608"
      unitRef="shares">87969</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430"
      decimals="2"
      id="f-609"
      unitRef="usdPerShare">13.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430"
      decimals="INF"
      id="f-610"
      unitRef="shares">67750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430"
      decimals="2"
      id="f-611"
      unitRef="usdPerShare">13.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430"
      decimals="INF"
      id="f-612"
      unitRef="shares">50315</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430"
      decimals="2"
      id="f-613"
      unitRef="usdPerShare">13.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430"
      decimals="INF"
      id="f-614"
      unitRef="shares">31943</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430"
      decimals="2"
      id="f-615"
      unitRef="usdPerShare">12.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430"
      decimals="INF"
      id="f-616"
      unitRef="shares">22841</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i1786268e3bcb4597a3fd576f004f469f_D20220501-20230430"
      decimals="2"
      id="f-617"
      unitRef="usdPerShare">15.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430"
      decimals="INF"
      id="f-618"
      unitRef="shares">16197</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i41c8d2e52a1945c38c6774fc696a40ca_D20210501-20220430"
      decimals="2"
      id="f-619"
      unitRef="usdPerShare">21.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i81ebd11ae8384005a4122c79a54d0388_I20230430"
      decimals="INF"
      id="f-620"
      unitRef="shares">159640</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i81ebd11ae8384005a4122c79a54d0388_I20230430"
      decimals="2"
      id="f-621"
      unitRef="usdPerShare">11.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="idadad6c5f93d416caf379a3ec3da9055_I20220430"
      decimals="INF"
      id="f-622"
      unitRef="shares">144827</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="idadad6c5f93d416caf379a3ec3da9055_I20220430"
      decimals="2"
      id="f-623"
      unitRef="usdPerShare">12.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ib7bce12c1c32423e8650a7aa2cca14a6_I20230430"
      decimals="INF"
      id="f-624"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i4ca44f1ca15a49c686f4c491a93f8591_D20150826-20150826"
      decimals="INF"
      id="f-625"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i93b7e975c5f64cc6b08cfc1e4e83c167_D20220501-20230430"
      id="f-626">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="iabe50ea0d70a4c4395aa06274568ff1c_D20220501-20230430"
      decimals="INF"
      id="f-627"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <kequ:ShareBasedCompensationDeferredTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-628"
      unitRef="usd">0</kequ:ShareBasedCompensationDeferredTaxExpenseBenefit>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-629"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <kequ:ShareBasedCompensationDeferredTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-630"
      unitRef="usd">0</kequ:ShareBasedCompensationDeferredTaxExpenseBenefit>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-631"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-632">Stock option activity and weighted average exercise price are summarized as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Number&lt;br/&gt;of&#160;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20.08&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14.54&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="INF"
      id="f-633"
      unitRef="shares">47400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="2"
      id="f-634"
      unitRef="usdPerShare">19.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430"
      decimals="INF"
      id="f-635"
      unitRef="shares">84300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430"
      decimals="2"
      id="f-636"
      unitRef="usdPerShare">18.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-637"
      unitRef="shares">7850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="2"
      id="f-638"
      unitRef="usdPerShare">20.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="INF"
      id="f-639"
      unitRef="shares">35400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="2"
      id="f-640"
      unitRef="usdPerShare">17.94</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-641"
      unitRef="shares">5650</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="2"
      id="f-642"
      unitRef="usdPerShare">14.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="INF"
      id="f-643"
      unitRef="shares">1500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="2"
      id="f-644"
      unitRef="usdPerShare">8.59</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="INF"
      id="f-645"
      unitRef="shares">33900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="2"
      id="f-646"
      unitRef="usdPerShare">19.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="INF"
      id="f-647"
      unitRef="shares">47400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="2"
      id="f-648"
      unitRef="usdPerShare">19.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="INF"
      id="f-649"
      unitRef="shares">33900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="2"
      id="f-650"
      unitRef="usdPerShare">19.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="INF"
      id="f-651"
      unitRef="shares">47400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="2"
      id="f-652"
      unitRef="usdPerShare">19.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-653">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of options outstanding, exercisable, and their weighted average exercise prices were within the following ranges at April&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.717%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$15.85-$23.62&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining contractual life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33,900&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-654"
      unitRef="usdPerShare">15.85</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-655"
      unitRef="usdPerShare">23.62</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="INF"
      id="f-656"
      unitRef="shares">33900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="2"
      id="f-657"
      unitRef="usdPerShare">19.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-658">P2Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-659"
      unitRef="usd">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="INF"
      id="f-660"
      unitRef="shares">33900</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="2"
      id="f-661"
      unitRef="usdPerShare">19.97</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-662"
      unitRef="usd">1400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-663">Accumulated Other Comprehensive Income (Loss)&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's other comprehensive income (loss) consists of unrealized gains and losses on the translation of the assets, liabilities, and equity of its foreign subsidiaries, and additional minimum pension liability adjustments, net of income taxes. The before tax income (loss), related income tax effect, and accumulated balances are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.555%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimum&lt;br/&gt;Pension&lt;br/&gt;Liability&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in unrecognized actuarial loss on pension obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in unrecognized actuarial loss on pension obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;590&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;590&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-664">The before tax income (loss), related income tax effect, and accumulated balances are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.555%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Minimum&lt;br/&gt;Pension&lt;br/&gt;Liability&lt;br/&gt;Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in unrecognized actuarial loss on pension obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in unrecognized actuarial loss on pension obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;590&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;590&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at April 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,442)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0587fe00cae74bec97d95dac2c6e3805_I20210430"
      decimals="-3"
      id="f-665"
      unitRef="usd">-2357000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i58cc8871d7854cf58997cb98992e51f7_I20210430"
      decimals="-3"
      id="f-666"
      unitRef="usd">-1220000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430"
      decimals="-3"
      id="f-667"
      unitRef="usd">-3577000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i375a69d8f72741c3b852a98fd7b2e36d_D20210501-20220430"
      decimals="-3"
      id="f-668"
      unitRef="usd">-186000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-669"
      unitRef="usd">-186000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ie4fb45c9d24746b3a2e1197cf86d9d3a_D20210501-20220430"
      decimals="-3"
      id="f-670"
      unitRef="usd">21000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-671"
      unitRef="usd">21000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i09cf305d1de04959b7bda23aa95706a3_I20220430"
      decimals="-3"
      id="f-672"
      unitRef="usd">-2543000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iceca130826c3475f9ab063adc1f5f5cb_I20220430"
      decimals="-3"
      id="f-673"
      unitRef="usd">-1199000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-674"
      unitRef="usd">-3742000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i302d0d54469e442197359aabf6bc4272_D20220501-20230430"
      decimals="-3"
      id="f-675"
      unitRef="usd">-290000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-676"
      unitRef="usd">-290000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i0ccfacb4e2c84a068c3ca01af64454f4_D20220501-20230430"
      decimals="-3"
      id="f-677"
      unitRef="usd">590000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-678"
      unitRef="usd">590000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i474fdf01402c4320988de23ca2856814_I20230430"
      decimals="-3"
      id="f-679"
      unitRef="usd">-2833000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id6ebb0ed884a4d85b16577907b09659a_I20230430"
      decimals="-3"
      id="f-680"
      unitRef="usd">-609000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-681"
      unitRef="usd">-3442000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-682">Leases, Commitments and Contingencies&lt;div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes lease assets and lease liabilities with respect to the rights and obligations created by leased assets previously classified as operating leases. The Company elected to:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Record the impact of adoption using a modified retrospective method with any cumulative effect as an adjustment to retained earnings (accumulated deficit) as opposed to restating comparative periods to reflect the effects of applying the new standard.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Elect the package of three transition practical expedients which alleviate the requirements to reassess embedded leases, lease classification and initial direct costs for leases that commenced prior to the adoption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Elected to use the short-term lease recognition exemption for all asset classes. This means, for those leases that qualify, the Company will not recognize right-of-use ("ROU") assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases of those assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating type leases for real estate and equipment in both the U.S. and internationally and financing leases for equipment in the United States. ROU assets totaled $9,170,000 and $7,573,000 at April&#160;30, 2023 and 2022, respectively. Operating cash paid to settle lease liabilities was $2,278,640 and $2,019,000 for the fiscal year ended April 30, 2023 and 2022, respectively. The Company's leases have remaining lease terms of up to 8 years. In addition, some of the leases may include options to extend the leases for up to 5 years or options to terminate the leases within 1 year. Operating lease expense was $3,344,000 for the twelve months ended April 30, 2023, inclusive of period cost for short-term leases, not included in lease liabilities, of $1,065,000. Operating lease expense was $3,067,000 for the fiscal year ended April 30, 2022, inclusive of period cost for short-term leases, not included in lease liabilities, of $1,048,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At April&#160;30, 2023, the weighted average remaining lease term for the capitalized operating leases was 5.1 years and the weighted average discount rate was 5.0%. At April&#160;30, 2022, the weighted average remaining lease term for the capitalized operating leases was 5.8 years and the weighted average discount rate was 4.1%. For the financing leases, the weighted average remaining lease term was 3.1 years and the weighted average discount rate was 6.8% at April&#160;30, 2023 as compared to 3.8 years and 6.6% at April&#160;30, 2022. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.198%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.288%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved in certain claims and legal proceedings in the normal course of business which management believes will not have a material adverse effect on the Company's consolidated financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-683"
      unitRef="usd">9170000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-684"
      unitRef="usd">7573000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeasePayments
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-1"
      id="f-685"
      unitRef="usd">2278640</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-686"
      unitRef="usd">2019000</us-gaap:OperatingLeasePayments>
    <kequ:LesseeRemainingLeaseTerm
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-687">P8Y</kequ:LesseeRemainingLeaseTerm>
    <kequ:LesseeOptiontoExtendTerm
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-688">P5Y</kequ:LesseeOptiontoExtendTerm>
    <kequ:LesseeOptiontoTerminateTerm
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-689">P1Y</kequ:LesseeOptiontoTerminateTerm>
    <us-gaap:OperatingLeaseExpense
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-690"
      unitRef="usd">3344000</us-gaap:OperatingLeaseExpense>
    <kequ:OperatingLeaseShortTermExpense
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-691"
      unitRef="usd">1065000</kequ:OperatingLeaseShortTermExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-692"
      unitRef="usd">3067000</us-gaap:OperatingLeaseExpense>
    <kequ:OperatingLeaseShortTermExpense
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-693"
      unitRef="usd">1048000</kequ:OperatingLeaseShortTermExpense>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      id="f-694">P5Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="3"
      id="f-695"
      unitRef="number">0.050</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      id="f-696">P5Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="3"
      id="f-697"
      unitRef="number">0.041</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      id="f-698">P3Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="3"
      id="f-699"
      unitRef="number">0.068</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      id="f-700">P3Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="3"
      id="f-701"
      unitRef="number">0.066</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-702">Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.198%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.288%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-703">Future minimum payments under the non-cancelable lease arrangements for the fiscal years ending April&#160;30 are as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.183%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:2.221%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.198%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.288%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;($ in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Minimum Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imputed Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-704"
      unitRef="usd">2373000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-705"
      unitRef="usd">91000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-706"
      unitRef="usd">2175000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-707"
      unitRef="usd">91000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-708"
      unitRef="usd">1920000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-709"
      unitRef="usd">72000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-710"
      unitRef="usd">1658000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-711"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-712"
      unitRef="usd">1130000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-713"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-714"
      unitRef="usd">1380000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-715"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-716"
      unitRef="usd">10636000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-717"
      unitRef="usd">254000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-718"
      unitRef="usd">1533000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-719"
      unitRef="usd">21000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-720"
      unitRef="usd">9103000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-721"
      unitRef="usd">233000</us-gaap:FinanceLeaseLiability>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-722">Retirement Benefits&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has non-contributory defined benefit pension plans covering some of its domestic employees. These plans were amended as of April&#160;30, 2005, no further benefits have been, or will be, earned under the plans subsequent to the amendment date, and no additional participants will be added to the plans. The defined benefit plan for salaried employees provides pension benefits that are based on each employee's years of service and average annual compensation during the last ten consecutive calendar years of employment as of April&#160;30, 2005. The benefit plan for hourly employees provides benefits at stated amounts based on years of service as of April&#160;30, 2005. The Company uses an April&#160;30 measurement date for its defined benefit plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in projected benefit obligations and the change in fair value of plan assets for the non-contributory defined benefit pension plans for each of the years ended April&#160;30 are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation, April 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Projected Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;845&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,867&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;251&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,732&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&#x2014;under&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in the Consolidated Balance Sheets consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actual loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,526&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After-tax actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,462&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Assumptions Used to Determine Benefit Obligations at April 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortality table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pri-2012&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pri-2012&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projection scale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MP-2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MP-2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.247%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended April 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the net periodic pension (income) expense for each of the fiscal years ended April&#160;30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.247%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;845&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;628&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-769"&gt;&lt;span style="-sec-ix-hidden:f-770"&gt;&lt;span style="-sec-ix-hidden:f-771"&gt;Net periodic pension expense (income)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;71&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated net actuarial loss for the defined benefit pension plans that will be amortized from accumulated other comprehensive income into net periodic benefit cost during fiscal year 2024 is $580,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's funding policy is to contribute to the plans when pension laws and economics either require or encourage funding. The Company expects to make no contributions during fiscal year 2024. There were no contributions made to the plans in fiscal year 2023 or 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following benefit payments are expected to be paid from the benefit plans in the fiscal years ending April&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.395%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029- 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected long-term portfolio return is established via a building block approach with proper consideration of diversification and rebalancing. Historical markets are studied and long-term historical relationships between equities and fixed-income securities are preserved consistent with the widely accepted capital market principle that assets with higher volatility generate a greater return over the long term. Current market factors such as inflation and interest rates are evaluated before long-term capital market assumptions are determined. Peer data and historical returns are also reviewed to check for reasonableness and appropriateness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a Yield Curve methodology to determine its GAAP discount rate. Under this approach, future benefit payment cash flows are projected from the pension plan on a projected benefit obligation basis. The payment stream is discounted to a present value using an interest rate applicable to the timing of each respective cash flow. The graph of these time-dependent interest rates is known as a yield curve. The interest rates comprising the Yield Curve are determined through a statistical analysis performed by the IRS and issued each month in the form of a pension discount curve. For this purpose, the universe of possible bonds consists of a set of bonds which are designated as corporate, have high quality ratings (AAA or AA) from nationally recognized statistical rating organizations, and have at least $250 million in par amount outstanding on at least one day during the reporting period. A 1% increase/decrease in the discount rate for fiscal years 2023 and 2022 would increase/decrease pension expense by approximately $231,000 and $271,000, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a total return investment approach, whereby a mix of equities and fixed-income investments are used to attempt to maximize the long-term return on plan assets for a prudent level of risk. Risk tolerance is established through careful consideration of plan liabilities, plan funded status, and corporate financial condition. The investment portfolio contains a diversified blend of equity and fixed-income investments. Furthermore, equity investments are diversified across U.S. and non-U.S. stocks, as well as growth, value, and small and large capitalizations. The target allocations based on the Company's investment policy were 75% in equity securities and 25% in fixed-income securities at April&#160;30, 2023 and April&#160;30, 2022. A 1% increase/decrease in the expected return on assets for fiscal years 2023 and 2022 would increase/decrease pension expense by approximately $181,000 and $207,000, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plan assets by asset categories as of April&#160;30 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,724&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,845&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,732&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of the assets in the Company's defined benefit pension plans at April&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.209%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Small/Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;702&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,845&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liquid Alternatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;627&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,732&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.209%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Small/Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liquid Alternatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1 retirement plan assets include United States currency held by a designated trustee and equity funds of common and preferred securities issued by domestic and foreign corporations. These equity funds are traded actively on exchanges and price quotes for these shares are readily available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Defined Contribution Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a defined contribution plan covering substantially all domestic salaried and hourly employees. The plan provides benefits to all employees who have attained age 21, completed three months of service, and who elect to participate. The plan provides that the Company make matching contributions equal to 100% of the employee's qualifying contribution up to 3% of the employee's compensation, and make matching contributions equal to 50% of the employee's contributions between 3% and 5% of the employee's compensation, resulting in a maximum employer contribution equal to 4% of the employee's compensation. The Company's matching contributions were $932,000 and $967,000 for years ending April&#160;30, 2023 and 2022. Additionally, the plan provides that the Company may elect to make a non-matching contribution for participants employed by the Company on December&#160;31 of each year. The Company did not elect to make a non-matching contribution in fiscal years 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-723">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in projected benefit obligations and the change in fair value of plan assets for the non-contributory defined benefit pension plans for each of the years ended April&#160;30 are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.413%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Benefit Obligation, April 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Projected Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;845&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected benefit obligations, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,368&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,867&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;251&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,732&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&#x2014;under&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in the Consolidated Balance Sheets consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actual loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,526&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After-tax actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,462&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Assumptions Used to Determine Benefit Obligations at April 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortality table&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pri-2012&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pri-2012&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projection scale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;MP-2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MP-2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.247%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended April 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-724"
      unitRef="usd">18368000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-725"
      unitRef="usd">20022000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-726"
      unitRef="usd">20022000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430"
      decimals="-3"
      id="f-727"
      unitRef="usd">22942000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-728"
      unitRef="usd">845000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-729"
      unitRef="usd">710000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-730"
      unitRef="usd">-1113000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-731"
      unitRef="usd">-2218000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-732"
      unitRef="usd">1386000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-733"
      unitRef="usd">1412000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-734"
      unitRef="usd">18368000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-735"
      unitRef="usd">20022000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-736"
      unitRef="usd">18867000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia08ef11dead048c8b9c14a66f2f30b19_I20210430"
      decimals="-3"
      id="f-737"
      unitRef="usd">21459000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-738"
      unitRef="usd">251000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-739"
      unitRef="usd">-1180000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-740"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-741"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-742"
      unitRef="usd">1386000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-743"
      unitRef="usd">1412000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-744"
      unitRef="usd">17732000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-745"
      unitRef="usd">18867000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-746"
      unitRef="usd">-636000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-747"
      unitRef="usd">-1155000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-748"
      unitRef="usd">636000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-749"
      unitRef="usd">1155000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-750"
      unitRef="usd">4526000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-751"
      unitRef="usd">5116000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-752"
      unitRef="usd">1064000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-753"
      unitRef="usd">1202000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-754"
      unitRef="usd">3462000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-755"
      unitRef="usd">3914000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="4"
      id="f-756"
      unitRef="number">0.0510</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="4"
      id="f-757"
      unitRef="number">0.0440</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="4"
      id="f-758"
      unitRef="number">0.0510</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="4"
      id="f-759"
      unitRef="number">0.0440</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="4"
      id="f-760"
      unitRef="number">0.0775</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="4"
      id="f-761"
      unitRef="number">0.0775</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-762">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the net periodic pension (income) expense for each of the fiscal years ended April&#160;30 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.247%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;845&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;628&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-769"&gt;&lt;span style="-sec-ix-hidden:f-770"&gt;&lt;span style="-sec-ix-hidden:f-771"&gt;Net periodic pension expense (income)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;71&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-763"
      unitRef="usd">845000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-764"
      unitRef="usd">710000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-765"
      unitRef="usd">1402000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-766"
      unitRef="usd">1604000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-767"
      unitRef="usd">-628000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-768"
      unitRef="usd">-539000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-772"
      unitRef="usd">71000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-773"
      unitRef="usd">-355000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanExpectedAmortizationNextFiscalYear
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-774"
      unitRef="usd">580000</us-gaap:DefinedBenefitPlanExpectedAmortizationNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="INF"
      id="f-775"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="INF"
      id="f-776"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-777"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-778">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following benefit payments are expected to be paid from the benefit plans in the fiscal years ending April&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.395%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029- 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-779"
      unitRef="usd">1640000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-780"
      unitRef="usd">1620000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-781"
      unitRef="usd">1600000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-782"
      unitRef="usd">1560000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-783"
      unitRef="usd">1540000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-784"
      unitRef="usd">7030000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i169a6334517a4b19877902820dba5e96_I20230430"
      decimals="-6"
      id="f-785"
      unitRef="usd">250000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <kequ:DefinedBenefitPlanPercentageChangesInDiscountRate
      contextRef="ib5dbb92c8fb44dc2ba4e9a4183b0e326_D20210501-20220430"
      decimals="2"
      id="f-786"
      unitRef="number">0.01</kequ:DefinedBenefitPlanPercentageChangesInDiscountRate>
    <kequ:DefinedBenefitPlanPercentageChangesInDiscountRate
      contextRef="ibb15b53ace4d4cc89a084c541d351ce9_D20220501-20230430"
      decimals="2"
      id="f-787"
      unitRef="number">0.01</kequ:DefinedBenefitPlanPercentageChangesInDiscountRate>
    <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations
      contextRef="ibb15b53ace4d4cc89a084c541d351ce9_D20220501-20230430"
      decimals="-3"
      id="f-788"
      unitRef="usd">231000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
    <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations
      contextRef="ib5dbb92c8fb44dc2ba4e9a4183b0e326_D20210501-20220430"
      decimals="-3"
      id="f-789"
      unitRef="usd">271000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i472a2c8c23a648a2a20e3abd4d4c0d6c_I20220430"
      decimals="INF"
      id="f-790"
      unitRef="number">0.75</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="id18cf987103643748c6db3d293c21a14_I20230430"
      decimals="INF"
      id="f-791"
      unitRef="number">0.75</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i8c34d5d2c07b404c96ed13f48c0378f7_I20230430"
      decimals="INF"
      id="f-792"
      unitRef="number">0.25</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i2618157cd36a473eb1be555923af9434_I20220430"
      decimals="INF"
      id="f-793"
      unitRef="number">0.25</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <kequ:DefinedBenefitPlanPercentageChangesInDiscountRate
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="2"
      id="f-794"
      unitRef="number">0.01</kequ:DefinedBenefitPlanPercentageChangesInDiscountRate>
    <kequ:DefinedBenefitPlanPercentageChangesInDiscountRate
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="2"
      id="f-795"
      unitRef="number">0.01</kequ:DefinedBenefitPlanPercentageChangesInDiscountRate>
    <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-796"
      unitRef="usd">181000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
    <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-797"
      unitRef="usd">207000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
    <kequ:ScheduleOfPlanAssetsByAssetCategoryTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-798">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plan assets by asset categories as of April&#160;30 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,724&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,845&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,732&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</kequ:ScheduleOfPlanAssetsByAssetCategoryTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i461991f9a104434190673d6c11e374a4_I20230430"
      decimals="-3"
      id="f-799"
      unitRef="usd">12724000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i461991f9a104434190673d6c11e374a4_I20230430"
      decimals="2"
      id="f-800"
      unitRef="number">0.72</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7564e3aaefde4cc68eb4d66be4958117_I20220430"
      decimals="-3"
      id="f-801"
      unitRef="usd">13856000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i7564e3aaefde4cc68eb4d66be4958117_I20220430"
      decimals="2"
      id="f-802"
      unitRef="number">0.73</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4021b8377b114d78bbf1ef3499af7718_I20230430"
      decimals="-3"
      id="f-803"
      unitRef="usd">4845000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i4021b8377b114d78bbf1ef3499af7718_I20230430"
      decimals="2"
      id="f-804"
      unitRef="number">0.27</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3bc3127d271f40c68917d5dfd4db4ba5_I20220430"
      decimals="-3"
      id="f-805"
      unitRef="usd">4703000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i3bc3127d271f40c68917d5dfd4db4ba5_I20220430"
      decimals="2"
      id="f-806"
      unitRef="number">0.25</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i000d0b9b003247e49169b92e76d8a09a_I20230430"
      decimals="-3"
      id="f-807"
      unitRef="usd">163000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i000d0b9b003247e49169b92e76d8a09a_I20230430"
      decimals="2"
      id="f-808"
      unitRef="number">0.01</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i03d983ee673f413c90842b0da9ff9f43_I20220430"
      decimals="-3"
      id="f-809"
      unitRef="usd">308000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i03d983ee673f413c90842b0da9ff9f43_I20220430"
      decimals="2"
      id="f-810"
      unitRef="number">0.02</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-811"
      unitRef="usd">17732000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="INF"
      id="f-812"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-813"
      unitRef="usd">18867000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="INF"
      id="f-814"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <kequ:ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-815">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of the assets in the Company's defined benefit pension plans at April&#160;30:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.209%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Small/Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;702&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,845&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liquid Alternatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;627&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;163&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,732&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.209%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Large Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Small/Mid Cap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Emerging Markets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liquid Alternatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</kequ:ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i923a5fb9c22b4ca38cc73db048a7825c_I20230430"
      decimals="-3"
      id="f-816"
      unitRef="usd">7326000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i312a8cb23fc94a6da460c8f4222f0639_I20230430"
      decimals="-3"
      id="f-817"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8a4fccb41c0d41d9bad0908cc0d8c23b_I20230430"
      decimals="-3"
      id="f-818"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9cc3a1c0b4c54acd9b37831a3bb584a3_I20230430"
      decimals="-3"
      id="f-819"
      unitRef="usd">2326000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if2aaffec262844dfacd06946a041d076_I20230430"
      decimals="-3"
      id="f-820"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i79fc58d8bcb0411fbe11a081e6d072a8_I20230430"
      decimals="-3"
      id="f-821"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i896cff42816940eaaee621949ddb6194_I20230430"
      decimals="-3"
      id="f-822"
      unitRef="usd">1743000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia0eb4dc2bb954fe79a558072049a1831_I20230430"
      decimals="-3"
      id="f-823"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib7de646a2dc541ca9f756667c74e21e8_I20230430"
      decimals="-3"
      id="f-824"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iadfc70c5513e41bb947fe21e6b0966c1_I20230430"
      decimals="-3"
      id="f-825"
      unitRef="usd">702000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i897db272c7af4c3197ac2a1529dc2f8a_I20230430"
      decimals="-3"
      id="f-826"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic212c7fd02eb41fe97da02135a2a32b5_I20230430"
      decimals="-3"
      id="f-827"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i84d2c48142ac411eb496c07b85230a6d_I20230430"
      decimals="-3"
      id="f-828"
      unitRef="usd">4845000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i93f86e2de3e8488eb7824809bf0d34e8_I20230430"
      decimals="-3"
      id="f-829"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i425180d6d80c4d73ad2fa942d6d8e85f_I20230430"
      decimals="-3"
      id="f-830"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iaba8749a1a26404e9c8bf4ea4a8c9546_I20230430"
      decimals="-3"
      id="f-831"
      unitRef="usd">627000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieb3130ef4af74fbabeb2632567506974_I20230430"
      decimals="-3"
      id="f-832"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1d2b508c96c041a5999e41c866d6dac5_I20230430"
      decimals="-3"
      id="f-833"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib1c69c8ad78245338093ee6b28093169_I20230430"
      decimals="-3"
      id="f-834"
      unitRef="usd">163000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i789bb8f7d31e4310960e2e37137bb32a_I20230430"
      decimals="-3"
      id="f-835"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if9efb8d4ca2d493eb707565a176dce6d_I20230430"
      decimals="-3"
      id="f-836"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i234054f8708d43f4811f8f93244fe91c_I20230430"
      decimals="-3"
      id="f-837"
      unitRef="usd">17732000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i251e9520bea74e6991781ef0e97f7a97_I20230430"
      decimals="-3"
      id="f-838"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib241eb5a32fa4fea9b004f728e78a69c_I20230430"
      decimals="-3"
      id="f-839"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id1f810c2a94b4f1aa8f0d78dbbca6e8f_I20220430"
      decimals="-3"
      id="f-840"
      unitRef="usd">7382000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iec155c938875403a9cd89d027b15e0c1_I20220430"
      decimals="-3"
      id="f-841"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4f78266f81774c8cb5cfab7eb95904c0_I20220430"
      decimals="-3"
      id="f-842"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i854a8abfd519441d95b99eb28db921d7_I20220430"
      decimals="-3"
      id="f-843"
      unitRef="usd">2775000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2b825859a1f84c25a9245c562c9110c8_I20220430"
      decimals="-3"
      id="f-844"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iab1212417875461884b453615e64caae_I20220430"
      decimals="-3"
      id="f-845"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i08c47e380ee54dabb1754d7ccb46e86a_I20220430"
      decimals="-3"
      id="f-846"
      unitRef="usd">2008000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie7b52ce2fc2241eb9007387adf55e35a_I20220430"
      decimals="-3"
      id="f-847"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i43427226e74849a88e0eb5b4a25adf12_I20220430"
      decimals="-3"
      id="f-848"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iffc659a9402841f48ab3f91f0d5a48a4_I20220430"
      decimals="-3"
      id="f-849"
      unitRef="usd">794000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iec243beb997e4e3d9e2437b00cb92051_I20220430"
      decimals="-3"
      id="f-850"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibe6caf6ca2e04c14b416ef5a51d235c1_I20220430"
      decimals="-3"
      id="f-851"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icee3a5c7b5744ec2a0b78771afc9000d_I20220430"
      decimals="-3"
      id="f-852"
      unitRef="usd">4703000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i517e6442cdb945718bfb4a5054667765_I20220430"
      decimals="-3"
      id="f-853"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0449597eea9b4e8bb4321131eeadb7d3_I20220430"
      decimals="-3"
      id="f-854"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iad9200d2ce534be78d4a456fc4ef6b6c_I20220430"
      decimals="-3"
      id="f-855"
      unitRef="usd">897000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9d0fa294085541439c1c28e09b131ee3_I20220430"
      decimals="-3"
      id="f-856"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7ecc70cd0abb4a2dbf24582b226b6ab8_I20220430"
      decimals="-3"
      id="f-857"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i912b55bb462d4adcad4393d6753058e8_I20220430"
      decimals="-3"
      id="f-858"
      unitRef="usd">308000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1115530ba0114611bc42e50e7b6324a4_I20220430"
      decimals="-3"
      id="f-859"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i55beed59b26e4f22a06bf6565cb3b9a4_I20220430"
      decimals="-3"
      id="f-860"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie732b5f45f464e6ca8f0b1fb3c13d76a_I20220430"
      decimals="-3"
      id="f-861"
      unitRef="usd">18867000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id38d9bc0dc4a4764ba3d1d2f6e881e3a_I20220430"
      decimals="-3"
      id="f-862"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3f2aaa221eb94ad69d94ee9d5db0943a_I20220430"
      decimals="-3"
      id="f-863"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <kequ:DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-864">P21Y</kequ:DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions>
    <kequ:DefinedContributionPlanEligibilityMinimumServicePeriod
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-865">P3M</kequ:DefinedContributionPlanEligibilityMinimumServicePeriod>
    <kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution
      contextRef="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430"
      decimals="INF"
      id="f-866"
      unitRef="number">1</kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-867"
      unitRef="number">0.03</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution
      contextRef="ia90c11936dba4904a9531ab5d52fbbd5_D20220501-20230430"
      decimals="INF"
      id="f-868"
      unitRef="number">0.50</kequ:DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430"
      decimals="INF"
      id="f-869"
      unitRef="number">0.03</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="ia90c11936dba4904a9531ab5d52fbbd5_D20220501-20230430"
      decimals="INF"
      id="f-870"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="i435c29a1ebfa44efad67bd3c713410d0_D20220501-20230430"
      decimals="INF"
      id="f-871"
      unitRef="number">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <kequ:DefinedContributionPlanEmployerMatchingContributionsAmount
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-872"
      unitRef="usd">932000</kequ:DefinedContributionPlanEmployerMatchingContributionsAmount>
    <kequ:DefinedContributionPlanEmployerMatchingContributionsAmount
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-873"
      unitRef="usd">967000</kequ:DefinedContributionPlanEmployerMatchingContributionsAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-874">Segment Information&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's operations are classified into two business segments: Domestic and International. The Domestic business segment principally designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. The International business segment, which consists of the foreign subsidiaries identified in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="#i1de8d1053c4044f7aa1eb1bfb086781f_94" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Note&#160;1&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, provides the Company's products and services, including facility design, detailed engineering, construction, and project management from the planning stage through testing and commissioning of laboratories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intersegment transactions are recorded at normal profit margins. All intercompany balances and transactions have been eliminated. Certain corporate expenses shown below are net of expenses that have been allocated to the business segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows revenues, earnings, and other financial information by business segment and unallocated corporate expenses for each of the years ended April&#160;30: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146,716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219,494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,604&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,822&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11,426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;282&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;191&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,867&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,408&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,382&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,498&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,139&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;621&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;621&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Kewaunee Scientific Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,408&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,511&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;738&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;80,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38,898&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;118,898&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenditures for segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,856&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues (excluding intersegment) from customers in foreign countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,559&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;75,337&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Kewaunee Scientific Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenditures for segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues (excluding intersegment) from customers in foreign countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="INF"
      id="f-875"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-876">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows revenues, earnings, and other financial information by business segment and unallocated corporate expenses for each of the years ended April&#160;30: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.979%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.410%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.415%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$ in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;146,716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219,494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,604&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,822&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11,426)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;282&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;191&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,867&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,408&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,382&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,498&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,139&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;621&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;621&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Kewaunee Scientific Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,408&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,511&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;738&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;80,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38,898&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;118,898&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenditures for segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,856&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues (excluding intersegment) from customers in foreign countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,559&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;75,337&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fiscal Year 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (loss) attributable to Kewaunee Scientific Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenditures for segment assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues (excluding intersegment) from customers in foreign countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430"
      decimals="-3"
      id="f-877"
      unitRef="usd">146716000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430"
      decimals="-3"
      id="f-878"
      unitRef="usd">72778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-879"
      unitRef="usd">219494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <kequ:RevenuesIncludingIntersegmentMarkup
      contextRef="ib99cbe4793c040dd859880b6ce8c5d6c_D20220501-20230430"
      decimals="-3"
      id="f-880"
      unitRef="usd">1604000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup
      contextRef="i66409b457de24b8ea9db0e15adf2f1c1_D20220501-20230430"
      decimals="-3"
      id="f-881"
      unitRef="usd">9822000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup
      contextRef="i17f99b083fb44457829907146d217534_D20220501-20230430"
      decimals="-3"
      id="f-882"
      unitRef="usd">-11426000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-883"
      unitRef="usd">0</kequ:RevenuesIncludingIntersegmentMarkup>
    <us-gaap:Depreciation
      contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430"
      decimals="-3"
      id="f-884"
      unitRef="usd">2394000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430"
      decimals="-3"
      id="f-885"
      unitRef="usd">282000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i17f99b083fb44457829907146d217534_D20220501-20230430"
      decimals="-3"
      id="f-886"
      unitRef="usd">191000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-887"
      unitRef="usd">2867000</us-gaap:Depreciation>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430"
      decimals="-3"
      id="f-888"
      unitRef="usd">3408000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430"
      decimals="-3"
      id="f-889"
      unitRef="usd">7382000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iba68a35a7cbd4325912b37c8a42846b6_D20220501-20230430"
      decimals="-3"
      id="f-890"
      unitRef="usd">-6292000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-891"
      unitRef="usd">4498000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430"
      decimals="-3"
      id="f-892"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430"
      decimals="-3"
      id="f-893"
      unitRef="usd">2250000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iba68a35a7cbd4325912b37c8a42846b6_D20220501-20230430"
      decimals="-3"
      id="f-894"
      unitRef="usd">889000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-895"
      unitRef="usd">3139000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430"
      decimals="-3"
      id="f-896"
      unitRef="usd">621000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-897"
      unitRef="usd">621000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430"
      decimals="-3"
      id="f-898"
      unitRef="usd">3408000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430"
      decimals="-3"
      id="f-899"
      unitRef="usd">4511000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iba68a35a7cbd4325912b37c8a42846b6_D20220501-20230430"
      decimals="-3"
      id="f-900"
      unitRef="usd">-7181000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-901"
      unitRef="usd">738000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets
      contextRef="ie729b60a90844b3893420d0d57361c11_I20230430"
      decimals="-3"
      id="f-902"
      unitRef="usd">80000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i34c4fe4e054c42a0be6b9bb2053335ca_I20230430"
      decimals="-3"
      id="f-903"
      unitRef="usd">38898000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iba2c6ce3d92e4dac939d0bb63984eb66_I20230430"
      decimals="-3"
      id="f-904"
      unitRef="usd">118898000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i69d939d6bb0d4862b73798c245d6335b_D20220501-20230430"
      decimals="-3"
      id="f-905"
      unitRef="usd">2856000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ideba7b4e000d4eb8886c09e3e9fe22d3_D20220501-20230430"
      decimals="-3"
      id="f-906"
      unitRef="usd">1292000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      decimals="-3"
      id="f-907"
      unitRef="usd">4148000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23df5675029345c288bde9f193ac67d7_D20220501-20230430"
      decimals="-3"
      id="f-908"
      unitRef="usd">2559000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5465457d161440f8737d4f3e58f566a_D20220501-20230430"
      decimals="-3"
      id="f-909"
      unitRef="usd">72778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaeefffc08f9c430ebb298fa36e4c30b8_D20220501-20230430"
      decimals="-3"
      id="f-910"
      unitRef="usd">75337000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430"
      decimals="-3"
      id="f-911"
      unitRef="usd">126848000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430"
      decimals="-3"
      id="f-912"
      unitRef="usd">42024000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-913"
      unitRef="usd">168872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <kequ:RevenuesIncludingIntersegmentMarkup
      contextRef="i68f7a9301a3f4938978283aee47bfa00_D20210501-20220430"
      decimals="-3"
      id="f-914"
      unitRef="usd">882000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup
      contextRef="i93a0af5a5c704ae09f78421067a08c16_D20210501-20220430"
      decimals="-3"
      id="f-915"
      unitRef="usd">3519000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup
      contextRef="i3f86e115975447b7b8aae1019a860422_D20210501-20220430"
      decimals="-3"
      id="f-916"
      unitRef="usd">-4401000</kequ:RevenuesIncludingIntersegmentMarkup>
    <kequ:RevenuesIncludingIntersegmentMarkup
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-917"
      unitRef="usd">0</kequ:RevenuesIncludingIntersegmentMarkup>
    <us-gaap:Depreciation
      contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430"
      decimals="-3"
      id="f-918"
      unitRef="usd">2402000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430"
      decimals="-3"
      id="f-919"
      unitRef="usd">276000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3f86e115975447b7b8aae1019a860422_D20210501-20220430"
      decimals="-3"
      id="f-920"
      unitRef="usd">91000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-921"
      unitRef="usd">2769000</us-gaap:Depreciation>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430"
      decimals="-3"
      id="f-922"
      unitRef="usd">-179000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430"
      decimals="-3"
      id="f-923"
      unitRef="usd">3585000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4d8e2f8f245e4158ba91b25300e91af8_D20210501-20220430"
      decimals="-3"
      id="f-924"
      unitRef="usd">-5891000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-925"
      unitRef="usd">-2485000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430"
      decimals="-3"
      id="f-926"
      unitRef="usd">50000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430"
      decimals="-3"
      id="f-927"
      unitRef="usd">1129000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4d8e2f8f245e4158ba91b25300e91af8_D20210501-20220430"
      decimals="-3"
      id="f-928"
      unitRef="usd">2339000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-929"
      unitRef="usd">3518000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430"
      decimals="-3"
      id="f-930"
      unitRef="usd">123000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-931"
      unitRef="usd">123000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430"
      decimals="-3"
      id="f-932"
      unitRef="usd">-229000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430"
      decimals="-3"
      id="f-933"
      unitRef="usd">2333000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4d8e2f8f245e4158ba91b25300e91af8_D20210501-20220430"
      decimals="-3"
      id="f-934"
      unitRef="usd">-8230000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-935"
      unitRef="usd">-6126000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets
      contextRef="i07eb9ad716994fadacba37a96ffddb15_I20220430"
      decimals="-3"
      id="f-936"
      unitRef="usd">91757000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib6a0995d858b40708d0b3419cfbc2624_I20220430"
      decimals="-3"
      id="f-937"
      unitRef="usd">27016000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2ca2ebd535504440b59023a1e53f9d80_I20220430"
      decimals="-3"
      id="f-938"
      unitRef="usd">118773000</us-gaap:Assets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i0ed419898ad14c8997f4f23ae9d0b06b_D20210501-20220430"
      decimals="-3"
      id="f-939"
      unitRef="usd">1613000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4d249c71e6544c83acb9fdbb7cac7290_D20210501-20220430"
      decimals="-3"
      id="f-940"
      unitRef="usd">295000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i767a6a8005e44d849db34afa14cd0874_D20210501-20220430"
      decimals="-3"
      id="f-941"
      unitRef="usd">1908000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e3c49b7bdf74b079553da120ca298d9_D20210501-20220430"
      decimals="-3"
      id="f-942"
      unitRef="usd">1317000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40c6621adfc5456994955d1968018f4e_D20210501-20220430"
      decimals="-3"
      id="f-943"
      unitRef="usd">42024000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc0cd04d9ec24d0e82564984d27f29ff_D20210501-20220430"
      decimals="-3"
      id="f-944"
      unitRef="usd">43341000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430"
      id="f-945">Restructuring CostsIn December 2019, the Company initiated a restructuring, which included the closure of the Company's subsidiary in China, a commercial sales organization for the Company's products in China, that was completed in March 2023. The Company incurred operating expenses of $32,000 in its international operations related to the closure of the China subsidiary in fiscal year 2023, offset by the recovery of bad debt collections of $51,000 that were originally written off when the Company initiated the restructuring. The Company incurred operating expenses of $28,000 related to the closure in the prior year period. The Company reflected all the expenses as operating expenses in the Consolidated Statement of Operations.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCosts
      contextRef="i7e800b6ee23a4e2894c72aa7f8abe31f_D20220501-20230430"
      decimals="-3"
      id="f-946"
      unitRef="usd">32000</us-gaap:RestructuringCosts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="i7e800b6ee23a4e2894c72aa7f8abe31f_D20220501-20230430"
      decimals="-3"
      id="f-947"
      unitRef="usd">51000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:RestructuringCosts
      contextRef="i72a92bc417734dbfa6b9630d85382b62_D20210501-20220430"
      decimals="-3"
      id="f-948"
      unitRef="usd">28000</us-gaap:RestructuringCosts>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>89
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M7/9$P5(4/VFF\QC?893!@52%WHKZ&[3Y3*U?*@KEGJAN8H//&*65TH*U8D/
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MT%X-.-V5Y[P/E'.:EK=;!$6W) W$^S6E_&4@CXZ;OSOF_P)02P,$%     @
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M-/<K*_;*BJBR+TIL>+U$XCL@4PO=KR)IUD)!7A[R!P_FC\)1E&&:3F3[C++
M2)=[U654]1_2\ :=3G"E\^XB+\FT8UVK$J=9ZI>(DY$YR8FNA3)$F9<+M '@
MF+YG;6K:0'U@+E GC!<QB3O,&4O(1+//+,4DD 7P 2AQ/ _8@@#)%=IJ$1GY
M72O'?99/.]9CE4,^"V@<N8:C+%G\IY^>$7'$S:(LR:;B7"N6XL#$Q".)<!Q%
MP]0,3\F=^]' V30T!9#?+@_VW@@AS,XJ"WZK^4/=U":0+7&493]:'+Q5:\<Q
MCW##<;K=KZ4RET:H%CU(!>YU]^B/V@4338LI@#U6."V*P,B,^,)Q?KV.S ;$
MVN(?5N&J[@#!H!8UN^%Z\<IVJ94Q)V6X1FD>RG(CV7 <;7'1 O8>>^FAF>:"
MK9A"Q&.#20#*>&0?CL//H]VF;&[.U^[2#9>9,U\\5A27 ?DC!'&<@K=5);=0
MY*(-?PF5%=B%&Z%I.:UZ?&8YQ8$>)B,#29R!/[>;1KX(@2K9V@*##[M:("%O
M!^W/M5FO1;/T[D]<R#&:L(EVGU6:!!(Y&4E(XB3\+%8"IL<2ZC8H*[?>WB4N
MX%A23H??8T53$AA^<K"].PN#5:6V8BS@O#)=U.$\G^8'CQ6E-#0%1B"2<X!X
M)G6(2SV6)"F=2O68$5(&V$A&-I+X#NTWV3T.F/CQ'$P\V[("4Z>7?69Y* ^3
M$7$DCKA3TL_)9L3#-38M3#Q&A 381T;VD3C[O/)_,!D3%W YIM.ZSV.5X3RT
M&D<.DC@';W?K<+,[_+,Y;OF:0HZR7R5UX#C&A1Q-F:/?M6(X#>D?64CB+-RG
MN[H#M0(9_CW0RR[,2N8L4->(!2?)"#P2!]Z0\3K97;[N34_-"!=K+)W6%AZC
ME 8V4G0D'XV3;TA[)](===%5) Q/>]-G1M)0NJ,CXF@<<7>R;6MCMZ/#OO].
M=G:U"4@90J/W_:E%Z3WEB3?LK^>1;V/P!@T=!S_BD\:/1^^-K+ZM9;,42O\#
M_0P;<W]>IV]Z2OI6K1T'?7!.>N*@%$8<4I"VL7N#=<&:)\6TXO)89641FHXC
M?6F<OK?+96TS)*P;>R9U64.NY)L:UI%7JN>L-$FGA:W'BK&@U)&V]-1QJ>'P
M%91=7'6AS23UD++(L^E9J->LOT'P:AR12N-(!2)MVVW3WWGL3O0 0TJL+:&>
M@*92^V6[@+RDS-E.>LWR [-CV2-(Z8D-Y<$4M1<R1@'[M^KE G'3L_,*4:37
M7 52JHO'2Z=^/&%TK'Q$*(TC=$CY_Q+/?-O!EN<>LBCDTU5=06)54-8,^#\[
M[[@(A>Y-G GN,4NS,K#]H2-K:9RUOUO* @^4;!I;@=4=5&=">\\LJ4M0G.33
MPL5CQ8K ]H*-G&7G</;<3F4N26G!G.,&GUF&BR0@=@0NBP/7*0IZ[)XM'CN7
M4MZC0[^=>W0X/[A0M;?9_^;JL>XT%-LK<$P^YM""&BZ(AP<C-_T=ZX,T1K;]
MQ[7@(-L:P.\K"17#[L%>V^ZOZ1?_!U!+ P04    " "C6-Y6ZW;D'>X"  "T
M"   &    'AL+W=O<FMS:&5E=',O<VAE970W+GAM;*V6WV^;,!#'_Q6+55,K
M=8% $M(N04I33=O#I*AIMX=I#PY<@E5C,]LD[?[ZG8&B)"5)*^T%_./NR^>.
M,\=H(]6C3@$,><JXT&,G-2:_=ET=IY!1W9$Y"-Q92I51@U.U<G6N@":E4\9=
MW_,&;D:9<*)1N393T4@6AC,!,T5TD654/=\ EYNQTW5>%N[8*C5VP8U&.5W!
M',Q#/E,X<QN5A&4@-)."*%B.G4GW>CJT]J7!#P8;O34F-I*%E(]V\BT9.YX%
M @ZQL0H4;VN8 N=6"#'^U)I.\TCKN#U^4?]2QHZQ+*B&J>0_66+2L3-T2 )+
M6G!S)S=?H8ZG;_5BR75Y)9O:UG-(7&@CL]H9"3(FJCM]JO.PY=#M'7#P:P?_
MK0Y![1"4@59D95BWU-!HI.2&*&N-:G90YJ;TQFB8L&]Q;A3N,O0ST50*+3E+
MJ(&$W%!.10QD;N4T.9]1!<*D8%A,^07Y1![FM^3\[(+H%'<T88+<I[+05"3Z
MDISMS$>N03S[$#>N46XJ%/\ RB17'1)XE\3W_*#%??IV=W_7W<6D-)GQF\SX
MI5YP0&]N,"=8KX;()?G"!&:&44YF4K.R ']-%MHH+,/?;:%6VKUV;7LTKW5.
M8Q@[>/8TJ#4XT<</W8'WN2WP_R2VDX:@24-P3#V:<#SH957@)P//;0QL31<<
M6E]P)=4OI>SW8QWUPL'(76\'\]HFZ(>-S0YCKV'L'66<RBS#-X*')7Z\)#E5
M9$UY >0<"]*6; ZJ*MF+-NA*.]P"\CO]/>CC-CO0_0:Z_P[H^D31PJ12L;]X
M&"U\M=I*78D/MHCZGN?M89\PVN$>--R#]W,SK8O3S(-7./XP"/:86XS"JZ"=
M.6R8P_<S8T_3!C]53*Q.@8=MX/O);C$*KPXD>]B #X^"WV-GUH5ZWD,_@3M\
M1;*?Y&,6%:B[U5-L/_].U8H)33@LT<?KA%A;JNJ1U<3(O&PS"VFP:97#%'\K
M0%D#W%]*:5XFMG,U/RK1/U!+ P04    " "C6-Y6P,<>P\@&  "''0  &
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MKAR%=$JQ !E:=IRF5,&D7\$RI7I%%JD-^"#RFY"D<-+44-*@[<[5/0)"G89
M&+2"%40,0BNX@DO5#T19 J_/96B^&T#*C(C3-&.3@64=V Z[+#4A0&SCZAHI
M$!Z!U X?POA;$74"4L?0%S*N\"!M9^.C&'L]4'Z6LUMO6VN/>'C:ZT=DSWG:
MON.* 5Q)H( D5-N&,G5"9TVB5Q+[ 6J2P]F 1@ 9"V4PD:D(PT@*2#@=DA/2
M48+5>+0FT%C8](<,1I&2VV!+ L$1@O>72<21CYPAP4F3B-O086 D]O16])K2
M'2.PAWRFVL:/V>F7QBT V16BU;(D_XOE:"G,6IQ?DBE=7&"@H$UZA'B6A&(V
MGZKKN3=>#JX0YU.8H^><%YTN+O%OL*&FG-QMM;R\,!M^*J'I.7 (C>#- 8;;
M[+*W$T(>, ,;;=RK$PYL5C+U,]"-(U%R^CO=241J%LI*QJ9)&59VWK;BTX,K
M.VN/:3A'++JA^A7"#0!$#QK-VD))C6R5M8/H3FH1$KD:YKN\]! ZSJP'+]T.
MQT-;XCY'P<OS:Q]V7D?S*PZ*Q['A&T1OI2F%#%/]+'A#8DQ.POLCB*E8^J2B
M*+%A8!L=Y\AIB5$\&J##)_)X)#EM=Y8!=/D+&JM.3UZ_>?W[R7,8=PAJ2G4(
MBG$[V._W>6QJ)Q2NUFP2_-O:O=7N[=!E,E0481)3^Z+/Q0^2;"02-R'T#'X1
MLU)-/,U*X_>]HX%(50V7;^L>R5'+ZLX5$Q8,4V:C](^*,6=4%38HL64;F7 $
M%J0Z>?:@73$N@^EZR%((FDMMX-;7'"7#>E)V#GEPB['L>9\ER/%(JC@BD-D
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ME0HJ5*#^XN([QFAQ]=V!^S7&-GS#+99#DL]N'+&=@].;S1#2(6#SA0 VGQT
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MEQZ%LWMR<E0Z?A 1;(_=-OK;5Z]DI'@>7<V7^/?RZD($S=/=:>! 9I@NE_Z
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MST^D>]7^ #_Y0ZZKJNNJ@O^DNTNZH0%XOZY@BLT/VL!]V?>7_P502P,$%
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M#ST7>)]<P*N;(\Y!!_=.VO<W?%Q #07;EW[T;.7PLQ>S@40BX$AA^-D:9FU
MV/<HAZVDHZ&OD&1>DW)PSEK?FNY)I1O(+"H/NIH-0LKF!F26=/:XM)X42_3
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M/;\^CZND_67?*A-).$<TL;P7*&%,[Z?VN!EC!CF-&98<>0S/=BQ?3^=73Q_
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M4K0 OR\=\D+X0@>D_QGQ\G]02P,$%     @ I%C>5K_"OOV  @  > 4  !D
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MC2XN^P&8QN?-P%%9>VM)CIU:ASE_C6A\ J^OB-Q^X#=H/]O97U!+ P04
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M 9[/#,JKO* -ZO]0G/\74$L#!!0    ( *18WE9I B4Y<@<  +,2   9
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MMV*9IMQ@<S7JX/)[014,(?D?\7]2U:!UK$UP# 2W><0)C4_*3()WP*M3F!G
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M*9LW'Y^?\G@_6,-I,)XPHP:+.53\XP0/#>?!9$I: @%A=,Y@^JK ,[(5 JE
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M1C_FL",A)SW6L^X9QLV. [)%BPBI=;_=Z9&5NSAU<'[9^ZB1*VR&Z=,--:P
ML_^^T3WMO@XM_4>1PW#_:>E7[*7I6#I3:TP-+V:3@;#^<XV_J4S)GTA &97)
M^>=626"$!N#]VIBJO:$%NF]FU_\'4$L#!!0    ( *18WE;AZV))#PD  #(8
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;*59;6_;.!+^*X2OV$L
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MP(H5:V_[,-P'V69LW63)D^2FN5]_I.RX*= 4.&Q VX@2W],C&5)=[+3Y84L
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M](-=96F TQ4EY4-PN*LA%^[^IN"23\0K6Y8Z(-K!"UD5N*Z"KC:JRK7R-Z,
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M<#$;Q'6RNPBVYM=_+%[!EOQS"^XK1P_@_MK:T%V0@?[_H+O_ E!+ P04
M" "D6-Y6Q9',-:D-  !])0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6RU6FUOVS@2_BM$+MUK ,>QY==TVP)IVMX6:'>#9O<6B\-]H"7:YD4255**
MX_OU]\R0DB7;2=,/]R$199'#>9^'([W>&'OGUDJ5XB%+<_?F9%V6Q:N+"Q>O
M529=WQ0JQY.EL9DL<6M7%ZZP2B:\*$LOHL%@>I%)G9^\?<V_W=BWKTU5ICI7
M-U:X*LNDW;Y3J=F\.1F>U#]\U:MU23]<O'U=R)6Z5>4?Q8W%W45#)=&9RITV
MN;!J^>;D:OCJW9CF\X1_:K5QK;$@21;&W-'-I^3-R8 84JF*2Z(@<;E7URI-
MB1#8^!9HGC1;TL+VN*;^D66'+ OIU+5)_]1)N7YS,C\1B5K**BV_FLTO*L@S
M(7JQ21W_%QL_=X0=X\J5)@N+<9_IW%_E0]!#:\%\\,B"*"R(F&^_$7/Y7I;R
M[6MK-L+2;%"C 8O*J\&<SLDHMZ7%4XUUY=NOJM160<NE>*=RM=2E>WU1@C ]
MOH@#D7>>2/0(D6$DOIB\7#OQ(4]4TB5P 8X:MJ*:K7?1DQ2O"ML7HT%/1(-H
M] 2]42/FB.F-GB^F^-?5PI46;O'O8Q)[>N/C]"A47KE"QNK-"6+!*7NO3M[^
M]+?A=/#S$]R.&V['3U%_KE%^F(AXCTNNDOH'<9/*W(G?UTI<FZR0^5:LI1.Y
MR<]CV-/J154:NR4OYV6+L*P(05GP\MC<*ZOSE7 F4\(L!>V48.Q*'0N5%:G9
M*N7ZM(]38=%&624DN(._".R)9;"Y3H/1!Y,>V!#+RI9K9>N-'=B[5[A3>4\8
MBU!)4]SUA)*6^*M S0JL")NX:N'4MXI44!K^G7=DG22RQ$*9)[2/3!)-24*F
MHI 6;&LH ]N%#>@YR <:3)NE.50,'@ED2N%D*JW&DT9\45ASKQ,:!.TU0I5K
M60H)?5!Z200>*1FOFZ5_=V(+ 5E'Y&DZ5LPW5&&1-S'.*S >PX*@+#G9)15;
MA-A-I8/X*L>$W*FXHBPH8IE"$=+N*/O=6#7'S.'E/9!S;2J;;H])V4@'V5P)
M98/AS%2DU4;,0[$>W;GVS\J!-C:OYXA,25<%/R>;,EOL@4=L$\P6KV4.Q>F<
MV/T/ZD-KFEFD>L5*=*SELC-_*;45]S*MV-%9#=(YA>UH6YK[@\%#R]C:($?+
MO4I\6#0RDF_XJJG_Z\-E:5*44_=*G!)7)<S@P*SC=$G_(G$5QU56I:SX.MQ_
M:V3K[8B?BN&\-YK.,8@&/5IZW8A[TZCGD(1K/3VBO!Y^7.D\)S>$;"37;@<,
MHM[E.!*?\A*)  X:&_R;CR=B-AR ][*"K'#JU#@G7@Y[P^'H3+R,>M%P?N8?
MISL/*Z1.:-)H/CVCZW@8G7V/.6BXQ=83&B 37WD3?WS,^,=E!='Y=$9$P=+D
MLF;;JK*RN0@>4+M/-!FRG//!F?C@H\F*QH]8W3_];1X-HY^;Z[/4\ 3/>RJ8
M]6:C:,?VQXI]D$*W<F%+GU]/Q<OI"%N<,L.3"0P2 ONKBLTJ9Q]EKZ2PS9U)
M=>+=$$DQ1Y3?$EIQG(\TK&Z6K\2O%#65M13%J98+G2(?(]*?NU?;VW_CDD$)
MPZHU!1ORW:<\IN+T\C/\Z8RY:G8&\)5>D^QLIV+<FT137"?PNBF53 6^D CD
M0^-*8&8P';.6$6Q@:@DW/J<9LNNZIV+4&T\COEX.Q^)/1HDJ.;\*R1NN566%
M-_ ?SA>9]PK4@/74T:A#/FUB][UV,:E#6,I\DSYBYX48]\=T^4H_P;Z=NJ#S
M&- =5?C7BRO^^V)L*:'L+>1;I IAH\^C 0!=:\"!1*L=E0WQY08/HF&X#L1?
MY$ ?.AFK]Z."DA5N@"), LA02WU-.6&7T9X2]L-#X8,]-?GJG*@^$F>S_FR"
M^>'R/!UQR< ,DRORO)"I<T6Y/+!<)_67FAWM3*@'^DD=Y/>E)B4^GN:?E=N[
M6?.4\^8I9\Y&#\>EIZQ _HKK= #_#4'$8H-!$HG==AK-Q61TR68YD+$6K9&5
MMJ8('5%\DK((^64<BWD=7;N0J OETW61,5$#OS)X*8?ZTIH,!'?!;CC8XTZP
M>[YP@8MUK%1OQ6H+$*EE$%+N6&A$[62..C 8=* '8-@2"9#6%$AI\99F8H<F
M2:L.0!0;L-,(E<J-AQ-0>&XR'</XFEFW *C Z01G%?BN.%C"1EWHH]BVO&<F
M[PAI[!6(1R1B*MB!(??!HDPF>XP3S.F2&!%WY'F>(>^@M%5C.\G(T;$+J]H'
M017&X[+$=BOW$*2KJ\1^4!#I.BH.PL 7 &\K5*O>% D -Q,:1CR<TG# PQF&
MDRD/YS3T<R_/\7\T$K/> &'''GN8/PKX'"35IHXEF!N.C2RI<=Q.Q+V60HI%
MI5/F=Y&:^$[( HB2PGT#ZQ*Z+'P9=\#$5M9QEL!+K=-+'?N?R#&L6G!Y9+/_
M@NIDK":E /3=J:!95U8)'2IH_H[1]6ZR5:FO$FM=$ 0O-S@J"?(PKJ:T;JD?
MD)5#B-!YP(9GH%\?99.Z-E,Y9DG(2AO( *R/Z%,%J2J6A2X;#K$81'6! N'/
M,S[C\.HU:@'T<&^(.RXV*[@!IW$I5DBV)0>"SUCWX0A' @H2L"^N S((.RV1
M48REXQT4+<F+ENE.D;I.CD0_>"0!(.FQ(-*/:BEO3PC9JE*T,JDK5-)'?0)G
M0#*2M^EHG3CW"V3JR&'NM=KX"(C7"GY!28^*"HZ8J+*Y<MX8["Y0''BCWXX=
M=<1?6J4)J0"9+5.(@\2D9K4EV@UW?.#YQ]75#5RK523[XH]P(H;OUJ[90W8!
MOVH_>*$*MQ9+*CW!&6H W01O.T53:9%/GI_HG*>#3/4>KH06,@JEFE&O)>E]
M#S,\5JT<Q93,N]8D&9!Y&:B$E(5"$U W5UE,I4#V1]P@CN=@96515V''Z]1Y
MH@HJP=AUSVG WUUN-E0WP=J6+1"3!3RMO=E<?;2K#]QM@W5]"(^MJ59P6L;5
MFAHD\!^9RW0+55&AHC8K:7/+I#Y]O?4^#;>D9@*)F%&GK<F<F$Y"R<8VC0,$
M?C^:8/^BLH5QJL?KJIQ3D#\4H"IK4NG"4'X-H>\\600Q#?RCS5I3Q+%,3J]R
M?ZJG)2!MN:'"#1J*=_&M\KB2TEZ^ O:XNKJB.G)U=>8]*I>^Y8*<8G=@OJT8
MOQ2+5A(/ZZ,;1Q]M@RR3*NING$:3@<@ %CQ\HQY.:#8(4Y6@Z$L*>6R]!%@.
ML;QM-TJLHI3/]9T!0U]<B>&+!@Y>)"K@PJ#[3JAQA'?J&-=-XI4AV\94:7*$
MUCZH@N$Y4!\80$$UI]%H2%B$29U&,[[IM1P]W1Y-&Z4I=X=-G=_#77USITD#
M&T(%M!]4]\ 1]&B=V*WWN:$* %Z6I4*Z]) $+,."3>Y^"H63LBCD*PZ^5$$*
M8@!!=-<77_$?%%,4"#HM[I7=.H1B\+&LTL/BRONTSI"]T*UJGV>]$S5N"V%S
M*KW<1<M]*[".]$9Q.SQ  $IJ2OB[2DXQFX83->MQ^Z06$9>^M0ED2_U+OV)?
MS6WJ,K:$GO_HW_9#US(_YQN4H?B.)**F*O RKBMK-B4LS+G4R^HR2<\(.$B[
M4G7=JZ/*2UO2([@(X%T<3IM-KZ[L(.&.7A@,,[J<32A>:G':Z(+BP#]\%("4
MG<9?")[.3]'W0E(='G]:'O=_"<_AO!V>@]FQ\+QIN3Y1H!$L4*H5$ 2)WFE[
MAM[XLYI\3.G:4]K6T/C%;O#!6^)VIV9 YJ@W W:><;-GU)M/IF(V$A_)+'6?
MI#5_W*/3)8#TN#<;8-L)MD-A)7%Y0#O<4S<9L@VG(S&$!',1B=\I_[A=8VDX
M&.R:2W33/4EP]\$U*(!K6Z=UQ=U[KT*][XU/'R5;CO7*ZVY/;9\Y_PS#-0K7
MD?C,D7(M"SKA]D;<%*J;;[O1+476Q1>=\,R(Y^VWZOC 7M<[G$-FX]'!G ^9
MLBM2Q9> ^&>#Z&!2QTK>-/M3/FM8!(&3ABT1J#C/SP[F/6W&_=G[YCRFB6,N
M^4S=SH]3W-?M;'8H;U>W$>)O_@S=7HZ_IUOR]N?H=G[Y([H='>%NI]NZ8WRH
MB5J/=O=6KUU0D;E2%%/@?4WI[[;TP)3/34C.:T*D7.I;P*VT%4YX_EU2R-A4
M)%UHB&7A/(60#!W05K(.@!0DFQ=]7.Y0S4"^J:Q-:4'J[&Q!U:VTDE_^A33)
M[[T>_*L6%W:F=T+?*D.RA+81"+DU5GL2]!F"IC/IO=0I99!^\XKSNM7E\ EX
M_S6G;/)&NR/BU;I[IUDM"#^6FG$JU=!&X.8='P/2O1=AX=A#M Y?B1%R J7=
M6[/-VM20EI %T41T1,,>GRU257K@ V-E_CW[[IV9+^]$@+]T(-K-*\Q2'6.#
MC^>M!.J[2:AG\9HD[K:'%,%X(HJ4_:+.PZTWDXSRE]O]A:(J:-'HV))VL]5S
M_RP&)D?W[TZN.Q[8E^A.OK\]/*E*&?1K.L\RBJVR>G[W%<R.E_'W".]W#A\1
MCBO]Z>4HVD&(RRE#"/;WHPVQ7A>Z !(U+Z_3;:_IXSUI[^W.65CWDN'D42:9
MD<Y+\2!R<TBMR6+N>Q6K; &UC8;-D9R$Z)Y0$DWPM?P!'KHMR3WPUC_VQ<5%
MZY,82O[\X0_9"+C(?QW3_-I\6W3E/ZG93?<?)J%FK CMIVJ)I8/^;'*"DPI_
M[.-O2E/P!S8+4Y8FX^$:B4E9FH#G2X,,%FYH@^:+J[?_ U!+ P04    " "D
M6-Y6Q7P/^AT&  !G#@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6RM
M5^]OXS82_5<&;M%S %XL4K(EI4F ;':+%D6+Q:9WAT/1#[1,V[S*I$M2<?+?
M]Y&RY&0WFRYP_9+PUSS.O'DS,B\/UOWNMTH%>MBUQE]-MB'L+V8SWVS53OIS
MNU<&.VOK=C)@ZC8SOW=*KI+1KIV)+%O,=E*;R?5E6GOOKB]M%UIMU'M'OMOM
MI'M\HUI[N)KPR;#P06^V(2[,KB_W<J/N5/C7_KW#;#:BK/1.&:^M(:?65Y,;
M?O&FB.?3@7]K=?!/QA0C65K[>YS\L+J:9-$AU:HF1 2)?_?J5K5M!((;?QPQ
M)^.5T?#I>$#_+L6.6);2JUO;_D>OPO9J4DUHI=:R:\,'>_A>'>.91[S&MC[]
MI4-_5M03:CH?[.YH# ]VVO3_Y<.1AR<&5?89 W$T$,GO_J+DY5L9Y/6ELP=R
M\330XB"%FJSAG#8Q*7?!85?#+ES?J0TH#O2#Z1,,IBYG <!Q>]8<0=[T(.(S
M(%S03]:$K:=W9J56SP%F\&AT2PQNO1&O(M[LW3GE&2.1B?P5O'P,,T]X^5^$
M^4'MK0O:;.C7FZ4/#J+X[:5X>[3B9;18*!=^+QMU-4$E>.7NU>3ZFZ_X(OOV
M%5^+T=?B-?0O3<FK("^[^ (R_;)5=&MW>VD>_^$)Q>[2NB?I%#6M]%ZOM5J1
M-L%2.%A:=AYW>4^^1_,7]-;NE ^Z(6E6  _*F00BV_.$/^Y_;$M[ITVC][)M
M'U%+7F^,9Y"WZ=;(3 ?'6<+4Q@><@5VC80:/^KN":K9&-[*E=>>,CA8,AYNV
M6\4<^Z!4FPX>K%U1*Y<6T5GW2(U<PI'@'ADL=XJVV,==#>H[=A&LMNI!+UM%
M_A$H.^RE/MDY.*:&6>BIZF=+9= QCPXW8+0##X3%UOH824_%,W8^X0-(6]UL
M88ZNYP/RL:8 *Z0+[<6@=2Z]7FGIM/*D5ST5*3GTLPV*.#&ZZ]MK-+V#3>1*
M@NF;IK&=2=)_;UO=1 0&_NT]<'RZY20#+*^Z!O?'6*)X= KZQ"Q8T*T.0](8
M_@>I6[BBS 8A*>1UPU(<P76I ??$ /E_:,@QQ^CY20-K9W?I_GTKC>GSACTL
M.=MMMDBR3VX?>=UI'[\(<04ACCG5D>'$[J M5+?QLCFIV:G&.O0GDH%,+( V
MNK/6T1L'KP%PT[91Z<HU/1?H^' *P?=R>XJXE?>*EDH94JU&9Y9!K<[I5CD0
M8>"HVT?'%*D'?$ ]$/S6'@PL\!U,[D!_,8)Q/VSAUPD5>K=-!*58>*#GD\+K
M%;6V.'B(= 29!(MK/&*]5Z:+25/21;*.PK1 <K2&NZ@[&8,]M8+EXZ<%&FTZ
M<_+EA;@ @$N@VJ-8'W&CAPXBT^CCND4COZ"OHTC#UG8>D/[4$IX7Q.T(_XM%
MQ=-WVL?J_B\@TZ< #;R/JU>->DC&[?%+B=SC'EXL6,D7&)6"E66%P3=?58*+
M;S$2O&9%73Q7RD 6<;;("JI9)01-.6>%6)R-QF\5.BE(2UP)E@-%5()XS3&K
M%B6].S)-4Y2\/T,:8]W&JH%KR,X#;LA9D554LAR6TP43M3BC AY5\&@X-E [
MWBR8F&=4537,>5[3SU#.D%:(.3B][/KD0RK&FG^B[H*#+J(JDIS!]8BV$/S9
M^!G:T?6/07]4!]FAK.GNU("'7$4Z^K *-N><IB7C%3^C,J]H^.+@,Z+03JJ,
M95E&><4J1#PXP7D_?Q?#7J4NWJO*/[<&R_,%<@321MN"\:(ZJ6*J'H86I9]D
M^*R7RTDET.+04U-;3 U5L/F\'D0S7%#.69Z7'PM1?)$0Q8)51=1?(5@FBF="
MY L$78K/"+&"/'*P6=,4ZLCX9U589()$N: DPG)1?Y$(I[RLSR)^-:?I'-P#
M?PJL:G[VD@RA/<ZXJ*/H\SKY5?V?&N0HY:?COT.#4R$05?0QIVG%1)Z=Q1+C
ML88_TF'-63DO01S+T"B>ZK L\[_4(;H$STG4\Y,EJ[._2X6<Y;P<%#/*/&=Y
MP>FE7Y>S)S_^@;I)3QS? _;O@'%U?$7=](^'T_'^"?93_QFD5JUAFIV7\PFY
M_EG33X+=IZ?$T@:$D(9;O 25BP>PO[;X%7*<Q O&M^7UGU!+ P04    " "D
M6-Y6;(3ISS$#  "%!P  &0   'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6R5
M54UOVS ,_2N"-VR7(':<M.NZ)$"2;E@/Q8IT'X=A!]FF8Z&RY$ETW>S7CY(=
MSRW28KW8^B#?>R0E:MYH<VL+ &3WI51V$12(U7D8VK2 DMNQKD#13JY-R9&F
M9A?:R@#/O%,IPSB*3L.2"Q4LYW[MVBSGND8I%%P;9NNRY&:_!JF;13 )#@M;
ML2O0+83+><5W< /XK;HV- M[E$R4H*S0BAG(%\%J<KZ>.7MO\%U 8P=CYB))
MM+YUD\ML$41.$$A(T2%P^MW!!J1T0"3C=X<9])3.<3@^H'_RL5,L";>PT?*'
MR+!8!&<!RR#GM<2M;CY#%\^)PTNUM/[+FM9V1L9I;5&7G3,I*(5J__R^R\/
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M5V+4@7;7+9<VFA[(WK'9<\[/.DK>=6LX=Z$:UBGMRHN9W=R>/P<@HKA<V)N
M5\G"<GMC<^B\UU6<\HRY@--RAE)+J/U C,T@!C#9'(_$* L M@6_IIT\Y*3"
MM?CZ0T%Z!1U&]G7LP*=IIY"$'*G9>4"BV_:6!"ZJ39%A\O!)4G9@! \K<1_X
MF9RO(<%ER"LVAK'[&)X0;KKQU9><8J$1I\:0?(^3$HDY.;*5N'<*8K! A-IU
M@!YTPB#CV(T&K+RF0@>K*$UV_7IM.5T41) -!WMWW_3K$)2Q(]DE*3GIR>S0
M+.L\RF# $15OC8DR9%(QEE$QEI.']PO[UBO6UX-G__G3U2^)GR;[/9*71=_^
MS6*V>+R8G9^?\T-\73Z^H*\S BN-X6IU0;!PG<:M#LD&4.A,?;.<75PNX_SE
M[,&C\R/S/5M;4TC$ CH!@@KHA)6OJJO3/Z!S %,4KJ!R2-I956>>OT7*[.+8
M4JPMR"1;P]Z<3XLM'92-))D<*AM?8YVK'P\_&".0<4;!V@W>BUSTF *)J*U7
MPT@N1&-?S*.'5+T\6 V,I4U?SU!<5W>QE"@FR!8XWB<D.*PD2KPR$M[#!CBL
M [2RM2*/KAPXD9R>"YB467\BK,52]F*R]OSLO>,-OO*6<UBYOXP$QWN/D0:P
M_3GE8!I$:3/E1"S'#72K95< _3,-Q[M8>V]B+=I*6'I?61ISW3$;5) %\H>7
M@VSA/L%1FIA1UH6,:7 :3N"Z<WW9^*R+TZ?UFI*LJ%+.QT@!79)2?FIO3#GS
M)3#B':Z1R]2,_<@TD-@XKZ>YQ9*ME$I WB4LSD<W+Y%S\I19%XH^HY6^L X_
MRN+[RF=8EK.1NW!YIIPIUJ?1AGSR1*%95+C3'TVH[OD+NL)*XDLF/:7#\8)C
M,7TI\9MN+8/#-[X@KUY!0[K;@[H\32H-TI"<=\!)=3_XZ:5HQUNX'A^A*7O/
MH609ZPPV2"<S\](-1_,K>=,9.RPI!1NJ>N(409H+ 3IC366*HJP\+P"36"*V
M'>7\&B[$;S[<1BC#FX=7R33P5UQ6%3K[X-*(3%;1,:CC:M:.4V?1$2,_A0KZ
MD9**[)K1&/;4DL<K@SP0EXTIF34X V@T17*WU:W8:Y"<N[L#+/8\)-5$WZ_&
MF4]W\( 0?X #R7@(<R0J'Y8AS$1V.!Q,$@'N2K"L<U,H?V=P4[-A[3^$/ER_
M4(\0W?:NP<:2BO40AJ_'1:(I"_\9;B%)46=(Y.&0)-!J'Y79;W$1^)9B'9P2
M\#K%-,H#9D%F+U*S?^YCU#7%*$1BS0@$"ESQLE52;Z:CB;R)@LRD3"'%&BAE
M+G<9M!MQE6IMB*,(XO8V-VGFL7B_F"ZYOR9,]UL BZ\'5_:&+TS*8W7\/T]5
M78TN_<+ODD>M.8F"&/?+_4C=;ZCHE$GIK^)[E-9M;1-UB1!6Y0W65_4&;"#(
M!8B%0U-:*TA*@S2GI4R,C@=Z:6\$8?@*C+]G -U*J@,']\&1)HQH--S,?"]G
M/S0MWF=$!Q907<A8!E&4/3.^AM7AVR'D-P'\J"I' 7-4&F,_V!*HK+DPQG=^
MI^R*5O!S@64\"/$&$J9D4A6UKB0D<^YXRC^N0*O>8;CW= >S$_)R'K97>1K'
ME&Z0$GWD:$P#H5))!J)>#Y_W=(:SY8\>*D*,F4_'=A&P2B6-PS&;JS/LS9 9
ML2O@2S2""SKN4]TCI?IH.R%Y/^"4(9$G B55#71^ R"!(%/WA(W:#Z8;[DJ'
MI2)=45>^M*!H%>_OP&JWHUJ7IT%*9&DIKE[*ZB6.!CZ"-8[<TER]^H@!Y!LI
MA2QJ>@I)KJB$DZJ9G\C(/DHU8+I11&#?B&. /^3?>X&F]8I0B??Q3>_/K[35
MG9%]=7<LES2%";[_3PZ6-"5A:6L1+MML>TO'/-2%Y9*N0-Y=,(X0LIP"21UO
MJ&.I;E<S-F#+@I2)0.2'F.8:&56.4TYGHC64L*^,W$+QG0+++64P[43XD1A2
M"_7??=T)"LDD,DOWDS]*N6N1XGF6EFS&ZI]4:$+]2,Y85EG"G;(LZQAYPOJ"
MLBEX)/LQE@<*GI+B!A4LY-M,RA58](\1[\2IPY$6NCW,YP][$VPU['+@@@"$
M2. 'FBT,>TTXP"JG<[J2VPBX$+[IEZN59) W"XA$"Y?]BBHROL[!Y]\7A;@G
M+\BO$_0%<J"[&CSP[?K&IRXKNFON.ME 50<.>>?6X\PX+4DZ/ Q(E&J*X<G(
M'Z]W%Y^ZGKTQ5<_(B&Z1CK4N?3D5%7ZSJ9MQ>[U P1HEXJ;^AK)S:B*1TA9'
M7+DN%X_.KM0[Z%925NDZN8L1^7*,4BOAAWV.[SJ2F\--3276-O2!$*G2.G^O
M$%'#/3LW\]GH CJBA?NTSX$A\1+Q G!.H)$7Q*AZ1>6C<*&3W!)N@WCBY:7/
M>A(W2MHC%/94?70929V@)!5?0G(AY876[>U6Y%7JW^O67]J.*S)>;+$2Y.\:
MI=AH2Q,.==B&/ZZAM2L,"&?B!>BX4]0G"U',<_6/>D>55H(F;(=2Y?@\KLBJ
M, LH$)GS:6 OB\)/CX@'(T#"U"%CGL7QG&8U^S7RE,-K[H'B_#M:\G!C*K(.
MXG ^8ROI5H_58D.BJR@ D]/ONVWMNTZ(BJ\$>%@B=^-TVZ6==2%*(06@3B :
M+E=884T:R?U9T#>DM*0C QO?^MX37U(68C=U 20 [E8"A3G/6!MOJM+J!>%0
MA+HQWK0^22&MMFFI(<O=2.4I^C(BR[F-7B(Y1D%#WDW$TO,0]^46F*-F[(8)
M"?P!+$^=.R%O"BMZB,V'.^CNT'_"926"<*#KKPW=734<6MVD-T&V=_>:,NYL
M/G4SZF)E.>#*X9IZK;Y97ES&VN_E\D*^'"URC\O"4%JD1PWY!.Z)PO\*J6$Y
M?]^=WG?*#>$Z["\HU7-?]_!RJ"0S)7I<M#[D/H*$9MRJM.-*!L%=YX+U)O=E
M[&_Y(HIYEB3"UV257G?>)HD;.2!F>TUPU>?7PM+,UQL9S,SBJLEF2]*HEM*N
M<0/(\?9:5HS0)!O*BH2 AT+.P).O+(=Z,V5CTS7EV(JTF&X1>@%*2#Y>U&R4
M[=%6XZ\@,XJ;@X_.9&2L$[G0US-XELF=Q5Z$Q70;P9N0FQ[<SF?.'>V!8B"9
M$WFA6$O%J6R-+KKM:49'!?W<M+H<HP8XX9;4,WJ>T&-'D+30MHSGJE;(J<C:
MA])U[]C*DFKW(;_%W2S1>=UM]=.%J^FF&("'9@]M-Z#0G/+LF,Y#A[EC,#"'
M3.^&*IB9CP+B1O8VF?_>NRZE$BO,U&EH3$Y]2MX1\=6F!+MUSV:_MP%?6_=(
M8W^CC>ZHAW=:5V+WQ.)3'1!< /^5 O!!=?G\Z=S=M-<[0M7'[Q[ GYZD(T_4
MO1/_Y.3^N%K:.]\!%_-Y?W%OT_16"@7UC76A<3JMY ^M3Q0I./D($2N..E8C
MJ0_<EHQOS^:T*VE*P@9(3UJJ?3J?(=^YNPB<>%P.U:#N 4GNDVH#CK6UJ[[S
M/7C$XN G._W!5.&B+?/@9V7\[W(#BO&(>7U;S9%=$1 <9)_*5S=-P0!)E0 ^
MI]*"=TJI[JE8WB%6N:Q#F1_6Z"MO"9V\PI"*HJX$/->^:2"EQN&L=B+[ 4NS
M%7"41^[ 542?=U^>_U4Q<W;+('OM[Q\=#$T@?]_4E,1H[KSFZH[DJ*#/3B.B
MP;&QYE;J[[(J?DCSQF%W(_G'"_"]UR8@%\('4Z:XC+T[R^E>FW?P&527D7X.
M]@;E<#E)WRN$#ZH^';+3?Q=M-1II]D::="0C]:UN-Z*.>T 'B*$NALM' 1Z?
M%\*7L1%F.=VL<I4#_G>6@\0+ B0')?.%-%3Z2X0YAX"(@*/A9I([)&$Q.WEM
M0-+& ([P&T,_^J=LBG#=*)6;T#'D%W$))$LZYP0=T?VZ'S8IQ=@ULIQN^W@-
M1T"O>[S@4G=VJWZEQ*XX"HC^!#DI11ZZWMUO4D_>')'7;O@MABVFLER&,H@@
M!.G)HQ"9A55]IKR&1?NW7<*CN7K%M^54!_E)WZK%S(/\KWESA)-@=A)B!9&?
M]_/KN<J1R7*=3]JF#S$S%LD(&L<33T#R]'M9DOD2WCD@HL]EZ>I(:-S/2-;^
MJ/=>+^#KC/0T0D;>>4W@<X6PQIT0PAC[VC428TRG]T).#?LA7ZMJ?7^!6%*P
M@UE\DR7V=26+T5T%O\U*GZE#;&/V2$JO?M*VHGY&QMDEFLLO17#=4/#K'>MD
M0Z:6AM9LJ8> JVR$-KA!W32:%N(!T!4IV0'891\HPG)10:XQY^KO K2K?/0Z
M2I#UH.#IBTGQYF=T%'_2@\3VG.5T;\TKW5:<U;^%"*[I,O6@W_A2(G2_#A,T
MX0$5DOBJ=N_BPMP]W?@2!+UOAU'^_CKI40_-2N$%I+EZ:8N>O?#=!5NS+J2&
M*C7DOF1O32_R^<N;A# ?*X0=,UF/*,&<\UBHC>_NR/"^(G.\=_+N^KT[N9]<
M_$=SHQ8 N@*3":1).$/13NIKDS9LTW12#25"_A6^E!T/>Q05.W/:,"FJ88<X
MJ0RQSV4YW9R2O'=,1G7-J_^2"$,Z"U])5\?53K?YX;C][U^&93G(3&)["+WT
M.L:=<Q.CEM^UD-CP:U+[+RR.P%!X@>JNN24Z1Q<3E!13O9U=SLR?.</VQ2.D
M3"FW?_O+H^5B^8-L,WTP/U&(N&N3@+)QX7.$P.A;O,[S6Z(Y:Z'Q"606NR"6
MT_T*/YM=^LK]-9G&T8/^.E*4;OX3@1#!>_%0DIS75]?/I1Z60XSO^<GIX@*B
M_"E)M.B5<"G%_"C^%;IPL*-B=N)EU1K85Q9>S6('W,6J!6?E/DD=WJT+I3@&
MD;):,:P6P[TDH:/^*T:1R?L<,\FD=163OX1@>'L , ).<=-;2;[I1: !Y$CO
M_!!178"M!$S+ 9K3*JPKE*3Y<2NSL17O04J&+\$6.];%I8"F<6K%+S_I'!8$
M,I8<E9P5:5W" ,U\L)>4U2:^D1D:&?.ZB:EC2@ZVZG/&-'>3]D(UOOSZC"(D
M-Z(<J$'RZUK#CJ%+CP]KV<_UG)^>+I9[=0ZX\U_K!B&,"QW? T "^=OU;0@[
M>SXLG0JSYA/M&VX0<S(S5!GT>.*H]H&TO>XW6Q4363@EAEPE54P\WH8(AW#2
MKSKB<E"!@6<Y(XT9^=#]VB5<<5YT5,T.:MFG-.I\O[)6<T/M^/S- ?R^\,P>
M59IQWO^?U9Q#/O0L^9LFI<&9T%]NX6[:JI,_;S+\.OQUF"OYFRAQN/QIF9]P
MI(01"[/&U//Y=_"@K?RU%OF"\^2_D+*JNZXN^>/6P*^T- #/UW7=A2^TP/ W
M<Y[]/U!+ P04    " "D6-Y61N')!J &   ^$@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970R,BYX;6S%6-MNVS@0_17"+=H$4&/=+#MI$B#I!5T@;8,F;1\6
M^T!)(YNH)*HD93?[]3M#2K*3.FJ!76 ?;$F\S!S.F3FD=+J1ZIM> 1CVHRIK
M?399&=.<3*<Z6T'%]9%LH,:>0JJ*&WQ4RZEN%/#<3JK*:>C[R;3BHIZ<G]JV
M:W5^*EM3BAJN%=-M57%U=PFEW)Q-@DG?\$DL5X8:IN>G#5_"#9C/S;7"I^E@
M)1<5U%K(FBDHSB87P<GE@L;; 5\$;/3./:.5I%)^HX<_\K.)3X"@A,R0!8Z7
M-;R"LB1#".-[9W,RN*2)N_>]];=V[;B6E&MX)<NO(C>KL\EBPG(H>%N:3W+S
M#KKUS,A>)DMM_]G&C9VCQZS51E;=9'RN1.VN_$<7AYT)"_^1"6$W(;2XG2.+
M\C4W_/Q4R0U3-!JMT8U=JIV-X$1-I-P8A;T"YYGS&T<&DP6[$<M:%"+CM6$7
M62;;VHAZR:YE*3(!FAW<\K0$?7@Z->B8ID^SSLFE<Q(^XB0(V7M9FY5F;^H<
M\OL&IHAX@!WVL"_#48L7C3IBD>^QT ^C$7O1$(;(VHL>L[=GO7]>I-HH3)N_
M]JW8V8OWVZ-2.M$-S^!L@K6B0:UA<O[L29#X+T?0Q@/:>,SZ^2NN5XS7.;,W
M;[ZW8LU+J(VVC9\ 88O,@.O?!W[4_'[PMRO (LQDG8E2<%M1*9@-0,T,=F&'
MQL#EG-RFO.1U!LS)"F'Z:8@V>,'B-I1Y&2VC0'W !6#N-4J42"X3^*A9(4OJ
M.6%/F2!?LM5H45OFZ2]D0SBL'=@)QU.V\/SY J^Q%T?1;FCLV)DWC^8L].(D
M8+?2\-(V>S\;(NOJP>2G+(B\13##F\1;',=LA-G9P.QLE-D;%-V\+8%]+-@%
MK=O&$?6'O99M:HJV[$M3[^-UU/CCO%II%.;.!1B?!\^H^BSO/?/.LVT%GJV(
M.QI_!UQI!E3;6_8V?(RSRRY%D.\4EJ*NJ?30')G"6=%L3F&-$AR8H\JFAC5*
MKH7="X+09\?A-B(#KHT2QF!"RJ)@!S680W80X"^:X_^.0P2ZXRJ>)YW#$?Z2
M@;_D]_A#^]<*MTYE[CQV79*F4@Y1K3:4]OO8&S6]G[VMCV;P ;T/6W%"4\)V
M1+E:HE#OU-D(2Y\U4("O1 'LBFQCN +W]V%ZP2Y;4>;6&G:)BABR-:U9,/>"
M>&XO2<P"_T7L=UGR'O,&5X9;SGVL<>P%"Y_%D1>$ 9N]"/H)KBZ3P(N2!4M\
M+PH3=@5:$^UMU9963G+ F&2=+AV@K>,D0>;CF1?ZLT/V 6S^C(0*BSGQ8C^D
MFYF%,)(-\R$;YJ/9\)8+Q;[PL@7V3H#B*EO=V>*YT!HZ5;D2/$5%-;CC[,N)
M<0>W]S@U=G_NSE?B;["4OY)5P^N[YUBUA&9MT:SNH1%4TJ+&\A 8:;[%5FZQ
ML0JX;A6&&C-GQQ(=K&A?:)7J$Z&6];8!3TQ.QC$#^X1SN[8=:[/L8#?[#D]<
M[Q6LH61!=PV[:]2EP]L!;A?*6\5M)FKR[!"OH,PIL1'/B^\M+_%L0]*-\< S
MI<L4R@1M10)I]P*?M/S9DT48A"_OW;D^N\]@$!0IW1"  L.$Y2%J[+$*TPP'
M)K3;V\#TG2T>/+FE;#V[UEV_M#-%.XO=21;VX9?+"@\?&#O&HOJYI8?QZY&6
MK?^!F# X?I08ZON7Q,R#!T];8IQGUWH_'K-C_[\B)O)\/]K3\C,QCXVD!=UN
MBYW1VYC!GV9F(W\=Y\U*X&8NZJQL<PK8&D\Z5A4[+1"VR'F:"F84OI,<D3,-
M?7>WS5#$47B^@=6A'<*]S@%7X+C)6:LI)[ZWDL3;34*!%AD)#;Y/B:8DJ.F=
ME;"ZK5*D%<WK%=I +=G4D'N=1.VE>(]+U"TTAL*5[<F6(TL*[=/W1(^F X6.
M&6FAB#K'DU).+0U7!GUAO(U^WI]!^J.OTT^)4^BDI! NBJ01RAUY4ZBA0-4]
M&MEC%L,>LQC= C[=/Y-CD"Y1<C,"_%J4+<7WJWTUI;/9&F5_">S&A?%C:_ 8
M7E-Y[MMZ1OT^?IC<[D<D_ _?&1!?VN/+.WR;'A_O\&&*5CBV9WL+\Z2'_LAY
MY>MO6^JB%'J+,,;_^2)QX1)K9+PH(+/IC*_?V3<F&X+>O5S=?-9LOE7RW_?8
MS>@7C8J*IPWG>5\:3'?>Z2M02_OE@FH-L\R]W@^MP\>1"_=-8#O<?5EYS]62
MM*"$ J?Z1W-\35#N:X5[,+*Q7PA2:8RL[.T*.!8'#<#^0F*==@_D8/AD=/X/
M4$L#!!0    ( *18WE9MY%$W[0(  (<&   9    >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;)5546_30 S^*U9 $TC5DERS-MW:2NT&@@?$M UX0#Q<$S<Y
MD=R%NVL[_CV^2QHZZ(IX26S'_OS9YW.F.Z6_FQ+1PF-=23,+2FN;RS T68DU
M-^>J04E?UDK7W)*JB] T&GGN@^HJ9%$T"FLN9#"?>MNMGD_5QE9"XJT&LZEK
MKG\NL5*[61 '>\.=*$KK#.%\VO "[]%^:FXU:6&/DHL:I1%*@L;U+%C$E\O$
M^7N'SP)WYD &5\E*J>].>9_/@L@1P@HSZQ XO;9XC57E@(C&CPXSZ%.ZP$-Y
MC_[6UTZUK+C!:U5]$;DM9T$:0(YKOJGLG=J]PZZ>"X>7J<KX)^Q:WV0<0+8Q
M5M5=,#&HA6S?_+'KPT% &CT3P+H YGFWB3S+&V[Y?*K5#K3S)C0G^%)]-)$3
MTAW*O=7T55"<G=_A%N4&X0XS54CA._7J@:\J-*^GH:4,SB_,.K1EB\:>08L9
M?%#2E@;>R!SSIP A4>OYL3V_)3N)N&CT.0RC ;"(#4_@#?MZAQYO^(]ZUUK5
M<$U<-<T%]=R6<.V[C1J^+E;&V[\=ZT"+GQS'=W?HTC0\PUE E\2@WF(P/WL1
MCZ*K$^R3GGUR"GU^(PPO"HT%]P>EUM#5<XSH2:CC1!?[R^F@):T$PVD0@)HA
MS1JUQARLZL82M0%N@4.CA+0@)%BZK<!E#FI+7?0:;0VP)8+=8;5%J-OA0#<<
M0$<K*CI;$ 1DR+6B#6'@E4,JU<80DGE]Z0\>;BB?L2*#]]*BEKY\7L&#LO3\
MZ-(]N'0O(4[BP622D#1F@_$X)8'%"4D,;O<\O2O9&(.S%RF+V56GM7#[$7%@
MH\$X'CT%FPP2PB=6[#]84=0DG9"4L$'$'+UX1%(\_(/5:)!>3'I6K?87*T;V
M)'T*E@Y2*O'8B(4'RX$.K? KT$"F-M*V>Z*W]EMVT2Z7W^[MBO[ =2&D@0K7
M%!J=CR\"T.W::Q6K&K]J5LK2A'BQI#\%:N= W]=*V;WB$O3_GODO4$L#!!0
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MV^(*[8]RJ<GS6Y24%R@-5Q(T9E-O'HX771=?!_SDN#,G-C@E&Z6>G?.03KW
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MK(4)OP,3A.RMK,R-9B^KG/)O >;PJ7<LW#MV%AY$7-?J&8M\CX5^&!W B_I
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M)%BR T1(>B(D!XEPA3F<-P79V@Q(<4FH6B8*P>UT&^/&0=AQ;GQ [3':-?@
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M;X(3RA_*@S/T5)"?6RRSK*D:R1WF\*<KT<"5KNAX2Y_W9X0;E>D*X>0/;>T
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MEEIHP@W=(%&[#?1^I93M%Z[ <">=_P=02P,$%     @ I%C>5BGEA1%)"0
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M*COH3[;0^XU,C_SO:+%4%!/UCEXH"K ;\D%-#Q2:?0V,Z8FN:WHB4-,#BI9
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M[*"@; #NIU*:W<1^H.W)\3]02P,$%     @ I%C>5NR:[XEU!   :AL  !D
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M_; ENK*PTS 8( \.NK49U90C(V7M#=W%SIA^Z7 L@6F5CNI*1SWI<V2S!9;
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MAV2PHAMN[N3N!S3Y1)8OE5Q77[*K?8<8,=UH(XL&C';!1/VGSTT=.H!!^ '
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MO/D,G9YKPY=Q*NT3-6WN6%?,:JEXV8%U7!+6OO%3Y\,!P(]. ((.$+P5$':
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MPE&TGTVA1@.41J$T!J5Q%,W4EC8:?+?1T/1F^>/+M*G:<BTEN5-"LTH+:BU
M:3&4ED!I%$IC4!I'T4P!:O_!C[#Y%>I$0&DQE)9 :11*8U :1]%,"6HGPG=/
M3J@E>$36HDB;I\K3W71KE2#4B6AI>PEV<)A@H1X#E$:A- :E<13-%)?V&'RW
MQW"08#]?7][>664%M1>@M!A*2Z T"J4Q*(VC:*;XM ?AC[')%>I&0&DQE)9
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M?%DCU25F5>6+YN5,BJDLZ@+J]X]Y7KV\J2MXSHOO3?/._PM02P,$%     @
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M4RI- _A_)H1>/9@.JK/9T?]02P,$%     @ I%C>5J-])&\+ P  )PL  !D
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M-#4N>&ULM9EM;ZLV%,>_BL6NIE;JRD,>VR61TL+5*MUN57OO]F+:"Q=.$E3
MF6V:]-O/!DI"2MP@G;U)>/#YV?[_P?;!DPWC+V(%(,DV33(QM592KJ]M6X0K
M2*FX9&O(U)T%XRF5ZI0O;;'F0*,B*$ULSW&&=DKCS)I-BFL/?#9AN4SB#!XX
M$7F:4OYV PG;3"W7>K_P&"]74E^P9Y,U7<(3R!_K!Z[.[)H2Q2ED(F89X;"8
M6G/W.G"O=$!1XL\8-F+OF.BN/#/VHD_NHJGEZ!9! J'4"*K^7N$6DD235#O^
MK:!67:<.W#]^IW\M.J\Z\TP%W++DKSB2JZDUMD@$"YHG\I%M?H.J0P/-"UDB
MBE^R*<N./(N$N9 LK8)5"](X*__IMA)B+\#M'PGPJ@#OU(!>%= [#!@>">A7
M ?U3:QA4 477[;+OA7 ^E70VX6Q#N"ZM:/J@4+^(5GK%F7Y0GB17=V,5)V=W
M6<A2(-_I%@3YA<RC*-8&TH3<9>5CJ.T\\T'2.#E7)7X\^>3LRSGY0N*,?%^Q
M7- L$A-;JL9HI!U6%?MEQ=Z1BEV/W+-,K@0)L@BB)L!6O:B[XKUWY<8S$N\I
MOR3>Z()XCN>T-.C6'.Y#J,(]'>Z.VOIC#I^O5>T]IZB]UQ(>G![N&<3HU;[V
M"E[O%%___J;NDCL)J?BGI6DW):K?CM)#U;58TQ"FEAJ+!/!7L&8__^0.G5_;
M5,:$^9BP  G6\*-?^]$WT6>W\\?@B<Q#>4%^_^,;"2GG;\\T?"%KX#&+R)EZ
MF]Z <G'>9I"9/2@CV\PP!G8U Q,6(,$:9@QJ,P9&P9ZJ6<H=]0ELU9RK!KV<
M@YI@HKR\4[K29H61W/5=,3?SN*\^9BL")%C#BF%MQ=#81Q\6P#E$1-(MH4*
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MHVG-+J=UC2F:RO"WQ^83<V1GO5&36%1:@$5K>K#+8]T^XIR"F3+>HM)\5%J
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M@2Z@[B\8D^\GNH)Z%WKV'U!+ P04    " "D6-Y6%N^O#C #  !N"P  &0
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M_Q>*%32VH)+#TJ="J1,CCP!/FI&0IS2S9G@YY.Y%_3:S@&!HV^ECK]4SSQG
M3?; ,BU P^K96*E63'.N:5J&%0ME'PZUZWU*Q,,]VA80QB-9QWLRC)VT/YM6
MRZ'--,_NRW3_NHYKEQVZP;)/=PC">"S+K2IBIP:M;J6(&4L4@GJ^HRE#GQCL
MI<9*N7;6Z:9EU!<("VI.<#A"M=4S[!:T+VU6#4>4MOL7*U?_-7UG08V50"MF
MV*UF7_2622NEH2"1L-]-%E"P5PQ=3JUL8;=N?1/0-*;O^YL@*T^++@7>?) [
MFWP%T5A-M@*&H]=OU?96V;I?PTXU/'3#]E;>NI&W&HC=(G@)IR1SF.'*;+[9
M4\Q@?(!PFT14M^$BEV:^Z.>3<FSK<BJR?PJ>PZ%,6U,TU, I#O"\OYPVV#P<
M$4O<JB5VR^6K@NK.GB9&:SA#K9S"X.[OK>PP,E:=K:YBM[#>2I93GJ"\.@);
M&0X5<;K$@X%N0XUU.FEUD[AU\^+V$A&_/.C)L<TI&4K?%/NXW^ VV'(^LC\E
MK402MT26KQC,HA<PQ<>G$!D*WA2'I+_.%MC(!"=[9T6W*EZSM48W2A7EF>0*
MMAFOTT<R5+XICOJ-9D4M@A'2K3X2MSY:1OPO))(,Q6\:!8,#GPT6+!=CE=KJ
M)''KY ^:%K1Z!_1R_K.R' KB=!%&@V*UP*+EWJZOR[)53N)63K.A.RBI0U6$
MMA[DU((*QH[1I)5.<H!T5JV%CO8('Z,XA=M\PP$#TQAV*C"#T[+,RW=/]G<B
M;ZJQ;^6MFZ)68XE;8[N["_=26A31LI06U/A2MK))W+)Y<-U9],Y"UH(:)]N*
M(G&+XF>13>,"J-IW(&[K@POHC;QU7ZNU NM[_T./^4Y5/S1%;^6MFZ)6X7VW
MPA_08[6GT%VV-M2P;&=[K\_-;Q=_47G/,P7GQ0V8>1_F8"^KGP.J"RWR\HWZ
M6F@M=N7'+:,)DP8 SS="Z)<+\Y*^^5%F]1]02P,$%     @ I%C>5NC[T=MN
M!@  "S4  !D   !X;"]W;W)K<VAE971S+W-H965T-#DN>&ULQ5M=;]LV%/TK
MA%<,+;#$$N7/+#&01!P68-V"N-D>ACW0-FT+E42/I.-DZ(\?*2F2Z<A4--S!
M?6CTP7MX=8Y\R4-)ESLNOLHU8PH])W$JKSIKI387W:Z<KUE"Y3G?L%2?67*1
M4*5WQ:HK-X+111:4Q%WL>8-N0J.T,[G,CMV+R27?JCA*V;U <ILD5+S<L)CO
MKCI^Y_7 0[1:*W.@.[G<T!6;,O6XN1=ZKUNB+**$I3+B*1)L>=6Y]B]($)B
MK,7O$=O)O6UD+F7&^5>S<[>XZG@F(Q:SN3(05/]Y8K<LC@V2SN/O K13]FD"
M][=?T7_*+EY?S(Q*=LOC/Z*%6E]U1AVT8$NZC=4#W_W,B@OJ&[PYCV7V/]H5
M;;T.FF^EXDD1K#-(HC3_2Y\+(O8"_-Z1 %P$X,. P9& H @(WMM#KPCHO3>@
M7P1DE][-KSTC+J2*3BX%WR%A6FLTLY&QGT5KOJ+4W"A3)?392,>IR53Q^5?T
MV\:H)A%-%VBZIH*=W6CR%^B6)_J.E#33] Q=+Q:1V:0QNDOSF]2<^!@R1:/X
MDV[Q. W1QP^?T <4I>C+FF^EAI277:53-1UVYT5:MWE:^$A:/D:?>:K6$I%T
MP18V0%=?8WFA^/5";[ 3\7J[.D=X\ /"GM^O2Z@A?"/.4>"9<!S4A(?O#\<U
MX>0=R>?A_M!!1E"J'F1XP3'5,XUG;S6^%H*F*Z8K@4*S%[3?[IZ^9(>O=U0L
MT)^_:$ATIU@B_ZJYGIN\_UY]_Z;Z7<@-G;.KCBYODHDGUIE\_YT_\'ZLDP82
M+(0$(T!@EHB]4L2>"WT2LB430BL3I7.>,*3H,YJQE"TC5:>($ZRM(CE8/P,S
M8]'3Y*QO?E9/^TS7-/*Q;S<B0&E9#/9+!OM.!K-;6:*5ON>5YO&CKEG2W/'R
M4QV!3JRV!.9@@SUNO /V&EL0H(0LZ@8E=0,G=?FXD5>&^7X%8<]FF]41Z$1L
M2^#@S<UU2&!C"P*4D$7@L"1P"/GK=8*UY6[8R-VP\>8#2LCB;E1R-W)RIT=!
M+YNKZ.GP"-W'-*VCS(G1EC)(L! 2C "!64*,2R'&)YY'C"%%A 0+(<$($)@E
MHN]5'L!S%_-LT$/T2<_BZ2QF2,_MT7*KMH+E@Z-L&AO=';35J4!SC8Z@'1(H
M-)O_/0_F-]6SX=$RYHYM32TD6@B*1J#0;!5PI0(^<3$K$H"2$A(M!$4C4&BV
ME)6]]9W&"Z*@@1K8 FV_H/F]L><-#ZL:J#FMZ16/]-2IJJ4VO97Q]-W.LZQ7
MZ!MZ8%*):&[\4^X)'M/(T/LP?3S"+*@1!44+0=$(%)JM4F5N_?ZIZQFH)09%
M"T'1"!2:+65EMOUWN.VS=F[;#=E:G+=N>M0[7/ I&NT7G*%WN. #E9=-966[
M?5#?[49KS>);Y^V/QX<LUC0:] ]9_#_\MU\9<-_MP'_753]*5VC#1,3SE;,7
M1L61B@_JQ!LR"_)$:DL"J.^&0K,5J)RW[_2$DP=F'@,:#8P4"55M2@.HJR[0
MK-+@X\.;&M0N0Z'93Y(JOXS=?GE__C/5Z-&<92,L3YF96GY#G[4RR3:IX]X-
MW99[4+00%(U H=DB5:8:^R>>_F!09PZ*%H*B$2@T6\K*F6.G76PWVKBQ6JOB
MS@P?'VU \R!0:+8"E:'&;D/=7/'H\]&*!VJE0=%"4#0"A6:+5-ERW#MUQ0/U
M[J!H(2@:@4*SI:R\.W8_F6Y7\4!M>$-FCODU:!X$"LU6H++<V&VYG8\6W;&M
M&8=$"T'1"!2:K4+EUO'PU"4-U."#HH6@: 0*S9:R6C+ ;F/^ZS:9,8'XLEAV
M1W2KUEQ$_VC)MNE"GY+9^C'/WD5$&S/9:%BD=_?86KO1F]6KP#/_#JPL:*\$
M"LU6I5I&P.YEA+MT+IC^V9CW-=,W"I7/3_ZK0.-W47KK3K+USP9TK0$*S7Y1
MLUIK"-QK#>W>47.#M7[OLODY/&B'! K-YKI:,@B:GL,78[[;T+A16I,,ZOM!
MT0@4FJU'Y?N#4S^1#T 7"T#10E T H5F2[GWPKE[ >$+$XDT0PO-='$;&C=6
M:U7<F?G><4<#F@B!0LLEZ.Y]])$PL<J^MI%HSK>IRC^+*(^67_1<9]^Q'!R_
M]2_"_+N<"B;_3.@S%:LHE2AF2PWIG0^U)1/YES?YCN*;[-.2&5>*)]GFFE$]
M53 -]/DEY^IUQW10?O\T^1=02P,$%     @ I%C>5EHW*S0&!   *A$  !D
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M2;>I?&3[OZ 2Y&N^B*6B^(OV5:QCH6@K),LJL,H@2_+R/WVMC#@"X. ,@%0
MT@1X9P!N!7"[ KP*4%AMEU(*'V94TO&0LSWB.EJQZ8?"S *MY">Y'O>YY.IM
MHG!R/)<L>D'?-GH0!*)YC.9KRN'V7GD9HRG+U 03M!BB6S0O)P=B2_0X?T(3
M/6:)?"M@WPN'%6:R ZYF#/K\"CQ*!* 'GD2 ;F8@:9**3XKG$814G3JZ_/Y3
MGDB!;A1I\?Y79".ATQ!#6RJ1.E4[J@3=EX+(&4&8H*\LEVN!/N<QQ!\);.5.
M;1%YM^B>M#).-KR'7.=W1!SB&A*:=H<3 WS6'8Y;U+CU@+L%GWN&[Y]MM@!>
M#:'1WQ+OF?%Z'[H3&QK!R%(;C0"^ VO\VR\X</XP>7--LMF5R#[XYM6^>6WL
MXV];*:2:Z$F^0E2B!:R2/-<-Y>0;4(YNDKR:M)],KI;L0<&N-^/=&'M>GX1#
M>W?LER&,^ 0WPF:MN5[HA%\[X;<Z\2>GN5ZZ/Q#LGRCIAX-@T-![&A6$H>\T
MY+8F=*'<H)8;M,I]5IO5C]4&)SIN?<?%?D.N(<S% \]MZ&W-Z$*]8:TW;-6K
MRND2D@Z2PU,MA/0]W)!L",,!'C1G=&M2%TKNUY+[/[.V096SCJNZ?[I<_4'@
M->;OU!!F6/RSUBPO]&!0>S!HK0LG];M8YD@=*@!]H0E'SS3=@LF#P37KQ37)
M9E<B^^ G=@XG*^?_5XR8I:EZW*B2W#+-JB^%QQ,(]P9>8YJ9PDB/-,)FYK#P
ML' _"CXZ2N+.A:&CKNIPZARGXO::^^'T3%QXHJPUP4M'G!P,(%U+14?]Q*BK
M'S3UF^)(SSO1WYK?I?H/1TO<>@)KE(Z.%K@&:7[/;1Z,3'$$]_K-TMF>XJ46
M'$Z)^*>.B<U2TM$3K]MR-X29EKLQ[&2YVT>7R SXJKB,"Q2Q;2[+RU+=6U_X
M)\4UM]%_C^^FY;7]0%/^BO"5<K4'"I3"4E$ZO5"=ZWAY,2\;DFV*J^J"277Q
M+1[70&/@.D"]7S(FWQOZ _7/(^/_ %!+ P04    " "D6-Y6R ><IM$#   T
M$0  &0   'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6RM6&N/VC@4_2M6NJI:
M:8>\ TP!B4=7NQ^Z'17M]K-)+A!-$J>V@9E_O[830H:8D&'Y K9SS\D]QQ<_
M&!T(?69; (Y>TB1C8V/+>?YHFBS<0HI9C^20B2=K0E/,19=N3)93P)$"I8GI
M6%9@ICC.C,E(C3W1R8CL>!)G\$01VZ4IIJ\S2,AA;-C&<>!'O-ER.6!.1CG>
MP!+X/_D3%3VS8HGB%#(6DPQ16(^-J?VXL#T)4!'_QG!@M3:24E:$/,O.7]'8
ML&1&D$#()0467WN80Y)()I''KY+4J-XI@?7VD?T/)5Z(66$&<Y+\C".^'1L#
M T6PQKN$_R"'/Z$4Y$N^D"1,?:)#&6L9*-PQ3M(2+#)(XZSXQB^E$36 '5P
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M6\ 14!D@GJ\)X<>.?$'U1\GD/U!+ P04    " "D6-Y6=RRG;O(#  !X$
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M'HI4,\KA5B*5)@F13U-@8C-RL+/=N*/+6-L-=SQ<D27<@_ZVNI5FY98H$4V
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M M<&ZOV",?DRT O436;\/U!+ P04    " "D6-Y6B^U>A#\#  !K#   &0
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M#JDNM%GOD*6FNLAL#,RCU4F$M-540F(<L8/C^M>'@S8KJQ2PTFTSD-2$M+8
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M/;J^NGEI8\JR^MKLOC9;^SK_4=NOQ98+)K^%WT,Y6[_9L)\Z'W->XP0B0QX
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MT*Q<K@$O@"D#>7U)J7@Z4-M;S?[GY']02P,$%     @ I%C>5B -3B0P"0
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MT13D5GC;-,[K/XWG)M9<&=MC7J3[9G&9P3Y*3G^'7QHB6@LLYX4%=K/ GKJ
M-0O8U 5.LZ"F>GTJI>:!AT6XN<S29R.KHDNTZD%-9KVZ+#]*JO_WNR(K7XW*
M=<7F@RBB3)3_D85Q+1)Q'Q6Y\9-Q=]H%1GIOO VCS/@SC(_">)/GHGPY2@Q>
M!B9B]W6)<=MLA-LX3'+C>RZ*,(I_*('^N./&]]_^8'Q;K?K],3WF8;+++]=%
MF7J5P'K;I'E]2M-^(<TWA^R5P<P?#=NTV<#RF^G+[8'E?/IR2UV^+OD^DVZ?
M2;=K//8"7H^^DC:#1_DV3O-C)HR_WY<O&^\*L<__&>+JA.X,HU??*5[GAW K
MKE;EMX)<9$]BM?GN&\LS?QYB#@G&06 *J^S,*J/0-_5.?:IW:KEO#Q6G8;UC
MAR@\0;DU5/6]\6EC^3XK]\93FYN!J"#P?#6*]Z-LRW$OSE%*-<ZY&H>LYI?/
MQZCXU[@3VV,6%9$8K(*$T-T(2# . E.H<\_4N8NVEXMD%0G&06 *J]Z950_7
M7B<HK]TXMF\[G?8:B&*!ZW7:BTQK9M'^N6B?+CKZ4FZD=\DVW8NA.LG5NEL%
M"<9!8 IKP9FU8-$&#)"L(L$X"$QA]>+,Z@6N 2]ZK>4$CMOIOX$@WV2=]B.3
MFEFR9<KQU"2+O@GS1Z.<&8WZ0?5#L62@G%:'9T@22W?C0-$X"DWEL37F6XNV
M9 ./HA:)QE%H*K5RF+?(J5:O+QLLY6>>UVFYFX$@9@:=OJ2SFENU'+8M>MI^
M+YY$?,*S!@LEEVMO&"0:1Z&IU,G)WG*6[47HV ]%XR@TE5HY^5OD"*S9BVZ_
M%P=$X%#8@ JD,YM;N9S.+7H\;_>C\9_Q/LP>1/E#\S!8.&BD;OA!HG$4FDJC
MG/<M?]G>A"H"*!I'H:G42E%@D=.Q9F\&O:8K.]/KMN905&!W.W.)J=V28[M%
MS^V=SKS;AW&\_BW:O=B=H(F[H0B)QE%HZK&I5 .VN>S!*50@0-$X"DVE5@H$
MFYR2];JSP6KWG=WOSJ$HW^^(4$[G-;?NUE$\/;UWNO-=4H@L":L[J3 >+!U[
M^(X]?5]"$MA2$MALV>Z$2@8H&D>AJ=1*R6#3MP%ZW>D,S+5.5V0.1-EF3V72
M><VM6\[S-CW/=[KSE[W('J+DP?@MS#Z]5#WT^!Z*QE%H*IM2(]C>L@T*U0U0
M-(Y"4ZF5NL$>N2C0:E"_/[::7=DY%'3A=-MSB9'>EB.]38_T7=$9?3Z6<^V;
MN/D9^C1\:TF#:F\CZ $_"DTE5&H%^V+9#H5J!R@:1Z&IY@"I'1A]DZ!G#S![
MS>?9?M<=T \*+GKF@"7&>B;'>D:/]9T.';O/I-%T]P\4C:/05":E4&#+FG88
M5#A T3@*3:6V9=Q!.G?8E*O-H:C^W2:=U]RZY53/Z*F^TYQ:=YTTM/9V@EX"
MH-!46J5H8,OZ?QA404#1. I-I58J" 8T ;$!?T_OKG,@J'_726<UMVHYW#-Z
MN&_UZ9![])I>KKUAH(?^*#25.JD0V+)6( ;5"E TCD)3J95:@0']0*SO]3&[
MG3@:PNF,9E;LR!'>H4?X=A^.W7'24-K>6.A1/PI-I5%J F=9+Y #%0E0-(Y"
M4ZF5(L$!>H&<OLVGVY/C(9S.:&[%<G9W)ON ["FWFS2<]N:!'O*CT%0J6X[_
M97U!#E020-$X"DVE5DH"!^@+<OJ&GUY?CH9P.J.Y%<M)W9GL![*GW&O2<-J;
M!WJVCT)3J93CO[.L)\B!R@,H&D>AJ=1*>>  /4%.W^W3Z\O1$$YG-+=B.;4[
MD]U ]L0;31I1>_] #_51:.HO>DE%X"YK"'*A*@&*QE%H*K52);A 0Y#;M_IT
M6W,\A-,9S:U8#N_N9"N0/?TVDP;5WD+0<WT4FDJHU ;NLH8@%ZH5H&@<A:92
M*[6""S0$N7VK3Z\[1T,XG='<BEN_U#O9"F1/N,FDT;3W#O;7>)>0!JZ4!NZR
M-B 7*A6@:!R%IE(KI8(+M &Y?8=/KRU'0SB=T=R*Y03O3K8 V;IWF#2T]D:"
M'NZCT%1:I4QPES4"N5#- $7C*#3U;0RD9O" 1B"O[_'I]NAX"*<SFENQ'.6]
MR2:@H3?/N::7ZVX6*!I'H:G424W@+>OZ\:#J (K&46@JM5(=>$#7C]?W\_3Z
M<#2$TQG-K5@.[=YDOP\;N[^DH;0W#O0P'X6FTBB5@+>LO\>#2@,H&D>AJ=2V
MWN,'^28_?>M.KR='0SB=T=R*Y<3N3?;VL"GWES2<]N:!'N:CT%0JI13PEO7Z
M>% Y $7C*#256BD'/*#7QQOW^HR'<#JCF17[<DKW)WM]V)3[2QI.=_- T3@*
M3:52CO_^LGX?'RH/H&@<A:92*^6!#_3[^.-^G_$03F<TMV(YM?N3_3YLXOTE
MC:B]?Z#'^"@TE4VI"/QE+3\^5"5 T3@*3:56J@0?:/GQQRT_XR&<SFANQ7)X
M]R=;?MCT^TL:5'L+04_S46@JH:TW_US6^.-CWQX4^_Z@2V@%7VH%'VC\\<>-
M/^,AG,YH;L5RA/<G&W_8A/M+&DU[[T /\%%HZIO+2FD0+&OZ":!2 8K&46@J
MM5(J!$#33S!N^AD/X71&<RN6$WPPV?3#=.\O:6CMC00]W$>AJ;1*F1 L:_T)
MH)H!BL91:"JU4C,$0.M/@^52/3H:PNF,="M>MSZNI/IPF5(ZEA(R-V)Q7\*;
MKZHQ.CM]7LOI29$>ZD\P^9@61;JO'SZ*<">R*J!\_3Y-BZ]/J@]%.7]JSN9_
M4$L#!!0    ( *18WE9R+0+!)@(  +($   9    >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;(54;8_3, S^*U&0$$BP=-T+:+25MCL0]^'0M GX@/B0MEX;
M79J4)%WO_CUYZ<I.VHTOC1W;CQ^[=I)>J@== QCTV'"A4UP;TZX(T44-#=43
MV8*PEH-4#3565171K0):^J"&DSB*EJ2A3. L\7=;E26R,YP)V"JDNZ:AZFD#
M7/8IGN+3Q8Y5M7$7)$M:6L$>S/=VJZQ&1I22-2 TDP(I.*1X/5UMYL[?._Q@
MT.LS&;E*<BD?G')7ICARA(!#81P"M<<1;H!S!V1I_!DP\9C2!9[+)_0OOG9;
M2TXUW$C^DY6F3O%'C$HXT(Z;G>R_PE#/PN$5DFO_17WP7<PQ*CIM9#,$6P8-
M$^&DCT,?S@+B^(6 > B(/>^0R+.\I89FB9(]4L[;HCG!E^JC+3DFW$_9&V6M
MS,:9; ^5;;%!=R+\8->I]VA=ELR)E#\SO+D%0QE_FQ!C4SL 4@QI-B%-_$*:
M:8SNI3"U1I]%">5S &(YC\3C$_%-?!5QW:H)FD7O4!S%,Z1#&5=P9V-#9AYW
M]I^&[*"5RC!1H5_K7!MEQ^?WI;H#VOPRFENIE6YI 2FV.Z-!'0%GKU]-E]&G
M*USG(]?Y-?3L6]?DH) \H+S3UJ;UY48$I@%KZ;'<KAZS."''\_3D;(X:4)7?
M%HT*V0D31FJ\'1=R'>;PGWO8YGNJ*B8TXG"PH='DPP(C%38D*$:V?BIS:>R,
M>[&VCPHHYV#M!RG-27$)QF<J^PM02P,$%     @ I%C>5K^A.=\I!P  $BX
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M+<*^6WUC9/GZHN7K2Z+G_P%02P,$%     @ I%C>5M))O&T1 @  %R8  !H
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MKH^_++].3M[>"\[IMJ(^_P502P,$%     @ I%C>5L"(;73I 0  ?B4  !,
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M'#\\\];4W2&?#7^[FKT!4$L! A0#%     @ HUC>5@=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "C
M6-Y6U@#"0N\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " "C6-Y6F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *-8WE;B/"KO
MZ <  )(O   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " "C6-Y6'<8ZZS("  "L!0  &
M@($L$   >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ HUC>
M5C[QE&7H!   KQ(  !@              ("!E!(  'AL+W=O<FMS:&5E=',O
M<VAE970S+GAM;%!+ 0(4 Q0    ( *-8WE:[ZP"TA0,  +,*   8
M      " @;(7  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M" "C6-Y6)!89;:L$  #Z&   &               @(%M&P  >&PO=V]R:W-H
M965T<R]S:&5E=#4N>&UL4$L! A0#%     @ HUC>5CCAJ$T?!P  LA\  !@
M             ("!3B   'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4
M Q0    ( *-8WE;K=N0=[@(  +0(   8              " @:,G  !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "C6-Y6P,<>P\@&  "'
M'0  &               @(''*@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL
M4$L! A0#%     @ I%C>5M/>9;3,'0  Y5<  !@              ("!Q3$
M 'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( *18WE:B[(Y%
M[A   "4Q   9              " @<=/  !X;"]W;W)K<VAE971S+W-H965T
M,3 N>&UL4$L! A0#%     @ I%C>5K_"OOV  @  > 4  !D
M ("![&   'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "D
M6-Y6U!^KCP0)  "M&   &0              @(&C8P  >&PO=V]R:W-H965T
M<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( *18WE9I B4Y<@<  +,2   9
M          " @=YL  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#
M%     @ I%C>5D4R,5KU"@  /QL  !D              ("!AW0  'AL+W=O
M<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "D6-Y6X>MB20\)   R
M&   &0              @(&S?P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM
M;%!+ 0(4 Q0    ( *18WE;6?7L.9 ,  !@(   9              " @?F(
M  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ I%C>5B.-
M&<0O!P  &Q(  !D              ("!E(P  'AL+W=O<FMS:&5E=',O<VAE
M970Q-RYX;6Q02P$"% ,4    " "D6-Y6Q9',-:D-  !])0  &0
M    @('ZDP  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    (
M *18WE;%? _Z'08  &<.   9              " @=JA  !X;"]W;W)K<VAE
M971S+W-H965T,3DN>&UL4$L! A0#%     @ I%C>5FR$Z<\Q P  A0<  !D
M             ("!+J@  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"
M% ,4    " "D6-Y6<QH<??L6   _1P  &0              @(&6JP  >&PO
M=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( *18WE9&X<D&H 8
M #X2   9              " @<C"  !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L! A0#%     @ I%C>5FWD43?M @  AP8  !D              ("!
MG\D  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "D6-Y6
M*P"KHXX"  " !0  &0              @('#S   >&PO=V]R:W-H965T<R]S
M:&5E=#(T+GAM;%!+ 0(4 Q0    ( *18WE8U>FX3TP(  !4&   9
M      " @8C/  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%
M  @ I%C>5K$ T#DB!@  + \  !D              ("!DM(  'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "D6-Y6PIFC.2X$  "H"P
M&0              @('KV   >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+
M 0(4 Q0    ( *18WE9_LE)P(0,  ",'   9              " @5#=  !X
M;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ I%C>5DGN]EX2
M P  7P@  !D              ("!J.   'AL+W=O<FMS:&5E=',O<VAE970R
M.2YX;6Q02P$"% ,4    " "D6-Y6D,(:Y.4&   G%   &0
M@('QXP  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( *18
MWE:L38T*:@0  )\*   9              " @0WK  !X;"]W;W)K<VAE971S
M+W-H965T,S$N>&UL4$L! A0#%     @ I%C>5BGEA1%)"0  :D4  !D
M         ("!KN\  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
M    " "D6-Y6VX6RS*H"   A"   &0              @($N^0  >&PO=V]R
M:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( *18WE:CP]ZY 0,   0(
M   9              " @0_\  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL
M4$L! A0#%     @ I%C>5JP>HAZ3!   WQH  !D              ("!1_\
M 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "D6-Y6UM;3
MH8(%  "F(0  &0              @($1! $ >&PO=V]R:W-H965T<R]S:&5E
M=#,V+GAM;%!+ 0(4 Q0    ( *18WE8WSUHJU0(  )\'   9
M  " @<H) 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @
MI%C>5NR:[XEU!   :AL  !D              ("!U@P! 'AL+W=O<FMS:&5E
M=',O<VAE970S."YX;6Q02P$"% ,4    " "D6-Y6;T@@"#T#  #A"P  &0
M            @(&"$0$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4
M Q0    ( *18WE:<+)W(E (  .T&   9              " @?84 0!X;"]W
M;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ I%C>5BRS/@]- @
M$ 8  !D              ("!P1<! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6Q02P$"% ,4    " "D6-Y6<8UJ^=L*  "[AP  &0              @(%%
M&@$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( *18WE:Q
M2. QT 0  *<5   9              " @5<E 0!X;"]W;W)K<VAE971S+W-H
M965T-#,N>&UL4$L! A0#%     @ I%C>5J-])&\+ P  )PL  !D
M     ("!7BH! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *18WE;H^]';;@8   LU   9              "
M@3-  0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ I%C>
M5EHW*S0&!   *A$  !D              ("!V$8! 'AL+W=O<FMS:&5E=',O
M<VAE970U,"YX;6Q02P$"% ,4    " "D6-Y6R ><IM$#   T$0  &0
M        @($52P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0
M   ( *18WE9W+*=N\@,  '@0   9              " @1U/ 0!X;"]W;W)K
M<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ I%C>5N;YYR :!   A!
M !D              ("!1E,! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q0
M2P$"% ,4    " "D6-Y6?00;\L<#  !P#@  &0              @(&75P$
M>&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( *18WE:+[5Z$
M/P,  &L,   9              " @95; 0!X;"]W;W)K<VAE971S+W-H965T
M-34N>&UL4$L! A0#%     @ I%C>5K "$1#+!0  ,!D  !D
M ("!"U\! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "D
M6-Y6UP+R!J #   _#   &0              @($-90$ >&PO=V]R:W-H965T
M<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( *18WE:"+F\'P@4  #$A   9
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M970V,BYX;6Q02P$"% ,4    " "D6-Y6OZ$YWRD'   2+@  &0
M    @($W@0$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    (
M *18WE:P#M 'CP(  *L&   9              " @9>( 0!X;"]W;W)K<VAE
M971S+W-H965T-C0N>&UL4$L! A0#%     @ I%C>5DV=!BDC P  [!$   T
M             ( !78L! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "D6-Y6
MEXJ[',     3 @  "P              @ &KC@$ 7W)E;',O+G)E;'-02P$"
M% ,4    " "D6-Y6Z>8+P<D$  "H*@  #P              @ &4CP$ >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ I%C>5M))O&T1 @  %R8  !H
M         ( !BI0! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ I%C>5L"(;73I 0  ?B4  !,              ( !TY8! %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     $@ 2 "O$P  [9@!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>233</ContextCount>
  <ElementCount>399</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>79</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statement of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity</Role>
      <ShortName>Consolidated Statement of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Long-term Debt and Other Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements</Role>
      <ShortName>Long-term Debt and Other Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Sale-Leaseback Financing Transaction</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction</Role>
      <ShortName>Sale-Leaseback Financing Transaction</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Stock Options and Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation</Role>
      <ShortName>Stock Options and Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Leases, Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LeasesCommitmentsandContingencies</Role>
      <ShortName>Leases, Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Retirement Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefits</Role>
      <ShortName>Retirement Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Restructuring Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RestructuringCosts</Role>
      <ShortName>Restructuring Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/RevenueRecognition</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/Inventories</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Sale-Leaseback Financing Transaction (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables</Role>
      <ShortName>Sale-Leaseback Financing Transaction (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/IncomeTaxes</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Stock Options and Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables</Role>
      <ShortName>Stock Options and Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Leases, Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables</Role>
      <ShortName>Leases, Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/LeasesCommitmentsandContingencies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Retirement Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsTables</Role>
      <ShortName>Retirement Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/RetirementBenefits</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/SegmentInformation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Summary of Significant Accounting Policies - Cash Equivalents Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Cash Equivalents Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail</Role>
      <ShortName>Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Revenue Recognition - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail</Role>
      <ShortName>Revenue Recognition - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Inventories - Summary of Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail</Role>
      <ShortName>Inventories - Summary of Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Inventories - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail</Role>
      <ShortName>Inventories - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Long-term Debt and Other Credit Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail</Role>
      <ShortName>Long-term Debt and Other Credit Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Sale-Leaseback Financing Transaction - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails</Role>
      <ShortName>Sale-Leaseback Financing Transaction - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails</Role>
      <ShortName>Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Income Taxes - Income Tax Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail</Role>
      <ShortName>Income Taxes - Income Tax Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Income Taxes - Schedule of Income Tax Reconciliation (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail</Role>
      <ShortName>Income Taxes - Schedule of Income Tax Reconciliation (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail</Role>
      <ShortName>Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Stock Options and Share-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock Options and Share-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails</Role>
      <ShortName>Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail</Role>
      <ShortName>Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail</Role>
      <ShortName>Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Leases, Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail</Role>
      <ShortName>Leases, Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails</Role>
      <ShortName>Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail</Role>
      <ShortName>Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail</Role>
      <ShortName>Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Retirement Benefits - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail</Role>
      <ShortName>Retirement Benefits - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Retirement Benefits - Summary of Expected Benefit Payments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail</Role>
      <ShortName>Retirement Benefits - Summary of Expected Benefit Payments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail</Role>
      <ShortName>Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail</Role>
      <ShortName>Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Segment Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail</Role>
      <ShortName>Segment Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Segment Information - (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/SegmentInformationDetail</Role>
      <ShortName>Segment Information - (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.kewaunee.com/role/SegmentInformationTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="kequ-20230430.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Restructuring Costs - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails</Role>
      <ShortName>Restructuring Costs - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept LondonInterbankOfferedRateLIBORMember in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. kequ-20230430.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="kequ-20230430.htm">kequ-20230430.htm</File>
    <File>exhibit1034b.htm</File>
    <File>exhibit211.htm</File>
    <File>exhibit231.htm</File>
    <File>exhibit311.htm</File>
    <File>exhibit312.htm</File>
    <File>exhibit321.htm</File>
    <File>exhibit322.htm</File>
    <File>kequ-20230430.xsd</File>
    <File>kequ-20230430_cal.xml</File>
    <File>kequ-20230430_def.xml</File>
    <File>kequ-20230430_lab.xml</File>
    <File>kequ-20230430_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="805">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>95
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "kequ-20230430.htm": {
   "axisCustom": 0,
   "axisStandard": 30,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 805,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 233,
   "dts": {
    "calculationLink": {
     "local": [
      "kequ-20230430_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "kequ-20230430_def.xml"
     ]
    },
    "inline": {
     "local": [
      "kequ-20230430.htm"
     ]
    },
    "labelLink": {
     "local": [
      "kequ-20230430_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "kequ-20230430_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "kequ-20230430.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 623,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 7
   },
   "keyCustom": 60,
   "keyStandard": 339,
   "memberCustom": 28,
   "memberStandard": 49,
   "nsprefix": "kequ",
   "nsuri": "http://www.kewaunee.com/20230430",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.kewaunee.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Revenue Recognition",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.kewaunee.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.kewaunee.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Long-term Debt and Other Credit Arrangements",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements",
     "shortName": "Long-term Debt and Other Credit Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleLeasebackTransactionDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Sale-Leaseback Financing Transaction",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction",
     "shortName": "Sale-Leaseback Financing Transaction",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleLeasebackTransactionDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.kewaunee.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Stock Options and Share-Based Compensation",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation",
     "shortName": "Stock Options and Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Leases, Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.kewaunee.com/role/LeasesCommitmentsandContingencies",
     "shortName": "Leases, Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Retirement Benefits",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.kewaunee.com/role/RetirementBenefits",
     "shortName": "Retirement Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Segment Information",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.kewaunee.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.kewaunee.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Restructuring Costs",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.kewaunee.com/role/RestructuringCosts",
     "shortName": "Restructuring Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "21",
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kequ:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kequ:ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Revenue Recognition (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.kewaunee.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.kewaunee.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kequ:ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Sale-Leaseback Financing Transaction (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables",
     "shortName": "Sale-Leaseback Financing Transaction (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kequ:ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.kewaunee.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Stock Options and Share-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables",
     "shortName": "Stock Options and Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Leases, Commitments and Contingencies (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables",
     "shortName": "Leases, Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Retirement Benefits (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.kewaunee.com/role/RetirementBenefitsTables",
     "shortName": "Retirement Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Segment Information (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.kewaunee.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Summary of Significant Accounting Policies - Cash Equivalents Table (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails",
     "shortName": "Summary of Significant Accounting Policies - Cash Equivalents Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i2ca2ebd535504440b59023a1e53f9d80_I20220430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Activity in Allowance for Doubtful Accounts (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "kequ:ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "ia08ef11dead048c8b9c14a66f2f30b19_I20210430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Property Plant and Equipment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail",
     "shortName": "Summary of Significant Accounting Policies - Summary of Fair Value Hierarchy for Financial Assets and Liabilities Measured Recurring and Nonrecurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail",
     "shortName": "Summary of Significant Accounting Policies - Reconciliation of Basic to Diluted Weighted Average Common Shares Outstanding (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail",
     "shortName": "Revenue Recognition - Summary of Net Sales Transferred to Customers at a Point in Time and Over Time (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i6a8537ecb2f1436aaeb85e43dc13d546_D20220501-20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Revenue Recognition - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
     "shortName": "Revenue Recognition - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Statements of Comprehensive Income",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Inventories - Summary of Inventories (Detail)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail",
     "shortName": "Inventories - Summary of Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "ieb2d1acd7b3446289e9ad791d76db1de_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FIFOInventoryAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Inventories - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail",
     "shortName": "Inventories - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "ieb2d1acd7b3446289e9ad791d76db1de_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FIFOInventoryAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i6a43198092b94ea889724f8b5846813b_I20130506",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Long-term Debt and Other Credit Arrangements - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail",
     "shortName": "Long-term Debt and Other Credit Arrangements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i6a43198092b94ea889724f8b5846813b_I20130506",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kequ:FinancingLiabilityTermOfContract",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Sale-Leaseback Financing Transaction - Narrative (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
     "shortName": "Sale-Leaseback Financing Transaction - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "0",
      "lang": "en-US",
      "name": "kequ:FinancingLiabilityNumberOfRenewalOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "renewaloption",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "kequ:FinancingLiabilityToBePaidYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails",
     "shortName": "Sale-Leaseback Financing Transaction - Remaining Future Cash Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "kequ:FinancingLiabilityToBePaidYearOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "ia4b416d20e6c41dca68290de29b3950c_D20200327-20200327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kequ:CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Income Taxes - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "ia4b416d20e6c41dca68290de29b3950c_D20200327-20200327",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "kequ:CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Income Taxes - Income Tax Expense (Detail)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail",
     "shortName": "Income Taxes - Income Tax Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Income Taxes - Schedule of Income Tax Reconciliation (Detail)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail",
     "shortName": "Income Taxes - Schedule of Income Tax Reconciliation (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail",
     "shortName": "Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Stock Options and Share-Based Compensation - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
     "shortName": "Stock Options and Share-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "kequ:ShareBasedCompensationDeferredTaxExpenseBenefit",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "ia08ef11dead048c8b9c14a66f2f30b19_I20210430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statement of Stockholders' Equity",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity",
     "shortName": "Consolidated Statement of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "ia08ef11dead048c8b9c14a66f2f30b19_I20210430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "idadad6c5f93d416caf379a3ec3da9055_I20220430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails",
     "shortName": "Stock Options and Share-Based Compensation - Summary of RSU Activity and Weighted Average Exercise Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "if60aac1ba48e4bd790f9b0fafdf6e109_I20210430",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i2ca2ebd535504440b59023a1e53f9d80_I20220430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail",
     "shortName": "Stock Options and Share-Based Compensation - Summary of Stock Option Activity and Weighted Average Exercise Price (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail",
     "shortName": "Stock Options and Share-Based Compensation - Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i2ca2ebd535504440b59023a1e53f9d80_I20220430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
     "shortName": "Accumulated Other Comprehensive Income (Loss) - Schedule of Before Tax Income (Loss) Related Income Tax effect and Accumulated Balances (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "ia08ef11dead048c8b9c14a66f2f30b19_I20210430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Leases, Commitments and Contingencies - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail",
     "shortName": "Leases, Commitments and Contingencies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-1",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails",
     "shortName": "Leases, Commitments and Contingencies - Schedule of Operating and Finance Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail",
     "shortName": "Retirement Benefits - Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanInterestCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail",
     "shortName": "Retirement Benefits - Summary of Components of Net Periodic Pension Cost (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedAmortizationNextFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Retirement Benefits - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
     "shortName": "Retirement Benefits - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedAmortizationNextFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Retirement Benefits - Summary of Expected Benefit Payments (Detail)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail",
     "shortName": "Retirement Benefits - Summary of Expected Benefit Payments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "kequ:ScheduleOfPlanAssetsByAssetCategoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail",
     "shortName": "Retirement Benefits - Summary of Plan Assets by Asset Categories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "kequ:ScheduleOfPlanAssetsByAssetCategoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "kequ:ScheduleOfPlanAssetsByAssetCategoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
     "shortName": "Retirement Benefits - Summary of Fair Value Assets in Defined Benefit Pension Plans (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "kequ:ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i234054f8708d43f4811f8f93244fe91c_I20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Segment Information - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail",
     "shortName": "Segment Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Segment Information - (Detail)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.kewaunee.com/role/SegmentInformationDetail",
     "shortName": "Segment Information - (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "kequ:RevenuesIncludingIntersegmentMarkup",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i7e800b6ee23a4e2894c72aa7f8abe31f_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Restructuring Costs - Additional Information (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails",
     "shortName": "Restructuring Costs - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i7e800b6ee23a4e2894c72aa7f8abe31f_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "iba2c6ce3d92e4dac939d0bb63984eb66_I20230430",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "kequ-20230430.htm",
      "contextRef": "i0c6df9e5525a44ccac97ffb482218846_D20220501-20230430",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 79,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "kequ_AccruedEmployeeBenefitPlanCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the aggregate carrying amounts of the noncurrent liabilities for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans and deferred compensation arrangements representing currently earned compensation under cash arrangements (such as a rabbi trust) that is not actually paid until a later date.",
        "label": "Accrued Employee Benefit Plan Costs",
        "terseLabel": "Accrued pension and deferred compensation costs"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitPlanCosts",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_AdvanceAmountOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance Amount One [Member]",
        "label": "Advance Amount One [Member]",
        "terseLabel": "Advance Amount One"
       }
      }
     },
     "localname": "AdvanceAmountOneMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_AdvanceAmountTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance Amount Two [Member]",
        "label": "Advance Amount Two [Member]",
        "terseLabel": "Advance Amount Two"
       }
      }
     },
     "localname": "AdvanceAmountTwoMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_AdvancesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advances [Member]",
        "label": "Advances [Member]",
        "terseLabel": "Advances"
       }
      }
     },
     "localname": "AdvancesMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.kewaunee.com/20230430",
     "xbrltype": "stringItemType"
    },
    "kequ_BankGuaranteesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank Guarantees [Member]",
        "label": "Bank Guarantees [Member]",
        "terseLabel": "Bank Guarantees"
       }
      }
     },
     "localname": "BankGuaranteesMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_ContractWithCustomerLiabilityRevenueRecognizedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer, liability, revenue recognized percentage.",
        "label": "Contract with Customer, Liability, Revenue Recognized Percentage",
        "terseLabel": "Contract liability recognized as revenue percentage"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognizedPercentage",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "kequ_CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coronavirus Aid, Relief And Economic Security Act, Net Operating Loss Carryback, Period",
        "label": "Coronavirus Aid, Relief And Economic Security Act, Net Operating Loss Carryback, Period",
        "terseLabel": "CARES Act, NOL carryback period (in years)"
       }
      }
     },
     "localname": "CoronavirusAidReliefAndEconomicSecurityActNetOperatingLossCarrybackPeriod",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_CreditAgreementMidCapFundingIVTrustMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement, Mid Cap Funding IV Trust",
        "label": "Credit Agreement, Mid Cap Funding IV Trust [Member]",
        "terseLabel": "Credit Agreement, Mid Cap Funding IV Trust"
       }
      }
     },
     "localname": "CreditAgreementMidCapFundingIVTrustMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Asset Based Lending, Maximum Borrowing Capacity",
        "label": "Debt Instrument, Asset Based Lending, Maximum Borrowing Capacity",
        "terseLabel": "Collateralized debt instrument, borrowing capacity"
       }
      }
     },
     "localname": "DebtInstrumentAssetBasedLendingMaximumBorrowingCapacity",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred income tax expense benefit net of rate adjustment.",
        "label": "Deferred Income Tax Expense Benefit Net Of Rate Adjustment",
        "terseLabel": "Provision for deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitNetOfRateAdjustment",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_DeferredTaxAssetLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Lease Liability",
        "label": "Deferred Tax Asset, Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetLeaseLiability",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_DeferredTaxAssetsProceedsOnSaleLeaseback": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Proceeds on Sale Leaseback",
        "label": "Deferred Tax Assets, Proceeds on Sale Leaseback",
        "terseLabel": "Proceeds on Sale Leaseback"
       }
      }
     },
     "localname": "DeferredTaxAssetsProceedsOnSaleLeaseback",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_DeferredTaxAssetsSection174REAddback": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Section 174 R&amp;E Addback",
        "label": "Deferred Tax Assets, Section 174 R&amp;E Addback",
        "terseLabel": "Section 174 R&amp;E Addback",
        "verboseLabel": "Deferred tax asset, Section 174 addback"
       }
      }
     },
     "localname": "DeferredTaxAssetsSection174REAddback",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_DeferredTaxLiabilitiesAPB23Assertion": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, APB 23 Assertion",
        "label": "Deferred Tax Liabilities, APB 23 Assertion",
        "negatedTerseLabel": "APB 23 Assertion"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAPB23Assertion",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_DeferredTaxLiabilitiesPrepaidPensionCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities Prepaid Pension Cost",
        "label": "Deferred Tax Liabilities Prepaid Pension Cost",
        "negatedLabel": "Prepaid pension"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPrepaidPensionCost",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_DeferredTaxLiabilitiesSaleLeasebackProperty": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Sale Leaseback Property",
        "label": "Deferred Tax Liabilities, Sale Leaseback Property",
        "negatedTerseLabel": "Book basis in excess of tax basis of Sale Leaseback property"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesSaleLeasebackProperty",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_DefinedBenefitPlanEmergingMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Emerging Markets [Member]",
        "label": "Defined Benefit Plan, Emerging Markets [Member]",
        "terseLabel": "Emerging Markets"
       }
      }
     },
     "localname": "DefinedBenefitPlanEmergingMarketsMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Equity Securities, US, Small Cap And Mid Cap [Member]",
        "label": "Defined Benefit Plan, Equity Securities, US, Small Cap And Mid Cap [Member]",
        "terseLabel": "Small/Mid Cap"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesUSSmallCapAndMidCapMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_DefinedBenefitPlanLiquidAlternativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Liquid Alternatives [Member]",
        "label": "Defined Benefit Plan, Liquid Alternatives [Member]",
        "terseLabel": "Liquid Alternatives"
       }
      }
     },
     "localname": "DefinedBenefitPlanLiquidAlternativesMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_DefinedBenefitPlanPercentageChangesInDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan percentage changes in discount rate.",
        "label": "Defined Benefit Plan Percentage Changes In Discount Rate",
        "terseLabel": "Increase decrease in the discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanPercentageChangesInDiscountRate",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "kequ_DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined contribution plan age limit of employees to be eligible for catch up contributions.",
        "label": "Defined Contribution Plan Age Limit Of Employees To Be Eligible For Catch Up Contributions",
        "terseLabel": "Age limit of employees to be eligible for contribution (in years)"
       }
      }
     },
     "localname": "DefinedContributionPlanAgeLimitOfEmployeesToBeEligibleForCatchUpContributions",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_DefinedContributionPlanEligibilityMinimumServicePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined contribution plan eligibility minimum service period.",
        "label": "Defined Contribution Plan Eligibility Minimum Service Period",
        "terseLabel": "Minimum service period of employees to be eligible for contribution (in months)"
       }
      }
     },
     "localname": "DefinedContributionPlanEligibilityMinimumServicePeriod",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_DefinedContributionPlanEmployerMatchingContributionsAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Employer Matching Contributions, Amount",
        "label": "Defined Contribution Plan, Employer Matching Contributions, Amount",
        "terseLabel": "Employer matching contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionsAmount",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined contribution plan employer matching percent of employee contribution.",
        "label": "Defined Contribution Plan Employer Matching Percent Of Employee Contribution",
        "terseLabel": "Matching contributions by company (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingPercentOfEmployeeContribution",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "kequ_DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "label": "Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "terseLabel": "Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag"
       }
      }
     },
     "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "kequ_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "label": "Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag",
        "terseLabel": "Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag"
       }
      }
     },
     "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "kequ_DomesticOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Domestic operations.",
        "label": "Domestic Operations [Member]",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "DomesticOperationsMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Net Operating Loss Carryback, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Net Operating Loss Carryback, Amount",
        "negatedTerseLabel": "Net operating loss adjustment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Return To Provision Adjustment, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Return To Provision Adjustment, Amount",
        "terseLabel": "Return to provision adjustment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentAmount",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FederalStateAndLocalTaxReturnsPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal, state and local tax returns period",
        "label": "Federal, state and local tax returns period",
        "terseLabel": "Federal, state and local tax returns period (in years)"
       }
      }
     },
     "localname": "FederalStateAndLocalTaxReturnsPeriod",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_FinancingLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability",
        "label": "Financing Liability",
        "terseLabel": "Total",
        "verboseLabel": "Financing liability"
       }
      }
     },
     "localname": "FinancingLiability",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability",
        "label": "Financing Liability [Abstract]"
       }
      }
     },
     "localname": "FinancingLiabilityAbstract",
     "nsuri": "http://www.kewaunee.com/20230430",
     "xbrltype": "stringItemType"
    },
    "kequ_FinancingLiabilityAnnualIncreasePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, Annual Increase, Percent",
        "label": "Financing Liability, Annual Increase, Percent",
        "terseLabel": "Annual rental increase, as a percent"
       }
      }
     },
     "localname": "FinancingLiabilityAnnualIncreasePercent",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "kequ_FinancingLiabilityBasicMonthlyPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, Basic Monthly Payment",
        "label": "Financing Liability, Basic Monthly Payment",
        "terseLabel": "Initial basic monthly rent"
       }
      }
     },
     "localname": "FinancingLiabilityBasicMonthlyPayment",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, Current",
        "label": "Financing Liability, Current",
        "terseLabel": "Current portion of financing liability"
       }
      }
     },
     "localname": "FinancingLiabilityCurrent",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability",
        "label": "Financing Liability [Line Items]",
        "terseLabel": "Financing Liability [Line Items]"
       }
      }
     },
     "localname": "FinancingLiabilityLineItems",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kequ_FinancingLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, Noncurrent",
        "label": "Financing Liability, Noncurrent",
        "terseLabel": "Long-term portion of financing liability"
       }
      }
     },
     "localname": "FinancingLiabilityNoncurrent",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityNumberOfRenewalOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, Number of Renewal Options",
        "label": "Financing Liability, Number of Renewal Options",
        "terseLabel": "Number of renewal options"
       }
      }
     },
     "localname": "FinancingLiabilityNumberOfRenewalOptions",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "kequ_FinancingLiabilityRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, Renewal Term",
        "label": "Financing Liability, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "FinancingLiabilityRenewalTerm",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_FinancingLiabilityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability",
        "label": "Financing Liability [Table]",
        "terseLabel": "Financing Liability [Table]"
       }
      }
     },
     "localname": "FinancingLiabilityTable",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "kequ_FinancingLiabilityTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, Term of Contract",
        "label": "Financing Liability, Term of Contract",
        "terseLabel": "Term of agreement"
       }
      }
     },
     "localname": "FinancingLiabilityTermOfContract",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_FinancingLiabilityToBePaid": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, to be Paid",
        "label": "Financing Liability, to be Paid",
        "totalLabel": "Total Minimum Liability Payments"
       }
      }
     },
     "localname": "FinancingLiabilityToBePaid",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityToBePaidAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails": {
       "order": 3.0,
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, to be Paid, After Year Five",
        "label": "Financing Liability, to be Paid, After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinancingLiabilityToBePaidAfterYearFive",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityToBePaidYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails": {
       "order": 4.0,
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, to be Paid, Year Five",
        "label": "Financing Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinancingLiabilityToBePaidYearFive",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityToBePaidYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails": {
       "order": 5.0,
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, to be Paid, Year Four",
        "label": "Financing Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinancingLiabilityToBePaidYearFour",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityToBePaidYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails": {
       "order": 2.0,
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, to be Paid, Year One",
        "label": "Financing Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinancingLiabilityToBePaidYearOne",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityToBePaidYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails": {
       "order": 6.0,
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, to be Paid, Year Three",
        "label": "Financing Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinancingLiabilityToBePaidYearThree",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityToBePaidYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails": {
       "order": 1.0,
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, to be Paid, Year Two",
        "label": "Financing Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinancingLiabilityToBePaidYearTwo",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FinancingLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "kequ_FinancingLiabilityToBePaid",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Liability, Undiscounted Excess Amount",
        "label": "Financing Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Imputed Interest"
       }
      }
     },
     "localname": "FinancingLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionRemainingFutureCashPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_FiscalYearTwoThousandTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal Year Two Thousand Twenty Four",
        "label": "Fiscal Year Two Thousand Twenty Four [Member]",
        "terseLabel": "Fiscal Year 2024"
       }
      }
     },
     "localname": "FiscalYearTwoThousandTwentyFourMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_ForeignSubsidiariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Subsidiaries [Member]",
        "label": "Foreign Subsidiaries [Member]",
        "terseLabel": "International Subsidiaries"
       }
      }
     },
     "localname": "ForeignSubsidiariesMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_ForeignSubsidiariesTaxReturnsPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign subsidiaries tax returns period.",
        "label": "Foreign subsidiaries tax returns period",
        "terseLabel": "Foreign subsidiaries tax returns period (in years)"
       }
      }
     },
     "localname": "ForeignSubsidiariesTaxReturnsPeriod",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "kequ_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "kequ_InterestExpenseFinancingLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense, Financing Liability",
        "label": "Interest Expense, Financing Liability",
        "terseLabel": "Interest expense on financing liability"
       }
      }
     },
     "localname": "InterestExpenseFinancingLiability",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_InternationalOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International operations.",
        "label": "International Operations [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalOperationsMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_InternationalSubsidiariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Subsidiaries",
        "label": "International Subsidiaries [Member]",
        "terseLabel": "International Subsidiaries"
       }
      }
     },
     "localname": "InternationalSubsidiariesMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_KequipGlobalLabSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kequip Global Lab Solutions [Member]",
        "label": "Kequip Global Lab Solutions [Member]",
        "terseLabel": "Kequip Global Lab Solutions Pvt. Ltd."
       }
      }
     },
     "localname": "KequipGlobalLabSolutionsMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_KewauneeLabwayAsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kewaunee Labway Asia [Member]",
        "label": "Kewaunee Labway Asia [Member]",
        "terseLabel": "Kewaunee Labway Asia Pte. Ltd."
       }
      }
     },
     "localname": "KewauneeLabwayAsiaMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_KewauneeLabwayIndiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kewaunee Labway India [Member]",
        "label": "Kewaunee Labway India [Member]",
        "terseLabel": "Kewaunee Labway India Pvt. Ltd."
       }
      }
     },
     "localname": "KewauneeLabwayIndiaMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_KewauneeScientificCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kewaunee Scientific Corporation [Member]",
        "label": "Kewaunee Scientific Corporation [Member]",
        "terseLabel": "Kewaunee Scientific Corporation"
       }
      }
     },
     "localname": "KewauneeScientificCorporationMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_KewauneeScientificCorporationSingaporeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kewaunee Scientific Corporation Singapore [Member]",
        "label": "Kewaunee Scientific Corporation Singapore [Member]",
        "terseLabel": "Kewaunee Scientific Corporation Singapore Pte. Ltd."
       }
      }
     },
     "localname": "KewauneeScientificCorporationSingaporeMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_KoncepoScientechInternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Koncepo Scientech International.",
        "label": "Koncepo Scientech International [Member]",
        "terseLabel": "Koncepo Scientech International"
       }
      }
     },
     "localname": "KoncepoScientechInternationalMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_LesseeOptiontoExtendTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Option to Extend, Term",
        "label": "Lessee, Option to Extend, Term",
        "terseLabel": "Option to extend, term (in years)"
       }
      }
     },
     "localname": "LesseeOptiontoExtendTerm",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_LesseeOptiontoTerminateTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Option to Terminate, Term",
        "label": "Lessee, Option to Terminate, Term",
        "terseLabel": "Option to terminate, term (in years)"
       }
      }
     },
     "localname": "LesseeOptiontoTerminateTerm",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_LesseeRemainingLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Remaining Lease Term",
        "label": "Lessee, Remaining Lease Term",
        "terseLabel": "Remaining lease term (in years)"
       }
      }
     },
     "localname": "LesseeRemainingLeaseTerm",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option",
        "label": "Line of Credit Facility, Accordion Feature, Higher Borrowing Capacity Option",
        "terseLabel": "Maximum borrowing availability"
       }
      }
     },
     "localname": "LineOfCreditFacilityAccordionFeatureHigherBorrowingCapacityOption",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_LineOfCreditFacilityAccordionFeatureIncreaseLimit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "label": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "terseLabel": "Additional tranche available, minimum amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_NonQualifiedCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Qualified Compensation Plan [Member]",
        "label": "Non Qualified Compensation Plan [Member]",
        "terseLabel": "Non Qualified Compensation Plans"
       }
      }
     },
     "localname": "NonQualifiedCompensationPlanMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_NumberOfNonqualifiedCompensationPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of nonqualified compensation plans.",
        "label": "Number Of Nonqualified Compensation Plans",
        "terseLabel": "Number of non-qualified compensation plans maintained"
       }
      }
     },
     "localname": "NumberOfNonqualifiedCompensationPlans",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "kequ_OperatingLeaseShortTermExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Short Term, Expense",
        "label": "Operating Lease, Short Term, Expense",
        "terseLabel": "Operating lease, short term, expense"
       }
      }
     },
     "localname": "OperatingLeaseShortTermExpense",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_OtherAssetsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for other noncurrent assets.",
        "label": "Other Assets [Policy Text Block]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsPolicyTextBlock",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kequ_PaymentsOnFinancingLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments On Financing Liability",
        "label": "Payments On Financing Liability",
        "negatedTerseLabel": "Repayments on financing liability"
       }
      }
     },
     "localname": "PaymentsOnFinancingLiability",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_ProceedsFromFinancingLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Financing Liability",
        "label": "Proceeds from Financing Liability",
        "terseLabel": "Proceeds from sale-leaseback transaction"
       }
      }
     },
     "localname": "ProceedsFromFinancingLiability",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_RestrictedStockUnitsRSUsServiceComponentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units (RSUs), Service Component",
        "label": "Restricted Stock Units (RSUs), Service Component [Member]",
        "terseLabel": "Service Components"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUsServiceComponentMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_RevenueRecognitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Recognition [Line Items]",
        "label": "Revenue Recognition [Line Items]",
        "terseLabel": "Revenue Recognition [Line Items]"
       }
      }
     },
     "localname": "RevenueRecognitionLineItems",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "kequ_RevenueRecognitionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Recognition [Table]",
        "label": "Revenue Recognition [Table]",
        "terseLabel": "Revenue Recognition [Table]"
       }
      }
     },
     "localname": "RevenueRecognitionTable",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "kequ_RevenuesIncludingIntersegmentMarkup": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues including intersegment markup.",
        "label": "Revenues Including Intersegment Markup",
        "terseLabel": "Intersegment revenues"
       }
      }
     },
     "localname": "RevenuesIncludingIntersegmentMarkup",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-Of-Use Asset Obtained In Exchange For Finance Or Operating Lease Liability",
        "label": "Right-Of-Use Asset Obtained In Exchange For Finance Or Operating Lease Liability",
        "terseLabel": "Assets obtained under new finance or operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceOrOperatingLeaseLiability",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule Of Allocation Of Plan Assets Fair Value Hierarchy Table [Text Block]",
        "terseLabel": "Summary of Fair Value Assets in Defined Benefit Pension Plans"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsFairValueHierarchyTableTextBlock",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kequ_ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of bad debt provision charged against earnings and the amounts of accounts receivable written off.",
        "label": "Schedule Of Allowance For Doubtful Accounts [Table Text Block]",
        "terseLabel": "Schedule Of Allowance For Doubtful Accounts"
       }
      }
     },
     "localname": "ScheduleOfAllowanceForDoubtfulAccountsTableTextBlock",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kequ_ScheduleOfPlanAssetsByAssetCategoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of additional asset categories and amounts within a category that is useful in understanding the risks associated with each asset category.",
        "label": "Schedule Of Plan Assets By Asset Category Table [Text Block]",
        "terseLabel": "Summary of Plan Assets by Asset Categories"
       }
      }
     },
     "localname": "ScheduleOfPlanAssetsByAssetCategoryTableTextBlock",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kequ_ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Remaining Future Cash Payments for Financing Liability",
        "label": "Schedule of Remaining Future Cash Payments for Financing Liability [Table Text Block]",
        "terseLabel": "Schedule of Remaining Future Cash Payments for Financing Liability"
       }
      }
     },
     "localname": "ScheduleOfRemainingFutureCashPaymentsForFinancingLiabilityTableTextBlock",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kequ_ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]",
        "label": "Schedule of Cash, Cash Equivalents, and Restricted Cash [Table Text Block]",
        "terseLabel": "Cash and Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleofCashCashEquivalentsandRestrictedCashTableTextBlock",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "kequ_Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Section 174 Research And Experimentation Expenditures, Period Of Deductibility",
        "label": "Section 174 Research And Experimentation Expenditures, Period Of Deductibility",
        "terseLabel": "Section 174 expenditure deduction period"
       }
      }
     },
     "localname": "Section174ResearchAndExperimentationExpendituresPeriodOfDeductibility",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "kequ_SecuredOvernightFinancingRateSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_ShareBasedCompensationDeferredTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax expense benefit related to deductible temporary differences from share-based compensation expense stock options at exercise.",
        "label": "Share Based Compensation Deferred Tax Expense Benefit",
        "terseLabel": "Deferred income tax benefit"
       }
      }
     },
     "localname": "ShareBasedCompensationDeferredTaxExpenseBenefit",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_SignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Line Items]",
        "label": "Significant Accounting Policies [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "kequ_SignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]",
        "terseLabel": "Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTable",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "kequ_TaxWithholdingExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Withholding Expense",
        "label": "Tax Withholding Expense",
        "terseLabel": "Tax withholding expense"
       }
      }
     },
     "localname": "TaxWithholdingExpense",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_TermLoanBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B [Member]",
        "label": "Term Loan B [Member]",
        "verboseLabel": "Term Loan B"
       }
      }
     },
     "localname": "TermLoanBMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_TradingSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading Securities [Member]",
        "label": "Trading Securities [Member]",
        "terseLabel": "Trading Securities Held in Non-Qualified Compensation Plans"
       }
      }
     },
     "localname": "TradingSecuritiesMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_TwoThousandAndEightPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand And Eight Plan [Member]",
        "label": "Two Thousand And Eight Plan [Member]",
        "terseLabel": "2008 Plan"
       }
      }
     },
     "localname": "TwoThousandAndEightPlanMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_TwoThousandSeventeenOmnibusIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand seventeen omnibus incentive plan.",
        "label": "Two Thousand Seventeen Omnibus Incentive Plan [Member]",
        "terseLabel": "2017 Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenOmnibusIncentivePlanMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_TwoThousandTenAndTwoThousandEightPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand ten and two thousand eight plan.",
        "label": "Two Thousand Ten And Two Thousand Eight Plan [Member]",
        "terseLabel": "2010 and 2008 Plan"
       }
      }
     },
     "localname": "TwoThousandTenAndTwoThousandEightPlanMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "kequ_UnbilledRetainageCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled Retainage, Current",
        "label": "Unbilled Retainage, Current",
        "terseLabel": "Unbilled retainage included in other assets",
        "verboseLabel": "Contract assets in other assets"
       }
      }
     },
     "localname": "UnbilledRetainageCurrent",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "kequ_YieldCurveTechniqueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield Curve Technique [Member]",
        "label": "Yield Curve Technique [Member]",
        "terseLabel": "Yield Curve Technique"
       }
      }
     },
     "localname": "YieldCurveTechniqueMember",
     "nsuri": "http://www.kewaunee.com/20230430",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r249",
      "r563",
      "r564",
      "r567",
      "r568",
      "r597",
      "r644",
      "r745",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r249",
      "r563",
      "r564",
      "r567",
      "r568",
      "r597",
      "r644",
      "r745",
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r249",
      "r283",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r305",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r361",
      "r363",
      "r364",
      "r746",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r249",
      "r283",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r305",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r361",
      "r363",
      "r364",
      "r746",
      "r747"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r491",
      "r602",
      "r622",
      "r645",
      "r646",
      "r688",
      "r706",
      "r715",
      "r750",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r491",
      "r602",
      "r622",
      "r645",
      "r646",
      "r688",
      "r706",
      "r715",
      "r750",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r442",
      "r491",
      "r522",
      "r523",
      "r524",
      "r601",
      "r602",
      "r622",
      "r645",
      "r646",
      "r688",
      "r706",
      "r715",
      "r743",
      "r750",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r352",
      "r442",
      "r491",
      "r522",
      "r523",
      "r524",
      "r601",
      "r602",
      "r622",
      "r645",
      "r646",
      "r688",
      "r706",
      "r715",
      "r743",
      "r750",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r308",
      "r309",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r690",
      "r714",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r308",
      "r309",
      "r630",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r690",
      "r714",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r759",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r19",
      "r713"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r313",
      "r314"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Receivables, less allowance: $476 (2023); $357 (2022)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r34",
      "r39",
      "r142",
      "r728",
      "r729",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Minimum Pension Liability Adjustment"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r82",
      "r211"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r35",
      "r39",
      "r758"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "terseLabel": "After-tax actuarial loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r215",
      "r615",
      "r627",
      "r628"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r228",
      "r229",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r36",
      "r39",
      "r142",
      "r596",
      "r623",
      "r624",
      "r728",
      "r729",
      "r730",
      "r735",
      "r736",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r32",
      "r39",
      "r142",
      "r229",
      "r230",
      "r577",
      "r578",
      "r579",
      "r580",
      "r582",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r527",
      "r528",
      "r529",
      "r735",
      "r736",
      "r737",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r123",
      "r124",
      "r495"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings (loss) to net cash used by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r533"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r526"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Stock based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r216",
      "r315",
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year",
        "terseLabel": "Allowance for receivables"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "auth_ref": [
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Recovery",
        "terseLabel": "Recovery of bad debt collections"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedLabel": "Doubtful accounts written off (net)"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive options exclude from computation of earning per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r53",
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Property plant and equipment impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r169",
      "r185",
      "r213",
      "r246",
      "r291",
      "r297",
      "r303",
      "r317",
      "r353",
      "r354",
      "r356",
      "r357",
      "r358",
      "r360",
      "r362",
      "r364",
      "r365",
      "r563",
      "r567",
      "r574",
      "r713",
      "r746",
      "r747",
      "r810"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets",
        "verboseLabel": "Segment assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r206",
      "r219",
      "r246",
      "r317",
      "r353",
      "r354",
      "r356",
      "r357",
      "r358",
      "r360",
      "r362",
      "r364",
      "r365",
      "r563",
      "r567",
      "r574",
      "r713",
      "r746",
      "r747",
      "r810"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrust": {
     "auth_ref": [
      "r731"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.",
        "label": "Assets Held-in-trust",
        "terseLabel": "Assets held in trust account for non-qualified benefit plans included in other assets"
       }
      }
     },
     "localname": "AssetsHeldInTrust",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNet": {
     "auth_ref": [
      "r0",
      "r196",
      "r197",
      "r198",
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net assets (liabilities).",
        "label": "Net Assets",
        "terseLabel": "Net assets"
       }
      }
     },
     "localname": "AssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r497",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail",
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r149",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail",
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingImprovementsMember": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building Improvements [Member]",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r55",
      "r209",
      "r665"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r56",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r50",
      "r55",
      "r61"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, Cash Equivalents and Restricted Cash at End of Year",
        "periodStartLabel": "Cash, Cash Equivalents and Restricted Cash at Beginning of Year",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r50",
      "r162"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase in Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashSurrenderValueMember": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash that could be realized under a life insurance contract or contracts owned by the Company (for example, but not limited to corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI)).",
        "label": "Cash Surrender Value [Member]",
        "terseLabel": "Cash Surrender Value of Life Insurance Policies"
       }
      }
     },
     "localname": "CashSurrenderValueMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashSurrenderValueOfLifeInsurance": {
     "auth_ref": [
      "r726"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity.",
        "label": "Cash Surrender Value of Life Insurance",
        "terseLabel": "Cash surrender value of life insurance policies included in other assets"
       }
      }
     },
     "localname": "CashSurrenderValueOfLifeInsurance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r26",
      "r175",
      "r192"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (Note 9)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r85",
      "r347",
      "r348",
      "r632",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Leases, Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r735",
      "r736",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r10",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r10",
      "r713"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Deferred tax assets (liabilities) classified in the balance sheet:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r40",
      "r224",
      "r226",
      "r235",
      "r610",
      "r619"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income (loss) attributable to Kewaunee Scientific Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r138",
      "r139",
      "r148",
      "r224",
      "r226",
      "r234",
      "r609",
      "r618"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less comprehensive income attributable to the non-controlling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r137",
      "r148",
      "r224",
      "r226",
      "r233",
      "r608",
      "r617"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r46",
      "r232",
      "r607",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r66",
      "r67",
      "r160",
      "r161",
      "r311",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r66",
      "r67",
      "r160",
      "r161",
      "r311",
      "r629",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r66",
      "r67",
      "r160",
      "r161",
      "r311",
      "r631",
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r181",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Credit Concentration"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r66",
      "r67",
      "r160",
      "r161",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r66",
      "r67",
      "r160",
      "r161",
      "r311",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r140",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r143",
      "r144",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionContractorReceivableRetainage": {
     "auth_ref": [
      "r214",
      "r603"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer withheld under retainage provision in long-term contract or program when right to consideration is unconditional.",
        "label": "Construction Contractor, Receivable, Retainage",
        "terseLabel": "Retainage included in accounts receivable"
       }
      }
     },
     "localname": "ConstructionContractorReceivableRetainage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r395",
      "r397",
      "r416"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract assets in accounts receivable",
        "verboseLabel": "Unbilled receivables"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerDurationAxis": {
     "auth_ref": [
      "r693",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract with Customer, Duration [Axis]",
        "terseLabel": "Contract with Customer, Duration [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerDurationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerDurationDomain": {
     "auth_ref": [
      "r693",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract with Customer, Duration [Domain]",
        "terseLabel": "Contract with Customer, Duration [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerDurationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r395",
      "r396",
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r395",
      "r396",
      "r416"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r74",
      "r296",
      "r297",
      "r298",
      "r299",
      "r305",
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r45",
      "r605"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r734",
      "r796",
      "r798"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r734",
      "r796"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r134",
      "r548",
      "r556",
      "r734"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current tax expense"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current tax expense:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r734",
      "r796",
      "r798"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r65",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r90",
      "r245",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r382",
      "r389",
      "r390",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-term Debt and Other Credit Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r170",
      "r172",
      "r184",
      "r249",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r585",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt, variable interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r24",
      "r249",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r585",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFiveMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period five representing fifth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Five [Member]",
        "terseLabel": "Expiration Date, Period Five"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFiveMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFourMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Four [Member]",
        "terseLabel": "Expiration Date, Period Four"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFourMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Expiration Date, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Expiration Date, Period Three"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Expiration Date, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Par amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r24",
      "r92",
      "r93",
      "r94",
      "r95",
      "r163",
      "r164",
      "r166",
      "r180",
      "r249",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r378",
      "r379",
      "r380",
      "r381",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r391",
      "r585",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r734",
      "r797",
      "r798"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r165",
      "r751"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs on financing liability"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r134",
      "r734",
      "r797"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r53",
      "r134",
      "r549",
      "r555",
      "r556",
      "r734"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Deferred income tax benefit",
        "totalLabel": "Total deferred tax expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred tax expense:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r7",
      "r8",
      "r171",
      "r183",
      "r543"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r536",
      "r537"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedLabel": "Deferred tax labilities",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r734",
      "r797",
      "r798"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory reserves and capitalized costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r131",
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credits (state, net of federal benefits)"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": {
     "auth_ref": [
      "r131",
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign",
        "terseLabel": "Foreign tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits": {
     "auth_ref": [
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 11.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits",
        "terseLabel": "Accrued employee benefit expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits": {
     "auth_ref": [
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      },
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits",
        "negatedLabel": "Deferred tax benefit",
        "terseLabel": "Unrecognized actuarial loss, defined benefit plans"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 12.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r545"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Deferred tax asset valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail",
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r127",
      "r794"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts": {
     "auth_ref": [
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from debt issuance costs.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs",
        "negatedTerseLabel": "Debt Issuance Cost on Sale Leaseback"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Right of use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r132",
      "r795"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Book basis in excess of tax basis of property, plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r6",
      "r102",
      "r103",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "negatedLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated Benefit Obligation, April 30"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r35",
      "r39",
      "r758"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "totalLabel": "Net actual loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax [Abstract]",
        "terseLabel": "Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Consist of:"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeLossAfterTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r433",
      "r698"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "verboseLabel": "Actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]",
        "terseLabel": "Amounts Recognized in the Consolidated Balance Sheets consist of:"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r465",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term return on plan assets (as a percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Projected benefit obligations, end of year",
        "periodStartLabel": "Projected benefit obligations, beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r428",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedLabel": "Actual benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r468",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in Projected Benefit Obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r435",
      "r445",
      "r483",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "auth_ref": [
      "r696",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": {
     "auth_ref": [
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities, Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesUsLargeCapMember": {
     "auth_ref": [
      "r698",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), classified as having large market capitalization, for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities, US, Large Cap [Member]",
        "terseLabel": "Large Cap"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesUsLargeCapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedAmortizationNextFiscalYear": {
     "auth_ref": [
      "r760"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost (credit) included in accumulated other comprehensive (income) loss expected to be recognized in net periodic benefit cost (credit) for fiscal year following most recent annual statement of financial position.",
        "label": "Defined Benefit Plan, Expected Amortization, Next Fiscal Year",
        "terseLabel": "Defined pension benefit plan, net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedAmortizationNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2029- 2033"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofExpectedBenefitPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r453",
      "r699"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Anticipated contribution in the next fiscal year related to pension plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r420",
      "r457",
      "r478",
      "r698",
      "r699"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r432",
      "r443",
      "r445",
      "r446",
      "r696",
      "r697",
      "r698"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets, end of year",
        "periodStartLabel": "Fair value of plan assets, beginning of year",
        "terseLabel": "Defined benefit plan, Plan asset",
        "verboseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r419",
      "r441",
      "r698"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status\u2014under"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r420",
      "r424",
      "r456",
      "r477",
      "r698",
      "r699"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r454",
      "r475",
      "r698",
      "r699"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic pension expense (income)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "auth_ref": [
      "r454",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes expected return (loss) on plan asset component of net periodic benefit (cost) credit for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditExpectedReturnLossStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "auth_ref": [
      "r454",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes interest cost component of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditInterestCostStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList": {
     "auth_ref": [
      "r454",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes settlement and curtailment gain (loss) component of net periodic benefit (cost) credit for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Settlement and Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostCreditSettlementAndCurtailmentGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r437",
      "r765"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedLabel": "Actual benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r442",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Defined benefit plan, Plan asset percentage"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r754",
      "r757",
      "r764"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedLabel": "Recognition of net loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofComponentsofNetPeriodicPensionCostDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r755"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Defined benefit plan, Plan asset percentage"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Weighted-average Assumptions Used to Determine Benefit Obligations at April 30"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost for Years Ended April 30"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofChangeinProjectedBenefitObligationsandChangeinFairValueofPlanAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Contributions by employer per employee's compensation (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employee's compensation (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Employee's compensation (as a percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r53",
      "r80"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r220",
      "r221",
      "r573",
      "r671"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Financial Assets"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r220",
      "r221",
      "r573",
      "r671"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Financial Liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r415",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r113",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "terseLabel": "Summary of RSU Activity and Weighted Average Exercise Price"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r236",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r263",
      "r265",
      "r267",
      "r268",
      "r269",
      "r271",
      "r570",
      "r571",
      "r611",
      "r620",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r236",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r265",
      "r267",
      "r268",
      "r269",
      "r271",
      "r570",
      "r571",
      "r611",
      "r620",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r63",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r575"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, net"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee compensation and amounts withheld"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r792"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Remaining estimated compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r91",
      "r202",
      "r228",
      "r229",
      "r230",
      "r250",
      "r251",
      "r252",
      "r254",
      "r260",
      "r262",
      "r273",
      "r318",
      "r394",
      "r527",
      "r528",
      "r529",
      "r551",
      "r552",
      "r569",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r582",
      "r596",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FIFOInventoryAmount": {
     "auth_ref": [
      "r667"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of FIFO (first in first out) inventory present at the reporting date when inventory is also valued using different valuation methods.",
        "label": "FIFO Inventory Amount",
        "terseLabel": "Inventories measured using FIFO method"
       }
      }
     },
     "localname": "FIFOInventoryAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Closing"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r151",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.",
        "label": "Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Hierarchy for Assets and Liabilities"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r151",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r151",
      "r158",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r380",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r572",
      "r598",
      "r599",
      "r600",
      "r684",
      "r685",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r380",
      "r445",
      "r450",
      "r572",
      "r598",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r380",
      "r445",
      "r450",
      "r572",
      "r599",
      "r684",
      "r685",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r380",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r572",
      "r600",
      "r684",
      "r685",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r380",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r598",
      "r599",
      "r600",
      "r684",
      "r685",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Financing"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r587",
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r587"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of Finance Lease Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r587"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term portion of financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total Minimum Lease Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Imputed Interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r592",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance lease, weighted average discount rate (as a percent)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r591",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance lease, weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FixedIncomeSecuritiesMember": {
     "auth_ref": [
      "r698",
      "r756"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.",
        "label": "Fixed Income Securities [Member]",
        "terseLabel": "Fixed Income",
        "verboseLabel": "Fixed Income Securities"
       }
      }
     },
     "localname": "FixedIncomeSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GeographicDistributionAxis": {
     "auth_ref": [
      "r612",
      "r613",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Axis]",
        "terseLabel": "Geographic Distribution [Axis]"
       }
      }
     },
     "localname": "GeographicDistributionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeographicDistributionDomain": {
     "auth_ref": [
      "r612",
      "r613",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Domain]",
        "terseLabel": "Geographic Distribution [Domain]"
       }
      }
     },
     "localname": "GeographicDistributionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionDomesticMember": {
     "auth_ref": [
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic.",
        "label": "Geographic Distribution, Domestic [Member]",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "GeographicDistributionDomesticMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionForeignMember": {
     "auth_ref": [
      "r612",
      "r613",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as foreign.",
        "label": "Geographic Distribution, Foreign [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "GeographicDistributionForeignMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r44",
      "r246",
      "r291",
      "r296",
      "r302",
      "r305",
      "r317",
      "r353",
      "r354",
      "r356",
      "r357",
      "r358",
      "r360",
      "r362",
      "r364",
      "r365",
      "r574",
      "r678",
      "r746"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsByNatureAxis": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of guarantee.",
        "label": "Guarantor Obligations, Nature [Axis]",
        "terseLabel": "Guarantor Obligations, Nature [Axis]"
       }
      }
     },
     "localname": "GuaranteeObligationsByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Bank Guarantees outstanding to customers"
       }
      }
     },
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsNatureDomain": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a description of the nature of the guarantee or each group of similar guarantees.",
        "label": "Guarantor Obligations, Nature [Domain]",
        "terseLabel": "Guarantor Obligations, Nature [Domain]"
       }
      }
     },
     "localname": "GuaranteeObligationsNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r42",
      "r167",
      "r176",
      "r194",
      "r291",
      "r296",
      "r302",
      "r305",
      "r613",
      "r678"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings (loss) before income taxes",
        "totalLabel": "Earnings (Loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r247",
      "r540",
      "r541",
      "r547",
      "r553",
      "r557",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r248",
      "r261",
      "r262",
      "r289",
      "r538",
      "r554",
      "r558",
      "r621"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "totalLabel": "Net income tax expense",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/IncomeTaxesIncomeTaxExpenseDetail",
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r227",
      "r534",
      "r535",
      "r541",
      "r542",
      "r546",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r793"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": {
     "auth_ref": [
      "r793"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount",
        "negatedTerseLabel": "Impact of foreign subsidiary income to parent"
       }
      }
     },
     "localname": "IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r793"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Effects of differing US and foreign tax rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r539"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax expense (benefit) at statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r793"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other items, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r793"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State and local taxes, net of federal income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "auth_ref": [
      "r793"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount",
        "negatedLabel": "Tax credits (state, net of federal benefit)"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesScheduleofIncomeTaxReconciliationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and other accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r672"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedTerseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for pension and other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits",
        "terseLabel": "(Decrease) increase pension expense"
       }
      }
     },
     "localname": "IncreaseDecreaseInPensionAndPostretirementObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r165",
      "r178",
      "r231",
      "r285",
      "r584"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r239",
      "r242",
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r283",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment revenues"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r77",
      "r668"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r218",
      "r666",
      "r713"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r208",
      "r217",
      "r272",
      "r323",
      "r324",
      "r325",
      "r604",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r77",
      "r670"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Materials and components"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r77",
      "r669"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesSummaryofInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r753"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseDiscountRate": {
     "auth_ref": [
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of finance lease payments.",
        "label": "Lessee, Finance Lease, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "LesseeFinanceLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total Minimum Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r593"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Imputed Interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r21",
      "r246",
      "r317",
      "r353",
      "r354",
      "r356",
      "r357",
      "r358",
      "r360",
      "r362",
      "r364",
      "r365",
      "r564",
      "r567",
      "r568",
      "r574",
      "r677",
      "r746",
      "r810",
      "r811"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r15",
      "r174",
      "r190",
      "r713",
      "r733",
      "r742",
      "r803"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r23",
      "r207",
      "r246",
      "r317",
      "r353",
      "r354",
      "r356",
      "r357",
      "r358",
      "r360",
      "r362",
      "r364",
      "r365",
      "r564",
      "r567",
      "r568",
      "r574",
      "r713",
      "r746",
      "r810",
      "r811"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r5",
      "r172",
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Credit facility outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate at period end"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Loan agreement"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Unused and available credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r5",
      "r172",
      "r187",
      "r379",
      "r393",
      "r684",
      "r685"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r24",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinistryOfFinanceIndiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of India.",
        "label": "Ministry of Finance, India [Member]",
        "terseLabel": "India Income Tax Department"
       }
      }
     },
     "localname": "MinistryOfFinanceIndiaMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r29",
      "r173",
      "r189",
      "r246",
      "r317",
      "r353",
      "r356",
      "r357",
      "r358",
      "r364",
      "r365",
      "r574"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "verboseLabel": "Percentage of controlling interest in subsidiaries"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r241"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r241"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r50",
      "r51",
      "r54"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r43",
      "r54",
      "r177",
      "r193",
      "r205",
      "r222",
      "r225",
      "r230",
      "r246",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r261",
      "r262",
      "r266",
      "r291",
      "r296",
      "r302",
      "r305",
      "r317",
      "r353",
      "r354",
      "r356",
      "r357",
      "r358",
      "r360",
      "r362",
      "r364",
      "r365",
      "r571",
      "r574",
      "r678",
      "r746"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net earnings (loss) attributable to Kewaunee Scientific Corporation",
        "totalLabel": "Net earnings (loss) attributable to Kewaunee Scientific Corporation",
        "verboseLabel": "Net earnings (loss) attributable to Kewaunee Scientific Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity",
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r141",
      "r147",
      "r222",
      "r225",
      "r261",
      "r262",
      "r730"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: net earnings attributable to the non-controlling interest",
        "verboseLabel": "Net earnings attributable to non-controlling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r313",
      "r314",
      "r606"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Note receivable",
        "verboseLabel": "Carrying value of redeemable preferred shares"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r740"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of business segment"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r291",
      "r296",
      "r302",
      "r305",
      "r678"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating earnings (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r804"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r587"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesScheduleofOperatingandFinanceLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r587"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r587"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r588",
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r586"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right of use assets",
        "verboseLabel": "ROU assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r592",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating lease, weighted average discount rate (as a percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r591",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating lease, weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LeasesCommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r33",
      "r37",
      "r462"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Change in unrecognized actuarial loss on pension obligations"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r31",
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r41",
      "r91",
      "r223",
      "r226",
      "r232",
      "r576",
      "r581",
      "r582",
      "r607",
      "r616",
      "r728",
      "r729"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r33",
      "r37",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Change in unrecognized actuarial loss on pension obligations"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Non-current",
        "verboseLabel": "Other Noncurrent Assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesSummaryofDeferredTaxAssetsandLiabilitiesDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1": {
     "auth_ref": [
      "r58",
      "r59",
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the noncash (or part noncash) consideration received in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Other Significant Noncash Transaction, Value of Consideration Received",
        "terseLabel": "Portion of sale agreement payable in redeemable preferred stock"
       }
      }
     },
     "localname": "OtherSignificantNoncashTransactionValueOfConsiderationReceived1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r238",
      "r799",
      "r800",
      "r801"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Capital expenditures",
        "terseLabel": "Expenditures for segment assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r442",
      "r444",
      "r450",
      "r467",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r485",
      "r486",
      "r488",
      "r493",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Retirement Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost (reversal of cost) for pension benefits. Excludes other postretirement benefits.",
        "label": "Pension Cost (Reversal of Cost)",
        "negatedTerseLabel": "Pension (expense) income"
       }
      }
     },
     "localname": "PensionExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r100",
      "r419",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r468",
      "r471",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r488",
      "r489",
      "r492",
      "r698",
      "r699",
      "r703",
      "r704",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r468",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]",
        "terseLabel": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r727"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r47"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Sale agreement for property"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-Term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r205",
      "r222",
      "r225",
      "r240",
      "r246",
      "r253",
      "r261",
      "r262",
      "r291",
      "r296",
      "r302",
      "r305",
      "r317",
      "r353",
      "r354",
      "r356",
      "r357",
      "r358",
      "r360",
      "r362",
      "r364",
      "r365",
      "r562",
      "r565",
      "r566",
      "r571",
      "r574",
      "r613",
      "r678",
      "r710",
      "r711",
      "r730",
      "r746"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings (loss)",
        "totalLabel": "Net earnings (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.kewaunee.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r81",
      "r210"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property plant and equipment gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentImpairment": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for assessing and recognizing impairments of its property, plant and equipment.",
        "label": "Property, Plant and Equipment, Impairment [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment, Impairment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r83",
      "r191",
      "r614",
      "r713"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Net property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r83",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful Life (in years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r237",
      "r320"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt provision"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofActivityinAllowanceforDoubtfulAccountsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-Term Debt",
        "negatedLabel": "Repayments on short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r126",
      "r200",
      "r818"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Experimentation Expenditures"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r55",
      "r61",
      "r209"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesCashEquivalentsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r336",
      "r338",
      "r341",
      "r345",
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RestructuringCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r337",
      "r338",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r12",
      "r96",
      "r188",
      "r626",
      "r628",
      "r713"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r202",
      "r250",
      "r251",
      "r252",
      "r254",
      "r260",
      "r262",
      "r318",
      "r527",
      "r528",
      "r529",
      "r551",
      "r552",
      "r569",
      "r623",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "verboseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r100",
      "r101",
      "r419",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r468",
      "r471",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r488",
      "r489",
      "r490",
      "r492",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r100",
      "r101",
      "r419",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r468",
      "r471",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r488",
      "r489",
      "r490",
      "r492",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r282",
      "r283",
      "r295",
      "r300",
      "r301",
      "r307",
      "r308",
      "r311",
      "r414",
      "r415",
      "r605"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net sales",
        "verboseLabel": "Net sales transferred to customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail",
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r418",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r417",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleAndLeasebackTransactionGainLossNet": {
     "auth_ref": [
      "r589",
      "r594",
      "r712"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.",
        "label": "Sale and Leaseback Transaction, Gain (Loss), Net",
        "terseLabel": "Gain (loss) on sale leaseback agreement"
       }
      }
     },
     "localname": "SaleAndLeasebackTransactionGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransactionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleLeasebackTransactionDisclosureTextBlock": {
     "auth_ref": [
      "r201",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for sale leaseback transaction. Includes, but is not limited to, terms and conditions of transaction and gain (loss) from transaction.",
        "label": "Sale Leaseback Transactions [Text Block]",
        "terseLabel": "Sale-Leaseback Financing Transaction"
       }
      }
     },
     "localname": "SaleLeasebackTransactionDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SaleLeasebackFinancingTransaction"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SalesRevenueSegmentMember": {
     "auth_ref": [
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from specified business segment, when it serves as benchmark in concentration of risk calculation. Includes, but is not limited to, revenue from contract with customer and other sources.",
        "label": "Revenue, Segment Benchmark [Member]",
        "terseLabel": "Sales Revenue, Segment"
       }
      }
     },
     "localname": "SalesRevenueSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r698",
      "r761",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefit obligation and plan assets of defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block]",
        "terseLabel": "Summary of Change in Projected Benefit Obligations and Change in Fair Value of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Summary of Components of Net Periodic Pension Cost"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r30"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Before Tax Income (Loss) Related Income Tax Effect and Accumulated Balances"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Summary of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r111",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofFairValueAssetsinDefinedBenefitPensionPlansDetail",
      "http://www.kewaunee.com/role/RetirementBenefitsSummaryofPlanAssetsbyAssetCategoriesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Basic to Diluted Weighted Average Shares Outstanding"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Income Tax Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Summary of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r16",
      "r17",
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Summary of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r494",
      "r496",
      "r497",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Summary of Options Outstanding, Exercisable, and Weighted Average Exercise Prices within Exercise Price Range"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r114",
      "r118",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity and Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r279",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r311",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r340",
      "r344",
      "r682",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r279",
      "r280",
      "r281",
      "r291",
      "r294",
      "r299",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r310",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfInsuranceReservePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).",
        "label": "Self Insurance Reserve [Policy Text Block]",
        "terseLabel": "Insurance"
       }
      }
     },
     "localname": "SelfInsuranceReservePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollar per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollar per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r509",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at end of year (in shares)",
        "periodStartLabel": "Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of RSUs"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r509",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Outstanding at beginning of year (in dollar per shares)",
        "verboseLabel": "Outstanding at end of year (in dollar per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollar per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of non-option equity instruments granted to participants.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "terseLabel": "Restricted stock units granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Increase in number of shares available under stock option plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized under stock option plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for future grants (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at end of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at end of year (in dollar per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Awards granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of year (in shares)",
        "periodStartLabel": "Outstanding at beginning of year (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of\u00a0Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r501",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "netLabel": "Outstanding at end of year (in dollar per shares)",
        "terseLabel": "Weighted average exercise price (in dollar per shares)",
        "verboseLabel": "Outstanding at beginning of year (in dollar per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r497",
      "r498",
      "r499",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail",
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofRSUActivityandWeightedAverageExercisePriceDetails",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollar per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled (in dollar per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r500",
      "r519",
      "r520",
      "r521",
      "r522",
      "r525",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Accounting for Stock Options and Other Equity Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Exercise price range lower limit (in dollar per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Options exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Exercise price range upper limit (in dollar per shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Terms of award (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price (in dollar per shares)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofOptionsOutstandingExercisableandWeightedAverageExercisePriceswithinExercisePriceRangeDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r99",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "terseLabel": "Stock Options and Share-Based Compensation"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r2",
      "r170",
      "r186",
      "r713"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r62",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r204",
      "r279",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r311",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r340",
      "r344",
      "r682",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SegmentInformationDetail",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r28",
      "r91",
      "r202",
      "r228",
      "r229",
      "r230",
      "r250",
      "r251",
      "r252",
      "r254",
      "r260",
      "r262",
      "r273",
      "r318",
      "r394",
      "r527",
      "r528",
      "r529",
      "r551",
      "r552",
      "r569",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r582",
      "r596",
      "r623",
      "r624",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/AccumulatedOtherComprehensiveIncomeLossScheduleofBeforeTaxIncomeLossRelatedIncomeTaxeffectandAccumulatedBalancesDetail",
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesSummaryofFairValueHierarchyforFinancialAssetsandLiabilitiesMeasuredRecurringandNonrecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r273",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r9",
      "r10",
      "r91",
      "r96",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/StockOptionsandShareBasedCompensationSummaryofStockOptionActivityandWeightedAverageExercisePriceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r10",
      "r13",
      "r14",
      "r76",
      "r713",
      "r733",
      "r742",
      "r803"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Kewaunee Scientific Corporation Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets",
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r135",
      "r136",
      "r146",
      "r202",
      "r203",
      "r229",
      "r250",
      "r251",
      "r252",
      "r254",
      "r260",
      "r318",
      "r394",
      "r527",
      "r528",
      "r529",
      "r551",
      "r552",
      "r569",
      "r576",
      "r577",
      "r582",
      "r596",
      "r624",
      "r625",
      "r733",
      "r742",
      "r803"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Disclosure of Cash Flow Information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r694",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r694",
      "r752"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for treatment of receivables that are billable but have not been billed as of the balance sheet date.",
        "label": "Trade and Other Accounts Receivable, Unbilled Receivables, Policy [Policy Text Block]",
        "terseLabel": "Unbilled Receivables"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivableUnbilledReceivablesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred at point in time.",
        "label": "Transferred at Point in Time [Member]",
        "terseLabel": "Point in Time"
       }
      }
     },
     "localname": "TransferredAtPointInTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RevenueRecognitionSummaryofNetSalesTransferredtoCustomersataPointinTimeandOverTimeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r27",
      "r97",
      "r98"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Common stock in treasury, at cost: 3 shares"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r337",
      "r338",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RestructuringCostsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r274",
      "r275",
      "r277",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/RetirementBenefitsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/LongtermDebtandOtherCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r738"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Dilutive effect of stock options and RSUs (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r264",
      "r269"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average common shares outstanding-diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding",
        "verboseLabel": "Weighted average number of common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r263",
      "r269"
     ],
     "calculation": {
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.kewaunee.com/role/ConsolidatedStatementsofOperations",
      "http://www.kewaunee.com/role/SummaryofSignificantAccountingPoliciesReconciliationofBasictoDilutedWeightedAverageCommonSharesOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(14)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "40",
   "Topic": "840",
   "URI": "https://asc.fasb.org/subtopic&trid=2209073",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(c)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e526-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "310",
   "URI": "https://asc.fasb.org/topic&trid=2196771",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919786-209982",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "40",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888253",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991598-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(i)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(ii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "1402",
   "Subsection": "Instruction 5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r716": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r717": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r718": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r719": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r721": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r722": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r723": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r724": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r725": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(b))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>96
<FILENAME>0000055529-23-000013-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000055529-23-000013-xbrl.zip
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M:(M2H,G3 CV'38^F1?;GYOKR\OJGR<U3-Y8WY)OW&\.TCIC8*DS:Z\HIQ=0
M;NM<]FR+8F7Y2I'+L-4I E"E2M' ;K&=U2T 0Z.D1'W*\G1N=LW*C6UL*1>
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M@#T<8GYS"4:G8^^)W -+ULE,21D&'C3(L>>8'A1(>6%Y]_K-\)AJ''U:WF[
MT .+^/R1NE72^BX8!I4=-76'Q[*_PY\U;?$P"+K!.0JW8H>@MK"N$T,9"7T
MN*HUF8Q22TJZ?TN="TD/HMG#"K5KH,@1EGN^*E-0Q4;7N!>U1(2%2/;B !>&
M!*PL=F%ALR[ FALC*J41@!OP\AG%7&9.<F]/DC8 [X=_G5ZGQ'C:4@H?E6;'
M-J^S__^A2J98J:,+I@53>!AD8R+*1_B6_LZIKO%GS45>EBKA(YPNK%59.X5Y
M(GC;8'A%/7=;<=1S-]>)5G$T^PQ2F4)D&//VG\G)T4\TBCL_P2TG'(J2>V)X
MA%[)Q%2CD\WS'S?SS1-PK^HW4$L#!!0    ( *18WE:1#0TJ30(  .(#   .
M    97AH:6)I=#(S,2YH=&UM4]MRVC 0?><KMG[HM#,X^)*0%(QG: @)#;D,
M,,GT4;;7MAHC>22YE'Y]5S:YM T/QBOOGG/V["JZVMPLXUYT=3&=Q=$'UX69
M3)LM"@,%"E3,8 ;)'AZE>N(_&2Q$"JY+!9O%9GD1XZ^2)]P$H1\-NI->-&BQ
M>M'7N]EW2(I45E)-G%W)#3IT/%L\ *MX(29.2C2HG@^UV5<X<;9,%5RX%>9F
MY.-VO..9*4>^=W(R=CJ%KZ2>YQ_]J(M.T1N,FF49%X5K9#T*",-2+&XN0:MT
MXOQ7[H#AQI;IBF?H.]!23AS+Z4")O"@-1>'PY" UCN9WMQO0_#<54?Z!-9?"
MN/9PY-=FW/8].K0-[>]<"FV=E3GYF&&-]*!PA0779 0Y?=\D%4]AFJ:R$89:
M@#E76X!'A/10;"28$H&+5*I:TH"X%'9""G."$*G]U&9TL(>$M:%)VK%JH&@N
MU58#K-TS^'0K]1% &(:N/_2"TV&_>S\='A^?=N^!'Q[[(3"1=6'@A6=?/MLN
MKG''&H$(ZY03-L])^_D;690B&T72Z,0 9.TV?:,*"+T^!%X0]LEL4U*&KC%]
M:<[V*FD8;7[.!1,I9Q7Y_-K$^^1OV?O6HZK)"*)UA&N8"M$0SJK3<S "?,^]
MAERJEGJ/3($=3 ;36O'J12F9! ,]@/G=ZF&Q[L-R>4]T)5.5- ;[<$N0)9PS
M1<(%@[_;!(@&=F?B:&#WIQ?=Q]'5"H34)<LPIO"?_2W0312R)S=!4H8C5NW8
M7M,B?Q2)KL?/,.__V9O77D1[M_\ 4$L#!!0    ( *18WE:YD(*'& 8  #,/
M   .    97AH:6)I=#,Q,2YH=&VM5VU3&S<0_LZOV+HS&9BQ@8/2IL8P0X 4
M-R]D4J:=?M3=[?E4SJ>+I+/C_OH^*YVQ,29#._T08NE6^_+LLZO5Z.;NP_OS
MG='-]<75^>B[P8"N3-9.N?8TX9JM\IQ3NJ _C+W7,T7C.J/!  ?NQG?OK\_Y
M:ZE3[8^39'00=W9&!T'7SNC-[=6?E$XR4QE[UIN7VG,/VU?CWTE5>E*?]3*8
M8;O<='Y1\5EOJNQ$UX.*"S],>'HZU[DOAZ^/?C[M10=7-@\/D_V_FDET:$U%
MH_)<UY.!-\WP""K$POC#+^1L=M9[<KQ'7GLYYBJ=<]*C8/&L!Y,]*EE/2G_6
M2XY_/.D</1^]O?UX1T[_C3,0[XP6IO8#V1PFC3\-40^[H(GH.EJEXV0_P?+R
M^O/=^.WX\N)N?/L1:QKWZ:XT4^7H:I]NVJJB\1A[&5NOBP7Y4OFAR"7[-*92
MS9@LSS3/D1U?:H=58ZPG4]-;8Z>4' [>D2GH'<]56S/3;YD&V+K0&5T:"UGE
MM:E/H?%HG]XH!STX.UW0?6WF%><3[C]2G!MV5!M/&<)4NB95+ZBMO6T9 ( E
M@3*PJ&B*E=6JHD)EV+)DI@C<FR@'@0V)FC-V3MF%R$S5/</PFE*'O1S>P&8E
MN1 C(I!I"Z)"K,9QN)*S)>"=E>1:^;,Z/V?+G9(0PE2[BI4P!*GV)4)T#6?!
M15'<P#>3(] 9S@7RKP$AB!U_ S&F0M=P2:);N= '7!#'9[OV7=<%<A42@=]9
MU>;0B3#7S/4!D;;5@JB!EP*Q0 ]V/$#8.>\V;"--N1;-?9%H*P@ -]-P3+P+
M#F7*E5149NZ6H%J>:.>M@B$EF]%QN!ECZ[!Q2V^>^"OPT _[X/*ZKE??OSY*
M?CIU'0(=J05_4X"1V!(K8U*60SSP3Z<5BUUBH)A6VI4B+F)3L$\8*.M<NZPR
MKL4YX:4U50P,_IF,<^P[VD4@.0.9Z.SUUZQ4]83I AG_W%:02([5(#G9Y;UP
M-CG)XRHNM;2H.B(J!DAHL09TC%N<$4,OLU0\LE3 DD2ZB3\DI-!#V1.I/;IB
MA[8)Y8'@S\6^"KTOQ9>IUKW\B-1 RHBBL]35E6DM-"#Y,^T"IR#&=5 DG6G%
MQG5*6ZY4 *:KJU5L_8[N\E&#F7#&&33?<-G 4.ITKI75$H*.]1^JK!95K9.2
M#$QRH7X# XUCD@;GPZ%&(2596RDI'006O%B5-D[$3A&8NVQQ^)FR2(+<4,"Y
MD#G=A/W%?'B"_LN9%).PRL+S24#F9KBT<%8Y4RLI&N60%VF* KBR^3)VI$.K
M5%?:+Z3:M]D-9 @X!01B&A_)KG754)Q?NY":%G>* W^D/669L7GP(+37.$=4
MR 2^<!-R+#*X/2+:((-N4!ZA>61[=#U351NX(+YP4:"_Z1FTN"U]ZJ&WO(#<
M<;F]<P5XY22(Z6*'3$WKGW?A)?6G'J19^G^Q[7[9N& H75XM@30<L0AW=>AL
ME(.1T?33&.12[II.^+(5J'_!0ZEMDV6M#8ZN%=(6M5/C//9EIH,RET'3EQ9U
M"-V[SQPI@#D(LB'=>8[+B<- (;-&W4*@\VPO^E4J]]!WA%LA1YR'L@N(=!6Q
MP-APSU4W76S(]U\,TK,H+?-R\E]OO3#-Y<N4]E<$$$:NH[KB@N"R/8W;.]&3
M#OS@FT(7]L:ZA](/&] YQ=#FF;]1<*E!=Y'ON8:#0<DNL >]G92/_)#+8$D9
M_M+B 5$%>K1U%J:0O6&\V2XPT4BOD_E4[CZY165@Q3_77?K=!3-G=2]5&%M-
MJ,/0)<.<N9QNGH=GA<X:S>-=$(>/+:11.4XZ?N#,LU!VS15'@ =:8#_V H=&
MX-HIWC5X',0>VY7KUE%PR2?</!<HY\(B(WWXR(%%"#.,L!T>_5@+NIZ9:L92
M$+6:=+.X[8C'TZ8R"\;7>6DBV]0CM GP_"\-8Q]N'[B#+2\9VK;W"3T2EU<W
MZUR6F@L,39RUTFKIMBL2HBL$.Z1?\8ZAX\,^'1T>'6-W="#/L//1@3S)=D:?
MSD<WGX&-*S$MG&.Y\2*<\"!%>N\'*0-J'JIJKA8.3\-7=>J:TZ6:[?_)4S:\
M;.6Q_ ]02P,$%     @ I%C>5M#(]H >!@  2 \   X   !E>&AI8FET,S$R
M+FAT;:U7VVX;-Q!]]U=,52"P <FVY+I-9=F XTNLYN(@%5+TD;L[JV5-+15R
M5XKZ]3U#KBQ9E@*W:( D(G<XES-G9LC!W>C#^XN]P=W-Y?7%X(=.AZYM6D^X
MK&C,)3M5<4;)@OZP[D'/% W+E#H='!@-1^]O+OA;H1-=G71[@Z.XLS<X"KKV
M!F_NK_^D9)Q:8]UY:U[HBEO8OAY^(67TN#QOI3##;KGIJX7A\]9$N;$N.X;S
MJM_ER=E<9U71?]W[]:P5'5S9/#[N'OXU'4>'UE1,59;I<MRI[+3?@PJQ,/SP
MEKQ+SUO/CK>HTI4<\T9GW&U1L'C>@LD6%:S'177>ZI[\?-HX>C&XO?\X(J__
MQAF(-T9S6U8=V>QWI]59B+K?!$U$-]$JG70/>UA>W7P>#6^'5Y>CX?U'K&G8
M!O"E,AF-#NFM<AFPI^$0VRF[2N<+J@I5]2'9/:0A%6K&Y'BF>8[\5(7V6$VM
MJ\B6=&O=A+K'G7=D<WK'<U67S/1[J@&WSG5*5]9!5E7:EF?0V#ND-\I##\Y.
M%O10VKGA;,SM)XHSRYY*6U&*0)4N294+JLO*U0P(P)- &EA4-,'*:64H5RFV
M'-D)0J]LE(/ AD3)*7NOW$)D)NJ!87A-J<=>!F]@TT@VQ(@(I-J!JA K<1RN
M9( ,B*<%^5K^69V?L^-&20AAHKUA)1Q!LJL"(?HII\%%43R%;S9#H#.<"_1?
M T(0._D.8DRY+N&21+=RH0VX(([/;NV[+G/D*B0"OU-39]"),-?,M0&1=F9!
M-(67 K% ;\P*PL9YOV$;:<JT:&Z+1&T@ -SLE&/B?7 H5;Z@W-BY7X+J>*Q]
MY10,*=F,CL/-&%N#C5]Z\\Q?@8=^.J31$UVO?GS=Z_YRYAL$&DX+_C8'([$E
M5H:D'(=XX)].#(M=8J"8&.T+$1>Q"=@G#)1UIGUJK*]Q3GCIK(F!P3^;<H9]
M3_L()&,@$YV]^986JAPS72+CGVL#B>Z)ZG1/]_D@G.V>9G$5EUJ:5!D1%0,D
MM%@#.L8MSHBAEUG*GUC*84DBW<0?$E+H4O7XHP[HFCT:)Y0'@N^*?15Z6XHO
M5;5_^1&I@80116.IJ2M;.VA \F?:!TY!C,N@2!K3BHWKE'9L5 "FJ:M5;.V&
M[O)1@YEPQENTWS!N8"CQ.M/*:0E!Q_H/55:*JMI+208F^5"_@8'6,TF#J\*A
MJ4)*TMHH*1T$%KQ8E39.Q$X1F+ML<?B9L$B"W%# F9 YV83]Q7QXAO[+F123
ML,K"[B0@<S.,+9Q5'@-$BD9YY$6:H@".4;*,'>G0*M%&5PNI]FUV QD"3@&!
MF,8GLFM=-13GMR:D:8V9XL$?:4]I:ET6/ CM-=XD##*!+SP-.1893(^(-LB@
MIRB/T#S2 [J9*5,'+H@OG.?H;WH&+7Y+GWKL+2\@=UQN[UP!7CD)8OK8(1-;
M5[M=>$G]J4=IEOZ?;YLO&P.&DN5H":3AB$68U:&S409&1M//8Y"AW#2=\&4K
M4/^"AU+;-DUK%QQ=*Z0M:B?65]B76QV4^12:OM:H0^C>WW$D!^8@R(9TXSF&
M$X<+A=PURAH"C6<'T:]"^<>^(]P*.>(LE%U I*F(!:X-#VR:V\6&?/O%(.U$
M:9F7T_\Z]<)M+ENFM+TB@#!R'=45%P27[6G<WHF>=>!'WQ2Z<&6=?RS]L &=
M$US:*N;O%%QBT5WD>Z;A8%"R#^Q!;R_E(S]D&"PIPU]K/"%,H$==IN$6<M"/
MD^T2-QKI=7(_E=DG4U0NK/CKFZ'?#)@YJP>IPMAJ0AV&+AGNF<O;S6YX5NBL
MT3S.@GCYV$(:E>&DYT?.[(2R::XX CS0 MNQ%W@T E]/\++!\R#VV*9<MUX%
MEWS"Y+E$.><.&6G#1PXL0ICA"MO@T8ZUH,N9-3.6@BC5N+F+NX9X/)D:NV!\
MG1<VLDT]09L S__2, [A]I$_VOZ6H1W;7U *] GM$G-,K@:W02\'%*X*S7FS
M(Y;NF\*!+@#0I]_PMJ&3XS;UCGLG1(,C>9M=#([DG;8W^'0QN/L,N'R!"\0%
MEAO/Q#%W$F3\H9,PT.>^,G.U\'@OOBH3/SU;JMG^G[QOPW-77M#_ %!+ P04
M    " "D6-Y67_10M7T#  !K!@  #@   &5X:&EB:70S,C$N:'1MK57O;]LV
M$/V>O^*F 44,6+8E+ZUCRP946YFUIK%A*UW[D99.%A>)U$BJJ??7[RC_:-IU
MP#XL,!#PR'OOW;LC%2R3]_>SJV 9A8M9\)/KPD*F387"P!X%*F8P@]T!?I?J
MB7]F$(L47)<2DCBYCV;XI> [;H:^%_2/D:N@WV)=!6]7BT^PVZ>RE&KJ/!?<
MH$/A1?P!6,GW8NJD1(/J'-3F4.+4J9C:<^&6F)NQA]7DF6>F&(_\VXES%/B5
M<S#P>G_4^Z.@%Q URS(N]JZ1]=@G",L0O_\5M$JGSC_2'3#<V#1=\@P]!UK&
MJ4.4#A3(]X69.M[P]<U)Z"RX6STDH/E?E$/'3Z2Y%,:UP;%7FTE;]?A4- !$
M1U88^CV/EO-HD\1W\3Q,XM4#K.Y@O8D?YO$ZO(?H8S1_3.(/$87I1+2!]>-F
M^Q@29;(";P2/O6UOWH-M-&^3O>'-H OA%L+%:IU$"_CF_/G4[>"UI4F6$6S#
MS=OP(=JZJX_WT2<(YXG=\0<#GX3% E(I!*:&2T%.F ),@<#25%8U$P>R%4(A
M&E;"!FNI#,@<WN$S:P0B;%-.+>4Y3V$N%6VS%N;:0KSZ>>3[@\G\B-.NO$D'
M:/M.J@J\@?L.<JF@Y<NY3HGB@$P!BHQF,*P5+V%(I?H#?]@%INE021L7C5M,
M&\4-1PU,9.1X6C"Q1U)255QK*X1^]F1&4TV=52CS+L1=2 I9$=ZB![!LRA+B
MF()KA9KF@2Z"19L7''/") [#/R.L<BH2E:W>(IZJZK:H=%UHBVPX0-THW3#"
M,-*V#B[-.QE\;!YQLTS6]JJ]3#@?LKT[\6R9VC&!VEU]*?$ 8=KZ;WO7I7W6
MIE4'>!+RF;S9XY@HX=KK@&[2XH71W\IN?;?K&A67V;\XGI,U5!FEE-;CB^\*
M_VRX0OMF: NL3[*IN&M&#5;@W5QGG4L)7]MT:=&I#N]V^ NIO3F[]&94V?0W
M(TGYG4G;""K'[[1 7)#LZCAA-+.&<4&JN?A?:F5<4;$US8 MJVMA&4T&$!_E
MT6C23DV%ZNYI7@43J8V3DHRWFJQ:.M641UMDC<?KH+]3U(/V;T'(8_B-[M%%
M!T!?]U],YWDXX4>Q_S:O $'?/E^SH&^?LJM@/0N6&Q!2%RS#&2V_>TGWZ.X4
MLB=WA^0<CEGYS Z:GM178J?KR1GFQ__L)Z#](MB/S-]02P,$%     @ I%C>
M5KAH]CR% P  D 8   X   !E>&AI8FET,S(R+FAT;:U5;9/:-A#^?K]BZ\YD
MCAD,&'K)'1AF'%YR;BZ8 5_:?!3VVE;/EEQ)E-!?WY5Y"4F3Z9<RGL%:[<NS
M^SR2_<?XP]/DQG^<![.)_Y/KPDPFNPJ%@1P%*F8PA>T!?I/JA?_%(!0)N"X%
MQ&'\-)_@YX)ON1GT^W[W:+GQNTVN&_]M-/L$VSR1I51C9U]P@PZ99^%'8"7/
MQ=A)J RJLU&;0XECIV(JY\(M,3-##ZO1GJ>F&-[W'T;.$>"7FKV>U_FCSH^
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MT0G>N@>O7ES]M'-8CB; E'OG-V.8BFT^_;0S\1\FS^*J/GOQ'__Q'S].BLG
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MQP-4@/&[RPK7=DG%['^H'0SQ;'F,YOGSA[9SJ,MI%3]%L^MY2[#XRK^+8-U
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M%QX\^_.O\"JZLI<W;_R5'RRSU^RBX]%X.JGC%;0GXB_E:>JDIYZJC+/<ZY2
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M:< ^M=A_A ;IF %I!^85%D2J/AQN\;L]OCYPQ!:WGXBUAHR:E LFN>+!IU*
MQ-4 6JV]#:('==[K!ZHG5]N/XBDX#?^7VRRH%'RZW.J0"J53;U.G%9!Q_5/?
M:T26AZM("#G1VE*CN02#&ZPB$I0A00<7<D])4_5&MV2Y%UGHP_G5U!M'J?8R
ME1P637/*F 6&R;@CJ93K+T?7B"P/N =1&.LIL]1B,3%V1 7'0FC-P+.@7.?K
M3Y;/J[>#_D5RN=4<+&18?V 297.9!VZYHEJE06:*QB1@1B3+][H_MK3YO.E(
M,XSALEDWP<]E)6]=^D?.\TN-\$ID8"+DW-K<$&F#I9Z## 1'J ]'K*W:Y7DZ
MB*RHM,EX[,5(G" :F#Q5F=88%N09%E92VP.(; D9TV^9%,$3/&I/<..M$DYE
M3EMF<_ 92;;^5N?9!%X=[\$ZP\G-S*FOE\V= VNGP^D =_W'HP$&34=J]Z]I
M/1D^2@S@4<S13%HKI:!.R(S;D$FEP*=7\!^&VQ_$)M+KE0_%R+N7?@1_1$ZL
M>T>W5&0Z5TX& 4(2C%8C,Z:5#$X8YM.\3^F4M66X-4AR\&!X9I5C7/#<8.4)
MI<"@0>9X4&V?SFE8>S9=/;6)LB$EF:/.$ZXR!3ZITRS56F6"Y#I=_T#:VK+R
MHT38K ??-$6_TZ9<9$%I0_)4.TM#%C+;@UV#:\^4CT*WE#!'\"#97'G.&0C4
M-%-:FY ;RYE@/7(VUI;AUL 3L39H:[AG5G)P)J5-K2:X^8/SC >^T51>I>Y<
M32&UX,$%0CEAEJ>,*"F=9T#Q> X+Y>L?OUU;5GZ<I&'NC2'>2>!-[F1F\&Q4
MH8@P1.4@C3>17JO3G0_8SBM7&DM8,BHT-U1))!J3C#BC,Z]ZD"?YNQY,(\^<
M>WLY*OX]78S4_;/P W<XK:[\[->'"O">^DE11< @Y3_.G[UK;HBP6$9*3Z!A
M,F>, FT+/BMWEAG-O=*<RA08/65].H;V@3'22V_4&)H9[)'CN>/62J6)Y#;C
MU*49M5[UR'Y:,W*NR$!B&GC3LE3G7&J&W9Y3;1P2%P^B7U]G]?%S;Q\KYI>Q
MV\!!7?O)(2SX15G-NOI^^J;&$(@=U&,7X)ZXPXY*&T"14Y+F/!5<VMR9U#&5
M6D;U.IO.6V0\\AX@FW*7.6;!+.>$6Y5[1], ""&ID&UR:(N,^R/C=?'!NV:K
M?^_ P'(J:2:L2W/-1>H--1[HI4"A!,73->YPM 7#@^L,GE.E:%":$@ZTIXKD
M(@4K@E(/&D2OL<[82O98S9_E',P_[8/S6)(EO>$NMDU1F:14K"\S]YE^#\A_
MX!0:F0J!/9"=D,8$ZD/*E=)!"-J#*N*>B,P'/"C!V)0RX9B@@1-@.44%&%<!
M/###C>[!-HF>D.P!&P<3XHA1!ENI<0&RD>;**.9%[J0F?0A2/Y"4/-3UY<'(
MX7]08%[I 0:Z>\)X)'5*IMZ#A1(X3:TBDC-#G%8AJ,![4%;17RH^'"^BGY$%
MHRQCAEN=2FO!XC2$2RTDR^SZ\^)K7508B?0O;V9__A5&U)6]O'GCK_S@EN3L
M+CH>C:>3.EY!USRP\6O]1E<7_E"/>R(<0"5K:0U+@U5<YT[SG%@9.&,LD#Q5
MWP:LV!96#QPYTSQ8:SBU!/L<*:,= ;UCX2.&X,VW :MT"ZN'A96R-M6 *8.)
M.&T!5ZF0*=6I,9GDN@>-L[Z*DC$_=P\RGIT-]6  9 3KICGT\Z& ]Q0Z>UW
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MWOWQ@ROJ\4#?@%L57R_>]$,[NBDGDW(8'W#EJPEJO?8A\7G-SW-8[),&&A,
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M">BB3G1R[0>#O?>C\AJFZ74-=''P0SU%3T_7B6L.9<+\].D43"I.LHZ0"R
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M &".<YBRU=.X $B+N1P8:N>3\;2JL5<XKA6^W8(V@3%]VS31#VI_C9^1'Z<
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MB2LJ.QVBH1"KN[J^\%WU>J0!:M^/NBXW_B/0=EC86<5+[6=(;'3CW3"\2W3
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M*]4V#+Z-LB&D3"&D!I-$3W87TTFQB@DI'I2H/+(K3*ZL-A15Y%)YF3DM581
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M;\00.\02HL%,0Z_"'8T@NHB0.@[AG1[(D8X9W'YBTN<E*JB&&:+; 6$&YJU
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M^;6OX $D2B'X9&P$%JW)!7#9+)9\&=*.<*5 CA9T^R(CN)<88"K>E;!:8F6
MG,U7W#J8/Z5WM!4C'R*O$?&8RC4.A>)#:X5$MD*B-0$[)TMBVII*+-_B"O1P
M.LX=/)3DR9X\E)ZO-!J%*$GR8=4[00,"EF*48!6\5NHM3#(O:[V>$@<11\,6
M(_0R@A'?1)G*.2!>O4,G@UBU62;[(_#C2/>Z5.@DZK:V@0VT5%\9H=70B6L#
M3=,?@+H$X070.M&[X)DH,3.@5O'=+<#7[F] DWF.R)\]$LJMM^T@13:/'7A\
M,1'C%5UHF^KVY2AZ^3:$RSBE?'/I=P$$3U'9CL1:4W@VXED4F@VAXR;V%;%0
M:XNC.T$IAQ)6J9QX6Q39$%O^:<1<J1W$9@ R"!E1O/QV_.,%"0F=)QL(?R(B
M-"0?EI"Q>C^0BEZX$^?1) &DT.UR!6Q.:.E$,"93+'ZU8":C3L2FA#5E8H##
M5[M2HD<I+;L&"X#=1Y(\&=(ZG\8=M!"W"#T@5D,SAJ5W?!Z$4Z'G805>RQ3Z
M_<5&E<R\A'TDIBVTF4B2*)Y,@O=#!*NU5EW/(DB'8R8. JJ?4Y)6"VAL$:%J
ME%L8GOKE:%:04B,V(;)/4R$)7:RDW]:[RP1<,,#% U4F/FG(TV5,FC$FQ5_%
MU_2A["9!/J))- 9- T%$^UC(E=P+>ESDZ<7'+T?6&@U-4?B2>PHEX2D3=+$H
M"H4QQ^4 @&F!3(L#-TUD@;YDD_%^P0,C&@Z:9W'+!UGJK$?/#Z%4#&^+./^B
MH46:8 F^&%!M)9L[&T/RI:*,H<(&[K1O]]&!%^0!BBT5Z!^QS5'.>8T2''Y2
M+.XH<1WC1 4,4X9#6Z*8148\"-*9>%AQ'60WP#(1MQ]PC$'),1AGG"/3E9>B
M#FP?I1 #KR_X#R3R_L(Y(/)Z$N?A>%("GBT6$-]5!$$9L?YEHET5'D)TK*+6
M+S)W%5<H"H"BTJ.B:UB$?86(6,%N)(X(R/"(M8%ILID>@PD%I5^WU$-%'XW=
M3O+4X%G>P>3WDJ8.<JY7P-_>.&>SR/,K8@6BH]>9D'X1]*NR.I^S7RDBGO%L
M,YEEBIK]W[,TRL)(SN'RA:DD#R[/O]_"^6L4E&AZ;WGL5\P.@V&&VY0N+R&7
MM1?0SP E.2_!1%(PEI"OB0!D7 1W,I CLF!QT%K$XWIXAR^OW4$672!?5M#6
MP XE2CKRM(',N"1.5Z,$$MTRG2&G/(WH9V+YT9FEM$,X,J%Q-XFB'J%X:S#7
MCY2L\?*44L G964![J6"<M7*H^'&ET!8""@1'97@+V8!3^:! 5*,:\P+%.W!
MVDO] B:3+78@%%X>5I6H0BH!Z NMD<D>'M3QX&P9"GJIS@R\'IF428V,&3#?
M@&\+L=6 EE1^79Q,7+/D.O5O;P2A.=_T0,2%NFR9HG!%08.64&!)7*AY,9Y3
M#/ H&2"N:\J N*#&6N:*ZE%68D6.A2DT?0LLS(S0F]6YBLBMUKV@^-K<%4T,
M'ID6A2Y<IE 8 4< ,:HLW_%8 HB[BSR:;[@L/= "^F+H6P6" N>89(-=@_"9
M^G[+I27<C0 Y,4E[Q!/+SXHV(*E]&3$0H>'&)#_)BDQZ&OV 7Y??3.'G(:44
MO8(Y+WHA- ZEXM4D:YY60Y ='H0JHFK8U19<+S<(CR"-GSRW26?BN*G2U#_[
MV+1?6US-O8.+D\MO7ZXNC?//QOG7DPL<>VK><2FU2HX1UB*#M Q8@W$6DE*_
MGVS+Z_2Y)$XF0CY4(P(Q#0H^B+EOVZ(# 6@4K8';\>05.L:Q3(LO&;G?[*E'
ML)Q!9UC]"/SZ5K\S_*^5G\4>=-SB6;#?0EZ+2^^29XLRK1LM3)$41+#90HN%
M.!$&FRU:5>9(K(45TSLO^$=N9[G,\D]+G: K+\S0+EYF85V&O8[]7U07>V1!
M'+O37;X>CST7&+WYQXI4T8T:AXLVETR432=<#Y@\!<KH'MAI!TVJ>H\J!4E4
M?KCWL> %*?<<(8CBCD29AJZ;*1?YFX:&(-0A!%AZD^3:N.<1!9?]8:$\T,&U
M4$*W>]B_I2O 3Q;?_">^9:M!8K7;\L8E<?=SZGC4C[YT[F\Z_]8/0+GGN ,?
M %\65.RA<<S=$V"'GD<3=0;(;WD678,ZZ&&P+E34?HDG<K*/0M,R44F&+QU>
MGAR>B5+/[<2774]%-4F^FXC3YUHB5,>GZHR&JC4NFB%7&99%,I@BPTXTIYC(
MVD.G)+B/%/S0 V9%=V3*@)8*AIV31C8L_BV%$(7OX1CI'@04$U]+:P &!Y;2
M<CJ]_T*MK[ 4&:TF?(YPA0M,L\G#H@FZUF]'BP*5;JA; ;EXI74$,U2RTGK:
MMZ)]DT<X-]C'(2QXZ6$$I+1/$CCO.I"]ZG8B6<QTX[S<T:#-N_&14)+GF2Q4
M_L7'9G$X2(,";@/%YEQ1*HJ##%%;_JG7[=B%J>)2\9/NH]<1'G(?5J_C"C'L
M=[Q"#)\2M&3^ 2L]W)RE7?"L]WXI5B!G6.H;A8XO2.!%>0&$B6&/%+0S,N&6
M^WT;, E-;1J&&KBQ^*Q6$$,:JT<?I=!=NU.U="^\)UW&-FUW@#B(%8U+NOZ0
MI K(AJ)^'\K#KN(1<'_Q/(RPV,9CGH?06(,PZ/B8<^6D>Z[6P)*G\C$J6B7!
M]WTZ2"A-^>(*.':Q @I376TCOIW=(RKO)W=]2<"%N+$*$]F' 9U]Q-_CB1=$
M-'-'LO<I=R_[87)/S;_"6^#EM#,$. ]0^'0J4^?RWZU^V/+ T*J/'F7S3P=#
M$U$,)SJES11/<KKD+AD)4 -MCVSED!*!D=700FFO4'*SI.+S)[%\@WK]_I+O
MVHN;=EMQ\P4+0=-:4#QYXO2\\&M^*7;3/Z.Z3><BE ;NW'E.!+ZP]":,H=#>
M>3V";$5WP;]9L1MKAAF)=J-*P[_$L MF8?%%T9\B,)V0-7OD3ZBW[H9-0AF/
MZ+ U)8Q9?29)5H'D8X;%[<KW05#^BZ+_:D[;YU"Z-;[DHFY(4P2ZV%=+4$NJ
ML&$TE)94X26D"F\TAEK]@(A:4C24Z:.9B< YT32L@<;W5)D;W6]:YK#G%-9W
MT+-?;GVC^3M5%[V6><Z5+)R6/IF546G9H2X\TIQ5+4QXRJ"A&R?;B+Y,CFHW
M<LOE$7)YTWL=JYRC]8JB\/QF/9&C\0\//)6B.59G@#D:GC?\*(ZA?H&3D%^K
M!*<XJ$LEXGFEJ,SBL7_'C?-(8_.5#E@7/OAWT<5?M._/5[ZT$YQ3R1]\ 4V<
M,Y"&D %H)5["&CK8PX:#N_"6)Y@EB=E;^ ><E!+/,A491BSPI_J;B<>2*.XE
M%RS&^9!#HQ@61'LCCIS \E!*P:6\X'645\-E8MIC4&451B/YK?&WU$NX4%A<
M" CD>9V:4RY=%A/ D)(]&F'$YQ)I$!W=5>ZI>(^*K:4,&[.QROW5>SZ++HBJ
M[6W;L%0;5J]MPZK!L[PI,E&MO$[5&4/,RJ7:JA-M/, RK2'E?R,&A^K5IGRQ
MI#5*DN_R1%OOSRX"C*4.G_U@P4P-=L]''WK,@6P<]S%F\SX>? #'XH,T^V#*
M<OZ;G 8D?'@87 ,HRRQ<")[T=I9R^R)G59=$.N,228$:)=7F5^5E&ABAG+%<
MZU>J$IPDWD=4D&2"1%$JD-/V<P'_0XU90IL(6"NQ;>5\752L![95Q+\651;7
M"H+(Y\WYJ/C9+X8]Y#Z7)W22Y'0KW: XH2) #ZV@)<_TY'(T72S$Z7C/I;(P
M7YZ?NAV[#U$-UW7PR:&1W2"PP%R  ^N"+3A@6@:F90^*2]@=NUMUB86=IXFG
MN=-#/-G6?_1D4E02"(QZ*H1"COF(4>M'#HA6[+BI+>//WL&7T__]=GH,4,.'
M9\?&T>'7TZO#+\;%R>7YMXNC!D(5$.Z1Q.7(N%$*Z#!F$OTYX[J8/\@F.#DT
M@:.D+$9"ZTS  .02TJ*HU(,?N!, /XAO@?:?G S,H)-A&R5IBG/ZF8:DNCR9
M-0Y5K0/2.#E ,N6&A[^9&!N%-MI;PJ%-)8F\Z)H$ZP7_FE#D4CQLB>P;N?2J
M@04RIJ\1+8&<_LUF,)\?B0E >&?B,KQ.X**J$7,>A5PV/TJ4<E;*S21TU%P*
MXM1ZPFH)UOZ2QA'LLX1TWNP[:"U+4]>%6/QD]8L^H<>$I*T/;[@^W!/U8:>M
M#\]Y Z[=^]#Z;ARS$4UUTFG1$<FDQD:Z9=3KEGRW)MI4>_+=1XX4-.I=Q V:
M-[RGBV?11-F.R2KV+*QV$ C=2B(PE:G2(AM[T9:R,B$[U0\38-?0WU'%.JWO
M:,\6V[-%[6QQFB#LDS(!&!2'48@U"N*PC/'\2O88\(04@'A\S?$MZ1B&?!:[
M59J7Z%^5$,8H%\YF4ZC9_8=E1=^%HO31$"HD.6Y!V%W8P/*J5:.5V+T/S^+>
MVC)=W3]_/SF[NC2.OYT8G_YI?#VY.#T_7OH:=7GL7WZBJE4RXU<)LU]767<B
M[1 R(8]EH!=[']"7_-N,?9!_^0@ 5!/_X4,4X[WQ2Q_%M<19#K_<QSN6XJ2C
M6!)<'?JU.-KPW(X][,/I1I[R_P_EC<7!1P<//G[+P\7?.79G8/66_KK;L9;^
M[K'+>IW^T'[651__7;^W_)[ML[;/^I)G]5:ZZF^H8:1E7(_!'OS/7F^O.*!$
M#.@/]NT/PRH;X D;+Z@R:?&FK9O[5"6S^WBD"<=YJ9C2/@(_=E[X+V4"Q4*M
MMP9DS>NS"MR5)SQ>6^.ENO!*>[OS_I;Q3YZJO>,%L/=[%%[!.JPCWKNV$,Y^
MOUT(K%-#9XG@&:;_/"RLR!-N #*ZZS3A-G5?/'00,,:3]37] P\HWS[T[99'
MI3!%79"'IUY4Q+R8B=SF!M8:#?G8^BITC:WZRA67XZ?7>W_]O5.X9:U>W.J:
M@]Z U.#5U@!^N^9:/&)LGE2^>8/5RO+[D&7;[ U[K2BWHMQ\47;,KM=O1;D5
MY>:+LFT.7;<5Y5:4FR_*EMESNS45Y;4SUC'^KSD9:W& BAGK2D5+>[WWKU2_
M^HFAW7?6%,+JO7Y5DSEWRZ5%I-W<(L]J=ZC>.V0-UDT5VRUZXRWZ[[^XMF5_
M;+>IW:;-ACY-*]:OTDKVK!BH8B$:(G1.S_2LX?-B\1IECCN^2Y;I]=:-A-I-
M>N--XIHT]-I-JO<F.:;E/+/TT&[2FVE2SW0'6W1*.U\#PFXN8YW^M:=>7=3E
M1#=NCR\\L.E.F*K-O=O:[>87J-[*VW=,M[NN\FY\D;:<JK;JTJK+J@%);^T3
MZE9;6FUYG]KBFG:O]2VMMK3:LLK*#$S/7K=EI-665EO>I[;T^J;M--:Y8,WB
M-QR-U09O:24/_CI*?U.@ G._?,-EMNP%XO4J("QCAM0A4)% !@=SZ%6Q!@A8
MI ($$D;&2Z0JJ<+9E_B3GC-4<( 209J(38@?,8-9=)Q)5HRQP+FJDZ_TS7Y?
M@-55(5/C8^L87TCT6;H7$(G&@!(F66%,KSM<P@NCH#13@5Z,CS!PB73D_.G5
M&YJNNY0!8W[U]$<N/<;\(P]->UC0.LROLVLZ V?Y$I6NO/K"6Q9_E8&ZZ3P$
MN +#+IX&O^81 4A#X1,*3='@#XJ]%B MVGY;#IP5X2H)HK8J7J1YA%7^2A.!
MB(T7Z9D#VRND)B9 U("Q,"/AKH!RUY%I%)+-,GX3R:<T=\EY)-GL)DES0H[2
M(/"$TGB/J&'*%*C$V)@H^*D0X*>(7-(J>'O67V3^Y4<7V:974B^(7^J;KB<
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M)*Y$O=2ZVI1] G L7%UAU)KU4DM!.[,ETN\+A#^0:2YJD0#T7$ 7+W *.X8
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M$$-WL4#9=@G5M=JQ^2YSP33_2/!02VUMDOL2&[Z@M&OJZ[ +^NIU%Q$T&N3
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M@S[M)[?UR594VD^VHM)^LA65]I.MJ+2?K/,G6U%I/]F*2OO)-Q65-\'CWA[
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M]@[ZO4TQT;?9QAK]X&_%\;)"2-;8'M?:N!%M,]=-^8?=O0.W:SK6#J0DM6D
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MUT3T8 S\'1'%YP1C@JZFQ3Q'4+7SQJ$?Q=H3D^^+'/:_2C37K*V)@Y!C44U
M(3>J<P:T@$72]"P 'HX1319#*DK2\04!3X29N6B*(>IBK81T@=K&0F%:+(:H
M(*R&I,UP54%9H-H*F0H$R_KO315&K#6&AJ&J.*M[K!0CB:1.I6D)M!(<)S2^
MN$Z@^?I-"M!&4E6HK19 E6FSB23D_GTFIP7,9)[CCR0'S Z&0DJE&37L60Y
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M$=<Z$CH0GT/>HG$ZH4NQ11N[]KLK*#3C]\U%%<4 X^\K,%9AN<VM])[7"/C
MT^J6_T-UD74%R#*?T^27# !\OM> OOL^"1=I_+URXM;K-%H+?=&KI<O6)6):
MSTGUHTNH&1T0'04,H$('((PS'@ D3H5$7( Q-5.$[C(O1NFL@:D873/5ML
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M.\,.VP^]V$J&O+%^6G)T/**?8]^JO^VI^&0OZ[<]N7RDB'@D6,SCP+.8*\/
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M3"(9)@#2PM &Y<Z6Y8-ZA?$5?5A'@$$WK>["N)J22L@%D?%=6HZ,R^MWAL]
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M"^\:16>3(&H@ELS'"1@VJDPQ8C>4;7@#([E0>U47Y.E>^2X=<'Z\4@#^J11
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MOU+<& J]5B<YXTM^G#!HT>O3W/30Y5&C4E%NJ@M4<LY2WIT*-FKIN<H!B B
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MO.&2GM%A:EU#*N3M H1M<ZF05OMB%Y7M6%B_/7TQ[X*R'<K54PF-*TMH+"B
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M^F5CY%%N^_\Z%1_@S5_EQMP?<E]NQ_-(X*3*/LU.]9#RP;ASK3B-N-5XMM
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M;!4)#YOC^^5O2J=^*OZ:%HTE9:<^?.T,_#)O+P7O*9MKH$9F:,PCH$B6EB_
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MZCTND4@SF/U66\.J=9#J,';HH=<3-.4LV1H#^)KSJ;;9&[JTTTDTU4&L'6I
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M03SJ<>[;\//,?I^!!Q+Z#E40"(K_C\+_3$=,S<#P?<^BH7 \9EDN&#V=>HQ
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MZ)#/LK[/3H-_#^*<W8A9Z?$/]D)0L'EG!UN-:%$BL!V' >L7 6SD,[<.5(F
M$H'=\0P4BS07)=<>RU\_2CIXC*I;6^T[J/#_RT98?F#52!61DR]]B(]BMN5H
MI"6.Z\8">%@XT&20EGFLFD2]+7 89AC9'<?6#,^T[,!P73\$TTKW3!ITG-!I
MX&P=3W/1Y[#MK:[[47&VY@H%M:V.C0,U](YN65KD@ML=6I');!>$I4,;*13>
M+LQ15%*AW!#%(LUBD56 $]\Q"C0W\@( 1>;[AN=&U.PP*S UWVTB<.J8YF:W
M3'.KF].N_U2C>I9<58>S_+H==W4/=8_I>[R39UQF_0T!ZF6,($3^R6A.$ _?
MU,-5]]BM>[S3F?-[2,<S02,>&X)5LCP%:1D%B=[BQ/G5P>/&A=YV8W3T_'=;
M)2[.0DOW7,^EH6X%KN<YD149)F68.*-UQ &Z7AFD1C,,4OW@1#<Z+7=.K'SK
MCVR4I.VHI%FA87F!H[..;8&DF33PO2CT?2>@@6-X6B,ES3@XL8R69LS.2%."
MI@3M7;U]'H937*>XKIGP[G0<VJ&NIMG,LD+7\D+?M&A$P:H*-=>Q&@GO)AA2
M';?E.K.I63M_\+\Y!ZX^HICDTIM3I_AO*9T=-W*H9VHZ-2/+,UW/<0TPP1BS
M'#^BVO+&U_)#IV>EC3>A?;6DJ>.=YK*99U*-1C:U T>S*-.\R'$MX"O0#9H;
MZ)TW8+,5$9]WA+7UV<P0Q87-YL)5^F68D=MANFY[#KB:CN_X+J5,UW2/NAW-
M,HPEV'"J7\:;\6.'CUG17M-"0[%B<P%Q;5;QRQCPJ5D?GNXLGO6Q\</EW3V^
MJ(_)5<5Q6Q7;?\6$8T_G.:F6UB1/4W%<TV/<3X^(]W0/F,J9+:U4++4S++4&
M6W8EEC*T@Q-OUAQ5'+4S'+7V2.UKU**AHUIT.J]VR%4 =H66#5.]G'T^593$
MH_F/*AS[QA&*-9BFFYA_/"N^QL&)[LP*KXI>-)9--VG.-F? L6>8/!+LV@V*
M?2@&7C?.@GW#C,B-# N,'=UV?>KIOF&;FL8\G49N0W%V15:V#D[LECO':E<P
MO!-<O :+?0NXF#>*LN8 \D:X>.?CT&K:^Y9'HY<>_^L9'5 0LWV754QG9YCK
MC2SUUT[@]0P'6Y_I1I/".XKYULY\KS:RWX;Y^)&;.6?\LV*^G6&^M4>SU\5\
MGL@T:U*)ULX'MM7P[R97HZ@80W-A=.T&Y!HFS7KPC!/=,%6$=LOX3L'#5FS3
M)JVLM<"#WC1XV/F@H9H$W?2S@K?++'AN>J-I@+L])]*CAH$VEK$:8R"NZEV;
MI@CMO!K\%<LU&,O>[O3^=<R'A:PMPYP]45%0MQ-\]W;G[:_C._O@I-/2C=E\
M_XWPW<Y'$]5PXG<\'7>8[]'0T3N>9T4T!/."F@[U.E$4AKYN\\F%2U@5+YL]
M8G:PZ*'EV+,M?E408V=XS.]0S?/LT 5+PM(<S06/R 1G*8C\P.@8UAOSF(.U
M6BU-?W6YEN(Q%<]4V_2ZJ38!-9@?VJ9M:Y9E:;[M:89)=6:;D1>ZVAM#@2L&
MY3J."EZ^9]F3FE2[0^F/:Q] 9WJ8J];154QIA]EP[6',)=APAM,L#4Q![]65
M1XK/ML(.5-O47#A8^[GVVK62A8?<+4]3>83OR$%J+FGS)9>9@>7YCA]&CN5K
MCF?;9DAU0P//SG-#KXG]ABVLEF^9NHHR[C!C6EK0Z1@Z#:/ MFP,9P-KAKK7
M<37=C2S62,8TUS7G0''F5MBD:IN:"R!!H('Q:84>"PPKU)AKV!W+<\%S=2+#
MBZ)& H@% &*V3.O5G</6'= \XGF)\'<8_SBI%O=M .\=!^+G0%2]4S'1DW]-
MK-7/CTY&Z^:_AS_X&\=ZR-P0]@!L$,VR(H=2G?FZ'_F:VW%</?J7CI6/M:OD
M^_9H_A"GAV#9'NL&Y_^W9<:9^8(&S^+,2D9THVK^.D&3J:A=T DCC]FV85/+
M"@(:>$X4^99K&+KK6IVY\UJGN:\H<_" !CFR6!K>LH26+#Q%GR@NP4X^CXL@
MR8I!SN[AN9^3+/@^YBM;" ?L#UR"[.B;-E+9=[P.^$9:X--.2 /;]=P@,CK,
M.B ,N+,/"X"G,C3E:X\G9UF!@=YI+IC>XSF[I4TBS%\@/'$T?'\T,2HTJ;.M
M8,IG27-RE9)S%K">SW"PI.ZU2-EE0)0>O,,0G!C8#]P;0DE>)UN+/';CH(L-
MP@ IX'.\2NX9R:+Z3?Y>D&+@%W$8TQSO2,ZZ<4I;<,<@ZP&Y@Y@FI #T*$B6
M/] T_H]X 0S'3]ZF+QSGHG:3LDM+\D@+O%<_8;A2^/ KS6%MR'YM<C_Q.L$@
MS^$[F6AF =LO&QT4N.C_6LG9<#7-[S!FF-1BANM9@6-0ZD0N]9FI1R\86UPC
M+V?*Y1!7&TM&Y^#$!)--F\U"0Z+$G'!\-"+^#HB>C5IZP.9R$<1D[7D[B<2>
MVL5(3"0=RHFD9@N^'!6L)/Z07Y.S( ,L'N(]?!K"N_LEJO2$!>*1FR;X:9)D
MCS0-V&66GV<#OXP&R6G ??7B%D0B_H%JXE:\!H#2RML!<&_K\[=#L"U#"H/6
M N(FR9 \YG%9LA3I"-(%_Y@OB8*X-69Y.QXWJ&?X@:4[CFF%?D0[OM<QM="U
M3=?P.ZLW&ET#CV,!MSN?J MX.!:$[.<Q  IG5R!,G(639,M9A)R)2)<D_((1
MU0!=YM RKO8G+;(D#OF3[TKXBY\? J7'#7/:<XR*10I&@KK9 =3O9T6,WS[F
M;Q;_8)\>X[#L5O9C[2IAY1QKXTNH#\L:E(LOJ6FN@"$L;$AQ6=HD+>I_KF!<
M8;Z6O*H[FD/>IP_LT,\9_7Y((WC%8YH\TF%Q<#2ITT&AU\D^3;&%=(FB-[/(
MA&$!<B!+9([!'F8Y?@O61!NS%M+-$2G^]OP& 1C>\W(@D QT.3 B_C]']&3>
MYB^VCC^]/]?.MY?/KK_=77R[)]>7Y.K;^<7-!?P!/]Y>_')U=W]Q>W%.;O[X
M_.7JC)R>G5W_\>W^ZMLOY/+J]NM"N5]H2"YR.IZ[[AWE6#> (G\R5!X%@I\$
M8&P>.ZKQ0K, > 54'FC<"CQOV4,,&D%\802> +<I :7<*\@=.B2:]\DE'[YE
M19N8IBE_ QZDX71:]=\X'<MRZK\Q=/ ^34+3L/Y+0S-=[R/RX3-E:?B5;)##
MLN$W)1$0_QM<0$RM)6V>1_":41OW07>,%$]=)42@W%-AXM;>[]EGM\:6-:=5
M7)#3%)1' C3CJY$D(KHFW^OWD<',=1Q+\=I3T'K):+GMBHN6Y(_3'-;].JX@
M,XS[)%=O@G6?@MJCXHA<7M_^X^JN1;Y\N5F1?FN5KX91<@$L=FF>@"W"6N0;
M<&F7G-$<1"&E#5G?A/2^.)"#:4'-#.0\Q<O8F%%$WKPV>'0T?1!6+,+C>5S0
MAYQ)>.*@)ETA*O%8_H@F,%YP.8*U<:QFF:!)I]+A,2PL+8\-J^W8[T"L^;;G
MMRQE[1>S 9[=;34;G+:Y*0826O!-O<FS@(68"[GD5F[*^,I0-Q:HHL&"H#D_
MC$?-=Q%%C"=6I*S@6G;,G*]\TSF!O@;Q,=A>/1J#L((XA^-7#NJOW!^]LH@^
M4.X:E\). ,L%O%J\AG\FK#?AF2.5<\835_CW?%8]0M@F:"%%<<++_SF;\:OO
M6 !./L9RR<7/@(,-0 CWBW7/M,@'_-)!_:.#CR3F(3YPFY,A7W()-$J&/)*4
MPRI;XAWP/*)%BD$/=@AH!/_&[PHCC8%7?PT+ HJ"ZX=H5AE2%8N<=6,6P9I@
M?<@HY#H"RPL6C?<0GXVA37[6(EWZ@U,3HX\8(4@)^T&3P<A*Y.&":=Y;8B,H
M_R(WTH1(5JJ)] =Y,:#"EIX@X.T@8>*[NDD/=:M-/E/<B2P56S=>6.NE[XO+
M'45U)3<L\S)YC0AM<@6LR+#F$2G__.5@2HN8(5SP'\F&&)=9^/4T@UT&2R,G
MW>P1+DX2^3R^057X"]DC@/V"*W_$(7B?*6<H6F0I]T9I 8O"("!N! V (#_X
M>N%.R._RZ23S_Q+O50ANX\L;,QE)&?(E\"/</2XFY(7V^_A+T*)_#4*17!Z/
M^4=R99 5Y:$OVLJ).!;&C;IQ'Y?5SXHBQL4NH,4<#=8@771P\G5$I[\7-??E
M2L2BDPJ9R?4/V,PQ-XIO H5V J+'1! ,4O1A@_FNHMO&"CR3C&''I7U5P3G_
M.01V E:NHO?)F"V18F,/,Z\H-GUVTAX3^]E+876T MJQ1 $C5R(T5WKR"3T,
M'!Q3'Y1"R</_\QXCI C#LJQ/Q_[V7'>94^BG? % 1A (:;H&J!GX KC-2L=&
M*F JW*>/ITH/(%<YC[##YZQ?5CXU(W^D\2AL6[1);8]6!?OEM\8?PS7L?4Y[
M[#'+O^.*WMB[Y'<\CDN0D& )AIT63WDTC+]^X,!*+D>+_V!HNOEQ0]ZQ(7)>
M4"7&P(^P,'D"!<S?PQ,5CNUW*&\9/_&]KITR%M6.W@-;AX]T**XJT+B<4*T@
M%G75VIM@E=H9:'6>4 DP_'K$+"MPR4++8#FPGW\TW2 X_,P".BCXSHASR2Y&
M!DN2Q+!E8F=:*Y"K!QN79B6BR0]^_)(#=)48D\.]'"$)MTHPC41L(B#:7[73
M2-RV25&?%'/ P&B I6+R $F8/,6 VP95\"^/B^_"/!AI:UR<SWAK?5AZ!>;^
MF +!V!E'W(GEZW,,K^POANXY_S(>=,=CS.,@FH%,Q_P O6Z1X8.1#'CR!8_<
M$=:Y1UFD(AA:A68SN#WNOPR:(FBC;5B4E?\BC(XJGHM19X;V67\ 6C>HZXTH
MSGLU;;8T"]:UQ]^+ZHF8F8#KJC%)?5T 5,LMJ.X.Y(.$C6"KYF>A1AVY"F,4
M$SP$' N"109%79-S8[@W9]ES0\Y--S-K(:W],BWO$3N%C^HSEJ)GQ/TN<.:0
M96KH@LPVS='%8E3EG),%,I\@%/E2W-^'/P!Z9 H(X%E>,@E6?!G@F#$\.T"3
MBT,HNF& 38B7(_-Q"&#_'?W[,IN]H+7B6E\1Q;.W/(KWN4VN 0IRX/I1Q&;O
M0K'NEF_B6;L>JQQ'-2]E"=%O('Q%&$MCA4O:C;1UKE)^^H@?;..VEV#E@D$3
MH$.Y6,7L7UJ,OI:T&%M7:3$J+>;=N/;F]/:>7%U=O1C(;6N[@5S7$,ASP.,L
M!Q=N)NXNS/0JT8.17]"@06MFJ=-3OE!9!W&(];''EM>VG[=/#PUG8PC_@6XP
M,#1)+-UN>[S$Z'[J?(OV^XSFPM_C;E51A04P-:=,P/H]N)")R^)84>[P =_.
M@Z^,E6+ "-]<&78:.6F?,]#F!Q,9/6C=WN39SV$M9Q3#G!@1$&& 5#Z.._GX
M=>GR]L2S\-Y%F07?NUD2(E^)H[DN2WC ZG3P 'P@>!+SE/BADCATFWJL.'<;
MYVK!^M"?B"<SMD2R[/2*'^,DP:=&,9)H%(ZXNSCC/\ ]8!-("+JE\KU[68$'
M' A2R;"6M%_+)E\^3+%MDN W21),JY($S-$6K$L?V&BGV BZLA%T\0\QAV;J
MM%(&\^.<^(,BYL$RS)/.8Y[L)QU''JBBL/T1WA1W6@;0&&=]X!V?)=GC\6RB
M4[.UWE.*81;_EWDY88Z+[ODC2S:'FV)%7$+[!3NN_O$IC(M^0H?'<<K7Q2_Z
M).\ES5\4B^D^"KAD\;&TZSRO[=H=-.UD%P?Y8&GUM;G5-U6J)SXSS+;C&0L_
MUMKZ"S^S=>]%5SZU6.![Q]J2M78Z;<WK+'7;9]IOK-AEXVW*8MWGC"PQ3@+
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M:SI570CC:R(L<L/--/! ,6.&%UF/G,5?Q>B:XR4X^$T;PBQ%_'5TG%&+G'G
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M[[$[CHGSBRW/MCR.@1V7C@IL;I)!4:L2/&<1RW.<W9[U^BPMZ#BI9V%*M[0
M:\T6-4]E<]?0;\W#(17XK0A^JD1&H=\<]!L;?]^R-KE.664$/G<FO IL*AQ4
M.-@4'%1%+?N*@Z[F.)JN'86V9;F:)7'0GX>#]X^9PL$WKG5Y>V_X")L@L8K4
M\$?U!+D2LP-+[6=%S/DL9PG%_?OT&(=E5RZS?I5XPK$VOH3Z198,RL673,A1
M,>CUP$6HOPD66['\_;? P(5:G2E>K/W9S<>[\< ._9S1[X<T@L4>T^21#HN#
MHXD7[<7I89VJJQ!D\>NO"6:<.:_?*!Q<<8$2!_\6ZR%S0UVSS<#2+"MR*-69
MK_N1K[D=Q]6C?SD')_<H QB8PP'MF 4X!X2FY0-VY0$V%#3UL<VQAPO26 YR
M6,DAD"&A_8(=5__X%,9%/Z'#XSCE+\,O^B3O)84';C=C#^![BH\EVWA>V[4[
MR#G2E)$/EDS5YDPU!1KB,Z-MVN;"3[6V_L+/;-U[T95/K=5IF^[+[KJ!M5IM
MP[.W9+%>V](Z2]UUH^;R-GQ5BKH47E3&H/#BD%3*Z0GC5ZBV][$YW.?PE.NA
M6[3+6!JP";M#N4S/N4R>\I@:8RDT('+D"8?I!CP;WESOWP/8I_^H&+F*#6T]
MT*D8N4*Z.M*]-D:^$",5Z"G0:P;H.6ILY;YBGF.8AF<X1Z&EV;8[V?7D.60S
M--TAU[TT]@=%K6F4PK:I(+?*?=THN)D*W/84W#S=<+V.=A1V+-LRO7I'Y>LH
M8CGYPLH2_@)+[CQ+:1*2^S;YA>9A"K^\NKJ2.:VG_3Q."*^KU[TV(1.E\)O@
M:B+^4P K 7;O9_ANE/Z(L:II_?YBK./"?T>AT[%-QZYC[%F7I@^C8\<\2V2G
M/.Y%C^L+)FJHP-XDNBN@=M3"Y#E#% .,]UV@44'.V^3709(@>K>5$5K#R+T?
M[;MQC+051BJ,'&&DL0&,G&OD*IA4,-D4^B-,.@HF]P,F.3,MA97V!K#R L]J
MX((NFI0WW3A)XGZAL%)A95/HCUBIJEGW!"N7@LG.!F#R=@B;?M<FWS(_89N.
MB[85-"MH;L*1D\J6W 5<?LDH.MW#?UK:$>OU>2=]@<DU!*93"'P=E!EOFM\2
M!^HSZ/N%^H]T2*[2,*;DYD?9)E]*D53YN9ME?5IVA^0._Z0];.4R5$9J'0E5
M9M$FD=!54]KW&PEM[2C#H_:$G[3#8D.:YS2E(=-GD'&^;5KAH_$2\_0K?R"Y
MY4]4N%C#135O::.XJ,;,[0(NKASEG!Y8''!?/8L"X:F'61!EB)(O]N3'<T 4
M6JHIQ+N"EBH_?4_0<CY08K^6;/#@TS+,\BBJ&91SDCDG^Y .B2.FJJ]X4#YX
M2. 6O[7)9_E0!8<U./04'&X2#E5&^[[#X93=6"'C*P^ %%(JI-P=I#3TMIIJ
MO.4X*==CZ#):>#?PBSB,*1]?";B%!=C888^F0P4[-=A1J+,QU#$5ZNP*ZIA5
M(4N6%F.+Z;<!AYKM?!4P\TQMB]?/3=0M7K^YQ6M'A7MY??N/JSN<&GW3PI0$
MUL<>3R ;M^PA+DJ&+6]O!GX"KL)I$&0#<!O2!W(9YSWR(4X#Z3W E_PAR:M>
M;%B BRU&15,HRQ":/2[@IO#UDH"O<9G!'73M\'?5*TKI^2;H>5-Y%[NBY\W*
MNSA#"D= 8Q[> !"ZR0&SXCY-:IV]KR/X!LNGO _2'^3%@(KY61<_17P&(!"
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M6=9.<=;9(,]%>?9$);4+]MH2S,*?B[DJK%_RMJ+B<]%;U-HOOK!WBB].TW1
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M9YT1]0+6(3Z=,ASL6^'N<\_#S=6S#N -S%^&TN.G,U48N^"LXT;QQ]$[)(A
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M(QW7KZ?K,]QA=\SB:JSC5=>^:Q>P*A T =]T65F^:B()U'QE87]TC^:=^V\
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M19EU9P!_7_W:\]GG;]WXXZ?%$\&$O/C:Q;]V?T'MT(4D 5/FH)B)$%SAD'3
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M\_+L\V3V#:_]\\@)@JL.#))@"51)6,-W!H:';+-E17$[F(S-72O8*EW('A\
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MZO=YP([EP6\P1P%,+N'M9#8;Y"PIS]X1G@4ETC-&;):>,,8%,\)$!%N9 G<
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M5.2*> Z6*,V#EL9;;U(K:WO7$\Y'O?4$>5^[JH[]^)\P2F_&GZ:X!0U$L":
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M+H6*/A&)=BJQVB2B<U:@0J!<ULX[;(^N_Y9]M71ZK]2S$X5TT)*JP55* [=
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M"UH2ZD+0*1@J3+N.[T^G<=\A6]SQPGDJC?M>^E&QW3Y> ,S?EM\N,F\&4"<
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M?P7NF8B9K BCB@^0!,YT]X0K'V<R.BO3D>GJGKX5-Q1XVIR2)3<I.=/]ZR_
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M3 9^JAO[#K1+/!;9=B'@JX#VZ!CC%L=VN7E0^-KY8<^I)'\K3/$A326)1!+
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M?6S8UZ_O[@##JN2[ZWHW1BJ+U>RK$?!KXO8P8Y@)0F 62:-X%5%(4DS- 4]
M&2(12P(;PGEQWZGQB>F/E9L(E,[!;QK:=2%K<1(=F=)\8;D$>@E>-Y5< ,G
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MPB0-)43<E,RA-($A02$-!.;:TTM%V Y&=?D:CR/ =GV!2+ -S';/NF?H!F:
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M\*2Y0I8SRC"."%:0132&"(4$4B$9#+. *R-$+8E3,QA7 Z;V\#>6/5==8J@
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M'IAKCD ,_AA$1>Y2L#S%-;W-&#7 N12LEY'.Q??KQXC5 5NY$8\(@R!+XU1
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M]5KD>E8^Z_F?I2218<@4Q $WBCLXA21%"B94)0GF+ UY:)N#N7/?J3WOC6G
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M(1%I!'$<"Q+(5 7$:I^]KP%3(Y4=^T%=(K+G :A= &^,$S^!/XP?H'+$,?7
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MI/4<V-FY?I#MV<(U0H,WC=B_&(0W?4QJT<$?C?!>&2E=$?/&46D]\,"LE:Z
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MECN];/Y\G[^5AG5F0L(XH!'5[CJ7VK9$<0RS2"JH'7J2!#(($\0G2Q/V=]K
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MOP-$9X[_;9XT9": @V9[20$N=W8+3K[G3_GLX4Y]UVO&0ADV_U_G<W%7W.L
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MLF)IZ1P.);_+![RO17_?\-UJN5C2F2C;("\!DP_Y;%8GN*YK!X<M&'1_,=)
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MMD.OGU*:)0CI(#>1(<0T$I!D"3'-CQ )**%IE-CT/;(;SLD(#=;^B%<R;T<
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M1QV;C[>NY-<?N1$4K"7MUJRV'7*+0^ ^@.S=$3Q"+3TLL-VZ 'L#^!I=@"\
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MXF2R1J/9V*SCKUMM9,5\.J4%T*'HP!UEO;\^=B9Y-/*.R/I[Z%Y;H;/E:RY
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M#4V[0R@Q3Q2A* V)4[?5ML'&9O]V934^2RUMG5_AV'NK%6<[=](7>CT;R.[
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M&)?M:V=U8U ? ER=,1T9X1N+RWE__26UQ!X*DD$J52_074ZG)9YS'HH/M[,
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M3&"B!'%;05X7.K;UH-$YV2EMG+XZM>_:6)+DCT9UY^ ABRZP7;N%!3;Z2BP
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MR2]TE5#CIF&,"N&\Y-2!%AO!H;LE,H_V.#:U%B7;3FMM2CZI[A_EP7M#]U8
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M89WI;X'IQ._^IL;\*/(M7<ZUK)5FWJ^/="G?3&=F9$]HB;CD*0($,@:@*%+
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MTJL6''#F]:<]"U&9BX]7U!366SR99.GUQW&_7.H>K8_K7CWO'OE,G\VO[DT
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M'EE#AV9>-_M,<*;%2QY91$^/%]_JIK_I3?-O=/E/N5ZU?G),H5R@3(%,Y01
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M^-0)FLNLZ=:,9RBDL<W<C1I"_C)=_;-)FV!^FN2JJF!>9D!BE0.8*P$P*P1
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MO,VAZC<?-CYL[>:SAIW4;3[_5*A,$'O7R_7YU)F+L^;B^H'^G&2<0T330J^
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M5 5Z6U$;99N*J'Q359N_C#]\ISGVX>S&+.=A-U?!P@$TTUK?@+:OC@HYFG$
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MZ)#(0%+.V;ML>(K5LS)/(7#L2Y7*.-K+M RFK 9<R!OY=MSR[Y>=-%,7SW^
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M2)Y+;3ZU))F@/$ T>!(,#L1]NL8-58;"Q*/0.U%!3;S0V>?J[?P;"GVQ+"U
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M$) D1R,$?B\96;O5Q$/T-/M$[2F(V$]655)  _T!=FU9[O;)NL-4%@Z,DY&
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MNKHLI+^[8YRTFJ?D2:+;0F!/O/4!3; ,442'(4OM=\R/D-0/6C];*KVF'AJ
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M:#PCV3J,E(7VY:)&$)T2\TY1P_LU1,!/OK$#\$_7Z-];=,0'Q;55N:@AUU8
M\6I1WD-/A.N&IUNBF"\]F;/%D]A)HCF7)@B1H^[UZK4O)+;+C@.*$Q5WG_J/
MD.+868'_V)WFGW 7X([ _?%RL42OK1/_W^$BP+*\R:,A6D8<X[@M>$H8Q8I
M+ 4F!#+J[J+BP G28[$&L'",%A<#BK1IB'Q"(^KQ#[!C3":95(RA=$:0I:N[
M)1;9(SR)8'GP2;-^S:F?LNHX]S3/!YI3A#PB>A),)^_@BY^][N94=S964Y#:
M2%OR8)E(8SO@&\+Q>.4\!?3&'JKG64'\ZY?%MU_QH[<'#'YQ?;;<L^ XT!C2
MX3A5JB,#8DOU;KMX[BVSJM0*R3(84R<2)'!BI,"M(QUR]=!-\.-HN+G:.$?+
MR>I:5)!=*T<(?M*?_L?9:NIWELPF*Y*4E&BK41)4H,N5O,1C,3#EHC,FY2<=
M%W=7&$_IQROKOG/A),FUHOY>AUO4QOG23$D9C381/"4!$B<NZ&P]:"]%ORO.
M]CV(^C"I+N%6H+/%_]MYNMH CL94G"W"?48NO'/$@_0$HS1T?Z(%GN01IN/&
M$N,46 QE.XZ5W>@(*+/;ORZVR(9X_A9_7<[]-I6\XR=;R"DG(-:4(:.E0Z5/
MUA$M(M D:%(F]</"XXN-4PA1$165Y3DZ/J",LOC;;!'\##_MTV*VZ2HO+V.E
M[,H+""B]83!6 @?$"Q^[L<8! $Q.NJ>9>&B=<6H2:MJ*:E)LH-COA9^5]PJ?
MS@'6[W;E$YWG[5)F/$1&N)*.2.D5L4R4@7<T&Z& YUR[.<LA6L8Y78:,3*M*
MOU$4[?99Y)Q;'AQA79X'8L0#E 6B\!2UF66TF[5++0Y3,^ZU6QUM]X#0$:)O
M $0?EO#53].N16-YJ+5]R[_MA'TYZF;KESL&)J$CKF*YI40/C5AM$M$Y*U A
M4"YKOW7K3UU[(#L&#WM3L0913@.PZ_CX#5V]>UAQ929AY(%$'M&VTX ;,RA/
MDLI,*0XB^MHX>X"<<1]9# 2L6N(_&DG?8!D6E;#T<M%-DMXF$SY.5W^\^/$9
M_VEGY(T0(AF#\:/KKB)P6WB(E*"G*3TWR.O=!%Z%9WX'R1DG-GL.GZJ6#AHP
M37NL%$9V>\XQPWQ@BFB-08RD6A./85@QNCE[$VR.@\/IFIRQ7S)64OEC4#I2
M_BU :3<?:8^EG:E-R3"F1234%Q/NN"6!8DS,LZ,T.>\EJ]T/^A&2&H/4L:J_
M"ZF*>F@ 5MLNEY=[+3K%*$=C;6P95.^A=!H*NAS?U%*C@_2UFT#=(F"<U-)S
M'&K'R[D!D!S?/_6:[7DJ3WI^\Q>7FQ" <L82H"&GEDA#,<K@&&5XYA4*U."O
MU9]&#\#'R(7 Q\/J[HN&L77< ,ZOY]YW725_GT_7JX^??M]9=N!*.PB<T%P2
MPUH'=$FR(R)8BL9=))=M9< ^2-#(SVI&Q\MB*.4U@,1['.(7,(_G%W[Y1[?5
M09O,M2A"2K3D&<L]B&4D,.]H2IYE41N,C]'4"X_Z9SR\JVJC271=<K/;AS)X
ME[)5!/=%*0_/$EF1E$0,MB@'%F6JW?WT,9H:BR9.0L"C\#I!'0W JPQ67.U&
M[NY>0.ZLL!"><1?1H%LM,#@J'<DC[D1JG!.6<>M9[5%C!XEI#5"GZ/RN+U=%
M 0T@:6?,D9<(TV_%CE\FEK7QB5I+:.0HG>"!^,R!*).CB<@AH[6/OT.TC-TY
M:4 <51'_R.^^4$ K= 12Z5G6U8^4QY+%8F>#45*QT]1E3R0M<\"U5"3CUO#2
M>Z"FU]70(P_ #JW?"S;F9_*6JDF[0<3L-A,-0AD;,2IAL<M%:^*U2$1H-*"6
M)O#0J^?"$9@9^_U@'<T^ I4CQ#PR6#YMPFJ:IKX,N=\91Z4QHM3@B$X0B025
MT.(FA[N(A9!Y4C37,"S[*[<%CF-TN:@FV :<E[_!XLO2?SV?QE?3DIH(FZMZ
M(1H9!%,>Q/B$0O'1D2"0,<$C,!.#<U [SWZ8FEZPL3_32519 \UBZ;)Z0S#+
M79G.S1W^(K:MMTRIX[ HIA2\J'WU]Q ]XP96M73>"TI'**!E,,%J/8T[8\MY
M=(*Q2)A2R%.@DEAG&%$N2^&I,K+Z5/ ^=+4(KF-0T!=>QZJD&1\:V7B[AHNM
MKRB\4Q)$(!"D)5);Y$!Q1G*PSOJ00O:]:EYZ^\\W5^\%'?<SG7.5)-T<5BYO
M@U*,*H9,T+%CI>TR(T%91YRCV<J@J*%U(_3;Z[?@3A^OTP<A<H2 &SBWKB;%
M['*:EW%!,(GYI -)3&,$6B;[>1HS,<)QSC1CTM?N7WV E)8@<XR.[Y;V5A!X
M [CYA"K8S@W9K*9S6*TNV=EV*$@Y"8Q&B6+H"TJ!NRH(SXF/!CB-&B/6ZMW/
M'R*H'X;HSW1.U5=$"ZC:TGY94DA9U%0HM,@^XI:0AMBH*$DB0U2.<BEKWYC>
M(F#D8I!ZBKT+F:.E//9CW5N/C7>6]/J5J96&X5'NB3*L*T$-Q&(P2AA7D27T
MZ)-^M"?JX\LTT7GW&-TM!A'DV)!XT+R^PXW3'=P3EE6B$27%E<?CU2!+02=/
MG(\857++Q-U2[F/:F%ZMUP\D/U6GRJ&DW<"Q\_?I?%%&T76[ E;KJ[9L'V!9
M;H+]%WCQXT,G^4FDW&F*7)E8GE]QI8E7R94.:@*BS2;T"[>?<"@]@;Q6&Z0>
M"8W%\^BIB6=RVT=^O\%Z AHMK$F2)$_+;&*5<6-Z#%&5P?C" !7]+KN>4HAQ
MN7BK#>_J .@X&3=@H7:%1V]08F509^E*_8_I^OSRX<SK[W&V2:41/S*(_TN?
M_?>)R=1&;]#(!X:"4AKP%.>"1$&]@^045'];>029K?:QJ .XH?76 #3OXZO;
M9]TV4]9H$(X$FEVYJ?;HJ@I&F-,\Q0 B51^H\1 ]K3[PK0.V:IIHYSQ\>_'5
M3Y<EXGEY[I=?8#6QR>DD<4\P%!61WKCM<P9&>>:!&BM<;43=3TFK[^HJGI2G
M27_LR/#W>9C.9E!&;&&LC+[AKB_')#-)0T:Y(+EV.V+:<[!$:1ZT--[ZGNW>
M#JW0ZJN-TZ!13Z@-G%I;3_#?89;>SC\OT5A.1+ F@(V$Q=)3G;%$G$1["9I2
MPVQV0=:^G-\CHM4"UIK>][$R;P T+_WJ_%.'=U3$;L#MNVF&M_/59EGZP$RR
MS#DDDXGQ.9<B[D"\P5]X J-*JK;^ ]Q'B6JU%JV2TU-5)PV [,-R$0'2JL0,
MY=')^XS?^0K+]8_RL'-]-D^O2Z_%<BI/I$DL& H$&3'E;6<@CK),LC/6I0C:
MVMJ3J)Y 7JO%(76 -Y2>&H!@UW[JA@A+)RK<9I]Q/ZTPOD %[C9:N2&?IMWM
MP?9%"R16YF7AJ8^<*BX$D5%2$H1F^(OA4G'GK:G]DNA$DIN](*Z#U>=4: /X
M_6VQ[KKQO5L@?]</K3 ,OO16?;#9Q\Q([AR/9#-Q'!3!;V& XZC@N7:Q^*-$
M-7MG5 >#=94R:HJB$]D;#'_F$<7T;NHQ)IJN?WR&Y46WA;93 U,NW="=)YY9
M7EX)9OPJX::1401D,0*]TRSX0)CYV$K]@//3)>WK2[D!TU0,['JYZ6SN)0^+
MY?5VN(JK)RQ)9TL3=: 8$>%N8,0F3DE$K[4\#!6Q>FN4WL3U0]Q/F[4?1DEM
MH._VR^;KBU,V40;C[^0B*0/ B*1)DY"D(,EK8T3PRN3!FR?>H*<?QG[F9'T=
M530 JX^H&R3@'$_W5_ -9HLNZMFU19Y0PW4LTPE#Y"@E68;:J:A(<L%%P%,^
MN=K7V0\2U ]8/VWFOIXR&D#664)_;3U=H90N.8  (7L+N#=X(K(T0?:N_%&B
MFQ@""R+73K'M4]$/0S]=BK^2V%L #DHE3<L4DF_P">)FV;V?WMZW0]K>QU]\
MW6QU]CZ_]LLY,KM"(]PU6#N[*'*=,&,XE>A21F=+WB8KXH!' B88B)(G5;\2
MIP;A_>#Y\UXD/+MR&T#TH\T!#_4&_ UE\+7\;,E'EN*YXMMVE>1_PW^[AC31
M4J605"0AA%)Q$BFQ(",&WIXY"(PI_^QM0X_FIA_V?]K[CD9@\#-OB*T8MFRO
MWL[1+$P7Z6_+Q6HU2=G1Q+(D#/ 7R:&DH&@BBM,<N40)Z=H7*@.PT6\+_+0W
M+V,KOAKV_^77/06AA/[H_JK[F_*O/D+^I?S^^\>WMS[_C]UXQK_&Q<7VXS]M
M+B[\\L<B/ZB#<F%:3, W/RN;OWL0\*HD-&:KVPRNIA=?9X\^F#E]T5^O^;TK
MB=W:>^@<G'?XOBX7RNDO57KMW:#@+*RV>4LI;3 Z C&N)+N-UZ62BA+I4N+9
MV619[6S+86IJ%$9@O'E'O&?KEWZY_('K=;=+$Q92Q",DX_:20&2(!J,';@AE
M2DCKN'*J]O2\7H2-W&Z\#D;NJXNHJY(&COSK?M3]V(O&0E8.SY;D4NFC1DF@
M%#W^('RD"6)0M8M%GTCBN)TN!\+>D&IJ (6%FSL<[7%\^QLW?G+"75(\@B0I
MEMD[SD5B@RTW"%)JK1RWU:^>3R)XG <:SV =GT>%Q^-UL>YFZ8[J+'Z*YY V
M,UCDL[B>?L.X<3H_F\T6?Y;*NKQ8OEILPCIO9I==;;?.U'!^Y)'T/*.+64-B
MPWN?R4NA/=5$1U7ZJV=/?!GYC-O&,1=LP#_\--[GE7C?[(OWQJ7M8C9#^9<X
M<,(#"R ](P 1#QPM)'%!*V*8-5H[GS6OW5GBR40VZY4^!3M[F=M!5=6 ;]"/
MP:N*)Y%!>.I)3 [=;UFFM @E"!?9X \'RU/UENM/(7!D# X+EJ.@>8SFCH;E
MURY!]6GME^M:I>7?IBO4WCTL3C@$$%IH0I4J;S&R0Z>&N3)M@XN@HU,P0"WY
M07I&#HR>%7K5]/+3&,!_+*=K>)_S:L(<<)2<((I9162*BOB0,_*H$Z<8!J;J
MK<*>2.+( 5"#1O X[3T=G&X+SCE\*4W01SB?A; BRN")]09='4J+E?= :$+C
M+Y5$0T^;/Y^KE\BU#,UC-'?B^?QZGMH)TV^]0?(WWB ]7V3^& FC!.-/DDNE
M^/O@>["K4,H(M)&2^^[!*WJ1)?V.1I-D95T04>B8:H?ACQ)U\K7\3N8/O(?;
M-B&S0CNM<IE$R1C!':F(B]00%LIAH@#06-2^:^])V[AQ3UW<[-V>#Z&?!AS/
M@]S<F'N?K$3;WW5[QE]D+K-0/?-$4T>-B4Z+6#OOTX.LD3M*#H*'_0BGJG):
MQEMAZ+)1=#=$0$02.$<O)"M.K'.*")84.&><L+7O>GJ0U:AU.Q8*?:%VI%X:
M@-H[=%AVK5DUH]S3P(G"'R.2,T#*:;DO%5YKSFRVO#*BKE=O%#C'*G911<H-
MX./%!@6';N_;BZ_+Q3>XV59>,\%3H*ITP$1.8NX$(HD5U C+8K I5<;+86K&
MS>D-C9]*6F@ 3W_W*,HY+'_<E-)E;VC<&B(+2R+3ADB+3"%C&2UUR(DJ:2BK
M7<3U #GCYN:&1E0M/8P\C.9CJ<O=SK6,TD7A!>%<ED(-GXBUM$QW"ERCG "J
MS(>]6G!<@S.H9WV\8%M P^7H;!=S\GBZ1EF:- ,R;IDNO^"VB,DKH+V\F3YX
M&'N:S)'*NJON(R0WLL+_/IU/+S87.\*ERX9W,+=EX)+TE@3PY>Z 4::Y5JBX
M"BJ_M>C(2C]&98L:\AM;\?[[#<)S-I8;R,1K61Z0%LZI Y)SXLIA7!="+\?A
M,<7?7'0<^U]-\4?+KP$?\N"1]^[J#9#+6<DD(]%2<B*58<2!H01T]"*EG"5[
MMFS<NR=-[AC,HQPW&7><:EH&V_9QE^"98CB/!ZX,JKQR""@L*.T//(@,G'I3
M.VGR,$6-)E*.U']?>#U=&0U ZRS&S<5F5@H07@$2$:>=GO#K&70*FZ>SB\5R
M/?V?[ON'>T R)8"JH(F7+!+\_T"LB8DX+0TSUF.@6+V70"7:&\W;U('K* IN
MHA;F("ME7H!U0H!![](R$4N08H@O@Y&#L8P+P9R- Y0#'J2GT43/P!;SJ8JH
M]MAD %#]OH*\F976S)-D,\?X%P@H#QC("$U"3(EH!4(*T-K%VJ:P!UGC%E.-
M!;$CU?)SOX&_^JDW?KIM&O[O4UB6KED_\F*YZSGI9]N&]7Z>+IM/XC_]._C5
M9ED&(,3-<HF?B7_]VV*^O/SC"[^:#O\,ZGGH?\Y*K1$T4JG,ZXKB5]-5G"T*
M+=>/90QCE)J$WFXJDQ9CI,2C@XM_]!"U,"K9VN7-#]%SJG6_^NP7/U[X6:G&
M_'0.4#S[S5<4]>5TR:B"PQ.+QDS1CA0?2.I(F#+9J3*?5M9^U=*'KG&#KFHH
MN6O9JZND@:#K!D_[]N!=Z6K8)=*Y=]FGC'XVCQ9=(ZY(D Y(8$$K+O'8,K4K
M"/M1U@C4JB'B,.1JJ:<ET.T.E.X"?Y^_W;VNB"G+ -W;KY)]%YXX%3T1)1$?
M+$WR[A"I>MCK0V S$*R&D$,@K*ZNEK#X=OYULUYU$F.[BP!P)CAJ'!&!8T!H
MI"6>1DELHI(RK:P/M8L*'R"G$9S5!\$AN)VHD4;!Q7>L<,U<D+J<"*QK;6%+
M:PM.0C+X05XZP0;S5_?)&3?Q."ZXCM%( ^#ZA/KI)+5M,UDZ]"WF7=.?8O"U
MC2&R8(A2KO0.H)GXP("H(*RC(5&O:V=^'B2H$8 -Y:C54T8#R+K#PV[;&2TT
M;@%T'"QR(K5GQ)>YMHD*2T74*>?:3S3O)63D1QSU%+VH+?6QY\#^MIC_WQL_
MF^;I[8:A)16ZL['.&0Z@'<G>X &N$R=.!$%RL%IGQ[*'.\T8#XSJ>7RM<7%2
M09N+X43;@)&Y89*[7./+F5]M-U&&G Q59<"+SL@(5<1'C%6L,,Y8PZB# 9,-
MMXD9]S;L.?,+)RBA)31M\]:7F>KW\X^WDM._SQ=A!<ON 7OG >)?+^9Q.MM>
M1=^4PF[':DZU*)V38TKEKIFC1+3/)'K+C>!6Y^O).+7!6)F71@+(TZ!V",!C
MZGWL<_?STI?G,-<#&BY?+L@HA<Z9<$L#>B-.HC?B,5K629O,?.(@>QVV!Q9H
M!%"CJGY160\-V-+]0<\[/ACH''4IAXVI#,MR*!A/.4&'Q@$HBO]5GUMV@)9&
MPLD6H%=5;0W [_J@N,?EN;J?OHK#7OKMK('KZ@U!A1-6X2:+HO +D;CRII2Z
MP(%)8='Y'LQ_/([F<2MBGM'-? :5-@#A5["<?O-E:-+60$RH $IUU$3[[BV)
MX\1*;4ETP2>FO0%7NP#_+@V-'-;/@H!%174T!:<;Q3AX5H"*6HC=G+BL.?&:
MX8;DF;%D=-"T=O''O80T<A2/"ZQC%3-VZ+#/P8\K6;W/5_+[L%A-NXE6I9!K
M-<7SX/5\<[&;7O_;8KTKM8'T9N:_3"@3&H+5Z,44?]<91YSAF8!- K*@F0K1
M*^X8@KI6,CK/"-<V-#TVU'_;%&_X??YM,?_O0ZG4U<3):)SV'$^%TG-;)^0H
MQS*K4*0<(2GA72_L]EJN%;_ON<%87Q=CH^N.CW'ZUK+94ZF!$I#EQ3J4? &'
M\K0U24MY8L[U V)MRGIAMOI0Y_$Q.ZJ&?^Y7 +?S'HM<LB-QO7A5)LM"^@=,
MOYSC[V??4%)? .W Q6+>S15<O=^L5Z6)*'[6T)7^%6E\QFK^H21;J6)_;R#P
M51UVU,EG4!B!&8GV'7>!3YH1$9P$S16-U<>B'*+EU.CLCI OC[8],5^/]7#*
M"I4LL2[@OL^X[QTM94<!;9-Q*N5<^Y'T4VD<^>Z\!FKNQFJ#JJF!)$%?_CH+
M,1$\B$!+F5MDZ+A'/ "= 8V_6.V,%DD%-Q(&.P+'!>"P6#D2F$]77*NHW)U.
M^^),_[59K;LGW@E !:,4H8D:(I,UQ&G*";41SW6;N(ZUDUM'DCIN^FM\I%96
M9JN8?9\/,3H!9;--&$S8DOK F)63X)(BGBIC@N?(<.W"R">2.&[.:WR,5E)>
MJQ,F/\(WF&^@Q (8*I1/NPH>?L- U<]@]7GIYZLMQ>O%2]R8"PQ+5W[M/RRF
M):#X/+T E,A[E%KY\OA@:S!:J@15SR.I2L'3CM@WN*%>+N;=UOC'='U^2=/5
M=N$I@=2E?7<*FDCM$O$2&-&.1143^@3_'WO?V>S6C:3]B[H6.7R4@^95E6RI
M)'FVYA,+H2%Q]XKTDKRRM;_^;?#F?$CB\(":W9URD.1[.CQH=#<ZR-:^W$#2
M#G[XFJ_#Y\^K.HF%5/6N7'[VXD&::2&<4@$2ND16(DMP2G/@RB,G-\EZU3J,
M>HZ>:3W6,;#RX+6KE38ZN./_@<O/J_#GEWDBKC:K>3S?:JJ6(UKI&$J60:08
MZK9CNGU2K=9&@1E9"-RDQKAZFIII4=5.X\M1Q-\MD"[+N:)2/#GK@)OZ/,9*
MA*BJAR&"$^1P&(RM"^:>HV=:,+72^2 H[:& GL&$Z\T\7?5YR&!]#AQ\K5M1
M4A?P3A-CULK(@@^Q>6??$+IZ!-<^*!@*KWU5TBW,7B]7%#M==1-E+0K)IXZ,
M-)H.HG,04"G(VB'GA:*BU+KO80!9TR9;C@RR_172 <8H-J+P^EVY"J?>E7\L
ME_G=ZB.NOLW3Q7AV'S37R=LZ6=F3!X$"7/$!F-$^>Q<2;]Y;,X"L:3$VFLO5
M6B']8^SR8&831*FC_Q,Y$J $>@@Z)P@V>E36\%A:3_$81-BT%V9S..P&MSUT
MTP/@;G)#5_F?J\$DAB63M +):W4\2@G12XJK4RPI"L%D;NV4/4E,U\#:1_'W
MH=5$"WW!Z=5FFUY\L[C%C4BL.,8EA,(D*$XGST7A(4EK@Z9_M*+UX*OG*9KV
M9CPJL [51P?H>L*3>'M3"<>UR74Y6JR/<<H4#DX' 2DP7[SAB9GF32DOT#3M
M0]5HOE=3570 K1>RS;_^G<[.MR]ZZS72__*G\/?,H648608N*8A1@AOP/$ER
M)E+0 H6UO+4UVX/,+O.M>^)D>5RE[8U+NL/C<LPBU8>O?J]RWOX]G+U9E.7J
MZ^4B@G:/GL]]8*27S,$\'?EYTB2>HT]T#_O:#N7J'JU2/)C,N77*F9!:O].-
M_#RY+0=_J("+>R+HQ'V.&9C%6$L6 OF@Z" X.I\L\+I(;%#=_A,?.(UWQEV4
M?J?*OH58.[@A'Q/.+^<7C0 7L76Q').NRWE2J>Y$!N+$ ^=1)<M*<=AZZ\=+
M-$V#K'9:OS\/H:4*.H?4]61,SPHK 4S@=>.3IO.7508I1!UNR8MWQP15#WFN
MMBC8 6)[J&3J'K;7\W4*9__"L/KTU_+3E^5YW?_PZ2^2\O?7R_/5U6-71JO0
MUE6JNOJ$%&9'Y33D:N4+-]9&,>B"&_2Y?M&SCX*7HTJ[ R-UNROO;?W35\<L
MYDR!BI*@4IULX^MB]KQ-SD0I!;D$Z%N;IJ=HF2:--=H]UT3DG4+G\HQQ'YVN
MSP]6":2PUS$(!0V()(H7:(IM/M'G:6JFM4AMM#T 0GN(O@,0O5_AGV&>?_V[
MMI+C^M4BO]M\P=7/V[E8FZMQ71?I7%=T\"I23,+J$B[N:Y5Y!HP2O9"N!#%H
M3?(.H!I.77\@VP</#U:CC:*<J=VFAT;])F'G)!9OI >9Z^KP4FTZN@@Z!;L=
MR^OEL'G'SWQDFJ1Y\_NLJ2P[,$6/YD<JQNNN2:$CEU&PNDT^UOQ(W6&A&6C+
MI,TF*>];]PP]1T]7H?^>&A\0F^TE_JG-RQ^+.#\[JUOW-F2 :QO_A;V<>:%Y
MHG,&KD1/AZP8"*EH8.AT=I81AWR0;7GJ"UTYRH>AHITD&SYSM+4MUV.=9EH;
M$PQ%BEQM+T_&(68?0,>B%0LN1=&Z>?99@KJZH,:S+OLI8&KS\BPG=\7WOYC?
MXRI5Y7W&&:(33$HD,' RI$PXNN.% ?2*,YVUDMD.,C_[4C#-\*SQS--1--'K
M(*$W"^*/8'I[0^VM7]O_;7;8#V[R)KL'#XW>8J^^\OUFY^E-RY_5*N8HP& 6
MH*Q.X*0@9&ID]=)S%$\UO@V>(>?0F^_Z1[^>+^;K+YAK$=B:?+I:+5&';>.:
M./;$57+ G>/5_$;PDMA.-9DJ4Q8RC\;QTV1-&]*W0LC]B["U/CH(W*Y9^L_E
MZK_?+-ZOE@G7]U@* EG,!8$%K\AC- D"%P@4\QJ?O/)H6L=O \B:MD!S=(@U
MTD=/$/L0_OHMT,^=A[-['!7)F/>H@'$>*$ZM[Y*H./!:>55<8:%Y>_O+5$U;
MGSDZP-IHHR=\U61')/ KY@*PHFKCOZ3HU@D+%ETQF)@IKO6LO=O?GW;&[>B8
MV57"O0Z1N>6H-JZ.'/B36[O@QZZ'? YI25&,Q@ED,;"Z<" %",9S(&1PYD-%
M3^M2^V/XX)?YLXN<OZA3F6-24#*KG1>">/3&UI<AD4HFXRE:CZ%YE)!^_>Q=
M4/"DO=E;YA->2^O5IF8WULNS>:;[-?^ZV&Q7)5RL?XLBFR@5Z%)J8X6-M6.'
M@7#.>Q%K-\^@ZXD^<@LS]&\W>'GN^YW 97^U+AO+N$.<7+T]IY CMPYTK$7%
M(I(35F_=F'6V7EDKU: 7^SV0,F7I1SO-O@"5/<0\=?;Z<D;"Q_.XGN=Y6-TL
MW=.)7"])$6$2->G@F0+G60*K2]9*J&+XL#K\)S_1%QKV4=ZRN21[BGUN4O+2
MIE0<\V!*JC6:2(<$<ZFKS%S(*BK7O/CP(16=)&<.OF@:R;D#I+Q^\_K=-1>O
MOM;1^C/-2I&.K&@,%.,K9!IB$@:\SM%$[2-OOE7K$3(Z<4KVU.S][7\'BKG7
M)ZNWR\5G^L377S#6:;(7M6Q$VWSS:K4*B\_;[2"M@^G#/]HDSF[,>Z,0O%+S
M2-P55='2TB5HC+3U3O3@T?FZ\R_)PIV2HO5PCL<I.7P18-R\6=#/.O]Z;<)]
ML39A$E#H:(!RTD&M6 '4M2M=J<K\",S=(V/BONG#]?YPM=]AHN[@>KLXCZ]#
MVA807$0+)C*E#;F#HM1$99U/IL@*<U3D -0&<M?Z9?0A%=-CY2#%WJ\$.DS*
MW>'D:IR=EM[7O52.*SH[3",X.C5@14#%=='<MGY^>HR.B=N_#M3MLU#90]!3
M1]NO\K?:%W#AP[U;7(]=PF)-%@)"M!0@6H,0BS,0@BC$E(GN_G;C)T+MQW]^
M3QC81VG+MA+L"@2?_EI>LA P%B:\!F9JXD'*")[7:U<5"BY5P:"'[2M\_.=/
M&SV/"(+])-@)"*Y21,9DKA3W@,;4Q5R&2&>1Y)&=\YIY9^VP9-O=GSMMN<$H
M2M]'8AWX"#43\*Y<2.3*9@4R6:HX<JQSW<XJZ$XD (,NT0B7ZDBBUIF2AU1,
M6US0#"&-Q#RU5?B$JZ]OEV'QTU7S>@F***2(RT5!SI*7$!E*R(S'5% ,OA/N
M_>!I5]"VM0N'R*R+7I0/^&UY]FV^^'Q7+I?L<,68]9$N-2WKQ+*4"+[;#8[2
M6,^C:;_([5F"!D''= ^=]L+OX)*Y&YI_P(Q?M]N;W^-JOLS;\"L5'TQ2 I*K
MJ^304J0>ZOK#(J)3TF((K4>&OTS5Q!/#&R<T&FNA>UQ=GL+  RM&*F!8-\Z+
M5" 4[@"E#;P(RYAN/9]R"%T])<L.Q\).4-M#,=V#[2;D+QB=U:I I"L=E'89
MO%41>,@!D\V8F[O/ TGK&7+[8&(GT.VGH.YQ=Y-E$#H9Z>F <ALSJ.C)V^!9
M05!."*^YRKIUY\I TGJZ1H^.N_T4U#_N"$)7!\I:JTJ)",PX0WZNBQ#1!0B6
ME6QD84JU?GP:3-S$@\<GQMZ>2NH>?;?FZ$G-7#":@\V"K'DJ$;SQY"!K3&3D
M"\/FRQ2&TC9M#FMB[.VIHOZA-_]VLS>BKNA*EH(Q76NG.$*-]R%E7[QC1J34
MNOIP*&W3)M*FAMY^*NH >O\X#ZNPV""^BV?SBV4!ZY^^_QXVM?JE!F6J,&/(
M>P5>9X4J&QUX5F5H?5T?5XKRS1>/OD!33S?LX4F2IAKH%%$7W%P>0X,1C601
M3+(*5& !? P2HA3>A+IBYRB(NDW3Q!M'FR)@ +SV5L?4KT(_A<5_7S-T]?X9
MG)(%C=HVJI!TL&Y+-9'<SB R<[9V%0QZ&GKLI_>'C/V5MVPIR0XLS3_#:E[-
M[X>PN3@G&#7G*6FP2G%0J.M*>D,7L+39^EQBC*T3$O=IZ,D#/_QN.DC"G2'D
MZHG,QY19S" -FKIZS9(X*#1E22#+"DW@K?NG'U(QK54Y3*O/0&0/$7< DI_"
M>DO]I1%D6I$$*'84"NOT:V7 NUI.H\D\^I2*;KY*^"X%_8!C'WT^F >^MW [
M@,;;Y2(O%V_HCEQ%NC#?%:("<^7G[9N?WGVXJK.()F4=+&19TZP"R3U3=5%D
M(I.K2@X!6\^4'T38M%GPQD!JKXJIG=F/F,XO%\\NYI^_;%[/%V&1YHO/E:F/
M[UY?\53+-:-EA=C1C"YP2];91PG$H<LB>,VU&N3?#OS@M.%U(]B,)N$.K-)=
M+V][@^M"@G"^@#59@HI,0 A&UJVR):5 T&\^!/PA%3VE %L7K^PLY>YP\GOX
M>G6@&,F%D3T$R>OZX8(<0A$.2M&1CEHR18Z;1KZAI:<*@=UU_"QD]A3XU-?2
M9>_MYQ5N.V]_F^>?PY^OSQ=UH>N;?WY:G:^OZHD=D@.'19-)KF&#%Q&<XPYL
M%,P+QY/0>M#%-/B3/:%E7_4N1Y=U!Z;G=E/W)_IOMD>K.O\RR !9US2F5K7U
M#2,4G7C4+#MQLU"]G9_\@(YIZW9;7U,'2[I#M%P>*R$$EJP3",LB*(P6?%0>
M@E6"H7&LL-:-HX]3,JW9.5S#+T!F#W'W )J'#2Y19BZCLQ"E,;7>B<Y1HG_B
MF>YRE#*YYLO='E+1%UCVT>W+G42["+K#(7#;$Q125M(G#H);3Y<VQ7LQ& 8R
M9PS91J[UH-MHS&&!MO=;J)F$.T3)U596@6@"T\"L2* 4,Q!UX.!\-LD)*9U.
M(^&DVU&!.VEVV*C 7<0\=8BTS4(NPL4\HD?&W%GEK;$Q@*/XD9QU*2$XA^2L
M&YN%"27'88'1"Q_J"QG[*'(YDE0[\$_NFMBW-TM]@I+%> 4Y.E;O3@4D%7+?
MT&HT(DI]OY.U<?+E[4YC!%WO5U!+>7< F]O>UG4/9OA[_O7\ZT_+U6KY5^W0
M#'_2[VR^SPQZ%3RY_5FQ3&>-&'0<;9W@ZJS4-HCF;Y6[T-=3NF9/0#SC"S?5
MSM17VKU,:-UN69]N\UO<)J.>YK&Z C9H,+7/6/D<*1+0$HSB/I406;+#5K?M
M24!/G3Z'0>QH:NC!R%&4^NDR2IW)E)PWU@+&2$8_DZ\0'!;ZURPM_0;ZTOHU
MXO;W>ZHF;F2D]I5N#\BX96!GGBLC?(@@E*WN0+ 0:M;"<\>-",5$WWH@Y>WO
M]U3+U_[ZVDFZG2'CZNK]@#7D($/XT"(6)X-ED= N%'%'$0+XPCU8JYQ3ENDH
M6Z\JVHW"GE[+QW..&FFH4_QM0U9<;[:5E)N+7J!?%WFFD$(7K(EY%WP=R55/
ME42(Y A&RX17OOE+UW#R>GH &P]Y+733 >SNBHN<P?GZ(]$2\KO%[5(I/A.6
M2Q.Y!<."(;Z\!A^R FV06^>$-KKUX\=0VGK*=;<!W"A:F3H&?.P4O4J)]$.:
M>HW;OI,WBT1LTM?F7\F%R )5+IP8*]J2<UDL1.\R.&-L"4J@C?<P]T3TM_.G
M>\I=-8C[QA7]*0#K_\T_?\'5 R_AW;;+=E:SQMEH!<BV2S.- Q\= OI4IU]R
M%>[7-QX M&=)&00\_T,!KYUJ.KA//WY9KC8U.K[F9STK3+K$27#(8W4)<J9(
MR!50DG,TDC,O6T]T>(2,8=E2=@K0:B7L#O#R6 OFY>*CG\-J]9UX^F<X.\=9
M0.&Y(6[(BZRM!RZ \ZD^3P47$5%DU;JQ;"AMPY!U4HGX4=32ZWJ@C^$,W]:K
M/X;TW]=-#)]( .N0Z@__G5BFKWS#BXTXZ[L,#5L'M/M'FJS_.9"W ]?]7.RK
MN_KJ6W+<+V[ J[TO-F:78A;@+')0B0GP,G'(RCC&/=>ZE$%^Q]/?.&QIX8,?
M6ZTM7>C+Q04#GFFEC4I@&9*;F"S!GZ< QFM;R&G,)L@]&;C[I6G>^EKJ[^X.
MPY:"G=K_?LC,[^>UI*)NI5_0B3R[<.7((OLD2T -,A5!%EFR6K;AP/J4@Y,<
MT_V:N,%H>?R+TSS?'1$U#03='WHNF:DG8J:=IPLV2@B*TR7.+4F-Z0C&*2&<
MHT."PZ9O//N9:1[ICHB3?47:'SAJ,BS]1F;RR]GW]^%[=?EFZ%V1+A8H49#/
M+X*'Z#/93E<7"VN&^KYO/!@DCWQNFG>[(X+E4!'W!YI7B\5Y7>UXD>%ZCZM4
M>3(F.KI&%6A67RAYG:7& QT$D3B)S#.N][4MCWYPFB>Y(P+G<#%W$)&_Q?4:
M\8*YB]"A+FRL"Y!JRGU6A.+9,07!95:'F4APM9J0N9 9LYGBS$'UVKN\O3U+
MT33/;6.@:@0-=("G&H&^6N3K(/16[/F/,%^\7:[7OV--N%N6&"<QU1TJJN[1
M\3XXB%IR+ZUS++1^TQU&V32O:V/B:P2-]'?ES2)Z$Z(.((5RH'Q2$$-08#0W
M%IG(_'YUT^#;;9K7L2->9#L)KXO=1K]<?OC2:OZ\7&\N0.R0OH<*BO>NSHNM
MFQN%!!V,9B:3!77M9S$\2LHT+UMCVI$6,N_/<%RFN6?>H]7%:;!%!G+;ZLY/
M:3W=M>A<)KE$E?:T'Y>?F.A%ZHAV9!]9]H>(WY>+=,E(X D-QP+2< H#C37D
MA<D"/'+IO(UH<=B>O.>^,M%[TC'3=OM)=&IH7-6\_?KWG[A8XR/WIM8A1V$E
M\%*'B6!BM>B7F$L1(_-"9#$LP_OBIX:!Y'1RNVUE.S52'GG?V';@)262)E+!
M**7JSD@/W@8)UI10I$DY#:SH>N(#PU!QRIG<W>7800S\?K7\$U>;[^_/PF)#
MH=>O_W,^_W-;VOC]>N1(*B(E(3/QH.OZ6'*=@I<17#!1.O*ZI6KMJ0X@JZMW
MQSUTOQQ7$3UCZ]9\$AFS=Y@\F%B?/()/X(P34'+@W@E=M&X]ZF< 6=/VKS:'
MPE"H[:F7#J#VTSE)M/9)7FY&%\E;J3(8G0IY]3J!3[G.M8XHG;-!N]9KPNY2
MT"F ]E7P_=G.^TN[ ZR\#8M\-?]5)X=.6;!)Y+HV60%Y P*XM"XFQ@J*YFWT
MUU^?MH-Y;(SL*>7^W..WUV6+2I<D;"A@;"U;I?@0G"?8"Q*,9%(0,V)/%_GM
M3J,YCA4[[>_5-)5E!S;CR=/RQQK+^=G;><$9DT1ZE5,(*8**QD%DC(%U(14K
ML"36>KW1 +*Z<I/WU/]0_V5/9?2,KW^LENOUC/$4K4@.3"YU I) B,8;"(GQ
MD@S3F(X&K2U%79FID5&UNPI.MIS\NFG[]7GM__DYK+]<EAFMQRPP'_#9XY2<
M[\K_Z$7HWD7'-$2"-9 ;92 ZZ0%-,%DZGJ78-Z<_5A'Z\B=\'^;Y7QA6[Q8X
M4XX'Y,P EA" _LV"UZRN9_5.>R4,]_MR<.]37=US>VGPI?3B :+MSZN^S<VG
MOY8S7E#S;"DR8'4FA#/T3W1_@[)&80I>L32LS_/%3W5U=8T-E%U%VSE0ZI+Q
M60D^F!@4)*&)"\,+1:6"HLO E"7T&Y]R"ZC4C_5:?CX.6'86;]]PJ7O!9R5K
M"EN1Z$=6A\V0K?2VD!M72%K19";V+I:X_ZU>R\]' <O.PNT<*_-O!'VF"B9K
M06M'5VK0!'U7&>,E)ZW0/-@ N!]6Z%N]5IR/@Y5=A=LO5EX5^L0U3QJUS%$:
M<KJ2K7.%$)SB$3Q:89V@G\H.-2YW/MAK17ESU.POYGZA,\L&+0L.(;-:4*2$
MAX@YTUDHD4FK-;O_*K4S6GHM"6\.D)V$N3\FEIMP-@8F_ECDR\8)S+_^G7"]
M?O6U_MM,*FT]UK%1G-G*%@>G48*($<D!BYG?WU(\&"-/?;/7FO%FF&DB[-TQ
MY"\PM,#/=5C^I]':"8R1*1DK0&^C.I7H8@VV ";-HI$F1;?O)=1K97@S:.PD
MO!\XK3N[U^=WM,3NC'>3VKTO@^OD[G_LJY@W"_I'_!3^QO6KG.<7"R[>+,IR
M]77+XL6']Y'\P)_<1+3[<'%@8OSJ3>;ZT[7-\&RY)L5=6P'IO;9">W 49M8F
M,+('SDB*)["XC/5<MY[S^PPY!U9O7TOXXLD]JIB23P%D(+NFDB*'5P0&0@95
M;)8RN&'9T/L_>=JZI%;JO%>>?8#P.GCZO:;_U?GFRW)5>Q#"UXLB/\^R8U$)
M,,:1))(GF0CFH0@6N/?&AFC'@O@#:B9\8#E,Q<M1Y-TM<JYVIQLA10P>$NJZ
M/)8'"(7\'(J6N4S">G4_2SX2=GJHJ&VE\T%0VD,!'8#I-W*.R!1_?U<NFR;?
M4-04+BOX?# 84$80?)NQ8PI\73K*)5TXP27BI?4^AN?HZ1%,^VA].9(*)MZI
M^"$L/E\<KB*L-:I6J;MM=&4MV6E65Y!:(\D]E I;K-J\_N"$;[M-[JC]I=>#
MRJ_*P;TOVI@$K'!":H@*HM<<BN?>)"]#28/FT0]1^M3K$/=4UGUU[R&YB15>
M;=77\Z^7A&/,Q2<F0>8Z2,@+,DXF9- V9[I&759L4"SV@LKO?'1BI>^CLF4+
M^4VM^(M-9)>$\Y!5Y!DA)\<)]9+8-Y;7<88I6*6EBX,:;5Y2_.V/3F/DFRE^
M;_E-_;)UZX9[>UUQFY36PKD()9#%4]YG<(FX0+KFA.8.^< G\\=^^H35-TVN
M\S9BFUKO/R]7RT7X-E^=KU_-\P<\FV.I]=%IN5A^G:>/F,Y7V^4!F]]Q\^Y/
MK$.;%Y_KK*;M0.Z:D+U8PC,3(B$:'PC>AM<MKZ:.*J18*^:Z.9@'ZX;-(&A&
M4A])C3UQL9Q<25-#DZ3WG_/-ER_+;3OBY8"&6:$H*T1=QS%PBL$",Q B!4TB
M""^<DLFH8:M)'_WQ?<08#2!SN/"F5C^ANLJ=6_6!M$!T?*F0)T96\Z]72MGR
ME>?US6=]@?!WY1?,Y_1?7CX!HB\9@RN02I&@&''LK YU<9-6*@42Z[!AHTW(
MZ>/.:P"OXRMG:CA>31VKJ:&ZP'=]2P2_OLJY&EGR^+1/H@0@KA0HB0Z"-773
MN1/*!YU##H/0-N1K$U:DM@53<]%V-1KPFJNZN>1"/6=GR[]J"G"FE2DRI0(B
M,[+'LC#P+!HHBN=L/86-I?7TT0%D35B^V@Q88VFA@V3^ Y;H'RY6?6V]O;)<
M_156>?UZN<+YY\5,,,S"F@@ZRT)&%@M$CG5SCG#))1^":-U>NAN%$]:]C@^W
M=KJ9^@)\C:2(</9Q4S>O+O);^M-GQ-T'I M^<7G!SZ(5:*22H!-CH+:-29I%
MX-Y9(2+]7QC8$CC@:Q/6P[:] )N+=G*L7.#[XWE<S_,\K.8UT7*/'^82>L$5
M!"Y)6CQ)"#EZL X%INQ0^H%K %[^V(15L(V1TEBPO58]WI+:]3]>!K%-ZNJ>
M^*&M2^J&T'Z$:KI"(LAU/[&P)1$B(F'#<PW"AU0PN?A@_&./U717/_IRNN]]
MV?Z$"RQTSRX7F_GB?+[X?)D(6R[6UX)()D5>1 2!-M0ME11$(,E%">V-R$%+
MVWITV/[4=E((<2">[GM(1])>!W[Z):>7E_L#5F<Y8F*"@@V1:T2+@E-$2P%N
M$,%R;;S*O'4!X LD38NX8R'C<4 V45,_J+OO2]YC*BBEL^>"CFS=,Q[)C_0Q
M2K"ZMFM:ACZW+B <1-BT8_.F16!#E?6#PTN']9%CI0-3O Y:(J" <DF RU&#
M9T6E;*T,H?5"IQ=(FB8YWP?VFJBI']0](<69<T4:6<?\8^;DN.2Z(H1Y0$>6
MW DG369']?^FR>'W@;D62IJP^?=^RF\?*6+"(#.7H&VM,^*.3I>T C(O,BM?
M&,ERI-SL6 '):)?S6 ')L?37@76\WIQTX>L^=0 94]H&D0"#(FGFE(DKQJ"(
MH*T)3),?,A(JGZ=LVOCD:$!Y:M]5.ZUUA,4[7N]3O$E>"D\N072BU%%$$1P*
M"2QG$Z/AQ&+K=M!=Z)O6,$Z-R^8:[ B=EW[Q4UQ%;8KW:$!'3JY*U Z\S0%X
M=%$HAE([-Y:E?):R:6.9J1'94&L=8?$I=H1/UJ3@0-;I[20B"3$S!<F['(3/
M(6'KH.8%DJ:-:J9&7PL]=1#7/,6&K[.9"D5FT6@Z/=)H<"0S8-8Z58RPV+Q=
MM$LC-U8\TD+NS> SWK/NQ_0%\_D9+LOU+W[ M%RD^=F\W?R4H5]I_?"[%W='
M> DV/KD0A07-E2$;I!D$5V,&$46H_4@/%HGV_!+\A&R?.$&O-K?J;,[I)W^_
M^>_K@GM??(G&D$\JD@3E1(3(30(ILV'DL2HVK-UM']FT8*#?]^)=4/>D.3RZ
MCCMP_9Y@_O&("]>S4*37AD40)9/[HE@A]X6D78I5*J8<LVF]S'%'$OO-(8X
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M!@<Q2@4!I37"Z9*;STW;D<1NRE,.1L<@X+51U:3C;^X[B+>XNQ--7+$Z<W1
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M'L_7%/C4/6O?\!9KENGH;'VFJBD_Y;2 F!B%QC(XJZ(LLK!= 33@N]/F$$;
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M65&G L":XM1.,<RA@+-*@HHL0G3;";O(5-(AQM!ZS.=0VJ9]/^D)@+LJZ@0
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M/IVBGN.=P,G1=3IY]5>9Y$4_-9R]693EZNM%H4?##/IS'Q@I5SZ8IREFW5-
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M_XIAP+__[?]02P$"% ,4    " "D6-Y6C$AE*[,.  "\+P  $
M    @ $     97AH:6)I=#$P,S1B+FAT;5!+ 0(4 Q0    ( *18WE:O--KI
MY0$  %P#   .              "  >$.  !E>&AI8FET,C$Q+FAT;5!+ 0(4
M Q0    ( *18WE:1#0TJ30(  .(#   .              "  ?(0  !E>&AI
M8FET,C,Q+FAT;5!+ 0(4 Q0    ( *18WE:YD(*'& 8  #,/   .
M      "  6L3  !E>&AI8FET,S$Q+FAT;5!+ 0(4 Q0    ( *18WE;0R/:
M'@8  $@/   .              "  :\9  !E>&AI8FET,S$R+FAT;5!+ 0(4
M Q0    ( *18WE9?]%"U?0,  &L&   .              "  ?D?  !E>&AI
M8FET,S(Q+FAT;5!+ 0(4 Q0    ( *18WE:X:/8\A0,  ) &   .
M      "  :(C  !E>&AI8FET,S(R+FAT;5!+ 0(4 Q0    ( *18WE;F2Q^W
MELP! !HI%0 1              "  5,G  !K97%U+3(P,C,P-#,P+FAT;5!+
M 0(4 Q0    ( *18WE;-T##TI!0  $[G   1              "  1CT 0!K
M97%U+3(P,C,P-#,P+GAS9%!+ 0(4 Q0    ( *18WE:?8,-V:B@  $Z= 0 5
M              "  >L( @!K97%U+3(P,C,P-#,P7V-A;"YX;6Q02P$"% ,4
M    " "D6-Y6#SQLM#]8  "#L@, %0              @ &(,0( :V5Q=2TR
M,#(S,#0S,%]D968N>&UL4$L! A0#%     @ I%C>5FU'8OLD)@$ /3$, !4
M             ( !^HD" &ME<74M,C R,S T,S!?;&%B+GAM;%!+ 0(4 Q0
M   ( *18WE8X/PQJ<:D  &V;!P 5              "  5&P P!K97%U+3(P
D,C,P-#,P7W!R92YX;6Q02P4&      T #0 P P  ]5D$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
